id	sid	tid	token	lemma	pos
ihlr-16470	1	1	anti	anti	NOUN
ihlr-16470	2	1	-	-	NOUN
ihlr-16470	2	2	depressants	depressant	NOUN
ihlr-16470	2	3	and	and	CCONJ
ihlr-16470	2	4	children	child	NOUN
ihlr-16470	2	5	:	:	PUNCT
ihlr-16470	2	6	suicidality	suicidality	NOUN
ihlr-16470	2	7	,	,	PUNCT
ihlr-16470	2	8	off	off	ADP
ihlr-16470	2	9	-	-	PUNCT
ihlr-16470	2	10	label	label	NOUN
ihlr-16470	2	11	use	use	NOUN
ihlr-16470	2	12	,	,	PUNCT
ihlr-16470	2	13	and	and	CCONJ
ihlr-16470	2	14	trial	trial	NOUN
ihlr-16470	2	15	publication	publication	NOUN
ihlr-16470	2	16	timothy	timothy	PROPN
ihlr-16470	2	17	j.	j.	PROPN
ihlr-16470	2	18	hixson	hixson	PROPN
ihlr-16470	2	19	·	·	PROPN
ihlr-16470	2	20	introduction	introduction	NOUN
ihlr-16470	2	21	antidepressants	antidepressant	NOUN
ihlr-16470	2	22	,	,	PUNCT
ihlr-16470	2	23	specifically	specifically	ADV
ihlr-16470	2	24	selective	selective	ADJ
ihlr-16470	2	25	serotonin	serotonin	NOUN
ihlr-16470	2	26	reuptake	reuptake	NOUN
ihlr-16470	2	27	inhibitors	inhibitor	NOUN
ihlr-16470	2	28	(	(	PUNCT
ihlr-16470	2	29	ssris	ssris	PROPN
ihlr-16470	2	30	)	)	PUNCT
ihlr-16470	2	31	,	,	PUNCT
ihlr-16470	2	32	have	have	AUX
ihlr-16470	2	33	been	be	AUX
ihlr-16470	2	34	used	use	VERB
ihlr-16470	2	35	to	to	PART
ihlr-16470	2	36	treat	treat	VERB
ihlr-16470	2	37	a	a	DET
ihlr-16470	2	38	plethora	plethora	NOUN
ihlr-16470	2	39	of	of	ADP
ihlr-16470	2	40	neurological	neurological	ADJ
ihlr-16470	2	41	diseases	disease	NOUN
ihlr-16470	2	42	,	,	PUNCT
ihlr-16470	2	43	such	such	ADJ
ihlr-16470	2	44	as	as	ADP
ihlr-16470	2	45	major	major	ADJ
ihlr-16470	2	46	depressive	depressive	ADJ
ihlr-16470	2	47	disorder	disorder	NOUN
ihlr-16470	2	48	(	(	PUNCT
ihlr-16470	2	49	mdd)and	mdd)and	CCONJ
ihlr-16470	2	50	obsessive	obsessive	ADJ
ihlr-16470	2	51	compulsive	compulsive	ADJ
ihlr-16470	2	52	disorder	disorder	NOUN
ihlr-16470	2	53	(	(	PUNCT
ihlr-16470	2	54	ocd	ocd	PROPN
ihlr-16470	2	55	)	)	PUNCT
ihlr-16470	2	56	.	.	PUNCT
ihlr-16470	3	1	1	1	NUM
ihlr-16470	3	2	the	the	DET
ihlr-16470	3	3	first	first	ADJ
ihlr-16470	3	4	ssri	ssri	PROPN
ihlr-16470	3	5	medication	medication	NOUN
ihlr-16470	3	6	available	available	ADJ
ihlr-16470	3	7	for	for	ADP
ihlr-16470	3	8	prescription	prescription	NOUN
ihlr-16470	3	9	was	be	AUX
ihlr-16470	3	10	eli	eli	PROPN
ihlr-16470	3	11	lilly	lilly	PROPN
ihlr-16470	3	12	company	company	NOUN
ihlr-16470	3	13	's	's	PART
ihlr-16470	3	14	prozac	prozac	NOUN
ihlr-16470	3	15	,	,	PUNCT
ihlr-16470	3	16	which	which	PRON
ihlr-16470	3	17	received	receive	VERB
ihlr-16470	3	18	food	food	NOUN
ihlr-16470	3	19	and	and	CCONJ
ihlr-16470	3	20	drug	drug	PROPN
ihlr-16470	3	21	administration	administration	PROPN
ihlr-16470	3	22	(	(	PUNCT
ihlr-16470	3	23	fda	fda	PROPN
ihlr-16470	3	24	)	)	PUNCT
ihlr-16470	3	25	approval	approval	NOUN
ihlr-16470	3	26	in	in	ADP
ihlr-16470	3	27	1987.2	1987.2	NUM
ihlr-16470	3	28	initially	initially	ADV
ihlr-16470	3	29	,	,	PUNCT
ihlr-16470	3	30	ssris	ssris	PROPN
ihlr-16470	3	31	were	be	AUX
ihlr-16470	3	32	attractive	attractive	ADJ
ihlr-16470	3	33	to	to	ADP
ihlr-16470	3	34	physicians	physician	NOUN
ihlr-16470	3	35	because	because	SCONJ
ihlr-16470	3	36	they	they	PRON
ihlr-16470	3	37	appeared	appear	VERB
ihlr-16470	3	38	to	to	PART
ihlr-16470	3	39	have	have	VERB
ihlr-16470	3	40	few	few	ADJ
ihlr-16470	3	41	side	side	NOUN
ihlr-16470	3	42	-	-	PUNCT
ihlr-16470	3	43	effects	effect	NOUN
ihlr-16470	3	44	and	and	CCONJ
ihlr-16470	3	45	be	be	AUX
ihlr-16470	3	46	more	more	ADV
ihlr-16470	3	47	effective	effective	ADJ
ihlr-16470	3	48	than	than	ADP
ihlr-16470	3	49	previous	previous	ADJ
ihlr-16470	3	50	medications.3	medications.3	NOUN
ihlr-16470	3	51	however	however	ADV
ihlr-16470	3	52	,	,	PUNCT
ihlr-16470	3	53	in	in	ADP
ihlr-16470	3	54	1990	1990	NUM
ihlr-16470	3	55	,	,	PUNCT
ihlr-16470	3	56	questions	question	NOUN
ihlr-16470	3	57	arose	arise	VERB
ihlr-16470	3	58	as	as	ADP
ihlr-16470	3	59	to	to	ADP
ihlr-16470	3	60	whether	whether	SCONJ
ihlr-16470	3	61	ssris	ssris	PROPN
ihlr-16470	3	62	caused	cause	VERB
ihlr-16470	3	63	patients	patient	NOUN
ihlr-16470	3	64	to	to	PART
ihlr-16470	3	65	commit	commit	VERB
ihlr-16470	3	66	suicide	suicide	NOUN
ihlr-16470	3	67	.	.	PUNCT
ihlr-16470	4	1	4	4	NUM
ihlr-16470	5	1	although	although	SCONJ
ihlr-16470	5	2	there	there	PRON
ihlr-16470	5	3	is	be	VERB
ihlr-16470	5	4	some	some	DET
ihlr-16470	5	5	anecdotal	anecdotal	ADJ
ihlr-16470	5	6	evidence	evidence	NOUN
ihlr-16470	5	7	to	to	PART
ihlr-16470	5	8	support	support	VERB
ihlr-16470	5	9	the	the	DET
ihlr-16470	5	10	theory	theory	NOUN
ihlr-16470	5	11	that	that	SCONJ
ihlr-16470	5	12	ssris	ssris	PROPN
ihlr-16470	5	13	cause	cause	VERB
ihlr-16470	5	14	suicide	suicide	NOUN
ihlr-16470	5	15	,	,	PUNCT
ihlr-16470	5	16	there	there	PRON
ihlr-16470	5	17	is	be	VERB
ihlr-16470	5	18	little	little	ADJ
ihlr-16470	5	19	scientific	scientific	ADJ
ihlr-16470	5	20	evidence	evidence	NOUN
ihlr-16470	5	21	to	to	PART
ihlr-16470	5	22	support	support	VERB
ihlr-16470	5	23	the	the	DET
ihlr-16470	5	24	claim	claim	NOUN
ihlr-16470	5	25	,	,	PUNCT
ihlr-16470	5	26	and	and	CCONJ
ihlr-16470	5	27	the	the	DET
ihlr-16470	5	28	fda	fda	PROPN
ihlr-16470	5	29	has	have	AUX
ihlr-16470	5	30	previously	previously	ADV
ihlr-16470	5	31	resisted	resist	VERB
ihlr-16470	5	32	placing	place	VERB
ihlr-16470	5	33	"	"	PUNCT
ihlr-16470	5	34	black	black	ADJ
ihlr-16470	5	35	box	box	NOUN
ihlr-16470	5	36	"	"	PUNCT
ihlr-16470	5	37	labels	label	NOUN
ihlr-16470	5	38	(	(	PUNCT
ihlr-16470	5	39	the	the	DET
ihlr-16470	5	40	strongest	strong	ADJ
ihlr-16470	5	41	available	available	ADJ
ihlr-16470	5	42	)	)	PUNCT
ihlr-16470	5	43	on	on	ADP
ihlr-16470	5	44	ssri	ssri	PROPN
ihlr-16470	5	45	medications	medication	NOUN
ihlr-16470	5	46	.	.	PUNCT
ihlr-16470	6	1	5	5	NUM
ihlr-16470	6	2	as	as	SCONJ
ihlr-16470	6	3	ssris	ssris	PROPN
ihlr-16470	6	4	became	become	VERB
ihlr-16470	6	5	more	more	ADV
ihlr-16470	6	6	prevalent	prevalent	ADJ
ihlr-16470	6	7	,	,	PUNCT
ihlr-16470	6	8	doctors	doctor	NOUN
ihlr-16470	6	9	began	begin	VERB
ihlr-16470	6	10	prescribing	prescribe	VERB
ihlr-16470	6	11	them	they	PRON
ihlr-16470	6	12	to	to	ADP
ihlr-16470	6	13	adolescent	adolescent	ADJ
ihlr-16470	6	14	and	and	CCONJ
ihlr-16470	6	15	pediatric	pediatric	ADJ
ihlr-16470	6	16	patients	patient	NOUN
ihlr-16470	6	17	,	,	PUNCT
ihlr-16470	6	18	although	although	SCONJ
ihlr-16470	6	19	the	the	DET
ihlr-16470	6	20	drugs	drug	NOUN
ihlr-16470	6	21	were	be	AUX
ihlr-16470	6	22	not	not	PART
ihlr-16470	6	23	approved	approve	VERB
ihlr-16470	6	24	for	for	ADP
ihlr-16470	6	25	such	such	ADJ
ihlr-16470	6	26	uses	use	NOUN
ihlr-16470	6	27	.	.	PUNCT
ihlr-16470	7	1	6	6	NUM
ihlr-16470	7	2	these	these	DET
ihlr-16470	7	3	prescriptions	prescription	NOUN
ihlr-16470	7	4	,	,	PUNCT
ihlr-16470	7	5	known	know	VERB
ihlr-16470	7	6	as	as	ADP
ihlr-16470	7	7	off	off	ADP
ihlr-16470	7	8	-	-	PUNCT
ihlr-16470	7	9	label	label	NOUN
ihlr-16470	7	10	prescriptions	prescription	NOUN
ihlr-16470	7	11	,	,	PUNCT
ihlr-16470	7	12	have	have	AUX
ihlr-16470	7	13	increased	increase	VERB
ihlr-16470	7	14	despite	despite	SCONJ
ihlr-16470	7	15	a	a	DET
ihlr-16470	7	16	lack	lack	NOUN
ihlr-16470	7	17	of	of	ADP
ihlr-16470	7	18	efficacy	efficacy	NOUN
ihlr-16470	7	19	data	datum	NOUN
ihlr-16470	7	20	and	and	CCONJ
ihlr-16470	7	21	pediatric	pediatric	ADJ
ihlr-16470	7	22	drug	drug	NOUN
ihlr-16470	7	23	trials	trial	NOUN
ihlr-16470	7	24	.	.	PUNCT
ihlr-16470	8	1	7	7	NUM
ihlr-16470	8	2	steps	step	NOUN
ihlr-16470	8	3	such	such	ADJ
ihlr-16470	8	4	as	as	ADP
ihlr-16470	8	5	collecting	collect	VERB
ihlr-16470	8	6	efficacy	efficacy	NOUN
ihlr-16470	8	7	data	datum	NOUN
ihlr-16470	8	8	and	and	CCONJ
ihlr-16470	8	9	performing	perform	VERB
ihlr-16470	8	10	drug	drug	NOUN
ihlr-16470	8	11	trials	trial	NOUN
ihlr-16470	8	12	are	be	AUX
ihlr-16470	8	13	important	important	ADJ
ihlr-16470	8	14	because	because	SCONJ
ihlr-16470	8	15	a	a	DET
ihlr-16470	8	16	drug	drug	NOUN
ihlr-16470	8	17	safe	safe	ADJ
ihlr-16470	8	18	for	for	ADP
ihlr-16470	8	19	use	use	NOUN
ihlr-16470	8	20	in	in	ADP
ihlr-16470	8	21	adults	adult	NOUN
ihlr-16470	8	22	may	may	AUX
ihlr-16470	8	23	not	not	PART
ihlr-16470	8	24	be	be	AUX
ihlr-16470	8	25	safe	safe	ADJ
ihlr-16470	8	26	for	for	ADP
ihlr-16470	8	27	children	child	NOUN
ihlr-16470	8	28	due	due	ADP
ihlr-16470	8	29	to	to	ADP
ihlr-16470	8	30	metabolic	metabolic	NOUN
ihlr-16470	8	31	and	and	CCONJ
ihlr-16470	8	32	*	*	PUNCT
ihlr-16470	8	33	j.d	j.d	PROPN
ihlr-16470	8	34	.	.	PROPN
ihlr-16470	8	35	candidate	candidate	PROPN
ihlr-16470	8	36	,	,	PUNCT
ihlr-16470	8	37	2006	2006	NUM
ihlr-16470	8	38	,	,	PUNCT
ihlr-16470	8	39	indiana	indiana	PROPN
ihlr-16470	8	40	university	university	PROPN
ihlr-16470	8	41	school	school	NOUN
ihlr-16470	8	42	of	of	ADP
ihlr-16470	8	43	law	law	NOUN
ihlr-16470	8	44	-	-	PUNCT
ihlr-16470	8	45	indianapolis	indianapolis	PROPN
ihlr-16470	8	46	;	;	PUNCT
ihlr-16470	8	47	ba	ba	PROPN
ihlr-16470	8	48	,	,	PUNCT
ihlr-16470	8	49	2003	2003	NUM
ihlr-16470	8	50	,	,	PUNCT
ihlr-16470	8	51	butler	butler	PROPN
ihlr-16470	8	52	university	university	PROPN
ihlr-16470	8	53	,	,	PUNCT
ihlr-16470	8	54	indianapolis	indianapolis	PROPN
ihlr-16470	8	55	,	,	PUNCT
ihlr-16470	8	56	indiana	indiana	PROPN
ihlr-16470	8	57	.	.	PUNCT
ihlr-16470	9	1	1	1	X
ihlr-16470	9	2	.	.	X
ihlr-16470	9	3	food	food	NOUN
ihlr-16470	9	4	&	&	CCONJ
ihlr-16470	9	5	drug	drug	PROPN
ihlr-16470	9	6	admin	admin	PROPN
ihlr-16470	9	7	.	.	PROPN
ihlr-16470	9	8	,	,	PUNCT
ihlr-16470	9	9	public	public	ADJ
ihlr-16470	9	10	health	health	NOUN
ihlr-16470	9	11	advisory	advisory	NOUN
ihlr-16470	9	12	,	,	PUNCT
ihlr-16470	9	13	worsening	worsen	VERB
ihlr-16470	9	14	depression	depression	NOUN
ihlr-16470	9	15	and	and	CCONJ
ihlr-16470	9	16	suicidality	suicidality	NOUN
ihlr-16470	9	17	in	in	ADP
ihlr-16470	9	18	patients	patient	NOUN
ihlr-16470	9	19	being	be	AUX
ihlr-16470	9	20	treated	treat	VERB
ihlr-16470	9	21	with	with	ADP
ihlr-16470	9	22	antidepressant	antidepressant	ADJ
ihlr-16470	9	23	medications	medication	NOUN
ihlr-16470	9	24	(	(	PUNCT
ihlr-16470	9	25	mar	mar	PROPN
ihlr-16470	9	26	.	.	PROPN
ihlr-16470	9	27	22	22	NUM
ihlr-16470	9	28	,	,	PUNCT
ihlr-16470	9	29	2004	2004	NUM
ihlr-16470	9	30	)	)	PUNCT
ihlr-16470	9	31	,	,	PUNCT
ihlr-16470	9	32	http://www.fda.gov/cder/drug/antidepressants/antidepressanstpha.htm	http://www.fda.gov/cder/drug/antidepressants/antidepressanstpha.htm	X
ihlr-16470	9	33	(	(	PUNCT
ihlr-16470	9	34	last	last	ADJ
ihlr-16470	9	35	visited	visit	VERB
ihlr-16470	9	36	feb	feb	PROPN
ihlr-16470	9	37	.	.	PROPN
ihlr-16470	9	38	27	27	NUM
ihlr-16470	9	39	,	,	PUNCT
ihlr-16470	9	40	2006	2006	NUM
ihlr-16470	9	41	)	)	PUNCT
ihlr-16470	9	42	.	.	PUNCT
ihlr-16470	10	1	2	2	X
ihlr-16470	10	2	.	.	X
ihlr-16470	10	3	andrew	andrew	PROPN
ihlr-16470	10	4	e.	e.	PROPN
ihlr-16470	10	5	falsetti	falsetti	PROPN
ihlr-16470	10	6	,	,	PUNCT
ihlr-16470	10	7	fluoxetine	fluoxetine	NOUN
ihlr-16470	10	8	-	-	PUNCT
ihlr-16470	10	9	induced	induce	VERB
ihlr-16470	10	10	suicidal	suicidal	ADJ
ihlr-16470	10	11	ideation	ideation	NOUN
ihlr-16470	10	12	:	:	PUNCT
ihlr-16470	10	13	an	an	DET
ihlr-16470	10	14	examination	examination	NOUN
ihlr-16470	10	15	of	of	ADP
ihlr-16470	10	16	the	the	DET
ihlr-16470	10	17	medical	medical	ADJ
ihlr-16470	10	18	literature	literature	NOUN
ihlr-16470	10	19	,	,	PUNCT
ihlr-16470	10	20	case	case	NOUN
ihlr-16470	10	21	law	law	NOUN
ihlr-16470	10	22	,	,	PUNCT
ihlr-16470	10	23	and	and	CCONJ
ihlr-16470	10	24	the	the	DET
ihlr-16470	10	25	legal	legal	ADJ
ihlr-16470	10	26	liability	liability	NOUN
ihlr-16470	10	27	of	of	ADP
ihlr-16470	10	28	drug	drug	NOUN
ihlr-16470	10	29	manufacturers	manufacturer	NOUN
ihlr-16470	10	30	,	,	PUNCT
ihlr-16470	10	31	51	51	NUM
ihlr-16470	10	32	food	food	NOUN
ihlr-16470	10	33	&	&	CCONJ
ihlr-16470	10	34	drug	drug	PROPN
ihlr-16470	10	35	l.j	l.j	PROPN
ihlr-16470	10	36	.	.	PROPN
ihlr-16470	10	37	273,274	273,274	NUM
ihlr-16470	10	38	(	(	PUNCT
ihlr-16470	10	39	2002	2002	NUM
ihlr-16470	10	40	)	)	PUNCT
ihlr-16470	10	41	.	.	PUNCT
ihlr-16470	11	1	3	3	X
ihlr-16470	11	2	.	.	X
ihlr-16470	11	3	see	see	VERB
ihlr-16470	11	4	symposium	symposium	NOUN
ihlr-16470	11	5	,	,	PUNCT
ihlr-16470	11	6	supporting	support	VERB
ihlr-16470	11	7	materials	material	NOUN
ihlr-16470	11	8	:	:	PUNCT
ihlr-16470	11	9	a	a	DET
ihlr-16470	11	10	sta.ffcompilation	sta.ffcompilation	NOUN
ihlr-16470	11	11	of	of	ADP
ihlr-16470	11	12	relevant	relevant	ADJ
ihlr-16470	11	13	statutory	statutory	ADJ
ihlr-16470	11	14	,	,	PUNCT
ihlr-16470	11	15	statistical	statistical	ADJ
ihlr-16470	11	16	,	,	PUNCT
ihlr-16470	11	17	and	and	CCONJ
ihlr-16470	11	18	case	case	NOUN
ihlr-16470	11	19	materials	material	NOUN
ihlr-16470	11	20	,	,	PUNCT
ihlr-16470	11	21	8	8	NUM
ihlr-16470	11	22	u.c	u.c	PROPN
ihlr-16470	11	23	.	.	PUNCT
ihlr-16470	11	24	davisj	davisj	PROPN
ihlr-16470	11	25	.	.	PUNCT
ihlr-16470	12	1	juv	juv	PROPN
ihlr-16470	12	2	.	.	PUNCT
ihlr-16470	13	1	l.	l.	PROPN
ihlr-16470	13	2	&	&	CCONJ
ihlr-16470	13	3	pol'y	pol'y	PROPN
ihlr-16470	13	4	315,334	315,334	NUM
ihlr-16470	13	5	(	(	PUNCT
ihlr-16470	13	6	2004	2004	NUM
ihlr-16470	13	7	)	)	PUNCT
ihlr-16470	14	1	[	[	X
ihlr-16470	14	2	hereinafter	hereinafter	NOUN
ihlr-16470	14	3	symposium	symposium	NOUN
ihlr-16470	14	4	]	]	PUNCT
ihlr-16470	14	5	.	.	PUNCT
ihlr-16470	15	1	4	4	X
ihlr-16470	15	2	.	.	NUM
ihlr-16470	15	3	falsetti	falsetti	ADJ
ihlr-16470	15	4	,	,	PUNCT
ihlr-16470	15	5	supra	supra	ADJ
ihlr-16470	15	6	note	note	NOUN
ihlr-16470	15	7	2	2	NUM
ihlr-16470	15	8	,	,	PUNCT
ihlr-16470	15	9	at	at	ADP
ihlr-16470	15	10	275	275	NUM
ihlr-16470	15	11	.	.	PUNCT
ihlr-16470	15	12	5	5	NUM
ihlr-16470	15	13	.	.	X
ihlr-16470	16	1	see	see	VERB
ihlr-16470	16	2	generally	generally	ADV
ihlr-16470	16	3	i	i	PRON
ihlr-16470	16	4	d.	d.	PROPN
ihlr-16470	16	5	6	6	NUM
ihlr-16470	16	6	.	.	PUNCT
ihlr-16470	17	1	see	see	VERB
ihlr-16470	17	2	food	food	NOUN
ihlr-16470	17	3	&	&	CCONJ
ihlr-16470	17	4	drug	drug	PROPN
ihlr-16470	17	5	admin	admin	PROPN
ihlr-16470	17	6	.	.	PROPN
ihlr-16470	17	7	,	,	PUNCT
ihlr-16470	17	8	fda	fda	PROPN
ihlr-16470	17	9	proposed	propose	VERB
ihlr-16470	17	10	medication	medication	NOUN
ihlr-16470	17	11	guide	guide	NOUN
ihlr-16470	17	12	:	:	PUNCT
ihlr-16470	17	13	about	about	ADP
ihlr-16470	17	14	using	use	VERB
ihlr-16470	17	15	antidepressants	antidepressant	NOUN
ihlr-16470	17	16	in	in	ADP
ihlr-16470	17	17	children	child	NOUN
ihlr-16470	17	18	or	or	CCONJ
ihlr-16470	17	19	teenagers	teenager	NOUN
ihlr-16470	17	20	(	(	PUNCT
ihlr-16470	17	21	oct	oct	PROPN
ihlr-16470	17	22	.	.	PROPN
ihlr-16470	17	23	21	21	NUM
ihlr-16470	17	24	,	,	PUNCT
ihlr-16470	17	25	2004	2004	NUM
ihlr-16470	17	26	)	)	PUNCT
ihlr-16470	17	27	,	,	PUNCT
ihlr-16470	17	28	http://www.fda.gov/cder/drugl	http://www.fda.gov/cder/drugl	X
ihlr-16470	17	29	antidepressants	antidepressant	NOUN
ihlr-16470	17	30	/	/	SYM
ihlr-16470	17	31	ssrimedicationguide.htm	ssrimedicationguide.htm	X
ihlr-16470	17	32	(	(	PUNCT
ihlr-16470	17	33	last	last	ADV
ihlr-16470	17	34	visited	visit	VERB
ihlr-16470	17	35	nov	nov	PROPN
ihlr-16470	17	36	.	.	PROPN
ihlr-16470	17	37	21	21	NUM
ihlr-16470	17	38	,	,	PUNCT
ihlr-16470	17	39	2004	2004	NUM
ihlr-16470	17	40	)	)	PUNCT
ihlr-16470	17	41	.	.	PUNCT
ihlr-16470	18	1	7	7	X
ihlr-16470	18	2	.	.	X
ihlr-16470	18	3	chris	chris	PROPN
ihlr-16470	18	4	adams	adams	PROPN
ihlr-16470	18	5	&	&	CCONJ
ihlr-16470	18	6	alison	alison	PROPN
ihlr-16470	18	7	young	young	PROPN
ihlr-16470	18	8	,	,	PUNCT
ihlr-16470	18	9	off	off	ADP
ihlr-16470	18	10	-	-	PUNCT
ihlr-16470	18	11	label	label	NOUN
ihlr-16470	18	12	prescriptions	prescription	NOUN
ihlr-16470	18	13	slipping	slip	VERB
ihlr-16470	18	14	by	by	ADP
ihlr-16470	18	15	fda	fda	PROPN
ihlr-16470	18	16	,	,	PUNCT
ihlr-16470	18	17	tallahassee	tallahassee	PROPN
ihlr-16470	18	18	democrat	democrat	PROPN
ihlr-16470	18	19	,	,	PUNCT
ihlr-16470	18	20	nov	nov	PROPN
ihlr-16470	18	21	.	.	PROPN
ihlr-16470	18	22	4	4	NUM
ihlr-16470	18	23	,	,	PUNCT
ihlr-16470	18	24	2003	2003	NUM
ihlr-16470	18	25	,	,	PUNCT
ihlr-16470	18	26	http://www.tallahassee.com/mld/democrat/7175710	http://www.tallahassee.com/mld/democrat/7175710	ADJ
ihlr-16470	18	27	.htm?template	.htm?template	PUNCT
ihlr-16470	19	1	=	=	NOUN
ihlr-16470	19	2	contentmodules	contentmodule	NOUN
ihlr-16470	19	3	/	/	SYM
ihlr-16470	19	4	prints	print	NOUN
ihlr-16470	19	5	...	...	PUNCT
ihlr-16470	20	1	(	(	PUNCT
ihlr-16470	20	2	last	last	ADV
ihlr-16470	20	3	visited	visit	VERB
ihlr-16470	20	4	october	october	PROPN
ihlr-16470	20	5	14	14	NUM
ihlr-16470	20	6	,	,	PUNCT
ihlr-16470	20	7	2004	2004	NUM
ihlr-16470	20	8	)	)	PUNCT
ihlr-16470	20	9	.	.	PUNCT
ihlr-16470	21	1	202	202	NUM
ihlr-16470	21	2	indiana	indiana	PROPN
ihlr-16470	21	3	health	health	PROPN
ihlr-16470	21	4	law	law	PROPN
ihlr-16470	21	5	review	review	NOUN
ihlr-16470	21	6	[	[	X
ihlr-16470	21	7	vol	vol	NOUN
ihlr-16470	21	8	.	.	PUNCT
ihlr-16470	22	1	3:201	3:201	NUM
ihlr-16470	22	2	physiological	physiological	ADJ
ihlr-16470	22	3	differences	difference	NOUN
ihlr-16470	22	4	between	between	ADP
ihlr-16470	22	5	children	child	NOUN
ihlr-16470	22	6	and	and	CCONJ
ihlr-16470	22	7	adults	adult	NOUN
ihlr-16470	22	8	.	.	PUNCT
ihlr-16470	23	1	8	8	NUM
ihlr-16470	23	2	recent	recent	ADJ
ihlr-16470	23	3	events	event	NOUN
ihlr-16470	23	4	have	have	AUX
ihlr-16470	23	5	called	call	VERB
ihlr-16470	23	6	into	into	ADP
ihlr-16470	23	7	question	question	NOUN
ihlr-16470	23	8	the	the	DET
ihlr-16470	23	9	safety	safety	NOUN
ihlr-16470	23	10	and	and	CCONJ
ihlr-16470	23	11	efficacy	efficacy	NOUN
ihlr-16470	23	12	ofssris	ofssris	NOUN
ihlr-16470	23	13	when	when	SCONJ
ihlr-16470	23	14	used	use	VERB
ihlr-16470	23	15	in	in	ADP
ihlr-16470	23	16	adolescents	adolescent	NOUN
ihlr-16470	23	17	and	and	CCONJ
ihlr-16470	23	18	children.9	children.9	VERB
ihlr-16470	23	19	as	as	ADP
ihlr-16470	23	20	a	a	DET
ihlr-16470	23	21	result	result	NOUN
ihlr-16470	23	22	,	,	PUNCT
ihlr-16470	23	23	the	the	DET
ihlr-16470	23	24	fda	fda	PROPN
ihlr-16470	23	25	convened	convene	VERB
ihlr-16470	23	26	a	a	DET
ihlr-16470	23	27	group	group	NOUN
ihlr-16470	23	28	of	of	ADP
ihlr-16470	23	29	experts	expert	NOUN
ihlr-16470	23	30	to	to	PART
ihlr-16470	23	31	scrutinize	scrutinize	VERB
ihlr-16470	23	32	data	datum	NOUN
ihlr-16470	23	33	available	available	ADJ
ihlr-16470	23	34	from	from	ADP
ihlr-16470	23	35	previous	previous	ADJ
ihlr-16470	23	36	drug	drug	NOUN
ihlr-16470	23	37	studies	study	NOUN
ihlr-16470	23	38	to	to	PART
ihlr-16470	23	39	determine	determine	VERB
ihlr-16470	23	40	whether	whether	SCONJ
ihlr-16470	23	41	a	a	DET
ihlr-16470	23	42	stronger	strong	ADJ
ihlr-16470	23	43	warning	warning	NOUN
ihlr-16470	23	44	should	should	AUX
ihlr-16470	23	45	be	be	AUX
ihlr-16470	23	46	placed	place	VERB
ihlr-16470	23	47	on	on	ADP
ihlr-16470	23	48	ssri	ssri	ADJ
ihlr-16470	23	49	labels	label	NOUN
ihlr-16470	23	50	.	.	PUNCT
ihlr-16470	24	1	10	10	NUM
ihlr-16470	24	2	the	the	DET
ihlr-16470	24	3	fda	fda	PROPN
ihlr-16470	24	4	•	•	PROPN
ihlr-16470	24	5	s	s	PROPN
ihlr-16470	24	6	study	study	NOUN
ihlr-16470	24	7	resulted	result	VERB
ihlr-16470	24	8	in	in	ADP
ihlr-16470	24	9	the	the	DET
ihlr-16470	24	10	agency	agency	NOUN
ihlr-16470	24	11	acknowledging	acknowledge	VERB
ihlr-16470	24	12	that	that	SCONJ
ihlr-16470	24	13	ssris	ssris	PROPN
ihlr-16470	24	14	could	could	AUX
ihlr-16470	24	15	cause	cause	VERB
ihlr-16470	24	16	some	some	DET
ihlr-16470	24	17	children	child	NOUN
ihlr-16470	24	18	and	and	CCONJ
ihlr-16470	24	19	teenagers	teenager	NOUN
ihlr-16470	24	20	to	to	PART
ihlr-16470	24	21	become	become	VERB
ihlr-16470	24	22	suicidal	suicidal	ADJ
ihlr-16470	24	23	,	,	PUNCT
ihlr-16470	24	24	''	''	PUNCT
ihlr-16470	24	25	and	and	CCONJ
ihlr-16470	24	26	raised	raise	VERB
ihlr-16470	24	27	questions	question	NOUN
ihlr-16470	24	28	concerning	concern	VERB
ihlr-16470	24	29	:	:	PUNCT
ihlr-16470	24	30	manufacturer	manufacturer	NOUN
ihlr-16470	24	31	versus	versus	ADP
ihlr-16470	24	32	prescriber	prescriber	NOUN
ihlr-16470	24	33	liability	liability	NOUN
ihlr-16470	24	34	,	,	PUNCT
ihlr-16470	24	35	pediatric	pediatric	ADJ
ihlr-16470	24	36	drug	drug	NOUN
ihlr-16470	24	37	testing	testing	NOUN
ihlr-16470	24	38	and	and	CCONJ
ihlr-16470	24	39	research	research	NOUN
ihlr-16470	24	40	,	,	PUNCT
ihlr-16470	24	41	and	and	CCONJ
ihlr-16470	24	42	publication	publication	NOUN
ihlr-16470	24	43	of	of	ADP
ihlr-16470	24	44	clinical	clinical	ADJ
ihlr-16470	24	45	/	/	SYM
ihlr-16470	24	46	drug	drug	NOUN
ihlr-16470	24	47	trial	trial	NOUN
ihlr-16470	24	48	results	result	NOUN
ihlr-16470	24	49	.	.	PUNCT
ihlr-16470	25	1	these	these	DET
ihlr-16470	25	2	questions	question	NOUN
ihlr-16470	25	3	are	be	AUX
ihlr-16470	25	4	important	important	ADJ
ihlr-16470	25	5	for	for	SCONJ
ihlr-16470	25	6	the	the	DET
ihlr-16470	25	7	legal	legal	ADJ
ihlr-16470	25	8	and	and	CCONJ
ihlr-16470	25	9	medical	medical	ADJ
ihlr-16470	25	10	communities	community	NOUN
ihlr-16470	25	11	to	to	PART
ihlr-16470	25	12	consider	consider	VERB
ihlr-16470	25	13	not	not	PART
ihlr-16470	25	14	only	only	ADV
ihlr-16470	25	15	because	because	SCONJ
ihlr-16470	25	16	of	of	ADP
ihlr-16470	25	17	the	the	DET
ihlr-16470	25	18	potential	potential	ADJ
ihlr-16470	25	19	harm	harm	NOUN
ihlr-16470	25	20	that	that	PRON
ihlr-16470	25	21	may	may	AUX
ihlr-16470	25	22	be	be	AUX
ihlr-16470	25	23	caused	cause	VERB
ihlr-16470	25	24	by	by	ADP
ihlr-16470	25	25	these	these	DET
ihlr-16470	25	26	drugs	drug	NOUN
ihlr-16470	25	27	,	,	PUNCT
ihlr-16470	25	28	but	but	CCONJ
ihlr-16470	25	29	also	also	ADV
ihlr-16470	25	30	their	their	PRON
ihlr-16470	25	31	potential	potential	ADJ
ihlr-16470	25	32	benefits	benefit	NOUN
ihlr-16470	25	33	.	.	PUNCT
ihlr-16470	26	1	i.	i.	PROPN
ihlr-16470	26	2	suicide	suicide	PROPN
ihlr-16470	26	3	link	link	PROPN
ihlr-16470	26	4	a.	a.	NOUN
ihlr-16470	26	5	depression	depression	NOUN
ihlr-16470	26	6	and	and	CCONJ
ihlr-16470	26	7	suicide	suicide	NOUN
ihlr-16470	26	8	part	part	NOUN
ihlr-16470	26	9	of	of	ADP
ihlr-16470	26	10	the	the	DET
ihlr-16470	26	11	difficulty	difficulty	NOUN
ihlr-16470	26	12	in	in	ADP
ihlr-16470	26	13	determining	determine	VERB
ihlr-16470	26	14	whether	whether	SCONJ
ihlr-16470	26	15	ssris	ssris	NOUN
ihlr-16470	26	16	are	be	AUX
ihlr-16470	26	17	causally	causally	ADV
ihlr-16470	26	18	linked	link	VERB
ihlr-16470	26	19	to	to	ADP
ihlr-16470	26	20	suicide	suicide	NOUN
ihlr-16470	26	21	is	be	AUX
ihlr-16470	26	22	the	the	DET
ihlr-16470	26	23	nature	nature	NOUN
ihlr-16470	26	24	of	of	ADP
ihlr-16470	26	25	depression	depression	NOUN
ihlr-16470	26	26	itself	itself	PRON
ihlr-16470	26	27	.	.	PUNCT
ihlr-16470	27	1	depression	depression	NOUN
ihlr-16470	27	2	is	be	AUX
ihlr-16470	27	3	widespread	widespread	ADJ
ihlr-16470	27	4	in	in	ADP
ihlr-16470	27	5	the	the	DET
ihlr-16470	27	6	united	united	PROPN
ihlr-16470	27	7	states	states	PROPN
ihlr-16470	27	8	and	and	CCONJ
ihlr-16470	27	9	suicidal	suicidal	ADJ
ihlr-16470	27	10	ideation	ideation	NOUN
ihlr-16470	27	11	occurs	occur	VERB
ihlr-16470	27	12	in	in	ADP
ihlr-16470	27	13	as	as	ADV
ihlr-16470	27	14	many	many	ADJ
ihlr-16470	27	15	as	as	ADP
ihlr-16470	27	16	ninety	ninety	NUM
ihlr-16470	27	17	percent	percent	NOUN
ihlr-16470	27	18	of	of	ADP
ihlr-16470	27	19	all	all	DET
ihlr-16470	27	20	depressed	depressed	ADJ
ihlr-16470	27	21	patients	patient	NOUN
ihlr-16470	27	22	.	.	PUNCT
ihlr-16470	28	1	12	12	NUM
ihlr-16470	28	2	furthermore	furthermore	ADV
ihlr-16470	28	3	,	,	PUNCT
ihlr-16470	28	4	approximately	approximately	ADV
ihlr-16470	28	5	fifteen	fifteen	NUM
ihlr-16470	28	6	percent	percent	NOUN
ihlr-16470	28	7	of	of	ADP
ihlr-16470	28	8	those	those	PRON
ihlr-16470	28	9	suffering	suffer	VERB
ihlr-16470	28	10	from	from	ADP
ihlr-16470	28	11	depression	depression	NOUN
ihlr-16470	28	12	will	will	AUX
ihlr-16470	28	13	take	take	VERB
ihlr-16470	28	14	their	their	PRON
ihlr-16470	28	15	own	own	ADJ
ihlr-16470	28	16	lives	life	NOUN
ihlr-16470	28	17	.	.	PUNCT
ihlr-16470	29	1	13	13	NUM
ihlr-16470	29	2	overall	overall	NOUN
ihlr-16470	29	3	,	,	PUNCT
ihlr-16470	29	4	"	"	PUNCT
ihlr-16470	29	5	suicide	suicide	NOUN
ihlr-16470	29	6	is	be	AUX
ihlr-16470	29	7	the	the	DET
ihlr-16470	29	8	eighth	eighth	ADJ
ihlr-16470	29	9	leading	lead	VERB
ihlr-16470	29	10	cause	cause	NOUN
ihlr-16470	29	11	of	of	ADP
ihlr-16470	29	12	death	death	NOUN
ihlr-16470	29	13	in	in	ADP
ihlr-16470	29	14	the	the	DET
ihlr-16470	29	15	united	united	PROPN
ihlr-16470	29	16	states	states	PROPN
ihlr-16470	29	17	and	and	CCONJ
ihlr-16470	29	18	accounts	account	VERB
ihlr-16470	29	19	for	for	ADP
ihlr-16470	29	20	1.5	1.5	NUM
ihlr-16470	29	21	%	%	NOUN
ihlr-16470	29	22	of	of	ADP
ihlr-16470	29	23	all	all	DET
ihlr-16470	29	24	annual	annual	ADJ
ihlr-16470	29	25	deaths	death	NOUN
ihlr-16470	29	26	.	.	PUNCT
ihlr-16470	30	1	"14	"14	VERB
ihlr-16470	30	2	as	as	ADP
ihlr-16470	30	3	a	a	DET
ihlr-16470	30	4	result	result	NOUN
ihlr-16470	30	5	,	,	PUNCT
ihlr-16470	30	6	it	it	PRON
ihlr-16470	30	7	is	be	AUX
ihlr-16470	30	8	often	often	ADV
ihlr-16470	30	9	difficult	difficult	ADJ
ihlr-16470	30	10	to	to	PART
ihlr-16470	30	11	determine	determine	VERB
ihlr-16470	30	12	whether	whether	SCONJ
ihlr-16470	30	13	a	a	DET
ihlr-16470	30	14	suicide	suicide	NOUN
ihlr-16470	30	15	or	or	CCONJ
ihlr-16470	30	16	suicidal	suicidal	ADJ
ihlr-16470	30	17	ideation	ideation	NOUN
ihlr-16470	30	18	is	be	AUX
ihlr-16470	30	19	caused	cause	VERB
ihlr-16470	30	20	by	by	ADP
ihlr-16470	30	21	the	the	DET
ihlr-16470	30	22	ssri	ssri	PROPN
ihlr-16470	30	23	medication	medication	NOUN
ihlr-16470	30	24	rather	rather	ADV
ihlr-16470	30	25	than	than	ADP
ihlr-16470	30	26	the	the	DET
ihlr-16470	30	27	underlying	underlying	ADJ
ihlr-16470	30	28	illness	illness	NOUN
ihlr-16470	30	29	.	.	PUNCT
ihlr-16470	31	1	8	8	X
ihlr-16470	31	2	.	.	X
ihlr-16470	32	1	gregory	gregory	PROPN
ihlr-16470	32	2	hazard	hazard	PROPN
ihlr-16470	32	3	,	,	PUNCT
ihlr-16470	32	4	please	please	INTJ
ihlr-16470	32	5	,	,	PUNCT
ihlr-16470	32	6	sir	sir	PROPN
ihlr-16470	32	7	,	,	PUNCT
ihlr-16470	32	8	i	i	PRON
ihlr-16470	32	9	want	want	VERB
ihlr-16470	32	10	some	some	PRON
ihlr-16470	32	11	more	more	ADJ
ihlr-16470	32	12	:	:	PUNCT
ihlr-16470	32	13	congress	congress	PROPN
ihlr-16470	32	14	'	'	PART
ihlr-16470	32	15	carrot	carrot	NOUN
ihlr-16470	32	16	-	-	PUNCT
ihlr-16470	32	17	and	and	CCONJ
ihlr-16470	32	18	-	-	PUNCT
ihlr-16470	32	19	stick	stick	NOUN
ihlr-16470	32	20	approach	approach	NOUN
ihlr-16470	32	21	to	to	ADP
ihlr-16470	32	22	pediatric	pediatric	ADJ
ihlr-16470	32	23	testing	testing	NOUN
ihlr-16470	32	24	leaves	leave	VERB
ihlr-16470	32	25	therapeutic	therapeutic	ADJ
ihlr-16470	32	26	orphans	orphan	NOUN
ihlr-16470	32	27	needing	need	VERB
ihlr-16470	32	28	more	more	ADJ
ihlr-16470	32	29	protection	protection	NOUN
ihlr-16470	32	30	,	,	PUNCT
ihlr-16470	32	31	20	20	NUM
ihlr-16470	32	32	j.	j.	PROPN
ihlr-16470	32	33	contemp	contemp	PROPN
ihlr-16470	32	34	.	.	PUNCT
ihlr-16470	33	1	heal	heal	NOUN
ihlr-16470	33	2	till	till	PROPN
ihlr-16470	33	3	.	.	PUNCT
ihlr-16470	33	4	&	&	CCONJ
ihlr-16470	33	5	pol'y	pol'y	PROPN
ihlr-16470	33	6	467,478	467,478	NUM
ihlr-16470	33	7	-	-	SYM
ihlr-16470	33	8	79	79	NUM
ihlr-16470	33	9	n.	n.	NOUN
ihlr-16470	33	10	64	64	NUM
ihlr-16470	33	11	(	(	PUNCT
ihlr-16470	33	12	2004	2004	NUM
ihlr-16470	33	13	)	)	PUNCT
ihlr-16470	33	14	.	.	PUNCT
ihlr-16470	34	1	9	9	X
ihlr-16470	34	2	.	.	X
ihlr-16470	34	3	see	see	VERB
ihlr-16470	34	4	mary	mary	PROPN
ihlr-16470	34	5	ann	ann	PROPN
ihlr-16470	34	6	liebert	liebert	PROPN
ihlr-16470	34	7	,	,	PUNCT
ihlr-16470	34	8	clinical	clinical	ADJ
ihlr-16470	34	9	trials	trial	NOUN
ihlr-16470	34	10	,	,	PUNCT
ihlr-16470	34	11	23	23	NUM
ihlr-16470	34	12	biotechnology	biotechnology	PROPN
ihlr-16470	34	13	l.	l.	PROPN
ihlr-16470	34	14	rep	rep	PROPN
ihlr-16470	34	15	.	.	PROPN
ihlr-16470	34	16	567	567	NUM
ihlr-16470	34	17	(	(	PUNCT
ihlr-16470	34	18	2004	2004	NUM
ihlr-16470	34	19	)	)	PUNCT
ihlr-16470	34	20	(	(	PUNCT
ihlr-16470	34	21	discussing	discuss	VERB
ihlr-16470	34	22	glaxosmithkline	glaxosmithkline	PROPN
ihlr-16470	34	23	withholding	withholding	NOUN
ihlr-16470	34	24	findings	finding	NOUN
ihlr-16470	34	25	that	that	SCONJ
ihlr-16470	34	26	its	its	PRON
ihlr-16470	34	27	ssri	ssri	NOUN
ihlr-16470	34	28	,	,	PUNCT
ihlr-16470	34	29	paxil	paxil	NOUN
ihlr-16470	34	30	,	,	PUNCT
ihlr-16470	34	31	was	be	AUX
ihlr-16470	34	32	no	no	PRON
ihlr-16470	34	33	more	more	ADV
ihlr-16470	34	34	effective	effective	ADJ
ihlr-16470	34	35	than	than	ADP
ihlr-16470	34	36	a	a	DET
ihlr-16470	34	37	placebo	placebo	NOUN
ihlr-16470	34	38	and	and	CCONJ
ihlr-16470	34	39	may	may	AUX
ihlr-16470	34	40	increase	increase	VERB
ihlr-16470	34	41	the	the	DET
ihlr-16470	34	42	risk	risk	NOUN
ihlr-16470	34	43	of	of	ADP
ihlr-16470	34	44	suicide	suicide	NOUN
ihlr-16470	34	45	)	)	PUNCT
ihlr-16470	34	46	.	.	PUNCT
ihlr-16470	35	1	l	l	NOUN
ihlr-16470	35	2	0	0	X
ihlr-16470	35	3	.	.	PUNCT
ihlr-16470	35	4	food	food	PROPN
ihlr-16470	35	5	&	&	CCONJ
ihlr-16470	35	6	drug	drug	PROPN
ihlr-16470	35	7	admin	admin	PROPN
ihlr-16470	35	8	.	.	PUNCT
ihlr-16470	35	9	,	,	PUNCT
ihlr-16470	35	10	talk	talk	NOUN
ihlr-16470	35	11	paper	paper	NOUN
ihlr-16470	35	12	,	,	PUNCT
ihlr-16470	35	13	fda	fda	PROPN
ihlr-16470	35	14	updates	update	VERB
ihlr-16470	35	15	its	its	PRON
ihlr-16470	35	16	review	review	NOUN
ihlr-16470	35	17	of	of	ADP
ihlr-16470	35	18	antidepressant	antidepressant	ADJ
ihlr-16470	35	19	drugs	drug	NOUN
ihlr-16470	35	20	inchi	inchi	NOUN
ihlr-16470	35	21	/	/	SYM
ihlr-16470	35	22	dren(aug.20,2004),http://www.fda.gov	dren(aug.20,2004),http://www.fda.gov	NOUN
ihlr-16470	35	23	/	/	SYM
ihlr-16470	35	24	bbs	bbs	PROPN
ihlr-16470	35	25	/	/	SYM
ihlr-16470	35	26	topics	topic	NOUN
ihlr-16470	35	27	/	/	SYM
ihlr-16470	35	28	answers/2004	answers/2004	NOUN
ihlr-16470	35	29	/	/	SYM
ihlr-16470	36	1	ans01306.html	ans01306.html	PROPN
ihlr-16470	36	2	(	(	PUNCT
ihlr-16470	36	3	last	last	ADJ
ihlr-16470	36	4	visited	visit	VERB
ihlr-16470	36	5	apr	apr	NOUN
ihlr-16470	36	6	.	.	PROPN
ihlr-16470	36	7	19	19	NUM
ihlr-16470	36	8	,	,	PUNCT
ihlr-16470	36	9	2006	2006	NUM
ihlr-16470	36	10	)	)	PUNCT
ihlr-16470	36	11	.	.	PUNCT
ihlr-16470	37	1	11	11	X
ihlr-16470	37	2	.	.	X
ihlr-16470	37	3	tell	tell	VERB
ihlr-16470	37	4	truth	truth	NOUN
ihlr-16470	37	5	about	about	ADP
ihlr-16470	37	6	antidepressants	antidepressant	NOUN
ihlr-16470	37	7	on	on	ADP
ihlr-16470	37	8	drug	drug	NOUN
ihlr-16470	37	9	labels	label	NOUN
ihlr-16470	37	10	and	and	CCONJ
ihlr-16470	37	11	in	in	ADP
ihlr-16470	37	12	medical	medical	ADJ
ihlr-16470	37	13	journals	journal	NOUN
ihlr-16470	37	14	,	,	PUNCT
ihlr-16470	37	15	newsday	newsday	PROPN
ihlr-16470	37	16	,	,	PUNCT
ihlr-16470	37	17	sept	sept	PROPN
ihlr-16470	37	18	.	.	PROPN
ihlr-16470	37	19	15	15	NUM
ihlr-16470	37	20	,	,	PUNCT
ihlr-16470	37	21	2004	2004	NUM
ihlr-16470	37	22	,	,	PUNCT
ihlr-16470	37	23	at	at	ADP
ihlr-16470	37	24	a42	a42	PROPN
ihlr-16470	37	25	.	.	PUNCT
ihlr-16470	38	1	12	12	NUM
ihlr-16470	38	2	.	.	PUNCT
ihlr-16470	39	1	falsetti	falsetti	ADJ
ihlr-16470	39	2	,	,	PUNCT
ihlr-16470	39	3	supra	supra	ADJ
ihlr-16470	39	4	note	note	NOUN
ihlr-16470	39	5	2	2	NUM
ihlr-16470	39	6	,	,	PUNCT
ihlr-16470	39	7	at	at	ADP
ihlr-16470	39	8	273	273	NUM
ihlr-16470	39	9	.	.	PUNCT
ihlr-16470	39	10	13.id	13.id	NUM
ihlr-16470	39	11	.	.	PUNCT
ihlr-16470	39	12	14.id	14.id	NUM
ihlr-16470	39	13	.	.	PUNCT
ihlr-16470	40	1	2006	2006	NUM
ihlr-16470	40	2	]	]	PUNCT
ihlr-16470	40	3	anti	anti	NOUN
ihlr-16470	40	4	-	-	NOUN
ihlr-16470	40	5	depressants	depressant	NOUN
ihlr-16470	40	6	and	and	CCONJ
ihlr-16470	40	7	clm.dren	clm.dren	NUM
ihlr-16470	40	8	203	203	NUM
ihlr-16470	40	9	b.	b.	PROPN
ihlr-16470	40	10	adults	adult	NOUN
ihlr-16470	40	11	1	1	NUM
ihlr-16470	40	12	.	.	PUNCT
ihlr-16470	40	13	theories	theory	NOUN
ihlr-16470	40	14	of	of	ADP
ihlr-16470	40	15	suicidality	suicidality	NOUN
ihlr-16470	40	16	at	at	ADP
ihlr-16470	40	17	their	their	PRON
ihlr-16470	40	18	introduction	introduction	NOUN
ihlr-16470	40	19	,	,	PUNCT
ihlr-16470	40	20	ssris	ssris	PROPN
ihlr-16470	40	21	were	be	AUX
ihlr-16470	40	22	widely	widely	ADV
ihlr-16470	40	23	regarded	regard	VERB
ihlr-16470	40	24	as	as	ADP
ihlr-16470	40	25	an	an	DET
ihlr-16470	40	26	important	important	ADJ
ihlr-16470	40	27	medical	medical	ADJ
ihlr-16470	40	28	discovery	discovery	NOUN
ihlr-16470	40	29	.	.	PUNCT
ihlr-16470	41	1	15	15	NUM
ihlr-16470	41	2	physicians	physician	NOUN
ihlr-16470	41	3	readily	readily	ADV
ihlr-16470	41	4	accepted	accept	VERB
ihlr-16470	41	5	ssris	ssris	NOUN
ihlr-16470	41	6	and	and	CCONJ
ihlr-16470	41	7	began	begin	VERB
ihlr-16470	41	8	prescribing	prescribe	VERB
ihlr-16470	41	9	them	they	PRON
ihlr-16470	41	10	to	to	ADP
ihlr-16470	41	11	patients	patient	NOUN
ihlr-16470	41	12	due	due	ADJ
ihlr-16470	41	13	to	to	ADP
ihlr-16470	41	14	favorable	favorable	ADJ
ihlr-16470	41	15	clinical	clinical	ADJ
ihlr-16470	41	16	trial	trial	NOUN
ihlr-16470	41	17	data	datum	NOUN
ihlr-16470	41	18	,	,	PUNCT
ihlr-16470	41	19	which	which	PRON
ihlr-16470	41	20	indicated	indicate	VERB
ihlr-16470	41	21	that	that	SCONJ
ihlr-16470	41	22	ssris	ssris	NOUN
ihlr-16470	41	23	were	be	AUX
ihlr-16470	41	24	more	more	ADV
ihlr-16470	41	25	effective	effective	ADJ
ihlr-16470	41	26	and	and	CCONJ
ihlr-16470	41	27	"	"	PUNCT
ihlr-16470	41	28	had	have	VERB
ihlr-16470	41	29	far	far	ADV
ihlr-16470	41	30	fewer	few	ADJ
ihlr-16470	41	31	dangerous	dangerous	ADJ
ihlr-16470	41	32	side	side	NOUN
ihlr-16470	41	33	effects	effect	NOUN
ihlr-16470	41	34	than	than	ADP
ihlr-16470	41	35	other	other	ADJ
ihlr-16470	41	36	classes	class	NOUN
ihlr-16470	41	37	of	of	ADP
ihlr-16470	41	38	antidepressants	antidepressant	NOUN
ihlr-16470	41	39	.	.	PUNCT
ihlr-16470	42	1	"16	"16	NOUN
ihlr-16470	42	2	despite	despite	SCONJ
ihlr-16470	42	3	the	the	DET
ihlr-16470	42	4	acceptance	acceptance	NOUN
ihlr-16470	42	5	of	of	ADP
ihlr-16470	42	6	the	the	DET
ihlr-16470	42	7	medical	medical	ADJ
ihlr-16470	42	8	community	community	NOUN
ihlr-16470	42	9	and	and	CCONJ
ihlr-16470	42	10	favorable	favorable	ADJ
ihlr-16470	42	11	drug	drug	NOUN
ihlr-16470	42	12	trial	trial	NOUN
ihlr-16470	42	13	data	datum	NOUN
ihlr-16470	42	14	,	,	PUNCT
ihlr-16470	42	15	shortly	shortly	ADV
ihlr-16470	42	16	after	after	ADP
ihlr-16470	42	17	the	the	DET
ihlr-16470	42	18	introduction	introduction	NOUN
ihlr-16470	42	19	of	of	ADP
ihlr-16470	42	20	ssris	ssris	NOUN
ihlr-16470	42	21	,	,	PUNCT
ihlr-16470	42	22	''	''	PUNCT
ihlr-16470	42	23	reports	report	NOUN
ihlr-16470	42	24	describing	describe	VERB
ihlr-16470	42	25	ssri	ssri	NOUN
ihlr-16470	42	26	-	-	PUNCT
ihlr-16470	42	27	induced	induce	VERB
ihlr-16470	42	28	violence	violence	NOUN
ihlr-16470	42	29	against	against	ADP
ihlr-16470	42	30	self	self	NOUN
ihlr-16470	42	31	and	and	CCONJ
ihlr-16470	42	32	others	other	NOUN
ihlr-16470	42	33	began	begin	VERB
ihlr-16470	42	34	to	to	PART
ihlr-16470	42	35	appear	appear	VERB
ihlr-16470	42	36	...	...	PUNCT
ihlr-16470	42	37	17	17	NUM
ihlr-16470	42	38	the	the	DET
ihlr-16470	42	39	ftrst	ftrst	NOUN
ihlr-16470	42	40	of	of	ADP
ihlr-16470	42	41	these	these	DET
ihlr-16470	42	42	reports	report	NOUN
ihlr-16470	42	43	was	be	AUX
ihlr-16470	42	44	produced	produce	VERB
ihlr-16470	42	45	by	by	ADP
ihlr-16470	42	46	dr	dr	PROPN
ihlr-16470	42	47	.	.	PROPN
ihlr-16470	42	48	martin	martin	PROPN
ihlr-16470	42	49	teicher	teicher	PROPN
ihlr-16470	42	50	and	and	CCONJ
ihlr-16470	42	51	colleagues	colleague	NOUN
ihlr-16470	42	52	,	,	PUNCT
ihlr-16470	42	53	which	which	PRON
ihlr-16470	42	54	spurred	spur	VERB
ihlr-16470	42	55	further	further	ADJ
ihlr-16470	42	56	reports	report	NOUN
ihlr-16470	42	57	with	with	ADP
ihlr-16470	42	58	theories	theory	NOUN
ihlr-16470	42	59	alleging	allege	VERB
ihlr-16470	42	60	that	that	SCONJ
ihlr-16470	42	61	ssris	ssris	NOUN
ihlr-16470	42	62	are	be	AUX
ihlr-16470	42	63	linked	link	VERB
ihlr-16470	42	64	to	to	PART
ihlr-16470	42	65	suicidality.18	suicidality.18	VERB
ihlr-16470	42	66	there	there	PRON
ihlr-16470	42	67	are	be	VERB
ihlr-16470	42	68	three	three	NUM
ihlr-16470	42	69	basic	basic	ADJ
ihlr-16470	42	70	"	"	PUNCT
ihlr-16470	42	71	direct	direct	ADJ
ihlr-16470	42	72	causation	causation	NOUN
ihlr-16470	42	73	"	"	PUNCT
ihlr-16470	42	74	theories	theory	NOUN
ihlr-16470	42	75	of	of	ADP
ihlr-16470	42	76	ssri	ssri	ADV
ihlr-16470	42	77	-	-	PUNCT
ihlr-16470	42	78	induced	induce	VERB
ihlr-16470	42	79	suicidality	suicidality	NOUN
ihlr-16470	42	80	,	,	PUNCT
ihlr-16470	42	81	and	and	CCONJ
ihlr-16470	42	82	a	a	DET
ihlr-16470	42	83	fourth	fourth	ADJ
ihlr-16470	42	84	theory	theory	NOUN
ihlr-16470	42	85	in	in	ADP
ihlr-16470	42	86	which	which	PRON
ihlr-16470	42	87	ssris	ssris	PROPN
ihlr-16470	42	88	are	be	AUX
ihlr-16470	42	89	thought	think	VERB
ihlr-16470	42	90	to	to	PART
ihlr-16470	42	91	have	have	VERB
ihlr-16470	42	92	an	an	DET
ihlr-16470	42	93	indirect	indirect	ADJ
ihlr-16470	42	94	causal	causal	NOUN
ihlr-16470	42	95	relationship.19	relationship.19	NOUN
ihlr-16470	42	96	the	the	DET
ihlr-16470	42	97	basic	basic	ADJ
ihlr-16470	42	98	theories	theory	NOUN
ihlr-16470	42	99	are	be	AUX
ihlr-16470	42	100	:	:	PUNCT
ihlr-16470	42	101	1	1	X
ihlr-16470	42	102	)	)	PUNCT
ihlr-16470	42	103	the	the	DET
ihlr-16470	42	104	·	·	SYM
ihlr-16470	42	105	initiative	initiative	NOUN
ihlr-16470	42	106	theory	theory	NOUN
ihlr-16470	42	107	;	;	PUNCT
ihlr-16470	42	108	2	2	X
ihlr-16470	42	109	)	)	PUNCT
ihlr-16470	42	110	the	the	DET
ihlr-16470	42	111	efficacy	efficacy	NOUN
ihlr-16470	42	112	theory	theory	NOUN
ihlr-16470	42	113	;	;	PUNCT
ihlr-16470	42	114	and	and	CCONJ
ihlr-16470	43	1	3	3	X
ihlr-16470	43	2	)	)	PUNCT
ihlr-16470	43	3	the	the	DET
ihlr-16470	43	4	"	"	PUNCT
ihlr-16470	43	5	rollback	rollback	NOUN
ihlr-16470	43	6	phenomena	phenomenon	NOUN
ihlr-16470	43	7	.	.	PUNCT
ihlr-16470	44	1	''20	''20	PROPN
ihlr-16470	44	2	under	under	ADP
ihlr-16470	44	3	initiative	initiative	NOUN
ihlr-16470	44	4	theory	theory	NOUN
ihlr-16470	44	5	,	,	PUNCT
ihlr-16470	44	6	it	it	PRON
ihlr-16470	44	7	is	be	AUX
ihlr-16470	44	8	thought	think	VERB
ihlr-16470	44	9	that	that	SCONJ
ihlr-16470	44	10	depressed	depressed	ADJ
ihlr-16470	44	11	patients	patient	NOUN
ihlr-16470	44	12	will	will	AUX
ihlr-16470	44	13	"	"	PUNCT
ihlr-16470	44	14	regain	regain	VERB
ihlr-16470	44	15	initiative	initiative	NOUN
ihlr-16470	44	16	and	and	CCONJ
ihlr-16470	44	17	energy	energy	NOUN
ihlr-16470	44	18	before	before	SCONJ
ihlr-16470	44	19	an	an	DET
ihlr-16470	44	20	improvement	improvement	NOUN
ihlr-16470	44	21	in	in	ADP
ihlr-16470	44	22	cognition	cognition	NOUN
ihlr-16470	44	23	and	and	CCONJ
ihlr-16470	44	24	mood	mood	NOUN
ihlr-16470	44	25	occurs	occur	VERB
ihlr-16470	44	26	,	,	PUNCT
ihlr-16470	44	27	and	and	CCONJ
ihlr-16470	44	28	this	this	PRON
ihlr-16470	44	29	could	could	AUX
ihlr-16470	44	30	mobilize	mobilize	VERB
ihlr-16470	44	31	an	an	DET
ihlr-16470	44	32	individual	individual	NOUN
ihlr-16470	44	33	to	to	PART
ihlr-16470	44	34	carry	carry	VERB
ihlr-16470	44	35	out	out	ADP
ihlr-16470	44	36	suicidal	suicidal	ADJ
ihlr-16470	44	37	thoughts	thought	NOUN
ihlr-16470	44	38	.	.	PUNCT
ihlr-16470	45	1	''21	''21	NOUN
ihlr-16470	45	2	efficacy	efficacy	NOUN
ihlr-16470	45	3	theory	theory	NOUN
ihlr-16470	45	4	suggests	suggest	VERB
ihlr-16470	45	5	that	that	SCONJ
ihlr-16470	45	6	in	in	ADP
ihlr-16470	45	7	situations	situation	NOUN
ihlr-16470	45	8	where	where	SCONJ
ihlr-16470	45	9	the	the	DET
ihlr-16470	45	10	medication	medication	NOUN
ihlr-16470	45	11	is	be	AUX
ihlr-16470	45	12	ineffective	ineffective	ADJ
ihlr-16470	45	13	,	,	PUNCT
ihlr-16470	45	14	the	the	DET
ihlr-16470	45	15	patient	patient	NOUN
ihlr-16470	45	16	may	may	AUX
ihlr-16470	45	17	commit	commit	VERB
ihlr-16470	45	18	suicide	suicide	NOUN
ihlr-16470	45	19	either	either	CCONJ
ihlr-16470	45	20	due	due	ADP
ihlr-16470	45	21	to	to	ADP
ihlr-16470	45	22	the	the	DET
ihlr-16470	45	23	natural	natural	ADJ
ihlr-16470	45	24	progression	progression	NOUN
ihlr-16470	45	25	of	of	ADP
ihlr-16470	45	26	the	the	DET
ihlr-16470	45	27	disease	disease	NOUN
ihlr-16470	45	28	or	or	CCONJ
ihlr-16470	45	29	discouragement	discouragement	NOUN
ihlr-16470	45	30	resulting	result	VERB
ihlr-16470	45	31	from	from	ADP
ihlr-16470	45	32	treatment	treatment	NOUN
ihlr-16470	45	33	failure.22	failure.22	NOUN
ihlr-16470	45	34	the	the	DET
ihlr-16470	45	35	theory	theory	NOUN
ihlr-16470	45	36	of"rollback	of"rollback	NOUN
ihlr-16470	45	37	phenomena	phenomena	PROPN
ihlr-16470	45	38	"	"	PUNCT
ihlr-16470	45	39	suggests	suggest	VERB
ihlr-16470	45	40	that	that	SCONJ
ihlr-16470	45	41	ssris	ssris	PROPN
ihlr-16470	45	42	will	will	AUX
ihlr-16470	45	43	work	work	VERB
ihlr-16470	45	44	to	to	PART
ihlr-16470	45	45	relieve	relieve	VERB
ihlr-16470	45	46	depression	depression	NOUN
ihlr-16470	45	47	"	"	PUNCT
ihlr-16470	45	48	in	in	ADP
ihlr-16470	45	49	the	the	DET
ihlr-16470	45	50	reverse	reverse	ADJ
ihlr-16470	45	51	order	order	NOUN
ihlr-16470	45	52	in	in	ADP
ihlr-16470	45	53	which	which	PRON
ihlr-16470	45	54	it	it	PRON
ihlr-16470	45	55	manifested	manifest	VERB
ihlr-16470	45	56	itself	itself	PRON
ihlr-16470	45	57	;	;	PUNCT
ihlr-16470	45	58	thus	thus	ADV
ihlr-16470	45	59	,	,	PUNCT
ihlr-16470	45	60	if	if	SCONJ
ihlr-16470	45	61	the	the	DET
ihlr-16470	45	62	patient	patient	NOUN
ihlr-16470	45	63	previously	previously	ADV
ihlr-16470	45	64	had	have	AUX
ihlr-16470	45	65	experienced	experience	VERB
ihlr-16470	45	66	a	a	DET
ihlr-16470	45	67	period	period	NOUN
ihlr-16470	45	68	of	of	ADP
ihlr-16470	45	69	suicidal	suicidal	ADJ
ihlr-16470	45	70	ideation	ideation	NOUN
ihlr-16470	45	71	,	,	PUNCT
ihlr-16470	45	72	it	it	PRON
ihlr-16470	45	73	may	may	AUX
ihlr-16470	45	74	reappear	reappear	VERB
ihlr-16470	45	75	with	with	ADP
ihlr-16470	45	76	continued	continue	VERB
ihlr-16470	45	77	treatment	treatment	NOUN
ihlr-16470	45	78	.	.	PUNCT
ihlr-16470	46	1	''23	''23	PROPN
ihlr-16470	46	2	the	the	DET
ihlr-16470	46	3	fourth	fourth	ADJ
ihlr-16470	46	4	theory	theory	NOUN
ihlr-16470	46	5	of	of	ADP
ihlr-16470	46	6	suicidality	suicidality	NOUN
ihlr-16470	46	7	suggests	suggest	VERB
ihlr-16470	46	8	that	that	SCONJ
ihlr-16470	46	9	the	the	DET
ihlr-16470	46	10	suicidal	suicidal	ADJ
ihlr-16470	46	11	ideation	ideation	NOUN
ihlr-16470	46	12	is	be	AUX
ihlr-16470	46	13	truly	truly	ADV
ihlr-16470	46	14	in	in	ADP
ihlr-16470	46	15	response	response	NOUN
ihlr-16470	46	16	to	to	ADP
ihlr-16470	46	17	a	a	DET
ihlr-16470	46	18	severe	severe	ADJ
ihlr-16470	46	19	form	form	NOUN
ihlr-16470	46	20	of	of	ADP
ihlr-16470	46	21	psychomotor	psychomotor	NOUN
ihlr-16470	46	22	agitation	agitation	NOUN
ihlr-16470	46	23	known	know	VERB
ihlr-16470	46	24	as	as	ADP
ihlr-16470	46	25	akathisia.24	akathisia.24	NOUN
ihlr-16470	46	26	akathisia	akathisia	NOUN
ihlr-16470	46	27	is	be	AUX
ihlr-16470	46	28	an	an	DET
ihlr-16470	46	29	inner	inner	ADJ
ihlr-16470	46	30	sense	sense	NOUN
ihlr-16470	46	31	of	of	ADP
ihlr-16470	46	32	restlessness	restlessness	NOUN
ihlr-16470	46	33	and	and	CCONJ
ihlr-16470	46	34	an	an	DET
ihlr-16470	46	35	inability	inability	NOUN
ihlr-16470	46	36	to	to	PART
ihlr-16470	46	37	sit	sit	VERB
ihlr-16470	46	38	still	still	ADV
ihlr-16470	46	39	,	,	PUNCT
ihlr-16470	46	40	which	which	PRON
ihlr-16470	46	41	patients	patient	NOUN
ihlr-16470	46	42	often	often	ADV
ihlr-16470	46	43	describe	describe	VERB
ihlr-16470	46	44	as	as	ADP
ihlr-16470	46	45	feeling	feel	VERB
ihlr-16470	46	46	like	like	SCONJ
ihlr-16470	46	47	they	they	PRON
ihlr-16470	46	48	are	be	AUX
ihlr-16470	46	49	"	"	PUNCT
ihlr-16470	46	50	jumping	jump	VERB
ihlr-16470	46	51	out	out	ADP
ihlr-16470	46	52	of	of	ADP
ihlr-16470	46	53	their	their	PRON
ihlr-16470	46	54	skin	skin	NOUN
ihlr-16470	46	55	.	.	PUNCT
ihlr-16470	47	1	"25	"25	PROPN
ihlr-16470	47	2	this	this	DET
ihlr-16470	47	3	theory	theory	NOUN
ihlr-16470	47	4	suggests	suggest	VERB
ihlr-16470	47	5	a	a	DET
ihlr-16470	47	6	link	link	NOUN
ihlr-16470	47	7	between	between	ADP
ihlr-16470	47	8	akathisia	akathisia	NOUN
ihlr-16470	47	9	and	and	CCONJ
ihlr-16470	47	10	suicidal	suicidal	ADJ
ihlr-16470	47	11	15	15	NUM
ihlr-16470	47	12	.	.	PUNCT
ihlr-16470	47	13	symposium	symposium	NOUN
ihlr-16470	47	14	,	,	PUNCT
ihlr-16470	47	15	supra	supra	PROPN
ihlr-16470	47	16	note	note	NOUN
ihlr-16470	47	17	3	3	NUM
ihlr-16470	47	18	,	,	PUNCT
ihlr-16470	47	19	at	at	ADP
ihlr-16470	47	20	334	334	NUM
ihlr-16470	47	21	.	.	PUNCT
ihlr-16470	48	1	16	16	NUM
ihlr-16470	48	2	.	.	PUNCT
ihlr-16470	49	1	/d	/d	INTJ
ihlr-16470	49	2	.	.	PUNCT
ihlr-16470	50	1	17	17	NUM
ihlr-16470	50	2	.	.	PUNCT
ihlr-16470	51	1	/d	/d	INTJ
ihlr-16470	51	2	.	.	PROPN
ihlr-16470	52	1	18	18	NUM
ihlr-16470	52	2	.	.	NUM
ihlr-16470	52	3	falsetti	falsetti	ADJ
ihlr-16470	52	4	,	,	PUNCT
ihlr-16470	52	5	supra	supra	ADJ
ihlr-16470	52	6	note	note	NOUN
ihlr-16470	52	7	2	2	NUM
ihlr-16470	52	8	,	,	PUNCT
ihlr-16470	52	9	at	at	ADP
ihlr-16470	52	10	275	275	NUM
ihlr-16470	52	11	.	.	PUNCT
ihlr-16470	52	12	19	19	NUM
ihlr-16470	52	13	.	.	PUNCT
ihlr-16470	53	1	/d	/d	INTJ
ihlr-16470	53	2	.	.	PUNCT
ihlr-16470	54	1	at	at	ADP
ihlr-16470	54	2	274	274	NUM
ihlr-16470	54	3	-	-	SYM
ihlr-16470	54	4	76	76	NUM
ihlr-16470	54	5	.	.	PUNCT
ihlr-16470	54	6	20	20	NUM
ihlr-16470	54	7	.	.	PUNCT
ihlr-16470	55	1	i	i	PRON
ihlr-16470	55	2	d.	d.	PROPN
ihlr-16470	55	3	21	21	NUM
ihlr-16470	55	4	.	.	PUNCT
ihlr-16470	56	1	i	i	PRON
ihlr-16470	56	2	d	d	PROPN
ihlr-16470	56	3	at	at	ADP
ihlr-16470	56	4	274	274	NUM
ihlr-16470	56	5	.	.	PUNCT
ihlr-16470	56	6	22	22	NUM
ihlr-16470	56	7	.	.	PUNCT
ihlr-16470	57	1	/d	/d	INTJ
ihlr-16470	57	2	.	.	PROPN
ihlr-16470	58	1	23	23	NUM
ihlr-16470	58	2	.	.	PUNCT
ihlr-16470	59	1	falsetti	falsetti	ADJ
ihlr-16470	59	2	,	,	PUNCT
ihlr-16470	59	3	supra	supra	ADJ
ihlr-16470	59	4	note	note	NOUN
ihlr-16470	59	5	2	2	NUM
ihlr-16470	59	6	,	,	PUNCT
ihlr-16470	59	7	at	at	ADP
ihlr-16470	59	8	274	274	NUM
ihlr-16470	59	9	.	.	PUNCT
ihlr-16470	59	10	24	24	NUM
ihlr-16470	59	11	.	.	PUNCT
ihlr-16470	60	1	/d	/d	PUNCT
ihlr-16470	60	2	.	.	PUNCT
ihlr-16470	61	1	see	see	AUX
ihlr-16470	61	2	alyo	alyo	VERB
ihlr-16470	61	3	miller	miller	PROPN
ihlr-16470	61	4	v.	v.	ADP
ihlr-16470	61	5	pfizer	pfizer	PROPN
ihlr-16470	61	6	,	,	PUNCT
ihlr-16470	61	7	inc	inc	PROPN
ihlr-16470	61	8	.	.	PROPN
ihlr-16470	61	9	,	,	PUNCT
ihlr-16470	61	10	196	196	NUM
ihlr-16470	61	11	f.	f.	PROPN
ihlr-16470	61	12	supp	supp	PROPN
ihlr-16470	61	13	.	.	PUNCT
ihlr-16470	62	1	2d	2d	PROPN
ihlr-16470	62	2	1095	1095	NUM
ihlr-16470	62	3	,	,	PUNCT
ihlr-16470	62	4	1109	1109	NUM
ihlr-16470	62	5	(	(	PUNCT
ihlr-16470	62	6	d.	d.	PROPN
ihlr-16470	62	7	kan	kan	PROPN
ihlr-16470	62	8	.	.	PROPN
ihlr-16470	62	9	2002	2002	NUM
ihlr-16470	62	10	)	)	PUNCT
ihlr-16470	62	11	.	.	PUNCT
ihlr-16470	63	1	25	25	NUM
ihlr-16470	63	2	.	.	NUM
ihlr-16470	63	3	falsetti	falsetti	ADJ
ihlr-16470	63	4	,	,	PUNCT
ihlr-16470	63	5	supra	supra	ADJ
ihlr-16470	63	6	note	note	NOUN
ihlr-16470	63	7	2	2	NUM
ihlr-16470	63	8	,	,	PUNCT
ihlr-16470	63	9	at	at	ADP
ihlr-16470	63	10	274	274	NUM
ihlr-16470	63	11	-	-	SYM
ihlr-16470	63	12	75	75	NUM
ihlr-16470	63	13	.	.	PUNCT
ihlr-16470	64	1	204	204	NUM
ihlr-16470	64	2	indiana	indiana	PROPN
ihlr-16470	64	3	health	health	PROPN
ihlr-16470	64	4	law	law	NOUN
ihlr-16470	64	5	review	review	NOUN
ihlr-16470	64	6	[	[	X
ihlr-16470	64	7	vol	vol	NOUN
ihlr-16470	64	8	.	.	PUNCT
ihlr-16470	65	1	3:201	3:201	NUM
ihlr-16470	65	2	ideation	ideation	NOUN
ihlr-16470	65	3	.	.	PUNCT
ihlr-16470	66	1	26	26	NUM
ihlr-16470	67	1	it	it	PRON
ihlr-16470	67	2	is	be	AUX
ihlr-16470	67	3	suggested	suggest	VERB
ihlr-16470	67	4	that	that	SCONJ
ihlr-16470	67	5	under	under	ADP
ihlr-16470	67	6	this	this	DET
ihlr-16470	67	7	theory	theory	NOUN
ihlr-16470	67	8	suicidal	suicidal	ADJ
ihlr-16470	67	9	ideation	ideation	NOUN
ihlr-16470	67	10	is	be	AUX
ihlr-16470	67	11	an	an	DET
ihlr-16470	67	12	extreme	extreme	ADJ
ihlr-16470	67	13	response	response	NOUN
ihlr-16470	67	14	to	to	ADP
ihlr-16470	67	15	the	the	DET
ihlr-16470	67	16	unpleasant	unpleasant	ADJ
ihlr-16470	67	17	sensation	sensation	NOUN
ihlr-16470	67	18	produced	produce	VERB
ihlr-16470	67	19	by	by	ADP
ihlr-16470	67	20	akathisia	akathisia	NOUN
ihlr-16470	67	21	and	and	CCONJ
ihlr-16470	67	22	''	''	PUNCT
ihlr-16470	67	23	not	not	PART
ihlr-16470	67	24	true	true	ADJ
ihlr-16470	67	25	suicidal	suicidal	ADJ
ihlr-16470	67	26	ideation	ideation	NOUN
ihlr-16470	67	27	as	as	SCONJ
ihlr-16470	67	28	is	be	AUX
ihlr-16470	67	29	typically	typically	ADV
ihlr-16470	67	30	described	describe	VERB
ihlr-16470	67	31	by	by	ADP
ihlr-16470	67	32	depressed	depressed	ADJ
ihlr-16470	67	33	patients	patient	NOUN
ihlr-16470	67	34	experiencing	experience	VERB
ihlr-16470	67	35	suicidal	suicidal	ADJ
ihlr-16470	67	36	ideation	ideation	NOUN
ihlr-16470	67	37	.	.	PUNCT
ihlr-16470	68	1	"	"	PUNCT
ihlr-16470	68	2	27	27	NUM
ihlr-16470	68	3	2	2	NUM
ihlr-16470	68	4	.	.	PUNCT
ihlr-16470	68	5	scientific	scientific	ADJ
ihlr-16470	68	6	link	link	NOUN
ihlr-16470	68	7	regardless	regardless	ADV
ihlr-16470	68	8	of	of	ADP
ihlr-16470	68	9	the	the	DET
ihlr-16470	68	10	theories	theory	NOUN
ihlr-16470	68	11	of	of	ADP
ihlr-16470	68	12	how	how	SCONJ
ihlr-16470	68	13	ssris	ssris	NOUN
ihlr-16470	68	14	may	may	AUX
ihlr-16470	68	15	cause	cause	VERB
ihlr-16470	68	16	suicide	suicide	NOUN
ihlr-16470	68	17	,	,	PUNCT
ihlr-16470	68	18	the	the	DET
ihlr-16470	68	19	underlying	underlying	ADJ
ihlr-16470	68	20	question	question	NOUN
ihlr-16470	68	21	is	be	AUX
ihlr-16470	68	22	whether	whether	SCONJ
ihlr-16470	68	23	there	there	PRON
ihlr-16470	68	24	is	be	VERB
ihlr-16470	68	25	a	a	DET
ihlr-16470	68	26	true	true	ADJ
ihlr-16470	68	27	scientific	scientific	ADJ
ihlr-16470	68	28	causal	causal	NOUN
ihlr-16470	68	29	relationship	relationship	NOUN
ihlr-16470	68	30	between	between	ADP
ihlr-16470	68	31	ssris	ssris	NOUN
ihlr-16470	68	32	and	and	CCONJ
ihlr-16470	68	33	suicide	suicide	NOUN
ihlr-16470	68	34	.	.	PUNCT
ihlr-16470	69	1	the	the	DET
ihlr-16470	69	2	fda	fda	PROPN
ihlr-16470	69	3	,	,	PUNCT
ihlr-16470	69	4	drug	drug	NOUN
ihlr-16470	69	5	manufacturers	manufacturer	NOUN
ihlr-16470	69	6	,	,	PUNCT
ihlr-16470	69	7	and	and	CCONJ
ihlr-16470	69	8	other	other	ADJ
ihlr-16470	69	9	agencies	agency	NOUN
ihlr-16470	69	10	have	have	AUX
ihlr-16470	69	11	studied	study	VERB
ihlr-16470	69	12	this	this	DET
ihlr-16470	69	13	possible	possible	ADJ
ihlr-16470	69	14	link	link	NOUN
ihlr-16470	69	15	since	since	SCONJ
ihlr-16470	69	16	just	just	ADV
ihlr-16470	69	17	after	after	SCONJ
ihlr-16470	69	18	the	the	DET
ihlr-16470	69	19	first	first	ADJ
ihlr-16470	69	20	anecdotal	anecdotal	ADJ
ihlr-16470	69	21	reports	report	NOUN
ihlr-16470	69	22	were	be	AUX
ihlr-16470	69	23	published	publish	VERB
ihlr-16470	69	24	in	in	ADP
ihlr-16470	69	25	1990.28	1990.28	NUM
ihlr-16470	69	26	in	in	ADP
ihlr-16470	69	27	1991	1991	NUM
ihlr-16470	69	28	,	,	PUNCT
ihlr-16470	69	29	1992	1992	NUM
ihlr-16470	69	30	,	,	PUNCT
ihlr-16470	69	31	1997	1997	NUM
ihlr-16470	69	32	,	,	PUNCT
ihlr-16470	69	33	and	and	CCONJ
ihlr-16470	69	34	2002	2002	NUM
ihlr-16470	69	35	,	,	PUNCT
ihlr-16470	69	36	the	the	DET
ihlr-16470	69	37	fda	fda	PROPN
ihlr-16470	69	38	conducted	conduct	VERB
ihlr-16470	69	39	periodic	periodic	ADJ
ihlr-16470	69	40	safety	safety	NOUN
ihlr-16470	69	41	reviews	review	NOUN
ihlr-16470	69	42	on	on	ADP
ihlr-16470	69	43	this	this	DET
ihlr-16470	69	44	issue	issue	NOUN
ihlr-16470	69	45	,	,	PUNCT
ihlr-16470	69	46	and	and	CCONJ
ihlr-16470	69	47	"	"	PUNCT
ihlr-16470	69	48	each	each	DET
ihlr-16470	69	49	time	time	NOUN
ihlr-16470	69	50	fl	fl	X
ihlr-16470	69	51	ound	ound	NOUN
ihlr-16470	69	52	]	]	PUNCT
ihlr-16470	69	53	no	no	DET
ihlr-16470	69	54	scientific	scientific	ADJ
ihlr-16470	69	55	basis	basis	NOUN
ihlr-16470	69	56	for	for	ADP
ihlr-16470	69	57	a	a	DET
ihlr-16470	69	58	warning	warning	NOUN
ihlr-16470	69	59	that	that	SCONJ
ihlr-16470	69	60	ssris	ssris	NOUN
ihlr-16470	69	61	cause	cause	VERB
ihlr-16470	69	62	suicide	suicide	NOUN
ihlr-16470	69	63	.	.	PUNCT
ihlr-16470	70	1	"	"	PUNCT
ihlr-16470	70	2	29	29	NUM
ihlr-16470	70	3	often	often	ADV
ihlr-16470	70	4	the	the	DET
ihlr-16470	70	5	nature	nature	NOUN
ihlr-16470	70	6	of	of	ADP
ihlr-16470	70	7	depression	depression	NOUN
ihlr-16470	70	8	itself	itself	PRON
ihlr-16470	70	9	makes	make	VERB
ihlr-16470	70	10	it	it	PRON
ihlr-16470	70	11	difficult	difficult	ADJ
ihlr-16470	70	12	to	to	PART
ihlr-16470	70	13	ascertain	ascertain	VERB
ihlr-16470	70	14	one	one	NUM
ihlr-16470	70	15	distinct	distinct	ADJ
ihlr-16470	70	16	cause	cause	NOUN
ihlr-16470	70	17	for	for	ADP
ihlr-16470	70	18	a	a	DET
ihlr-16470	70	19	patient	patient	NOUN
ihlr-16470	70	20	's	's	PART
ihlr-16470	70	21	suicide	suicide	NOUN
ihlr-16470	70	22	.	.	PUNCT
ihlr-16470	71	1	the	the	DET
ihlr-16470	71	2	fda	fda	PROPN
ihlr-16470	71	3	has	have	AUX
ihlr-16470	71	4	recognized	recognize	VERB
ihlr-16470	71	5	that	that	SCONJ
ihlr-16470	71	6	"	"	PUNCT
ihlr-16470	71	7	although	although	SCONJ
ihlr-16470	71	8	antidepressants	antidepressant	NOUN
ihlr-16470	71	9	in	in	ADP
ihlr-16470	71	10	general	general	ADJ
ihlr-16470	71	11	may	may	AUX
ihlr-16470	71	12	have	have	VERB
ihlr-16470	71	13	the	the	DET
ihlr-16470	71	14	ability	ability	NOUN
ihlr-16470	71	15	to	to	PART
ihlr-16470	71	16	cause	cause	VERB
ihlr-16470	71	17	suicidal	suicidal	ADJ
ihlr-16470	71	18	ideation	ideation	NOUN
ihlr-16470	71	19	,	,	PUNCT
ihlr-16470	71	20	its	its	PRON
ihlr-16470	71	21	occurrence	occurrence	NOUN
ihlr-16470	71	22	is	be	AUX
ihlr-16470	71	23	too	too	ADV
ihlr-16470	71	24	rare	rare	ADJ
ihlr-16470	71	25	to	to	PART
ihlr-16470	71	26	be	be	AUX
ihlr-16470	71	27	affirmatively	affirmatively	ADV
ihlr-16470	71	28	attributed	attribute	VERB
ihlr-16470	71	29	to	to	ADP
ihlr-16470	71	30	the	the	DET
ihlr-16470	71	31	drugs	drug	NOUN
ihlr-16470	71	32	,	,	PUNCT
ihlr-16470	71	33	and	and	CCONJ
ihlr-16470	71	34	that	that	SCONJ
ihlr-16470	71	35	depression	depression	NOUN
ihlr-16470	71	36	itself	itself	PRON
ihlr-16470	71	37	is	be	AUX
ihlr-16470	71	38	a	a	DET
ihlr-16470	71	39	cause	cause	NOUN
ihlr-16470	71	40	ofsuicide	ofsuicide	NOUN
ihlr-16470	71	41	.	.	PUNCT
ihlr-16470	72	1	"30	"30	PUNCT
ihlr-16470	73	1	despite	despite	SCONJ
ihlr-16470	73	2	the	the	DET
ihlr-16470	73	3	lack	lack	NOUN
ihlr-16470	73	4	of	of	ADP
ihlr-16470	73	5	scientific	scientific	ADJ
ihlr-16470	73	6	evidence	evidence	NOUN
ihlr-16470	73	7	to	to	PART
ihlr-16470	73	8	support	support	VERB
ihlr-16470	73	9	a	a	DET
ihlr-16470	73	10	claim	claim	NOUN
ihlr-16470	73	11	that	that	SCONJ
ihlr-16470	73	12	ssris	ssris	NOUN
ihlr-16470	73	13	cause	cause	VERB
ihlr-16470	73	14	suicide	suicide	NOUN
ihlr-16470	73	15	,	,	PUNCT
ihlr-16470	73	16	the	the	DET
ihlr-16470	73	17	anecdotal	anecdotal	ADJ
ihlr-16470	73	18	evidence	evidence	NOUN
ihlr-16470	73	19	has	have	AUX
ihlr-16470	73	20	been	be	AUX
ihlr-16470	73	21	enough	enough	ADJ
ihlr-16470	73	22	to	to	PART
ihlr-16470	73	23	persuade	persuade	VERB
ihlr-16470	73	24	people	people	NOUN
ihlr-16470	73	25	who	who	PRON
ihlr-16470	73	26	could	could	AUX
ihlr-16470	73	27	benefit	benefit	VERB
ihlr-16470	73	28	from	from	ADP
ihlr-16470	73	29	the	the	DET
ihlr-16470	73	30	drugs	drug	NOUN
ihlr-16470	73	31	not	not	PART
ihlr-16470	73	32	to	to	PART
ihlr-16470	73	33	use	use	VERB
ihlr-16470	73	34	them.31	them.31	NOUN
ihlr-16470	73	35	when	when	SCONJ
ihlr-16470	73	36	considering	consider	VERB
ihlr-16470	73	37	the	the	DET
ihlr-16470	73	38	question	question	NOUN
ihlr-16470	73	39	of	of	ADP
ihlr-16470	73	40	whether	whether	SCONJ
ihlr-16470	73	41	ssris	ssris	NOUN
ihlr-16470	73	42	cause	cause	VERB
ihlr-16470	73	43	suicide	suicide	NOUN
ihlr-16470	73	44	it	it	PRON
ihlr-16470	73	45	is	be	AUX
ihlr-16470	73	46	important	important	ADJ
ihlr-16470	73	47	to	to	PART
ihlr-16470	73	48	consider	consider	VERB
ihlr-16470	73	49	the	the	DET
ihlr-16470	73	50	benefits	benefit	NOUN
ihlr-16470	73	51	these	these	DET
ihlr-16470	73	52	drugs	drug	NOUN
ihlr-16470	73	53	could	could	AUX
ihlr-16470	73	54	have	have	VERB
ihlr-16470	73	55	in	in	ADP
ihlr-16470	73	56	a	a	DET
ihlr-16470	73	57	patient	patient	NOUN
ihlr-16470	73	58	's	's	PART
ihlr-16470	73	59	life	life	NOUN
ihlr-16470	73	60	.	.	PUNCT
ihlr-16470	74	1	as	as	SCONJ
ihlr-16470	74	2	the	the	DET
ihlr-16470	74	3	court	court	NOUN
ihlr-16470	74	4	noted	note	VERB
ihlr-16470	74	5	in	in	ADP
ihlr-16470	74	6	the	the	DET
ihlr-16470	74	7	recent	recent	ADJ
ihlr-16470	74	8	case	case	NOUN
ihlr-16470	74	9	of	of	ADP
ihlr-16470	74	10	miller	miller	PROPN
ihlr-16470	74	11	v.	v.	ADP
ihlr-16470	74	12	pfizer	pfizer	PROPN
ihlr-16470	74	13	,	,	PUNCT
ihlr-16470	74	14	inc	inc	PROPN
ihlr-16470	74	15	.	.	PROPN
ihlr-16470	74	16	:	:	PUNCT
ihlr-16470	75	1	[	[	X
ihlr-16470	75	2	w]hatever	w]hatever	ADP
ihlr-16470	75	3	the	the	DET
ihlr-16470	75	4	explanation	explanation	NOUN
ihlr-16470	75	5	,	,	PUNCT
ihlr-16470	75	6	studies	study	NOUN
ihlr-16470	75	7	of	of	ADP
ihlr-16470	75	8	suicide	suicide	NOUN
ihlr-16470	75	9	rates	rate	NOUN
ihlr-16470	75	10	among	among	ADP
ihlr-16470	75	11	fluoxetine	fluoxetine	NOUN
ihlr-16470	75	12	users	user	NOUN
ihlr-16470	75	13	have	have	AUX
ihlr-16470	75	14	not	not	PART
ihlr-16470	75	15	indicated	indicate	VERB
ihlr-16470	75	16	an	an	DET
ihlr-16470	75	17	increased	increased	ADJ
ihlr-16470	75	18	risk	risk	NOUN
ihlr-16470	75	19	of	of	ADP
ihlr-16470	75	20	suicide	suicide	NOUN
ihlr-16470	75	21	attempts	attempt	NOUN
ihlr-16470	75	22	or	or	CCONJ
ihlr-16470	75	23	completions	completion	NOUN
ihlr-16470	75	24	,	,	PUNCT
ihlr-16470	75	25	relative	relative	ADJ
ihlr-16470	75	26	to	to	ADP
ihlr-16470	75	27	users	user	NOUN
ihlr-16470	75	28	of	of	ADP
ihlr-16470	75	29	other	other	ADJ
ihlr-16470	75	30	antidepressants	antidepressant	NOUN
ihlr-16470	75	31	;	;	PUNCT
ihlr-16470	75	32	in	in	ADP
ihlr-16470	75	33	fact	fact	NOUN
ihlr-16470	75	34	,	,	PUNCT
ihlr-16470	75	35	[	[	X
ihlr-16470	75	36	the	the	DET
ihlr-16470	75	37	most	most	ADV
ihlr-16470	75	38	recent	recent	ADJ
ihlr-16470	75	39	textbook	textbook	NOUN
ihlr-16470	75	40	by	by	ADP
ihlr-16470	75	41	the	the	DET
ihlr-16470	75	42	american	american	PROPN
ihlr-16470	75	43	psychiatric	psychiatric	PROPN
ihlr-16470	75	44	association	association	PROPN
ihlr-16470	75	45	]	]	PUNCT
ihlr-16470	75	46	notes	note	VERB
ihlr-16470	75	47	that	that	SCONJ
ihlr-16470	75	48	larger	large	ADJ
ihlr-16470	75	49	controlled	control	VERB
ihlr-16470	75	50	studies	study	NOUN
ihlr-16470	75	51	have	have	AUX
ihlr-16470	75	52	confirmed	confirm	VERB
ihlr-16470	75	53	that	that	SCONJ
ihlr-16470	75	54	suicide	suicide	NOUN
ihlr-16470	75	55	rates	rate	NOUN
ihlr-16470	75	56	among	among	ADP
ihlr-16470	75	57	depressed	depressed	ADJ
ihlr-16470	75	58	patients	patient	NOUN
ihlr-16470	75	59	treated	treat	VERB
ihlr-16470	75	60	with	with	ADP
ihlr-16470	75	61	fluoxetine	fluoxetine	NOUN
ihlr-16470	75	62	(	(	PUNCT
ihlr-16470	75	63	and	and	CCONJ
ihlr-16470	75	64	all	all	DET
ihlr-16470	75	65	other	other	ADJ
ihlr-16470	75	66	·	·	PUNCT
ihlr-16470	75	67	antidepressants	antidepressant	NOUN
ihlr-16470	75	68	)	)	PUNCT
ihlr-16470	75	69	are	be	AUX
ihlr-16470	75	70	markedly	markedly	ADV
ihlr-16470	75	71	reduced	reduce	VERB
ihlr-16470	75	72	from	from	ADP
ihlr-16470	75	73	those	those	PRON
ihlr-16470	75	74	of	of	ADP
ihlr-16470	75	75	depressed	depressed	ADJ
ihlr-16470	75	76	patients	patient	NOUN
ihlr-16470	75	77	who	who	PRON
ihlr-16470	75	78	do	do	AUX
ihlr-16470	75	79	not	not	PART
ihlr-16470	75	80	receive	receive	VERB
ihlr-16470	75	81	antidepressants	antidepressant	NOUN
ihlr-16470	75	82	.	.	PUNCT
ihlr-16470	76	1	32	32	NUM
ihlr-16470	76	2	26	26	NUM
ihlr-16470	76	3	.	.	PUNCT
ihlr-16470	77	1	see	see	VERB
ihlr-16470	77	2	miller	miller	PROPN
ihlr-16470	77	3	v.	v.	ADP
ihlr-16470	77	4	pfizer	pfizer	PROPN
ihlr-16470	77	5	,	,	PUNCT
ihlr-16470	77	6	inc	inc	PROPN
ihlr-16470	77	7	.	.	PROPN
ihlr-16470	77	8	,	,	PUNCT
ihlr-16470	77	9	196	196	NUM
ihlr-16470	77	10	f.	f.	PROPN
ihlr-16470	77	11	supp	supp	PROPN
ihlr-16470	77	12	.	.	PUNCT
ihlr-16470	78	1	2d	2d	PROPN
ihlr-16470	78	2	1095	1095	NUM
ihlr-16470	78	3	,	,	PUNCT
ihlr-16470	78	4	1109	1109	NUM
ihlr-16470	78	5	(	(	PUNCT
ihlr-16470	78	6	d.	d.	PROPN
ihlr-16470	78	7	kan	kan	PROPN
ihlr-16470	78	8	.	.	PROPN
ihlr-16470	78	9	2002	2002	NUM
ihlr-16470	78	10	)	)	PUNCT
ihlr-16470	78	11	;	;	PUNCT
ihlr-16470	78	12	cloud	cloud	NOUN
ihlr-16470	78	13	v.	v.	ADP
ihlr-16470	78	14	pfizer	pfizer	PROPN
ihlr-16470	78	15	,	,	PUNCT
ihlr-16470	78	16	inc	inc	PROPN
ihlr-16470	78	17	.	.	PROPN
ihlr-16470	78	18	,	,	PUNCT
ihlr-16470	78	19	198	198	NUM
ihlr-16470	78	20	f.	f.	PROPN
ihlr-16470	78	21	supp	supp	PROPN
ihlr-16470	78	22	.	.	PUNCT
ihlr-16470	79	1	2d	2d	PROPN
ihlr-16470	79	2	1118	1118	NUM
ihlr-16470	79	3	,	,	PUNCT
ihlr-16470	79	4	1123	1123	NUM
ihlr-16470	79	5	(	(	PUNCT
ihlr-16470	79	6	d.	d.	PROPN
ihlr-16470	79	7	ariz	ariz	PROPN
ihlr-16470	79	8	.	.	PUNCT
ihlr-16470	79	9	2001	2001	NUM
ihlr-16470	79	10	)	)	PUNCT
ihlr-16470	79	11	.	.	PUNCT
ihlr-16470	80	1	27	27	NUM
ihlr-16470	80	2	.	.	PUNCT
ihlr-16470	81	1	cloud	cloud	ADJ
ihlr-16470	81	2	,	,	PUNCT
ihlr-16470	81	3	198	198	NUM
ihlr-16470	81	4	f.	f.	PROPN
ihlr-16470	81	5	supp	supp	PROPN
ihlr-16470	81	6	.	.	PUNCT
ihlr-16470	82	1	2dat	2dat	NUM
ihlr-16470	82	2	1123	1123	NUM
ihlr-16470	82	3	(	(	PUNCT
ihlr-16470	82	4	d.	d.	PROPN
ihlr-16470	82	5	ariz	ariz	PROPN
ihlr-16470	82	6	.	.	PUNCT
ihlr-16470	82	7	2001	2001	NUM
ihlr-16470	82	8	)	)	PUNCT
ihlr-16470	82	9	.	.	PUNCT
ihlr-16470	83	1	28	28	NUM
ihlr-16470	83	2	.	.	PUNCT
ihlr-16470	83	3	see	see	VERB
ihlr-16470	83	4	needleman	needleman	PROPN
ihlr-16470	83	5	v.	v.	ADP
ihlr-16470	83	6	pfizer	pfizer	PROPN
ihlr-16470	83	7	,	,	PUNCT
ihlr-16470	83	8	inc	inc	PROPN
ihlr-16470	83	9	.	.	PROPN
ihlr-16470	83	10	,	,	PUNCT
ihlr-16470	83	11	2004	2004	NUM
ihlr-16470	83	12	wl	wl	NOUN
ihlr-16470	83	13	1773697	1773697	NUM
ihlr-16470	83	14	,	,	PUNCT
ihlr-16470	83	15	at	at	ADP
ihlr-16470	83	16	*	*	NOUN
ihlr-16470	83	17	2	2	NUM
ihlr-16470	83	18	(	(	PUNCT
ihlr-16470	83	19	n.d	n.d	PROPN
ihlr-16470	83	20	.	.	PROPN
ihlr-16470	83	21	tex	tex	PROPN
ihlr-16470	83	22	.	.	PROPN
ihlr-16470	83	23	2004	2004	NUM
ihlr-16470	83	24	)	)	PUNCT
ihlr-16470	83	25	.	.	PUNCT
ihlr-16470	84	1	29	29	NUM
ihlr-16470	84	2	.	.	PUNCT
ihlr-16470	85	1	i	i	PRON
ihlr-16470	85	2	d.	d.	PROPN
ihlr-16470	85	3	30	30	NUM
ihlr-16470	85	4	.	.	PUNCT
ihlr-16470	86	1	falsetti	falsetti	ADJ
ihlr-16470	86	2	,	,	PUNCT
ihlr-16470	86	3	supra	supra	ADJ
ihlr-16470	86	4	note	note	NOUN
ihlr-16470	86	5	2	2	NUM
ihlr-16470	86	6	,	,	PUNCT
ihlr-16470	86	7	at	at	ADP
ihlr-16470	86	8	279	279	NUM
ihlr-16470	86	9	.	.	PUNCT
ihlr-16470	87	1	31	31	NUM
ihlr-16470	87	2	.	.	PUNCT
ihlr-16470	88	1	/d	/d	INTJ
ihlr-16470	88	2	.	.	PUNCT
ihlr-16470	89	1	32	32	NUM
ihlr-16470	89	2	.	.	PUNCT
ihlr-16470	90	1	miller	miller	PROPN
ihlr-16470	90	2	,	,	PUNCT
ihlr-16470	90	3	196	196	NUM
ihlr-16470	90	4	f.	f.	PROPN
ihlr-16470	90	5	supp	supp	PROPN
ihlr-16470	90	6	.	.	PUNCT
ihlr-16470	91	1	2d	2d	PROPN
ihlr-16470	91	2	at	at	ADP
ihlr-16470	91	3	1109	1109	NUM
ihlr-16470	91	4	(	(	PUNCT
ihlr-16470	91	5	d.	d.	PROPN
ihlr-16470	91	6	kan	kan	PROPN
ihlr-16470	91	7	.	.	PUNCT
ihlr-16470	92	1	2002)(citing	2002)(cite	VERB
ihlr-16470	92	2	american	american	PROPN
ihlr-16470	92	3	psyc	psyc	PROPN
ihlr-16470	92	4	.	.	PUNCT
ihlr-16470	93	1	assoc	assoc	PROPN
ihlr-16470	93	2	.	.	PROPN
ihlr-16470	93	3	,	,	PUNCT
ihlr-16470	93	4	textbook	textbook	NOUN
ihlr-16470	93	5	of	of	ADP
ihlr-16470	93	6	psycidatry	psycidatry	NOUN
ihlr-16470	93	7	(	(	PUNCT
ihlr-16470	93	8	3d	3d	NOUN
ihlr-16470	93	9	.	.	PUNCT
ihlr-16470	93	10	edition	edition	PROPN
ihlr-16470	93	11	1999	1999	NUM
ihlr-16470	93	12	)	)	PUNCT
ihlr-16470	93	13	)	)	PUNCT
ihlr-16470	93	14	.	.	PUNCT
ihlr-16470	94	1	2006	2006	NUM
ihlr-16470	94	2	]	]	PUNCT
ihlr-16470	94	3	anti	anti	NOUN
ihlr-16470	94	4	-	-	NOUN
ihlr-16470	94	5	depressants	depressant	NOUN
ihlr-16470	94	6	and	and	CCONJ
ihlr-16470	94	7	children	child	NOUN
ihlr-16470	94	8	205	205	NUM
ihlr-16470	94	9	additionally	additionally	ADV
ihlr-16470	94	10	,	,	PUNCT
ihlr-16470	94	11	the	the	DET
ihlr-16470	94	12	american	american	PROPN
ihlr-16470	94	13	college	college	PROPN
ihlr-16470	94	14	of	of	ADP
ihlr-16470	94	15	neuropsychophannacology	neuropsychophannacology	PROPN
ihlr-16470	94	16	(	(	PUNCT
ihlr-16470	94	17	acn	acn	PROPN
ihlr-16470	94	18	)	)	PUNCT
ihlr-16470	94	19	notes	note	VERB
ihlr-16470	94	20	several	several	ADJ
ihlr-16470	94	21	shortcomings	shortcoming	NOUN
ihlr-16470	94	22	common	common	ADJ
ihlr-16470	94	23	to	to	ADP
ihlr-16470	94	24	the	the	DET
ihlr-16470	94	25	case	case	NOUN
ihlr-16470	94	26	reports	report	VERB
ihlr-16470	94	27	suggesting	suggest	VERB
ihlr-16470	94	28	a	a	DET
ihlr-16470	94	29	link	link	NOUN
ihlr-16470	94	30	between	between	ADP
ihlr-16470	94	31	ssris	ssris	NOUN
ihlr-16470	94	32	and	and	CCONJ
ihlr-16470	94	33	suicidal	suicidal	ADJ
ihlr-16470	94	34	ideation	ideation	NOUN
ihlr-16470	94	35	.	.	PUNCT
ihlr-16470	95	1	33	33	NUM
ihlr-16470	95	2	reports	report	NOUN
ihlr-16470	95	3	suggesting	suggest	VERB
ihlr-16470	95	4	a	a	DET
ihlr-16470	95	5	link	link	NOUN
ihlr-16470	95	6	between	between	ADP
ihlr-16470	95	7	ssris	ssris	NOUN
ihlr-16470	95	8	and	and	CCONJ
ihlr-16470	95	9	suicidal	suicidal	ADJ
ihlr-16470	95	10	ideation	ideation	NOUN
ihlr-16470	95	11	failed	fail	VERB
ihlr-16470	95	12	to	to	PART
ihlr-16470	95	13	distinguish	distinguish	VERB
ihlr-16470	95	14	between	between	ADP
ihlr-16470	95	15	the	the	DET
ihlr-16470	95	16	potential	potential	ADJ
ihlr-16470	95	17	contribution	contribution	NOUN
ihlr-16470	95	18	of	of	ADP
ihlr-16470	95	19	the	the	DET
ihlr-16470	95	20	disease	disease	NOUN
ihlr-16470	95	21	process	process	NOUN
ihlr-16470	95	22	,	,	PUNCT
ihlr-16470	95	23	external	external	ADJ
ihlr-16470	95	24	stressors	stressor	NOUN
ihlr-16470	95	25	,	,	PUNCT
ihlr-16470	95	26	and	and	CCONJ
ihlr-16470	95	27	the	the	DET
ihlr-16470	95	28	medication	medication	NOUN
ihlr-16470	95	29	.	.	PUNCT
ihlr-16470	96	1	34	34	NUM
ihlr-16470	96	2	also	also	ADV
ihlr-16470	96	3	,	,	PUNCT
ihlr-16470	96	4	such	such	ADJ
ihlr-16470	96	5	suicidal	suicidal	ADJ
ihlr-16470	96	6	ideation	ideation	NOUN
ihlr-16470	96	7	is	be	AUX
ihlr-16470	96	8	not	not	PART
ihlr-16470	96	9	specific	specific	ADJ
ihlr-16470	96	10	to	to	ADP
ihlr-16470	96	11	any	any	DET
ihlr-16470	96	12	one	one	NUM
ihlr-16470	96	13	type	type	NOUN
ihlr-16470	96	14	of	of	ADP
ihlr-16470	96	15	antidepressant	antidepressant	NOUN
ihlr-16470	96	16	,	,	PUNCT
ihlr-16470	96	17	which	which	PRON
ihlr-16470	96	18	suggests	suggest	VERB
ihlr-16470	96	19	that	that	SCONJ
ihlr-16470	96	20	the	the	DET
ihlr-16470	96	21	suicidal	suicidal	ADJ
ihlr-16470	96	22	ideation	ideation	NOUN
ihlr-16470	96	23	may	may	AUX
ihlr-16470	96	24	be	be	AUX
ihlr-16470	96	25	a	a	DET
ihlr-16470	96	26	manifestation	manifestation	NOUN
ihlr-16470	96	27	of	of	ADP
ihlr-16470	96	28	the	the	DET
ihlr-16470	96	29	disease	disease	NOUN
ihlr-16470	96	30	itself.35	itself.35	NOUN
ihlr-16470	96	31	in	in	ADP
ihlr-16470	96	32	light	light	NOUN
ihlr-16470	96	33	of	of	ADP
ihlr-16470	96	34	this	this	DET
ihlr-16470	96	35	evidence	evidence	NOUN
ihlr-16470	96	36	,	,	PUNCT
ihlr-16470	96	37	and	and	CCONJ
ihlr-16470	96	38	the	the	DET
ihlr-16470	96	39	shortcomings	shortcoming	NOUN
ihlr-16470	96	40	of	of	ADP
ihlr-16470	96	41	the	the	DET
ihlr-16470	96	42	reports	report	NOUN
ihlr-16470	96	43	suggesting	suggest	VERB
ihlr-16470	96	44	a	a	DET
ihlr-16470	96	45	link	link	NOUN
ihlr-16470	96	46	between	between	ADP
ihlr-16470	96	47	ssris	ssris	NOUN
ihlr-16470	96	48	and	and	CCONJ
ihlr-16470	96	49	suicidality	suicidality	NOUN
ihlr-16470	96	50	,	,	PUNCT
ihlr-16470	96	51	the	the	DET
ihlr-16470	96	52	american	american	PROPN
ihlr-16470	96	53	college	college	PROPN
ihlr-16470	96	54	ofneuropsycho­	ofneuropsycho­	PROPN
ihlr-16470	96	55	phannacology	phannacology	NOUN
ihlr-16470	96	56	issued	issue	VERB
ihlr-16470	96	57	a	a	DET
ihlr-16470	96	58	consensus	consensus	NOUN
ihlr-16470	96	59	statement	statement	NOUN
ihlr-16470	96	60	that	that	PRON
ihlr-16470	96	61	concluded	conclude	VERB
ihlr-16470	96	62	:	:	PUNCT
ihlr-16470	96	63	there	there	PRON
ihlr-16470	96	64	is	be	VERB
ihlr-16470	96	65	no	no	DET
ihlr-16470	96	66	evidence	evidence	NOUN
ihlr-16470	96	67	that	that	SCONJ
ihlr-16470	96	68	antidepressants	antidepressant	VERB
ihlr-16470	96	69	such	such	ADJ
ihlr-16470	96	70	as	as	ADP
ihlr-16470	96	71	the	the	DET
ihlr-16470	96	72	selective	selective	ADJ
ihlr-16470	96	73	serotonin	serotonin	NOUN
ihlr-16470	96	74	reuptake	reuptake	NOUN
ihlr-16470	96	75	inhibitors	inhibitor	NOUN
ihlr-16470	96	76	[	[	X
ihlr-16470	96	77	ssris	ssris	NOUN
ihlr-16470	96	78	]	]	PUNCT
ihlr-16470	96	79	,	,	PUNCT
ihlr-16470	96	80	for	for	ADP
ihlr-16470	96	81	example	example	NOUN
ihlr-16470	96	82	,	,	PUNCT
ihlr-16470	96	83	fluoxetine	fluoxetine	NOUN
ihlr-16470	96	84	[	[	X
ihlr-16470	96	85	prozac	prozac	NOUN
ihlr-16470	96	86	]	]	PUNCT
ihlr-16470	96	87	,	,	PUNCT
ihlr-16470	96	88	trigger	trigger	NOUN
ihlr-16470	96	89	emergent	emergent	ADJ
ihlr-16470	96	90	suicidal	suicidal	ADJ
ihlr-16470	96	91	ideation	ideation	NOUN
ihlr-16470	96	92	over	over	ADP
ihlr-16470	96	93	and	and	CCONJ
ihlr-16470	96	94	above	above	ADP
ihlr-16470	96	95	rates	rate	NOUN
ihlr-16470	96	96	that	that	PRON
ihlr-16470	96	97	may	may	AUX
ihlr-16470	96	98	be	be	AUX
ihlr-16470	96	99	associated	associate	VERB
ihlr-16470	96	100	with	with	ADP
ihlr-16470	96	101	depression	depression	NOUN
ihlr-16470	96	102	and	and	CCONJ
ihlr-16470	96	103	other	other	ADJ
ihlr-16470	96	104	antidepressants	antidepressant	NOUN
ihlr-16470	96	105	.	.	PUNCT
ihlr-16470	97	1	what	what	PRON
ihlr-16470	97	2	is	be	AUX
ihlr-16470	97	3	clear	clear	ADJ
ihlr-16470	97	4	is	be	AUX
ihlr-16470	97	5	that	that	SCONJ
ihlr-16470	97	6	most	most	ADJ
ihlr-16470	97	7	patients	patient	NOUN
ihlr-16470	97	8	receive	receive	VERB
ihlr-16470	97	9	substantial	substantial	ADJ
ihlr-16470	97	10	benefit	benefit	NOUN
ihlr-16470	97	11	from	from	ADP
ihlr-16470	97	12	treatment	treatment	NOUN
ihlr-16470	97	13	with	with	ADP
ihlr-16470	97	14	this	this	DET
ihlr-16470	97	15	drug	drug	NOUN
ihlr-16470	97	16	and	and	CCONJ
ihlr-16470	97	17	related	related	ADJ
ihlr-16470	97	18	antidepressants	antidepressant	NOUN
ihlr-16470	97	19	.	.	PUNCT
ihlr-16470	98	1	36	36	NUM
ihlr-16470	98	2	an	an	DET
ihlr-16470	98	3	acn	acn	PROPN
ihlr-16470	98	4	task	task	PROPN
ihlr-16470	98	5	force	force	PROPN
ihlr-16470	98	6	review	review	NOUN
ihlr-16470	98	7	further	far	ADV
ihlr-16470	98	8	concluded	conclude	VERB
ihlr-16470	98	9	that	that	SCONJ
ihlr-16470	98	10	"	"	PUNCT
ihlr-16470	98	11	new	new	ADJ
ihlr-16470	98	12	generation	generation	NOUN
ihlr-16470	98	13	low­	low­	NOUN
ihlr-16470	98	14	toxicity	toxicity	NOUN
ihlr-16470	98	15	antidepressants	antidepressant	NOUN
ihlr-16470	98	16	,	,	PUNCT
ihlr-16470	98	17	including	include	VERB
ihlr-16470	98	18	ssris	ssris	NOUN
ihlr-16470	98	19	,	,	PUNCT
ihlr-16470	98	20	may	may	AUX
ihlr-16470	98	21	carry	carry	VERB
ihlr-16470	98	22	a	a	DET
ihlr-16470	98	23	lower	low	ADJ
ihlr-16470	98	24	risk	risk	NOUN
ihlr-16470	98	25	for	for	ADP
ihlr-16470	98	26	suicide	suicide	NOUN
ihlr-16470	98	27	than	than	ADP
ihlr-16470	98	28	older	old	ADJ
ihlr-16470	98	29	tcas	tcas	PROPN
ihlr-16470	99	1	[	[	X
ihlr-16470	99	2	tricyclic	tricyclic	NOUN
ihlr-16470	99	3	antidepressants].'m	antidepressants].'m	VERB
ihlr-16470	99	4	nearly	nearly	ADV
ihlr-16470	99	5	all	all	PRON
ihlr-16470	99	6	scientific	scientific	ADJ
ihlr-16470	99	7	reviews	review	NOUN
ihlr-16470	99	8	of	of	ADP
ihlr-16470	99	9	the	the	DET
ihlr-16470	99	10	issue	issue	NOUN
ihlr-16470	99	11	agree	agree	VERB
ihlr-16470	99	12	that	that	SCONJ
ihlr-16470	99	13	although	although	SCONJ
ihlr-16470	99	14	suicidal	suicidal	ADJ
ihlr-16470	99	15	ideation	ideation	NOUN
ihlr-16470	99	16	may	may	AUX
ihlr-16470	99	17	enierge	enierge	VERB
ihlr-16470	99	18	during	during	ADP
ihlr-16470	99	19	treatment	treatment	NOUN
ihlr-16470	99	20	with	with	ADP
ihlr-16470	99	21	antidepressants	antidepressant	NOUN
ihlr-16470	99	22	,	,	PUNCT
ihlr-16470	99	23	a	a	DET
ihlr-16470	99	24	causal	causal	ADJ
ihlr-16470	99	25	relationship	relationship	NOUN
ihlr-16470	99	26	between	between	ADP
ihlr-16470	99	27	suicidality	suicidality	NOUN
ihlr-16470	99	28	and	and	CCONJ
ihlr-16470	99	29	anti­	anti­	CCONJ
ihlr-16470	99	30	depressant	depressant	NOUN
ihlr-16470	99	31	drugs	drug	NOUN
ihlr-16470	99	32	can	can	AUX
ihlr-16470	99	33	not	not	PART
ihlr-16470	99	34	be	be	AUX
ihlr-16470	99	35	established	establish	VERB
ihlr-16470	99	36	.	.	PUNCT
ihlr-16470	100	1	38	38	NUM
ihlr-16470	100	2	nevertheless	nevertheless	ADV
ihlr-16470	100	3	,	,	PUNCT
ihlr-16470	100	4	the	the	DET
ihlr-16470	100	5	research	research	NOUN
ihlr-16470	100	6	of	of	ADP
ihlr-16470	100	7	the	the	DET
ihlr-16470	100	8	acn	acn	PROPN
ihlr-16470	100	9	,	,	PUNCT
ihlr-16470	100	10	the	the	DET
ihlr-16470	100	11	fda	fda	PROPN
ihlr-16470	100	12	,	,	PUNCT
ihlr-16470	100	13	and	and	CCONJ
ihlr-16470	100	14	other	other	ADJ
ihlr-16470	100	15	groups	group	NOUN
ihlr-16470	100	16	that	that	PRON
ihlr-16470	100	17	have	have	AUX
ihlr-16470	100	18	studied	study	VERB
ihlr-16470	100	19	the	the	DET
ihlr-16470	100	20	i8sue	i8sue	NOUN
ihlr-16470	100	21	do	do	AUX
ihlr-16470	100	22	not	not	PART
ihlr-16470	100	23	address	address	VERB
ihlr-16470	100	24	ssri	ssri	PROPN
ihlr-16470	100	25	use	use	NOUN
ihlr-16470	100	26	in	in	ADP
ihlr-16470	100	27	children	child	NOUN
ihlr-16470	100	28	and	and	CCONJ
ihlr-16470	100	29	adolescents	adolescent	NOUN
ihlr-16470	100	30	.	.	PUNCT
ihlr-16470	101	1	the	the	DET
ihlr-16470	101	2	studies	study	NOUN
ihlr-16470	101	3	used	use	VERB
ihlr-16470	101	4	by	by	ADP
ihlr-16470	101	5	these	these	DET
ihlr-16470	101	6	groups	group	NOUN
ihlr-16470	101	7	focused	focus	VERB
ihlr-16470	101	8	almost	almost	ADV
ihlr-16470	101	9	exclusively	exclusively	ADV
ihlr-16470	101	10	on	on	ADP
ihlr-16470	101	11	the	the	DET
ihlr-16470	101	12	effect	effect	NOUN
ihlr-16470	101	13	of	of	ADP
ihlr-16470	101	14	ssris	ssris	NOUN
ihlr-16470	101	15	in	in	ADP
ihlr-16470	101	16	adults	adult	NOUN
ihlr-16470	101	17	,	,	PUNCT
ihlr-16470	101	18	and	and	CCONJ
ihlr-16470	101	19	the	the	DET
ihlr-16470	101	20	data	datum	NOUN
ihlr-16470	101	21	should	should	AUX
ihlr-16470	101	22	not	not	PART
ihlr-16470	101	23	be	be	AUX
ihlr-16470	101	24	simply	simply	ADV
ihlr-16470	101	25	applied	apply	VERB
ihlr-16470	101	26	to	to	ADP
ihlr-16470	101	27	children	child	NOUN
ihlr-16470	101	28	without	without	ADP
ihlr-16470	101	29	modification	modification	NOUN
ihlr-16470	101	30	.	.	PUNCT
ihlr-16470	102	1	instead	instead	ADV
ihlr-16470	102	2	,	,	PUNCT
ihlr-16470	102	3	additional	additional	ADJ
ihlr-16470	102	4	studies	study	NOUN
ihlr-16470	102	5	should	should	AUX
ihlr-16470	102	6	be	be	AUX
ihlr-16470	102	7	performed	perform	VERB
ihlr-16470	102	8	taking	take	VERB
ihlr-16470	102	9	into	into	ADP
ihlr-16470	102	10	account	account	NOUN
ihlr-16470	102	11	the	the	DET
ihlr-16470	102	12	important	important	ADJ
ihlr-16470	102	13	metabolic	metabolic	NOUN
ihlr-16470	102	14	and	and	CCONJ
ihlr-16470	102	15	physiological	physiological	ADJ
ihlr-16470	102	16	differences	difference	NOUN
ihlr-16470	102	17	between	between	ADP
ihlr-16470	102	18	children	child	NOUN
ihlr-16470	102	19	and	and	CCONJ
ihlr-16470	102	20	adults	adult	NOUN
ihlr-16470	102	21	.	.	PUNCT
ihlr-16470	103	1	39	39	NUM
ihlr-16470	103	2	33	33	NUM
ihlr-16470	103	3	.	.	PUNCT
ihlr-16470	104	1	i	i	PRON
ihlr-16470	104	2	d	d	PROPN
ihlr-16470	104	3	at	at	ADP
ihlr-16470	104	4	1112	1112	NUM
ihlr-16470	104	5	(	(	PUNCT
ihlr-16470	104	6	citations	citation	NOUN
ihlr-16470	104	7	omitted	omit	VERB
ihlr-16470	104	8	)	)	PUNCT
ihlr-16470	104	9	.	.	PUNCT
ihlr-16470	105	1	34	34	NUM
ihlr-16470	105	2	.	.	PUNCT
ihlr-16470	106	1	/d	/d	INTJ
ihlr-16470	106	2	.	.	PROPN
ihlr-16470	107	1	35	35	NUM
ihlr-16470	107	2	.	.	PUNCT
ihlr-16470	108	1	/d	/d	PUNCT
ihlr-16470	108	2	.	.	PUNCT
ihlr-16470	109	1	36	36	NUM
ihlr-16470	109	2	.	.	PUNCT
ihlr-16470	110	1	/d	/d	INTJ
ihlr-16470	110	2	.	.	PUNCT
ihlr-16470	111	1	37	37	NUM
ihlr-16470	111	2	.	.	PUNCT
ihlr-16470	112	1	miller	miller	PROPN
ihlr-16470	112	2	,	,	PUNCT
ihlr-16470	112	3	196	196	NUM
ihlr-16470	112	4	f.	f.	PROPN
ihlr-16470	112	5	supp	supp	PROPN
ihlr-16470	112	6	.	.	PUNCT
ihlr-16470	113	1	2d	2d	PROPN
ihlr-16470	113	2	at	at	ADP
ihlr-16470	113	3	1114	1114	NUM
ihlr-16470	113	4	(	(	PUNCT
ihlr-16470	113	5	quoting	quote	VERB
ihlr-16470	113	6	m.	m.	NOUN
ihlr-16470	113	7	goldblatt	goldblatt	PROPN
ihlr-16470	113	8	&	&	CCONJ
ihlr-16470	113	9	m.	m.	PROPN
ihlr-16470	113	10	silverman	silverman	PROPN
ihlr-16470	113	11	.	.	PUNCT
ihlr-16470	114	1	psychopharmacological	psychopharmacological	ADJ
ihlr-16470	114	2	treatment	treatment	NOUN
ihlr-16470	114	3	of	of	ADP
ihlr-16470	114	4	suicidal	suicidal	ADJ
ihlr-16470	114	5	patients	patient	NOUN
ihlr-16470	114	6	,	,	PUNCT
ihlr-16470	114	7	in	in	ADP
ihlr-16470	114	8	review	review	NOUN
ihlr-16470	114	9	of	of	ADP
ihlr-16470	114	10	suicidology	suicidology	NOUN
ihlr-16470	114	11	143	143	NUM
ihlr-16470	114	12	-	-	SYM
ihlr-16470	114	13	44	44	NUM
ihlr-16470	114	14	(	(	PUNCT
ihlr-16470	114	15	r.	r.	PROPN
ihlr-16470	114	16	maris	maris	PROPN
ihlr-16470	114	17	,	,	PUNCT
ihlr-16470	114	18	s.	s.	PROPN
ihlr-16470	114	19	canetto	canetto	PROPN
ihlr-16470	114	20	,	,	PUNCT
ihlr-16470	114	21	j.	j.	PROPN
ihlr-16470	114	22	mcintosh	mcintosh	PROPN
ihlr-16470	114	23	,	,	PUNCT
ihlr-16470	114	24	m.	m.	NOUN
ihlr-16470	114	25	silverman	silverman	PROPN
ihlr-16470	114	26	eds	eds	PROPN
ihlr-16470	114	27	.	.	PROPN
ihlr-16470	114	28	,	,	PUNCT
ihlr-16470	114	29	1999	1999	NUM
ihlr-16470	114	30	)	)	PUNCT
ihlr-16470	114	31	.	.	PUNCT
ihlr-16470	115	1	38	38	NUM
ihlr-16470	115	2	.	.	PUNCT
ihlr-16470	116	1	miller	miller	PROPN
ihlr-16470	116	2	,	,	PUNCT
ihlr-16470	116	3	196	196	NUM
ihlr-16470	116	4	f.	f.	PROPN
ihlr-16470	116	5	supp	supp	PROPN
ihlr-16470	116	6	.	.	PUNCT
ihlr-16470	117	1	2d	2d	PROPN
ihlr-16470	117	2	at	at	ADP
ihlr-16470	117	3	1109	1109	NUM
ihlr-16470	117	4	.	.	PUNCT
ihlr-16470	118	1	39	39	NUM
ihlr-16470	118	2	.	.	PUNCT
ihlr-16470	119	1	see	see	VERB
ihlr-16470	119	2	hazard	hazard	NOUN
ihlr-16470	119	3	,	,	PUNCT
ihlr-16470	119	4	supra	supra	PROPN
ihlr-16470	119	5	note	note	NOUN
ihlr-16470	119	6	8	8	NUM
ihlr-16470	119	7	.	.	X
ihlr-16470	119	8	206	206	NUM
ihlr-16470	119	9	indiana	indiana	PROPN
ihlr-16470	119	10	health	health	PROPN
ihlr-16470	119	11	law	law	PROPN
ihlr-16470	119	12	review	review	NOUN
ihlr-16470	120	1	[	[	X
ihlr-16470	120	2	vol	vol	NOUN
ihlr-16470	120	3	.	.	PUNCT
ihlr-16470	121	1	3:201	3:201	NUM
ihlr-16470	121	2	c.	c.	NOUN
ihlr-16470	121	3	children	child	NOUN
ihlr-16470	121	4	1	1	NUM
ihlr-16470	121	5	.	.	PUNCT
ihlr-16470	121	6	differences	difference	NOUN
ihlr-16470	121	7	in	in	ADP
ihlr-16470	121	8	testing	testing	NOUN
ihlr-16470	121	9	/	/	SYM
ihlr-16470	121	10	or	or	CCONJ
ihlr-16470	121	11	children	child	NOUN
ihlr-16470	121	12	and	and	CCONJ
ihlr-16470	121	13	adults	adult	NOUN
ihlr-16470	121	14	testing	testing	NOUN
ihlr-16470	121	15	of	of	ADP
ihlr-16470	121	16	new	new	ADJ
ihlr-16470	121	17	or	or	CCONJ
ihlr-16470	121	18	marketed	market	VERB
ihlr-16470	121	19	drugs	drug	NOUN
ihlr-16470	121	20	on	on	ADP
ihlr-16470	121	21	children	child	NOUN
ihlr-16470	121	22	was	be	AUX
ihlr-16470	121	23	not	not	PART
ihlr-16470	121	24	required	require	VERB
ihlr-16470	121	25	by	by	ADP
ihlr-16470	121	26	the	the	DET
ihlr-16470	121	27	fda	fda	PROPN
ihlr-16470	121	28	until1997	until1997	PROPN
ihlr-16470	121	29	.	.	PUNCT
ihlr-16470	122	1	40	40	NUM
ihlr-16470	122	2	prior	prior	ADV
ihlr-16470	122	3	to	to	ADP
ihlr-16470	122	4	1997	1997	NUM
ihlr-16470	122	5	,	,	PUNCT
ihlr-16470	122	6	the	the	DET
ihlr-16470	122	7	fda	fda	PROPN
ihlr-16470	122	8	merely	merely	ADV
ihlr-16470	122	9	prohibited	prohibit	VERB
ihlr-16470	122	10	drug	drug	NOUN
ihlr-16470	122	11	companies	company	NOUN
ihlr-16470	122	12	from	from	ADP
ihlr-16470	122	13	marketing	market	VERB
ihlr-16470	122	14	drugs	drug	NOUN
ihlr-16470	122	15	for	for	ADP
ihlr-16470	122	16	pediatric	pediatric	ADJ
ihlr-16470	122	17	pwposes	pwpose	NOUN
ihlr-16470	122	18	if	if	SCONJ
ihlr-16470	122	19	they	they	PRON
ihlr-16470	122	20	had	have	AUX
ihlr-16470	122	21	not	not	PART
ihlr-16470	122	22	been	be	AUX
ihlr-16470	122	23	tested	test	VERB
ihlr-16470	122	24	on	on	ADP
ihlr-16470	122	25	children	child	NOUN
ihlr-16470	122	26	for	for	ADP
ihlr-16470	122	27	safety	safety	NOUN
ihlr-16470	122	28	and	and	CCONJ
ihlr-16470	122	29	efficacy.41	efficacy.41	NOUN
ihlr-16470	122	30	this	this	DET
ihlr-16470	122	31	regulatory	regulatory	ADJ
ihlr-16470	122	32	scheme	scheme	NOUN
ihlr-16470	122	33	had	have	VERB
ihlr-16470	122	34	an	an	DET
ihlr-16470	122	35	unintended	unintended	ADJ
ihlr-16470	122	36	dual	dual	ADJ
ihlr-16470	122	37	effect	effect	NOUN
ihlr-16470	122	38	;	;	PUNCT
ihlr-16470	122	39	not	not	PART
ihlr-16470	122	40	only	only	ADV
ihlr-16470	122	41	did	do	AUX
ihlr-16470	122	42	it	it	PRON
ihlr-16470	122	43	protect	protect	VERB
ihlr-16470	122	44	children	child	NOUN
ihlr-16470	122	45	from	from	ADP
ihlr-16470	122	46	false	false	ADJ
ihlr-16470	122	47	and	and	CCONJ
ihlr-16470	122	48	misleading	misleading	ADJ
ihlr-16470	122	49	claims	claim	NOUN
ihlr-16470	122	50	on	on	ADP
ihlr-16470	122	51	drug	drug	NOUN
ihlr-16470	122	52	labels	label	NOUN
ihlr-16470	122	53	,	,	PUNCT
ihlr-16470	122	54	but	but	CCONJ
ihlr-16470	122	55	it	it	PRON
ihlr-16470	122	56	also	also	ADV
ihlr-16470	122	57	discouraged	discourage	VERB
ihlr-16470	122	58	pharmaceutical	pharmaceutical	ADJ
ihlr-16470	122	59	companies	company	NOUN
ihlr-16470	122	60	from	from	ADP
ihlr-16470	122	61	testing	test	VERB
ihlr-16470	122	62	new	new	ADJ
ihlr-16470	122	63	drugs	drug	NOUN
ihlr-16470	122	64	on	on	ADP
ihlr-16470	122	65	children.42	children.42	NOUN
ihlr-16470	122	66	as	as	ADP
ihlr-16470	122	67	a	a	DET
ihlr-16470	122	68	result	result	NOUN
ihlr-16470	122	69	,	,	PUNCT
ihlr-16470	122	70	there	there	PRON
ihlr-16470	122	71	was	be	VERB
ihlr-16470	122	72	very	very	ADV
ihlr-16470	122	73	little	little	ADJ
ihlr-16470	122	74	,	,	PUNCT
ihlr-16470	122	75	if	if	SCONJ
ihlr-16470	122	76	any	any	PRON
ihlr-16470	122	77	,	,	PUNCT
ihlr-16470	122	78	information	information	NOUN
ihlr-16470	122	79	available	available	ADJ
ihlr-16470	122	80	to	to	ADP
ihlr-16470	122	81	pediatricians	pediatrician	NOUN
ihlr-16470	122	82	prescribing	prescribe	VERB
ihlr-16470	122	83	drugs	drug	NOUN
ihlr-16470	122	84	to	to	ADP
ihlr-16470	122	85	children	child	NOUN
ihlr-16470	122	86	.	.	PUNCT
ihlr-16470	123	1	the	the	DET
ihlr-16470	123	2	lack	lack	NOUN
ihlr-16470	123	3	of	of	ADP
ihlr-16470	123	4	information	information	NOUN
ihlr-16470	123	5	forced	force	VERB
ihlr-16470	123	6	pediatricians	pediatrician	NOUN
ihlr-16470	123	7	to	to	PART
ihlr-16470	123	8	speculate	speculate	VERB
ihlr-16470	123	9	on	on	ADP
ihlr-16470	123	10	proper	proper	ADJ
ihlr-16470	123	11	dosages	dosage	NOUN
ihlr-16470	123	12	or	or	CCONJ
ihlr-16470	123	13	avoid	avoid	VERB
ihlr-16470	123	14	prescribing	prescribe	VERB
ihlr-16470	123	15	a	a	DET
ihlr-16470	123	16	potentially	potentially	ADV
ihlr-16470	123	17	beneficial	beneficial	ADJ
ihlr-16470	123	18	drug	drug	NOUN
ihlr-16470	123	19	altogether.43	altogether.43	NOUN
ihlr-16470	123	20	particularized	particularize	VERB
ihlr-16470	123	21	studies	study	NOUN
ihlr-16470	123	22	for	for	ADP
ihlr-16470	123	23	pediatric	pediatric	ADJ
ihlr-16470	123	24	patients	patient	NOUN
ihlr-16470	123	25	are	be	AUX
ihlr-16470	123	26	especially	especially	ADV
ihlr-16470	123	27	important	important	ADJ
ihlr-16470	123	28	because	because	SCONJ
ihlr-16470	123	29	children	child	NOUN
ihlr-16470	123	30	undergo	undergo	VERB
ihlr-16470	123	31	rapid	rapid	ADJ
ihlr-16470	123	32	metabolic	metabolic	NOUN
ihlr-16470	123	33	and	and	CCONJ
ihlr-16470	123	34	physiological	physiological	ADJ
ihlr-16470	123	35	changes	change	NOUN
ihlr-16470	123	36	,	,	PUNCT
ihlr-16470	123	37	thereby	thereby	ADV
ihlr-16470	123	38	creating	create	VERB
ihlr-16470	123	39	a	a	DET
ihlr-16470	123	40	need	need	NOUN
ihlr-16470	123	41	to	to	ADP
ihlr-16470	123	42	fine	fine	ADJ
ihlr-16470	123	43	-	-	PUNCT
ihlr-16470	123	44	tune	tune	NOUN
ihlr-16470	123	45	dosages	dosage	NOUN
ihlr-16470	123	46	based	base	VERB
ihlr-16470	123	47	on	on	ADP
ihlr-16470	123	48	the	the	DET
ihlr-16470	123	49	rate	rate	NOUN
ihlr-16470	123	50	of	of	ADP
ihlr-16470	123	51	elimination	elimination	NOUN
ihlr-16470	123	52	of	of	ADP
ihlr-16470	123	53	a	a	DET
ihlr-16470	123	54	drug	drug	NOUN
ihlr-16470	123	55	from	from	ADP
ihlr-16470	123	56	a	a	DET
ihlr-16470	123	57	child	child	NOUN
ihlr-16470	123	58	's	's	PART
ihlr-16470	123	59	system.44	system.44	NOUN
ihlr-16470	123	60	despite	despite	SCONJ
ihlr-16470	123	61	the	the	DET
ihlr-16470	123	62	importance	importance	NOUN
ihlr-16470	123	63	of	of	ADP
ihlr-16470	123	64	pediatric	pediatric	ADJ
ihlr-16470	123	65	studies	study	NOUN
ihlr-16470	123	66	,	,	PUNCT
ihlr-16470	123	67	by	by	ADP
ihlr-16470	123	68	the	the	DET
ihlr-16470	123	69	time	time	NOUN
ihlr-16470	123	70	the	the	DET
ihlr-16470	123	71	fda	fda	PROPN
ihlr-16470	123	72	began	begin	VERB
ihlr-16470	123	73	addressing	address	VERB
ihlr-16470	123	74	the	the	DET
ihlr-16470	123	75	problem	problem	NOUN
ihlr-16470	123	76	,	,	PUNCT
ihlr-16470	123	77	only	only	ADV
ihlr-16470	123	78	twenty	twenty	NUM
ihlr-16470	123	79	percent	percent	NOUN
ihlr-16470	123	80	of	of	ADP
ihlr-16470	123	81	drugs	drug	NOUN
ihlr-16470	123	82	were	be	AUX
ihlr-16470	123	83	labeled	label	VERB
ihlr-16470	123	84	for	for	ADP
ihlr-16470	123	85	use	use	NOUN
ihlr-16470	123	86	in	in	ADP
ihlr-16470	123	87	children	child	NOUN
ihlr-16470	123	88	,	,	PUNCT
ihlr-16470	123	89	·	·	PUNCT
ihlr-16470	123	90	and	and	CCONJ
ihlr-16470	123	91	six	six	NUM
ihlr-16470	123	92	of	of	ADP
ihlr-16470	123	93	the	the	DET
ihlr-16470	123	94	ten	ten	NUM
ihlr-16470	123	95	leading	lead	VERB
ihlr-16470	123	96	drugs	drug	NOUN
ihlr-16470	123	97	prescribed	prescribe	VERB
ihlr-16470	123	98	by	by	ADP
ihlr-16470	123	99	pediatricians	pediatrician	NOUN
ihlr-16470	123	100	had	have	AUX
ihlr-16470	123	101	never	never	ADV
ihlr-16470	123	102	been	be	AUX
ihlr-16470	123	103	tested	test	VERB
ihlr-16470	123	104	on	on	ADP
ihlr-16470	123	105	children.45	children.45	NOUN
ihlr-16470	123	106	ssris	ssris	PROPN
ihlr-16470	123	107	provide	provide	VERB
ihlr-16470	123	108	a	a	DET
ihlr-16470	123	109	terrific	terrific	ADJ
ihlr-16470	123	110	illustration	illustration	NOUN
ihlr-16470	123	111	of	of	ADP
ihlr-16470	123	112	the	the	DET
ihlr-16470	123	113	inadequacies	inadequacy	NOUN
ihlr-16470	123	114	of	of	ADP
ihlr-16470	123	115	such	such	DET
ihlr-16470	123	116	a	a	DET
ihlr-16470	123	117	system	system	NOUN
ihlr-16470	123	118	.	.	PUNCT
ihlr-16470	124	1	despite	despite	SCONJ
ihlr-16470	124	2	a	a	DET
ihlr-16470	124	3	dearth	dearth	NOUN
ihlr-16470	124	4	of	of	ADP
ihlr-16470	124	5	safety	safety	NOUN
ihlr-16470	124	6	and	and	CCONJ
ihlr-16470	124	7	efficacy	efficacy	NOUN
ihlr-16470	124	8	data	datum	NOUN
ihlr-16470	124	9	and	and	CCONJ
ihlr-16470	124	10	an	an	DET
ihlr-16470	124	11	absence	absence	NOUN
ihlr-16470	124	12	of	of	ADP
ihlr-16470	124	13	guidelines	guideline	NOUN
ihlr-16470	124	14	for	for	ADP
ihlr-16470	124	15	use	use	NOUN
ihlr-16470	124	16	in	in	ADP
ihlr-16470	124	17	children	child	NOUN
ihlr-16470	124	18	,	,	PUNCT
ihlr-16470	124	19	ssri	ssri	ADJ
ihlr-16470	124	20	prescriptions	prescription	NOUN
ihlr-16470	124	21	for	for	ADP
ihlr-16470	124	22	children	child	NOUN
ihlr-16470	124	23	and	and	CCONJ
ihlr-16470	124	24	adolescents	adolescent	NOUN
ihlr-16470	124	25	have	have	AUX
ihlr-16470	124	26	increased	increase	VERB
ihlr-16470	124	27	greatly	greatly	ADV
ihlr-16470	124	28	in	in	ADP
ihlr-16470	124	29	recent	recent	ADJ
ihlr-16470	124	30	years.46	years.46	NOUN
ihlr-16470	124	31	in	in	ADP
ihlr-16470	124	32	fact	fact	NOUN
ihlr-16470	124	33	,	,	PUNCT
ihlr-16470	124	34	ssris	ssris	PROPN
ihlr-16470	124	35	have	have	AUX
ihlr-16470	124	36	come	come	VERB
ihlr-16470	124	37	to	to	PART
ihlr-16470	124	38	be	be	AUX
ihlr-16470	124	39	viewed	view	VERB
ihlr-16470	124	40	as	as	ADP
ihlr-16470	124	41	safe	safe	ADJ
ihlr-16470	124	42	and	and	CCONJ
ihlr-16470	124	43	effective	effective	ADJ
ihlr-16470	124	44	for	for	ADP
ihlr-16470	124	45	children	child	NOUN
ihlr-16470	124	46	and	and	CCONJ
ihlr-16470	124	47	are	be	AUX
ihlr-16470	124	48	widely	widely	ADV
ihlr-16470	124	49	prescribed	prescribe	VERB
ihlr-16470	124	50	,	,	PUNCT
ihlr-16470	124	51	notwithstanding	notwithstanding	ADP
ihlr-16470	124	52	their	their	PRON
ihlr-16470	124	53	lack	lack	NOUN
ihlr-16470	124	54	of	of	ADP
ihlr-16470	124	55	approval	approval	NOUN
ihlr-16470	124	56	for	for	ADP
ihlr-16470	124	57	use	use	NOUN
ihlr-16470	124	58	in	in	ADP
ihlr-16470	124	59	children	child	NOUN
ihlr-16470	124	60	.	.	PUNCT
ihlr-16470	125	1	additionally	additionally	ADV
ihlr-16470	125	2	,	,	PUNCT
ihlr-16470	125	3	physicians	physician	NOUN
ihlr-16470	125	4	prescribe	prescribe	VERB
ihlr-16470	125	5	ssris	ssris	NOUN
ihlr-16470	125	6	to	to	ADP
ihlr-16470	125	7	children	child	NOUN
ihlr-16470	125	8	for	for	ADP
ihlr-16470	125	9	a	a	DET
ihlr-16470	125	10	variety	variety	NOUN
ihlr-16470	125	11	of	of	ADP
ihlr-16470	125	12	psychiatric	psychiatric	ADJ
ihlr-16470	125	13	illnesses	illness	NOUN
ihlr-16470	125	14	outside	outside	ADV
ihlr-16470	125	15	of	of	ADP
ihlr-16470	125	16	the	the	DET
ihlr-16470	125	17	approved	approve	VERB
ihlr-16470	125	18	uses.47	uses.47	NOUN
ihlr-16470	125	19	as	as	ADP
ihlr-16470	125	20	a	a	DET
ihlr-16470	125	21	result	result	NOUN
ihlr-16470	125	22	,	,	PUNCT
ihlr-16470	125	23	children	child	NOUN
ihlr-16470	125	24	are	be	AUX
ihlr-16470	125	25	placed	place	VERB
ihlr-16470	125	26	in	in	ADP
ihlr-16470	125	27	.	.	PUNCT
ihlr-16470	126	1	the	the	DET
ihlr-16470	126	2	undesirable	undesirable	ADJ
ihlr-16470	126	3	and	and	CCONJ
ihlr-16470	126	4	dangerous	dangerous	ADJ
ihlr-16470	126	5	position	position	NOUN
ihlr-16470	126	6	of	of	ADP
ihlr-16470	126	7	de	de	X
ihlr-16470	126	8	facto	facto	X
ihlr-16470	126	9	guinea	guinea	NOUN
ihlr-16470	126	10	pigs	pig	NOUN
ihlr-16470	126	11	for	for	ADP
ihlr-16470	126	12	pediatric	pediatric	ADJ
ihlr-16470	126	13	experimentation	experimentation	NOUN
ihlr-16470	126	14	outside	outside	ADP
ihlr-16470	126	15	the	the	DET
ihlr-16470	126	16	scope	scope	NOUN
ihlr-16470	126	17	of	of	ADP
ihlr-16470	126	18	a	a	DET
ihlr-16470	126	19	controlled	control	VERB
ihlr-16470	126	20	and	and	CCONJ
ihlr-16470	126	21	relatively	relatively	ADV
ihlr-16470	126	22	safe	safe	ADJ
ihlr-16470	126	23	drug	drug	NOUN
ihlr-16470	126	24	trial.48	trial.48	NOUN
ihlr-16470	126	25	thus	thus	ADV
ihlr-16470	126	26	,	,	PUNCT
ihlr-16470	126	27	children	child	NOUN
ihlr-16470	126	28	are	be	AUX
ihlr-16470	126	29	less	less	ADV
ihlr-16470	126	30	40	40	NUM
ihlr-16470	126	31	.	.	PUNCT
ihlr-16470	126	32	hawd	hawd	ADJ
ihlr-16470	126	33	.	.	PUNCT
ihlr-16470	127	1	supra	supra	PROPN
ihlr-16470	127	2	~ote	~ote	VERB
ihlr-16470	127	3	8	8	NUM
ihlr-16470	127	4	,	,	PUNCT
ihlr-16470	127	5	at	at	ADP
ihlr-16470	127	6	478	478	NUM
ihlr-16470	127	7	.	.	NOUN
ihlr-16470	127	8	41	41	NUM
ihlr-16470	127	9	.	.	PUNCT
ihlr-16470	128	1	i	i	PRON
ihlr-16470	128	2	d.	d.	PROPN
ihlr-16470	128	3	42	42	NUM
ihlr-16470	128	4	.	.	PUNCT
ihlr-16470	129	1	i	i	PRON
ihlr-16470	129	2	d.	d.	PROPN
ihlr-16470	129	3	43	43	NUM
ihlr-16470	129	4	.	.	PUNCT
ihlr-16470	130	1	i	i	PRON
ihlr-16470	130	2	d.	d.	PROPN
ihlr-16470	130	3	44.jd	44.jd	NUM
ihlr-16470	130	4	.	.	PUNCT
ihlr-16470	131	1	at477	at477	NOUN
ihlr-16470	131	2	.	.	PUNCT
ihlr-16470	132	1	45	45	NUM
ihlr-16470	132	2	.	.	X
ihlr-16470	132	3	hazard	hazard	NOUN
ihlr-16470	132	4	,	,	PUNCT
ihlr-16470	132	5	supra	supra	PROPN
ihlr-16470	132	6	note	note	NOUN
ihlr-16470	132	7	8	8	NUM
ihlr-16470	132	8	,	,	PUNCT
ihlr-16470	132	9	at	at	ADP
ihlr-16470	132	10	418	418	NUM
ihlr-16470	132	11	.	.	PUNCT
ihlr-16470	133	1	46	46	NUM
ihlr-16470	133	2	.	.	PUNCT
ihlr-16470	133	3	symposium	symposium	NOUN
ihlr-16470	133	4	,	,	PUNCT
ihlr-16470	133	5	supra	supra	PROPN
ihlr-16470	133	6	note	note	NOUN
ihlr-16470	133	7	3	3	NUM
ihlr-16470	133	8	,	,	PUNCT
ihlr-16470	133	9	at	at	ADP
ihlr-16470	133	10	334	334	NUM
ihlr-16470	133	11	-	-	SYM
ihlr-16470	133	12	35	35	NUM
ihlr-16470	133	13	.	.	PUNCT
ihlr-16470	134	1	47	47	NUM
ihlr-16470	134	2	.	.	PUNCT
ihlr-16470	135	1	ld	ld	AUX
ihlr-16470	135	2	.	.	PROPN
ihlr-16470	135	3	see	see	VERB
ihlr-16470	135	4	food	food	PROPN
ihlr-16470	135	5	&	&	CCONJ
ihlr-16470	135	6	.	.	PUNCT
ihlr-16470	135	7	drug	drug	PROPN
ihlr-16470	135	8	admin	admin	PROPN
ihlr-16470	135	9	••	••	PROPN
ihlr-16470	135	10	public	public	PROPN
ihlr-16470	135	11	health	health	NOUN
ihlr-16470	135	12	advisory	advisory	NOUN
ihlr-16470	135	13	,	,	PUNCT
ihlr-16470	135	14	suicidalily	suicidalily	ADV
ihlr-16470	135	15	in	in	SCONJ
ihlr-16470	135	16	children	child	NOUN
ihlr-16470	135	17	and	and	CCONJ
ihlr-16470	135	18	adolescents	adolescent	NOUN
ihlr-16470	135	19	being	be	AUX
ihlr-16470	135	20	treated	treat	VERB
ihlr-16470	135	21	·	·	PUNCT
ihlr-16470	135	22	with	with	ADP
ihlr-16470	135	23	antidepressant	antidepressant	ADJ
ihlr-16470	135	24	medications	medication	NOUN
ihlr-16470	135	25	(	(	PUNCT
ihlr-16470	135	26	oct	oct	PROPN
ihlr-16470	135	27	.	.	PROPN
ihlr-16470	135	28	15	15	NUM
ihlr-16470	135	29	,	,	PUNCT
ihlr-16470	135	30	2004	2004	NUM
ihlr-16470	135	31	)	)	PUNCT
ihlr-16470	135	32	,	,	PUNCT
ihlr-16470	135	33	http://www	http://www	PROPN
ihlr-16470	135	34	.fda.gov	.fda.gov	NOUN
ihlr-16470	135	35	/	/	SYM
ihlr-16470	135	36	cder	cder	NOUN
ihlr-16470	135	37	/	/	SYM
ihlr-16470	135	38	drug	drug	NOUN
ihlr-16470	135	39	/	/	SYM
ihlr-16470	135	40	antidepressants	antidepressant	NOUN
ihlr-16470	135	41	/	/	SYM
ihlr-16470	135	42	ssripha20041	ssripha20041	PROPN
ihlr-16470	135	43	o.btm	o.btm	NOUN
ihlr-16470	135	44	.	.	PUNCT
ihlr-16470	136	1	(	(	PUNCT
ihlr-16470	136	2	"	"	PUNCT
ihlr-16470	136	3	among	among	ADP
ihlr-16470	136	4	.	.	PUNCT
ihlr-16470	136	5	.	.	PUNCT
ihlr-16470	136	6	.	.	PUNCT
ihlr-16470	137	1	antidepressants	antidepressant	NOUN
ihlr-16470	137	2	,	,	PUNCT
ihlr-16470	137	3	only	only	ADV
ihlr-16470	137	4	prozac	prozac	NOUN
ihlr-16470	137	5	is	be	AUX
ihlr-16470	137	6	approved	approve	VERB
ihlr-16470	137	7	for	for	ADP
ihlr-16470	137	8	use	use	NOUN
ihlr-16470	137	9	in	in	ADP
ihlr-16470	137	10	treating	treat	VERB
ihlr-16470	137	11	mdd	mdd	PROPN
ihlr-16470	137	12	in	in	ADP
ihlr-16470	137	13	pediatric	pediatric	ADJ
ihlr-16470	137	14	patients	patient	NOUN
ihlr-16470	137	15	.	.	PUNCT
ihlr-16470	138	1	prozac	prozac	PROPN
ihlr-16470	138	2	,	,	PUNCT
ihlr-16470	138	3	zoloft	zoloft	PROPN
ihlr-16470	138	4	,	,	PUNCT
ihlr-16470	138	5	luvox	luvox	PROPN
ihlr-16470	138	6	,	,	PUNCT
ihlr-16470	138	7	and	and	CCONJ
ihlr-16470	138	8	anafranil	anafranil	NOUN
ihlr-16470	138	9	are	be	AUX
ihlr-16470	138	10	approved	approve	VERB
ihlr-16470	138	11	for	for	ADP
ihlr-16470	138	12	ocd	ocd	PROPN
ihlr-16470	138	13	in	in	ADP
ihlr-16470	138	14	pediatric	pediatric	ADJ
ihlr-16470	138	15	patients	patient	NOUN
ihlr-16470	138	16	.	.	PUNCT
ihlr-16470	139	1	none	none	NOUN
ihlr-16470	139	2	of	of	ADP
ihlr-16470	139	3	the	the	DET
ihlr-16470	139	4	drugs	drug	NOUN
ihlr-16470	139	5	is	be	AUX
ihlr-16470	139	6	approved	approve	VERB
ihlr-16470	139	7	for	for	ADP
ihlr-16470	139	8	other	other	ADJ
ihlr-16470	139	9	psychiatric	psychiatric	ADJ
ihlr-16470	139	10	indications	indication	NOUN
ihlr-16470	139	11	in	in	ADP
ihlr-16470	139	12	children	child	NOUN
ihlr-16470	139	13	.	.	PUNCT
ihlr-16470	139	14	''	''	PUNCT
ihlr-16470	139	15	)	)	PUNCT
ihlr-16470	140	1	(	(	PUNCT
ihlr-16470	140	2	last	last	ADJ
ihlr-16470	140	3	visited	visit	VERB
ihlr-16470	140	4	april14	april14	NOUN
ihlr-16470	140	5	,	,	PUNCT
ihlr-16470	140	6	2006	2006	NUM
ihlr-16470	140	7	)	)	PUNCT
ihlr-16470	140	8	.	.	PUNCT
ihlr-16470	141	1	48	48	NUM
ihlr-16470	141	2	.	.	PUNCT
ihlr-16470	142	1	hazard	hazard	NOUN
ihlr-16470	142	2	,	,	PUNCT
ihlr-16470	142	3	supra	supra	PROPN
ihlr-16470	142	4	note	note	NOUN
ihlr-16470	142	5	8	8	NUM
ihlr-16470	142	6	,	,	PUNCT
ihlr-16470	142	7	at	at	ADP
ihlr-16470	142	8	478	478	NUM
ihlr-16470	142	9	-	-	SYM
ihlr-16470	142	10	79	79	NUM
ihlr-16470	142	11	.	.	PUNCT
ihlr-16470	143	1	2006	2006	NUM
ihlr-16470	143	2	]	]	PUNCT
ihlr-16470	143	3	anti	anti	NOUN
ihlr-16470	143	4	-	-	NOUN
ihlr-16470	143	5	depressants	depressant	NOUN
ihlr-16470	143	6	and	and	CCONJ
ihlr-16470	143	7	children	child	NOUN
ihlr-16470	143	8	207	207	NUM
ihlr-16470	143	9	likely	likely	ADJ
ihlr-16470	143	10	to	to	PART
ihlr-16470	143	11	receive	receive	VERB
ihlr-16470	143	12	the	the	DET
ihlr-16470	143	13	most	most	ADV
ihlr-16470	143	14	effective	effective	ADJ
ihlr-16470	143	15	treatment	treatment	NOUN
ihlr-16470	143	16	available	available	ADJ
ihlr-16470	143	17	,	,	PUNCT
ihlr-16470	143	18	and	and	CCONJ
ihlr-16470	143	19	there	there	PRON
ihlr-16470	143	20	is	be	VERB
ihlr-16470	143	21	a	a	DET
ihlr-16470	143	22	lack	lack	NOUN
ihlr-16470	143	23	of	of	ADP
ihlr-16470	143	24	reliable	reliable	ADJ
ihlr-16470	143	25	efficacy	efficacy	NOUN
ihlr-16470	143	26	data	datum	NOUN
ihlr-16470	143	27	available	available	ADJ
ihlr-16470	143	28	to	to	PART
ihlr-16470	143	29	allow	allow	VERB
ihlr-16470	143	30	pediatricians	pediatrician	NOUN
ihlr-16470	143	31	to	to	PART
ihlr-16470	143	32	make	make	VERB
ihlr-16470	143	33	the	the	DET
ihlr-16470	143	34	best	good	ADJ
ihlr-16470	143	35	and	and	CCONJ
ihlr-16470	143	36	most	most	ADV
ihlr-16470	143	37	informed	inform	VERB
ihlr-16470	143	38	choice	choice	NOUN
ihlr-16470	143	39	when	when	SCONJ
ihlr-16470	143	40	prescribing	prescribing	NOUN
ihlr-16470	143	41	drugs	drug	NOUN
ihlr-16470	143	42	.	.	PUNCT
ihlr-16470	144	1	2	2	X
ihlr-16470	144	2	.	.	X
ihlr-16470	144	3	recent	recent	ADJ
ihlr-16470	144	4	developments	development	NOUN
ihlr-16470	144	5	of	of	ADP
ihlr-16470	144	6	ssri	ssri	ADJ
ihlr-16470	144	7	use	use	NOUN
ihlr-16470	144	8	in	in	ADP
ihlr-16470	144	9	children	child	NOUN
ihlr-16470	144	10	ssri	ssri	NOUN
ihlr-16470	144	11	use	use	NOUN
ihlr-16470	144	12	in	in	ADP
ihlr-16470	144	13	children	child	NOUN
ihlr-16470	144	14	has	have	AUX
ihlr-16470	144	15	come	come	VERB
ihlr-16470	144	16	under	under	ADP
ihlr-16470	144	17	heavy	heavy	ADJ
ihlr-16470	144	18	attack	attack	NOUN
ihlr-16470	144	19	recently	recently	ADV
ihlr-16470	144	20	as	as	SCONJ
ihlr-16470	144	21	several	several	ADJ
ihlr-16470	144	22	agencies	agency	NOUN
ihlr-16470	144	23	have	have	AUX
ihlr-16470	144	24	declared	declare	VERB
ihlr-16470	144	25	them	they	PRON
ihlr-16470	144	26	unsafe	unsafe	ADJ
ihlr-16470	144	27	for	for	ADP
ihlr-16470	144	28	use	use	NOUN
ihlr-16470	144	29	in	in	ADP
ihlr-16470	144	30	children	child	NOUN
ihlr-16470	144	31	.	.	PUNCT
ihlr-16470	145	1	for	for	ADP
ihlr-16470	145	2	example	example	NOUN
ihlr-16470	145	3	,	,	PUNCT
ihlr-16470	145	4	new	new	PROPN
ihlr-16470	145	5	york	york	PROPN
ihlr-16470	145	6	attorney	attorney	PROPN
ihlr-16470	145	7	general	general	PROPN
ihlr-16470	145	8	elliot	elliot	PROPN
ihlr-16470	145	9	spitzer	spitzer	PROPN
ihlr-16470	145	10	sued	sue	VERB
ihlr-16470	145	11	glaxosmithk.line	glaxosmithk.line	NOUN
ihlr-16470	145	12	,	,	PUNCT
ihlr-16470	145	13	the	the	DET
ihlr-16470	145	14	maker	maker	NOUN
ihlr-16470	145	15	of	of	ADP
ihlr-16470	145	16	paxil	paxil	NOUN
ihlr-16470	145	17	,	,	PUNCT
ihlr-16470	145	18	for	for	ADP
ihlr-16470	145	19	withholding	withholding	NOUN
ihlr-16470	145	20	data	datum	NOUN
ihlr-16470	145	21	that	that	PRON
ihlr-16470	145	22	showed	show	VERB
ihlr-16470	145	23	that	that	SCONJ
ihlr-16470	145	24	paxil	paxil	NOUN
ihlr-16470	145	25	was	be	AUX
ihlr-16470	145	26	ineffective	ineffective	ADJ
ihlr-16470	145	27	for	for	ADP
ihlr-16470	145	28	children	child	NOUN
ihlr-16470	145	29	.	.	PUNCT
ihlr-16470	146	1	49	49	NUM
ihlr-16470	146	2	most	most	ADJ
ihlr-16470	146	3	of	of	ADP
ihlr-16470	146	4	the	the	DET
ihlr-16470	146	5	current	current	ADJ
ihlr-16470	146	6	interest	interest	NOUN
ihlr-16470	146	7	in	in	ADP
ihlr-16470	146	8	ssri	ssri	ADJ
ihlr-16470	146	9	use	use	NOUN
ihlr-16470	146	10	in	in	ADP
ihlr-16470	146	11	children	child	NOUN
ihlr-16470	146	12	was	be	AUX
ihlr-16470	146	13	spurred	spur	VERB
ihlr-16470	146	14	by	by	ADP
ihlr-16470	146	15	the	the	DET
ihlr-16470	146	16	medicines	medicine	NOUN
ihlr-16470	146	17	and	and	CCONJ
ihlr-16470	146	18	healthcare	healthcare	NOUN
ihlr-16470	146	19	products	product	NOUN
ihlr-16470	146	20	regulatory	regulatory	ADJ
ihlr-16470	146	21	agency	agency	NOUN
ihlr-16470	146	22	's	's	PART
ihlr-16470	146	23	(	(	PUNCT
ihlr-16470	146	24	mhra	mhra	NOUN
ihlr-16470	146	25	)	)	PUNCT
ihlr-16470	146	26	(	(	PUNCT
ihlr-16470	146	27	britain	britain	PROPN
ihlr-16470	146	28	's	's	PART
ihlr-16470	146	29	equivalent	equivalent	NOUN
ihlr-16470	146	30	to	to	ADP
ihlr-16470	146	31	the	the	DET
ihlr-16470	146	32	fda	fda	PROPN
ihlr-16470	146	33	)	)	PUNCT
ihlr-16470	146	34	statement	statement	NOUN
ihlr-16470	146	35	on	on	ADP
ihlr-16470	146	36	june	june	PROPN
ihlr-16470	146	37	10.2003	10.2003	NUM
ihlr-16470	146	38	that	that	PRON
ihlr-16470	146	39	the	the	DET
ihlr-16470	146	40	ssri	ssri	PROPN
ihlr-16470	146	41	seroxat	seroxat	PROPN
ihlr-16470	146	42	(	(	PUNCT
ihlr-16470	146	43	marketed	market	VERB
ihlr-16470	146	44	as	as	ADP
ihlr-16470	146	45	paxil	paxil	NOUN
ihlr-16470	146	46	in	in	ADP
ihlr-16470	146	47	the	the	DET
ihlr-16470	146	48	u.s	u.s	PROPN
ihlr-16470	146	49	.	.	PROPN
ihlr-16470	146	50	)	)	PUNCT
ihlr-16470	146	51	must	must	AUX
ihlr-16470	146	52	not	not	PART
ihlr-16470	146	53	be	be	AUX
ihlr-16470	146	54	used	use	VERB
ihlr-16470	146	55	for	for	ADP
ihlr-16470	146	56	treatment	treatment	NOUN
ihlr-16470	146	57	of	of	ADP
ihlr-16470	146	58	children	child	NOUN
ihlr-16470	146	59	.	.	PUNCT
ihlr-16470	147	1	50	50	NUM
ihlr-16470	147	2	after	after	ADP
ihlr-16470	147	3	reviewing	review	VERB
ihlr-16470	147	4	data	datum	NOUN
ihlr-16470	147	5	from	from	ADP
ihlr-16470	147	6	clinical	clinical	ADJ
ihlr-16470	147	7	trials	trial	NOUN
ihlr-16470	147	8	conducted	conduct	VERB
ihlr-16470	147	9	by	by	ADP
ihlr-16470	147	10	phar­	phar­	VERB
ihlr-16470	147	11	maceutical	maceutical	ADJ
ihlr-16470	147	12	companies	company	NOUN
ihlr-16470	147	13	,	,	PUNCT
ihlr-16470	147	14	the	the	DET
ihlr-16470	147	15	mhra	mhra	NOUN
ihlr-16470	147	16	's	's	PART
ihlr-16470	147	17	committee	committee	NOUN
ihlr-16470	147	18	on	on	ADP
ihlr-16470	147	19	safety	safety	NOUN
ihlr-16470	147	20	of	of	ADP
ihlr-16470	147	21	medicines	medicine	NOUN
ihlr-16470	147	22	(	(	PUNCT
ihlr-16470	147	23	csm	csm	NOUN
ihlr-16470	147	24	)	)	PUNCT
ihlr-16470	147	25	concluded	conclude	VERB
ihlr-16470	147	26	that	that	SCONJ
ihlr-16470	147	27	for	for	SCONJ
ihlr-16470	147	28	six	six	NUM
ihlr-16470	147	29	of	of	ADP
ihlr-16470	147	30	the	the	DET
ihlr-16470	147	31	seven	seven	NUM
ihlr-16470	147	32	ssris	ssris	NOUN
ihlr-16470	147	33	investigated	investigate	VERB
ihlr-16470	147	34	,	,	PUNCT
ihlr-16470	147	35	the	the	DET
ihlr-16470	147	36	risks	risk	NOUN
ihlr-16470	147	37	of	of	ADP
ihlr-16470	147	38	suicide	suicide	NOUN
ihlr-16470	147	39	and	and	CCONJ
ihlr-16470	147	40	suicidal	suicidal	ADJ
ihlr-16470	147	41	ideation	ideation	NOUN
ihlr-16470	147	42	outweigh	outweigh	VERB
ihlr-16470	147	43	any	any	DET
ihlr-16470	147	44	benefits	benefit	NOUN
ihlr-16470	147	45	in	in	ADP
ihlr-16470	147	46	children	child	NOUN
ihlr-16470	147	47	with	with	ADP
ihlr-16470	147	48	depression	depression	NOUN
ihlr-16470	147	49	,	,	PUNCT
ihlr-16470	147	50	and	and	CCONJ
ihlr-16470	147	51	therefore	therefore	ADV
ihlr-16470	147	52	ssris	ssris	PROPN
ihlr-16470	147	53	should	should	AUX
ihlr-16470	147	54	not	not	PART
ihlr-16470	147	55	be	be	AUX
ihlr-16470	147	56	used	use	VERB
ihlr-16470	147	57	for	for	ADP
ihlr-16470	147	58	pediatric	pediatric	ADJ
ihlr-16470	147	59	patients	patient	NOUN
ihlr-16470	147	60	.	.	PUNCT
ihlr-16470	148	1	51	51	NUM
ihlr-16470	148	2	after	after	ADP
ihlr-16470	148	3	the	the	DET
ihlr-16470	148	4	mhraannouncement	mhraannouncement	NOUN
ihlr-16470	148	5	in	in	ADP
ihlr-16470	148	6	june2003	june2003	PROPN
ihlr-16470	148	7	,	,	PUNCT
ihlr-16470	148	8	the	the	DET
ihlr-16470	148	9	fda	fda	PROPN
ihlr-16470	148	10	and	and	CCONJ
ihlr-16470	148	11	other	other	ADJ
ihlr-16470	148	12	groups	group	NOUN
ihlr-16470	148	13	began	begin	VERB
ihlr-16470	148	14	taking	take	VERB
ihlr-16470	148	15	a	a	DET
ihlr-16470	148	16	closer	close	ADJ
ihlr-16470	148	17	look	look	NOUN
ihlr-16470	148	18	at	at	ADP
ihlr-16470	148	19	ssri	ssri	PROPN
ihlr-16470	148	20	use	use	NOUN
ihlr-16470	148	21	in	in	ADP
ihlr-16470	148	22	children	child	NOUN
ihlr-16470	148	23	.	.	PUNCT
ihlr-16470	149	1	twelve	twelve	NUM
ihlr-16470	149	2	of	of	ADP
ihlr-16470	149	3	fifteen	fifteen	NUM
ihlr-16470	149	4	subsequent	subsequent	ADJ
ihlr-16470	149	5	studies	study	NOUN
ihlr-16470	149	6	of	of	ADP
ihlr-16470	149	7	ssris	ssris	PROPN
ihlr-16470	149	8	failed	fail	VERB
ihlr-16470	149	9	to	to	PART
ihlr-16470	149	10	show	show	VERB
ihlr-16470	149	11	that	that	SCONJ
ihlr-16470	149	12	the	the	DET
ihlr-16470	149	13	drugs	drug	NOUN
ihlr-16470	149	14	were	be	AUX
ihlr-16470	149	15	effective	effective	ADJ
ihlr-16470	149	16	in	in	ADP
ihlr-16470	149	17	children	child	NOUN
ihlr-16470	149	18	.	.	PUNCT
ihlr-16470	150	1	52	52	NUM
ihlr-16470	150	2	initial	initial	ADJ
ihlr-16470	150	3	studies	study	NOUN
ihlr-16470	150	4	on	on	ADP
ihlr-16470	150	5	paxil	paxil	NOUN
ihlr-16470	150	6	appeared	appear	VERB
ihlr-16470	150	7	to	to	PART
ihlr-16470	150	8	suggest	suggest	VERB
ihlr-16470	150	9	an	an	DET
ihlr-16470	150	10	increased	increased	ADJ
ihlr-16470	150	11	risk	risk	NOUN
ihlr-16470	150	12	of	of	ADP
ihlr-16470	150	13	suicidal	suicidal	ADJ
ihlr-16470	150	14	thoughts	thought	NOUN
ihlr-16470	150	15	and	and	CCONJ
ihlr-16470	150	16	actions	action	NOUN
ihlr-16470	150	17	in	in	ADP
ihlr-16470	150	18	children	child	NOUN
ihlr-16470	150	19	who	who	PRON
ihlr-16470	150	20	were	be	AUX
ihlr-16470	150	21	given	give	VERB
ihlr-16470	150	22	paxil	paxil	NOUN
ihlr-16470	150	23	when	when	SCONJ
ihlr-16470	150	24	compared	compare	VERB
ihlr-16470	150	25	to	to	ADP
ihlr-16470	150	26	children	child	NOUN
ihlr-16470	150	27	given	give	VERB
ihlr-16470	150	28	placebos	placebo	NOUN
ihlr-16470	150	29	.	.	PUNCT
ihlr-16470	151	1	53	53	NUM
ihlr-16470	151	2	subsequent	subsequent	ADJ
ihlr-16470	151	3	studies	study	NOUN
ihlr-16470	151	4	of	of	ADP
ihlr-16470	151	5	other	other	ADJ
ihlr-16470	151	6	ssris	ssris	NOUN
ihlr-16470	151	7	indicated	indicate	VERB
ihlr-16470	151	8	that	that	SCONJ
ihlr-16470	151	9	children	child	NOUN
ihlr-16470	151	10	on	on	ADP
ihlr-16470	151	11	these	these	DET
ihlr-16470	151	12	medications	medication	NOUN
ihlr-16470	151	13	may	may	AUX
ihlr-16470	151	14	also	also	ADV
ihlr-16470	151	15	have	have	VERB
ihlr-16470	151	16	an	an	DET
ihlr-16470	151	17	increased	increase	VERB
ihlr-16470	151	18	risk	risk	NOUN
ihlr-16470	151	19	of	of	ADP
ihlr-16470	151	20	suicidal	suicidal	ADJ
ihlr-16470	151	21	thoughts	thought	NOUN
ihlr-16470	151	22	and	and	CCONJ
ihlr-16470	151	23	behaviors	behavior	NOUN
ihlr-16470	151	24	.	.	PUNCT
ihlr-16470	152	1	54	54	NUM
ihlr-16470	152	2	after	after	ADP
ihlr-16470	152	3	reviewing	review	VERB
ihlr-16470	152	4	the	the	DET
ihlr-16470	152	5	data	datum	NOUN
ihlr-16470	152	6	from	from	ADP
ihlr-16470	152	7	studies	study	NOUN
ihlr-16470	152	8	performed	perform	VERB
ihlr-16470	152	9	on	on	ADP
ihlr-16470	152	10	all	all	DET
ihlr-16470	152	11	ssr.l	ssr.l	PROPN
ihlr-16470	152	12	drugs	drug	NOUN
ihlr-16470	152	13	,	,	PUNCT
ihlr-16470	152	14	the	the	DET
ihlr-16470	152	15	members	member	NOUN
ihlr-16470	152	16	of	of	ADP
ihlr-16470	152	17	the	the	DET
ihlr-16470	152	18	fda	fda	PROPN
ihlr-16470	152	19	psychopharmacologic	psychopharmacologic	PROPN
ihlr-16470	152	20	drugs	drug	NOUN
ihlr-16470	152	21	and	and	CCONJ
ihlr-16470	152	22	pediatric	pediatric	ADJ
ihlr-16470	152	23	advisory	advisory	ADJ
ihlr-16470	152	24	committees	committee	NOUN
ihlr-16470	152	25	determined	determine	VERB
ihlr-16470	152	26	that	that	SCONJ
ihlr-16470	152	27	the	the	DET
ihlr-16470	152	28	finding	finding	NOUN
ihlr-16470	152	29	of	of	ADP
ihlr-16470	152	30	an	an	DET
ihlr-16470	152	31	increased	increase	VERB
ihlr-16470	152	32	risk	risk	NOUN
ihlr-16470	152	33	of	of	ADP
ihlr-16470	152	34	suicidality	suicidality	NOUN
ihlr-16470	152	35	in	in	ADP
ihlr-16470	152	36	pediatric	pediatric	ADJ
ihlr-16470	152	37	patients	patient	NOUN
ihlr-16470	152	38	applied	apply	VERB
ihlr-16470	152	39	to	to	ADP
ihlr-16470	152	40	all	all	PRON
ihlr-16470	152	41	of	of	ADP
ihlr-16470	152	42	the	the	DET
ihlr-16470	152	43	drugs	drug	NOUN
ihlr-16470	152	44	studied	study	VERB
ihlr-16470	152	45	in	in	ADP
ihlr-16470	152	46	controlled	control	VERB
ihlr-16470	152	47	clinical	clinical	ADJ
ihlr-16470	152	48	trials	trial	NOUN
ihlr-16470	152	49	.	.	PUNCT
ihlr-16470	153	1	ss	ss	VERB
ihlr-16470	153	2	the	the	DET
ihlr-16470	153	3	results	result	NOUN
ihlr-16470	153	4	from	from	ADP
ihlr-16470	153	5	these	these	DET
ihlr-16470	153	6	studies	study	NOUN
ihlr-16470	153	7	led	lead	VERB
ihlr-16470	153	8	the	the	DET
ihlr-16470	153	9	fda	fda	PROPN
ihlr-16470	153	10	to	to	PART
ihlr-16470	153	11	conduct	conduct	VERB
ihlr-16470	153	12	one	one	NUM
ihlr-16470	153	13	final	final	ADJ
ihlr-16470	153	14	study	study	NOUN
ihlr-16470	153	15	on	on	ADP
ihlr-16470	153	16	suicidality	suicidality	NOUN
ihlr-16470	153	17	combining	combine	VERB
ihlr-16470	153	18	results	result	NOUN
ihlr-16470	153	19	of	of	ADP
ihlr-16470	153	20	twenty­	twenty­	NUM
ihlr-16470	153	21	four	four	NUM
ihlr-16470	153	22	smaller	small	ADJ
ihlr-16470	153	23	studies	study	NOUN
ihlr-16470	153	24	of	of	ADP
ihlr-16470	153	25	children	child	NOUN
ihlr-16470	153	26	and	and	CCONJ
ihlr-16470	153	27	teenagers	teenager	NOUN
ihlr-16470	153	28	who	who	PRON
ihlr-16470	153	29	took	take	VERB
ihlr-16470	153	30	either	either	CCONJ
ihlr-16470	153	31	a	a	DET
ihlr-16470	153	32	sugar	sugar	NOUN
ihlr-16470	153	33	pill	pill	NOUN
ihlr-16470	153	34	or	or	CCONJ
ihlr-16470	153	35	49	49	NUM
ihlr-16470	153	36	.	.	PUNCT
ihlr-16470	154	1	see	see	VERB
ihlr-16470	154	2	jeffery	jeffery	PROPN
ihlr-16470	154	3	krasner	krasner	PROPN
ihlr-16470	154	4	,	,	PUNCT
ihlr-16470	154	5	sec	sec	PROPN
ihlr-16470	154	6	focusing	focus	VERB
ihlr-16470	154	7	on	on	ADP
ihlr-16470	154	8	drug	drug	NOUN
ihlr-16470	154	9	makers	maker	NOUN
ihlr-16470	154	10	;	;	PUNCT
ihlr-16470	154	11	full	full	ADJ
ihlr-16470	154	12	disclosure	disclosure	NOUN
ihlr-16470	154	13	oftests	oftest	NOUN
ihlr-16470	154	14	called	call	VERB
ihlr-16470	154	15	key	key	ADJ
ihlr-16470	154	16	,	,	PUNCT
ihlr-16470	154	17	bost	bost	NOUN
ihlr-16470	154	18	.	.	PUNCT
ihlr-16470	155	1	gl	gl	PROPN
ihlr-16470	155	2	,	,	PUNCT
ihlr-16470	155	3	sept	sept	PROPN
ihlr-16470	155	4	.	.	PROPN
ihlr-16470	155	5	27	27	NUM
ihlr-16470	155	6	,	,	PUNCT
ihlr-16470	155	7	2004	2004	NUM
ihlr-16470	155	8	,	,	PUNCT
ihlr-16470	155	9	at	at	ADP
ihlr-16470	155	10	c4	c4	NOUN
ihlr-16470	155	11	,	,	PUNCT
ihlr-16470	155	12	available	available	ADJ
ihlr-16470	155	13	at	at	ADP
ihlr-16470	155	14	2004	2004	NUM
ihlr-16470	155	15	wl	wl	PROPN
ihlr-16470	155	16	59807884	59807884	NUM
ihlr-16470	155	17	.	.	PUNCT
ihlr-16470	156	1	50	50	NUM
ihlr-16470	156	2	.	.	X
ihlr-16470	156	3	symposium	symposium	NOUN
ihlr-16470	156	4	,	,	PUNCT
ihlr-16470	156	5	supra	supra	PROPN
ihlr-16470	156	6	note	note	NOUN
ihlr-16470	156	7	3	3	NUM
ihlr-16470	156	8	.	.	NOUN
ihlr-16470	156	9	51	51	NUM
ihlr-16470	156	10	.	.	PUNCT
ihlr-16470	157	1	i	i	PRON
ihlr-16470	157	2	d.	d.	PROPN
ihlr-16470	157	3	52	52	NUM
ihlr-16470	157	4	.	.	PUNCT
ihlr-16470	158	1	olympian	olympian	PROPN
ihlr-16470	158	2	news	news	PROPN
ihlr-16470	158	3	services	services	PROPN
ihlr-16470	158	4	.	.	PUNCT
ihlr-16470	159	1	fda	fda	PROPN
ihlr-16470	159	2	.	.	PROPN
ihlr-16470	160	1	blocked	block	VERB
ihlr-16470	160	2	data	datum	NOUN
ihlr-16470	160	3	on	on	ADP
ihlr-16470	160	4	children	child	NOUN
ihlr-16470	160	5	and	and	CCONJ
ihlr-16470	160	6	antidepressants	antidepressant	NOUN
ihlr-16470	160	7	,	,	PUNCT
ihlr-16470	160	8	sept	sept	PROPN
ihlr-16470	160	9	.	.	PROPN
ihlr-16470	160	10	10	10	NUM
ihlr-16470	160	11	,	,	PUNCT
ihlr-16470	160	12	2004	2004	NUM
ihlr-16470	160	13	,	,	PUNCT
ihlr-16470	160	14	http://www.antidepressants.com/2004-09-1	http://www.antidepressants.com/2004-09-1	PROPN
ihlr-16470	160	15	0-fda-blocked-ssri-data-kids.htm	0-fda-blocked-ssri-data-kids.htm	NUM
ihlr-16470	161	1	(	(	PUNCT
ihlr-16470	161	2	last	last	ADJ
ihlr-16470	161	3	visited	visit	VERB
ihlr-16470	161	4	apr	apr	NOUN
ihlr-16470	161	5	.	.	PROPN
ihlr-16470	161	6	17	17	NUM
ihlr-16470	161	7	,	,	PUNCT
ihlr-16470	161	8	2006	2006	NUM
ihlr-16470	161	9	)	)	PUNCT
ihlr-16470	161	10	.	.	PUNCT
ihlr-16470	162	1	53	53	NUM
ihlr-16470	162	2	.	.	PUNCT
ihlr-16470	163	1	fda	fda	PROPN
ihlr-16470	163	2	,	,	PUNCT
ihlr-16470	163	3	talk	talk	NOUN
ihlr-16470	163	4	paper	paper	NOUN
ihlr-16470	163	5	,	,	PUNCT
ihlr-16470	163	6	supra	supra	PROPN
ihlr-16470	163	7	note	note	NOUN
ihlr-16470	163	8	10	10	NUM
ihlr-16470	163	9	.	.	PUNCT
ihlr-16470	163	10	54	54	NUM
ihlr-16470	163	11	.	.	PUNCT
ihlr-16470	164	1	i	i	PRON
ihlr-16470	164	2	d.	d.	PROPN
ihlr-16470	164	3	55	55	NUM
ihlr-16470	164	4	.	.	PUNCT
ihlr-16470	165	1	food	food	NOUN
ihlr-16470	165	2	&	&	CCONJ
ihlr-16470	165	3	drug	drug	PROPN
ihlr-16470	165	4	admin	admin	PROPN
ihlr-16470	165	5	.	.	PUNCT
ihlr-16470	165	6	,	,	PUNCT
ihlr-16470	165	7	statement	statement	NOUN
ihlr-16470	165	8	,	,	PUNCT
ihlr-16470	165	9	fda	fda	PROPN
ihlr-16470	165	10	statement	statement	NOUN
ihlr-16470	165	11	on	on	ADP
ihlr-16470	165	12	recommendations	recommendation	NOUN
ihlr-16470	165	13	of	of	ADP
ihlr-16470	165	14	the	the	DET
ihlr-16470	165	15	psychopharmacologic	psychopharmacologic	ADJ
ihlr-16470	165	16	drugs	drug	NOUN
ihlr-16470	165	17	and	and	CCONJ
ihlr-16470	165	18	pediatric	pediatric	ADJ
ihlr-16470	165	19	advisory	advisory	ADJ
ihlr-16470	165	20	committees	committee	NOUN
ihlr-16470	165	21	(	(	PUNCT
ihlr-16470	165	22	sept	sept	PROPN
ihlr-16470	165	23	.	.	PROPN
ihlr-16470	165	24	16	16	NUM
ihlr-16470	165	25	,	,	PUNCT
ihlr-16470	165	26	2004	2004	NUM
ihlr-16470	165	27	)	)	PUNCT
ihlr-16470	165	28	,	,	PUNCT
ihlr-16470	165	29	http://www.fda.gov/bbs/topicslnews/20041new01116.html	http://www.fda.gov/bbs/topicslnews/20041new01116.html	NOUN
ihlr-16470	165	30	(	(	PUNCT
ihlr-16470	165	31	last	last	ADV
ihlr-16470	165	32	visited	visit	VERB
ihlr-16470	165	33	nov	nov	PROPN
ihlr-16470	165	34	.	.	PROPN
ihlr-16470	165	35	21	21	NUM
ihlr-16470	165	36	,	,	PUNCT
ihlr-16470	165	37	2004	2004	NUM
ihlr-16470	165	38	)	)	PUNCT
ihlr-16470	165	39	.	.	PUNCT
ihlr-16470	166	1	208	208	NUM
ihlr-16470	166	2	indiana	indiana	PROPN
ihlr-16470	166	3	health	health	PROPN
ihlr-16470	166	4	lawrevmw	lawrevmw	NOUN
ihlr-16470	166	5	[	[	X
ihlr-16470	166	6	vol	vol	NOUN
ihlr-16470	166	7	.	.	PUNCT
ihlr-16470	167	1	3:201	3:201	NUM
ihlr-16470	167	2	antidepressants	antidepressant	NOUN
ihlr-16470	167	3	for	for	ADP
ihlr-16470	167	4	one	one	NUM
ihlr-16470	167	5	to	to	PART
ihlr-16470	167	6	four	four	NUM
ihlr-16470	167	7	montbs.56	montbs.56	NOUN
ihlr-16470	167	8	data	datum	NOUN
ihlr-16470	167	9	collected	collect	VERB
ihlr-16470	167	10	from	from	ADP
ihlr-16470	167	11	this	this	DET
ihlr-16470	167	12	study	study	NOUN
ihlr-16470	167	13	,	,	PUNCT
ihlr-16470	167	14	known	know	VERB
ihlr-16470	167	15	as	as	ADP
ihlr-16470	167	16	the	the	DET
ihlr-16470	167	17	columbia	columbia	PROPN
ihlr-16470	167	18	study	study	NOUN
ihlr-16470	167	19	,	,	PUNCT
ihlr-16470	167	20	showed	show	VERB
ihlr-16470	167	21	that	that	SCONJ
ihlr-16470	167	22	two	two	NUM
ihlr-16470	167	23	children	child	NOUN
ihlr-16470	167	24	out	out	ADP
ihlr-16470	167	25	of	of	ADP
ihlr-16470	167	26	every	every	DET
ihlr-16470	167	27	hundred	hundred	NUM
ihlr-16470	167	28	on	on	ADP
ihlr-16470	167	29	placebos	placebo	NOUN
ihlr-16470	167	30	became	become	VERB
ihlr-16470	167	31	suicidal	suicidal	ADJ
ihlr-16470	167	32	,	,	PUNCT
ihlr-16470	167	33	while	while	SCONJ
ihlr-16470	167	34	four	four	NUM
ihlr-16470	167	35	out	out	ADP
ihlr-16470	167	36	of	of	ADP
ihlr-16470	167	37	every	every	DET
ihlr-16470	167	38	hundred	hundred	NUM
ihlr-16470	167	39	children	child	NOUN
ihlr-16470	167	40	on	on	ADP
ihlr-16470	167	41	antidepressants	antidepressant	NOUN
ihlr-16470	167	42	became	become	VERB
ihlr-16470	167	43	suicidal	suicidal	ADJ
ihlr-16470	167	44	.	.	PUNCT
ihlr-16470	168	1	s7	s7	VERB
ihlr-16470	168	2	the	the	DET
ihlr-16470	168	3	results	result	NOUN
ihlr-16470	168	4	of	of	ADP
ihlr-16470	168	5	this	this	DET
ihlr-16470	168	6	study	study	NOUN
ihlr-16470	168	7	were	be	AUX
ihlr-16470	168	8	instrumental	instrumental	ADJ
ihlr-16470	168	9	in	in	ADP
ihlr-16470	168	10	the	the	DET
ihlr-16470	168	11	fda	fda	PROPN
ihlr-16470	168	12	's	's	PART
ihlr-16470	168	13	ultimate	ultimate	ADJ
ihlr-16470	168	14	decision	decision	NOUN
ihlr-16470	168	15	to	to	PART
ihlr-16470	168	16	place	place	VERB
ihlr-16470	168	17	a	a	DET
ihlr-16470	168	18	''	''	PUNCT
ihlr-16470	168	19	black	black	ADJ
ihlr-16470	168	20	box	box	NOUN
ihlr-16470	168	21	"	"	PUNCT
ihlr-16470	168	22	warning	warn	VERB
ihlr-16470	168	23	on	on	ADP
ihlr-16470	168	24	all	all	DET
ihlr-16470	168	25	ssri	ssri	PROPN
ihlr-16470	168	26	drugs	drug	NOUN
ihlr-16470	168	27	;	;	PUNCT
ihlr-16470	168	28	3	3	X
ihlr-16470	168	29	.	.	X
ihlr-16470	168	30	columbia	columbia	PROPN
ihlr-16470	168	31	study	study	PROPN
ihlr-16470	168	32	a.	a.	NOUN
ihlr-16470	168	33	method	method	NOUN
ihlr-16470	168	34	and	and	CCONJ
ihlr-16470	168	35	results	result	VERB
ihlr-16470	168	36	the	the	PRON
ihlr-16470	168	37	·	·	PUNCT
ihlr-16470	168	38	fda	fda	PROPN
ihlr-16470	168	39	orgimized	orgimize	VERB
ihlr-16470	168	40	the	the	DET
ihlr-16470	168	41	columbia	columbia	PROPN
ihlr-16470	168	42	study	study	NOUN
ihlr-16470	168	43	because	because	SCONJ
ihlr-16470	168	44	of	of	ADP
ihlr-16470	168	45	concerns	concern	NOUN
ihlr-16470	168	46	about	about	ADP
ihlr-16470	168	47	whether	whether	SCONJ
ihlr-16470	168	48	the	the	DET
ihlr-16470	168	49	varied	varied	ADJ
ihlr-16470	168	50	'	'	PUNCT
ihlr-16470	168	51	events	event	NOUN
ihlr-16470	168	52	identified	identify	VERB
ihlr-16470	168	53	in	in	ADP
ihlr-16470	168	54	earlier	early	ADJ
ihlr-16470	168	55	studies	study	NOUN
ihlr-16470	168	56	as	as	SCONJ
ihlr-16470	168	57	possibly	possibly	ADV
ihlr-16470	168	58	suicide	suicide	AUX
ihlr-16470	168	59	related	relate	VERB
ihlr-16470	168	60	could	could	AUX
ihlr-16470	168	61	reasonably	reasonably	ADV
ihlr-16470	168	62	be	be	AUX
ihlr-16470	168	63	considered	consider	VERB
ihlr-16470	168	64	to	to	PART
ihlr-16470	168	65	represent	represent	VERB
ihlr-16470	168	66	suicidality	suicidality	NOUN
ihlr-16470	168	67	.	.	PUNCT
ihlr-16470	169	1	58	58	NUM
ihlr-16470	170	1	the	the	DET
ihlr-16470	170	2	original	original	ADJ
ihlr-16470	170	3	studies	study	NOUN
ihlr-16470	170	4	and	and	CCONJ
ihlr-16470	170	5	clinical	clinical	ADJ
ihlr-16470	170	6	trials	trial	NOUN
ihlr-16470	170	7	ofssris	ofssris	NOUN
ihlr-16470	170	8	in	in	ADP
ihlr-16470	170	9	pediatric	pediatric	ADJ
ihlr-16470	170	10	patients	patient	NOUN
ihlr-16470	170	11	lacked	lack	VERB
ihlr-16470	170	12	a	a	DET
ihlr-16470	170	13	systematic	systematic	ADJ
ihlr-16470	170	14	or	or	CCONJ
ihlr-16470	170	15	standardized	standardized	ADJ
ihlr-16470	170	16	language	language	NOUN
ihlr-16470	170	17	to	to	PART
ihlr-16470	170	18	define	define	VERB
ihlr-16470	170	19	suicidal	suicidal	ADJ
ihlr-16470	170	20	behavior.59	behavior.59	NOUN
ihlr-16470	170	21	''	''	PUNCT
ihlr-16470	170	22	this	this	DET
ihlr-16470	170	23	lack	lack	NOUN
ihlr-16470	170	24	of	of	ADP
ihlr-16470	170	25	standardized	standardized	ADJ
ihlr-16470	170	26	terminology	terminology	NOUN
ihlr-16470	170	27	for	for	ADP
ihlr-16470	170	28	suicidal	suicidal	ADJ
ihlr-16470	170	29	acts	act	NOUN
ihlr-16470	170	30	[	[	AUX
ihlr-16470	170	31	made	make	VERB
ihlr-16470	170	32	]	]	X
ihlr-16470	170	33	it	it	PRON
ihlr-16470	170	34	difficult	difficult	ADJ
ihlr-16470	170	35	to	to	PART
ihlr-16470	170	36	interpret	interpret	VERB
ihlr-16470	170	37	the	the	DET
ihlr-16470	170	38	meaning	meaning	NOUN
ihlr-16470	170	39	of	of	ADP
ihlr-16470	170	40	reported	report	VERB
ihlr-16470	170	41	adverse	adverse	ADJ
ihlr-16470	170	42	events	event	NOUN
ihlr-16470	170	43	(	(	PUNCT
ihlr-16470	170	44	aes	aes	NOUN
ihlr-16470	170	45	)	)	PUNCT
ihlr-16470	170	46	that	that	PRON
ihlr-16470	170	47	occurred	occur	VERB
ihlr-16470	170	48	"	"	PUNCT
ihlr-16470	170	49	in	in	ADP
ihlr-16470	170	50	the	the	DET
ihlr-16470	170	51	original	original	ADJ
ihlr-16470	170	52	studies	study	NOUN
ihlr-16470	170	53	.	.	PUNCT
ihlr-16470	171	1	60	60	NUM
ihlr-16470	171	2	in	in	ADP
ihlr-16470	171	3	order	order	NOUN
ihlr-16470	171	4	to	to	PART
ihlr-16470	171	5	.	.	PUNCT
ihlr-16470	172	1	provide	provide	VERB
ihlr-16470	172	2	a	a	DET
ihlr-16470	172	3	more	more	ADV
ihlr-16470	172	4	accurate	accurate	ADJ
ihlr-16470	172	5	account	account	NOUN
ihlr-16470	172	6	of	of	ADP
ihlr-16470	172	7	suicidality	suicidality	NOUN
ihlr-16470	172	8	,	,	PUNCT
ihlr-16470	172	9	the	the	DET
ihlr-16470	172	10	fda	fda	PROPN
ihlr-16470	172	11	needed	need	VERB
ihlr-16470	172	12	to	to	PART
ihlr-16470	172	13	.ensure	.ensure	VERB
ihlr-16470	172	14	that	that	SCONJ
ihlr-16470	172	15	definitions	definition	NOUN
ihlr-16470	172	16	of	of	ADP
ihlr-16470	172	17	suicidality	suicidality	NOUN
ihlr-16470	172	18	in	in	ADP
ihlr-16470	172	19	earlier	early	ADJ
ihlr-16470	172	20	studies	study	NOUN
ihlr-16470	172	21	were	be	AUX
ihlr-16470	172	22	consistent	consistent	ADJ
ihlr-16470	172	23	with	with	ADP
ihlr-16470	172	24	each	each	DET
ihlr-16470	172	25	other.61	other.61	NOUN
ihlr-16470	172	26	to	to	ADP
ihlr-16470	172	27	meetthe	meetthe	DET
ihlr-16470	172	28	goal	goal	NOUN
ihlr-16470	172	29	of	of	ADP
ihlr-16470	172	30	consistent	consistent	ADJ
ihlr-16470	172	31	terminology	terminology	NOUN
ihlr-16470	172	32	,	,	PUNCT
ihlr-16470	172	33	the	the	DET
ihlr-16470	172	34	fda	fda	PROPN
ihlr-16470	172	35	asked	ask	VERB
ihlr-16470	172	36	columbia	columbia	PROPN
ihlr-16470	172	37	university	university	PROPN
ihlr-16470	172	38	to	to	PART
ihlr-16470	172	39	.assemble	.assemble	VERB
ihlr-16470	172	40	a	a	DET
ihlr-16470	172	41	panel	panel	NOUN
ihlr-16470	172	42	of	of	ADP
ihlr-16470	172	43	pediatric	pediatric	ADJ
ihlr-16470	172	44	suicidality	suicidality	NOUN
ihlr-16470	172	45	experts	expert	NOUN
ihlr-16470	172	46	to	to	PART
ihlr-16470	172	47	undertake	undertake	VERB
ihlr-16470	172	48	a	a	DET
ihlr-16470	172	49	blind	blind	ADJ
ihlr-16470	172	50	review	review	NOUN
ihlr-16470	172	51	of	of	ADP
ihlr-16470	172	52	the	the	DET
ihlr-16470	172	53	reported	report	VERB
ihlr-16470	172	54	behaviors	behavior	NOUN
ihlr-16470	172	55	using	use	VERB
ihlr-16470	172	56	a	a	DET
ihlr-16470	172	57	rigorous	rigorous	ADJ
ihlr-16470	172	58	classification	classification	NOUN
ihlr-16470	172	59	system.62	system.62	NOUN
ihlr-16470	172	60	the	the	DET
ihlr-16470	172	61	tasks	task	NOUN
ihlr-16470	172	62	of	of	ADP
ihlr-16470	172	63	the	the	DET
ihlr-16470	172	64	columbia	columbia	PROPN
ihlr-16470	172	65	study	study	NOUN
ihlr-16470	172	66	included	include	VERB
ihlr-16470	172	67	identifying	identify	VERB
ihlr-16470	172	68	adverse	adverse	ADJ
ihlr-16470	172	69	events	event	NOUN
ihlr-16470	172	70	in	in	ADP
ihlr-16470	172	71	previous	previous	ADJ
ihlr-16470	172	72	studies	study	NOUN
ihlr-16470	172	73	"	"	PUNCT
ihlr-16470	172	74	that	that	PRON
ihlr-16470	172	75	were	be	AUX
ihlr-16470	172	76	inappropriately	inappropriately	ADV
ihlr-16470	172	77	classified	classify	VERB
ihlr-16470	172	78	as	as	ADP
ihlr-16470	172	79	suicidal	suicidal	ADJ
ihlr-16470	172	80	,	,	PUNCT
ihlr-16470	172	81	'	'	PUNCT
ihlr-16470	172	82	;	;	PUNCT
ihlr-16470	172	83	or	or	CCONJ
ihlr-16470	172	84	suicidal	suicidal	ADJ
ihlr-16470	172	85	aes	aes	PROPN
ihlr-16470	172	86	that	that	PRON
ihlr-16470	172	87	were	be	AUX
ihlr-16470	172	88	missed	miss	VERB
ihlr-16470	172	89	altogether	altogether	ADV
ihlr-16470	172	90	,	,	PUNCT
ihlr-16470	172	91	in	in	ADP
ihlr-16470	172	92	order	order	NOUN
ihlr-16470	172	93	to	to	PART
ihlr-16470	172	94	avoid	avoid	VERB
ihlr-16470	172	95	misinterpretation	misinterpretation	NOUN
ihlr-16470	172	96	of	of	ADP
ihlr-16470	172	97	the	the	DET
ihlr-16470	172	98	ssri	ssri	PROPN
ihlr-16470	172	99	trial	trial	NOUN
ihlr-16470	172	100	data	datum	NOUN
ihlr-16470	172	101	.	.	PUNCT
ihlr-16470	173	1	63	63	NUM
ihlr-16470	173	2	before	before	ADP
ihlr-16470	173	3	interpreting	interpret	VERB
ihlr-16470	173	4	the	the	DET
ihlr-16470	173	5	data	datum	NOUN
ihlr-16470	173	6	,	,	PUNCT
ihlr-16470	173	7	columbia	columbia	PROPN
ihlr-16470	173	8	study	study	NOUN
ihlr-16470	173	9	clinicians	clinician	NOUN
ihlr-16470	173	10	agreed	agree	VERB
ihlr-16470	173	11	upon	upon	SCONJ
ihlr-16470	173	12	terminology	terminology	NOUN
ihlr-16470	173	13	''	''	PUNCT
ihlr-16470	173	14	using	use	VERB
ihlr-16470	173	15	research	research	NOUN
ihlr-16470	173	16	-	-	PUNCT
ihlr-16470	173	17	supported	support	VERB
ihlr-16470	173	18	definitions	definition	NOUN
ihlr-16470	173	19	that	that	PRON
ihlr-16470	173	20	[	[	X
ihlr-16470	173	21	were	be	AUX
ihlr-16470	173	22	]	]	X
ihlr-16470	173	23	both	both	CCONJ
ihlr-16470	173	24	valid	valid	ADJ
ihlr-16470	173	25	(	(	PUNCT
ihlr-16470	173	26	relevant	relevant	ADJ
ihlr-16470	173	27	features	feature	NOUN
ihlr-16470	173	28	have	have	AUX
ihlr-16470	173	29	been	be	AUX
ihlr-16470	173	30	shown	show	VERB
ihlr-16470	173	31	to	to	PART
ihlr-16470	173	32	be	be	AUX
ihlr-16470	173	33	associated	associate	VERB
ihlr-16470	173	34	with	with	ADP
ihlr-16470	173	35	the	the	DET
ihlr-16470	173	36	definition	definition	NOUN
ihlr-16470	173	37	)	)	PUNCT
ihlr-16470	173	38	and	and	CCONJ
ihlr-16470	173	39	reliable	reliable	ADJ
ihlr-16470	173	40	(	(	PUNCT
ihlr-16470	173	41	clinicians	clinician	NOUN
ihlr-16470	173	42	are	be	AUX
ihlr-16470	173	43	able	able	ADJ
ihlr-16470	173	44	to	to	PART
ihlr-16470	173	45	use	use	VERB
ihlr-16470	173	46	these	these	DET
ihlr-16470	173	47	definitions	definition	NOUN
ihlr-16470	173	48	in	in	ADP
ihlr-16470	173	49	similar	similar	ADJ
ihlr-16470	173	50	ways	way	NOUN
ihlr-16470	173	51	)	)	PUNCT
ihlr-16470	173	52	"	"	PUNCT
ihlr-16470	173	53	for	for	ADP
ihlr-16470	173	54	determining	determine	VERB
ihlr-16470	173	55	whether	whether	SCONJ
ihlr-16470	173	56	an	an	DET
ihlr-16470	173	57	ae	ae	PROPN
ihlr-16470	173	58	was	be	AUX
ihlr-16470	173	59	a	a	DET
ihlr-16470	173	60	suicidal	suicidal	ADJ
ihlr-16470	173	61	event	event	NOUN
ihlr-16470	173	62	.	.	PUNCT
ihlr-16470	174	1	64	64	NUM
ihlr-16470	174	2	after	after	ADP
ihlr-16470	174	3	agreeing	agree	VERB
ihlr-16470	174	4	on	on	ADP
ihlr-16470	174	5	terminology	terminology	NOUN
ihlr-16470	174	6	and	and	CCONJ
ihlr-16470	174	7	participating	participate	VERB
ihlr-16470	174	8	in	in	ADP
ihlr-16470	174	9	training	training	NOUN
ihlr-16470	174	10	sessions	session	NOUN
ihlr-16470	174	11	,	,	PUNCT
ihlr-16470	174	12	the	the	DET
ihlr-16470	174	13	members	member	NOUN
ihlr-16470	174	14	of	of	ADP
ihlr-16470	174	15	the	the	DET
ihlr-16470	174	16	columbia	columbia	PROPN
ihlr-16470	174	17	study	study	NOUN
ihlr-16470	174	18	"	"	PUNCT
ihlr-16470	174	19	systematically	systematically	ADV
ihlr-16470	174	20	review	review	VERB
ihlr-16470	174	21	[	[	PUNCT
ihlr-16470	174	22	ed	ed	NOUN
ihlr-16470	174	23	]	]	X
ihlr-16470	174	24	over	over	ADP
ihlr-16470	174	25	400	400	NUM
ihlr-16470	174	26	case	case	NOUN
ihlr-16470	174	27	descriptions	description	NOUN
ihlr-16470	174	28	from	from	ADP
ihlr-16470	174	29	56	56	NUM
ihlr-16470	174	30	.	.	PUNCT
ihlr-16470	175	1	fda	fda	PROPN
ihlr-16470	175	2	proposed	propose	VERB
ihlr-16470	175	3	medication	medication	NOUN
ihlr-16470	175	4	guide	guide	NOUN
ihlr-16470	175	5	,	,	PUNCT
ihlr-16470	175	6	supra	supra	PROPN
ihlr-16470	175	7	note	note	NOUN
ihlr-16470	175	8	53	53	NUM
ihlr-16470	175	9	.	.	PUNCT
ihlr-16470	175	10	57	57	NUM
ihlr-16470	175	11	.	.	PUNCT
ihlr-16470	176	1	/d	/d	INTJ
ihlr-16470	176	2	.	.	PUNCT
ihlr-16470	177	1	58	58	NUM
ihlr-16470	177	2	.	.	PUNCT
ihlr-16470	178	1	fda	fda	PROPN
ihlr-16470	178	2	talk	talk	PROPN
ihlr-16470	178	3	paper	paper	PROPN
ihlr-16470	178	4	,	,	PUNCT
ihlr-16470	178	5	supra	supra	PROPN
ihlr-16470	178	6	note	note	NOUN
ihlr-16470	178	7	10	10	NUM
ihlr-16470	178	8	.	.	X
ihlr-16470	178	9	59	59	NUM
ihlr-16470	178	10	.	.	PUNCT
ihlr-16470	179	1	food	food	PROPN
ihlr-16470	179	2	&	&	CCONJ
ihlr-16470	179	3	drug	drug	PROPN
ihlr-16470	179	4	admin	admin	PROPN
ihlr-16470	179	5	.	.	PROPN
ihlr-16470	179	6	,	,	PUNCT
ihlr-16470	179	7	background	background	NOUN
ihlr-16470	179	8	information	information	NOUN
ihlr-16470	179	9	on	on	ADP
ihlr-16470	179	10	the	the	DET
ihlr-16470	179	11	suicidality	suicidality	NOUN
ihlr-16470	179	12	classification	classification	NOUN
ihlr-16470	179	13	project	project	NOUN
ihlr-16470	179	14	(	(	PUNCT
ihlr-16470	179	15	mar	mar	PROPN
ihlr-16470	179	16	.	.	PROPN
ihlr-16470	179	17	22	22	NUM
ihlr-16470	179	18	,	,	PUNCT
ihlr-16470	179	19	2004	2004	NUM
ihlr-16470	179	20	)	)	PUNCT
ihlr-16470	179	21	,	,	PUNCT
ihlr-16470	179	22	bttp:/lwww.fda.gov	bttp:/lwww.fda.gov	NOUN
ihlr-16470	179	23	/	/	SYM
ihlr-16470	179	24	cder	cder	NOUN
ihlr-16470	179	25	/	/	SYM
ihlr-16470	179	26	druglantideplessants	druglantideplessant	NOUN
ihlr-16470	179	27	/	/	SYM
ihlr-16470	179	28	classificationproject.hbn	classificationproject.hbn	PROPN
ihlr-16470	179	29	(	(	PUNCT
ihlr-16470	179	30	last	last	ADV
ihlr-16470	179	31	visited	visit	VERB
ihlr-16470	179	32	oct	oct	PROPN
ihlr-16470	179	33	.	.	PROPN
ihlr-16470	179	34	7	7	NUM
ihlr-16470	179	35	,	,	PUNCT
ihlr-16470	179	36	2004	2004	NUM
ihlr-16470	179	37	)	)	PUNCT
ihlr-16470	179	38	.	.	PUNCT
ihlr-16470	180	1	60	60	NUM
ihlr-16470	180	2	.	.	PUNCT
ihlr-16470	181	1	i	i	PRON
ihlr-16470	181	2	d.	d.	PROPN
ihlr-16470	181	3	61	61	NUM
ihlr-16470	181	4	.	.	PUNCT
ihlr-16470	182	1	see	see	VERB
ihlr-16470	182	2	fda	fda	PROPN
ihlr-16470	182	3	talk	talk	PROPN
ihlr-16470	182	4	paper	paper	NOUN
ihlr-16470	182	5	,	,	PUNCT
ihlr-16470	182	6	supra	supra	PROPN
ihlr-16470	182	7	note	note	VERB
ihlr-16470	182	8	i	i	PRON
ihlr-16470	182	9	0	0	NUM
ihlr-16470	182	10	.	.	PUNCT
ihlr-16470	183	1	62	62	NUM
ihlr-16470	183	2	.	.	PUNCT
ihlr-16470	184	1	i	i	PRON
ihlr-16470	184	2	d.	d.	PROPN
ihlr-16470	184	3	63	63	NUM
ihlr-16470	184	4	.	.	PUNCT
ihlr-16470	185	1	bilckground	bilckground	PROPN
ihlr-16470	185	2	information	information	PROPN
ihlr-16470	185	3	,	,	PUNCT
ihlr-16470	185	4	supra	supra	PROPN
ihlr-16470	185	5	note	note	NOUN
ihlr-16470	185	6	59	59	NUM
ihlr-16470	185	7	.	.	NOUN
ihlr-16470	185	8	64	64	NUM
ihlr-16470	185	9	.	.	PUNCT
ihlr-16470	186	1	/d	/d	PUNCT
ihlr-16470	186	2	.	.	PUNCT
ihlr-16470	187	1	2006	2006	NUM
ihlr-16470	187	2	]	]	PUNCT
ihlr-16470	187	3	anti	anti	NOUN
ihlr-16470	187	4	-	-	NOUN
ihlr-16470	187	5	depressants	depressant	NOUN
ihlr-16470	187	6	and	and	CCONJ
ihlr-16470	187	7	chrdren	chrdren	PROPN
ihlr-16470	187	8	209	209	NUM
ihlr-16470	187	9	the	the	DET
ihlr-16470	187	10	twenty	twenty	NUM
ihlr-16470	187	11	-	-	PUNCT
ihlr-16470	187	12	five	five	NUM
ihlr-16470	187	13	pediatric	pediatric	ADJ
ihlr-16470	187	14	trials	trial	NOUN
ihlr-16470	187	15	....	....	PUNCT
ihlr-16470	187	16	"	"	PUNCT
ihlr-16470	187	17	65	65	NUM
ihlr-16470	187	18	the	the	DET
ihlr-16470	187	19	columbia	columbia	PROPN
ihlr-16470	187	20	study	study	NOUN
ihlr-16470	187	21	reviewed	review	VERB
ihlr-16470	187	22	"	"	PUNCT
ihlr-16470	187	23	all	all	DET
ihlr-16470	187	24	events	event	NOUN
ihlr-16470	187	25	that	that	PRON
ihlr-16470	187	26	were	be	AUX
ihlr-16470	187	27	originally	originally	ADV
ihlr-16470	187	28	described	describe	VERB
ihlr-16470	187	29	~	~	PUNCT
ihlr-16470	187	30	possibly	possibly	ADV
ihlr-16470	187	31	suicidal	suicidal	ADJ
ihlr-16470	187	32	,	,	PUNCT
ihlr-16470	187	33	.	.	PUNCT
ihlr-16470	187	34	.	.	PUNCT
ihlr-16470	188	1	.	.	PUNCT
ihlr-16470	189	1	coded	code	VERB
ihlr-16470	189	2	as	as	ADP
ihlr-16470	189	3	aecidental	aecidental	ADJ
ihlr-16470	189	4	injuries	injury	NOUN
ihlr-16470	189	5	,	,	PUNCT
ihlr-16470	189	6	and	and	CCONJ
ihlr-16470	189	7	all	all	DET
ihlr-16470	189	8	serious	serious	ADJ
ihlr-16470	189	9	adverse	adverse	ADJ
ihlr-16470	189	10	events	event	NOUN
ihlr-16470	189	11	.	.	PUNCT
ihlr-16470	190	1	'o66	'o66	NOUN
ihlr-16470	190	2	after	after	ADP
ihlr-16470	190	3	reviewing	review	VERB
ihlr-16470	190	4	the	the	DET
ihlr-16470	190	5	events	event	NOUN
ihlr-16470	190	6	,	,	PUNCT
ihlr-16470	190	7	the	the	DET
ihlr-16470	190	8	members	member	NOUN
ihlr-16470	190	9	of	of	ADP
ihlr-16470	190	10	the	the	DET
ihlr-16470	190	11	study	study	NOUN
ihlr-16470	190	12	classified	classify	VERB
ihlr-16470	190	13	the	the	DET
ihlr-16470	190	14	eventsjn	eventsjn	NOUN
ihlr-16470	190	15	~	~	ADP
ihlr-16470	190	16	o	o	NOUN
ihlr-16470	190	17	three	three	NUM
ihlr-16470	190	18	categories	category	NOUN
ihlr-16470	190	19	:	:	PUNCT
ihlr-16470	190	20	"	"	PUNCT
ihlr-16470	190	21	suicidal	suicidal	ADJ
ihlr-16470	190	22	events	event	NOUN
ihlr-16470	190	23	(	(	PUNCT
ihlr-16470	190	24	suicide	suicide	NOUN
ihlr-16470	190	25	attempts	attempt	NOUN
ihlr-16470	190	26	,	,	PUNCT
ihlr-16470	190	27	aborted	aborted	ADJ
ihlr-16470	190	28	attempts	attempt	NOUN
ihlr-16470	190	29	,	,	PUNCT
ihlr-16470	190	30	...	...	PUNCT
ihlr-16470	190	31	interrupted	interrupted	ADJ
ihlr-16470	190	32	attempts	attempt	NOUN
ihlr-16470	190	33	,	,	PUNCT
ihlr-16470	190	34	and	and	CCONJ
ihlr-16470	190	35	suicidal	suicidal	ADJ
ihlr-16470	190	36	ideation	ideation	NOUN
ihlr-16470	190	37	-	-	PUNCT
ihlr-16470	190	38	related	relate	VERB
ihlr-16470	190	39	events	event	NOUN
ihlr-16470	190	40	)	)	PUNCT
ihlr-16470	190	41	;	;	PUNCT
ihlr-16470	190	42	non	non	ADJ
ihlr-16470	190	43	-	-	ADJ
ihlr-16470	190	44	suicidal	suicidal	ADJ
ihlr-16470	190	45	events	event	NOUN
ihlr-16470	190	46	(	(	PUNCT
ihlr-16470	190	47	self	self	NOUN
ihlr-16470	190	48	-	-	PUNCT
ihlr-16470	190	49	injury	injury	NOUN
ihlr-16470	190	50	or	or	CCONJ
ihlr-16470	190	51	mutilation	mutilation	NOUN
ihlr-16470	190	52	without	without	ADP
ihlr-16470	190	53	suicidal	suicidal	ADJ
ihlr-16470	190	54	intent	intent	NOUN
ihlr-16470	190	55	,	,	PUNCT
ihlr-16470	190	56	events	event	NOUN
ihlr-16470	190	57	attributable	attributable	ADJ
ihlr-16470	190	58	to	to	ADP
ihlr-16470	190	59	other	other	ADJ
ihlr-16470	190	60	psychiatric	psychiatric	ADJ
ihlr-16470	190	61	symptoms	symptom	NOUN
ihlr-16470	190	62	,	,	PUNCT
ihlr-16470	190	63	medical	medical	ADJ
ihlr-16470	190	64	or	or	CCONJ
ihlr-16470	190	65	accidental	accidental	ADJ
ihlr-16470	190	66	injuries	injury	NOUN
ihlr-16470	190	67	)	)	PUNCT
ihlr-16470	190	68	;	;	PUNCT
ihlr-16470	190	69	and	and	CCONJ
ihlr-16470	190	70	indetenninate	indetenninate	VERB
ihlr-16470	190	71	events	event	NOUN
ihlr-16470	190	72	(	(	PUNCT
ihlr-16470	190	73	non­	non­	NOUN
ihlr-16470	190	74	consensus	consensus	NOUN
ihlr-16470	190	75	or	or	CCONJ
ihlr-16470	190	76	unable	unable	ADJ
ihlr-16470	190	77	to	to	PART
ihlr-16470	190	78	classify	classify	VERB
ihlr-16470	190	79	due	due	ADJ
ihlr-16470	190	80	to	to	ADP
ihlr-16470	190	81	limited	limit	VERB
ihlr-16470	190	82	data).'>67	data).'>67	NOUN
ihlr-16470	190	83	·	·	PUNCT
ihlr-16470	190	84	the	the	DET
ihlr-16470	190	85	columbia	columbia	PROPN
ihlr-16470	190	86	study	study	NOUN
ihlr-16470	190	87	reanalyzed	reanalyze	VERB
ihlr-16470	190	88	data	datum	NOUN
ihlr-16470	190	89	from	from	ADP
ihlr-16470	190	90	published	publish	VERB
ihlr-16470	190	91	and	and	CCONJ
ihlr-16470	190	92	unpublished	unpublished	ADJ
ihlr-16470	190	93	pediatric	pediatric	ADJ
ihlr-16470	190	94	trials	trial	NOUN
ihlr-16470	190	95	of	of	ADP
ihlr-16470	190	96	ssris	ssris	PROPN
ihlr-16470	190	97	conducted	conduct	VERB
ihlr-16470	190	98	between	between	ADP
ihlr-16470	190	99	1983	1983	NUM
ihlr-16470	190	100	and	and	CCONJ
ihlr-16470	190	101	200	200	NUM
ihlr-16470	190	102	l.	l.	NOUN
ihlr-16470	190	103	68	68	NUM
ihlr-16470	190	104	after	after	SCONJ
ihlr-16470	190	105	the	the	DET
ihlr-16470	190	106	columbia	columbia	PROPN
ihlr-16470	190	107	study	study	NOUN
ihlr-16470	190	108	finished	finish	VERB
ihlr-16470	190	109	reviewing	review	VERB
ihlr-16470	190	110	the	the	DET
ihlr-16470	190	111	data	datum	NOUN
ihlr-16470	190	112	from	from	ADP
ihlr-16470	190	113	the	the	DET
ihlr-16470	190	114	pediatric	pediatric	ADJ
ihlr-16470	190	115	trials	trial	NOUN
ihlr-16470	190	116	,	,	PUNCT
ihlr-16470	190	117	tareck	tareck	PROPN
ihlr-16470	190	118	hammad	hammad	PROPN
ihlr-16470	190	119	,	,	PUNCT
ihlr-16470	190	120	an	an	DET
ihlr-16470	190	121	fda	fda	PROPN
ihlr-16470	190	122	medical	medical	ADJ
ihlr-16470	190	123	reviewer	reviewer	NOUN
ihlr-16470	190	124	,	,	PUNCT
ihlr-16470	190	125	analyzed	analyze	VERB
ihlr-16470	190	126	the	the	DET
ihlr-16470	190	127	columbia	columbia	PROPN
ihlr-16470	190	128	research	research	NOUN
ihlr-16470	190	129	to	to	PART
ihlr-16470	190	130	assess	assess	VERB
ihlr-16470	190	131	the	the	DET
ihlr-16470	190	132	risk	risk	NOUN
ihlr-16470	190	133	of	of	ADP
ihlr-16470	190	134	suicidal	suicidal	ADJ
ihlr-16470	190	135	tendencies	tendency	NOUN
ihlr-16470	190	136	.	.	PUNCT
ihlr-16470	191	1	69	69	NUM
ihlr-16470	191	2	hammad	hammad	PROPN
ihlr-16470	191	3	concluded	conclude	VERB
ihlr-16470	191	4	:	:	PUNCT
ihlr-16470	191	5	that	that	SCONJ
ihlr-16470	191	6	minors	minor	NOUN
ihlr-16470	191	7	given	give	VERB
ihlr-16470	191	8	the	the	DET
ihlr-16470	191	9	nine	nine	NUM
ihlr-16470	191	10	antidepressants	antidepressant	NOUN
ihlr-16470	191	11	had	have	AUX
ihlr-16470	191	12	been	be	AUX
ihlr-16470	191	13	1	1	NUM
ihlr-16470	191	14	.	.	NUM
ihlr-16470	191	15	78	78	NUM
ihlr-16470	191	16	times	time	NOUN
ihlr-16470	191	17	more	more	ADV
ihlr-16470	191	18	likely	likely	ADJ
ihlr-16470	191	19	to	to	PART
ihlr-16470	191	20	have	have	AUX
ihlr-16470	191	21	exhibited	exhibit	VERB
ihlr-16470	191	22	suicidal	suicidal	ADJ
ihlr-16470	191	23	behavior	behavior	NOUN
ihlr-16470	191	24	than	than	ADP
ihlr-16470	191	25	those	those	PRON
ihlr-16470	191	26	taking	take	VERB
ihlr-16470	191	27	placebos	placebo	NOUN
ihlr-16470	191	28	.	.	PUNCT
ihlr-16470	192	1	the	the	DET
ihlr-16470	192	2	rate	rate	NOUN
ihlr-16470	192	3	was	be	AUX
ihlr-16470	192	4	significantly	significantly	ADV
ihlr-16470	192	5	higher	high	ADJ
ihlr-16470	192	6	for	for	ADP
ihlr-16470	192	7	some	some	DET
ihlr-16470	192	8	antidepressants	antidepressant	NOUN
ihlr-16470	192	9	,	,	PUNCT
ihlr-16470	192	10	especially	especially	ADV
ihlr-16470	192	11	wyeth	wyeth	PROPN
ihlr-16470	192	12	's	's	PART
ihlr-16470	192	13	effexor	effexor	PROPN
ihlr-16470	192	14	(	(	PUNCT
ihlr-16470	192	15	4.97	4.97	NUM
ihlr-16470	192	16	)	)	PUNCT
ihlr-16470	192	17	and	and	CCONJ
ihlr-16470	192	18	anglo	anglo	ADJ
ihlr-16470	192	19	-	-	PUNCT
ihlr-16470	192	20	american	american	PROPN
ihlr-16470	192	21	glaxosmithkline	glaxosmithkline	PROPN
ihlr-16470	192	22	plc	plc	PROPN
ihlr-16470	192	23	's	's	PART
ihlr-16470	192	24	.	.	PUNCT
ihlr-16470	193	1	paxil	paxil	NOUN
ihlr-16470	193	2	(	(	PUNCT
ihlr-16470	193	3	2.65	2.65	NUM
ihlr-16470	193	4	)	)	PUNCT
ihlr-16470	193	5	.	.	PUNCT
ihlr-16470	194	1	hammad	hammad	PROPN
ihlr-16470	194	2	september	september	PROPN
ihlr-16470	194	3	13	13	NUM
ihlr-16470	194	4	told	tell	VERB
ihlr-16470	194	5	.	.	PUNCT
ihlr-16470	195	1	the	the	DET
ihlr-16470	195	2	advisory.panel	advisory.panel	PROPN
ihlr-16470	195	3	that	that	SCONJ
ihlr-16470	195	4	out	out	ADP
ihlr-16470	195	5	of	of	ADP
ihlr-16470	195	6	100	100	NUM
ihlr-16470	195	7	minors	minor	NOUN
ihlr-16470	195	8	taking	take	VERB
ihlr-16470	195	9	antidepressants	antidepressant	NOUN
ihlr-16470	195	10	,	,	PUNCT
ihlr-16470	195	11	two	two	NUM
ihlr-16470	195	12	or	or	CCONJ
ihlr-16470	195	13	·	·	SYM
ihlr-16470	195	14	three	three	NUM
ihlr-16470	195	15	would	would	AUX
ihlr-16470	195	16	become	become	VERB
ihlr-16470	195	17	suicidal	suicidal	ADJ
ihlr-16470	195	18	due	due	ADP
ihlr-16470	195	19	to	to	ADP
ihlr-16470	195	20	short	short	ADJ
ihlr-16470	195	21	-	-	PUNCT
ihlr-16470	195	22	tei'dl	tei'dl	NOUN
ihlr-16470	195	23	use	use	VERB
ihlr-16470	195	24	ofthe.drug	ofthe.drug	NOUN
ihlr-16470	195	25	....	....	PUNCT
ihlr-16470	196	1	the	the	DET
ihlr-16470	196	2	analyses	analysis	NOUN
ihlr-16470	196	3	by	by	ADP
ihlr-16470	196	4	hammad	hammad	PROPN
ihlr-16470	196	5	and	and	CCONJ
ihlr-16470	196	6	the	the	DET
ihlr-16470	196	7	columbia	columbia	PROPN
ihlr-16470	196	8	team	team	NOUN
ihlr-16470	196	9	backed	back	VERB
ihlr-16470	196	10	up	up	ADP
ihlr-16470	196	11	an	an	DET
ihlr-16470	196	12	earlier	early	ADJ
ihlr-16470	196	13	analysis	analysis	NOUN
ihlr-16470	196	14	by	by	ADP
ihlr-16470	196	15	fda	fda	PROPN
ihlr-16470	196	16	epidemiologist	epidemiologist	NOUN
ihlr-16470	196	17	andrew	andrew	PROPN
ihlr-16470	196	18	mosholder	mosholder	PROPN
ihlr-16470	196	19	,	,	PUNCT
ihlr-16470	196	20	who	who	PRON
ihlr-16470	196	21	in	in	ADP
ihlr-16470	196	22	february	february	PROPN
ihlr-16470	196	23	[	[	X
ihlr-16470	196	24	2004	2004	NUM
ihlr-16470	196	25	]	]	PUNCT
ihlr-16470	196	26	had	have	AUX
ihlr-16470	196	27	concluded	conclude	VERB
ihlr-16470	196	28	that	that	SCONJ
ihlr-16470	196	29	minors	minor	NOUN
ihlr-16470	196	30	taking	take	VERB
ihlr-16470	196	31	antidepressants	antidepressant	NOUN
ihlr-16470	196	32	were	be	AUX
ihlr-16470	196	33	1.89	1.89	NUM
ihlr-16470	196	34	times	time	NOUN
ihlr-16470	196	35	as	as	ADV
ihlr-16470	196	36	likely	likely	ADJ
ihlr-16470	196	37	to	to	PART
ihlr-16470	196	38	show	show	VERB
ihlr-16470	196	39	suicidal	suicidal	ADJ
ihlr-16470	196	40	tendencies	tendency	NOUN
ihlr-16470	196	41	.	.	PUNCT
ihlr-16470	197	1	70	70	NUM
ihlr-16470	197	2	as	as	ADP
ihlr-16470	197	3	a	a	DET
ihlr-16470	197	4	result	result	NOUN
ihlr-16470	197	5	of	of	ADP
ihlr-16470	197	6	the	the	DET
ihlr-16470	197	7	data	datum	NOUN
ihlr-16470	197	8	from	from	ADP
ihlr-16470	197	9	the	the	DET
ihlr-16470	197	10	columbia	columbia	PROPN
ihlr-16470	197	11	study	study	NOUN
ihlr-16470	197	12	,	,	PUNCT
ihlr-16470	197	13	the	the	DET
ihlr-16470	197	14	fda	fda	PROPN
ihlr-16470	197	15	determined	determine	VERB
ihlr-16470	197	16	that	that	SCONJ
ihlr-16470	197	17	a	a	DET
ihlr-16470	197	18	"	"	PUNCT
ihlr-16470	197	19	black	black	ADJ
ihlr-16470	197	20	box	box	NOUN
ihlr-16470	197	21	"	"	PUNCT
ihlr-16470	197	22	warning	warning	NOUN
ihlr-16470	197	23	was	be	AUX
ihlr-16470	197	24	appropriate	appropriate	ADJ
ihlr-16470	197	25	for	for	ADP
ihlr-16470	197	26	ssri	ssri	ADJ
ihlr-16470	197	27	labels	label	NOUN
ihlr-16470	197	28	.	.	PUNCT
ihlr-16470	198	1	71	71	NUM
ihlr-16470	198	2	b.	b.	NOUN
ihlr-16470	198	3	possible	possible	ADJ
ihlr-16470	198	4	problems	problem	NOUN
ihlr-16470	198	5	with	with	ADP
ihlr-16470	198	6	the	the	DET
ihlr-16470	198	7	columbia	columbia	PROPN
ihlr-16470	198	8	study	study	NOUN
ihlr-16470	198	9	although	although	SCONJ
ihlr-16470	198	10	the	the	DET
ihlr-16470	198	11	fda	fda	PROPN
ihlr-16470	198	12	determined	determine	VERB
ihlr-16470	198	13	that	that	SCONJ
ihlr-16470	198	14	"	"	PUNCT
ihlr-16470	198	15	black	black	ADJ
ihlr-16470	198	16	box	box	NOUN
ihlr-16470	198	17	"	"	PUNCT
ihlr-16470	198	18	warnings	warning	NOUN
ihlr-16470	198	19	were	be	AUX
ihlr-16470	198	20	appropriate	appropriate	ADJ
ihlr-16470	198	21	based	base	VERB
ihlr-16470	198	22	on	on	ADP
ihlr-16470	198	23	the	the	DET
ihlr-16470	198	24	conclusions	conclusion	NOUN
ihlr-16470	198	25	of	of	ADP
ihlr-16470	198	26	the	the	DET
ihlr-16470	198	27	columbia	columbia	PROPN
ihlr-16470	198	28	study	study	NOUN
ihlr-16470	198	29	,	,	PUNCT
ihlr-16470	198	30	the	the	DET
ihlr-16470	198	31	study	study	NOUN
ihlr-16470	198	32	still	still	ADV
ihlr-16470	198	33	65	65	NUM
ihlr-16470	198	34	.	.	PUNCT
ihlr-16470	199	1	/d	/d	INTJ
ihlr-16470	199	2	.	.	PUNCT
ihlr-16470	200	1	66	66	NUM
ihlr-16470	200	2	.	.	PUNCT
ihlr-16470	201	1	/d	/d	INTJ
ihlr-16470	201	2	.	.	PUNCT
ihlr-16470	202	1	67	67	NUM
ihlr-16470	202	2	.	.	PUNCT
ihlr-16470	203	1	/d	/d	INTJ
ihlr-16470	203	2	.	.	PUNCT
ihlr-16470	204	1	68	68	NUM
ihlr-16470	204	2	.	.	PUNCT
ihlr-16470	205	1	medicine	medicine	NOUN
ihlr-16470	205	2	and	and	CCONJ
ihlr-16470	205	3	health	health	NOUN
ihlr-16470	205	4	;	;	PUNCT
ihlr-16470	205	5	fda	fda	PROPN
ihlr-16470	205	6	backs	back	VERB
ihlr-16470	205	7	child	child	NOUN
ihlr-16470	205	8	antidepressant	antidepressant	ADJ
ihlr-16470	205	9	warnings	warning	NOUN
ihlr-16470	205	10	;	;	PUNCT
ihlr-16470	205	11	other	other	ADJ
ihlr-16470	205	12	developments	development	NOUN
ihlr-16470	205	13	,	,	PUNCT
ihlr-16470	205	14	facts	fact	NOUN
ihlr-16470	205	15	on	on	ADP
ihlr-16470	205	16	file	file	NOUN
ihlr-16470	205	17	world	world	NOUN
ihlr-16470	205	18	news	news	NOUN
ihlr-16470	205	19	dig	dig	NOUN
ihlr-16470	205	20	.	.	PUNCT
ihlr-16470	205	21	,	,	PUNCT
ihlr-16470	205	22	sept	sept	PROPN
ihlr-16470	205	23	.	.	PROPN
ihlr-16470	205	24	30	30	NUM
ihlr-16470	205	25	,	,	PUNCT
ihlr-16470	205	26	20()4	20()4	NUM
ihlr-16470	205	27	,	,	PUNCT
ihlr-16470	205	28	at	at	ADP
ihlr-16470	205	29	756c3	756c3	NUM
ihlr-16470	205	30	.	.	PROPN
ihlr-16470	205	31	69	69	NUM
ihlr-16470	205	32	.	.	PUNCT
ihlr-16470	206	1	/d	/d	INTJ
ihlr-16470	206	2	.	.	PUNCT
ihlr-16470	207	1	70	70	NUM
ihlr-16470	207	2	.	.	PUNCT
ihlr-16470	208	1	/d	/d	INTJ
ihlr-16470	208	2	.	.	PUNCT
ihlr-16470	209	1	71	71	NUM
ihlr-16470	209	2	.	.	PUNCT
ihlr-16470	209	3	public	public	ADJ
ihlr-16470	209	4	health	health	NOUN
ihlr-16470	209	5	advisory	advisory	NOUN
ihlr-16470	209	6	,	,	PUNCT
ihlr-16470	209	7	supra	supra	PROPN
ihlr-16470	209	8	note	note	NOUN
ihlr-16470	209	9	47	47	NUM
ihlr-16470	209	10	.	.	NOUN
ihlr-16470	210	1	210	210	NUM
ihlr-16470	210	2	indiana	indiana	PROPN
ihlr-16470	210	3	health	health	PROPN
ihlr-16470	210	4	law	law	PROPN
ihlr-16470	210	5	review	review	NOUN
ihlr-16470	210	6	[	[	X
ihlr-16470	210	7	vol	vol	NOUN
ihlr-16470	210	8	.	.	PUNCT
ihlr-16470	211	1	3:201	3:201	NUM
ihlr-16470	211	2	contained	contain	VERB
ihlr-16470	211	3	several	several	ADJ
ihlr-16470	211	4	flaws	flaw	NOUN
ihlr-16470	211	5	.	.	PUNCT
ihlr-16470	212	1	to	to	ADP
ihlr-16470	212	2	a	a	DET
ihlr-16470	212	3	large	large	ADJ
ihlr-16470	212	4	extent	extent	NOUN
ihlr-16470	212	5	,	,	PUNCT
ihlr-16470	212	6	the	the	DET
ihlr-16470	212	7	columbia	columbia	PROPN
ihlr-16470	212	8	study	study	NOUN
ihlr-16470	212	9	relied	rely	VERB
ihlr-16470	212	10	on	on	ADP
ihlr-16470	212	11	data	datum	NOUN
ihlr-16470	212	12	submitted	submit	VERB
ihlr-16470	212	13	to	to	ADP
ihlr-16470	212	14	the	the	DET
ihlr-16470	212	15	fda	fda	PROPN
ihlr-16470	212	16	from	from	ADP
ihlr-16470	212	17	the	the	DET
ihlr-16470	212	18	drug	drug	NOUN
ihlr-16470	212	19	companies	company	NOUN
ihlr-16470	212	20	themselves	themselves	PRON
ihlr-16470	212	21	,	,	PUNCT
ihlr-16470	212	22	and	and	CCONJ
ihlr-16470	212	23	much	much	ADJ
ihlr-16470	212	24	of	of	ADP
ihlr-16470	212	25	the	the	DET
ihlr-16470	212	26	data	datum	NOUN
ihlr-16470	212	27	provided	provide	VERB
ihlr-16470	212	28	was	be	AUX
ihlr-16470	212	29	incomplete	incomplete	ADJ
ihlr-16470	212	30	.	.	PUNCT
ihlr-16470	213	1	72	72	NUM
ihlr-16470	214	1	in	in	ADP
ihlr-16470	214	2	addition	addition	NOUN
ihlr-16470	214	3	to	to	ADP
ihlr-16470	214	4	incomplete	incomplete	ADJ
ihlr-16470	214	5	data	datum	NOUN
ihlr-16470	214	6	,	,	PUNCT
ihlr-16470	214	7	reliance	reliance	NOUN
ihlr-16470	214	8	on	on	ADP
ihlr-16470	214	9	data	datum	NOUN
ihlr-16470	214	10	provided	provide	VERB
ihlr-16470	214	11	by	by	ADP
ihlr-16470	214	12	drug	drug	NOUN
ihlr-16470	214	13	companies	company	NOUN
ihlr-16470	214	14	could	could	AUX
ihlr-16470	214	15	have	have	VERB
ihlr-16470	214	16	other	other	ADJ
ihlr-16470	214	17	policy	policy	NOUN
ihlr-16470	214	18	implications	implication	NOUN
ihlr-16470	214	19	as	as	ADV
ihlr-16470	214	20	well	well	ADV
ihlr-16470	214	21	.	.	PUNCT
ihlr-16470	215	1	by	by	ADP
ihlr-16470	215	2	relying	rely	VERB
ihlr-16470	215	3	on	on	ADP
ihlr-16470	215	4	data	datum	NOUN
ihlr-16470	215	5	from	from	ADP
ihlr-16470	215	6	the	the	DET
ihlr-16470	215	7	pharmaceutical	pharmaceutical	ADJ
ihlr-16470	215	8	companies	company	NOUN
ihlr-16470	215	9	,	,	PUNCT
ihlr-16470	215	10	the	the	DET
ihlr-16470	215	11	fda	fda	PROPN
ihlr-16470	215	12	left	leave	VERB
ihlr-16470	215	13	the	the	DET
ihlr-16470	215	14	door	door	NOUN
ihlr-16470	215	15	open	open	ADJ
ihlr-16470	215	16	to	to	ADP
ihlr-16470	215	17	misleading	misleading	ADJ
ihlr-16470	215	18	and	and	CCONJ
ihlr-16470	215	19	possibly	possibly	ADV
ihlr-16470	215	20	false	false	ADJ
ihlr-16470	215	21	data	datum	NOUN
ihlr-16470	215	22	designed	design	VERB
ihlr-16470	215	23	to	to	PART
ihlr-16470	215	24	protect	protect	VERB
ihlr-16470	215	25	the	the	DET
ihlr-16470	215	26	companies	company	NOUN
ihlr-16470	215	27	•	•	ADP
ihlr-16470	215	28	interests	interest	NOUN
ihlr-16470	215	29	.	.	PUNCT
ihlr-16470	216	1	73	73	NUM
ihlr-16470	217	1	it	it	PRON
ihlr-16470	217	2	is	be	AUX
ihlr-16470	217	3	not	not	PART
ihlr-16470	217	4	an	an	DET
ihlr-16470	217	5	uncomn1on	uncomn1on	ADJ
ihlr-16470	217	6	practice	practice	NOUN
ihlr-16470	217	7	for	for	SCONJ
ihlr-16470	217	8	pharmaceutical	pharmaceutical	ADJ
ihlr-16470	217	9	companies	company	NOUN
ihlr-16470	217	10	to	to	PART
ihlr-16470	217	11	emphasize	emphasize	VERB
ihlr-16470	217	12	favorable	favorable	ADJ
ihlr-16470	217	13	data	datum	NOUN
ihlr-16470	217	14	while	while	SCONJ
ihlr-16470	217	15	obscuring	obscure	VERB
ihlr-16470	217	16	or	or	CCONJ
ihlr-16470	217	17	excluding	exclude	VERB
ihlr-16470	217	18	data	datum	NOUN
ihlr-16470	217	19	that	that	PRON
ihlr-16470	217	20	may	may	AUX
ihlr-16470	217	21	be	be	AUX
ihlr-16470	217	22	harmful	harmful	ADJ
ihlr-16470	217	23	to	to	ADP
ihlr-16470	217	24	their	their	PRON
ihlr-16470	217	25	ability	ability	NOUN
ihlr-16470	217	26	to	to	PART
ihlr-16470	217	27	sell	sell	VERB
ihlr-16470	217	28	a	a	DET
ihlr-16470	217	29	drug	drug	NOUN
ihlr-16470	217	30	,	,	PUNCT
ihlr-16470	217	31	74	74	NUM
ihlr-16470	217	32	thus	thus	ADV
ihlr-16470	217	33	stricter	strict	ADJ
ihlr-16470	217	34	guidelines	guideline	NOUN
ihlr-16470	217	35	are	be	AUX
ihlr-16470	217	36	necessary	necessary	ADJ
ihlr-16470	217	37	to	to	PART
ihlr-16470	217	38	allow	allow	VERB
ihlr-16470	217	39	the	the	DET
ihlr-16470	217	40	fda	fda	PROPN
ihlr-16470	217	41	to	to	PART
ihlr-16470	217	42	properly	properly	ADV
ihlr-16470	217	43	interpret	interpret	VERB
ihlr-16470	217	44	the	the	DET
ihlr-16470	217	45	available	available	ADJ
ihlr-16470	217	46	data	datum	NOUN
ihlr-16470	217	47	.	.	PUNCT
ihlr-16470	218	1	additionally	additionally	ADV
ihlr-16470	218	2	,	,	PUNCT
ihlr-16470	218	3	the	the	DET
ihlr-16470	218	4	very	very	ADJ
ihlr-16470	218	5	nature	nature	NOUN
ihlr-16470	218	6	of	of	ADP
ihlr-16470	218	7	the	the	DET
ihlr-16470	218	8	columbia	columbia	PROPN
ihlr-16470	218	9	study	study	NOUN
ihlr-16470	218	10	may	may	AUX
ihlr-16470	218	11	have	have	AUX
ihlr-16470	218	12	made	make	VERB
ihlr-16470	218	13	it	it	PRON
ihlr-16470	218	14	difficult	difficult	ADJ
ihlr-16470	218	15	to	to	PART
ihlr-16470	218	16	ensure	ensure	VERB
ihlr-16470	218	17	that	that	SCONJ
ihlr-16470	218	18	the	the	DET
ihlr-16470	218	19	results	result	NOUN
ihlr-16470	218	20	of	of	ADP
ihlr-16470	218	21	the	the	DET
ihlr-16470	218	22	study	study	NOUN
ihlr-16470	218	23	were	be	AUX
ihlr-16470	218	24	truly	truly	ADV
ihlr-16470	218	25	accurate	accurate	ADJ
ihlr-16470	218	26	.	.	PUNCT
ihlr-16470	219	1	the	the	DET
ihlr-16470	219	2	very	very	ADJ
ihlr-16470	219	3	purpose	purpose	NOUN
ihlr-16470	219	4	of	of	ADP
ihlr-16470	219	5	the	the	DET
ihlr-16470	219	6	study	study	NOUN
ihlr-16470	219	7	indicates	indicate	VERB
ihlr-16470	219	8	that	that	SCONJ
ihlr-16470	219	9	the	the	DET
ihlr-16470	219	10	columbia	columbia	PROPN
ihlr-16470	219	11	researchers	researcher	NOUN
ihlr-16470	219	12	were	be	AUX
ihlr-16470	219	13	dealing	deal	VERB
ihlr-16470	219	14	with	with	ADP
ihlr-16470	219	15	data	datum	NOUN
ihlr-16470	219	16	that	that	PRON
ihlr-16470	219	17	had	have	VERB
ihlr-16470	219	18	serious	serious	ADJ
ihlr-16470	219	19	shortcomings	shortcoming	NOUN
ihlr-16470	219	20	.	.	PUNCT
ihlr-16470	220	1	75	75	NUM
ihlr-16470	220	2	at	at	ADP
ihlr-16470	220	3	the	the	DET
ihlr-16470	220	4	time	time	NOUN
ihlr-16470	220	5	the	the	DET
ihlr-16470	220	6	original	original	ADJ
ihlr-16470	220	7	data	datum	NOUN
ihlr-16470	220	8	were	be	AUX
ihlr-16470	220	9	compiled	compile	VERB
ihlr-16470	220	10	,	,	PUNCT
ihlr-16470	220	11	the	the	DET
ihlr-16470	220	12	researchers	researcher	NOUN
ihlr-16470	220	13	''	''	PUNCT
ihlr-16470	220	14	were	be	AUX
ihlr-16470	220	15	not	not	PART
ihlr-16470	220	16	looking	look	VERB
ihlr-16470	220	17	for	for	ADP
ihlr-16470	220	18	suicidal	suicidal	ADJ
ihlr-16470	220	19	behavior	behavior	NOUN
ihlr-16470	220	20	as	as	ADP
ihlr-16470	220	21	a	a	DET
ihlr-16470	220	22	possible	possible	ADJ
ihlr-16470	220	23	adverse	adverse	ADJ
ihlr-16470	220	24	event	event	NOUN
ihlr-16470	220	25	.	.	PUNCT
ihlr-16470	221	1	"76	"76	PROPN
ihlr-16470	221	2	as	as	ADP
ihlr-16470	221	3	a	a	DET
ihlr-16470	221	4	result	result	NOUN
ihlr-16470	221	5	it	it	PRON
ihlr-16470	221	6	is	be	AUX
ihlr-16470	221	7	likely	likely	ADJ
ihlr-16470	221	8	thatmany	thatmany	NOUN
ihlr-16470	221	9	incidents	incident	NOUN
ihlr-16470	221	10	were	be	AUX
ihlr-16470	221	11	not	not	PART
ihlr-16470	221	12	only	only	ADV
ihlr-16470	221	13	incorrectly	incorrectly	ADV
ihlr-16470	221	14	categorized	categorize	VERB
ihlr-16470	221	15	,	,	PUNCT
ihlr-16470	221	16	but	but	CCONJ
ihlr-16470	221	17	not	not	PART
ihlr-16470	221	18	recorded	record	VERB
ihlr-16470	221	19	at	at	ADV
ihlr-16470	221	20	all	all	ADV
ihlr-16470	221	21	.	.	PUNCT
ihlr-16470	222	1	77	77	NUM
ihlr-16470	222	2	since	since	SCONJ
ihlr-16470	222	3	suicidality	suicidality	NOUN
ihlr-16470	222	4	was	be	AUX
ihlr-16470	222	5	not	not	PART
ihlr-16470	222	6	an	an	DET
ihlr-16470	222	7	expected	expect	VERB
ihlr-16470	222	8	effect	effect	NOUN
ihlr-16470	222	9	of	of	ADP
ihlr-16470	222	10	the	the	DET
ihlr-16470	222	11	drugs	drug	NOUN
ihlr-16470	222	12	,	,	PUNCT
ihlr-16470	222	13	it	it	PRON
ihlr-16470	222	14	is	be	AUX
ihlr-16470	222	15	unlikely	unlikely	ADJ
ihlr-16470	222	16	that	that	SCONJ
ihlr-16470	222	17	the	the	DET
ihlr-16470	222	18	original	original	ADJ
ihlr-16470	222	19	studies	study	NOUN
ihlr-16470	222	20	provided	provide	VERB
ihlr-16470	222	21	a	a	DET
ihlr-16470	222	22	control	control	NOUN
ihlr-16470	222	23	to	to	PART
ihlr-16470	222	24	determine	determine	VERB
ihlr-16470	222	25	the	the	DET
ihlr-16470	222	26	cause	cause	NOUN
ihlr-16470	222	27	of	of	ADP
ihlr-16470	222	28	the	the	DET
ihlr-16470	222	29	emergent	emergent	ADJ
ihlr-16470	222	30	suicidal	suicidal	ADJ
ihlr-16470	222	31	ideation	ideation	NOUN
ihlr-16470	222	32	.	.	PUNCT
ihlr-16470	223	1	78	78	NUM
ihlr-16470	223	2	another	another	DET
ihlr-16470	223	3	factor	factor	NOUN
ihlr-16470	223	4	that	that	PRON
ihlr-16470	223	5	may	may	AUX
ihlr-16470	223	6	reduce	reduce	VERB
ihlr-16470	223	7	the	the	DET
ihlr-16470	223	8	accuracy	accuracy	NOUN
ihlr-16470	223	9	of	of	ADP
ihlr-16470	223	10	the	the	DET
ihlr-16470	223	11	columbia	columbia	PROPN
ihlr-16470	223	12	group	group	NOUN
ihlr-16470	223	13	's	's	PART
ihlr-16470	223	14	determination	determination	NOUN
ihlr-16470	223	15	is	be	AUX
ihlr-16470	223	16	the	the	DET
ihlr-16470	223	17	fact	fact	NOUN
ihlr-16470	223	18	that	that	SCONJ
ihlr-16470	223	19	drug	drug	NOUN
ihlr-16470	223	20	-	-	PUNCT
ihlr-16470	223	21	company	company	NOUN
ihlr-16470	223	22	trials	trial	NOUN
ihlr-16470	223	23	often	often	ADV
ihlr-16470	223	24	confuse	confuse	VERB
ihlr-16470	223	25	self­	self­	ADJ
ihlr-16470	223	26	destructiveness	destructiveness	NOUN
ihlr-16470	223	27	with	with	ADP
ihlr-16470	223	28	suicide	suicide	NOUN
ihlr-16470	223	29	attempts	attempt	NOUN
ihlr-16470	223	30	.	.	PUNCT
ihlr-16470	224	1	79	79	NUM
ihlr-16470	224	2	when	when	SCONJ
ihlr-16470	224	3	determining	determine	VERB
ihlr-16470	224	4	whether	whether	SCONJ
ihlr-16470	224	5	an	an	DET
ihlr-16470	224	6	act	act	NOUN
ihlr-16470	224	7	is	be	AUX
ihlr-16470	224	8	suicidal	suicidal	ADJ
ihlr-16470	224	9	in	in	ADP
ihlr-16470	224	10	nature	nature	NOUN
ihlr-16470	224	11	or	or	CCONJ
ihlr-16470	224	12	merely	merely	ADV
ihlr-16470	224	13	self	self	NOUN
ihlr-16470	224	14	-	-	PUNCT
ihlr-16470	224	15	destructive	destructive	ADJ
ihlr-16470	224	16	,	,	PUNCT
ihlr-16470	224	17	intent	intent	NOUN
ihlr-16470	224	18	is	be	AUX
ihlr-16470	224	19	the	the	DET
ihlr-16470	224	20	controlling	control	VERB
ihlr-16470	224	21	factor	factor	NOUN
ihlr-16470	224	22	.	.	PUNCT
ihlr-16470	225	1	80	80	NUM
ihlr-16470	226	1	if	if	SCONJ
ihlr-16470	226	2	an	an	DET
ihlr-16470	226	3	individual	individual	NOUN
ihlr-16470	226	4	lacks	lack	VERB
ihlr-16470	226	5	the	the	DET
ihlr-16470	226	6	intent	intent	NOUN
ihlr-16470	226	7	to	to	PART
ihlr-16470	226	8	commit	commit	VERB
ihlr-16470	226	9	suicide	suicide	NOUN
ihlr-16470	226	10	,	,	PUNCT
ihlr-16470	226	11	then	then	ADV
ihlr-16470	226	12	the	the	DET
ihlr-16470	226	13	self	self	NOUN
ihlr-16470	226	14	-	-	PUNCT
ihlr-16470	226	15	destructive	destructive	ADJ
ihlr-16470	226	16	act	act	NOUN
ihlr-16470	226	17	can	can	AUX
ihlr-16470	226	18	not	not	PART
ihlr-16470	226	19	be	be	AUX
ihlr-16470	226	20	classified	classify	VERB
ihlr-16470	226	21	as	as	ADP
ihlr-16470	226	22	suicidal	suicidal	ADJ
ihlr-16470	226	23	in	in	ADP
ihlr-16470	226	24	nature.81	nature.81	PROPN
ihlr-16470	226	25	"	"	PUNCT
ihlr-16470	226	26	dr	dr	PROPN
ihlr-16470	226	27	.	.	PROPN
ihlr-16470	226	28	thomas	thomas	PROPN
ihlr-16470	226	29	laughren	laughren	PROPN
ihlr-16470	226	30	,	,	PUNCT
ihlr-16470	226	31	leader	leader	NOUN
ihlr-16470	226	32	of	of	ADP
ihlr-16470	226	33	the	the	DET
ihlr-16470	226	34	fda	fda	PROPN
ihlr-16470	226	35	's	's	PART
ihlr-16470	226	36	psychiatric	psychiatric	ADJ
ihlr-16470	226	37	drug	drug	NOUN
ihlr-16470	226	38	products	product	NOUN
ihlr-16470	226	39	group	group	NOUN
ihlr-16470	226	40	,	,	PUNCT
ihlr-16470	226	41	noted	note	VERB
ihlr-16470	226	42	that	that	SCONJ
ihlr-16470	226	43	the	the	DET
ihlr-16470	226	44	[	[	X
ihlr-16470	226	45	brief	brief	ADJ
ihlr-16470	226	46	notes	note	NOUN
ihlr-16470	226	47	provided	provide	VERB
ihlr-16470	226	48	by	by	ADP
ihlr-16470	226	49	the	the	DET
ihlr-16470	226	50	]	]	PUNCT
ihlr-16470	226	51	drug	drug	NOUN
ihlr-16470	226	52	companies	company	NOUN
ihlr-16470	226	53	.	.	PUNCT
ihlr-16470	226	54	.	.	PUNCT
ihlr-16470	227	1	.	.	PUNCT
ihlr-16470	227	2	were	be	AUX
ihlr-16470	227	3	often	often	ADV
ihlr-16470	227	4	poor	poor	ADJ
ihlr-16470	227	5	''	''	PUNCT
ihlr-16470	227	6	which	which	PRON
ihlr-16470	227	7	made	make	VERB
ihlr-16470	227	8	discovering	discover	VERB
ihlr-16470	227	9	the	the	DET
ihlr-16470	227	10	underlying	underlying	ADJ
ihlr-16470	227	11	intent	intent	NOUN
ihlr-16470	227	12	difficult.82	difficult.82	ADJ
ihlr-16470	227	13	as	as	SCONJ
ihlr-16470	227	14	he	he	PRON
ihlr-16470	227	15	stated	state	VERB
ihlr-16470	227	16	,	,	PUNCT
ihlr-16470	227	17	"	"	PUNCT
ihlr-16470	227	18	[	[	PUNCT
ihlr-16470	227	19	w	w	NOUN
ihlr-16470	227	20	]	]	X
ihlr-16470	227	21	e	e	NOUN
ihlr-16470	227	22	did	do	AUX
ihlr-16470	227	23	not	not	PART
ihlr-16470	227	24	have	have	VERB
ihlr-16470	227	25	the	the	DET
ihlr-16470	227	26	level	level	NOUN
ihlr-16470	227	27	of	of	ADP
ihlr-16470	227	28	detail	detail	NOUN
ihlr-16470	227	29	in	in	ADP
ihlr-16470	227	30	these	these	DET
ihlr-16470	227	31	cases	case	NOUN
ihlr-16470	227	32	that	that	SCONJ
ihlr-16470	227	33	one	one	PRON
ihlr-16470	227	34	would	would	AUX
ihlr-16470	227	35	have	have	AUX
ihlr-16470	227	36	liked	like	VERB
ihlr-16470	227	37	to	to	PART
ihlr-16470	227	38	do	do	VERB
ihlr-16470	227	39	a	a	DET
ihlr-16470	227	40	rational	rational	ADJ
ihlr-16470	227	41	classification	classification	NOUN
ihlr-16470	227	42	.	.	PUNCT
ihlr-16470	228	1	"	"	PUNCT
ihlr-16470	228	2	83	83	NUM
ihlr-16470	228	3	72	72	NUM
ihlr-16470	228	4	.	.	PUNCT
ihlr-16470	229	1	see	see	VERB
ihlr-16470	229	2	fda	fda	PROPN
ihlr-16470	229	3	study	study	PROPN
ihlr-16470	229	4	confirms	confirm	VERB
ihlr-16470	229	5	link	link	VERB
ihlr-16470	229	6	between	between	ADP
ihlr-16470	229	7	antidepressants	antidepressant	NOUN
ihlr-16470	229	8	,	,	PUNCT
ihlr-16470	229	9	child	child	NOUN
ihlr-16470	229	10	suicide	suicide	NOUN
ihlr-16470	229	11	,	,	PUNCT
ihlr-16470	229	12	drugindust	drugindust	NOUN
ihlr-16470	229	13	.	.	PUNCT
ihlr-16470	230	1	dad.y	dad.y	PROPN
ihlr-16470	230	2	,	,	PUNCT
ihlr-16470	230	3	aug	aug	PROPN
ihlr-16470	230	4	.	.	PROPN
ihlr-16470	230	5	ii	ii	PROPN
ihlr-16470	230	6	,	,	PUNCT
ihlr-16470	230	7	2004	2004	NUM
ihlr-16470	230	8	,	,	PUNCT
ihlr-16470	230	9	§	§	PROPN
ihlr-16470	230	10	156	156	NUM
ihlr-16470	230	11	.	.	PUNCT
ihlr-16470	230	12	73	73	NUM
ihlr-16470	230	13	.	.	PUNCT
ihlr-16470	231	1	see	see	VERB
ihlr-16470	231	2	liebert	liebert	PROPN
ihlr-16470	231	3	,	,	PUNCT
ihlr-16470	231	4	supra	supra	PROPN
ihlr-16470	231	5	note	note	NOUN
ihlr-16470	231	6	9	9	NUM
ihlr-16470	231	7	(	(	PUNCT
ihlr-16470	231	8	discussinggjaxosmitbkiinewitbholding	discussinggjaxosmitbkiinewitbholding	NOUN
ihlr-16470	231	9	findings	finding	VERB
ihlr-16470	231	10	tbattheir	tbattheir	PROPN
ihlr-16470	231	11	ssri	ssri	PROPN
ihlr-16470	231	12	,	,	PUNCT
ihlr-16470	231	13	paxil	paxil	NOUN
ihlr-16470	231	14	,	,	PUNCT
ihlr-16470	231	15	was	be	AUX
ihlr-16470	231	16	no	no	PRON
ihlr-16470	231	17	more	more	ADV
ihlr-16470	231	18	effective	effective	ADJ
ihlr-16470	231	19	than	than	ADP
ihlr-16470	231	20	placebo	placebo	NOUN
ihlr-16470	231	21	and	and	CCONJ
ihlr-16470	231	22	may	may	AUX
ihlr-16470	231	23	increase	increase	VERB
ihlr-16470	231	24	the	the	DET
ihlr-16470	231	25	risk	risk	NOUN
ihlr-16470	231	26	of	of	ADP
ihlr-16470	231	27	suicide	suicide	NOUN
ihlr-16470	231	28	)	)	PUNCT
ihlr-16470	231	29	.	.	PUNCT
ihlr-16470	232	1	74	74	NUM
ihlr-16470	232	2	.	.	PUNCT
ihlr-16470	233	1	/d	/d	INTJ
ihlr-16470	233	2	.	.	PUNCT
ihlr-16470	234	1	75	75	NUM
ihlr-16470	234	2	.	.	PUNCT
ihlr-16470	235	1	see	see	VERB
ihlr-16470	235	2	drug	drug	NOUN
ihlr-16470	235	3	indust	indust	NOUN
ihlr-16470	235	4	.	.	PUNCT
ihlr-16470	236	1	dad.y	dad.y	PROPN
ihlr-16470	236	2	,	,	PUNCT
ihlr-16470	236	3	supra	supra	PROPN
ihlr-16470	236	4	note	note	NOUN
ihlr-16470	236	5	72	72	NUM
ihlr-16470	236	6	.	.	PUNCT
ihlr-16470	237	1	76	76	NUM
ihlr-16470	237	2	.	.	PUNCT
ihlr-16470	238	1	/d	/d	INTJ
ihlr-16470	238	2	.	.	PUNCT
ihlr-16470	239	1	77	77	NUM
ihlr-16470	239	2	.	.	PUNCT
ihlr-16470	240	1	see	see	VERB
ihlr-16470	240	2	background	background	NOUN
ihlr-16470	240	3	information	information	NOUN
ihlr-16470	240	4	,	,	PUNCT
ihlr-16470	240	5	supra	supra	PROPN
ihlr-16470	240	6	note	note	NOUN
ihlr-16470	240	7	59	59	NUM
ihlr-16470	240	8	.	.	PUNCT
ihlr-16470	241	1	78	78	NUM
ihlr-16470	241	2	.	.	PUNCT
ihlr-16470	242	1	see	see	VERB
ihlr-16470	242	2	drug	drug	NOUN
ihlr-16470	242	3	indust	indust	NOUN
ihlr-16470	242	4	.	.	PUNCT
ihlr-16470	243	1	dad.y	dad.y	PROPN
ihlr-16470	243	2	,	,	PUNCT
ihlr-16470	243	3	supra	supra	PROPN
ihlr-16470	243	4	note	note	NOUN
ihlr-16470	243	5	72	72	NUM
ihlr-16470	243	6	.	.	PUNCT
ihlr-16470	243	7	79	79	NUM
ihlr-16470	243	8	.	.	PUNCT
ihlr-16470	244	1	gardiner	gardiner	PROPN
ihlr-16470	244	2	harris	harris	PROPN
ihlr-16470	244	3	,	,	PUNCT
ihlr-16470	244	4	antidepressants	antidepressant	NOUN
ihlr-16470	244	5	restudied	restudie	VERB
ihlr-16470	244	6	for	for	ADP
ihlr-16470	244	7	relation	relation	NOUN
ihlr-16470	244	8	to	to	ADP
ihlr-16470	244	9	child	child	NOUN
ihlr-16470	244	10	suicide	suicide	PROPN
ihlr-16470	244	11	,	,	PUNCT
ihlr-16470	244	12	n.y	n.y	PROPN
ihlr-16470	244	13	.	.	PROPN
ihlr-16470	244	14	times	times	PROPN
ihlr-16470	244	15	,	,	PUNCT
ihlr-16470	244	16	june	june	PROPN
ihlr-16470	244	17	20	20	NUM
ihlr-16470	244	18	,	,	PUNCT
ihlr-16470	244	19	2004	2004	NUM
ihlr-16470	244	20	,	,	PUNCT
ihlr-16470	244	21	§	§	PROPN
ihlr-16470	244	22	1	1	NUM
ihlr-16470	244	23	at	at	ADP
ihlr-16470	244	24	20	20	NUM
ihlr-16470	244	25	.	.	PUNCT
ihlr-16470	244	26	80	80	NUM
ihlr-16470	244	27	.	.	PUNCT
ihlr-16470	245	1	/d	/d	INTJ
ihlr-16470	245	2	.	.	PUNCT
ihlr-16470	246	1	81	81	NUM
ihlr-16470	246	2	.	.	PUNCT
ihlr-16470	247	1	/d	/d	INTJ
ihlr-16470	247	2	.	.	PUNCT
ihlr-16470	248	1	82	82	NUM
ihlr-16470	248	2	.	.	PUNCT
ihlr-16470	249	1	/d	/d	INTJ
ihlr-16470	249	2	.	.	PUNCT
ihlr-16470	250	1	83	83	NUM
ihlr-16470	250	2	.	.	PUNCT
ihlr-16470	251	1	/d	/d	PUNCT
ihlr-16470	251	2	.	.	PUNCT
ihlr-16470	252	1	2006	2006	NUM
ihlr-16470	252	2	]	]	PUNCT
ihlr-16470	252	3	anti	anti	NOUN
ihlr-16470	252	4	-	-	NOUN
ihlr-16470	252	5	depressants	depressant	NOUN
ihlr-16470	252	6	and	and	CCONJ
ihlr-16470	252	7	children	child	NOUN
ihlr-16470	252	8	211	211	NUM
ihlr-16470	252	9	another	another	DET
ihlr-16470	252	10	difficulty	difficulty	NOUN
ihlr-16470	252	11	results	result	VERB
ihlr-16470	252	12	from	from	ADP
ihlr-16470	252	13	the	the	DET
ihlr-16470	252	14	diversified	diversify	VERB
ihlr-16470	252	15	nature	nature	NOUN
ihlr-16470	252	16	of	of	ADP
ihlr-16470	252	17	the	the	DET
ihlr-16470	252	18	original	original	ADJ
ihlr-16470	252	19	trials	trial	NOUN
ihlr-16470	252	20	.	.	PUNCT
ihlr-16470	253	1	each	each	DET
ihlr-16470	253	2	pharmaceutical	pharmaceutical	NOUN
ihlr-16470	253	3	trial	trial	NOUN
ihlr-16470	253	4	is	be	AUX
ihlr-16470	253	5	unique	unique	ADJ
ihlr-16470	253	6	in	in	ADP
ihlr-16470	253	7	several	several	ADJ
ihlr-16470	253	8	ways	way	NOUN
ihlr-16470	253	9	that	that	PRON
ihlr-16470	253	10	may	may	AUX
ihlr-16470	253	11	compromise	compromise	VERB
ihlr-16470	253	12	the	the	DET
ihlr-16470	253	13	integrity	integrity	NOUN
ihlr-16470	253	14	of	of	ADP
ihlr-16470	253	15	the	the	DET
ihlr-16470	253	16	columbia	columbia	PROPN
ihlr-16470	253	17	group	group	NOUN
ihlr-16470	253	18	's	's	PART
ihlr-16470	253	19	determination	determination	NOUN
ihlr-16470	253	20	.	.	PUNCT
ihlr-16470	254	1	since	since	SCONJ
ihlr-16470	254	2	each	each	DET
ihlr-16470	254	3	individual	individual	ADJ
ihlr-16470	254	4	trial	trial	NOUN
ihlr-16470	254	5	is	be	AUX
ihlr-16470	254	6	focused	focus	VERB
ihlr-16470	254	7	for	for	ADP
ihlr-16470	254	8	unique	unique	ADJ
ihlr-16470	254	9	purposes	purpose	NOUN
ihlr-16470	254	10	,	,	PUNCT
ihlr-16470	254	11	there	there	PRON
ihlr-16470	254	12	is	be	VERB
ihlr-16470	254	13	no	no	DET
ihlr-16470	254	14	single	single	ADJ
ihlr-16470	254	15	constant	constant	ADJ
ihlr-16470	254	16	method	method	NOUN
ihlr-16470	254	17	utilized	utilize	VERB
ihlr-16470	254	18	.	.	PUNCT
ihlr-16470	255	1	dosages	dosage	NOUN
ihlr-16470	255	2	,	,	PUNCT
ihlr-16470	255	3	methods	method	NOUN
ihlr-16470	255	4	of	of	ADP
ihlr-16470	255	5	administration	administration	NOUN
ihlr-16470	255	6	,	,	PUNCT
ihlr-16470	255	7	and	and	CCONJ
ihlr-16470	255	8	subject	subject	NOUN
ihlr-16470	255	9	group	group	NOUN
ihlr-16470	255	10	will	will	AUX
ihlr-16470	255	11	be	be	AUX
ihlr-16470	255	12	almost	almost	ADV
ihlr-16470	255	13	as	as	ADV
ihlr-16470	255	14	varied	varied	ADJ
ihlr-16470	255	15	as	as	ADP
ihlr-16470	255	16	the	the	DET
ihlr-16470	255	17	number	number	NOUN
ihlr-16470	255	18	of	of	ADP
ihlr-16470	255	19	trials	trial	NOUN
ihlr-16470	255	20	themselves.84	themselves.84	ADV
ihlr-16470	255	21	given	give	VERB
ihlr-16470	255	22	the	the	DET
ihlr-16470	255	23	inherent	inherent	ADJ
ihlr-16470	255	24	differences	difference	NOUN
ihlr-16470	255	25	in	in	ADP
ihlr-16470	255	26	the	the	DET
ihlr-16470	255	27	original	original	ADJ
ihlr-16470	255	28	trials	trial	NOUN
ihlr-16470	255	29	,	,	PUNCT
ihlr-16470	255	30	it	it	PRON
ihlr-16470	255	31	calls	call	VERB
ihlr-16470	255	32	into	into	ADP
ihlr-16470	255	33	question	question	NOUN
ihlr-16470	255	34	how	how	SCONJ
ihlr-16470	255	35	the	the	DET
ihlr-16470	255	36	columbia	columbia	PROPN
ihlr-16470	255	37	researchers	researcher	NOUN
ihlr-16470	255	38	can	can	AUX
ihlr-16470	255	39	be	be	AUX
ihlr-16470	255	40	sure	sure	ADJ
ihlr-16470	255	41	,	,	PUNCT
ihlr-16470	255	42	after	after	ADP
ihlr-16470	255	43	mere	mere	ADJ
ihlr-16470	255	44	second	second	ADJ
ihlr-16470	255	45	hand	hand	NOUN
ihlr-16470	255	46	review	review	NOUN
ihlr-16470	255	47	of	of	ADP
ihlr-16470	255	48	clinical	clinical	ADJ
ihlr-16470	255	49	notes	note	NOUN
ihlr-16470	255	50	,	,	PUNCT
ihlr-16470	255	51	that	that	SCONJ
ihlr-16470	255	52	at	at	ADV
ihlr-16470	255	53	least	least	ADJ
ihlr-16470	255	54	some	some	PRON
ihlr-16470	255	55	of	of	ADP
ihlr-16470	255	56	the	the	DET
ihlr-16470	255	57	adverse	adverse	ADJ
ihlr-16470	255	58	reactions	reaction	NOUN
ihlr-16470	255	59	were	be	AUX
ihlr-16470	255	60	not	not	PART
ihlr-16470	255	61	caused	cause	VERB
ihlr-16470	255	62	by	by	ADP
ihlr-16470	255	63	unusually	unusually	ADV
ihlr-16470	255	64	high	high	ADJ
ihlr-16470	255	65	dosages	dosage	NOUN
ihlr-16470	255	66	,	,	PUNCT
ihlr-16470	255	67	or	or	CCONJ
ihlr-16470	255	68	another	another	DET
ihlr-16470	255	69	external	external	ADJ
ihlr-16470	255	70	factor	factor	NOUN
ihlr-16470	255	71	,	,	PUNCT
ihlr-16470	255	72	rather	rather	ADV
ihlr-16470	255	73	than	than	ADP
ihlr-16470	255	74	the	the	DET
ihlr-16470	255	75	drug	drug	NOUN
ihlr-16470	255	76	itself	itself	PRON
ihlr-16470	255	77	.	.	PUNCT
ihlr-16470	256	1	how	how	SCONJ
ihlr-16470	256	2	can	can	AUX
ihlr-16470	256	3	one	one	PRON
ihlr-16470	256	4	be	be	AUX
ihlr-16470	256	5	sure	sure	ADJ
ihlr-16470	256	6	that	that	SCONJ
ihlr-16470	256	7	this	this	DET
ihlr-16470	256	8	collection	collection	NOUN
ihlr-16470	256	9	and	and	CCONJ
ihlr-16470	256	10	review	review	NOUN
ihlr-16470	256	11	of	of	ADP
ihlr-16470	256	12	suboptimal	suboptimal	ADJ
ihlr-16470	256	13	data	datum	NOUN
ihlr-16470	256	14	may	may	AUX
ihlr-16470	256	15	be	be	AUX
ihlr-16470	256	16	reduced	reduce	VERB
ihlr-16470	256	17	to	to	ADP
ihlr-16470	256	18	a	a	DET
ihlr-16470	256	19	concrete	concrete	ADJ
ihlr-16470	256	20	and	and	CCONJ
ihlr-16470	256	21	conclusive	conclusive	ADJ
ihlr-16470	256	22	result?85	result?85	NOUN
ihlr-16470	256	23	4	4	NUM
ihlr-16470	256	24	.	.	PUNCT
ihlr-16470	257	1	new	new	ADJ
ihlr-16470	257	2	fda	fda	PROPN
ihlr-16470	257	3	warnings	warning	NOUN
ihlr-16470	257	4	relying	rely	VERB
ihlr-16470	257	5	on	on	ADP
ihlr-16470	257	6	the	the	DET
ihlr-16470	257	7	columbia	columbia	PROPN
ihlr-16470	257	8	study	study	NOUN
ihlr-16470	257	9	's	's	PART
ihlr-16470	257	10	findings	finding	NOUN
ihlr-16470	257	11	,	,	PUNCT
ihlr-16470	257	12	the	the	DET
ihlr-16470	257	13	fda	fda	PROPN
ihlr-16470	257	14	psychopharmaco­	psychopharmaco­	NOUN
ihlr-16470	257	15	logic	logic	ADJ
ihlr-16470	257	16	drugs	drug	NOUN
ihlr-16470	257	17	and	and	CCONJ
ihlr-16470	257	18	pediatric	pediatric	ADJ
ihlr-16470	257	19	advisory	advisory	ADJ
ihlr-16470	257	20	committees	committee	NOUN
ihlr-16470	257	21	(	(	PUNCT
ihlr-16470	257	22	pdpac	pdpac	PROPN
ihlr-16470	257	23	)	)	PUNCT
ihlr-16470	257	24	issued	issue	VERB
ihlr-16470	257	25	the	the	DET
ihlr-16470	257	26	following	follow	VERB
ihlr-16470	257	27	findings	finding	NOUN
ihlr-16470	257	28	and	and	CCONJ
ihlr-16470	257	29	recommendations	recommendation	NOUN
ihlr-16470	257	30	to	to	ADP
ihlr-16470	257	31	the	the	DET
ihlr-16470	257	32	fda	fda	PROPN
ihlr-16470	257	33	:	:	PUNCT
ihlr-16470	257	34	increased	increase	VERB
ihlr-16470	257	35	risk	risk	NOUN
ihlr-16470	257	36	of	of	ADP
ihlr-16470	257	37	suicidality	suicidality	NOUN
ihlr-16470	257	38	in	in	ADP
ihlr-16470	257	39	pediatric	pediatric	ADJ
ihlr-16470	257	40	patients	patient	NOUN
ihlr-16470	257	41	applied	apply	VERB
ihlr-16470	257	42	to	to	ADP
ihlr-16470	257	43	all	all	DET
ihlr-16470	257	44	the	the	DET
ihlr-16470	257	45	drugs	drug	NOUN
ihlr-16470	257	46	studied	study	VERB
ihlr-16470	257	47	(	(	PUNCT
ihlr-16470	257	48	prozac	prozac	NOUN
ihlr-16470	257	49	,	,	PUNCT
ihlr-16470	257	50	zoloft	zoloft	PROPN
ihlr-16470	257	51	,	,	PUNCT
ihlr-16470	257	52	remeron	remeron	NOUN
ihlr-16470	257	53	,	,	PUNCT
ihlr-16470	257	54	paxil	paxil	NOUN
ihlr-16470	257	55	,	,	PUNCT
ihlr-16470	257	56	effexor	effexor	PROPN
ihlr-16470	257	57	,	,	PUNCT
ihlr-16470	257	58	celexa	celexa	PROPN
ihlr-16470	257	59	wellbutrin	wellbutrin	NOUN
ihlr-16470	257	60	,	,	PUNCT
ihlr-16470	257	61	luvox	luvox	PROPN
ihlr-16470	257	62	and	and	CCONJ
ihlr-16470	257	63	serzone	serzone	NOUN
ihlr-16470	257	64	)	)	PUNCT
ihlr-16470	257	65	in	in	ADP
ihlr-16470	257	66	controlled	control	VERB
ihlr-16470	257	67	clinical	clinical	ADJ
ihlr-16470	257	68	trials	trial	NOUN
ihlr-16470	257	69	;	;	PUNCT
ihlr-16470	257	70	that	that	SCONJ
ihlr-16470	257	71	any	any	DET
ihlr-16470	257	72	warning	warning	NOUN
ihlr-16470	257	73	related	relate	VERB
ihlr-16470	257	74	to	to	ADP
ihlr-16470	257	75	an	an	DET
ihlr-16470	257	76	increased	increase	VERB
ihlr-16470	257	77	risk	risk	NOUN
ihlr-16470	257	78	of	of	ADP
ihlr-16470	257	79	suicidality	suicidality	NOUN
ihlr-16470	257	80	in	in	ADP
ihlr-16470	257	81	pediatric	pediatric	ADJ
ihlr-16470	257	82	patients	patient	NOUN
ihlr-16470	257	83	should	should	AUX
ihlr-16470	257	84	be	be	AUX
ihlr-16470	257	85	applied	apply	VERB
ihlr-16470	257	86	to	to	ADP
ihlr-16470	257	87	all	all	DET
ihlr-16470	257	88	antidepressant	antidepressant	ADJ
ihlr-16470	257	89	drugs	drug	NOUN
ihlr-16470	257	90	,	,	PUNCT
ihlr-16470	257	91	including	include	VERB
ihlr-16470	257	92	those	those	PRON
ihlr-16470	257	93	that	that	PRON
ihlr-16470	257	94	have	have	AUX
ihlr-16470	257	95	not	not	PART
ihlr-16470	257	96	been	be	AUX
ihlr-16470	257	97	studied	study	VERB
ihlr-16470	257	98	in	in	ADP
ihlr-16470	257	99	controlled	control	VERB
ihlr-16470	257	100	clinical	clinical	ADJ
ihlr-16470	257	101	trials	trial	NOUN
ihlr-16470	257	102	...	...	PUNCT
ihlr-16470	257	103	;	;	PUNCT
ihlr-16470	258	1	[	[	X
ihlr-16470	258	2	r]eached	r]eache	VERB
ihlr-16470	258	3	a	a	DET
ihlr-16470	258	4	split	split	ADJ
ihlr-16470	258	5	decision	decision	NOUN
ihlr-16470	258	6	...	...	PUNCT
ihlr-16470	258	7	regarding	regard	VERB
ihlr-16470	258	8	recommending	recommend	VERB
ihlr-16470	258	9	a	a	DET
ihlr-16470	258	10	"	"	PUNCT
ihlr-16470	258	11	black	black	ADJ
ihlr-16470	258	12	box	box	NOUN
ihlr-16470	258	13	"	"	PUNCT
ihlr-16470	258	14	warning	warning	NOUN
ihlr-16470	258	15	related	relate	VERB
ihlr-16470	258	16	to	to	ADP
ihlr-16470	258	17	an	an	DET
ihlr-16470	258	18	increased	increase	VERB
ihlr-16470	258	19	risk	risk	NOUN
ihlr-16470	258	20	for	for	ADP
ihlr-16470	258	21	suicid­	suicid­	PROPN
ihlr-16470	258	22	ality	ality	NOUN
ihlr-16470	258	23	in	in	ADP
ihlr-16470	258	24	pediatric	pediatric	ADJ
ihlr-16470	258	25	patients	patient	NOUN
ihlr-16470	258	26	for	for	ADP
ihlr-16470	258	27	all	all	DET
ihlr-16470	258	28	antidepressant	antidepressant	ADJ
ihlr-16470	258	29	drugs	drug	NOUN
ihlr-16470	258	30	;	;	PUNCT
ihlr-16470	258	31	...	...	PUNCT
ihlr-16470	259	1	[	[	X
ihlr-16470	259	2	r]ecommended	r]ecommende	VERB
ihlr-16470	259	3	that	that	SCONJ
ihlr-16470	259	4	the	the	DET
ihlr-16470	259	5	products	product	NOUN
ihlr-16470	259	6	not	not	PART
ihlr-16470	259	7	be	be	AUX
ihlr-16470	259	8	contraindicated	contraindicate	VERB
ihlr-16470	259	9	in	in	ADP
ihlr-16470	259	10	this	this	DET
ihlr-16470	259	11	country	country	NOUN
ihlr-16470	259	12	because	because	SCONJ
ihlr-16470	259	13	the	the	DET
ihlr-16470	259	14	committees	committee	NOUN
ihlr-16470	259	15	thought	think	VERB
ihlr-16470	259	16	access	access	NOUN
ihlr-16470	259	17	to	to	ADP
ihlr-16470	259	18	these	these	DET
ihlr-16470	259	19	therapies	therapy	NOUN
ihlr-16470	259	20	was	be	AUX
ihlr-16470	259	21	important	important	ADJ
ihlr-16470	259	22	for	for	ADP
ihlr-16470	259	23	those	those	PRON
ihlr-16470	259	24	who	who	PRON
ihlr-16470	259	25	could	could	AUX
ihlr-16470	259	26	benefit	benefit	VERB
ihlr-16470	259	27	....	....	PUNCT
ihlr-16470	259	28	86	86	NUM
ihlr-16470	259	29	84	84	NUM
ihlr-16470	259	30	.	.	PUNCT
ihlr-16470	260	1	see	see	VERB
ihlr-16470	260	2	andrew	andrew	PROPN
ihlr-16470	260	3	d.	d.	PROPN
ihlr-16470	260	4	mosholder	mosholder	PROPN
ihlr-16470	260	5	,	,	PUNCT
ihlr-16470	260	6	m.d	m.d	PROPN
ihlr-16470	260	7	.	.	PROPN
ihlr-16470	260	8	,	,	PUNCT
ihlr-16470	260	9	m.p.h	m.p.h	PROPN
ihlr-16470	260	10	.	.	PROPN
ihlr-16470	260	11	,	,	PUNCT
ihlr-16470	260	12	review	review	NOUN
ihlr-16470	260	13	and	and	CCONJ
ihlr-16470	260	14	evaluation	evaluation	NOUN
ihlr-16470	260	15	of	of	ADP
ihlr-16470	260	16	clinical	clinical	ADJ
ihlr-16470	260	17	data	datum	NOUN
ihlr-16470	260	18	(	(	PUNCT
ihlr-16470	260	19	sertraline	sertraline	PROPN
ihlr-16470	260	20	)	)	PUNCT
ihlr-16470	260	21	(	(	PUNCT
ihlr-16470	260	22	aug	aug	PROPN
ihlr-16470	260	23	.	.	PROPN
ihlr-16470	260	24	13	13	NUM
ihlr-16470	260	25	,	,	PUNCT
ihlr-16470	260	26	2002	2002	NUM
ihlr-16470	260	27	)	)	PUNCT
ihlr-16470	260	28	,	,	PUNCT
ihlr-16470	260	29	available	available	ADJ
ihlr-16470	260	30	at	at	ADP
ihlr-16470	260	31	http://www.fda.gov/cder/foi/esum/2004/	http://www.fda.gov/cder/foi/esum/2004/	PROPN
ihlr-16470	260	32	l9839se5_044_20990se5-0l0zoloft_mo_review2fin.pdf	l9839se5_044_20990se5-0l0zoloft_mo_review2fin.pdf	PROPN
ihlr-16470	260	33	(	(	PUNCT
ihlr-16470	260	34	last	last	ADJ
ihlr-16470	260	35	visited	visit	VERB
ihlr-16470	260	36	feb	feb	PROPN
ihlr-16470	260	37	.	.	PROPN
ihlr-16470	260	38	27	27	NUM
ihlr-16470	260	39	,	,	PUNCT
ihlr-16470	260	40	2006	2006	NUM
ihlr-16470	260	41	)	)	PUNCT
ihlr-16470	260	42	;	;	PUNCT
ihlr-16470	260	43	andrew	andrew	PROPN
ihlr-16470	260	44	d.	d.	PROPN
ihlr-16470	260	45	mosholder	mosholder	PROPN
ihlr-16470	260	46	,	,	PUNCT
ihlr-16470	260	47	m.d	m.d	PROPN
ihlr-16470	260	48	.	.	PROPN
ihlr-16470	260	49	,	,	PUNCT
ihlr-16470	260	50	m.p.h	m.p.h	PROPN
ihlr-16470	260	51	.	.	PROPN
ihlr-16470	260	52	,	,	PUNCT
ihlr-16470	260	53	review	review	NOUN
ihlr-16470	260	54	and	and	CCONJ
ihlr-16470	260	55	evaluation	evaluation	NOUN
ihlr-16470	260	56	of	of	ADP
ihlr-16470	260	57	clinical	clinical	ADJ
ihlr-16470	260	58	data	datum	NOUN
ihlr-16470	260	59	(	(	PUNCT
ihlr-16470	260	60	paxil	paxil	NOUN
ihlr-16470	260	61	)	)	PUNCT
ihlr-16470	260	62	(	(	PUNCT
ihlr-16470	260	63	oct	oct	PROPN
ihlr-16470	260	64	.	.	PROPN
ihlr-16470	260	65	7	7	NUM
ihlr-16470	260	66	,	,	PUNCT
ihlr-16470	260	67	2002	2002	NUM
ihlr-16470	260	68	)	)	PUNCT
ihlr-16470	260	69	,	,	PUNCT
ihlr-16470	260	70	available	available	ADJ
ihlr-16470	260	71	at	at	ADP
ihlr-16470	260	72	http://www.fda.gov/cder/foi/esum/2004/20031	http://www.fda.gov/cder/foi/esum/2004/20031	PROPN
ihlr-16470	260	73	s037	s037	PROPN
ihlr-16470	260	74	_	_	PUNCT
ihlr-16470	260	75	paxil_clincal_bpca_fin.pdf(last	paxil_clincal_bpca_fin.pdf(last	NUM
ihlr-16470	260	76	visited	visit	VERB
ihlr-16470	260	77	feb	feb	PROPN
ihlr-16470	260	78	.	.	PROPN
ihlr-16470	260	79	27	27	NUM
ihlr-16470	260	80	,	,	PUNCT
ihlr-16470	260	81	2006	2006	NUM
ihlr-16470	260	82	)	)	PUNCT
ihlr-16470	260	83	.	.	PUNCT
ihlr-16470	261	1	85	85	NUM
ihlr-16470	261	2	.	.	PUNCT
ihlr-16470	262	1	see	see	VERB
ihlr-16470	262	2	,	,	PUNCT
ihlr-16470	262	3	drug	drug	NOUN
ihlr-16470	262	4	indust	indust	NOUN
ihlr-16470	262	5	.	.	PUNCT
ihlr-16470	263	1	daily	daily	PROPN
ihlr-16470	263	2	,	,	PUNCT
ihlr-16470	263	3	supra	supra	PROPN
ihlr-16470	263	4	note	note	NOUN
ihlr-16470	263	5	72	72	NUM
ihlr-16470	263	6	.	.	PUNCT
ihlr-16470	263	7	86	86	NUM
ihlr-16470	263	8	.	.	PUNCT
ihlr-16470	264	1	statement	statement	NOUN
ihlr-16470	264	2	on	on	ADP
ihlr-16470	264	3	recommendations	recommendation	NOUN
ihlr-16470	264	4	,	,	PUNCT
ihlr-16470	264	5	supra	supra	PROPN
ihlr-16470	264	6	note	note	NOUN
ihlr-16470	264	7	55	55	NUM
ihlr-16470	264	8	.	.	PUNCT
ihlr-16470	265	1	212	212	NUM
ihlr-16470	265	2	indiana	indiana	PROPN
ihlr-16470	265	3	health	health	PROPN
ihlr-16470	265	4	law	law	NOUN
ihlr-16470	265	5	review	review	NOUN
ihlr-16470	265	6	[	[	X
ihlr-16470	265	7	vol	vol	NOUN
ihlr-16470	265	8	.	.	PUNCT
ihlr-16470	266	1	3:201	3:201	NUM
ihlr-16470	266	2	the	the	DET
ihlr-16470	266	3	fda	fda	PROPN
ihlr-16470	266	4	generally	generally	ADV
ihlr-16470	266	5	supported	support	VERB
ihlr-16470	266	6	the	the	DET
ihlr-16470	266	7	findings	finding	NOUN
ihlr-16470	266	8	of	of	ADP
ihlr-16470	266	9	the	the	DET
ihlr-16470	266	10	pdpac	pdpac	NOUN
ihlr-16470	266	11	and	and	CCONJ
ihlr-16470	266	12	began	begin	VERB
ihlr-16470	266	13	working	work	VERB
ihlr-16470	266	14	toward	toward	ADP
ihlr-16470	266	15	adopting	adopt	VERB
ihlr-16470	266	16	new	new	ADJ
ihlr-16470	266	17	labeling	labeling	NOUN
ihlr-16470	266	18	with	with	ADP
ihlr-16470	266	19	regard	regard	NOUN
ihlr-16470	266	20	to	to	ADP
ihlr-16470	266	21	ssris	ssris	NOUN
ihlr-16470	266	22	.	.	PUNCT
ihlr-16470	267	1	87	87	NUM
ihlr-16470	267	2	on	on	ADP
ihlr-16470	267	3	october	october	PROPN
ihlr-16470	267	4	15	15	NUM
ihlr-16470	267	5	,	,	PUNCT
ihlr-16470	267	6	2004	2004	NUM
ihlr-16470	267	7	,	,	PUNCT
ihlr-16470	267	8	the	the	DET
ihlr-16470	267	9	fda	fda	PROPN
ihlr-16470	267	10	announced	announce	VERB
ihlr-16470	267	11	its	its	PRON
ihlr-16470	267	12	new	new	ADJ
ihlr-16470	267	13	strategy	strategy	NOUN
ihlr-16470	267	14	to	to	PART
ihlr-16470	267	15	warn	warn	VERB
ihlr-16470	267	16	the	the	DET
ihlr-16470	267	17	public	public	NOUN
ihlr-16470	267	18	regarding	regard	VERB
ihlr-16470	267	19	the	the	DET
ihlr-16470	267	20	increased	increase	VERB
ihlr-16470	267	21	risk	risk	NOUN
ihlr-16470	267	22	of	of	ADP
ihlr-16470	267	23	suicidality	suicidality	NOUN
ihlr-16470	267	24	in	in	ADP
ihlr-16470	267	25	children	child	NOUN
ihlr-16470	267	26	and	and	CCONJ
ihlr-16470	267	27	adolescents	adolescent	NOUN
ihlr-16470	267	28	being	be	AUX
ihlr-16470	267	29	treated	treat	VERB
ihlr-16470	267	30	with	with	ADP
ihlr-16470	267	31	ssri	ssri	PROPN
ihlr-16470	267	32	med.ications.88	med.ications.88	PROPN
ihlr-16470	267	33	as	as	ADP
ihlr-16470	267	34	of	of	ADP
ihlr-16470	267	35	october	october	PROPN
ihlr-16470	267	36	15	15	NUM
ihlr-16470	267	37	,	,	PUNCT
ihlr-16470	267	38	2004	2004	NUM
ihlr-16470	267	39	,	,	PUNCT
ihlr-16470	267	40	the	the	DET
ihlr-16470	267	41	fda	fda	PROPN
ihlr-16470	267	42	began	begin	VERB
ihlr-16470	267	43	directing	direct	VERB
ihlr-16470	267	44	ssri	ssri	PROPN
ihlr-16470	267	45	manufacturers	manufacturer	NOUN
ihlr-16470	267	46	to	to	PART
ihlr-16470	267	47	place	place	VERB
ihlr-16470	267	48	a	a	DET
ihlr-16470	267	49	"	"	PUNCT
ihlr-16470	267	50	black	black	ADJ
ihlr-16470	267	51	box	box	NOUN
ihlr-16470	267	52	"	"	PUNCT
ihlr-16470	267	53	warning	warn	VERB
ihlr-16470	267	54	on	on	ADP
ihlr-16470	267	55	the	the	DET
ihlr-16470	267	56	drug	drug	NOUN
ihlr-16470	267	57	label89	label89	NOUN
ihlr-16470	267	58	and	and	CCONJ
ihlr-16470	267	59	that	that	SCONJ
ihlr-16470	267	60	patients	patient	NOUN
ihlr-16470	267	61	should	should	AUX
ihlr-16470	267	62	be	be	AUX
ihlr-16470	267	63	given	give	VERB
ihlr-16470	267	64	a	a	DET
ihlr-16470	267	65	patient	patient	ADJ
ihlr-16470	267	66	medication	medication	NOUN
ihlr-16470	267	67	guide	guide	NOUN
ihlr-16470	267	68	(	(	PUNCT
ihlr-16470	267	69	medguide	medguide	PROPN
ihlr-16470	267	70	)	)	PUNCT
ihlr-16470	267	71	"	"	PUNCT
ihlr-16470	267	72	advis[ing	advis[e	VERB
ihlr-16470	267	73	]	]	PUNCT
ihlr-16470	267	74	them	they	PRON
ihlr-16470	267	75	of	of	ADP
ihlr-16470	267	76	the	the	DET
ihlr-16470	267	77	risk	risk	NOUN
ihlr-16470	267	78	and	and	CCONJ
ihlr-16470	267	79	precautions	precaution	NOUN
ihlr-16470	267	80	that	that	PRON
ihlr-16470	267	81	can	can	AUX
ihlr-16470	267	82	be	be	AUX
ihlr-16470	267	83	taken	take	VERB
ihlr-16470	267	84	.	.	PUNCT
ihlr-16470	268	1	'>90	'>90	PROPN
ihlr-16470	268	2	black	black	PROPN
ihlr-16470	268	3	box	box	PROPN
ihlr-16470	268	4	warnings	warning	NOUN
ihlr-16470	268	5	are	be	AUX
ihlr-16470	268	6	the	the	DET
ihlr-16470	268	7	most	most	ADV
ihlr-16470	268	8	serious	serious	ADJ
ihlr-16470	268	9	warning	warning	NOUN
ihlr-16470	268	10	labels	label	NOUN
ihlr-16470	268	11	available	available	ADJ
ihlr-16470	268	12	to	to	ADP
ihlr-16470	268	13	the	the	DET
ihlr-16470	268	14	fda	fda	PROPN
ihlr-16470	268	15	.	.	PUNCT
ihlr-16470	269	1	when	when	SCONJ
ihlr-16470	269	2	used	use	VERB
ihlr-16470	269	3	,	,	PUNCT
ihlr-16470	269	4	the	the	DET
ihlr-16470	269	5	drug	drug	NOUN
ihlr-16470	269	6	manufacturer	manufacturer	NOUN
ihlr-16470	269	7	is	be	AUX
ihlr-16470	269	8	restricted	restrict	VERB
ihlr-16470	269	9	from	from	ADP
ihlr-16470	269	10	certain	certain	ADJ
ihlr-16470	269	11	actions	action	NOUN
ihlr-16470	269	12	.	.	PUNCT
ihlr-16470	270	1	91	91	NUM
ihlr-16470	270	2	for	for	ADP
ihlr-16470	270	3	example	example	NOUN
ihlr-16470	270	4	,	,	PUNCT
ihlr-16470	270	5	pharmaceutical	pharmaceutical	ADJ
ihlr-16470	270	6	companies	company	NOUN
ihlr-16470	270	7	maynotnm	maynotnm	VERB
ihlr-16470	270	8	advertisements	advertisement	NOUN
ihlr-16470	270	9	to	to	PART
ihlr-16470	270	10	remind	remind	VERB
ihlr-16470	270	11	health	health	NOUN
ihlr-16470	270	12	care	care	NOUN
ihlr-16470	270	13	professionals	professional	NOUN
ihlr-16470	270	14	of	of	ADP
ihlr-16470	270	15	a	a	DET
ihlr-16470	270	16	product	product	NOUN
ihlr-16470	270	17	's	's	PART
ihlr-16470	270	18	availability	availability	NOUN
ihlr-16470	270	19	ifthe	ifthe	NOUN
ihlr-16470	270	20	product	product	NOUN
ihlr-16470	270	21	carries	carry	VERB
ihlr-16470	270	22	a	a	DET
ihlr-16470	270	23	black	black	ADJ
ihlr-16470	270	24	box	box	NOUN
ihlr-16470	270	25	warning.92	warning.92	PROPN
ihlr-16470	270	26	until	until	ADP
ihlr-16470	270	27	the	the	DET
ihlr-16470	270	28	issuance	issuance	NOUN
ihlr-16470	270	29	of	of	ADP
ihlr-16470	270	30	a	a	DET
ihlr-16470	270	31	black	black	ADJ
ihlr-16470	270	32	box	box	NOUN
ihlr-16470	270	33	warning	warn	VERB
ihlr-16470	270	34	for	for	ADP
ihlr-16470	270	35	ssri	ssri	PROPN
ihlr-16470	270	36	medications	medication	NOUN
ihlr-16470	270	37	,	,	PUNCT
ihlr-16470	270	38	only	only	ADV
ihlr-16470	270	39	ten	ten	NUM
ihlr-16470	270	40	drug	drug	NOUN
ihlr-16470	270	41	products	product	NOUN
ihlr-16470	270	42	approved	approve	VERB
ihlr-16470	270	43	for	for	ADP
ihlr-16470	270	44	children	child	NOUN
ihlr-16470	270	45	contained	contain	VERB
ihlr-16470	270	46	a	a	DET
ihlr-16470	270	47	black	black	ADJ
ihlr-16470	270	48	box	box	NOUN
ihlr-16470	270	49	warning	warn	VERB
ihlr-16470	270	50	about	about	ADP
ihlr-16470	270	51	their	their	PRON
ihlr-16470	270	52	use	use	NOUN
ihlr-16470	270	53	in	in	ADP
ihlr-16470	270	54	children.93	children.93	NOUN
ihlr-16470	270	55	although	although	SCONJ
ihlr-16470	270	56	the	the	DET
ihlr-16470	270	57	black	black	PROPN
ihlr-16470	270	58	box	box	PROPN
ihlr-16470	270	59	warning	warning	NOUN
ihlr-16470	270	60	is	be	AUX
ihlr-16470	270	61	serious	serious	ADJ
ihlr-16470	270	62	,	,	PUNCT
ihlr-16470	270	63	it	it	PRON
ihlr-16470	270	64	is	be	AUX
ihlr-16470	270	65	important	important	ADJ
ihlr-16470	270	66	to	to	PART
ihlr-16470	270	67	recognize	recognize	VERB
ihlr-16470	270	68	that	that	SCONJ
ihlr-16470	270	69	the	the	DET
ihlr-16470	270	70	fda	fda	PROPN
ihlr-16470	270	71	does	do	AUX
ihlr-16470	270	72	not	not	PART
ihlr-16470	270	73	prohibit	prohibit	VERB
ihlr-16470	270	74	the	the	DET
ihlr-16470	270	75	use	use	NOUN
ihlr-16470	270	76	of	of	ADP
ihlr-16470	270	77	ssris	ssris	NOUN
ihlr-16470	270	78	in	in	ADP
ihlr-16470	270	79	children	child	NOUN
ihlr-16470	270	80	and	and	CCONJ
ihlr-16470	270	81	adolescents	adolescent	NOUN
ihlr-16470	270	82	.	.	PUNCT
ihlr-16470	271	1	the	the	DET
ihlr-16470	271	2	fda	fda	PROPN
ihlr-16470	271	3	recognizes	recognize	VERB
ihlr-16470	271	4	that	that	SCONJ
ihlr-16470	271	5	the	the	DET
ihlr-16470	271	6	illnesses	illness	NOUN
ihlr-16470	271	7	87	87	NUM
ihlr-16470	271	8	.	.	PUNCT
ihlr-16470	272	1	i	i	PRON
ihlr-16470	272	2	d.	d.	PROPN
ihlr-16470	272	3	88	88	NUM
ihlr-16470	272	4	.	.	PUNCT
ihlr-16470	273	1	food	food	NOUN
ihlr-16470	273	2	and	and	CCONJ
ihlr-16470	273	3	drug.admin	drug.admin	NOUN
ihlr-16470	273	4	.	.	PROPN
ihlr-16470	273	5	,	,	PUNCT
ihlr-16470	273	6	fda	fda	PROPN
ihlr-16470	273	7	news	news	PROPN
ihlr-16470	273	8	.	.	PUNCT
ihlr-16470	274	1	fda	fda	PROPN
ihlr-16470	274	2	launches	launch	VERB
ihlr-16470	274	3	a	a	DET
ihlr-16470	274	4	multi·pronged	multi·pronged	ADJ
ihlr-16470	274	5	strategy	strategy	NOUN
ihlr-16470	274	6	to	to	PART
ihlr-16470	274	7	strengthen	strengthen	VERB
ihlr-16470	274	8	safeguards	safeguard	NOUN
ihlr-16470	274	9	for	for	ADP
ihlr-16470	274	10	children	child	NOUN
ihlr-16470	274	11	treated	treat	VERB
ihlr-16470	274	12	with	with	ADP
ihlr-16470	274	13	antidepressant	antidepressant	ADJ
ihlr-16470	274	14	medications	medication	NOUN
ihlr-16470	274	15	(	(	PUNCT
ihlr-16470	274	16	oct	oct	PROPN
ihlr-16470	274	17	15	15	NUM
ihlr-16470	274	18	,	,	PUNCT
ihlr-16470	274	19	2004	2004	NUM
ihlr-16470	274	20	)	)	PUNCT
ihlr-16470	274	21	,	,	PUNCT
ihlr-16470	274	22	available	available	ADJ
ihlr-16470	274	23	at	at	ADP
ihlr-16470	274	24	http://www.fda.gov/bbsltopicslnews120041new01124.html	http://www.fda.gov/bbsltopicslnews120041new01124.html	PROPN
ihlr-16470	274	25	.	.	PUNCT
ihlr-16470	275	1	(	(	PUNCT
ihlr-16470	275	2	last	last	ADJ
ihlr-16470	275	3	visited	visit	VERB
ihlr-16470	275	4	apr	apr	NOUN
ihlr-16470	275	5	.	.	PROPN
ihlr-16470	275	6	19	19	NUM
ihlr-16470	275	7	,	,	PUNCT
ihlr-16470	275	8	2006	2006	NUM
ihlr-16470	275	9	)	)	PUNCT
ihlr-16470	275	10	.	.	PUNCT
ihlr-16470	276	1	89	89	NUM
ihlr-16470	276	2	.	.	PUNCT
ihlr-16470	277	1	public	public	ADJ
ihlr-16470	277	2	heal~	heal~	PROPN
ihlr-16470	277	3	advisory	advisory	NOUN
ihlr-16470	277	4	,	,	PUNCT
ihlr-16470	277	5	supra	supra	PROPN
ihlr-16470	277	6	note	note	NOUN
ihlr-16470	277	7	47	47	NUM
ihlr-16470	277	8	.	.	PUNCT
ihlr-16470	278	1	based	base	VERB
ihlr-16470	278	2	on	on	ADP
ihlr-16470	278	3	these	these	DET
ihlr-16470	278	4	data	datum	NOUN
ihlr-16470	278	5	[	[	X
ihlr-16470	278	6	ftom	ftom	X
ihlr-16470	278	7	the	the	DET
ihlr-16470	278	8	"	"	PUNCT
ihlr-16470	278	9	columbia	columbia	PROPN
ihlr-16470	278	10	"	"	PUNCT
ihlr-16470	278	11	study	study	NOUN
ihlr-16470	278	12	]	]	PUNCT
ihlr-16470	278	13	,	,	PUNCT
ihlr-16470	278	14	fda	fda	PROPN
ihlr-16470	278	15	has	have	AUX
ihlr-16470	278	16	determined	determine	VERB
ihlr-16470	278	17	that	that	SCONJ
ihlr-16470	278	18	the	the	DET
ihlr-16470	278	19	following	follow	VERB
ihlr-16470	278	20	points	point	NOUN
ihlr-16470	278	21	ate	eat	VERB
ihlr-16470	278	22	appropriate	appropriate	ADJ
ihlr-16470	278	23	for	for	ADP
ihlr-16470	278	24	inclusion	inclusion	NOUN
ihlr-16470	278	25	in	in	ADP
ihlr-16470	278	26	the	the	DET
ihlr-16470	278	27	boxed	boxed	ADJ
ihlr-16470	278	28	warning	warning	NOUN
ihlr-16470	278	29	:	:	PUNCT
ihlr-16470	278	30	•	•	NUM
ihlr-16470	278	31	antidepressants	antidepressant	NOUN
ihlr-16470	278	32	increase	increase	VERB
ihlr-16470	278	33	the	the	DET
ihlr-16470	278	34	risk	risk	NOUN
ihlr-16470	278	35	of	of	ADP
ihlr-16470	278	36	suicidal	suicidal	ADJ
ihlr-16470	278	37	thinking	thinking	NOUN
ihlr-16470	278	38	and	and	CCONJ
ihlr-16470	278	39	behavior	behavior	NOUN
ihlr-16470	278	40	(	(	PUNCT
ihlr-16470	278	41	suicidality	suicidality	NOUN
ihlr-16470	278	42	)	)	PUNCT
ihlr-16470	278	43	in	in	ADP
ihlr-16470	278	44	children	child	NOUN
ihlr-16470	278	45	and	and	CCONJ
ihlr-16470	278	46	adolescents	adolescent	NOUN
ihlr-16470	278	47	with	with	ADP
ihlr-16470	278	48	mdd	mdd	PROPN
ihlr-16470	278	49	and	and	CCONJ
ihlr-16470	278	50	other	other	ADJ
ihlr-16470	278	51	psychiatric	psychiatric	ADJ
ihlr-16470	278	52	disorders	disorder	NOUN
ihlr-16470	278	53	.	.	PUNCT
ihlr-16470	279	1	•	•	NUM
ihlr-16470	279	2	anyone	anyone	PRON
ihlr-16470	279	3	considering	consider	VERB
ihlr-16470	279	4	the	the	DET
ihlr-16470	279	5	use	use	NOUN
ihlr-16470	279	6	of	of	ADP
ihlr-16470	279	7	an	an	DET
ihlr-16470	279	8	antidepressant	antidepressant	NOUN
ihlr-16470	279	9	in	in	ADP
ihlr-16470	279	10	a	a	DET
ihlr-16470	279	11	child	child	NOUN
ihlr-16470	279	12	or	or	CCONJ
ihlr-16470	279	13	adolescent	adolescent	ADJ
ihlr-16470	279	14	for	for	ADP
ihlr-16470	279	15	any	any	DET
ihlr-16470	279	16	clinical	clinical	ADJ
ihlr-16470	279	17	use	use	NOUN
ihlr-16470	279	18	must	must	AUX
ihlr-16470	279	19	balance	balance	VERB
ihlr-16470	279	20	the	the	DET
ihlr-16470	279	21	risk	risk	NOUN
ihlr-16470	279	22	of	of	ADP
ihlr-16470	279	23	increased	increase	VERB
ihlr-16470	279	24	suicidality	suicidality	NOUN
ihlr-16470	279	25	with	with	ADP
ihlr-16470	279	26	clinical	clinical	ADJ
ihlr-16470	279	27	need	need	NOUN
ihlr-16470	279	28	.	.	PUNCT
ihlr-16470	280	1	•	•	NUM
ihlr-16470	280	2	patients	patient	NOUN
ihlr-16470	280	3	who	who	PRON
ihlr-16470	280	4	are	be	AUX
ihlr-16470	280	5	started	start	VERB
ihlr-16470	280	6	on	on	ADP
ihlr-16470	280	7	therapy	therapy	NOUN
ihlr-16470	280	8	should	should	AUX
ihlr-16470	280	9	be	be	AUX
ihlr-16470	280	10	observed	observe	VERB
ihlr-16470	280	11	closely	closely	ADV
ihlr-16470	280	12	for	for	ADP
ihlr-16470	280	13	clinical	clinical	ADJ
ihlr-16470	280	14	worsening	worsening	NOUN
ihlr-16470	280	15	,	,	PUNCT
ihlr-16470	280	16	suicidality	suicidality	NOUN
ihlr-16470	280	17	,	,	PUNCT
ihlr-16470	280	18	or	or	CCONJ
ihlr-16470	280	19	unusual	unusual	ADJ
ihlr-16470	280	20	changes	change	NOUN
ihlr-16470	280	21	in	in	ADP
ihlr-16470	280	22	behavior	behavior	NOUN
ihlr-16470	280	23	.	.	PUNCT
ihlr-16470	281	1	•	•	NUM
ihlr-16470	281	2	families	family	NOUN
ihlr-16470	281	3	and	and	CCONJ
ihlr-16470	281	4	caregivers	caregiver	NOUN
ihlr-16470	281	5	should	should	AUX
ihlr-16470	281	6	be	be	AUX
ihlr-16470	281	7	advised	advise	VERB
ihlr-16470	281	8	to	to	PART
ihlr-16470	281	9	closely	closely	ADV
ihlr-16470	281	10	observe	observe	VERB
ihlr-16470	281	11	the	the	DET
ihlr-16470	281	12	patient	patient	NOUN
ihlr-16470	281	13	and	and	CCONJ
ihlr-16470	281	14	communicate	communicate	VERB
ihlr-16470	281	15	with	with	ADP
ihlr-16470	281	16	the	the	DET
ihlr-16470	281	17	prescriber	prescriber	NOUN
ihlr-16470	281	18	.	.	PUNCT
ihlr-16470	282	1	•	•	NUM
ihlr-16470	282	2	a	a	DET
ihlr-16470	282	3	statement	statement	NOUN
ihlr-16470	282	4	regarding	regard	VERB
ihlr-16470	282	5	whether	whether	SCONJ
ihlr-16470	282	6	the	the	DET
ihlr-16470	282	7	particular	particular	ADJ
ihlr-16470	282	8	drug	drug	NOUN
ihlr-16470	282	9	is	be	AUX
ihlr-16470	282	10	approved	approve	VERB
ihlr-16470	282	11	for	for	ADP
ihlr-16470	282	12	any	any	DET
ihlr-16470	282	13	·	·	PUNCT
ihlr-16470	282	14	pediatric	pediatric	ADJ
ihlr-16470	282	15	indication(s	indication(s	PROPN
ihlr-16470	282	16	)	)	PUNCT
ihlr-16470	283	1	and	and	CCONJ
ihlr-16470	283	2	,	,	PUNCT
ihlr-16470	283	3	if	if	SCONJ
ihlr-16470	283	4	so	so	ADV
ihlr-16470	283	5	,	,	PUNCT
ihlr-16470	284	1	which	which	PRON
ihlr-16470	284	2	one(s	one(s	NOUN
ihlr-16470	284	3	)	)	PUNCT
ihlr-16470	285	1	.	.	PUNCT
ihlr-16470	286	1	among	among	ADP
ihlr-16470	286	2	the	the	DET
ihlr-16470	286	3	antidepressants	antidepressant	NOUN
ihlr-16470	286	4	,	,	PUNCT
ihlr-16470	286	5	only	only	ADV
ihlr-16470	286	6	prozac	prozac	NOUN
ihlr-16470	286	7	is	be	AUX
ihlr-16470	286	8	approved	approve	VERB
ihlr-16470	286	9	for	for	ADP
ihlr-16470	286	10	use	use	NOUN
ihlr-16470	286	11	in	in	ADP
ihlr-16470	286	12	treating	treat	VERB
ihlr-16470	286	13	mdd	mdd	PROPN
ihlr-16470	286	14	in	in	ADP
ihlr-16470	286	15	pediatric	pediatric	ADJ
ihlr-16470	286	16	patients	patient	NOUN
ihlr-16470	286	17	.	.	PUNCT
ihlr-16470	287	1	prozac	prozac	PROPN
ihlr-16470	287	2	,	,	PUNCT
ihlr-16470	287	3	zoloft	zoloft	PROPN
ihlr-16470	287	4	,	,	PUNCT
ihlr-16470	287	5	luvox	luvox	PROPN
ihlr-16470	287	6	,	,	PUNCT
ihlr-16470	287	7	and	and	CCONJ
ihlr-16470	287	8	anaftanil	anaftanil	NOUN
ihlr-16470	287	9	are	be	AUX
ihlr-16470	287	10	approved	approve	VERB
ihlr-16470	287	11	for	for	ADP
ihlr-16470	287	12	ocd	ocd	PROPN
ihlr-16470	287	13	in	in	ADP
ihlr-16470	287	14	pediatric	pediatric	ADJ
ihlr-16470	287	15	patients	patient	NOUN
ihlr-16470	287	16	.	.	PUNCT
ihlr-16470	288	1	none	none	NOUN
ihlr-16470	288	2	of	of	ADP
ihlr-16470	288	3	the	the	DET
ihlr-16470	288	4	drugs	drug	NOUN
ihlr-16470	288	5	is	be	AUX
ihlr-16470	288	6	approved	approve	VERB
ihlr-16470	288	7	for	for	ADP
ihlr-16470	288	8	other	other	ADJ
ihlr-16470	288	9	psychiatric	psychiatric	ADJ
ihlr-16470	288	10	indications	indication	NOUN
ihlr-16470	288	11	·	·	PUNCT
ihlr-16470	288	12	in	in	ADP
ihlr-16470	288	13	children	child	NOUN
ihlr-16470	288	14	.	.	PUNCT
ihlr-16470	289	1	see	see	VERB
ihlr-16470	289	2	public	public	ADJ
ihlr-16470	289	3	health	health	NOUN
ihlr-16470	289	4	advisory	advisory	NOUN
ihlr-16470	289	5	,	,	PUNCT
ihlr-16470	289	6	supra	supra	PROPN
ihlr-16470	289	7	note	note	NOUN
ihlr-16470	289	8	47	47	NUM
ihlr-16470	289	9	.	.	PUNCT
ihlr-16470	290	1	90	90	NUM
ihlr-16470	290	2	.	.	PUNCT
ihlr-16470	291	1	food	food	PROPN
ihlr-16470	291	2	&	&	CCONJ
ihlr-16470	291	3	drug	drug	PROPN
ihlr-16470	291	4	admin	admin	PROPN
ihlr-16470	291	5	.	.	PUNCT
ihlr-16470	292	1	news	news	NOUN
ihlr-16470	292	2	,	,	PUNCT
ihlr-16470	292	3	supra	supra	PROPN
ihlr-16470	292	4	note	note	PROPN
ihlr-16470	292	5	88	88	NUM
ihlr-16470	292	6	.	.	PUNCT
ihlr-16470	292	7	91	91	NUM
ihlr-16470	292	8	.	.	PUNCT
ihlr-16470	293	1	jd	jd	PROPN
ihlr-16470	293	2	.	.	PROPN
ihlr-16470	293	3	92	92	NUM
ihlr-16470	293	4	.	.	PUNCT
ihlr-16470	294	1	jd	jd	PROPN
ihlr-16470	294	2	.	.	PROPN
ihlr-16470	294	3	93	93	NUM
ihlr-16470	294	4	.	.	PUNCT
ihlr-16470	295	1	/d	/d	INTJ
ihlr-16470	295	2	.	.	PUNCT
ihlr-16470	296	1	2006	2006	NUM
ihlr-16470	296	2	]	]	PUNCT
ihlr-16470	296	3	anti	anti	NOUN
ihlr-16470	296	4	-	-	NOUN
ihlr-16470	296	5	depressants	depressant	NOUN
ihlr-16470	296	6	and	and	CCONJ
ihlr-16470	296	7	chhdren	chhdren	NOUN
ihlr-16470	296	8	213	213	NUM
ihlr-16470	296	9	ssris	ssris	NOUN
ihlr-16470	296	10	are	be	AUX
ihlr-16470	296	11	designed	design	VERB
ihlr-16470	296	12	to	to	PART
ihlr-16470	296	13	treat	treat	VERB
ihlr-16470	296	14	have	have	AUX
ihlr-16470	296	15	serious	serious	ADJ
ihlr-16470	296	16	consequences	consequence	NOUN
ihlr-16470	296	17	if	if	SCONJ
ihlr-16470	296	18	not	not	PART
ihlr-16470	296	19	appropriately	appropriately	ADV
ihlr-16470	296	20	treated	treat	VERB
ihlr-16470	296	21	,	,	PUNCT
ihlr-16470	296	22	but	but	CCONJ
ihlr-16470	296	23	those	those	PRON
ihlr-16470	296	24	taking	take	VERB
ihlr-16470	296	25	ssris	ssris	NOUN
ihlr-16470	296	26	should	should	AUX
ihlr-16470	296	27	be	be	AUX
ihlr-16470	296	28	fully	fully	ADV
ihlr-16470	296	29	informed	inform	VERB
ihlr-16470	296	30	of	of	ADP
ihlr-16470	296	31	the	the	DET
ihlr-16470	296	32	dangers	danger	NOUN
ihlr-16470	296	33	.	.	PUNCT
ihlr-16470	297	1	94	94	NUM
ihlr-16470	297	2	ii	ii	PROPN
ihlr-16470	297	3	.	.	PUNCT
ihlr-16470	297	4	off	off	ADP
ihlr-16470	297	5	-	-	PUNCT
ihlr-16470	297	6	label	label	NOUN
ihlr-16470	297	7	uses	use	NOUN
ihlr-16470	297	8	currently	currently	ADV
ihlr-16470	297	9	,	,	PUNCT
ihlr-16470	297	10	there	there	PRON
ihlr-16470	297	11	is	be	VERB
ihlr-16470	297	12	only	only	ADV
ihlr-16470	297	13	one	one	NUM
ihlr-16470	297	14	ssri	ssri	NOUN
ihlr-16470	297	15	,	,	PUNCT
ihlr-16470	297	16	prozac	prozac	NOUN
ihlr-16470	297	17	,	,	PUNCT
ihlr-16470	297	18	approved	approve	VERB
ihlr-16470	297	19	by	by	ADP
ihlr-16470	297	20	the	the	DET
ihlr-16470	297	21	fda	fda	PROPN
ihlr-16470	297	22	for	for	ADP
ihlr-16470	297	23	treating	treat	VERB
ihlr-16470	297	24	children	child	NOUN
ihlr-16470	297	25	with	with	ADP
ihlr-16470	297	26	mdd.95	mdd.95	NOUN
ihlr-16470	297	27	in	in	ADP
ihlr-16470	297	28	addition	addition	NOUN
ihlr-16470	297	29	to	to	ADP
ihlr-16470	297	30	prozac	prozac	NOUN
ihlr-16470	297	31	,	,	PUNCT
ihlr-16470	297	32	three	three	NUM
ihlr-16470	297	33	other	other	ADJ
ihlr-16470	297	34	ssri	ssri	PROPN
ihlr-16470	297	35	medications	medication	NOUN
ihlr-16470	297	36	are	be	AUX
ihlr-16470	297	37	approved	approve	VERB
ihlr-16470	297	38	for	for	ADP
ihlr-16470	297	39	treating	treat	VERB
ihlr-16470	297	40	ocd	ocd	NOUN
ihlr-16470	297	41	in	in	ADP
ihlr-16470	297	42	pediatric	pediatric	ADJ
ihlr-16470	297	43	patients	patient	NOUN
ihlr-16470	297	44	.	.	PUNCT
ihlr-16470	298	1	96	96	NUM
ihlr-16470	298	2	however	however	ADV
ihlr-16470	298	3	,	,	PUNCT
ihlr-16470	298	4	doctors	doctor	NOUN
ihlr-16470	298	5	have	have	AUX
ihlr-16470	298	6	routinely	routinely	ADV
ihlr-16470	298	7	prescribed	prescribe	VERB
ihlr-16470	298	8	these	these	DET
ihlr-16470	298	9	medications	medication	NOUN
ihlr-16470	298	10	outside	outside	ADP
ihlr-16470	298	11	the	the	DET
ihlr-16470	298	12	scope	scope	NOUN
ihlr-16470	298	13	of	of	ADP
ihlr-16470	298	14	these	these	DET
ihlr-16470	298	15	approved	approve	VERB
ihlr-16470	298	16	uses	use	NOUN
ihlr-16470	298	17	in	in	ADP
ihlr-16470	298	18	order	order	NOUN
ihlr-16470	298	19	to	to	PART
ihlr-16470	298	20	meet	meet	VERB
ihlr-16470	298	21	the	the	DET
ihlr-16470	298	22	best	good	ADJ
ihlr-16470	298	23	interests	interest	NOUN
ihlr-16470	298	24	of	of	ADP
ihlr-16470	298	25	their	their	PRON
ihlr-16470	298	26	patients	patient	NOUN
ihlr-16470	298	27	.	.	PUNCT
ihlr-16470	299	1	this	this	PRON
ihlr-16470	299	2	is	be	AUX
ihlr-16470	299	3	known	know	VERB
ihlr-16470	299	4	as	as	ADP
ihlr-16470	299	5	"	"	PUNCT
ihlr-16470	299	6	off	off	ADP
ihlr-16470	299	7	-	-	PUNCT
ihlr-16470	299	8	label	label	NOUN
ihlr-16470	299	9	use	use	NOUN
ihlr-16470	299	10	,	,	PUNCT
ihlr-16470	299	11	''	''	PUNCT
ihlr-16470	299	12	which	which	PRON
ihlr-16470	299	13	is	be	AUX
ihlr-16470	299	14	defined	define	VERB
ihlr-16470	299	15	as	as	ADP
ihlr-16470	299	16	"	"	PUNCT
ihlr-16470	299	17	[	[	X
ihlr-16470	299	18	t]he	t]he	ADJ
ihlr-16470	299	19	use	use	NOUN
ihlr-16470	299	20	of	of	ADP
ihlr-16470	299	21	a	a	DET
ihlr-16470	299	22	drug	drug	NOUN
ihlr-16470	299	23	to	to	PART
ihlr-16470	299	24	treat	treat	VERB
ihlr-16470	299	25	a	a	DET
ihlr-16470	299	26	condition	condition	NOUN
ihlr-16470	299	27	for	for	ADP
ihlr-16470	299	28	which	which	PRON
ihlr-16470	299	29	it	it	PRON
ihlr-16470	299	30	has	have	AUX
ihlr-16470	299	31	not	not	PART
ihlr-16470	299	32	been	be	AUX
ihlr-16470	299	33	approved	approve	VERB
ihlr-16470	299	34	by	by	ADP
ihlr-16470	299	35	the	the	DET
ihlr-16470	299	36	u.s	u.s	PROPN
ihlr-16470	299	37	.	.	PROPN
ihlr-16470	299	38	food	food	PROPN
ihlr-16470	299	39	and	and	CCONJ
ihlr-16470	299	40	drug	drug	PROPN
ihlr-16470	299	41	administration	administration	PROPN
ihlr-16470	299	42	(	(	PUNCT
ihlr-16470	299	43	fda	fda	PROPN
ihlr-16470	299	44	)	)	PUNCT
ihlr-16470	299	45	,	,	PUNCT
ihlr-16470	299	46	esp[ecially	esp[ecially	ADV
ihlr-16470	299	47	]	]	PUNCT
ihlr-16470	299	48	when	when	SCONJ
ihlr-16470	299	49	such	such	ADJ
ihlr-16470	299	50	use	use	NOUN
ihlr-16470	299	51	may	may	AUX
ihlr-16470	299	52	relieve	relieve	VERB
ihlr-16470	299	53	unpleasant	unpleasant	ADJ
ihlr-16470	299	54	symptoms	symptom	NOUN
ihlr-16470	299	55	,	,	PUNCT
ihlr-16470	299	56	or	or	CCONJ
ihlr-16470	299	57	prove	prove	VERB
ihlr-16470	299	58	compassionate	compassionate	ADJ
ihlr-16470	299	59	.	.	PUNCT
ihlr-16470	300	1	"	"	PUNCT
ihlr-16470	300	2	97	97	NUM
ihlr-16470	300	3	since	since	SCONJ
ihlr-16470	300	4	so	so	ADV
ihlr-16470	300	5	few	few	ADJ
ihlr-16470	300	6	drugs	drug	NOUN
ihlr-16470	300	7	are	be	AUX
ihlr-16470	300	8	approved	approve	VERB
ihlr-16470	300	9	for	for	ADP
ihlr-16470	300	10	use	use	NOUN
ihlr-16470	300	11	in	in	ADP
ihlr-16470	300	12	children	child	NOUN
ihlr-16470	300	13	,	,	PUNCT
ihlr-16470	300	14	the	the	DET
ihlr-16470	300	15	use	use	NOUN
ihlr-16470	300	16	of	of	ADP
ihlr-16470	300	17	off	off	ADP
ihlr-16470	300	18	-	-	PUNCT
ihlr-16470	300	19	label	label	NOUN
ihlr-16470	300	20	prescribing	prescribing	NOUN
ihlr-16470	300	21	is	be	AUX
ihlr-16470	300	22	especially	especially	ADV
ihlr-16470	300	23	prevalent	prevalent	ADJ
ihlr-16470	300	24	in	in	ADP
ihlr-16470	300	25	the	the	DET
ihlr-16470	300	26	realm	realm	NOUN
ihlr-16470	300	27	of	of	ADP
ihlr-16470	300	28	pediatric	pediatric	ADJ
ihlr-16470	300	29	care.98	care.98	NOUN
ihlr-16470	300	30	while	while	SCONJ
ihlr-16470	300	31	this	this	PRON
ihlr-16470	300	32	may	may	AUX
ihlr-16470	300	33	often	often	ADV
ihlr-16470	300	34	be	be	AUX
ihlr-16470	300	35	in	in	ADP
ihlr-16470	300	36	the	the	DET
ihlr-16470	300	37	best	good	ADJ
ihlr-16470	300	38	interest	interest	NOUN
ihlr-16470	300	39	ofthe	ofthe	NOUN
ihlr-16470	300	40	child	child	NOUN
ihlr-16470	300	41	,	,	PUNCT
ihlr-16470	300	42	it	it	PRON
ihlr-16470	300	43	causes	cause	VERB
ihlr-16470	300	44	some	some	DET
ihlr-16470	300	45	confusion	confusion	NOUN
ihlr-16470	300	46	in	in	ADP
ihlr-16470	300	47	determining	determine	VERB
ihlr-16470	300	48	who	who	PRON
ihlr-16470	300	49	bears	bear	VERB
ihlr-16470	300	50	liability	liability	NOUN
ihlr-16470	300	51	for	for	ADP
ihlr-16470	300	52	the	the	DET
ihlr-16470	300	53	harmful	harmful	ADJ
ihlr-16470	300	54	effects	effect	NOUN
ihlr-16470	300	55	of	of	ADP
ihlr-16470	300	56	the	the	DET
ihlr-16470	300	57	drugs	drug	NOUN
ihlr-16470	300	58	;	;	PUNCT
ihlr-16470	300	59	the	the	DET
ihlr-16470	300	60	physician	physician	NOUN
ihlr-16470	300	61	or	or	CCONJ
ihlr-16470	300	62	the	the	DET
ihlr-16470	300	63	pharmaceutical	pharmaceutical	ADJ
ihlr-16470	300	64	manufacturer	manufacturer	NOUN
ihlr-16470	300	65	?	?	PUNCT
ihlr-16470	301	1	a.	a.	NOUN
ihlr-16470	301	2	history	history	NOUN
ihlr-16470	301	3	the	the	DET
ihlr-16470	301	4	role	role	NOUN
ihlr-16470	301	5	of	of	ADP
ihlr-16470	301	6	the	the	DET
ihlr-16470	301	7	fda	fda	PROPN
ihlr-16470	301	8	in	in	ADP
ihlr-16470	301	9	the	the	DET
ihlr-16470	301	10	united	united	PROPN
ihlr-16470	301	11	states	states	PROPN
ihlr-16470	301	12	is	be	AUX
ihlr-16470	301	13	to	to	PART
ihlr-16470	301	14	assess	assess	VERB
ihlr-16470	301	15	the	the	DET
ihlr-16470	301	16	safety	safety	NOUN
ihlr-16470	301	17	and	and	CCONJ
ihlr-16470	301	18	effectiveness	effectiveness	NOUN
ihlr-16470	301	19	of	of	ADP
ihlr-16470	301	20	all	all	DET
ihlr-16470	301	21	drugs	drug	NOUN
ihlr-16470	301	22	before	before	SCONJ
ihlr-16470	301	23	they	they	PRON
ihlr-16470	301	24	can	can	AUX
ihlr-16470	301	25	be	be	AUX
ihlr-16470	301	26	sold.99	sold.99	NOUN
ihlr-16470	301	27	unfortunately	unfortunately	ADV
ihlr-16470	301	28	a	a	DET
ihlr-16470	301	29	large	large	ADJ
ihlr-16470	301	30	portion	portion	NOUN
ihlr-16470	301	31	of	of	ADP
ihlr-16470	301	32	drugs	drug	NOUN
ihlr-16470	301	33	sold	sell	VERB
ihlr-16470	301	34	in	in	ADP
ihlr-16470	301	35	the	the	DET
ihlr-16470	301	36	united	united	PROPN
ihlr-16470	301	37	states	states	PROPN
ihlr-16470	301	38	are	be	AUX
ihlr-16470	301	39	avoiding	avoid	VERB
ihlr-16470	301	40	fda	fda	PROPN
ihlr-16470	301	41	scrutiny	scrutiny	NOUN
ihlr-16470	301	42	through	through	ADP
ihlr-16470	301	43	off	off	ADP
ihlr-16470	301	44	-	-	PUNCT
ihlr-16470	301	45	label	label	NOUN
ihlr-16470	301	46	prescribing	prescribing	NOUN
ihlr-16470	301	47	,	,	PUNCT
ihlr-16470	301	48	basically	basically	ADV
ihlr-16470	301	49	prescriptions	prescription	NOUN
ihlr-16470	301	50	of	of	ADP
ihlr-16470	301	51	unapproved	unapproved	ADJ
ihlr-16470	301	52	uses	use	NOUN
ihlr-16470	301	53	.	.	PUNCT
ihlr-16470	302	1	100	100	NUM
ihlr-16470	302	2	this	this	DET
ihlr-16470	302	3	practice	practice	NOUN
ihlr-16470	302	4	has	have	AUX
ihlr-16470	302	5	become	become	VERB
ihlr-16470	302	6	common	common	ADJ
ihlr-16470	302	7	if	if	SCONJ
ihlr-16470	302	8	not	not	PART
ihlr-16470	302	9	the	the	DET
ihlr-16470	302	10	standard	standard	NOUN
ihlr-16470	302	11	of	of	ADP
ihlr-16470	302	12	care	care	NOUN
ihlr-16470	302	13	in	in	ADP
ihlr-16470	302	14	many	many	ADJ
ihlr-16470	302	15	instances	instance	NOUN
ihlr-16470	302	16	,	,	PUNCT
ihlr-16470	302	17	101	101	NUM
ihlr-16470	302	18	but	but	CCONJ
ihlr-16470	302	19	places	place	VERB
ihlr-16470	302	20	the	the	DET
ihlr-16470	302	21	patient	patient	NOUN
ihlr-16470	302	22	at	at	ADP
ihlr-16470	302	23	risk	risk	NOUN
ihlr-16470	302	24	while	while	SCONJ
ihlr-16470	302	25	offering	offer	VERB
ihlr-16470	302	26	no	no	DET
ihlr-16470	302	27	assurances	assurance	NOUN
ihlr-16470	302	28	that	that	SCONJ
ihlr-16470	302	29	the	the	DET
ihlr-16470	302	30	drugs	drug	NOUN
ihlr-16470	302	31	will	will	AUX
ihlr-16470	302	32	work	work	VERB
ihlr-16470	302	33	.	.	PUNCT
ihlr-16470	303	1	102	102	NUM
ihlr-16470	303	2	the	the	DET
ihlr-16470	303	3	fda	fda	PROPN
ihlr-16470	303	4	drug	drug	PROPN
ihlr-16470	303	5	approval	approval	NOUN
ihlr-16470	303	6	process	process	NOUN
ihlr-16470	303	7	currently	currently	ADV
ihlr-16470	303	8	takes	take	VERB
ihlr-16470	303	9	the	the	DET
ihlr-16470	303	10	following	follow	VERB
ihlr-16470	303	11	form	form	NOUN
ihlr-16470	303	12	:	:	PUNCT
ihlr-16470	303	13	the	the	DET
ihlr-16470	303	14	fda	fda	PROPN
ihlr-16470	303	15	must	must	AUX
ihlr-16470	303	16	approve	approve	VERB
ihlr-16470	303	17	each	each	DET
ihlr-16470	303	18	drug	drug	NOUN
ihlr-16470	303	19	marketed	market	VERB
ihlr-16470	303	20	in	in	ADP
ihlr-16470	303	21	the	the	DET
ihlr-16470	303	22	united	united	PROPN
ihlr-16470	303	23	states	states	PROPN
ihlr-16470	303	24	.	.	PUNCT
ihlr-16470	304	1	once	once	SCONJ
ihlr-16470	304	2	the	the	DET
ihlr-16470	304	3	''	''	PUNCT
ihlr-16470	304	4	new	new	ADJ
ihlr-16470	304	5	drug	drug	NOUN
ihlr-16470	304	6	application	application	NOUN
ihlr-16470	304	7	"	"	PUNCT
ihlr-16470	304	8	is	be	AUX
ihlr-16470	304	9	filed	file	VERB
ihlr-16470	304	10	,	,	PUNCT
ihlr-16470	304	11	the	the	DET
ihlr-16470	304	12	94	94	NUM
ihlr-16470	304	13	.	.	PUNCT
ihlr-16470	305	1	/d	/d	INTJ
ihlr-16470	305	2	.	.	PUNCT
ihlr-16470	306	1	95	95	NUM
ihlr-16470	306	2	.	.	PUNCT
ihlr-16470	307	1	public	public	ADJ
ihlr-16470	307	2	health	health	NOUN
ihlr-16470	307	3	advisory	advisory	NOUN
ihlr-16470	307	4	,	,	PUNCT
ihlr-16470	307	5	supra	supra	PROPN
ihlr-16470	307	6	note	note	NOUN
ihlr-16470	307	7	47	47	NUM
ihlr-16470	307	8	.	.	PUNCT
ihlr-16470	308	1	96	96	NUM
ihlr-16470	308	2	.	.	PUNCT
ihlr-16470	309	1	/d	/d	INTJ
ihlr-16470	309	2	.	.	PUNCT
ihlr-16470	310	1	97	97	NUM
ihlr-16470	310	2	.	.	PUNCT
ihlr-16470	310	3	tardyv	tardyv	PROPN
ihlr-16470	310	4	.	.	PUNCT
ihlr-16470	311	1	eli	eli	PROPN
ihlr-16470	311	2	lilly	lilly	PROPN
ihlr-16470	311	3	&	&	CCONJ
ihlr-16470	311	4	co.	co.	PROPN
ihlr-16470	311	5	,	,	PUNCT
ihlr-16470	311	6	2004	2004	NUM
ihlr-16470	311	7	wl	wl	X
ihlr-16470	311	8	1925536	1925536	NUM
ihlr-16470	311	9	at	at	ADP
ihlr-16470	311	10	*	*	NUM
ihlr-16470	311	11	1	1	NUM
ihlr-16470	311	12	n.3	n.3	NOUN
ihlr-16470	311	13	(	(	PUNCT
ihlr-16470	311	14	me	i	PRON
ihlr-16470	311	15	.	.	PUNCT
ihlr-16470	312	1	super	super	ADJ
ihlr-16470	312	2	.	.	PUNCT
ihlr-16470	313	1	ct	ct	PROPN
ihlr-16470	313	2	.	.	NOUN
ihlr-16470	313	3	2004	2004	NUM
ihlr-16470	313	4	)	)	PUNCT
ihlr-16470	314	1	(	(	PUNCT
ihlr-16470	314	2	quoting	quote	VERB
ihlr-16470	314	3	taber	taber	PROPN
ihlr-16470	314	4	's	's	PART
ihlr-16470	314	5	cycwpedic	cycwpedic	ADJ
ihlr-16470	314	6	medical	medical	ADJ
ihlr-16470	314	7	dictionary	dictionary	NOUN
ihlr-16470	314	8	(	(	PUNCT
ihlr-16470	314	9	f.a	f.a	PROPN
ihlr-16470	314	10	davis	davis	PROPN
ihlr-16470	314	11	inc	inc	PROPN
ihlr-16470	314	12	.	.	PROPN
ihlr-16470	314	13	,	,	PUNCT
ihlr-16470	314	14	2002	2002	NUM
ihlr-16470	314	15	)	)	PUNCT
ihlr-16470	314	16	.	.	PUNCT
ihlr-16470	315	1	98	98	NUM
ihlr-16470	315	2	.	.	PUNCT
ihlr-16470	316	1	see	see	VERB
ihlr-16470	316	2	hazard	hazard	NOUN
ihlr-16470	316	3	,	,	PUNCT
ihlr-16470	316	4	supra	supra	PROPN
ihlr-16470	316	5	note	note	NOUN
ihlr-16470	316	6	8	8	NUM
ihlr-16470	316	7	,	,	PUNCT
ihlr-16470	316	8	at478	at478	PROPN
ihlr-16470	316	9	.	.	PROPN
ihlr-16470	317	1	99	99	NUM
ihlr-16470	317	2	.	.	PUNCT
ihlr-16470	318	1	adams	adams	PROPN
ihlr-16470	318	2	&	&	CCONJ
ihlr-16470	318	3	young	young	ADJ
ihlr-16470	318	4	,	,	PUNCT
ihlr-16470	318	5	supra	supra	ADJ
ihlr-16470	318	6	note	note	NOUN
ihlr-16470	318	7	7	7	NUM
ihlr-16470	318	8	.	.	NOUN
ihlr-16470	318	9	100	100	NUM
ihlr-16470	318	10	.	.	PUNCT
ihlr-16470	319	1	/d	/d	INTJ
ihlr-16470	319	2	.	.	PUNCT
ihlr-16470	320	1	101	101	NUM
ihlr-16470	320	2	.	.	PUNCT
ihlr-16470	321	1	see	see	VERB
ihlr-16470	321	2	kaspar	kaspar	PROPN
ihlr-16470	321	3	j.	j.	PROPN
ihlr-16470	321	4	stoffelmayr	stoffelmayr	PROPN
ihlr-16470	321	5	,	,	PUNCT
ihlr-16470	321	6	products	product	NOUN
ihlr-16470	321	7	liability	liability	NOUN
ihlr-16470	321	8	and	and	CCONJ
ihlr-16470	321	9	"	"	PUNCT
ihlr-16470	321	10	off	off	ADP
ihlr-16470	321	11	-	-	PUNCT
ihlr-16470	321	12	label	label	NOUN
ihlr-16470	321	13	"	"	PUNCT
ihlr-16470	321	14	uses	use	NOUN
ihlr-16470	321	15	of	of	ADP
ihlr-16470	321	16	prescription	prescription	NOUN
ihlr-16470	321	17	drugs	drug	NOUN
ihlr-16470	321	18	,	,	PUNCT
ihlr-16470	321	19	63	63	NUM
ihlr-16470	321	20	u.	u.	NOUN
ihlr-16470	321	21	cln	cln	PROPN
ihlr-16470	321	22	.	.	PUNCT
ihlr-16470	322	1	l.	l.	PROPN
ihlr-16470	322	2	rev	rev	PROPN
ihlr-16470	322	3	.	.	PROPN
ihlr-16470	322	4	275	275	NUM
ihlr-16470	322	5	(	(	PUNCT
ihlr-16470	322	6	1996	1996	NUM
ihlr-16470	322	7	)	)	PUNCT
ihlr-16470	322	8	;	;	PUNCT
ihlr-16470	323	1	ala	ala	PROPN
ihlr-16470	323	2	.	.	PUNCT
ihlr-16470	324	1	code§	code§	NOUN
ihlr-16470	324	2	27	27	NUM
ihlr-16470	324	3	-	-	SYM
ihlr-16470	324	4	1	1	NUM
ihlr-16470	324	5	-	-	SYM
ihlr-16470	324	6	10.1	10.1	NUM
ihlr-16470	324	7	(	(	PUNCT
ihlr-16470	324	8	2004	2004	NUM
ihlr-16470	324	9	)	)	PUNCT
ihlr-16470	324	10	;	;	PUNCT
ihlr-16470	325	1	cal	cal	X
ihlr-16470	325	2	.	.	PUNCT
ihlr-16470	326	1	ins	in	NOUN
ihlr-16470	326	2	.	.	PUNCT
ihlr-16470	327	1	code§	code§	PROPN
ihlr-16470	327	2	10123.195	10123.195	PROPN
ihlr-16470	327	3	(	(	PUNCT
ihlr-16470	327	4	2004	2004	NUM
ihlr-16470	327	5	)	)	PUNCT
ihlr-16470	327	6	;	;	PUNCT
ihlr-16470	327	7	conn	conn	PROPN
ihlr-16470	327	8	.	.	PUNCT
ihlr-16470	328	1	gen	gen	PROPN
ihlr-16470	328	2	.	.	PROPN
ihlr-16470	328	3	stat	stat	PROPN
ihlr-16470	328	4	.	.	PUNCT
ihlr-16470	329	1	ann	ann	PROPN
ihlr-16470	329	2	.	.	PUNCT
ihlr-16470	330	1	§	§	PROPN
ihlr-16470	330	2	38a-492b	38a-492b	NUM
ihlr-16470	330	3	(	(	PUNCT
ihlr-16470	330	4	west	west	NOUN
ihlr-16470	330	5	2004	2004	NUM
ihlr-16470	330	6	)	)	PUNCT
ihlr-16470	330	7	;	;	PUNCT
ihlr-16470	331	1	kan	kan	PROPN
ihlr-16470	331	2	.	.	PROPN
ihlr-16470	331	3	stat	stat	PROPN
ihlr-16470	331	4	.	.	PUNCT
ihlr-16470	332	1	ann	ann	PROPN
ihlr-16470	332	2	.	.	PUNCT
ihlr-16470	333	1	§	§	PROPN
ihlr-16470	333	2	402,167,2,170(2003);md.codeann.ins	402,167,2,170(2003);md.codeann.ins	PROPN
ihlr-16470	333	3	.	.	PUNCT
ihlr-16470	334	1	§	§	PROPN
ihlr-16470	334	2	15	15	NUM
ihlr-16470	334	3	-	-	NOUN
ihlr-16470	334	4	804(2004	804(2004	NUM
ihlr-16470	334	5	)	)	PUNCT
ihlr-16470	334	6	.	.	PUNCT
ihlr-16470	335	1	102	102	NUM
ihlr-16470	335	2	.	.	PUNCT
ihlr-16470	336	1	adams	adams	PROPN
ihlr-16470	336	2	&	&	CCONJ
ihlr-16470	336	3	young	young	ADJ
ihlr-16470	336	4	,	,	PUNCT
ihlr-16470	336	5	supra	supra	ADJ
ihlr-16470	336	6	note	note	NOUN
ihlr-16470	336	7	7	7	NUM
ihlr-16470	336	8	.	.	SYM
ihlr-16470	336	9	214	214	NUM
ihlr-16470	336	10	indiana	indiana	PROPN
ihlr-16470	336	11	health	health	PROPN
ihlr-16470	336	12	law	law	PROPN
ihlr-16470	336	13	review	review	NOUN
ihlr-16470	337	1	[	[	X
ihlr-16470	337	2	vol	vol	NOUN
ihlr-16470	337	3	.	.	PUNCT
ihlr-16470	338	1	3:201	3:201	NUM
ihlr-16470	338	2	applicant	applicant	NOUN
ihlr-16470	338	3	must	must	AUX
ihlr-16470	338	4	show	show	VERB
ihlr-16470	338	5	that	that	SCONJ
ihlr-16470	338	6	the	the	DET
ihlr-16470	338	7	proposed	propose	VERB
ihlr-16470	338	8	drug	drug	NOUN
ihlr-16470	338	9	is	be	AUX
ihlr-16470	338	10	safe	safe	ADJ
ihlr-16470	338	11	and	and	CCONJ
ihlr-16470	338	12	effective	effective	ADJ
ihlr-16470	338	13	for	for	ADP
ihlr-16470	338	14	its	its	PRON
ihlr-16470	338	15	intended	intended	ADJ
ihlr-16470	338	16	use	use	NOUN
ihlr-16470	338	17	.	.	PUNCT
ihlr-16470	339	1	this	this	PRON
ihlr-16470	339	2	is	be	AUX
ihlr-16470	339	3	usually	usually	ADV
ihlr-16470	339	4	accomplished	accomplish	VERB
ihlr-16470	339	5	with	with	ADP
ihlr-16470	339	6	the	the	DET
ihlr-16470	339	7	results	result	NOUN
ihlr-16470	339	8	of	of	ADP
ihlr-16470	339	9	clinical	clinical	ADJ
ihlr-16470	339	10	trials	trial	NOUN
ihlr-16470	339	11	.	.	PUNCT
ihlr-16470	340	1	clinical	clinical	ADJ
ihlr-16470	340	2	investigators	investigator	NOUN
ihlr-16470	340	3	must	must	AUX
ihlr-16470	340	4	be	be	AUX
ihlr-16470	340	5	qualified	qualified	ADJ
ihlr-16470	340	6	,	,	PUNCT
ihlr-16470	340	7	and	and	CCONJ
ihlr-16470	340	8	the	the	DET
ihlr-16470	340	9	testing	testing	NOUN
ihlr-16470	340	10	typically	typically	ADV
ihlr-16470	340	11	involves	involve	VERB
ihlr-16470	340	12	controlled	control	VERB
ihlr-16470	340	13	experiments	experiment	NOUN
ihlr-16470	340	14	.	.	PUNCT
ihlr-16470	341	1	the	the	DET
ihlr-16470	341	2	promoter	promoter	NOUN
ihlr-16470	341	3	of	of	ADP
ihlr-16470	341	4	the	the	DET
ihlr-16470	341	5	drug	drug	NOUN
ihlr-16470	341	6	must	must	AUX
ihlr-16470	341	7	also	also	ADV
ihlr-16470	341	8	submit	submit	VERB
ihlr-16470	341	9	a	a	DET
ihlr-16470	341	10	proposed	propose	VERB
ihlr-16470	341	11	label	label	NOUN
ihlr-16470	341	12	that	that	PRON
ihlr-16470	341	13	will	will	AUX
ihlr-16470	341	14	accompany	accompany	VERB
ihlr-16470	341	15	the	the	DET
ihlr-16470	341	16	drug	drug	NOUN
ihlr-16470	341	17	.	.	PUNCT
ihlr-16470	342	1	if	if	SCONJ
ihlr-16470	342	2	the	the	DET
ihlr-16470	342	3	application	application	NOUN
ihlr-16470	342	4	meets	meet	VERB
ihlr-16470	342	5	fda	fda	PROPN
ihlr-16470	342	6	standards	standard	NOUN
ihlr-16470	342	7	,	,	PUNCT
ihlr-16470	342	8	the	the	DET
ihlr-16470	342	9	agency	agency	NOUN
ihlr-16470	342	10	will	will	AUX
ihlr-16470	342	11	approve	approve	VERB
ihlr-16470	342	12	the	the	DET
ihlr-16470	342	13	drug	drug	NOUN
ihlr-16470	342	14	for	for	ADP
ihlr-16470	342	15	the	the	DET
ihlr-16470	342	16	particular	particular	ADJ
ihlr-16470	342	17	use	use	NOUN
ihlr-16470	342	18	or	or	CCONJ
ihlr-16470	342	19	uses	use	NOUN
ihlr-16470	342	20	included	include	VERB
ihlr-16470	342	21	in	in	ADP
ihlr-16470	342	22	the	the	DET
ihlr-16470	342	23	application	application	NOUN
ihlr-16470	342	24	and	and	CCONJ
ihlr-16470	342	25	will	will	AUX
ihlr-16470	342	26	also	also	ADV
ihlr-16470	342	27	approve	approve	VERB
ihlr-16470	342	28	the	the	DET
ihlr-16470	342	29	proposed	propose	VERB
ihlr-16470	342	30	label	label	NOUN
ihlr-16470	342	31	.	.	PUNCT
ihlr-16470	343	1	this	this	DET
ihlr-16470	343	2	approval	approval	NOUN
ihlr-16470	343	3	process	process	NOUN
ihlr-16470	343	4	is	be	AUX
ihlr-16470	343	5	both	both	PRON
ihlr-16470	343	6	extremely	extremely	ADV
ihlr-16470	343	7	costly	costly	ADJ
ihlr-16470	343	8	and	and	CCONJ
ihlr-16470	343	9	time	time	NOUN
ihlr-16470	343	10	consuming	consume	VERB
ihlr-16470	343	11	.	.	PUNCT
ihlr-16470	344	1	once	once	SCONJ
ihlr-16470	344	2	the	the	DET
ihlr-16470	344	3	fda	fda	PROPN
ihlr-16470	344	4	has	have	AUX
ihlr-16470	344	5	approved	approve	VERB
ihlr-16470	344	6	a	a	DET
ihlr-16470	344	7	drug	drug	NOUN
ihlr-16470	344	8	,	,	PUNCT
ihlr-16470	344	9	the	the	DET
ihlr-16470	344	10	manufacturer	manufacturer	NOUN
ihlr-16470	344	11	may	may	AUX
ihlr-16470	344	12	only	only	ADV
ihlr-16470	344	13	market	market	VERB
ihlr-16470	344	14	the	the	DET
ihlr-16470	344	15	product	product	NOUN
ihlr-16470	344	16	for	for	ADP
ihlr-16470	344	17	the	the	DET
ihlr-16470	344	18	approved	approve	VERB
ihlr-16470	344	19	uses	use	NOUN
ihlr-16470	344	20	.	.	PUNCT
ihlr-16470	345	1	because	because	SCONJ
ihlr-16470	345	2	the	the	DET
ihlr-16470	345	3	fda	fda	PROPN
ihlr-16470	345	4	-	-	PUNCT
ihlr-16470	345	5	approved	approve	VERB
ihlr-16470	345	6	label	label	NOUN
ihlr-16470	345	7	must	must	AUX
ihlr-16470	345	8	reflect	reflect	VERB
ihlr-16470	345	9	those	those	DET
ihlr-16470	345	10	uses	use	NOUN
ihlr-16470	345	11	,	,	PUNCT
ihlr-16470	345	12	any	any	DET
ihlr-16470	345	13	other	other	ADJ
ihlr-16470	345	14	use	use	NOUN
ihlr-16470	345	15	of	of	ADP
ihlr-16470	345	16	the	the	DET
ihlr-16470	345	17	product	product	NOUN
ihlr-16470	345	18	is	be	AUX
ihlr-16470	345	19	deemed	deem	VERB
ihlr-16470	345	20	"	"	PUNCT
ihlr-16470	345	21	off	off	ADP
ihlr-16470	345	22	-	-	PUNCT
ihlr-16470	345	23	label	label	NOUN
ihlr-16470	345	24	.	.	PUNCT
ihlr-16470	345	25	"	"	PUNCT
ihlr-16470	346	1	"	"	PUNCT
ihlr-16470	346	2	misbranding	misbrande	VERB
ihlr-16470	346	3	,	,	PUNCT
ihlr-16470	346	4	"	"	PUNCT
ihlr-16470	346	5	which	which	PRON
ihlr-16470	346	6	includes	include	VERB
ihlr-16470	346	7	off	off	ADP
ihlr-16470	346	8	-	-	PUNCT
ihlr-16470	346	9	label	label	NOUN
ihlr-16470	346	10	marketing	marketing	NOUN
ihlr-16470	346	11	,	,	PUNCT
ihlr-16470	346	12	is	be	AUX
ihlr-16470	346	13	prohibited	prohibit	VERB
ihlr-16470	346	14	by	by	ADP
ihlr-16470	346	15	the	the	DET
ihlr-16470	346	16	fdca	fdca	NOUN
ihlr-16470	347	1	[	[	X
ihlr-16470	347	2	food	food	NOUN
ihlr-16470	347	3	,	,	PUNCT
ihlr-16470	347	4	drug	drug	NOUN
ihlr-16470	347	5	,	,	PUNCT
ihlr-16470	347	6	and	and	CCONJ
ihlr-16470	347	7	cosmetic	cosmetic	ADJ
ihlr-16470	347	8	act	act	PROPN
ihlr-16470	347	9	]	]	PUNCT
ihlr-16470	347	10	.	.	PUNCT
ihlr-16470	348	1	these	these	DET
ihlr-16470	348	2	regulatory	regulatory	ADJ
ihlr-16470	348	3	guidelines	guideline	NOUN
ihlr-16470	348	4	are	be	AUX
ihlr-16470	348	5	complicated	complicate	VERB
ihlr-16470	348	6	by	by	ADP
ihlr-16470	348	7	an	an	DET
ihlr-16470	348	8	important	important	ADJ
ihlr-16470	348	9	feature	feature	NOUN
ihlr-16470	348	10	of	of	ADP
ihlr-16470	348	11	the	the	DET
ihlr-16470	348	12	law	law	NOUN
ihlr-16470	348	13	of	of	ADP
ihlr-16470	348	14	off­	off­	NOUN
ihlr-16470	348	15	label	label	NOUN
ihlr-16470	348	16	use	use	NOUN
ihlr-16470	348	17	and	and	CCONJ
ihlr-16470	348	18	promotion	promotion	NOUN
ihlr-16470	348	19	:	:	PUNCT
ihlr-16470	348	20	physicians	physician	NOUN
ihlr-16470	348	21	may	may	AUX
ihlr-16470	348	22	prescribe	prescribe	VERB
ihlr-16470	348	23	drugs	drug	NOUN
ihlr-16470	348	24	for	for	ADP
ihlr-16470	348	25	non	non	ADJ
ihlr-16470	348	26	-	-	ADJ
ihlr-16470	348	27	approved	approved	ADJ
ihlr-16470	348	28	or	or	CCONJ
ihlr-16470	348	29	off	off	ADP
ihlr-16470	348	30	-	-	PUNCT
ihlr-16470	348	31	label	label	NOUN
ihlr-16470	348	32	uses	use	NOUN
ihlr-16470	348	33	.	.	PUNCT
ihlr-16470	349	1	thus	thus	ADV
ihlr-16470	349	2	,	,	PUNCT
ihlr-16470	349	3	a	a	DET
ihlr-16470	349	4	doctor	doctor	NOUN
ihlr-16470	349	5	may	may	AUX
ihlr-16470	349	6	know	know	VERB
ihlr-16470	349	7	that	that	SCONJ
ihlr-16470	349	8	a	a	DET
ihlr-16470	349	9	particular	particular	ADJ
ihlr-16470	349	10	drug	drug	NOUN
ihlr-16470	349	11	is	be	AUX
ihlr-16470	349	12	effective	effective	ADJ
ihlr-16470	349	13	for	for	ADP
ihlr-16470	349	14	one	one	NUM
ihlr-16470	349	15	indication	indication	NOUN
ihlr-16470	349	16	but	but	CCONJ
ihlr-16470	349	17	only	only	ADV
ihlr-16470	349	18	fda	fda	PROPN
ihlr-16470	349	19	-	-	PUNCT
ihlr-16470	349	20	approved	approve	VERB
ihlr-16470	349	21	for	for	ADP
ihlr-16470	349	22	a	a	DET
ihlr-16470	349	23	different	different	ADJ
ihlr-16470	349	24	indication	indication	NOUN
ihlr-16470	349	25	.	.	PUNCT
ihlr-16470	350	1	in	in	ADP
ihlr-16470	350	2	this	this	DET
ihlr-16470	350	3	common	common	ADJ
ihlr-16470	350	4	scenario	scenario	NOUN
ihlr-16470	350	5	,	,	PUNCT
ihlr-16470	350	6	the	the	DET
ihlr-16470	350	7	doctor	doctor	NOUN
ihlr-16470	350	8	may	may	AUX
ihlr-16470	350	9	prescribe	prescribe	VERB
ihlr-16470	350	10	the	the	DET
ihlr-16470	350	11	drug	drug	NOUN
ihlr-16470	350	12	for	for	ADP
ihlr-16470	350	13	the	the	DET
ihlr-16470	350	14	unapproved	unapproved	ADJ
ihlr-16470	350	15	use	use	NOUN
ihlr-16470	350	16	,	,	PUNCT
ihlr-16470	350	17	even	even	ADV
ihlr-16470	350	18	though	though	SCONJ
ihlr-16470	350	19	the	the	DET
ihlr-16470	350	20	manufacturer	manufacturer	NOUN
ihlr-16470	350	21	may	may	AUX
ihlr-16470	350	22	not	not	PART
ihlr-16470	350	23	promote	promote	VERB
ihlr-16470	350	24	it	it	PRON
ihlr-16470	350	25	for	for	ADP
ihlr-16470	350	26	that	that	DET
ihlr-16470	350	27	use	use	NOUN
ihlr-16470	350	28	.	.	PUNCT
ihlr-16470	350	29	103	103	NUM
ihlr-16470	350	30	when	when	SCONJ
ihlr-16470	350	31	a	a	DET
ihlr-16470	350	32	drug	drug	NOUN
ihlr-16470	350	33	exhibits	exhibit	VERB
ihlr-16470	350	34	properties	property	NOUN
ihlr-16470	350	35	that	that	PRON
ihlr-16470	350	36	have	have	AUX
ihlr-16470	350	37	not	not	PART
ihlr-16470	350	38	been	be	AUX
ihlr-16470	350	39	specifically	specifically	ADV
ihlr-16470	350	40	proven	prove	VERB
ihlr-16470	350	41	in	in	ADP
ihlr-16470	350	42	a	a	DET
ihlr-16470	350	43	clinical	clinical	ADJ
ihlr-16470	350	44	trial	trial	NOUN
ihlr-16470	350	45	,	,	PUNCT
ihlr-16470	350	46	these	these	DET
ihlr-16470	350	47	properties	property	NOUN
ihlr-16470	350	48	may	may	AUX
ihlr-16470	350	49	be	be	AUX
ihlr-16470	350	50	exploited	exploit	VERB
ihlr-16470	350	51	through	through	ADP
ihlr-16470	350	52	the	the	DET
ihlr-16470	350	53	use	use	NOUN
ihlr-16470	350	54	of	of	ADP
ihlr-16470	350	55	off	off	ADP
ihlr-16470	350	56	-	-	PUNCT
ihlr-16470	350	57	label	label	NOUN
ihlr-16470	350	58	prescriptions	prescription	NOUN
ihlr-16470	350	59	for	for	ADP
ihlr-16470	350	60	unproven	unproven	ADJ
ihlr-16470	350	61	uses	use	NOUN
ihlr-16470	350	62	.	.	PUNCT
ihlr-16470	351	1	104	104	NUM
ihlr-16470	352	1	this	this	PRON
ihlr-16470	352	2	allows	allow	VERB
ihlr-16470	352	3	a	a	DET
ihlr-16470	352	4	drug	drug	NOUN
ihlr-16470	352	5	company	company	NOUN
ihlr-16470	352	6	to	to	PART
ihlr-16470	352	7	profit	profit	VERB
ihlr-16470	352	8	from	from	ADP
ihlr-16470	352	9	the	the	DET
ihlr-16470	352	10	use	use	NOUN
ihlr-16470	352	11	of	of	ADP
ihlr-16470	352	12	the	the	DET
ihlr-16470	352	13	drug	drug	NOUN
ihlr-16470	352	14	while	while	SCONJ
ihlr-16470	352	15	avoiding	avoid	VERB
ihlr-16470	352	16	the	the	DET
ihlr-16470	352	17	strict	strict	ADJ
ihlr-16470	352	18	data	datum	NOUN
ihlr-16470	352	19	requirements	requirement	NOUN
ihlr-16470	352	20	,	,	PUNCT
ihlr-16470	352	21	rigorous	rigorous	ADJ
ihlr-16470	352	22	scrutiny	scrutiny	NOUN
ihlr-16470	352	23	,	,	PUNCT
ihlr-16470	352	24	and	and	CCONJ
ihlr-16470	352	25	cost	cost	NOUN
ihlr-16470	352	26	of	of	ADP
ihlr-16470	352	27	the	the	DET
ihlr-16470	352	28	fda	fda	PROPN
ihlr-16470	352	29	drug	drug	PROPN
ihlr-16470	352	30	approval	approval	NOUN
ihlr-16470	352	31	process	process	NOUN
ihlr-16470	352	32	.	.	PUNCT
ihlr-16470	353	1	105	105	NUM
ihlr-16470	353	2	off	off	ADP
ihlr-16470	353	3	-	-	PUNCT
ihlr-16470	353	4	label	label	NOUN
ihlr-16470	353	5	prescribing	prescribing	NOUN
ihlr-16470	353	6	is	be	AUX
ihlr-16470	353	7	a	a	DET
ihlr-16470	353	8	rapidly	rapidly	ADV
ihlr-16470	353	9	growing	grow	VERB
ihlr-16470	353	10	practice	practice	NOUN
ihlr-16470	353	11	,	,	PUNCT
ihlr-16470	353	12	or	or	CCONJ
ihlr-16470	353	13	as	as	SCONJ
ihlr-16470	353	14	some	some	PRON
ihlr-16470	353	15	view	view	NOUN
ihlr-16470	353	16	it	it	PRON
ihlr-16470	353	17	,	,	PUNCT
ihlr-16470	353	18	a	a	DET
ihlr-16470	353	19	rapidly	rapidly	ADV
ihlr-16470	353	20	growing	grow	VERB
ihlr-16470	353	21	problem	problem	NOUN
ihlr-16470	353	22	.	.	PUNCT
ihlr-16470	354	1	it	it	PRON
ihlr-16470	354	2	is	be	AUX
ihlr-16470	354	3	estimated	estimate	VERB
ihlr-16470	354	4	that	that	SCONJ
ihlr-16470	354	5	nearly	nearly	ADV
ihlr-16470	354	6	one	one	NUM
ihlr-16470	354	7	-	-	PUNCT
ihlr-16470	354	8	half	half	NOUN
ihlr-16470	354	9	of	of	ADP
ihlr-16470	354	10	all	all	DET
ihlr-16470	354	11	american	american	ADJ
ihlr-16470	354	12	drug	drug	NOUN
ihlr-16470	354	13	prescriptions	prescription	NOUN
ihlr-16470	354	14	are	be	AUX
ihlr-16470	354	15	for	for	ADP
ihlr-16470	354	16	off	off	ADP
ihlr-16470	354	17	-	-	PUNCT
ihlr-16470	354	18	label	label	NOUN
ihlr-16470	354	19	uses	use	NOUN
ihlr-16470	354	20	.	.	PUNCT
ihlr-16470	355	1	106	106	NUM
ihlr-16470	355	2	part	part	NOUN
ihlr-16470	355	3	of	of	ADP
ihlr-16470	355	4	the	the	DET
ihlr-16470	355	5	reason	reason	NOUN
ihlr-16470	355	6	for	for	ADP
ihlr-16470	355	7	the	the	DET
ihlr-16470	355	8	growth	growth	NOUN
ihlr-16470	355	9	of	of	ADP
ihlr-16470	355	10	off	off	ADP
ihlr-16470	355	11	-	-	PUNCT
ihlr-16470	355	12	label	label	NOUN
ihlr-16470	355	13	prescribing	prescribing	NOUN
ihlr-16470	355	14	is	be	AUX
ihlr-16470	355	15	a	a	DET
ihlr-16470	355	16	lack	lack	NOUN
ihlr-16470	355	17	of	of	ADP
ihlr-16470	355	18	incentive	incentive	NOUN
ihlr-16470	355	19	for	for	SCONJ
ihlr-16470	355	20	the	the	DET
ihlr-16470	355	21	drug	drug	NOUN
ihlr-16470	355	22	manufacturers	manufacturer	NOUN
ihlr-16470	355	23	to	to	PART
ihlr-16470	355	24	seek	seek	VERB
ihlr-16470	355	25	approval	approval	NOUN
ihlr-16470	355	26	for	for	ADP
ihlr-16470	355	27	new	new	ADJ
ihlr-16470	355	28	uses	use	NOUN
ihlr-16470	355	29	for	for	ADP
ihlr-16470	355	30	prescription	prescription	NOUN
ihlr-16470	355	31	drugs	drug	NOUN
ihlr-16470	355	32	.	.	PUNCT
ihlr-16470	356	1	seeking	seek	VERB
ihlr-16470	356	2	approval	approval	NOUN
ihlr-16470	356	3	for	for	ADP
ihlr-16470	356	4	new	new	ADJ
ihlr-16470	356	5	uses	use	NOUN
ihlr-16470	356	6	would	would	AUX
ihlr-16470	356	7	likely	likely	ADV
ihlr-16470	356	8	have	have	VERB
ihlr-16470	356	9	little	little	ADJ
ihlr-16470	356	10	effect	effect	NOUN
ihlr-16470	356	11	on	on	ADP
ihlr-16470	356	12	drug	drug	NOUN
ihlr-16470	356	13	sales	sale	NOUN
ihlr-16470	356	14	,	,	PUNCT
ihlr-16470	356	15	so	so	SCONJ
ihlr-16470	356	16	the	the	DET
ihlr-16470	356	17	103	103	NUM
ihlr-16470	356	18	.	.	PUNCT
ihlr-16470	357	1	mark	mark	PROPN
ihlr-16470	357	2	ford	ford	PROPN
ihlr-16470	357	3	,	,	PUNCT
ihlr-16470	357	4	another	another	DET
ihlr-16470	357	5	use	use	NOUN
ihlr-16470	357	6	ofoxycontin	ofoxycontin	VERB
ihlr-16470	357	7	:	:	PUNCT
ihlr-16470	357	8	the	the	DET
ihlr-16470	357	9	case	case	NOUN
ihlr-16470	357	10	for	for	ADP
ihlr-16470	357	11	enhancing	enhance	VERB
ihlr-16470	357	12	liability	liability	NOUN
ihlr-16470	357	13	for	for	ADP
ihlr-16470	357	14	off­	off­	NOUN
ihlr-16470	357	15	label	label	NOUN
ihlr-16470	357	16	drug	drug	NOUN
ihlr-16470	357	17	marketing	marketing	NOUN
ihlr-16470	357	18	,	,	PUNCT
ihlr-16470	357	19	83	83	NUM
ihlr-16470	357	20	b.d	b.d	PROPN
ihlr-16470	357	21	.	.	PROPN
ihlr-16470	357	22	l.	l.	PROPN
ihlr-16470	357	23	rev	rev	PROPN
ihlr-16470	357	24	.	.	PROPN
ihlr-16470	357	25	429,431	429,431	NUM
ihlr-16470	357	26	-	-	SYM
ihlr-16470	357	27	32	32	NUM
ihlr-16470	357	28	(	(	PUNCT
ihlr-16470	357	29	2003	2003	NUM
ihlr-16470	357	30	)	)	PUNCT
ihlr-16470	357	31	.	.	PUNCT
ihlr-16470	358	1	104	104	NUM
ihlr-16470	358	2	.	.	PUNCT
ihlr-16470	359	1	tardy	tardy	NOUN
ihlr-16470	359	2	v.	v.	ADP
ihlr-16470	359	3	eli	eli	PROPN
ihlr-16470	359	4	lilly	lilly	PROPN
ihlr-16470	359	5	&	&	CCONJ
ihlr-16470	359	6	co.	co.	PROPN
ihlr-16470	359	7	,	,	PUNCT
ihlr-16470	359	8	2004	2004	NUM
ihlr-16470	359	9	wl	wl	X
ihlr-16470	359	10	1925536	1925536	NUM
ihlr-16470	359	11	at	at	ADP
ihlr-16470	359	12	*	*	NUM
ihlr-16470	359	13	1	1	NUM
ihlr-16470	359	14	n.3	n.3	NOUN
ihlr-16470	359	15	(	(	PUNCT
ihlr-16470	359	16	me	i	PRON
ihlr-16470	359	17	.	.	PUNCT
ihlr-16470	360	1	super	super	ADJ
ihlr-16470	360	2	.	.	PUNCT
ihlr-16470	361	1	2004)(quoting	2004)(quote	VERB
ihlr-16470	361	2	taber	taber	PROPN
ihlr-16470	361	3	's	's	PART
ihlr-16470	361	4	cyclopedic	cyclopedic	ADJ
ihlr-16470	361	5	medical	medical	ADJ
ihlr-16470	361	6	dictionary	dictionary	NOUN
ihlr-16470	361	7	(	(	PUNCT
ihlr-16470	361	8	f.a	f.a	PROPN
ihlr-16470	361	9	.	.	PROPN
ihlr-16470	361	10	davis	davis	PROPN
ihlr-16470	361	11	inc	inc	PROPN
ihlr-16470	361	12	.	.	PROPN
ihlr-16470	361	13	,	,	PUNCT
ihlr-16470	361	14	2002	2002	NUM
ihlr-16470	361	15	)	)	PUNCT
ihlr-16470	361	16	.	.	PUNCT
ihlr-16470	362	1	105	105	NUM
ihlr-16470	362	2	.	.	PUNCT
ihlr-16470	362	3	see	see	VERB
ihlr-16470	362	4	i	i	PRON
ihlr-16470	362	5	d.	d.	PROPN
ihlr-16470	362	6	106	106	NUM
ihlr-16470	362	7	.	.	PUNCT
ihlr-16470	363	1	see	see	VERB
ihlr-16470	363	2	stoffelmayr	stoffelmayr	PROPN
ihlr-16470	363	3	,	,	PUNCT
ihlr-16470	363	4	supra	supra	PROPN
ihlr-16470	363	5	note	note	NOUN
ihlr-16470	363	6	101	101	NUM
ihlr-16470	363	7	,	,	PUNCT
ihlr-16470	363	8	at	at	ADP
ihlr-16470	363	9	275	275	NUM
ihlr-16470	363	10	.	.	PUNCT
ihlr-16470	364	1	2006	2006	NUM
ihlr-16470	364	2	]	]	PUNCT
ihlr-16470	364	3	anti	anti	NOUN
ihlr-16470	364	4	-	-	NOUN
ihlr-16470	364	5	depressants	depressant	NOUN
ihlr-16470	364	6	and	and	CCONJ
ihlr-16470	364	7	children	child	NOUN
ihlr-16470	364	8	215	215	NUM
ihlr-16470	364	9	benefit	benefit	NOUN
ihlr-16470	364	10	to	to	ADP
ihlr-16470	364	11	drug	drug	NOUN
ihlr-16470	364	12	manufacturers	manufacturer	NOUN
ihlr-16470	364	13	does	do	AUX
ihlr-16470	364	14	not	not	PART
ihlr-16470	364	15	outweigh	outweigh	VERB
ihlr-16470	364	16	the	the	DET
ihlr-16470	364	17	costs	cost	NOUN
ihlr-16470	364	18	of	of	ADP
ihlr-16470	364	19	the	the	DET
ihlr-16470	364	20	approval	approval	NOUN
ihlr-16470	364	21	process.107	process.107	NOUN
ihlr-16470	364	22	additionally	additionally	ADV
ihlr-16470	364	23	,	,	PUNCT
ihlr-16470	364	24	when	when	SCONJ
ihlr-16470	364	25	new	new	ADJ
ihlr-16470	364	26	uses	use	NOUN
ihlr-16470	364	27	are	be	AUX
ihlr-16470	364	28	discovered	discover	VERB
ihlr-16470	364	29	,	,	PUNCT
ihlr-16470	364	30	less	less	ADJ
ihlr-16470	364	31	than	than	SCONJ
ihlr-16470	364	32	the	the	DET
ihlr-16470	364	33	entire	entire	ADJ
ihlr-16470	364	34	patent	patent	NOUN
ihlr-16470	364	35	term	term	NOUN
ihlr-16470	364	36	remains	remain	VERB
ihlr-16470	364	37	for	for	ADP
ihlr-16470	364	38	the	the	DET
ihlr-16470	364	39	drug	drug	NOUN
ihlr-16470	364	40	.	.	PUNCT
ihlr-16470	365	1	therefore	therefore	ADV
ihlr-16470	365	2	,	,	PUNCT
ihlr-16470	365	3	even	even	ADV
ihlr-16470	365	4	with	with	ADP
ihlr-16470	365	5	extended	extended	ADJ
ihlr-16470	365	6	patent	patent	NOUN
ihlr-16470	365	7	terms	term	NOUN
ihlr-16470	365	8	,	,	PUNCT
ihlr-16470	365	9	it	it	PRON
ihlr-16470	365	10	is	be	AUX
ihlr-16470	365	11	difficult	difficult	ADJ
ihlr-16470	365	12	for	for	SCONJ
ihlr-16470	365	13	a	a	DET
ihlr-16470	365	14	drug	drug	NOUN
ihlr-16470	365	15	manufacturer	manufacturer	NOUN
ihlr-16470	365	16	to	to	PART
ihlr-16470	365	17	recover	recover	VERB
ihlr-16470	365	18	its	its	PRON
ihlr-16470	365	19	investment	investment	NOUN
ihlr-16470	365	20	in	in	ADP
ihlr-16470	365	21	having	have	VERB
ihlr-16470	365	22	an	an	DET
ihlr-16470	365	23	off	off	ADP
ihlr-16470	365	24	-	-	PUNCT
ihlr-16470	365	25	label	label	NOUN
ihlr-16470	365	26	use	use	NOUN
ihlr-16470	365	27	approved	approve	VERB
ihlr-16470	365	28	.	.	PUNCT
ihlr-16470	366	1	108	108	NUM
ihlr-16470	366	2	b.	b.	PROPN
ihlr-16470	366	3	off	off	ADP
ihlr-16470	366	4	-	-	PUNCT
ihlr-16470	366	5	label	label	NOUN
ihlr-16470	366	6	prescriptions	prescription	NOUN
ihlr-16470	366	7	and	and	CCONJ
ihlr-16470	366	8	children	child	NOUN
ihlr-16470	366	9	off	off	ADP
ihlr-16470	366	10	-	-	PUNCT
ihlr-16470	366	11	label	label	NOUN
ihlr-16470	366	12	prescribing	prescribing	NOUN
ihlr-16470	366	13	encompasses	encompass	VERB
ihlr-16470	366	14	more	more	ADJ
ihlr-16470	366	15	than	than	ADP
ihlr-16470	366	16	simply	simply	ADV
ihlr-16470	366	17	using	use	VERB
ihlr-16470	366	18	a	a	DET
ihlr-16470	366	19	drug	drug	NOUN
ihlr-16470	366	20	for	for	ADP
ihlr-16470	366	21	an	an	DET
ihlr-16470	366	22	unapproved	unapproved	ADJ
ihlr-16470	366	23	use	use	NOUN
ihlr-16470	366	24	.	.	PUNCT
ihlr-16470	367	1	one	one	NUM
ihlr-16470	367	2	common	common	ADJ
ihlr-16470	367	3	form	form	NOUN
ihlr-16470	367	4	of	of	ADP
ihlr-16470	367	5	off	off	ADP
ihlr-16470	367	6	-	-	PUNCT
ihlr-16470	367	7	label	label	NOUN
ihlr-16470	367	8	prescribing	prescribing	NOUN
ihlr-16470	367	9	in	in	ADP
ihlr-16470	367	10	children	child	NOUN
ihlr-16470	367	11	is	be	AUX
ihlr-16470	367	12	when	when	SCONJ
ihlr-16470	367	13	a	a	DET
ihlr-16470	367	14	drug	drug	NOUN
ihlr-16470	367	15	is	be	AUX
ihlr-16470	367	16	used	use	VERB
ihlr-16470	367	17	for	for	ADP
ihlr-16470	367	18	its	its	PRON
ihlr-16470	367	19	approved	approve	VERB
ihlr-16470	367	20	use	use	NOUN
ihlr-16470	367	21	but	but	CCONJ
ihlr-16470	367	22	in	in	ADP
ihlr-16470	367	23	an	an	DET
ihlr-16470	367	24	unapproved	unapproved	ADJ
ihlr-16470	367	25	patient	patient	ADJ
ihlr-16470	367	26	population	population	NOUN
ihlr-16470	367	27	,	,	PUNCT
ihlr-16470	367	28	such	such	ADJ
ihlr-16470	367	29	as	as	ADP
ihlr-16470	367	30	when	when	SCONJ
ihlr-16470	367	31	children	child	NOUN
ihlr-16470	367	32	are	be	AUX
ihlr-16470	367	33	prescribed	prescribe	VERB
ihlr-16470	367	34	drugs	drug	NOUN
ihlr-16470	367	35	approved	approve	VERB
ihlr-16470	367	36	for	for	ADP
ihlr-16470	367	37	use	use	NOUN
ihlr-16470	367	38	in	in	ADP
ihlr-16470	367	39	adults	adult	NOUN
ihlr-16470	367	40	only.109	only.109	VERB
ihlr-16470	367	41	when	when	SCONJ
ihlr-16470	367	42	prescribing	prescribe	VERB
ihlr-16470	367	43	off	off	ADP
ihlr-16470	367	44	-	-	PUNCT
ihlr-16470	367	45	label	label	NOUN
ihlr-16470	367	46	for	for	ADP
ihlr-16470	367	47	children	child	NOUN
ihlr-16470	367	48	,	,	PUNCT
ihlr-16470	367	49	physicians	physician	NOUN
ihlr-16470	367	50	necessarily	necessarily	ADV
ihlr-16470	367	51	take	take	VERB
ihlr-16470	367	52	a	a	DET
ihlr-16470	367	53	greater	great	ADJ
ihlr-16470	367	54	role	role	NOUN
ihlr-16470	367	55	in	in	ADP
ihlr-16470	367	56	the	the	DET
ihlr-16470	367	57	administration	administration	NOUN
ihlr-16470	367	58	of	of	ADP
ihlr-16470	367	59	that	that	DET
ihlr-16470	367	60	drug	drug	NOUN
ihlr-16470	367	61	.	.	PUNCT
ihlr-16470	368	1	11	11	NUM
ihlr-16470	368	2	°	°	NOUN
ihlr-16470	368	3	for	for	ADP
ihlr-16470	368	4	example	example	NOUN
ihlr-16470	368	5	,	,	PUNCT
ihlr-16470	368	6	when	when	SCONJ
ihlr-16470	368	7	prescribing	prescribe	VERB
ihlr-16470	368	8	off	off	ADP
ihlr-16470	368	9	-	-	PUNCT
ihlr-16470	368	10	label	label	NOUN
ihlr-16470	368	11	,	,	PUNCT
ihlr-16470	368	12	physicians	physician	NOUN
ihlr-16470	368	13	must	must	AUX
ihlr-16470	368	14	calculate	calculate	VERB
ihlr-16470	368	15	the	the	DET
ihlr-16470	368	16	proper	proper	ADJ
ihlr-16470	368	17	dosage	dosage	NOUN
ihlr-16470	368	18	based	base	VERB
ihlr-16470	368	19	on	on	ADP
ihlr-16470	368	20	the	the	DET
ihlr-16470	368	21	patient	patient	NOUN
ihlr-16470	368	22	's	's	PART
ihlr-16470	368	23	age	age	NOUN
ihlr-16470	368	24	and	and	CCONJ
ihlr-16470	368	25	weight	weight	NOUN
ihlr-16470	368	26	,	,	PUNCT
ihlr-16470	368	27	and	and	CCONJ
ihlr-16470	368	28	often	often	ADV
ihlr-16470	368	29	the	the	DET
ihlr-16470	368	30	solutions	solution	NOUN
ihlr-16470	368	31	must	must	AUX
ihlr-16470	368	32	be	be	AUX
ihlr-16470	368	33	compounded	compound	VERB
ihlr-16470	368	34	based	base	VERB
ihlr-16470	368	35	on	on	ADP
ihlr-16470	368	36	physician	physician	NOUN
ihlr-16470	368	37	or	or	CCONJ
ihlr-16470	368	38	pharmacist	pharmacist	NOUN
ihlr-16470	368	39	experience	experience	NOUN
ihlr-16470	368	40	due	due	ADP
ihlr-16470	368	41	to	to	ADP
ihlr-16470	368	42	the	the	DET
ihlr-16470	368	43	absence	absence	NOUN
ihlr-16470	368	44	of	of	ADP
ihlr-16470	368	45	pediatric	pediatric	ADJ
ihlr-16470	368	46	formulations	formulation	NOUN
ihlr-16470	368	47	.	.	PUNCT
ihlr-16470	369	1	111	111	NUM
ihlr-16470	369	2	the	the	DET
ihlr-16470	369	3	fda	fda	PROPN
ihlr-16470	369	4	recognizes	recognize	VERB
ihlr-16470	369	5	many	many	ADJ
ihlr-16470	369	6	of	of	ADP
ihlr-16470	369	7	the	the	DET
ihlr-16470	369	8	inadequacies	inadequacy	NOUN
ihlr-16470	369	9	of	of	ADP
ihlr-16470	369	10	prescribing	prescribing	NOUN
ihlr-16470	369	11	guidelines	guideline	NOUN
ihlr-16470	369	12	for	for	ADP
ihlr-16470	369	13	many	many	ADJ
ihlr-16470	369	14	drugs	drug	NOUN
ihlr-16470	369	15	commonly	commonly	ADV
ihlr-16470	369	16	used	use	VERB
ihlr-16470	369	17	in	in	ADP
ihlr-16470	369	18	children	child	NOUN
ihlr-16470	369	19	.	.	PUNCT
ihlr-16470	370	1	112	112	NUM
ihlr-16470	370	2	new	new	ADJ
ihlr-16470	370	3	standards	standard	NOUN
ihlr-16470	370	4	have	have	AUX
ihlr-16470	370	5	been	be	AUX
ihlr-16470	370	6	developed	develop	VERB
ihlr-16470	370	7	to	to	PART
ihlr-16470	370	8	address	address	VERB
ihlr-16470	370	9	some	some	PRON
ihlr-16470	370	10	of	of	ADP
ihlr-16470	370	11	these	these	DET
ihlr-16470	370	12	problems	problem	NOUN
ihlr-16470	370	13	unique	unique	ADJ
ihlr-16470	370	14	to	to	ADP
ihlr-16470	370	15	the	the	DET
ihlr-16470	370	16	pediatric	pediatric	ADJ
ihlr-16470	370	17	patient	patient	ADJ
ihlr-16470	370	18	population	population	NOUN
ihlr-16470	370	19	,	,	PUNCT
ihlr-16470	370	20	most	most	ADV
ihlr-16470	370	21	importantly	importantly	ADV
ihlr-16470	370	22	in	in	ADP
ihlr-16470	370	23	the	the	DET
ihlr-16470	370	24	new	new	ADJ
ihlr-16470	370	25	drug	drug	NOUN
ihlr-16470	370	26	application	application	NOUN
ihlr-16470	370	27	process	process	NOUN
ihlr-16470	370	28	.	.	PUNCT
ihlr-16470	371	1	113	113	NUM
ihlr-16470	371	2	in	in	ADP
ihlr-16470	371	3	the	the	DET
ihlr-16470	371	4	past	past	NOUN
ihlr-16470	371	5	,	,	PUNCT
ihlr-16470	371	6	manufacturers	manufacturer	NOUN
ihlr-16470	371	7	applied	apply	VERB
ihlr-16470	371	8	for	for	ADP
ihlr-16470	371	9	approval	approval	NOUN
ihlr-16470	371	10	for	for	ADP
ihlr-16470	371	11	a	a	DET
ihlr-16470	371	12	new	new	ADJ
ihlr-16470	371	13	drug	drug	NOUN
ihlr-16470	371	14	under	under	ADP
ihlr-16470	371	15	the	the	DET
ihlr-16470	371	16	presumption	presumption	NOUN
ihlr-16470	371	17	that	that	SCONJ
ihlr-16470	371	18	pediatric	pediatric	ADJ
ihlr-16470	371	19	studies	study	NOUN
ihlr-16470	371	20	would	would	AUX
ihlr-16470	371	21	not	not	PART
ihlr-16470	371	22	be	be	AUX
ihlr-16470	371	23	conducted	conduct	VERB
ihlr-16470	371	24	.	.	PUNCT
ihlr-16470	372	1	however	however	ADV
ihlr-16470	372	2	,	,	PUNCT
ihlr-16470	372	3	new	new	ADJ
ihlr-16470	372	4	approval	approval	NOUN
ihlr-16470	372	5	standards	standard	NOUN
ihlr-16470	372	6	require	require	VERB
ihlr-16470	372	7	manufacturers	manufacturer	NOUN
ihlr-16470	372	8	to	to	PART
ihlr-16470	372	9	explain	explain	VERB
ihlr-16470	372	10	why	why	SCONJ
ihlr-16470	372	11	a	a	DET
ihlr-16470	372	12	pediatric	pediatric	ADJ
ihlr-16470	372	13	study	study	NOUN
ihlr-16470	372	14	will	will	AUX
ihlr-16470	372	15	not	not	PART
ihlr-16470	372	16	be	be	AUX
ihlr-16470	372	17	conducted	conduct	VERB
ihlr-16470	372	18	as	as	ADP
ihlr-16470	372	19	part	part	NOUN
ihlr-16470	372	20	of	of	ADP
ihlr-16470	372	21	the	the	DET
ihlr-16470	372	22	application	application	NOUN
ihlr-16470	372	23	process	process	NOUN
ihlr-16470	372	24	.	.	PUNCT
ihlr-16470	373	1	114	114	NUM
ihlr-16470	373	2	c.	c.	NOUN
ihlr-16470	373	3	manufacturer	manufacturer	NOUN
ihlr-16470	373	4	vs.	vs.	ADP
ihlr-16470	373	5	prescriber	prescriber	NOUN
ihlr-16470	373	6	liability	liability	NOUN
ihlr-16470	373	7	1	1	NUM
ihlr-16470	373	8	.	.	PUNCT
ihlr-16470	373	9	off	off	ADP
ihlr-16470	373	10	-	-	PUNCT
ihlr-16470	373	11	label	label	NOUN
ihlr-16470	373	12	marketing	marketing	NOUN
ihlr-16470	373	13	there	there	PRON
ihlr-16470	373	14	is	be	VERB
ihlr-16470	373	15	a	a	DET
ihlr-16470	373	16	long	long	ADJ
ihlr-16470	373	17	history	history	NOUN
ihlr-16470	373	18	and	and	CCONJ
ihlr-16470	373	19	tradition	tradition	NOUN
ihlr-16470	373	20	in	in	ADP
ihlr-16470	373	21	the	the	DET
ihlr-16470	373	22	united	united	PROPN
ihlr-16470	373	23	states	states	PROPN
ihlr-16470	373	24	of	of	ADP
ihlr-16470	373	25	restricting	restrict	VERB
ihlr-16470	373	26	the	the	DET
ihlr-16470	373	27	claims	claim	NOUN
ihlr-16470	373	28	manufacturers	manufacturer	NOUN
ihlr-16470	373	29	may	may	AUX
ihlr-16470	373	30	make	make	VERB
ihlr-16470	373	31	about	about	ADP
ihlr-16470	373	32	their	their	PRON
ihlr-16470	373	33	drugs	drug	NOUN
ihlr-16470	373	34	in	in	ADP
ihlr-16470	373	35	advertising	advertising	NOUN
ihlr-16470	373	36	.	.	PUNCT
ihlr-16470	374	1	prior	prior	ADV
ihlr-16470	374	2	to	to	ADP
ihlr-16470	374	3	the	the	DET
ihlr-16470	374	4	1970s	1970	NOUN
ihlr-16470	374	5	,	,	PUNCT
ihlr-16470	374	6	regulations	regulation	NOUN
ihlr-16470	374	7	prevented	prevent	VERB
ihlr-16470	374	8	manufacturers	manufacturer	NOUN
ihlr-16470	374	9	from	from	ADP
ihlr-16470	374	10	marketing	market	VERB
ihlr-16470	374	11	drugs	drug	NOUN
ihlr-16470	374	12	to	to	ADP
ihlr-16470	374	13	the	the	DET
ihlr-16470	374	14	107	107	NUM
ihlr-16470	374	15	.	.	PUNCT
ihlr-16470	375	1	see	see	VERB
ihlr-16470	375	2	i	i	PRON
ihlr-16470	375	3	d.	d.	PROPN
ihlr-16470	375	4	at	at	ADP
ihlr-16470	375	5	277	277	NUM
ihlr-16470	375	6	.	.	PUNCT
ihlr-16470	376	1	108	108	NUM
ihlr-16470	376	2	.	.	PUNCT
ihlr-16470	377	1	i	i	PRON
ihlr-16470	377	2	d.	d.	PROPN
ihlr-16470	377	3	109	109	NUM
ihlr-16470	377	4	.	.	PUNCT
ihlr-16470	378	1	i	i	PRON
ihlr-16470	378	2	d.	d.	PROPN
ihlr-16470	378	3	110	110	NUM
ihlr-16470	378	4	.	.	PUNCT
ihlr-16470	379	1	veronica	veronica	PROPN
ihlr-16470	379	2	henry	henry	PROPN
ihlr-16470	379	3	,	,	PUNCT
ihlr-16470	379	4	off	off	ADP
ihlr-16470	379	5	-	-	PUNCT
ihlr-16470	379	6	label	label	NOUN
ihlr-16470	379	7	prescribing	prescribing	ADJ
ihlr-16470	379	8	legal	legal	ADJ
ihlr-16470	379	9	implications	implication	NOUN
ihlr-16470	379	10	,	,	PUNCT
ihlr-16470	379	11	20	20	NUM
ihlr-16470	379	12	j.	j.	PROPN
ihlr-16470	379	13	legal	legal	ADJ
ihlr-16470	379	14	men	man	NOUN
ihlr-16470	379	15	.	.	PUNCT
ihlr-16470	380	1	365	365	NUM
ihlr-16470	380	2	,	,	PUNCT
ihlr-16470	380	3	380(1999	380(1999	NUM
ihlr-16470	380	4	)	)	PUNCT
ihlr-16470	380	5	.	.	PUNCT
ihlr-16470	381	1	111	111	NUM
ihlr-16470	381	2	.	.	PUNCT
ihlr-16470	382	1	i	i	PRON
ihlr-16470	382	2	d.	d.	PROPN
ihlr-16470	382	3	112	112	NUM
ihlr-16470	382	4	.	.	PUNCT
ihlr-16470	383	1	i	i	PRON
ihlr-16470	383	2	d.	d.	PROPN
ihlr-16470	383	3	113	113	NUM
ihlr-16470	383	4	.	.	PUNCT
ihlr-16470	384	1	ld	ld	PROPN
ihlr-16470	384	2	.	.	PUNCT
ihlr-16470	385	1	these	these	DET
ihlr-16470	385	2	new	new	ADJ
ihlr-16470	385	3	standards	standard	NOUN
ihlr-16470	385	4	allow	allow	VERB
ihlr-16470	385	5	extrapolation	extrapolation	NOUN
ihlr-16470	385	6	from	from	ADP
ihlr-16470	385	7	adult	adult	NOUN
ihlr-16470	385	8	clinical	clinical	ADJ
ihlr-16470	385	9	trials	trial	NOUN
ihlr-16470	385	10	and	and	CCONJ
ihlr-16470	385	11	the	the	DET
ihlr-16470	385	12	use	use	NOUN
ihlr-16470	385	13	of	of	ADP
ihlr-16470	385	14	pediatric	pediatric	ADJ
ihlr-16470	385	15	pharmacokinetics	pharmacokinetic	NOUN
ihlr-16470	385	16	(	(	PUNCT
ihlr-16470	385	17	the	the	DET
ihlr-16470	385	18	study	study	NOUN
ihlr-16470	385	19	of	of	ADP
ihlr-16470	385	20	the	the	DET
ihlr-16470	385	21	process	process	NOUN
ihlr-16470	385	22	by	by	ADP
ihlr-16470	385	23	which	which	PRON
ihlr-16470	385	24	a	a	DET
ihlr-16470	385	25	drug	drug	NOUN
ihlr-16470	385	26	is	be	AUX
ihlr-16470	385	27	absorbed	absorb	VERB
ihlr-16470	385	28	,	,	PUNCT
ihlr-16470	385	29	distributed	distribute	VERB
ihlr-16470	385	30	,	,	PUNCT
ihlr-16470	385	31	metabolized	metabolize	VERB
ihlr-16470	385	32	,	,	PUNCT
ihlr-16470	385	33	and	and	CCONJ
ihlr-16470	385	34	eliminated	eliminate	VERB
ihlr-16470	385	35	from	from	ADP
ihlr-16470	385	36	the	the	DET
ihlr-16470	385	37	body	body	NOUN
ihlr-16470	385	38	)	)	PUNCT
ihlr-16470	385	39	in	in	ADP
ihlr-16470	385	40	formulating	formulate	VERB
ihlr-16470	385	41	pediatric	pediatric	ADJ
ihlr-16470	385	42	use	use	NOUN
ihlr-16470	385	43	guidelines	guideline	NOUN
ihlr-16470	385	44	.	.	PUNCT
ihlr-16470	386	1	114	114	NUM
ihlr-16470	386	2	.	.	PUNCT
ihlr-16470	387	1	ld	ld	PROPN
ihlr-16470	387	2	.	.	PROPN
ihlr-16470	387	3	216	216	NUM
ihlr-16470	387	4	indiana	indiana	PROPN
ihlr-16470	387	5	health	health	PROPN
ihlr-16470	387	6	law	law	NOUN
ihlr-16470	387	7	review	review	NOUN
ihlr-16470	388	1	[	[	X
ihlr-16470	388	2	vol	vol	NOUN
ihlr-16470	388	3	.	.	PUNCT
ihlr-16470	389	1	3:201	3:201	NUM
ihlr-16470	389	2	consuming	consume	VERB
ihlr-16470	389	3	public	public	NOUN
ihlr-16470	389	4	.	.	PUNCT
ihlr-16470	390	1	rather	rather	ADV
ihlr-16470	390	2	,	,	PUNCT
ihlr-16470	390	3	companies	company	NOUN
ihlr-16470	390	4	focused	focus	VERB
ihlr-16470	390	5	advertising	advertising	NOUN
ihlr-16470	390	6	on	on	ADP
ihlr-16470	390	7	the	the	DET
ihlr-16470	390	8	doctors	doctor	NOUN
ihlr-16470	390	9	prescribing	prescribe	VERB
ihlr-16470	390	10	the	the	DET
ihlr-16470	390	11	drugs.115	drugs.115	NOUN
ihlr-16470	390	12	in	in	ADP
ihlr-16470	390	13	the	the	DET
ihlr-16470	390	14	early	early	ADJ
ihlr-16470	390	15	1970s	1970	NOUN
ihlr-16470	390	16	,	,	PUNCT
ihlr-16470	390	17	however	however	ADV
ihlr-16470	390	18	,	,	PUNCT
ihlr-16470	390	19	the	the	DET
ihlr-16470	390	20	restrictions	restriction	NOUN
ihlr-16470	390	21	on	on	ADP
ihlr-16470	390	22	direct	direct	ADJ
ihlr-16470	390	23	promotion	promotion	NOUN
ihlr-16470	390	24	were	be	AUX
ihlr-16470	390	25	lessened	lessen	VERB
ihlr-16470	390	26	for	for	ADP
ihlr-16470	390	27	the	the	DET
ihlr-16470	390	28	narrow	narrow	ADJ
ihlr-16470	390	29	purpose	purpose	NOUN
ihlr-16470	390	30	of	of	ADP
ihlr-16470	390	31	providing	provide	VERB
ihlr-16470	390	32	price	price	NOUN
ihlr-16470	390	33	compari­	compari­	NOUN
ihlr-16470	390	34	sons	son	NOUN
ihlr-16470	390	35	to	to	ADP
ihlr-16470	390	36	consumers	consumer	NOUN
ihlr-16470	390	37	but	but	CCONJ
ihlr-16470	390	38	did	do	AUX
ihlr-16470	390	39	not	not	PART
ihlr-16470	390	40	allow	allow	VERB
ihlr-16470	390	41	advertisements	advertisement	NOUN
ihlr-16470	390	42	to	to	ADP
ihlr-16470	390	43	consumers	consumer	NOUN
ihlr-16470	390	44	to	to	PART
ihlr-16470	390	45	include	include	VERB
ihlr-16470	390	46	any	any	DET
ihlr-16470	390	47	representations	representation	NOUN
ihlr-16470	390	48	of	of	ADP
ihlr-16470	390	49	the	the	DET
ihlr-16470	390	50	drug	drug	NOUN
ihlr-16470	390	51	's	's	PART
ihlr-16470	390	52	safety	safety	NOUN
ihlr-16470	390	53	,	,	PUNCT
ihlr-16470	390	54	effectiveness	effectiveness	NOUN
ihlr-16470	390	55	,	,	PUNCT
ihlr-16470	390	56	or	or	CCONJ
ihlr-16470	390	57	indications.116	indications.116	VERB
ihlr-16470	390	58	in	in	ADP
ihlr-16470	390	59	the	the	DET
ihlr-16470	390	60	mid	mid	ADJ
ihlr-16470	390	61	1980s	1980	NOUN
ihlr-16470	390	62	,	,	PUNCT
ihlr-16470	390	63	the	the	DET
ihlr-16470	390	64	fda	fda	PROPN
ihlr-16470	390	65	lifted	lift	VERB
ihlr-16470	390	66	the	the	DET
ihlr-16470	390	67	advertising	advertising	NOUN
ihlr-16470	390	68	moratorium	moratorium	NOUN
ihlr-16470	390	69	on	on	ADP
ihlr-16470	390	70	safety	safety	NOUN
ihlr-16470	390	71	,	,	PUNCT
ihlr-16470	390	72	effectiveness	effectiveness	NOUN
ihlr-16470	390	73	,	,	PUNCT
ihlr-16470	390	74	and	and	CCONJ
ihlr-16470	390	75	indications	indication	NOUN
ihlr-16470	390	76	,	,	PUNCT
ihlr-16470	390	77	117	117	NUM
ihlr-16470	390	78	and	and	CCONJ
ihlr-16470	390	79	by	by	ADP
ihlr-16470	390	80	the	the	DET
ihlr-16470	390	81	1990s	1990	NOUN
ihlr-16470	390	82	,	,	PUNCT
ihlr-16470	390	83	direct	direct	ADJ
ihlr-16470	390	84	to	to	ADP
ihlr-16470	390	85	consumer	consumer	NOUN
ihlr-16470	390	86	advertising	advertising	NOUN
ihlr-16470	390	87	became	become	VERB
ihlr-16470	390	88	more	more	ADV
ihlr-16470	390	89	commonplace	commonplace	ADJ
ihlr-16470	390	90	.	.	PUNCT
ihlr-16470	391	1	however	however	ADV
ihlr-16470	391	2	,	,	PUNCT
ihlr-16470	391	3	manufacturers	manufacturer	NOUN
ihlr-16470	391	4	are	be	AUX
ihlr-16470	391	5	still	still	ADV
ihlr-16470	391	6	subject	subject	ADJ
ihlr-16470	391	7	to	to	ADP
ihlr-16470	391	8	limitations	limitation	NOUN
ihlr-16470	391	9	on	on	ADP
ihlr-16470	391	10	the	the	DET
ihlr-16470	391	11	claims	claim	NOUN
ihlr-16470	391	12	they	they	PRON
ihlr-16470	391	13	may	may	AUX
ihlr-16470	391	14	make	make	VERB
ihlr-16470	391	15	about	about	ADP
ihlr-16470	391	16	their	their	PRON
ihlr-16470	391	17	drugs	drug	NOUN
ihlr-16470	391	18	.	.	PUNCT
ihlr-16470	392	1	118	118	NUM
ihlr-16470	392	2	of	of	ADP
ihlr-16470	392	3	special	special	ADJ
ihlr-16470	392	4	importance	importance	NOUN
ihlr-16470	392	5	to	to	ADP
ihlr-16470	392	6	the	the	DET
ihlr-16470	392	7	issue	issue	NOUN
ihlr-16470	392	8	of	of	ADP
ihlr-16470	392	9	manufacturer	manufacturer	NOUN
ihlr-16470	392	10	or	or	CCONJ
ihlr-16470	392	11	prescriber	prescriber	NOUN
ihlr-16470	392	12	liability	liability	NOUN
ihlr-16470	392	13	for	for	ADP
ihlr-16470	392	14	off	off	ADP
ihlr-16470	392	15	-	-	PUNCT
ihlr-16470	392	16	label	label	NOUN
ihlr-16470	392	17	use	use	NOUN
ihlr-16470	392	18	of	of	ADP
ihlr-16470	392	19	ssris	ssris	NOUN
ihlr-16470	392	20	in	in	ADP
ihlr-16470	392	21	children	child	NOUN
ihlr-16470	392	22	are	be	AUX
ihlr-16470	392	23	the	the	DET
ihlr-16470	392	24	provisions	provision	NOUN
ihlr-16470	392	25	that	that	PRON
ihlr-16470	392	26	prohibit	prohibit	VERB
ihlr-16470	392	27	manufacturers	manufacturer	NOUN
ihlr-16470	392	28	from	from	ADP
ihlr-16470	392	29	advertising	advertise	VERB
ihlr-16470	392	30	or	or	CCONJ
ihlr-16470	392	31	promoting	promote	VERB
ihlr-16470	392	32	unapproved	unapproved	ADJ
ihlr-16470	392	33	uses	use	NOUN
ihlr-16470	392	34	for	for	ADP
ihlr-16470	392	35	their	their	PRON
ihlr-16470	392	36	drugs	drug	NOUN
ihlr-16470	392	37	,	,	PUNCT
ihlr-16470	392	38	or	or	CCONJ
ihlr-16470	392	39	including	include	VERB
ihlr-16470	392	40	instructions	instruction	NOUN
ihlr-16470	392	41	for	for	ADP
ihlr-16470	392	42	off­	off­	NOUN
ihlr-16470	392	43	label	label	NOUN
ihlr-16470	392	44	uses	use	VERB
ihlr-16470	392	45	in	in	ADP
ihlr-16470	392	46	the	the	DET
ihlr-16470	392	47	drug	drug	NOUN
ihlr-16470	392	48	labels.119	labels.119	NOUN
ihlr-16470	392	49	these	these	DET
ihlr-16470	392	50	provisions	provision	NOUN
ihlr-16470	392	51	are	be	AUX
ihlr-16470	392	52	important	important	ADJ
ihlr-16470	392	53	because	because	SCONJ
ihlr-16470	392	54	they	they	PRON
ihlr-16470	392	55	115	115	NUM
ihlr-16470	392	56	.	.	PUNCT
ihlr-16470	393	1	see	see	VERB
ihlr-16470	393	2	peter	peter	PROPN
ihlr-16470	393	3	barton	barton	PROPN
ihlr-16470	393	4	hurr	hurr	PROPN
ihlr-16470	393	5	&	&	CCONJ
ihlr-16470	393	6	richard	richard	PROPN
ihlr-16470	393	7	a.	a.	PROPN
ihlr-16470	393	8	melull	melull	PROPN
ihlr-16470	393	9	,	,	PUNCT
ihlr-16470	393	10	food	food	NOUN
ihlr-16470	393	11	&	&	CCONJ
ihlr-16470	393	12	drug	drug	PROPN
ihlr-16470	393	13	law	law	NOUN
ihlr-16470	393	14	:	:	PUNCT
ihlr-16470	393	15	cases	case	NOUN
ihlr-16470	393	16	and	and	CCONJ
ihlr-16470	393	17	materjals	materjal	NOUN
ihlr-16470	393	18	465	465	NUM
ihlr-16470	393	19	(	(	PUNCT
ihlr-16470	393	20	2d	2d	NUM
ihlr-16470	393	21	ed	ed	NOUN
ihlr-16470	393	22	.	.	PROPN
ihlr-16470	393	23	1991	1991	NUM
ihlr-16470	393	24	)	)	PUNCT
ihlr-16470	393	25	.	.	PUNCT
ihlr-16470	394	1	116	116	NUM
ihlr-16470	394	2	.	.	PUNCT
ihlr-16470	394	3	!	!	PUNCT
ihlr-16470	395	1	d.	d.	PROPN
ihlr-16470	395	2	117	117	NUM
ihlr-16470	395	3	.	.	PUNCT
ihlr-16470	396	1	i	i	PRON
ihlr-16470	396	2	d.	d.	PROPN
ihlr-16470	396	3	118	118	NUM
ihlr-16470	396	4	.	.	PUNCT
ihlr-16470	397	1	advertising	advertising	NOUN
ihlr-16470	397	2	claims	claim	NOUN
ihlr-16470	397	3	by	by	ADP
ihlr-16470	397	4	manufacturers	manufacturer	NOUN
ihlr-16470	397	5	are	be	AUX
ihlr-16470	397	6	subject	subject	ADJ
ihlr-16470	397	7	to	to	ADP
ihlr-16470	397	8	21	21	NUM
ihlr-16470	397	9	c.f.r	c.f.r	NOUN
ihlr-16470	397	10	.	.	PUNCT
ihlr-16470	398	1	§	§	PROPN
ihlr-16470	398	2	202.1(e)(4	202.1(e)(4	NUM
ihlr-16470	398	3	)	)	PUNCT
ihlr-16470	398	4	(	(	PUNCT
ihlr-16470	398	5	year	year	NOUN
ihlr-16470	398	6	)	)	PUNCT
ihlr-16470	398	7	,	,	PUNCT
ihlr-16470	398	8	which	which	PRON
ihlr-16470	398	9	provides	provide	VERB
ihlr-16470	398	10	in	in	ADP
ihlr-16470	398	11	part	part	NOUN
ihlr-16470	398	12	:	:	PUNCT
ihlr-16470	398	13	(	(	PUNCT
ihlr-16470	398	14	ii	ii	NOUN
ihlr-16470	398	15	)	)	PUNCT
ihlr-16470	398	16	in	in	ADP
ihlr-16470	398	17	the	the	DET
ihlr-16470	398	18	case	case	NOUN
ihlr-16470	398	19	of	of	ADP
ihlr-16470	398	20	an	an	DET
ihlr-16470	398	21	advertisement	advertisement	NOUN
ihlr-16470	398	22	for	for	ADP
ihlr-16470	398	23	a	a	DET
ihlr-16470	398	24	prescription	prescription	NOUN
ihlr-16470	398	25	drug	drug	NOUN
ihlr-16470	398	26	other	other	ADJ
ihlr-16470	398	27	than	than	ADP
ihlr-16470	398	28	a	a	DET
ihlr-16470	398	29	drug	drug	NOUN
ihlr-16470	398	30	the	the	DET
ihlr-16470	398	31	labeling	labeling	NOUN
ihlr-16470	398	32	of	of	ADP
ihlr-16470	398	33	which	which	PRON
ihlr-16470	398	34	causes	cause	VERB
ihlr-16470	398	35	it	it	PRON
ihlr-16470	398	36	to	to	PART
ihlr-16470	398	37	be	be	AUX
ihlr-16470	398	38	an	an	DET
ihlr-16470	398	39	unapproved	unapproved	ADJ
ihlr-16470	398	40	''	''	PUNCT
ihlr-16470	398	41	new	new	ADJ
ihlr-16470	398	42	drug	drug	NOUN
ihlr-16470	398	43	"	"	PUNCT
ihlr-16470	398	44	and	and	CCONJ
ihlr-16470	398	45	other	other	ADJ
ihlr-16470	398	46	than	than	ADP
ihlr-16470	398	47	drugs	drug	NOUN
ihlr-16470	398	48	covered	cover	VERB
ihlr-16470	398	49	by	by	ADP
ihlr-16470	398	50	paragraph	paragraph	NOUN
ihlr-16470	398	51	(	(	PUNCT
ihlr-16470	398	52	ex	ex	X
ihlr-16470	398	53	4	4	NUM
ihlr-16470	398	54	xi	xi	NOUN
ihlr-16470	398	55	)	)	PUNCT
ihlr-16470	398	56	of	of	ADP
ihlr-16470	398	57	this	this	DET
ihlr-16470	398	58	section	section	NOUN
ihlr-16470	398	59	,	,	PUNCT
ihlr-16470	398	60	an	an	DET
ihlr-16470	398	61	advertisement	advertisement	NOUN
ihlr-16470	398	62	may	may	AUX
ihlr-16470	398	63	recommend	recommend	VERB
ihlr-16470	398	64	and	and	CCONJ
ihlr-16470	398	65	suggest	suggest	VERB
ihlr-16470	398	66	the	the	DET
ihlr-16470	398	67	drug	drug	NOUN
ihlr-16470	398	68	only	only	ADV
ihlr-16470	398	69	for	for	ADP
ihlr-16470	398	70	those	those	DET
ihlr-16470	398	71	uses	use	NOUN
ihlr-16470	398	72	contained	contain	VERB
ihlr-16470	398	73	in	in	ADP
ihlr-16470	398	74	the	the	DET
ihlr-16470	398	75	labeling	labeling	NOUN
ihlr-16470	398	76	thereof	thereof	ADV
ihlr-16470	398	77	:	:	PUNCT
ihlr-16470	399	1	(	(	PUNCT
ihlr-16470	399	2	a	a	X
ihlr-16470	399	3	)	)	PUNCT
ihlr-16470	399	4	for	for	ADP
ihlr-16470	399	5	which	which	PRON
ihlr-16470	399	6	the	the	DET
ihlr-16470	399	7	drug	drug	NOUN
ihlr-16470	399	8	is	be	AUX
ihlr-16470	399	9	generally	generally	ADV
ihlr-16470	399	10	recognized	recognize	VERB
ihlr-16470	399	11	as	as	ADP
ihlr-16470	399	12	safe	safe	ADJ
ihlr-16470	399	13	and	and	CCONJ
ihlr-16470	399	14	effective	effective	ADJ
ihlr-16470	399	15	among	among	ADP
ihlr-16470	399	16	experts	expert	NOUN
ihlr-16470	399	17	qualified	qualify	VERB
ihlr-16470	399	18	by	by	ADP
ihlr-16470	399	19	scientific	scientific	ADJ
ihlr-16470	399	20	training	training	NOUN
ihlr-16470	399	21	and	and	CCONJ
ihlr-16470	399	22	experience	experience	NOUN
ihlr-16470	399	23	to	to	PART
ihlr-16470	399	24	evaluate	evaluate	VERB
ihlr-16470	399	25	the	the	DET
ihlr-16470	399	26	safety	safety	NOUN
ihlr-16470	399	27	and	and	CCONJ
ihlr-16470	399	28	effectiveness	effectiveness	NOUN
ihlr-16470	399	29	of	of	ADP
ihlr-16470	399	30	such	such	ADJ
ihlr-16470	399	31	drugs	drug	NOUN
ihlr-16470	399	32	;	;	PUNCT
ihlr-16470	399	33	or	or	CCONJ
ihlr-16470	399	34	(	(	PUNCT
ihlr-16470	399	35	b	b	NOUN
ihlr-16470	399	36	)	)	PUNCT
ihlr-16470	399	37	for	for	ADP
ihlr-16470	399	38	which	which	PRON
ihlr-16470	399	39	there	there	PRON
ihlr-16470	399	40	exists	exist	VERB
ihlr-16470	399	41	substantial	substantial	ADJ
ihlr-16470	399	42	evidence	evidence	NOUN
ihlr-16470	399	43	of	of	ADP
ihlr-16470	399	44	safety	safety	NOUN
ihlr-16470	399	45	and	and	CCONJ
ihlr-16470	399	46	effectiveness	effectiveness	NOUN
ihlr-16470	399	47	,	,	PUNCT
ihlr-16470	399	48	consisting	consist	VERB
ihlr-16470	399	49	of	of	ADP
ihlr-16470	399	50	adequate	adequate	ADJ
ihlr-16470	399	51	and	and	CCONJ
ihlr-16470	399	52	well	well	ADV
ihlr-16470	399	53	-	-	PUNCT
ihlr-16470	399	54	controlled	control	VERB
ihlr-16470	399	55	investigations	investigation	NOUN
ihlr-16470	399	56	,	,	PUNCT
ihlr-16470	399	57	including	include	VERB
ihlr-16470	399	58	clinical	clinical	ADJ
ihlr-16470	399	59	investigations	investigation	NOUN
ihlr-16470	399	60	(	(	PUNCT
ihlr-16470	399	61	as	as	SCONJ
ihlr-16470	399	62	used	use	VERB
ihlr-16470	399	63	in	in	ADP
ihlr-16470	399	64	this	this	DET
ihlr-16470	399	65	section	section	NOUN
ihlr-16470	399	66	"	"	PUNCT
ihlr-16470	399	67	clinical	clinical	ADJ
ihlr-16470	399	68	investigations	investigation	NOUN
ihlr-16470	399	69	,	,	PUNCT
ihlr-16470	399	70	"	"	PUNCT
ihlr-16470	399	71	"	"	PUNCT
ihlr-16470	399	72	clinical	clinical	ADJ
ihlr-16470	399	73	experience	experience	NOUN
ihlr-16470	399	74	,	,	PUNCT
ihlr-16470	399	75	"	"	PUNCT
ihlr-16470	399	76	and	and	CCONJ
ihlr-16470	399	77	"	"	PUNCT
ihlr-16470	399	78	clinical	clinical	ADJ
ihlr-16470	399	79	significance	significance	NOUN
ihlr-16470	399	80	"	"	PUNCT
ihlr-16470	399	81	mean	mean	NOUN
ihlr-16470	399	82	in	in	ADP
ihlr-16470	399	83	the	the	DET
ihlr-16470	399	84	case	case	NOUN
ihlr-16470	399	85	of	of	ADP
ihlr-16470	399	86	drugs	drug	NOUN
ihlr-16470	399	87	intended	intend	VERB
ihlr-16470	399	88	for	for	ADP
ihlr-16470	399	89	administration	administration	NOUN
ihlr-16470	399	90	to	to	ADP
ihlr-16470	399	91	man	man	NOUN
ihlr-16470	399	92	,	,	PUNCT
ihlr-16470	399	93	investigations	investigation	NOUN
ihlr-16470	399	94	,	,	PUNCT
ihlr-16470	399	95	experience	experience	NOUN
ihlr-16470	399	96	,	,	PUNCT
ihlr-16470	399	97	or	or	CCONJ
ihlr-16470	399	98	significance	significance	NOUN
ihlr-16470	399	99	in	in	ADP
ihlr-16470	399	100	humans	human	NOUN
ihlr-16470	399	101	,	,	PUNCT
ihlr-16470	399	102	and	and	CCONJ
ihlr-16470	399	103	in	in	ADP
ihlr-16470	399	104	the	the	DET
ihlr-16470	399	105	case	case	NOUN
ihlr-16470	399	106	of	of	ADP
ihlr-16470	399	107	drugs	drug	NOUN
ihlr-16470	399	108	intended	intend	VERB
ihlr-16470	399	109	for	for	ADP
ihlr-16470	399	110	administration	administration	NOUN
ihlr-16470	399	111	to	to	ADP
ihlr-16470	399	112	other	other	ADJ
ihlr-16470	399	113	animals	animal	NOUN
ihlr-16470	399	114	,	,	PUNCT
ihlr-16470	399	115	investigations	investigation	NOUN
ihlr-16470	399	116	,	,	PUNCT
ihlr-16470	399	117	experience	experience	NOUN
ihlr-16470	399	118	,	,	PUNCT
ihlr-16470	399	119	or	or	CCONJ
ihlr-16470	399	120	significance	significance	NOUN
ihlr-16470	399	121	in	in	ADP
ihlr-16470	399	122	the	the	DET
ihlr-16470	399	123	specie	specie	NOUN
ihlr-16470	399	124	or	or	CCONJ
ihlr-16470	399	125	species	specie	NOUN
ihlr-16470	399	126	for	for	ADP
ihlr-16470	399	127	which	which	PRON
ihlr-16470	399	128	the	the	DET
ihlr-16470	399	129	drug	drug	NOUN
ihlr-16470	399	130	is	be	AUX
ihlr-16470	399	131	advertised	advertise	VERB
ihlr-16470	399	132	)	)	PUNCT
ihlr-16470	399	133	,	,	PUNCT
ihlr-16470	399	134	by	by	ADP
ihlr-16470	399	135	experts	expert	NOUN
ihlr-16470	399	136	qualified	qualify	VERB
ihlr-16470	399	137	by	by	ADP
ihlr-16470	399	138	scientific	scientific	ADJ
ihlr-16470	399	139	training	training	NOUN
ihlr-16470	399	140	and	and	CCONJ
ihlr-16470	399	141	experience	experience	NOUN
ihlr-16470	399	142	to	to	PART
ihlr-16470	399	143	evaluate	evaluate	VERB
ihlr-16470	399	144	the	the	DET
ihlr-16470	399	145	safety	safety	NOUN
ihlr-16470	399	146	and	and	CCONJ
ihlr-16470	399	147	effectiveness	effectiveness	NOUN
ihlr-16470	399	148	of	of	ADP
ihlr-16470	399	149	the	the	DET
ihlr-16470	399	150	drug	drug	NOUN
ihlr-16470	399	151	involved	involve	VERB
ihlr-16470	399	152	,	,	PUNCT
ihlr-16470	399	153	on	on	ADP
ihlr-16470	399	154	the	the	DET
ihlr-16470	399	155	basis	basis	NOUN
ihlr-16470	399	156	of	of	ADP
ihlr-16470	399	157	which	which	PRON
ihlr-16470	399	158	it	it	PRON
ihlr-16470	399	159	can	can	AUX
ihlr-16470	399	160	fairly	fairly	ADV
ihlr-16470	399	161	and	and	CCONJ
ihlr-16470	399	162	responsibly	responsibly	ADV
ihlr-16470	399	163	be	be	AUX
ihlr-16470	399	164	concluded	conclude	VERB
ihlr-16470	399	165	by	by	ADP
ihlr-16470	399	166	such	such	ADJ
ihlr-16470	399	167	experts	expert	NOUN
ihlr-16470	399	168	that	that	SCONJ
ihlr-16470	399	169	the	the	DET
ihlr-16470	399	170	drug	drug	NOUN
ihlr-16470	399	171	is	be	AUX
ihlr-16470	399	172	safe	safe	ADJ
ihlr-16470	399	173	and	and	CCONJ
ihlr-16470	399	174	effective	effective	ADJ
ihlr-16470	399	175	for	for	ADP
ihlr-16470	399	176	such	such	ADJ
ihlr-16470	399	177	uses	use	NOUN
ihlr-16470	399	178	;	;	PUNCT
ihlr-16470	399	179	or	or	CCONJ
ihlr-16470	399	180	(	(	PUNCT
ihlr-16470	399	181	c	c	NOUN
ihlr-16470	399	182	)	)	PUNCT
ihlr-16470	399	183	for	for	ADP
ihlr-16470	399	184	which	which	PRON
ihlr-16470	399	185	there	there	PRON
ihlr-16470	399	186	exists	exist	VERB
ihlr-16470	399	187	substantial	substantial	ADJ
ihlr-16470	399	188	clinical	clinical	ADJ
ihlr-16470	399	189	experience	experience	NOUN
ihlr-16470	399	190	(	(	PUNCT
ihlr-16470	399	191	as	as	SCONJ
ihlr-16470	399	192	used	use	VERB
ihlr-16470	399	193	in	in	ADP
ihlr-16470	399	194	this	this	DET
ihlr-16470	399	195	section	section	NOUN
ihlr-16470	399	196	this	this	PRON
ihlr-16470	399	197	means	mean	VERB
ihlr-16470	399	198	substantial	substantial	ADJ
ihlr-16470	399	199	clinical	clinical	ADJ
ihlr-16470	399	200	experience	experience	NOUN
ihlr-16470	399	201	adequately	adequately	ADV
ihlr-16470	399	202	documented	document	VERB
ihlr-16470	399	203	in	in	ADP
ihlr-16470	399	204	medical	medical	ADJ
ihlr-16470	399	205	literature	literature	NOUN
ihlr-16470	399	206	or	or	CCONJ
ihlr-16470	399	207	by	by	ADP
ihlr-16470	399	208	other	other	ADJ
ihlr-16470	399	209	data	datum	NOUN
ihlr-16470	399	210	(	(	PUNCT
ihlr-16470	399	211	to	to	PART
ihlr-16470	399	212	be	be	AUX
ihlr-16470	399	213	supplied	supply	VERB
ihlr-16470	399	214	to	to	ADP
ihlr-16470	399	215	the	the	DET
ihlr-16470	399	216	food	food	NOUN
ihlr-16470	399	217	and	and	CCONJ
ihlr-16470	399	218	drug	drug	NOUN
ihlr-16470	399	219	administration	administration	NOUN
ihlr-16470	399	220	,	,	PUNCT
ihlr-16470	399	221	if	if	SCONJ
ihlr-16470	399	222	requested	request	VERB
ihlr-16470	399	223	)	)	PUNCT
ihlr-16470	399	224	)	)	PUNCT
ihlr-16470	399	225	,	,	PUNCT
ihlr-16470	399	226	on	on	ADP
ihlr-16470	399	227	the	the	DET
ihlr-16470	399	228	basis	basis	NOUN
ihlr-16470	399	229	of	of	ADP
ihlr-16470	399	230	which	which	PRON
ihlr-16470	399	231	it	it	PRON
ihlr-16470	399	232	can	can	AUX
ihlr-16470	399	233	fairly	fairly	ADV
ihlr-16470	399	234	and	and	CCONJ
ihlr-16470	399	235	responsibly	responsibly	ADV
ihlr-16470	399	236	be	be	AUX
ihlr-16470	399	237	concluded	conclude	VERB
ihlr-16470	399	238	by	by	ADP
ihlr-16470	399	239	qualified	qualified	ADJ
ihlr-16470	399	240	experts	expert	NOUN
ihlr-16470	399	241	that	that	PRON
ihlr-16470	399	242	the	the	DET
ihlr-16470	399	243	drug	drug	NOUN
ihlr-16470	399	244	is	be	AUX
ihlr-16470	399	245	safe	safe	ADJ
ihlr-16470	399	246	and	and	CCONJ
ihlr-16470	399	247	effective	effective	ADJ
ihlr-16470	399	248	for	for	ADP
ihlr-16470	399	249	such	such	ADJ
ihlr-16470	399	250	uses	use	NOUN
ihlr-16470	399	251	;	;	PUNCT
ihlr-16470	399	252	or	or	CCONJ
ihlr-16470	399	253	(	(	PUNCT
ihlr-16470	399	254	d	d	NOUN
ihlr-16470	399	255	)	)	PUNCT
ihlr-16470	399	256	for	for	ADP
ihlr-16470	399	257	which	which	PRON
ihlr-16470	399	258	safety	safety	NOUN
ihlr-16470	399	259	is	be	AUX
ihlr-16470	399	260	supported	support	VERB
ihlr-16470	399	261	under	under	ADP
ihlr-16470	399	262	any	any	PRON
ihlr-16470	399	263	of	of	ADP
ihlr-16470	399	264	the	the	DET
ihlr-16470	399	265	preceding	precede	VERB
ihlr-16470	399	266	clauses	clause	NOUN
ihlr-16470	399	267	in	in	ADP
ihlr-16470	399	268	paragraphs(ex4xiiixa	paragraphs(ex4xiiixa	PROPN
ihlr-16470	399	269	)	)	PUNCT
ihlr-16470	399	270	,	,	PUNCT
ihlr-16470	399	271	(	(	PUNCT
ihlr-16470	399	272	b	b	NOUN
ihlr-16470	399	273	)	)	PUNCT
ihlr-16470	399	274	,	,	PUNCT
ihlr-16470	399	275	and	and	CCONJ
ihlr-16470	399	276	(	(	PUNCT
ihlr-16470	399	277	c	c	NOUN
ihlr-16470	399	278	)	)	PUNCT
ihlr-16470	399	279	of	of	ADP
ihlr-16470	399	280	this	this	DET
ihlr-16470	399	281	section	section	NOUN
ihlr-16470	399	282	and	and	CCONJ
ihlr-16470	399	283	effectiveness	effectiveness	NOUN
ihlr-16470	399	284	is	be	AUX
ihlr-16470	399	285	supported	support	VERB
ihlr-16470	399	286	under	under	ADP
ihlr-16470	399	287	any	any	DET
ihlr-16470	399	288	other	other	ADJ
ihlr-16470	399	289	of	of	ADP
ihlr-16470	399	290	such	such	ADJ
ihlr-16470	399	291	clauses	clause	NOUN
ihlr-16470	399	292	.	.	PUNCT
ihlr-16470	400	1	119	119	NUM
ihlr-16470	400	2	.	.	X
ihlr-16470	400	3	stoffelmayr	stoffelmayr	PROPN
ihlr-16470	400	4	,	,	PUNCT
ihlr-16470	400	5	supra	supra	PROPN
ihlr-16470	400	6	note	note	NOUN
ihlr-16470	400	7	101	101	NUM
ihlr-16470	400	8	,	,	PUNCT
ihlr-16470	400	9	at279	at279	NOUN
ihlr-16470	400	10	.	.	PUNCT
ihlr-16470	400	11	2006	2006	NUM
ihlr-16470	400	12	]	]	PUNCT
ihlr-16470	400	13	anti	anti	NOUN
ihlr-16470	400	14	-	-	NOUN
ihlr-16470	400	15	depressants	depressant	NOUN
ihlr-16470	400	16	and	and	CCONJ
ihlr-16470	400	17	children	child	NOUN
ihlr-16470	400	18	217	217	NUM
ihlr-16470	400	19	serve	serve	VERB
ihlr-16470	400	20	as	as	ADP
ihlr-16470	400	21	a	a	DET
ihlr-16470	400	22	basis	basis	NOUN
ihlr-16470	400	23	for	for	ADP
ihlr-16470	400	24	shifting	shift	VERB
ihlr-16470	400	25	liability	liability	NOUN
ihlr-16470	400	26	of	of	ADP
ihlr-16470	400	27	off	off	ADP
ihlr-16470	400	28	-	-	PUNCT
ihlr-16470	400	29	label	label	NOUN
ihlr-16470	400	30	uses	use	NOUN
ihlr-16470	400	31	from	from	ADP
ihlr-16470	400	32	the	the	DET
ihlr-16470	400	33	prescribing	prescribe	VERB
ihlr-16470	400	34	physician	physician	NOUN
ihlr-16470	400	35	to	to	ADP
ihlr-16470	400	36	the	the	DET
ihlr-16470	400	37	manufacturer.120	manufacturer.120	NOUN
ihlr-16470	400	38	despite	despite	SCONJ
ihlr-16470	400	39	the	the	DET
ihlr-16470	400	40	fda	fda	PROPN
ihlr-16470	400	41	's	's	PART
ihlr-16470	400	42	safeguards	safeguard	NOUN
ihlr-16470	400	43	,	,	PUNCT
ihlr-16470	400	44	drug	drug	NOUN
ihlr-16470	400	45	companies	company	NOUN
ihlr-16470	400	46	have	have	AUX
ihlr-16470	400	47	become	become	VERB
ihlr-16470	400	48	very	very	ADV
ihlr-16470	400	49	successful	successful	ADJ
ihlr-16470	400	50	in	in	ADP
ihlr-16470	400	51	indirectly	indirectly	ADV
ihlr-16470	400	52	promoting	promote	VERB
ihlr-16470	400	53	off	off	ADP
ihlr-16470	400	54	-	-	PUNCT
ihlr-16470	400	55	label	label	NOUN
ihlr-16470	400	56	uses.121	uses.121	NOUN
ihlr-16470	400	57	generally	generally	ADV
ihlr-16470	400	58	,	,	PUNCT
ihlr-16470	400	59	methods	method	NOUN
ihlr-16470	400	60	employed	employ	VERB
ihlr-16470	400	61	by	by	ADP
ihlr-16470	400	62	the	the	DET
ihlr-16470	400	63	drug	drug	NOUN
ihlr-16470	400	64	companies	company	NOUN
ihlr-16470	400	65	to	to	PART
ihlr-16470	400	66	promote	promote	VERB
ihlr-16470	400	67	off	off	ADP
ihlr-16470	400	68	-	-	PUNCT
ihlr-16470	400	69	label	label	NOUN
ihlr-16470	400	70	uses	use	NOUN
ihlr-16470	400	71	are	be	AUX
ihlr-16470	400	72	well	well	ADV
ihlr-16470	400	73	within	within	ADP
ihlr-16470	400	74	what	what	PRON
ihlr-16470	400	75	the	the	DET
ihlr-16470	400	76	fda	fda	PROPN
ihlr-16470	400	77	allows	allow	VERB
ihlr-16470	400	78	,	,	PUNCT
ihlr-16470	400	79	although	although	SCONJ
ihlr-16470	400	80	some	some	DET
ihlr-16470	400	81	methods	method	NOUN
ihlr-16470	400	82	are	be	AUX
ihlr-16470	400	83	considered	consider	VERB
ihlr-16470	400	84	less	less	ADJ
ihlr-16470	400	85	than	than	ADP
ihlr-16470	400	86	ethical	ethical	ADJ
ihlr-16470	400	87	.	.	PUNCT
ihlr-16470	401	1	some	some	PRON
ihlr-16470	401	2	of	of	ADP
ihlr-16470	401	3	the	the	DET
ihlr-16470	401	4	most	most	ADV
ihlr-16470	401	5	common	common	ADJ
ihlr-16470	401	6	methods	method	NOUN
ihlr-16470	401	7	of	of	ADP
ihlr-16470	401	8	promoting	promote	VERB
ihlr-16470	401	9	off	off	ADP
ihlr-16470	401	10	-	-	PUNCT
ihlr-16470	401	11	label	label	NOUN
ihlr-16470	401	12	use	use	NOUN
ihlr-16470	401	13	include	include	VERB
ihlr-16470	401	14	:	:	PUNCT
ihlr-16470	401	15	"	"	PUNCT
ihlr-16470	401	16	funding	fund	VERB
ihlr-16470	401	17	research	research	NOUN
ihlr-16470	401	18	into	into	ADP
ihlr-16470	401	19	off	off	ADP
ihlr-16470	401	20	-	-	PUNCT
ihlr-16470	401	21	label	label	NOUN
ihlr-16470	401	22	drug	drug	NOUN
ihlr-16470	401	23	uses	use	NOUN
ihlr-16470	401	24	,	,	PUNCT
ihlr-16470	401	25	sponsoring	sponsor	VERB
ihlr-16470	401	26	continuing	continue	VERB
ihlr-16470	401	27	education	education	NOUN
ihlr-16470	401	28	programs	program	NOUN
ihlr-16470	401	29	and	and	CCONJ
ihlr-16470	401	30	symposia	symposia	NOUN
ihlr-16470	401	31	in	in	ADP
ihlr-16470	401	32	which	which	PRON
ihlr-16470	401	33	ostensibly	ostensibly	ADV
ihlr-16470	401	34	independent	independent	ADJ
ihlr-16470	401	35	researchers	researcher	NOUN
ihlr-16470	401	36	discuss	discuss	VERB
ihlr-16470	401	37	off	off	ADP
ihlr-16470	401	38	-	-	PUNCT
ihlr-16470	401	39	label	label	NOUN
ihlr-16470	401	40	uses	use	NOUN
ihlr-16470	401	41	,	,	PUNCT
ihlr-16470	401	42	distributing	distribute	VERB
ihlr-16470	401	43	reprints	reprint	NOUN
ihlr-16470	401	44	of	of	ADP
ihlr-16470	401	45	journal	journal	ADJ
ihlr-16470	401	46	articles	article	NOUN
ihlr-16470	401	47	on	on	ADP
ihlr-16470	401	48	off	off	ADP
ihlr-16470	401	49	-	-	PUNCT
ihlr-16470	401	50	label	label	NOUN
ihlr-16470	401	51	uses	use	NOUN
ihlr-16470	401	52	,	,	PUNCT
ihlr-16470	401	53	and	and	CCONJ
ihlr-16470	401	54	purchasing	purchase	VERB
ihlr-16470	401	55	special	special	ADJ
ihlr-16470	401	56	journal	journal	NOUN
ihlr-16470	401	57	supplements	supplement	NOUN
ihlr-16470	401	58	that	that	PRON
ihlr-16470	401	59	feature	feature	VERB
ihlr-16470	401	60	articles	article	NOUN
ihlr-16470	401	61	about	about	ADP
ihlr-16470	401	62	off	off	ADP
ihlr-16470	401	63	-	-	PUNCT
ihlr-16470	401	64	label	label	NOUN
ihlr-16470	401	65	uses	use	NOUN
ihlr-16470	401	66	.	.	PUNCT
ihlr-16470	402	1	"122	"122	PROPN
ihlr-16470	402	2	all	all	PRON
ihlr-16470	402	3	of	of	ADP
ihlr-16470	402	4	these	these	DET
ihlr-16470	402	5	methods	method	NOUN
ihlr-16470	402	6	are	be	AUX
ihlr-16470	402	7	permitted	permit	VERB
ihlr-16470	402	8	by	by	ADP
ihlr-16470	402	9	the	the	DET
ihlr-16470	402	10	fda	fda	PROPN
ihlr-16470	402	11	as	as	ADV
ihlr-16470	402	12	long	long	ADV
ihlr-16470	402	13	as	as	SCONJ
ihlr-16470	402	14	the	the	DET
ihlr-16470	402	15	drug	drug	NOUN
ihlr-16470	402	16	manufacturers	manufacturer	NOUN
ihlr-16470	402	17	follow	follow	VERB
ihlr-16470	402	18	rules	rule	NOUN
ihlr-16470	402	19	designed	design	VERB
ihlr-16470	402	20	to	to	PART
ihlr-16470	402	21	ensure	ensure	VERB
ihlr-16470	402	22	that	that	SCONJ
ihlr-16470	402	23	the	the	DET
ihlr-16470	402	24	research	research	NOUN
ihlr-16470	402	25	remains	remain	VERB
ihlr-16470	402	26	objective.123	objective.123	PROPN
ihlr-16470	402	27	other	other	ADJ
ihlr-16470	402	28	restrictions	restriction	NOUN
ihlr-16470	402	29	upon	upon	SCONJ
ihlr-16470	402	30	drug	drug	NOUN
ihlr-16470	402	31	manufacturers	manufacturer	NOUN
ihlr-16470	402	32	include	include	VERB
ihlr-16470	402	33	regulations	regulation	NOUN
ihlr-16470	402	34	regarding	regard	VERB
ihlr-16470	402	35	shipment	shipment	NOUN
ihlr-16470	402	36	of	of	ADP
ihlr-16470	402	37	drugs	drug	NOUN
ihlr-16470	402	38	.	.	PUNCT
ihlr-16470	403	1	it	it	PRON
ihlr-16470	403	2	is	be	AUX
ihlr-16470	403	3	illegal	illegal	ADJ
ihlr-16470	403	4	under	under	ADP
ihlr-16470	403	5	federal	federal	ADJ
ihlr-16470	403	6	law	law	NOUN
ihlr-16470	403	7	to	to	PART
ihlr-16470	403	8	ship	ship	VERB
ihlr-16470	403	9	a	a	DET
ihlr-16470	403	10	new	new	ADJ
ihlr-16470	403	11	drug	drug	NOUN
ihlr-16470	403	12	interstate	interstate	NOUN
ihlr-16470	403	13	unless	unless	SCONJ
ihlr-16470	403	14	it	it	PRON
ihlr-16470	403	15	is	be	AUX
ihlr-16470	403	16	the	the	DET
ihlr-16470	403	17	subject	subject	NOUN
ihlr-16470	403	18	of	of	ADP
ihlr-16470	403	19	an	an	DET
ihlr-16470	403	20	approved	approve	VERB
ihlr-16470	403	21	new	new	ADJ
ihlr-16470	403	22	drug	drug	NOUN
ihlr-16470	403	23	application.124	application.124	PROPN
ihlr-16470	403	24	federal	federal	ADJ
ihlr-16470	403	25	law	law	NOUN
ihlr-16470	403	26	defines	define	VERB
ihlr-16470	403	27	a	a	DET
ihlr-16470	403	28	new	new	ADJ
ihlr-16470	403	29	drug	drug	NOUN
ihlr-16470	403	30	as	as	SCONJ
ihlr-16470	403	31	:	:	PUNCT
ihlr-16470	403	32	"	"	PUNCT
ihlr-16470	403	33	[	[	X
ihlr-16470	403	34	a]ny	a]ny	X
ihlr-16470	403	35	drug	drug	NOUN
ihlr-16470	403	36	...	...	PUNCT
ihlr-16470	403	37	not	not	PART
ihlr-16470	403	38	generally	generally	ADV
ihlr-16470	403	39	recognized	recognize	VERB
ihlr-16470	403	40	,	,	PUNCT
ihlr-16470	403	41	...	...	PUNCT
ihlr-16470	403	42	as	as	ADP
ihlr-16470	403	43	safe	safe	ADJ
ihlr-16470	403	44	and	and	CCONJ
ihlr-16470	403	45	effective	effective	ADJ
ihlr-16470	403	46	for	for	ADP
ihlr-16470	403	47	use	use	NOUN
ihlr-16470	403	48	under	under	ADP
ihlr-16470	403	49	the	the	DET
ihlr-16470	403	50	condition	condition	NOUN
ihlr-16470	403	51	prescribed	prescribe	VERB
ihlr-16470	403	52	,	,	PUNCT
ihlr-16470	403	53	recommended	recommend	VERB
ihlr-16470	403	54	,	,	PUNCT
ihlr-16470	403	55	or	or	CCONJ
ihlr-16470	403	56	suggested	suggest	VERB
ihlr-16470	403	57	in	in	ADP
ihlr-16470	403	58	the	the	DET
ihlr-16470	403	59	labeling	labeling	NOUN
ihlr-16470	403	60	....	....	PUNCT
ihlr-16470	404	1	"	"	PUNCT
ihlr-16470	404	2	125	125	NUM
ihlr-16470	404	3	therefore	therefore	ADV
ihlr-16470	404	4	,	,	PUNCT
ihlr-16470	404	5	manufacturers	manufacturer	NOUN
ihlr-16470	404	6	face	face	VERB
ihlr-16470	404	7	liability	liability	NOUN
ihlr-16470	404	8	if	if	SCONJ
ihlr-16470	404	9	a	a	DET
ihlr-16470	404	10	drug	drug	NOUN
ihlr-16470	404	11	is	be	AUX
ihlr-16470	404	12	shipped	ship	VERB
ihlr-16470	404	13	containing	contain	VERB
ihlr-16470	404	14	information	information	NOUN
ihlr-16470	404	15	regarding	regard	VERB
ihlr-16470	404	16	off	off	ADP
ihlr-16470	404	17	-	-	PUNCT
ihlr-16470	404	18	label	label	NOUN
ihlr-16470	404	19	uses	use	NOUN
ihlr-16470	404	20	.	.	PUNCT
ihlr-16470	405	1	126	126	NUM
ihlr-16470	405	2	it	it	PRON
ihlr-16470	405	3	is	be	AUX
ihlr-16470	405	4	important	important	ADJ
ihlr-16470	405	5	to	to	PART
ihlr-16470	405	6	remember	remember	VERB
ihlr-16470	405	7	that	that	SCONJ
ihlr-16470	405	8	fda	fda	PROPN
ihlr-16470	405	9	approval	approval	NOUN
ihlr-16470	405	10	for	for	ADP
ihlr-16470	405	11	a	a	DET
ihlr-16470	405	12	drug	drug	NOUN
ihlr-16470	405	13	's	's	PART
ihlr-16470	405	14	shipment	shipment	NOUN
ihlr-16470	405	15	is	be	AUX
ihlr-16470	405	16	limited	limit	VERB
ihlr-16470	405	17	to	to	ADP
ihlr-16470	405	18	the	the	DET
ihlr-16470	405	19	intended	intend	VERB
ihlr-16470	405	20	uses	use	NOUN
ihlr-16470	405	21	as	as	SCONJ
ihlr-16470	405	22	approved	approve	VERB
ihlr-16470	405	23	by	by	ADP
ihlr-16470	405	24	the	the	DET
ihlr-16470	405	25	fda	fda	PROPN
ihlr-16470	405	26	.	.	PROPN
ihlr-16470	406	1	127	127	NUM
ihlr-16470	406	2	the	the	DET
ihlr-16470	406	3	intended	intend	VERB
ihlr-16470	406	4	use	use	NOUN
ihlr-16470	406	5	for	for	ADP
ihlr-16470	406	6	a	a	DET
ihlr-16470	406	7	drug	drug	NOUN
ihlr-16470	406	8	is	be	AUX
ihlr-16470	406	9	not	not	PART
ihlr-16470	406	10	limited	limit	VERB
ihlr-16470	406	11	to	to	ADP
ihlr-16470	406	12	the	the	DET
ihlr-16470	406	13	actual	actual	ADJ
ihlr-16470	406	14	label	label	NOUN
ihlr-16470	406	15	on	on	ADP
ihlr-16470	406	16	the	the	DET
ihlr-16470	406	17	packaging	packaging	NOUN
ihlr-16470	406	18	,	,	PUNCT
ihlr-16470	406	19	but	but	CCONJ
ihlr-16470	406	20	includes	include	VERB
ihlr-16470	406	21	any	any	DET
ihlr-16470	406	22	statement	statement	NOUN
ihlr-16470	406	23	in	in	ADP
ihlr-16470	406	24	advertising	advertising	NOUN
ihlr-16470	406	25	,	,	PUNCT
ihlr-16470	406	26	''	''	PUNCT
ihlr-16470	406	27	promotional	promotional	ADJ
ihlr-16470	406	28	material	material	NOUN
ihlr-16470	406	29	,	,	PUNCT
ihlr-16470	406	30	or	or	CCONJ
ihlr-16470	406	31	oral	oral	ADJ
ihlr-16470	406	32	statements	statement	NOUN
ihlr-16470	406	33	by	by	ADP
ihlr-16470	406	34	the	the	DET
ihlr-16470	406	35	manufacture	manufacture	NOUN
ihlr-16470	406	36	or	or	CCONJ
ihlr-16470	406	37	120	120	NUM
ihlr-16470	406	38	.	.	PUNCT
ihlr-16470	407	1	see	see	VERB
ihlr-16470	407	2	richard	richard	PROPN
ihlr-16470	407	3	heafey	heafey	PROPN
ihlr-16470	407	4	&	&	CCONJ
ihlr-16470	407	5	don	don	PROPN
ihlr-16470	407	6	m.	m.	PROPN
ihlr-16470	407	7	kennedy	kennedy	PROPN
ihlr-16470	407	8	,	,	PUNCT
ihlr-16470	407	9	product	product	NOUN
ihlr-16470	407	10	liabiuty	liabiuty	NOUN
ihlr-16470	407	11	:	:	PUNCT
ihlr-16470	407	12	winning	win	VERB
ihlr-16470	407	13	strategies	strategy	NOUN
ihlr-16470	407	14	and	and	CCONJ
ihlr-16470	407	15	techniques	technique	NOUN
ihlr-16470	407	16	(	(	PUNCT
ihlr-16470	407	17	8th	8th	ADJ
ihlr-16470	407	18	prtg	prtg	NOUN
ihlr-16470	407	19	.	.	PUNCT
ihlr-16470	408	1	2001	2001	NUM
ihlr-16470	408	2	)	)	PUNCT
ihlr-16470	409	1	(	(	PUNCT
ihlr-16470	409	2	discussing	discuss	VERB
ihlr-16470	409	3	application	application	NOUN
ihlr-16470	409	4	of	of	ADP
ihlr-16470	409	5	the	the	DET
ihlr-16470	409	6	learned	learn	VERB
ihlr-16470	409	7	intermediary	intermediary	ADJ
ihlr-16470	409	8	doctrine	doctrine	NOUN
ihlr-16470	409	9	)	)	PUNCT
ihlr-16470	409	10	.	.	PUNCT
ihlr-16470	410	1	121	121	NUM
ihlr-16470	410	2	.	.	PUNCT
ihlr-16470	410	3	stoffelmayr	stoffelmayr	PROPN
ihlr-16470	410	4	,	,	PUNCT
ihlr-16470	410	5	supra	supra	PROPN
ihlr-16470	410	6	note	note	NOUN
ihlr-16470	410	7	101	101	NUM
ihlr-16470	410	8	,	,	PUNCT
ihlr-16470	410	9	at279	at279	NOUN
ihlr-16470	410	10	-	-	PUNCT
ihlr-16470	410	11	80	80	NUM
ihlr-16470	410	12	.	.	PUNCT
ihlr-16470	411	1	122	122	NUM
ihlr-16470	411	2	.	.	PUNCT
ihlr-16470	412	1	i	i	PRON
ihlr-16470	412	2	d.	d.	PROPN
ihlr-16470	412	3	at	at	ADP
ihlr-16470	412	4	280	280	NUM
ihlr-16470	412	5	.	.	PUNCT
ihlr-16470	412	6	123	123	NUM
ihlr-16470	412	7	.	.	PUNCT
ihlr-16470	413	1	i	i	PRON
ihlr-16470	413	2	d.	d.	PROPN
ihlr-16470	413	3	less	less	ADV
ihlr-16470	413	4	ethical	ethical	ADJ
ihlr-16470	413	5	efforts	effort	NOUN
ihlr-16470	413	6	by	by	ADP
ihlr-16470	413	7	manufacturers	manufacturer	NOUN
ihlr-16470	413	8	to	to	PART
ihlr-16470	413	9	promote	promote	VERB
ihlr-16470	413	10	off	off	ADP
ihlr-16470	413	11	-	-	PUNCT
ihlr-16470	413	12	label	label	NOUN
ihlr-16470	413	13	drug	drug	NOUN
ihlr-16470	413	14	uses	use	NOUN
ihlr-16470	413	15	include	include	VERB
ihlr-16470	413	16	,	,	PUNCT
ihlr-16470	413	17	for	for	ADP
ihlr-16470	413	18	example	example	NOUN
ihlr-16470	413	19	,	,	PUNCT
ihlr-16470	413	20	paying	pay	VERB
ihlr-16470	413	21	physicians	physician	NOUN
ihlr-16470	413	22	to	to	PART
ihlr-16470	413	23	participate	participate	VERB
ihlr-16470	413	24	in	in	ADP
ihlr-16470	413	25	sham	sham	ADJ
ihlr-16470	413	26	"	"	PUNCT
ihlr-16470	413	27	seeding	seed	VERB
ihlr-16470	413	28	trials	trial	NOUN
ihlr-16470	413	29	,	,	PUNCT
ihlr-16470	413	30	"	"	PUNCT
ihlr-16470	413	31	in	in	ADP
ihlr-16470	413	32	which	which	PRON
ihlr-16470	413	33	physicians	physician	NOUN
ihlr-16470	413	34	prescribe	prescribe	VERB
ihlr-16470	413	35	off	off	ADP
ihlr-16470	413	36	-	-	PUNCT
ihlr-16470	413	37	label	label	NOUN
ihlr-16470	413	38	drug	drug	NOUN
ihlr-16470	413	39	therapies	therapy	NOUN
ihlr-16470	413	40	as	as	ADP
ihlr-16470	413	41	part	part	NOUN
ihlr-16470	413	42	of	of	ADP
ihlr-16470	413	43	supposed	suppose	VERB
ihlr-16470	413	44	scientific	scientific	ADJ
ihlr-16470	413	45	studies	study	NOUN
ihlr-16470	413	46	that	that	PRON
ihlr-16470	413	47	in	in	ADP
ihlr-16470	413	48	reality	reality	NOUN
ihlr-16470	413	49	serve	serve	VERB
ihlr-16470	413	50	only	only	ADV
ihlr-16470	413	51	to	to	PART
ihlr-16470	413	52	introduce	introduce	VERB
ihlr-16470	413	53	participating	participate	VERB
ihlr-16470	413	54	physicians	physician	NOUN
ihlr-16470	413	55	and	and	CCONJ
ihlr-16470	413	56	their	their	PRON
ihlr-16470	413	57	colleagues	colleague	NOUN
ihlr-16470	413	58	to	to	ADP
ihlr-16470	413	59	the	the	DET
ihlr-16470	413	60	off	off	ADP
ihlr-16470	413	61	-	-	PUNCT
ihlr-16470	413	62	label	label	NOUN
ihlr-16470	413	63	uses	use	NOUN
ihlr-16470	413	64	.	.	PUNCT
ihlr-16470	414	1	124	124	NUM
ihlr-16470	414	2	.	.	PUNCT
ihlr-16470	414	3	21	21	NUM
ihlr-16470	415	1	u.s.c.a	u.s.c.a	PROPN
ihlr-16470	415	2	.	.	PUNCT
ihlr-16470	415	3	§	§	PROPN
ihlr-16470	415	4	355(a	355(a	PROPN
ihlr-16470	415	5	)	)	PUNCT
ihlr-16470	415	6	(	(	PUNCT
ihlr-16470	415	7	west	west	NOUN
ihlr-16470	415	8	2004	2004	NUM
ihlr-16470	415	9	)	)	PUNCT
ihlr-16470	415	10	;	;	PUNCT
ihlr-16470	415	11	marsha	marsha	PROPN
ihlr-16470	415	12	cohen	cohen	PROPN
ihlr-16470	415	13	,	,	PUNCT
ihlr-16470	415	14	commentary	commentary	NOUN
ihlr-16470	415	15	:	:	PUNCT
ihlr-16470	415	16	can	can	AUX
ihlr-16470	415	17	we	we	PRON
ihlr-16470	415	18	talk	talk	VERB
ihlr-16470	415	19	?	?	PUNCT
ihlr-16470	416	1	about	about	ADP
ihlr-16470	416	2	food	food	NOUN
ihlr-16470	416	3	and	and	CCONJ
ihlr-16470	416	4	drug	drug	NOUN
ihlr-16470	416	5	regulation	regulation	NOUN
ihlr-16470	416	6	and	and	CCONJ
ihlr-16470	416	7	the	the	DET
ihlr-16470	416	8	first	first	ADJ
ihlr-16470	416	9	amendment	amendment	NOUN
ihlr-16470	416	10	,	,	PUNCT
ihlr-16470	416	11	58	58	NUM
ihlr-16470	416	12	food	food	NOUN
ihlr-16470	416	13	&	&	CCONJ
ihlr-16470	416	14	drug	drug	PROPN
ihlr-16470	416	15	l.j	l.j	PROPN
ihlr-16470	416	16	.	.	PROPN
ihlr-16470	416	17	741	741	NUM
ihlr-16470	416	18	,	,	PUNCT
ihlr-16470	416	19	745	745	NUM
ihlr-16470	416	20	(	(	PUNCT
ihlr-16470	416	21	2003	2003	NUM
ihlr-16470	416	22	)	)	PUNCT
ihlr-16470	416	23	.	.	PUNCT
ihlr-16470	417	1	125	125	NUM
ihlr-16470	417	2	.	.	NUM
ihlr-16470	417	3	21	21	NUM
ihlr-16470	418	1	u.s.c.a	u.s.c.a	PROPN
ihlr-16470	418	2	§	§	PROPN
ihlr-16470	418	3	321(p)(1	321(p)(1	NUM
ihlr-16470	418	4	)	)	PUNCT
ihlr-16470	418	5	(	(	PUNCT
ihlr-16470	418	6	west	west	NOUN
ihlr-16470	418	7	2004	2004	NUM
ihlr-16470	418	8	)	)	PUNCT
ihlr-16470	418	9	.	.	PUNCT
ihlr-16470	419	1	126	126	NUM
ihlr-16470	419	2	.	.	X
ihlr-16470	420	1	cohen	cohen	PROPN
ihlr-16470	420	2	,	,	PUNCT
ihlr-16470	420	3	supra	supra	PROPN
ihlr-16470	420	4	note	note	PROPN
ihlr-16470	420	5	124	124	NUM
ihlr-16470	420	6	,	,	PUNCT
ihlr-16470	420	7	at	at	ADP
ihlr-16470	420	8	745	745	NUM
ihlr-16470	420	9	.	.	PUNCT
ihlr-16470	421	1	stating	state	VERB
ihlr-16470	421	2	:	:	PUNCT
ihlr-16470	421	3	it	it	PRON
ihlr-16470	421	4	is	be	AUX
ihlr-16470	421	5	undisputed	undisputed	ADJ
ihlr-16470	421	6	that	that	SCONJ
ihlr-16470	421	7	if	if	SCONJ
ihlr-16470	421	8	compound	compound	NOUN
ihlr-16470	421	9	x	x	PUNCT
ihlr-16470	421	10	has	have	AUX
ihlr-16470	421	11	been	be	AUX
ihlr-16470	421	12	approved	approve	VERB
ihlr-16470	421	13	in	in	ADP
ihlr-16470	421	14	a	a	DET
ihlr-16470	421	15	100	100	NUM
ihlr-16470	421	16	mg	mg	NOUN
ihlr-16470	421	17	.	.	PUNCT
ihlr-16470	422	1	dose	dose	PROPN
ihlr-16470	422	2	,	,	PUNCT
ihlr-16470	422	3	four	four	NUM
ihlr-16470	422	4	times	time	NOUN
ihlr-16470	422	5	a	a	DET
ihlr-16470	422	6	day	day	NOUN
ihlr-16470	422	7	,	,	PUNCT
ihlr-16470	422	8	for	for	ADP
ihlr-16470	422	9	headache	headache	NOUN
ihlr-16470	422	10	,	,	PUNCT
ihlr-16470	422	11	it	it	PRON
ihlr-16470	422	12	is	be	AUX
ihlr-16470	422	13	illegal	illegal	ADJ
ihlr-16470	422	14	to	to	PART
ihlr-16470	422	15	ship	ship	NOUN
ihlr-16470	422	16	compound	compound	NOUN
ihlr-16470	422	17	x	x	PUNCT
ihlr-16470	422	18	in	in	ADP
ihlr-16470	422	19	a	a	DET
ihlr-16470	422	20	200	200	NUM
ihlr-16470	422	21	mg	mg	NOUN
ihlr-16470	422	22	.	.	PUNCT
ihlr-16470	423	1	dose	dose	PROPN
ihlr-16470	423	2	,	,	PUNCT
ihlr-16470	423	3	or	or	CCONJ
ihlr-16470	423	4	for	for	ADP
ihlr-16470	423	5	use	use	NOUN
ihlr-16470	423	6	six	six	NUM
ihlr-16470	423	7	times	time	NOUN
ihlr-16470	423	8	a	a	DET
ihlr-16470	423	9	day	day	NOUN
ihlr-16470	423	10	,	,	PUNCT
ihlr-16470	423	11	or	or	CCONJ
ihlr-16470	423	12	for	for	ADP
ihlr-16470	423	13	nausea	nausea	NOUN
ihlr-16470	423	14	.	.	PUNCT
ihlr-16470	424	1	a	a	DET
ihlr-16470	424	2	drug	drug	NOUN
ihlr-16470	424	3	may	may	AUX
ihlr-16470	424	4	be	be	AUX
ihlr-16470	424	5	proven	prove	VERB
ihlr-16470	424	6	safe	safe	ADJ
ihlr-16470	424	7	and	and	CCONJ
ihlr-16470	424	8	effective	effective	ADJ
ihlr-16470	424	9	for	for	ADP
ihlr-16470	424	10	one	one	NUM
ihlr-16470	424	11	use	use	NOUN
ihlr-16470	424	12	,	,	PUNCT
ihlr-16470	424	13	but	but	CCONJ
ihlr-16470	424	14	be	be	AUX
ihlr-16470	424	15	neither	neither	CCONJ
ihlr-16470	424	16	safe	safe	ADJ
ihlr-16470	424	17	nor	nor	CCONJ
ihlr-16470	424	18	effective	effective	ADJ
ihlr-16470	424	19	for	for	ADP
ihlr-16470	424	20	another	another	PRON
ihlr-16470	424	21	.	.	PUNCT
ihlr-16470	425	1	different	different	ADJ
ihlr-16470	425	2	uses	use	NOUN
ihlr-16470	425	3	are	be	AUX
ihlr-16470	425	4	simply	simply	ADV
ihlr-16470	425	5	not	not	PART
ihlr-16470	425	6	interchangeable	interchangeable	ADJ
ihlr-16470	425	7	.	.	PUNCT
ihlr-16470	426	1	127	127	NUM
ihlr-16470	426	2	.	.	PUNCT
ihlr-16470	427	1	i	i	PRON
ihlr-16470	427	2	d.	d.	PROPN
ihlr-16470	427	3	218	218	NUM
ihlr-16470	427	4	indiana	indiana	PROPN
ihlr-16470	427	5	heal1h	heal1h	PROPN
ihlr-16470	427	6	law	law	NOUN
ihlr-16470	427	7	review	review	NOUN
ihlr-16470	427	8	[	[	X
ihlr-16470	427	9	vol	vol	NOUN
ihlr-16470	427	10	.	.	PUNCT
ihlr-16470	428	1	3:201	3:201	NUM
ihlr-16470	428	2	its	its	PRON
ihlr-16470	428	3	representative	representative	NOUN
ihlr-16470	428	4	.	.	PUNCT
ihlr-16470	429	1	"128	"128	NOUN
ihlr-16470	429	2	as	as	ADP
ihlr-16470	429	3	a	a	DET
ihlr-16470	429	4	result	result	NOUN
ihlr-16470	429	5	,	,	PUNCT
ihlr-16470	429	6	manufacturers	manufacturer	NOUN
ihlr-16470	429	7	face	face	VERB
ihlr-16470	429	8	liability	liability	NOUN
ihlr-16470	429	9	for	for	ADP
ihlr-16470	429	10	illegally	illegally	ADV
ihlr-16470	429	11	shipping	ship	VERB
ihlr-16470	429	12	a	a	DET
ihlr-16470	429	13	drug	drug	NOUN
ihlr-16470	429	14	if	if	SCONJ
ihlr-16470	429	15	it	it	PRON
ihlr-16470	429	16	advertises	advertise	VERB
ihlr-16470	429	17	an	an	DET
ihlr-16470	429	18	unapproved	unapproved	ADJ
ihlr-16470	429	19	use	use	NOUN
ihlr-16470	429	20	.	.	PUNCT
ihlr-16470	430	1	129	129	NUM
ihlr-16470	430	2	despite	despite	SCONJ
ihlr-16470	430	3	the	the	DET
ihlr-16470	430	4	liabilities	liability	NOUN
ihlr-16470	430	5	imposed	impose	VERB
ihlr-16470	430	6	on	on	ADP
ihlr-16470	430	7	manufacturers	manufacturer	NOUN
ihlr-16470	430	8	for	for	ADP
ihlr-16470	430	9	advertising	advertise	VERB
ihlr-16470	430	10	unapproved	unapproved	ADJ
ihlr-16470	430	11	uses	use	NOUN
ihlr-16470	430	12	,	,	PUNCT
ihlr-16470	430	13	these	these	DET
ihlr-16470	430	14	uses	use	NOUN
ihlr-16470	430	15	are	be	AUX
ihlr-16470	430	16	far	far	ADV
ihlr-16470	430	17	from	from	ADP
ihlr-16470	430	18	illegal	illegal	ADJ
ihlr-16470	430	19	.	.	PUNCT
ihlr-16470	431	1	in	in	ADP
ihlr-16470	431	2	fact	fact	NOUN
ihlr-16470	431	3	,	,	PUNCT
ihlr-16470	431	4	the	the	DET
ihlr-16470	431	5	off	off	ADP
ihlr-16470	431	6	-	-	PUNCT
ihlr-16470	431	7	label	label	NOUN
ihlr-16470	431	8	uses	use	NOUN
ihlr-16470	431	9	are	be	AUX
ihlr-16470	431	10	recognized	recognize	VERB
ihlr-16470	431	11	by	by	ADP
ihlr-16470	431	12	the	the	DET
ihlr-16470	431	13	fda	fda	PROPN
ihlr-16470	431	14	and	and	CCONJ
ihlr-16470	431	15	play	play	VERB
ihlr-16470	431	16	a	a	DET
ihlr-16470	431	17	vital	vital	ADJ
ihlr-16470	431	18	role	role	NOUN
ihlr-16470	431	19	in	in	ADP
ihlr-16470	431	20	american	american	PROPN
ihlr-16470	431	21	healthcare.130	healthcare.130	PROPN
ihlr-16470	431	22	a	a	DET
ihlr-16470	431	23	manufacturer	manufacturer	NOUN
ihlr-16470	431	24	effectively	effectively	ADV
ihlr-16470	431	25	limits	limit	VERB
ihlr-16470	431	26	its	its	PRON
ihlr-16470	431	27	liability	liability	NOUN
ihlr-16470	431	28	by	by	ADP
ihlr-16470	431	29	following	follow	VERB
ihlr-16470	431	30	the	the	DET
ihlr-16470	431	31	fda	fda	PROPN
ihlr-16470	431	32	guidelines	guideline	NOUN
ihlr-16470	431	33	in	in	ADP
ihlr-16470	431	34	advertising	advertising	NOUN
ihlr-16470	431	35	.	.	PUNCT
ihlr-16470	432	1	labeling	labeling	NOUN
ihlr-16470	432	2	,	,	PUNCT
ihlr-16470	432	3	and	and	CCONJ
ihlr-16470	432	4	promoting	promote	VERB
ihlr-16470	432	5	its	its	PRON
ihlr-16470	432	6	drug	drug	NOUN
ihlr-16470	432	7	.	.	PUNCT
ihlr-16470	433	1	after	after	SCONJ
ihlr-16470	433	2	the	the	DET
ihlr-16470	433	3	fda	fda	PROPN
ihlr-16470	433	4	approves	approve	VERB
ihlr-16470	433	5	a	a	DET
ihlr-16470	433	6	drug	drug	NOUN
ihlr-16470	433	7	for	for	ADP
ihlr-16470	433	8	any	any	DET
ihlr-16470	433	9	use	use	NOUN
ihlr-16470	433	10	,	,	PUNCT
ihlr-16470	433	11	the	the	DET
ihlr-16470	433	12	actual	actual	ADJ
ihlr-16470	433	13	prescription	prescription	NOUN
ihlr-16470	433	14	choices	choice	NOUN
ihlr-16470	433	15	are	be	AUX
ihlr-16470	433	16	left	leave	VERB
ihlr-16470	433	17	to	to	ADP
ihlr-16470	433	18	the	the	DET
ihlr-16470	433	19	discretion	discretion	NOUN
ihlr-16470	433	20	of	of	ADP
ihlr-16470	433	21	the	the	DET
ihlr-16470	433	22	physician,131	physician,131	PROPN
ihlr-16470	433	23	thereby	thereby	ADV
ihlr-16470	433	24	potentially	potentially	ADV
ihlr-16470	433	25	placing	place	VERB
ihlr-16470	433	26	liability	liability	NOUN
ihlr-16470	433	27	for	for	ADP
ihlr-16470	433	28	any	any	DET
ihlr-16470	433	29	ill	ill	ADJ
ihlr-16470	433	30	~	~	NOUN
ihlr-16470	433	31	ffects	ffect	NOUN
ihlr-16470	433	32	for	for	ADP
ihlr-16470	433	33	off­	off­	NOUN
ihlr-16470	433	34	label	label	NOUN
ihlr-16470	433	35	use	use	NOUN
ihlr-16470	433	36	on	on	ADP
ihlr-16470	433	37	the	the	DET
ihlr-16470	433	38	prescribing	prescribing	NOUN
ihlr-16470	433	39	physician	physician	NOUN
ihlr-16470	433	40	.	.	PUNCT
ihlr-16470	434	1	however	however	ADV
ihlr-16470	434	2	,	,	PUNCT
ihlr-16470	434	3	the	the	DET
ihlr-16470	434	4	liability	liability	NOUN
ihlr-16470	434	5	may	may	AUX
ihlr-16470	434	6	not	not	PART
ihlr-16470	434	7	shift	shift	VERB
ihlr-16470	434	8	to	to	ADP
ihlr-16470	434	9	the	the	DET
ihlr-16470	434	10	physician	physician	NOUN
ihlr-16470	434	11	if	if	SCONJ
ihlr-16470	434	12	the	the	DET
ihlr-16470	434	13	manufacturer	manufacturer	NOUN
ihlr-16470	434	14	failed	fail	VERB
ihlr-16470	434	15	to	to	PART
ihlr-16470	434	16	adequately	adequately	ADV
ihlr-16470	434	17	warn	warn	VERB
ihlr-16470	434	18	the	the	DET
ihlr-16470	434	19	physician	physician	NOUN
ihlr-16470	434	20	of	of	ADP
ihlr-16470	434	21	the	the	DET
ihlr-16470	434	22	risks	risk	NOUN
ihlr-16470	434	23	.	.	PUNCT
ihlr-16470	435	1	2	2	X
ihlr-16470	435	2	.	.	X
ihlr-16470	435	3	failure	failure	NOUN
ihlr-16470	435	4	to	to	PART
ihlr-16470	435	5	warn	warn	VERB
ihlr-16470	435	6	one	one	NUM
ihlr-16470	435	7	dispositive	dispositive	ADJ
ihlr-16470	435	8	issue	issue	NOUN
ihlr-16470	435	9	in	in	ADP
ihlr-16470	435	10	products	product	NOUN
ihlr-16470	435	11	liability	liability	NOUN
ihlr-16470	435	12	cases	case	NOUN
ihlr-16470	435	13	against	against	ADP
ihlr-16470	435	14	drug	drug	NOUN
ihlr-16470	435	15	manufacturers	manufacturer	NOUN
ihlr-16470	435	16	is	be	AUX
ihlr-16470	435	17	whether	whether	SCONJ
ihlr-16470	435	18	the	the	DET
ihlr-16470	435	19	manufacturer	manufacturer	NOUN
ihlr-16470	435	20	provided	provide	VERB
ihlr-16470	435	21	sufficient	sufficient	ADJ
ihlr-16470	435	22	warning	warning	NOUN
ihlr-16470	435	23	of	of	ADP
ihlr-16470	435	24	the	the	DET
ihlr-16470	435	25	drug	drug	NOUN
ihlr-16470	435	26	's	's	PART
ihlr-16470	435	27	risks	risk	NOUN
ihlr-16470	435	28	.	.	PUNCT
ihlr-16470	436	1	132	132	NUM
ihlr-16470	436	2	manufacturers	manufacturer	NOUN
ihlr-16470	436	3	are	be	AUX
ihlr-16470	436	4	only	only	ADV
ihlr-16470	436	5	required	require	VERB
ihlr-16470	436	6	to	to	PART
ihlr-16470	436	7	warn	warn	VERB
ihlr-16470	436	8	of	of	ADP
ihlr-16470	436	9	risks	risk	NOUN
ihlr-16470	436	10	of	of	ADP
ihlr-16470	436	11	which	which	PRON
ihlr-16470	436	12	they	they	PRON
ihlr-16470	436	13	know	know	VERB
ihlr-16470	436	14	or	or	CCONJ
ihlr-16470	436	15	should	should	AUX
ihlr-16470	436	16	know.133	know.133	PROPN
ihlr-16470	436	17	however	however	ADV
ihlr-16470	436	18	,	,	PUNCT
ihlr-16470	436	19	this	this	PRON
ihlr-16470	436	20	does	do	AUX
ihlr-16470	436	21	not	not	PART
ihlr-16470	436	22	allow	allow	VERB
ihlr-16470	436	23	manufacturers	manufacturer	NOUN
ihlr-16470	436	24	to	to	PART
ihlr-16470	436	25	purposely	purposely	ADV
ihlr-16470	436	26	remain	remain	VERB
ihlr-16470	436	27	ignorant	ignorant	ADJ
ihlr-16470	436	28	of	of	ADP
ihlr-16470	436	29	the	the	DET
ihlr-16470	436	30	risks	risk	NOUN
ihlr-16470	436	31	of	of	ADP
ihlr-16470	436	32	their	their	PRON
ihlr-16470	436	33	product	product	NOUN
ihlr-16470	436	34	.	.	PUNCT
ihlr-16470	437	1	in	in	ADP
ihlr-16470	437	2	determining	determine	VERB
ihlr-16470	437	3	whether	whether	SCONJ
ihlr-16470	437	4	a	a	DET
ihlr-16470	437	5	drug	drug	NOUN
ihlr-16470	437	6	manufacturer	manufacturer	NOUN
ihlr-16470	437	7	adequately	adequately	ADV
ihlr-16470	437	8	warned	warn	VERB
ihlr-16470	437	9	of	of	ADP
ihlr-16470	437	10	the	the	DET
ihlr-16470	437	11	risks	risk	NOUN
ihlr-16470	437	12	,	,	PUNCT
ihlr-16470	437	13	the	the	DET
ihlr-16470	437	14	court	court	NOUN
ihlr-16470	437	15	holds	hold	VERB
ihlr-16470	437	16	the	the	DET
ihlr-16470	437	17	manufacturer	manufacturer	NOUN
ihlr-16470	437	18	up	up	ADP
ihlr-16470	437	19	as	as	ADP
ihlr-16470	437	20	an	an	DET
ihlr-16470	437	21	expert	expert	NOUN
ihlr-16470	437	22	in	in	ADP
ihlr-16470	437	23	the	the	DET
ihlr-16470	437	24	field	field	NOUN
ihlr-16470	437	25	.	.	PUNCT
ihlr-16470	438	1	134	134	NUM
ihlr-16470	438	2	fda	fda	PROPN
ihlr-16470	438	3	regulations	regulation	NOUN
ihlr-16470	438	4	also	also	ADV
ihlr-16470	438	5	impose	impose	VERB
ihlr-16470	438	6	other	other	ADJ
ihlr-16470	438	7	duties	duty	NOUN
ihlr-16470	438	8	upon	upon	SCONJ
ihlr-16470	438	9	manufacturers	manufacturer	NOUN
ihlr-16470	438	10	to	to	PART
ihlr-16470	438	11	discover	discover	VERB
ihlr-16470	438	12	the	the	DET
ihlr-16470	438	13	risks	risk	NOUN
ihlr-16470	438	14	of	of	ADP
ihlr-16470	438	15	the	the	DET
ihlr-16470	438	16	drug	drug	NOUN
ihlr-16470	438	17	.	.	PUNCT
ihlr-16470	439	1	135	135	NUM
ihlr-16470	439	2	therefore	therefore	ADV
ihlr-16470	439	3	,	,	PUNCT
ihlr-16470	439	4	manufacturers	manufacturer	NOUN
ihlr-16470	439	5	are	be	AUX
ihlr-16470	439	6	deemed	deem	VERB
ihlr-16470	439	7	to	to	PART
ihlr-16470	439	8	have	have	VERB
ihlr-16470	439	9	constructive	constructive	ADJ
ihlr-16470	439	10	knowledge	knowledge	NOUN
ihlr-16470	439	11	of	of	ADP
ihlr-16470	439	12	all	all	DET
ihlr-16470	439	13	documented	document	VERB
ihlr-16470	439	14	risks	risk	NOUN
ihlr-16470	439	15	associated	associate	VERB
ihlr-16470	439	16	with	with	ADP
ihlr-16470	439	17	the	the	DET
ihlr-16470	439	18	drug.136	drug.136	NOUN
ihlr-16470	439	19	in	in	ADP
ihlr-16470	439	20	addition	addition	NOUN
ihlr-16470	439	21	to	to	ADP
ihlr-16470	439	22	being	be	AUX
ihlr-16470	439	23	liable	liable	ADJ
ihlr-16470	439	24	for	for	ADP
ihlr-16470	439	25	failing	fail	VERB
ihlr-16470	439	26	to	to	PART
ihlr-16470	439	27	warn	warn	VERB
ihlr-16470	439	28	for	for	ADP
ihlr-16470	439	29	risks	risk	NOUN
ihlr-16470	439	30	of	of	ADP
ihlr-16470	439	31	the	the	DET
ihlr-16470	439	32	drug	drug	NOUN
ihlr-16470	439	33	,	,	PUNCT
ihlr-16470	439	34	manufacturers	manufacturer	NOUN
ihlr-16470	439	35	have	have	VERB
ihlr-16470	439	36	a	a	DET
ihlr-16470	439	37	duty	duty	NOUN
ihlr-16470	439	38	to	to	PART
ihlr-16470	439	39	warn	warn	VERB
ihlr-16470	439	40	of	of	ADP
ihlr-16470	439	41	foreseeable	foreseeable	ADJ
ihlr-16470	439	42	misuses	misuse	NOUN
ihlr-16470	439	43	of	of	ADP
ihlr-16470	439	44	the	the	DET
ihlr-16470	439	45	drug	drug	NOUN
ihlr-16470	439	46	.	.	PUNCT
ihlr-16470	440	1	137	137	NUM
ihlr-16470	440	2	this	this	DET
ihlr-16470	440	3	duty	duty	NOUN
ihlr-16470	440	4	generally	generally	ADV
ihlr-16470	440	5	arises	arise	VERB
ihlr-16470	440	6	out	out	ADP
ihlr-16470	440	7	of	of	ADP
ihlr-16470	440	8	actions	action	NOUN
ihlr-16470	440	9	subsequent	subsequent	ADJ
ihlr-16470	440	10	to	to	ADP
ihlr-16470	440	11	the	the	DET
ihlr-16470	440	12	manufacturer	manufacturer	NOUN
ihlr-16470	440	13	's	's	PART
ihlr-16470	440	14	128	128	NUM
ihlr-16470	440	15	.	.	PUNCT
ihlr-16470	441	1	/d	/d	PUNCT
ihlr-16470	441	2	.	.	PUNCT
ihlr-16470	442	1	(	(	PUNCT
ihlr-16470	442	2	quoting	quote	VERB
ihlr-16470	442	3	jonathan	jonathan	PROPN
ihlr-16470	442	4	s.	s.	PROPN
ihlr-16470	442	5	kahan	kahan	PROPN
ihlr-16470	442	6	&	&	CCONJ
ihlr-16470	442	7	jefferey	jefferey	PROPN
ihlr-16470	442	8	k.	k.	PROPN
ihlr-16470	442	9	shapiro	shapiro	PROPN
ihlr-16470	442	10	,	,	PUNCT
ihlr-16470	442	11	the	the	DET
ihlr-16470	442	12	first	first	ADJ
ihlr-16470	442	13	amendment	amendment	NOUN
ihlr-16470	442	14	and	and	CCONJ
ihlr-16470	442	15	the	the	DET
ihlr-16470	442	16	food	food	NOUN
ihlr-16470	442	17	and	and	CCONJ
ihlr-16470	442	18	drug	drug	PROPN
ihlr-16470	442	19	administration	administration	NOUN
ihlr-16470	442	20	's	's	PART
ihlr-16470	442	21	regulation	regulation	NOUN
ihlr-16470	442	22	of	of	ADP
ihlr-16470	442	23	labeling	labeling	NOUN
ihlr-16470	442	24	and	and	CCONJ
ihlr-16470	442	25	advertising	advertising	NOUN
ihlr-16470	442	26	:	:	PUNCT
ihlr-16470	442	27	three	three	NUM
ihlr-16470	442	28	proposed	propose	VERB
ihlr-16470	442	29	reforms	reform	NOUN
ihlr-16470	442	30	,	,	PUNCT
ihlr-16470	442	31	58	58	NUM
ihlr-16470	442	32	food	food	NOUN
ihlr-16470	442	33	&	&	CCONJ
ihlr-16470	442	34	drug	drug	PROPN
ihlr-16470	442	35	l.j	l.j	PROPN
ihlr-16470	442	36	.	.	PROPN
ihlr-16470	442	37	353	353	NUM
ihlr-16470	442	38	,	,	PUNCT
ihlr-16470	442	39	360	360	NUM
ihlr-16470	442	40	(	(	PUNCT
ihlr-16470	442	41	2003	2003	NUM
ihlr-16470	442	42	)	)	PUNCT
ihlr-16470	442	43	)	)	PUNCT
ihlr-16470	442	44	.	.	PUNCT
ihlr-16470	443	1	129	129	NUM
ihlr-16470	443	2	.	.	PUNCT
ihlr-16470	444	1	i	i	PRON
ihlr-16470	444	2	d.	d.	PROPN
ihlr-16470	444	3	130	130	NUM
ihlr-16470	444	4	.	.	PUNCT
ihlr-16470	445	1	huti&merill	huti&merill	AUX
ihlr-16470	445	2	,	,	PUNCT
ihlr-16470	445	3	supranote	supranote	VERB
ihlr-16470	445	4	115	115	NUM
ihlr-16470	445	5	,	,	PUNCT
ihlr-16470	445	6	at616	at616	PROPN
ihlr-16470	445	7	-	-	X
ihlr-16470	445	8	17	17	NUM
ihlr-16470	445	9	(	(	PUNCT
ihlr-16470	445	10	noting	note	VERB
ihlr-16470	445	11	,	,	PUNCT
ihlr-16470	445	12	however	however	ADV
ihlr-16470	445	13	,	,	PUNCT
ihlr-16470	445	14	that	that	SCONJ
ihlr-16470	445	15	although	although	SCONJ
ihlr-16470	445	16	off	off	ADP
ihlr-16470	445	17	-	-	PUNCT
ihlr-16470	445	18	label	label	NOUN
ihlr-16470	445	19	uses	use	NOUN
ihlr-16470	445	20	often	often	ADV
ihlr-16470	445	21	represent	represent	VERB
ihlr-16470	445	22	sound	sound	ADJ
ihlr-16470	445	23	medical	medical	ADJ
ihlr-16470	445	24	care	care	NOUN
ihlr-16470	445	25	they	they	PRON
ihlr-16470	445	26	can	can	AUX
ihlr-16470	445	27	be	be	AUX
ihlr-16470	445	28	abused	abuse	VERB
ihlr-16470	445	29	and	and	CCONJ
ihlr-16470	445	30	"	"	PUNCT
ihlr-16470	445	31	represent	represent	VERB
ihlr-16470	445	32	poor	poor	ADJ
ihlr-16470	445	33	judgment	judgment	NOUN
ihlr-16470	445	34	...	...	PUNCT
ihlr-16470	445	35	or	or	CCONJ
ihlr-16470	445	36	inadequate	inadequate	ADJ
ihlr-16470	445	37	medical	medical	ADJ
ihlr-16470	445	38	training	training	NOUN
ihlr-16470	445	39	.	.	PUNCT
ihlr-16470	446	1	"	"	PUNCT
ihlr-16470	446	2	)	)	PUNCT
ihlr-16470	446	3	.	.	PUNCT
ihlr-16470	447	1	131	131	X
ihlr-16470	447	2	.	.	X
ihlr-16470	447	3	cohen	cohen	PROPN
ihlr-16470	447	4	,	,	PUNCT
ihlr-16470	447	5	supra	supra	PROPN
ihlr-16470	447	6	note	note	PROPN
ihlr-16470	447	7	124	124	NUM
ihlr-16470	447	8	,	,	PUNCT
ihlr-16470	447	9	at	at	ADP
ihlr-16470	447	10	745	745	NUM
ihlr-16470	447	11	.	.	PUNCT
ihlr-16470	448	1	132	132	NUM
ihlr-16470	448	2	.	.	PUNCT
ihlr-16470	448	3	stoffelmayr	stoffelmayr	PROPN
ihlr-16470	448	4	,	,	PUNCT
ihlr-16470	448	5	supra	supra	PROPN
ihlr-16470	448	6	note	note	NOUN
ihlr-16470	448	7	101	101	NUM
ihlr-16470	448	8	,	,	PUNCT
ihlr-16470	448	9	at282	at282	PROPN
ihlr-16470	448	10	.	.	PUNCT
ihlr-16470	449	1	133	133	NUM
ihlr-16470	449	2	.	.	PUNCT
ihlr-16470	450	1	/d	/d	INTJ
ihlr-16470	450	2	.	.	PUNCT
ihlr-16470	451	1	at	at	ADP
ihlr-16470	451	2	283	283	NUM
ihlr-16470	451	3	.	.	PUNCT
ihlr-16470	452	1	134	134	NUM
ihlr-16470	452	2	.	.	PUNCT
ihlr-16470	453	1	/d	/d	INTJ
ihlr-16470	453	2	.	.	PUNCT
ihlr-16470	454	1	135	135	NUM
ihlr-16470	454	2	.	.	PUNCT
ihlr-16470	455	1	/d	/d	INTJ
ihlr-16470	455	2	.	.	PUNCT
ihlr-16470	456	1	(	(	PUNCT
ihlr-16470	456	2	manufacturers	manufacturer	NOUN
ihlr-16470	456	3	must	must	AUX
ihlr-16470	456	4	"	"	PUNCT
ihlr-16470	456	5	carefully	carefully	ADV
ihlr-16470	456	6	motiitor	motiitor	PROPN
ihlr-16470	456	7	reports	report	NOUN
ihlr-16470	456	8	from	from	ADP
ihlr-16470	456	9	physicians	physician	NOUN
ihlr-16470	456	10	-	-	PUNCT
ihlr-16470	456	11	whether	whether	SCONJ
ihlr-16470	456	12	made	make	VERB
ihlr-16470	456	13	directlytomanufacturersorpublishedinthemedicalliterature	directlytomanufacturersorpublishedinthemedicalliterature	NOUN
ihlr-16470	456	14	-	-	PUNCT
ihlr-16470	456	15	regardinginjuriesrelatedtotheir	regardinginjuriesrelatedtotheir	NOUN
ihlr-16470	456	16	drugs	drug	NOUN
ihlr-16470	456	17	•	•	NOUN
ihlr-16470	456	18	.	.	PUNCT
ihlr-16470	457	1	•	•	NUM
ihlr-16470	457	2	•	•	NOUN
ihlr-16470	457	3	manufacturers	manufacturer	NOUN
ihlr-16470	457	4	also	also	ADV
ihlr-16470	457	5	have	have	VERB
ihlr-16470	457	6	a	a	DET
ihlr-16470	457	7	duty	duty	NOUN
ihlr-16470	457	8	to	to	PART
ihlr-16470	457	9	conduct	conduct	VERB
ihlr-16470	457	10	postmarketing	postmarkete	VERB
ihlr-16470	457	11	studies	study	NOUN
ihlr-16470	457	12	on	on	ADP
ihlr-16470	457	13	the	the	DET
ihlr-16470	457	14	safety	safety	NOUN
ihlr-16470	457	15	of	of	ADP
ihlr-16470	457	16	their	their	PRON
ihlr-16470	457	17	drugs	drug	NOUN
ihlr-16470	457	18	and	and	CCONJ
ihlr-16470	457	19	to	to	PART
ihlr-16470	457	20	monitor	monitor	VERB
ihlr-16470	457	21	for	for	ADP
ihlr-16470	457	22	and	and	CCONJ
ihlr-16470	457	23	investigate	investigate	VERB
ihlr-16470	457	24	possible	possible	ADJ
ihlr-16470	457	25	undetected	undetected	ADJ
ihlr-16470	457	26	risks	risk	NOUN
ihlr-16470	457	27	.	.	PUNCT
ihlr-16470	458	1	j.	j.	PROPN
ihlr-16470	458	2	136	136	NUM
ihlr-16470	458	3	.	.	PUNCT
ihlr-16470	459	1	/d	/d	INTJ
ihlr-16470	459	2	.	.	PUNCT
ihlr-16470	460	1	137	137	NUM
ihlr-16470	460	2	.	.	PUNCT
ihlr-16470	461	1	heafey&kennedy	heafey&kennedy	NOUN
ihlr-16470	461	2	,	,	PUNCT
ihlr-16470	461	3	supranote	supranote	VERB
ihlr-16470	461	4	120	120	NUM
ihlr-16470	461	5	.	.	PUNCT
ihlr-16470	462	1	2006	2006	NUM
ihlr-16470	462	2	]	]	PUNCT
ihlr-16470	462	3	anti	anti	NOUN
ihlr-16470	462	4	-	-	NOUN
ihlr-16470	462	5	depressants	depressant	NOUN
ihlr-16470	462	6	and	and	CCONJ
ihlr-16470	462	7	clm.dren	clm.dren	NOUN
ihlr-16470	462	8	219	219	NUM
ihlr-16470	462	9	production	production	NOUN
ihlr-16470	462	10	of	of	ADP
ihlr-16470	462	11	the	the	DET
ihlr-16470	462	12	drug	drug	NOUN
ihlr-16470	462	13	and	and	CCONJ
ihlr-16470	462	14	can	can	AUX
ihlr-16470	462	15	develop	develop	VERB
ihlr-16470	462	16	over	over	ADP
ihlr-16470	462	17	time.138	time.138	NOUN
ihlr-16470	462	18	such	such	DET
ihlr-16470	462	19	a	a	DET
ihlr-16470	462	20	duty	duty	NOUN
ihlr-16470	462	21	arises	arise	VERB
ihlr-16470	462	22	when	when	SCONJ
ihlr-16470	462	23	a	a	DET
ihlr-16470	462	24	drug	drug	NOUN
ihlr-16470	462	25	is	be	AUX
ihlr-16470	462	26	commonly	commonly	ADV
ihlr-16470	462	27	prescribed	prescribe	VERB
ihlr-16470	462	28	for	for	ADP
ihlr-16470	462	29	off	off	ADP
ihlr-16470	462	30	-	-	PUNCT
ihlr-16470	462	31	label	label	NOUN
ihlr-16470	462	32	uses	use	NOUN
ihlr-16470	462	33	,	,	PUNCT
ihlr-16470	462	34	or	or	CCONJ
ihlr-16470	462	35	when	when	SCONJ
ihlr-16470	462	36	such	such	ADJ
ihlr-16470	462	37	uses	use	NOUN
ihlr-16470	462	38	constitute	constitute	VERB
ihlr-16470	462	39	a	a	DET
ihlr-16470	462	40	substantial	substantial	ADJ
ihlr-16470	462	41	portion	portion	NOUN
ihlr-16470	462	42	of	of	ADP
ihlr-16470	462	43	the	the	DET
ihlr-16470	462	44	prescribed	prescribe	VERB
ihlr-16470	462	45	uses	use	NOUN
ihlr-16470	462	46	,	,	PUNCT
ihlr-16470	462	47	139	139	NUM
ihlr-16470	462	48	such	such	ADJ
ihlr-16470	462	49	as	as	ADP
ihlr-16470	462	50	in	in	ADP
ihlr-16470	462	51	treating	treat	VERB
ihlr-16470	462	52	cancer	cancer	NOUN
ihlr-16470	462	53	or	or	CCONJ
ihlr-16470	462	54	aids.t40	aids.t40	NOUN
ihlr-16470	462	55	the	the	DET
ihlr-16470	462	56	nature	nature	NOUN
ihlr-16470	462	57	of	of	ADP
ihlr-16470	462	58	"	"	PUNCT
ihlr-16470	462	59	foreseeable	foreseeable	ADJ
ihlr-16470	462	60	misuse	misuse	NOUN
ihlr-16470	462	61	"	"	PUNCT
ihlr-16470	462	62	often	often	ADV
ihlr-16470	462	63	makes	make	VERB
ihlr-16470	462	64	it	it	PRON
ihlr-16470	462	65	difficult	difficult	ADJ
ihlr-16470	462	66	for	for	SCONJ
ihlr-16470	462	67	drug	drug	NOUN
ihlr-16470	462	68	manufacturers	manufacturer	NOUN
ihlr-16470	462	69	to	to	PART
ihlr-16470	462	70	adequately	adequately	ADV
ihlr-16470	462	71	warn	warn	VERB
ihlr-16470	462	72	of	of	ADP
ihlr-16470	462	73	certain	certain	ADJ
ihlr-16470	462	74	risks	risk	NOUN
ihlr-16470	462	75	.	.	PUNCT
ihlr-16470	463	1	off	off	ADP
ihlr-16470	463	2	-	-	PUNCT
ihlr-16470	463	3	label	label	NOUN
ihlr-16470	463	4	uses	use	NOUN
ihlr-16470	463	5	of	of	ADP
ihlr-16470	463	6	drugs	drug	NOUN
ihlr-16470	463	7	develop	develop	VERB
ihlr-16470	463	8	over	over	ADP
ihlr-16470	463	9	time	time	NOUN
ihlr-16470	463	10	,	,	PUNCT
ihlr-16470	463	11	and	and	CCONJ
ihlr-16470	463	12	therefore	therefore	ADV
ihlr-16470	463	13	may	may	AUX
ihlr-16470	463	14	not	not	PART
ihlr-16470	463	15	be	be	AUX
ihlr-16470	463	16	expected	expect	VERB
ihlr-16470	463	17	or	or	CCONJ
ihlr-16470	463	18	foreseeable	foreseeable	ADJ
ihlr-16470	463	19	at	at	ADP
ihlr-16470	463	20	the	the	DET
ihlr-16470	463	21	time	time	NOUN
ihlr-16470	463	22	the	the	DET
ihlr-16470	463	23	drug	drug	NOUN
ihlr-16470	463	24	is	be	AUX
ihlr-16470	463	25	approved	approve	VERB
ihlr-16470	463	26	and	and	CCONJ
ihlr-16470	463	27	marketed	market	VERB
ihlr-16470	463	28	.	.	PUNCT
ihlr-16470	464	1	as	as	ADP
ihlr-16470	464	2	a	a	DET
ihlr-16470	464	3	result	result	NOUN
ihlr-16470	464	4	the	the	DET
ihlr-16470	464	5	approved	approve	VERB
ihlr-16470	464	6	labeling	labeling	NOUN
ihlr-16470	464	7	of	of	ADP
ihlr-16470	464	8	the	the	DET
ihlr-16470	464	9	drug	drug	NOUN
ihlr-16470	464	10	often	often	ADV
ihlr-16470	464	11	does	do	AUX
ihlr-16470	464	12	not	not	PART
ihlr-16470	464	13	adequately	adequately	ADV
ihlr-16470	464	14	address	address	VERB
ihlr-16470	464	15	common	common	ADJ
ihlr-16470	464	16	off	off	ADP
ihlr-16470	464	17	-	-	PUNCT
ihlr-16470	464	18	label	label	NOUN
ihlr-16470	464	19	uses	use	NOUN
ihlr-16470	464	20	of	of	ADP
ihlr-16470	464	21	many	many	ADJ
ihlr-16470	464	22	drugs	drug	NOUN
ihlr-16470	464	23	.	.	PUNCT
ihlr-16470	465	1	however	however	ADV
ihlr-16470	465	2	,	,	PUNCT
ihlr-16470	465	3	drug	drug	NOUN
ihlr-16470	465	4	manufacturers	manufacturer	NOUN
ihlr-16470	465	5	must	must	AUX
ihlr-16470	465	6	receive	receive	VERB
ihlr-16470	465	7	fda	fda	PROPN
ihlr-16470	465	8	approval	approval	NOUN
ihlr-16470	465	9	for	for	ADP
ihlr-16470	465	10	any	any	DET
ihlr-16470	465	11	changes	change	NOUN
ihlr-16470	465	12	made	make	VERB
ihlr-16470	465	13	to	to	ADP
ihlr-16470	465	14	the	the	DET
ihlr-16470	465	15	drug	drug	NOUN
ihlr-16470	465	16	label	label	NOUN
ihlr-16470	465	17	and	and	CCONJ
ihlr-16470	465	18	warning	warning	NOUN
ihlr-16470	465	19	,	,	PUNCT
ihlr-16470	465	20	even	even	ADV
ihlr-16470	465	21	if	if	SCONJ
ihlr-16470	465	22	the	the	DET
ihlr-16470	465	23	desired	desire	VERB
ihlr-16470	465	24	result	result	NOUN
ihlr-16470	465	25	is	be	AUX
ihlr-16470	465	26	a	a	DET
ihlr-16470	465	27	stronger	strong	ADJ
ihlr-16470	465	28	warning	warning	NOUN
ihlr-16470	465	29	message.141	message.141	INTJ
ihlr-16470	465	30	as	as	ADP
ihlr-16470	465	31	a	a	DET
ihlr-16470	465	32	result	result	NOUN
ihlr-16470	465	33	,	,	PUNCT
ihlr-16470	465	34	many	many	ADJ
ihlr-16470	465	35	of	of	ADP
ihlr-16470	465	36	these	these	DET
ihlr-16470	465	37	off	off	ADP
ihlr-16470	465	38	-	-	PUNCT
ihlr-16470	465	39	label	label	NOUN
ihlr-16470	465	40	uses	use	NOUN
ihlr-16470	465	41	are	be	AUX
ihlr-16470	465	42	not	not	PART
ihlr-16470	465	43	addressed	address	VERB
ihlr-16470	465	44	and	and	CCONJ
ihlr-16470	465	45	unnecessary	unnecessary	ADJ
ihlr-16470	465	46	harm	harm	NOUN
ihlr-16470	465	47	results	result	NOUN
ihlr-16470	465	48	.	.	PUNCT
ihlr-16470	466	1	this	this	PRON
ihlr-16470	466	2	is	be	AUX
ihlr-16470	466	3	because	because	SCONJ
ihlr-16470	466	4	a	a	DET
ihlr-16470	466	5	manufacturer	manufacturer	NOUN
ihlr-16470	466	6	was	be	AUX
ihlr-16470	466	7	unable	unable	ADJ
ihlr-16470	466	8	to	to	PART
ihlr-16470	466	9	gain	gain	VERB
ihlr-16470	466	10	fda	fda	PROPN
ihlr-16470	466	11	approval	approval	NOUN
ihlr-16470	466	12	for	for	ADP
ihlr-16470	466	13	new	new	ADJ
ihlr-16470	466	14	warning	warning	NOUN
ihlr-16470	466	15	messages	message	NOUN
ihlr-16470	466	16	or	or	CCONJ
ihlr-16470	466	17	the	the	DET
ihlr-16470	466	18	approval	approval	NOUN
ihlr-16470	466	19	process	process	NOUN
ihlr-16470	466	20	caused	cause	VERB
ihlr-16470	466	21	significant	significant	ADJ
ihlr-16470	466	22	delay	delay	NOUN
ihlr-16470	466	23	.	.	PUNCT
ihlr-16470	467	1	142	142	NUM
ihlr-16470	467	2	138	138	NUM
ihlr-16470	467	3	.	.	PUNCT
ihlr-16470	468	1	liability	liability	NOUN
ihlr-16470	468	2	for	for	ADP
ihlr-16470	468	3	"	"	PUNCT
ihlr-16470	468	4	foreseeable	foreseeable	ADJ
ihlr-16470	468	5	misuse	misuse	NOUN
ihlr-16470	468	6	"	"	PUNCT
ihlr-16470	468	7	usually	usually	ADV
ihlr-16470	468	8	,	,	PUNCT
ihlr-16470	468	9	but	but	CCONJ
ihlr-16470	468	10	not	not	PART
ihlr-16470	468	11	always	always	ADV
ihlr-16470	468	12	,	,	PUNCT
ihlr-16470	468	13	develops	develop	VERB
ihlr-16470	468	14	<	<	X
ihlr-16470	468	15	>	>	X
ihlr-16470	468	16	ver	ver	NOUN
ihlr-16470	468	17	time	time	NOUN
ihlr-16470	468	18	as	as	SCONJ
ihlr-16470	468	19	doctors	doctor	NOUN
ihlr-16470	468	20	accumulate	accumulate	VERB
ihlr-16470	468	21	data	datum	NOUN
ihlr-16470	468	22	from	from	ADP
ihlr-16470	468	23	off	off	ADP
ihlr-16470	468	24	-	-	PUNCT
ihlr-16470	468	25	label	label	NOUN
ihlr-16470	468	26	prescriptions	prescription	NOUN
ihlr-16470	468	27	and	and	CCONJ
ihlr-16470	468	28	scholarly	scholarly	ADJ
ihlr-16470	468	29	journals	journal	NOUN
ihlr-16470	468	30	indicating	indicate	VERB
ihlr-16470	468	31	possible	possible	ADJ
ihlr-16470	468	32	uses	use	NOUN
ihlr-16470	468	33	for	for	ADP
ihlr-16470	468	34	a	a	DET
ihlr-16470	468	35	drug	drug	NOUN
ihlr-16470	468	36	.	.	PUNCT
ihlr-16470	468	37	.as	.as	PUNCT
ihlr-16470	469	1	a	a	DET
ihlr-16470	469	2	method	method	NOUN
ihlr-16470	469	3	of	of	ADP
ihlr-16470	469	4	prescription	prescription	NOUN
ihlr-16470	469	5	gains	gain	NOUN
ihlr-16470	469	6	acceptance	acceptance	NOUN
ihlr-16470	469	7	over	over	ADP
ihlr-16470	469	8	time	time	NOUN
ihlr-16470	469	9	the	the	DET
ihlr-16470	469	10	manufacturer	manufacturer	NOUN
ihlr-16470	469	11	may	may	AUX
ihlr-16470	469	12	face	face	VERB
ihlr-16470	469	13	liability	liability	NOUN
ihlr-16470	469	14	under	under	ADP
ihlr-16470	469	15	"	"	PUNCT
ihlr-16470	469	16	foreseeable	foreseeable	ADJ
ihlr-16470	469	17	misuse	misuse	NOUN
ihlr-16470	469	18	.	.	PUNCT
ihlr-16470	469	19	"	"	PUNCT
ihlr-16470	470	1	however	however	ADV
ihlr-16470	470	2	,	,	PUNCT
ihlr-16470	470	3	such	such	ADJ
ihlr-16470	470	4	liability	liability	NOUN
ihlr-16470	470	5	may	may	AUX
ihlr-16470	470	6	arise	arise	VERB
ihlr-16470	470	7	at	at	ADP
ihlr-16470	470	8	the	the	DET
ihlr-16470	470	9	time	time	NOUN
ihlr-16470	470	10	the	the	DET
ihlr-16470	470	11	drug	drug	NOUN
ihlr-16470	470	12	is	be	AUX
ihlr-16470	470	13	introduced	introduce	VERB
ihlr-16470	470	14	for	for	ADP
ihlr-16470	470	15	marketing	marketing	NOUN
ihlr-16470	470	16	,	,	PUNCT
ihlr-16470	470	17	and	and	CCONJ
ihlr-16470	470	18	may	may	AUX
ihlr-16470	470	19	be	be	AUX
ihlr-16470	470	20	created	create	VERB
ihlr-16470	470	21	by	by	ADP
ihlr-16470	470	22	the	the	DET
ihlr-16470	470	23	drug	drug	NOUN
ihlr-16470	470	24	company	company	NOUN
ihlr-16470	470	25	itself	itself	PRON
ihlr-16470	470	26	.	.	PUNCT
ihlr-16470	471	1	.as	.as	PUNCT
ihlr-16470	472	1	one	one	NUM
ihlr-16470	472	2	court	court	NOUN
ihlr-16470	472	3	noted	note	VERB
ihlr-16470	472	4	,	,	PUNCT
ihlr-16470	472	5	"	"	PUNCT
ihlr-16470	472	6	[	[	X
ihlr-16470	472	7	i]f	i]f	ADP
ihlr-16470	472	8	the	the	DET
ihlr-16470	472	9	manufacturer	manufacturer	NOUN
ihlr-16470	472	10	negligently	negligently	ADV
ihlr-16470	472	11	overpromotes	overpromote	VERB
ihlr-16470	472	12	its	its	PRON
ihlr-16470	472	13	products	product	NOUN
ihlr-16470	472	14	,	,	PUNCT
ihlr-16470	472	15	or	or	CCONJ
ihlr-16470	472	16	downplays	downplay	VERB
ihlr-16470	472	17	their	their	PRON
ihlr-16470	472	18	dangerous	dangerous	ADJ
ihlr-16470	472	19	effects	effect	NOUN
ihlr-16470	472	20	,	,	PUNCT
ihlr-16470	472	21	it	it	PRON
ihlr-16470	472	22	will	will	AUX
ihlr-16470	472	23	not	not	PART
ihlr-16470	472	24	be	be	AUX
ihlr-16470	472	25	relieved	relieve	VERB
ihlr-16470	472	26	ofliability	ofliability	NOUN
ihlr-16470	472	27	for	for	ADP
ihlr-16470	472	28	the	the	DET
ihlr-16470	472	29	foreseeable	foreseeable	ADJ
ihlr-16470	472	30	misuse	misuse	NOUN
ihlr-16470	472	31	of	of	ADP
ihlr-16470	472	32	the	the	DET
ihlr-16470	472	33	drug	drug	NOUN
ihlr-16470	472	34	and	and	CCONJ
ihlr-16470	472	35	resulting	result	VERB
ihlr-16470	472	36	injuries	injury	NOUN
ihlr-16470	472	37	.	.	PUNCT
ihlr-16470	472	38	"	"	PUNCT
ihlr-16470	472	39	evraets	evraet	VERB
ihlr-16470	472	40	v.lntermedics	v.lntermedic	NOUN
ihlr-16470	472	41	intraocular	intraocular	NOUN
ihlr-16470	472	42	,	,	PUNCT
ihlr-16470	472	43	lnc	lnc	PROPN
ihlr-16470	472	44	.	.	PROPN
ihlr-16470	472	45	,	,	PUNCT
ihlr-16470	472	46	34	34	NUM
ihlr-16470	472	47	cal.rptr.2d	cal.rptr.2d	NUM
ihlr-16470	472	48	852	852	NUM
ihlr-16470	472	49	,	,	PUNCT
ihlr-16470	472	50	860	860	NUM
ihlr-16470	472	51	(	(	PUNCT
ihlr-16470	472	52	cal	cal	PROPN
ihlr-16470	472	53	.	.	PUNCT
ihlr-16470	473	1	ct	ct	PROPN
ihlr-16470	473	2	.	.	PUNCT
ihlr-16470	474	1	app	app	PROPN
ihlr-16470	474	2	.	.	PROPN
ihlr-16470	474	3	1994	1994	NUM
ihlr-16470	474	4	}	}	PUNCT
ihlr-16470	474	5	(	(	PUNCT
ihlr-16470	475	1	citations	citation	NOUN
ihlr-16470	475	2	omitted	omit	VERB
ihlr-16470	475	3	)	)	PUNCT
ihlr-16470	475	4	.	.	PUNCT
ihlr-16470	476	1	139	139	NUM
ihlr-16470	476	2	.	.	PUNCT
ihlr-16470	477	1	anderson	anderson	PROPN
ihlr-16470	477	2	v.	v.	PROPN
ihlr-16470	477	3	hedstrom	hedstrom	PROPN
ihlr-16470	477	4	corp	corp	PROPN
ihlr-16470	478	1	.	.	PROPN
ihlr-16470	478	2	,	,	PUNCT
ihlr-16470	478	3	76	76	NUM
ihlr-16470	478	4	f.supp.2d	f.supp.2d	NUM
ihlr-16470	478	5	422	422	NUM
ihlr-16470	478	6	,	,	PUNCT
ihlr-16470	478	7	439	439	NUM
ihlr-16470	478	8	-	-	SYM
ihlr-16470	478	9	40	40	NUM
ihlr-16470	478	10	(	(	PUNCT
ihlr-16470	478	11	s.d.n.y	s.d.n.y	PROPN
ihlr-16470	478	12	.	.	PROPN
ihlr-16470	478	13	1999}(quoting	1999}(quoting	PROPN
ihlr-16470	479	1	liriano	liriano	PROPN
ihlr-16470	479	2	v.	v.	PROPN
ihlr-16470	479	3	hobart	hobart	PROPN
ihlr-16470	479	4	corp	corp	PROPN
ihlr-16470	479	5	.	.	PROPN
ihlr-16470	479	6	,	,	PUNCT
ihlr-16470	479	7	700	700	NUM
ihlr-16470	479	8	n.e	n.e	PROPN
ihlr-16470	479	9	.	.	PUNCT
ihlr-16470	479	10	2d	2d	PROPN
ihlr-16470	479	11	303	303	NUM
ihlr-16470	479	12	,	,	PUNCT
ihlr-16470	479	13	305	305	NUM
ihlr-16470	479	14	,	,	PUNCT
ihlr-16470	479	15	307	307	NUM
ihlr-16470	479	16	(	(	PUNCT
ihlr-16470	479	17	1998	1998	NUM
ihlr-16470	479	18	)	)	PUNCT
ihlr-16470	479	19	}	}	PUNCT
ihlr-16470	479	20	(	(	PUNCT
ihlr-16470	479	21	"	"	PUNCT
ihlr-16470	479	22	such	such	DET
ihlr-16470	479	23	a	a	DET
ihlr-16470	479	24	duty	duty	NOUN
ihlr-16470	479	25	will	will	AUX
ihlr-16470	479	26	generally	generally	ADV
ihlr-16470	479	27	arise	arise	VERB
ihlr-16470	479	28	where	where	SCONJ
ihlr-16470	479	29	a	a	DET
ihlr-16470	479	30	defect	defect	NOUN
ihlr-16470	479	31	or	or	CCONJ
ihlr-16470	479	32	danger	danger	NOUN
ihlr-16470	479	33	is	be	AUX
ihlr-16470	479	34	revealed	reveal	VERB
ihlr-16470	479	35	by	by	ADP
ihlr-16470	479	36	user	user	NOUN
ihlr-16470	479	37	operation	operation	NOUN
ihlr-16470	479	38	and	and	CCONJ
ihlr-16470	479	39	brought	bring	VERB
ihlr-16470	479	40	to	to	ADP
ihlr-16470	479	41	the	the	DET
ihlr-16470	479	42	attention	attention	NOUN
ihlr-16470	479	43	of	of	ADP
ihlr-16470	479	44	the	the	DET
ihlr-16470	479	45	manufacturer	manufacturer	NOUN
ihlr-16470	479	46	...	...	PUNCT
ihlr-16470	479	47	"	"	PUNCT
ihlr-16470	479	48	)	)	PUNCT
ihlr-16470	479	49	.	.	PUNCT
ihlr-16470	480	1	140	140	NUM
ihlr-16470	480	2	.	.	PUNCT
ihlr-16470	480	3	daniel	daniel	PROPN
ihlr-16470	480	4	b.	b.	PROPN
ihlr-16470	480	5	klein	klein	PROPN
ihlr-16470	480	6	and	and	CCONJ
ihlr-16470	480	7	alexander	alexander	PROPN
ihlr-16470	480	8	t.	t.	PROPN
ihlr-16470	480	9	tabarrot	tabarrot	PROPN
ihlr-16470	480	10	,	,	PUNCT
ihlr-16470	480	11	"	"	PUNCT
ihlr-16470	480	12	who	who	PRON
ihlr-16470	480	13	certifies	certify	VERB
ihlr-16470	480	14	off	off	ADP
ihlr-16470	480	15	-	-	PUNCT
ihlr-16470	480	16	label	label	NOUN
ihlr-16470	480	17	?	?	PUNCT
ihlr-16470	480	18	''	''	PUNCT
ihlr-16470	480	19	,	,	PUNCT
ihlr-16470	480	20	regulation	regulation	NOUN
ihlr-16470	480	21	,	,	PUNCT
ihlr-16470	480	22	vol	vol	NOUN
ihlr-16470	480	23	.	.	PROPN
ihlr-16470	480	24	27	27	NUM
ihlr-16470	480	25	,	,	PUNCT
ihlr-16470	480	26	no.2	no.2	PROPN
ihlr-16470	480	27	,	,	PUNCT
ihlr-16470	480	28	p	p	NOUN
ihlr-16470	480	29	60	60	NUM
ihlr-16470	480	30	-	-	SYM
ihlr-16470	480	31	63	63	NUM
ihlr-16470	480	32	(	(	PUNCT
ihlr-16470	480	33	summer	summer	NOUN
ihlr-16470	480	34	2004	2004	NUM
ihlr-16470	480	35	)	)	PUNCT
ihlr-16470	480	36	.	.	PUNCT
ihlr-16470	481	1	"	"	PUNCT
ihlr-16470	481	2	most	most	ADJ
ihlr-16470	481	3	cancer	cancer	NOUN
ihlr-16470	481	4	and	and	CCONJ
ihlr-16470	481	5	aids	aid	NOUN
ihlr-16470	481	6	patients	patient	NOUN
ihlr-16470	481	7	are	be	AUX
ihlr-16470	481	8	given	give	VERB
ihlr-16470	481	9	drugs	drug	NOUN
ihlr-16470	481	10	that	that	PRON
ihlr-16470	481	11	are	be	AUX
ihlr-16470	481	12	not	not	PART
ihlr-16470	481	13	fda	fda	PROPN
ihlr-16470	481	14	-	-	PUNCT
ihlr-16470	481	15	certified	certify	VERB
ihlr-16470	481	16	for	for	ADP
ihlr-16470	481	17	the	the	DET
ihlr-16470	481	18	prescribed	prescribed	ADJ
ihlr-16470	481	19	use	use	NOUN
ihlr-16470	481	20	.	.	PUNCT
ihlr-16470	482	1	1n	1n	X
ihlr-16470	482	2	a	a	DET
ihlr-16470	482	3	large	large	ADJ
ihlr-16470	482	4	number	number	NOUN
ihlr-16470	482	5	of	of	ADP
ihlr-16470	482	6	fields	field	NOUN
ihlr-16470	482	7	,	,	PUNCT
ihlr-16470	482	8	a	a	DET
ihlr-16470	482	9	majority	majority	NOUN
ihlr-16470	482	10	of	of	ADP
ihlr-16470	482	11	patients	patient	NOUN
ihlr-16470	482	12	are	be	AUX
ihlr-16470	482	13	prescribed	prescribe	VERB
ihlr-16470	482	14	at	at	ADP
ihlr-16470	482	15	least	least	ADV
ihlr-16470	482	16	one	one	NUM
ihlr-16470	482	17	drug	drug	NOUN
ihlr-16470	482	18	off	off	ADP
ihlr-16470	482	19	-	-	PUNCT
ihlr-16470	482	20	label	label	NOUN
ihlr-16470	482	21	,	,	PUNCT
ihlr-16470	482	22	and	and	CCONJ
ihlr-16470	482	23	in	in	ADP
ihlr-16470	482	24	some	some	DET
ihlr-16470	482	25	cases	case	NOUN
ihlr-16470	482	26	the	the	DET
ihlr-16470	482	27	off	off	ADP
ihlr-16470	482	28	-	-	PUNCT
ihlr-16470	482	29	label	label	NOUN
ihlr-16470	482	30	prescription	prescription	NOUN
ihlr-16470	482	31	is	be	AUX
ihlr-16470	482	32	the	the	DET
ihlr-16470	482	33	•gold	•gold	ADJ
ihlr-16470	482	34	-	-	PUNCT
ihlr-16470	482	35	standard	standard	NOUN
ihlr-16470	482	36	'	'	PUNCT
ihlr-16470	482	37	treatment	treatment	NOUN
ihlr-16470	482	38	"	"	PUNCT
ihlr-16470	482	39	141	141	NUM
ihlr-16470	482	40	.	.	PUNCT
ihlr-16470	483	1	see	see	VERB
ihlr-16470	483	2	stoffelmayr	stoffelmayr	PROPN
ihlr-16470	483	3	,	,	PUNCT
ihlr-16470	483	4	supra	supra	PROPN
ihlr-16470	483	5	note	note	VERB
ihlr-16470	483	6	101	101	NUM
ihlr-16470	483	7	at285	at285	PROPN
ihlr-16470	483	8	-	-	SYM
ihlr-16470	483	9	86	86	NUM
ihlr-16470	483	10	.	.	PUNCT
ihlr-16470	484	1	142	142	NUM
ihlr-16470	484	2	.	.	PUNCT
ihlr-16470	485	1	some	some	PRON
ihlr-16470	485	2	of	of	ADP
ihlr-16470	485	3	this	this	DET
ihlr-16470	485	4	difficulty	difficulty	NOUN
ihlr-16470	485	5	can	can	AUX
ihlr-16470	485	6	be	be	AUX
ihlr-16470	485	7	seen	see	VERB
ihlr-16470	485	8	in	in	ADP
ihlr-16470	485	9	the	the	DET
ihlr-16470	485	10	reasoning	reasoning	NOUN
ihlr-16470	485	11	and	and	CCONJ
ihlr-16470	485	12	arguments	argument	NOUN
ihlr-16470	485	13	found	find	VERB
ihlr-16470	485	14	in	in	ADP
ihlr-16470	485	15	needleman	needleman	PROPN
ihlr-16470	485	16	v.	v.	CCONJ
ihlr-16470	485	17	pfizer	pfizer	PROPN
ihlr-16470	485	18	,	,	PUNCT
ihlr-16470	485	19	lnc	lnc	PROPN
ihlr-16470	485	20	.	.	PUNCT
ihlr-16470	485	21	:	:	PUNCT
ihlr-16470	486	1	the	the	DET
ihlr-16470	486	2	fda	fda	PROPN
ihlr-16470	486	3	has	have	AUX
ihlr-16470	486	4	clearly	clearly	ADV
ihlr-16470	486	5	determined	determine	VERB
ihlr-16470	486	6	that	that	SCONJ
ihlr-16470	486	7	a	a	DET
ihlr-16470	486	8	warning	warning	NOUN
ihlr-16470	486	9	linking	link	VERB
ihlr-16470	486	10	zoloft	zoloft	NOUN
ihlr-16470	486	11	and	and	CCONJ
ihlr-16470	486	12	suicide	suicide	NOUN
ihlr-16470	486	13	would	would	AUX
ihlr-16470	486	14	be	be	AUX
ihlr-16470	486	15	false	false	ADJ
ihlr-16470	486	16	,	,	PUNCT
ihlr-16470	486	17	misleading	misleading	ADJ
ihlr-16470	486	18	,	,	PUNCT
ihlr-16470	486	19	and	and	CCONJ
ihlr-16470	486	20	harmful	harmful	ADJ
ihlr-16470	486	21	to	to	ADP
ihlr-16470	486	22	patients	patient	NOUN
ihlr-16470	486	23	.	.	PUNCT
ihlr-16470	487	1	plaintiffs	plaintiff	NOUN
ihlr-16470	487	2	'	'	PART
ihlr-16470	487	3	inadequate	inadequate	ADJ
ihlr-16470	487	4	warning	warning	NOUN
ihlr-16470	487	5	claim	claim	NOUN
ihlr-16470	487	6	would	would	AUX
ihlr-16470	487	7	thus	thus	ADV
ihlr-16470	487	8	conflict	conflict	VERB
ihlr-16470	487	9	with	with	ADP
ihlr-16470	487	10	the	the	DET
ihlr-16470	487	11	federal	federal	ADJ
ihlr-16470	487	12	requirements	requirement	NOUN
ihlr-16470	487	13	imposed	impose	VERB
ihlr-16470	487	14	during	during	ADP
ihlr-16470	487	15	the	the	DET
ihlr-16470	487	16	regulation	regulation	NOUN
ihlr-16470	487	17	of	of	ADP
ihlr-16470	487	18	zoloft	zoloft	NOUN
ihlr-16470	487	19	;	;	PUNCT
ihlr-16470	487	20	in	in	ADP
ihlr-16470	487	21	effect	effect	NOUN
ihlr-16470	487	22	allowing	allow	VERB
ihlr-16470	487	23	a	a	DET
ihlr-16470	487	24	state	state	NOUN
ihlr-16470	487	25	regulation	regulation	NOUN
ihlr-16470	487	26	to	to	PART
ihlr-16470	487	27	impose	impose	VERB
ihlr-16470	487	28	labeling	labeling	NOUN
ihlr-16470	487	29	requirements	requirement	NOUN
ihlr-16470	487	30	contrary	contrary	ADJ
ihlr-16470	487	31	to	to	ADP
ihlr-16470	487	32	those	those	PRON
ihlr-16470	487	33	required	require	VERB
ihlr-16470	487	34	by	by	ADP
ihlr-16470	487	35	federal	federal	ADJ
ihlr-16470	487	36	law	law	NOUN
ihlr-16470	487	37	....	....	PUNCT
ihlr-16470	488	1	plaintiffs	plaintiff	NOUN
ihlr-16470	488	2	'	'	PART
ihlr-16470	488	3	..	..	PUNCT
ihlr-16470	488	4	failure	failure	NOUN
ihlr-16470	488	5	to	to	PART
ihlr-16470	488	6	warn	warn	VERB
ihlr-16470	488	7	claim	claim	NOUN
ihlr-16470	488	8	"	"	PUNCT
ihlr-16470	488	9	seeks	seek	VERB
ihlr-16470	488	10	to	to	PART
ihlr-16470	488	11	impose	impose	VERB
ihlr-16470	488	12	liability	liability	NOUN
ihlr-16470	488	13	on	on	ADP
ihlr-16470	488	14	pfizer	pfizer	NOUN
ihlr-16470	488	15	for	for	ADP
ihlr-16470	488	16	not	not	PART
ihlr-16470	488	17	including	include	VERB
ihlr-16470	488	18	a	a	DET
ihlr-16470	488	19	warning	warning	NOUN
ihlr-16470	488	20	in	in	ADP
ihlr-16470	488	21	zoloft	zoloft	PROPN
ihlr-16470	488	22	packaging	packaging	NOUN
ihlr-16470	488	23	that	that	PRON
ihlr-16470	488	24	indicates	indicate	VERB
ihlr-16470	488	25	a	a	DET
ihlr-16470	488	26	relationship	relationship	NOUN
ihlr-16470	488	27	between	between	ADP
ihlr-16470	488	28	zoloft	zoloft	PROPN
ihlr-16470	488	29	and	and	CCONJ
ihlr-16470	488	30	suicide	suicide	NOUN
ihlr-16470	488	31	.	.	PUNCT
ihlr-16470	489	1	1n	1n	NUM
ihlr-16470	489	2	response	response	NOUN
ihlr-16470	489	3	.	.	PUNCT
ihlr-16470	490	1	pfizer	pfizer	NOUN
ihlr-16470	490	2	argues	argue	VERB
ihlr-16470	490	3	that	that	SCONJ
ihlr-16470	490	4	such	such	DET
ihlr-16470	490	5	a	a	DET
ihlr-16470	490	6	statement	statement	NOUN
ihlr-16470	490	7	would	would	AUX
ihlr-16470	490	8	be	be	AUX
ihlr-16470	490	9	considered	consider	VERB
ihlr-16470	490	10	..	..	PUNCT
ihlr-16470	490	11	false	false	ADJ
ihlr-16470	490	12	and	and	CCONJ
ihlr-16470	490	13	misleading	misleading	ADJ
ihlr-16470	490	14	"	"	PUNCT
ihlr-16470	490	15	by	by	ADP
ihlr-16470	490	16	the	the	DET
ihlr-16470	490	17	fda	fda	PROPN
ihlr-16470	490	18	,	,	PUNCT
ihlr-16470	490	19	and	and	CCONJ
ihlr-16470	490	20	would	would	AUX
ihlr-16470	490	21	directly	directly	ADV
ihlr-16470	490	22	conflict	conflict	VERB
ihlr-16470	490	23	with	with	ADP
ihlr-16470	490	24	thefdca	thefdca	PROPN
ihlr-16470	490	25	.	.	PUNCT
ihlr-16470	491	1	see21	see21	PROPN
ihlr-16470	491	2	u.s.c	u.s.c	ADJ
ihlr-16470	491	3	.	.	PUNCT
ihlr-16470	492	1	§	§	NOUN
ihlr-16470	492	2	355(d)(groundsforrefusinganewdrugapplication	355(d)(groundsforrefusinganewdrugapplication	NOUN
ihlr-16470	492	3	}	}	PUNCT
ihlr-16470	492	4	needleman	needleman	NOUN
ihlr-16470	492	5	v.	v.	ADP
ihlr-16470	492	6	pfizer	pfizer	PROPN
ihlr-16470	492	7	,	,	PUNCT
ihlr-16470	492	8	lnc	lnc	PROPN
ihlr-16470	492	9	.•	.•	PROPN
ihlr-16470	492	10	2004	2004	NUM
ihlr-16470	492	11	wl	wl	X
ihlr-16470	492	12	1773697	1773697	NUM
ihlr-16470	492	13	at	at	ADP
ihlr-16470	492	14	*	*	SYM
ihlr-16470	492	15	2	2	NUM
ihlr-16470	492	16	(	(	PUNCT
ihlr-16470	492	17	n.d	n.d	PROPN
ihlr-16470	492	18	.	.	PROPN
ihlr-16470	492	19	tex	tex	PROPN
ihlr-16470	492	20	.	.	PROPN
ihlr-16470	492	21	2004	2004	NUM
ihlr-16470	492	22	}	}	PUNCT
ihlr-16470	492	23	(	(	PUNCT
ihlr-16470	492	24	italics	italic	NOUN
ihlr-16470	492	25	in	in	ADP
ihlr-16470	492	26	original	original	ADJ
ihlr-16470	492	27	)	)	PUNCT
ihlr-16470	492	28	.	.	PUNCT
ihlr-16470	493	1	trial	trial	NOUN
ihlr-16470	493	2	lawyers	lawyer	NOUN
ihlr-16470	493	3	of	of	ADP
ihlr-16470	493	4	america	america	PROPN
ihlr-16470	493	5	,	,	PUNCT
ihlr-16470	493	6	governing	govern	VERB
ihlr-16470	493	7	product	product	NOUN
ihlr-16470	493	8	safety	safety	NOUN
ihlr-16470	493	9	:	:	PUNCT
ihlr-16470	493	10	are	be	AUX
ihlr-16470	493	11	government	government	NOUN
ihlr-16470	493	12	regulatory	regulatory	ADJ
ihlr-16470	493	13	agencies	agency	NOUN
ihlr-16470	493	14	doing	do	VERB
ihlr-16470	493	15	220	220	NUM
ihlr-16470	493	16	indiana	indiana	PROPN
ihlr-16470	493	17	heal1h	heal1h	PROPN
ihlr-16470	493	18	law	law	NOUN
ihlr-16470	493	19	review	review	NOUN
ihlr-16470	493	20	[	[	X
ihlr-16470	493	21	vol	vol	NOUN
ihlr-16470	493	22	.	.	PUNCT
ihlr-16470	494	1	3:201	3:201	NUM
ihlr-16470	494	2	despite	despite	SCONJ
ihlr-16470	494	3	the	the	DET
ihlr-16470	494	4	duties	duty	NOUN
ihlr-16470	494	5	placed	place	VERB
ihlr-16470	494	6	on	on	ADP
ihlr-16470	494	7	manufacturers	manufacturer	NOUN
ihlr-16470	494	8	to	to	PART
ihlr-16470	494	9	adequately	adequately	ADV
ihlr-16470	494	10	warn	warn	VERB
ihlr-16470	494	11	of	of	ADP
ihlr-16470	494	12	a	a	DET
ihlr-16470	494	13	drug	drug	NOUN
ihlr-16470	494	14	's	's	PART
ihlr-16470	494	15	risks	risk	NOUN
ihlr-16470	494	16	,	,	PUNCT
ihlr-16470	494	17	plaintiffs	plaintiff	NOUN
ihlr-16470	494	18	still	still	ADV
ihlr-16470	494	19	face	face	VERB
ihlr-16470	494	20	a	a	DET
ihlr-16470	494	21	difficult	difficult	ADJ
ihlr-16470	494	22	road	road	NOUN
ihlr-16470	494	23	in	in	ADP
ihlr-16470	494	24	seeking	seek	VERB
ihlr-16470	494	25	recovery	recovery	NOUN
ihlr-16470	494	26	.	.	PUNCT
ihlr-16470	495	1	a	a	DET
ihlr-16470	495	2	plaintiff	plaintiff	NOUN
ihlr-16470	495	3	must	must	AUX
ihlr-16470	495	4	prove	prove	VERB
ihlr-16470	495	5	two	two	NUM
ihlr-16470	495	6	elements	element	NOUN
ihlr-16470	495	7	to	to	PART
ihlr-16470	495	8	recover	recover	VERB
ihlr-16470	495	9	on	on	ADP
ihlr-16470	495	10	a	a	DET
ihlr-16470	495	11	failure	failure	NOUN
ihlr-16470	495	12	to	to	PART
ihlr-16470	495	13	warn	warn	VERB
ihlr-16470	495	14	claim	claim	NOUN
ihlr-16470	495	15	.	.	PUNCT
ihlr-16470	496	1	the	the	DET
ihlr-16470	496	2	plaintiff	plaintiff	NOUN
ihlr-16470	496	3	must	must	AUX
ihlr-16470	496	4	show	show	VERB
ihlr-16470	496	5	that	that	SCONJ
ihlr-16470	496	6	1	1	X
ihlr-16470	496	7	)	)	PUNCT
ihlr-16470	496	8	the	the	DET
ihlr-16470	496	9	drug	drug	NOUN
ihlr-16470	496	10	caused	cause	VERB
ihlr-16470	496	11	the	the	DET
ihlr-16470	496	12	injury	injury	NOUN
ihlr-16470	496	13	;	;	PUNCT
ihlr-16470	496	14	and	and	CCONJ
ihlr-16470	496	15	2	2	X
ihlr-16470	496	16	)	)	PUNCT
ihlr-16470	496	17	that	that	SCONJ
ihlr-16470	496	18	a	a	DET
ihlr-16470	496	19	different	different	ADJ
ihlr-16470	496	20	or	or	CCONJ
ihlr-16470	496	21	alternate	alternate	ADJ
ihlr-16470	496	22	warning	warning	NOUN
ihlr-16470	496	23	would	would	AUX
ihlr-16470	496	24	have	have	AUX
ihlr-16470	496	25	changed	change	VERB
ihlr-16470	496	26	the	the	DET
ihlr-16470	496	27	decision	decision	NOUN
ihlr-16470	496	28	to	to	PART
ihlr-16470	496	29	prescribe	prescribe	VERB
ihlr-16470	496	30	the	the	DET
ihlr-16470	496	31	drug.143	drug.143	NOUN
ihlr-16470	496	32	it	it	PRON
ihlr-16470	496	33	is	be	AUX
ihlr-16470	496	34	often	often	ADV
ihlr-16470	496	35	the	the	DET
ihlr-16470	496	36	second	second	ADJ
ihlr-16470	496	37	element	element	NOUN
ihlr-16470	496	38	that	that	PRON
ihlr-16470	496	39	proves	prove	VERB
ihlr-16470	496	40	the	the	DET
ihlr-16470	496	41	most	most	ADV
ihlr-16470	496	42	significant	significant	ADJ
ihlr-16470	496	43	hurdle	hurdle	NOUN
ihlr-16470	496	44	in	in	ADP
ihlr-16470	496	45	drug	drug	NOUN
ihlr-16470	496	46	manufacturer	manufacturer	NOUN
ihlr-16470	496	47	liability	liability	NOUN
ihlr-16470	496	48	cases	case	NOUN
ihlr-16470	496	49	.	.	PUNCT
ihlr-16470	497	1	even	even	ADV
ihlr-16470	497	2	if	if	SCONJ
ihlr-16470	497	3	the	the	DET
ihlr-16470	497	4	drug	drug	NOUN
ihlr-16470	497	5	is	be	AUX
ihlr-16470	497	6	proven	prove	VERB
ihlr-16470	497	7	to	to	PART
ihlr-16470	497	8	have	have	AUX
ihlr-16470	497	9	caused	cause	VERB
ihlr-16470	497	10	the	the	DET
ihlr-16470	497	11	injury	injury	NOUN
ihlr-16470	497	12	,	,	PUNCT
ihlr-16470	497	13	the	the	DET
ihlr-16470	497	14	plaintiff	plaintiff	NOUN
ihlr-16470	497	15	must	must	AUX
ihlr-16470	497	16	show	show	VERB
ihlr-16470	497	17	that	that	SCONJ
ihlr-16470	497	18	the	the	DET
ihlr-16470	497	19	warning	warning	NOUN
ihlr-16470	497	20	provided	provide	VERB
ihlr-16470	497	21	by	by	ADP
ihlr-16470	497	22	the	the	DET
ihlr-16470	497	23	manufacturer	manufacturer	NOUN
ihlr-16470	497	24	was	be	AUX
ihlr-16470	497	25	relied	rely	VERB
ihlr-16470	497	26	upon	upon	SCONJ
ihlr-16470	497	27	.	.	PUNCT
ihlr-16470	498	1	144	144	NUM
ihlr-16470	498	2	there	there	PRON
ihlr-16470	498	3	are	be	VERB
ihlr-16470	498	4	two	two	NUM
ihlr-16470	498	5	aspects	aspect	NOUN
ihlr-16470	498	6	to	to	ADP
ihlr-16470	498	7	this	this	DET
ihlr-16470	498	8	element	element	NOUN
ihlr-16470	498	9	that	that	PRON
ihlr-16470	498	10	make	make	VERB
ihlr-16470	498	11	it	it	PRON
ihlr-16470	498	12	difficult	difficult	ADJ
ihlr-16470	498	13	for	for	SCONJ
ihlr-16470	498	14	the	the	DET
ihlr-16470	498	15	plaintiff	plaintiff	NOUN
ihlr-16470	498	16	to	to	PART
ihlr-16470	498	17	overcome	overcome	VERB
ihlr-16470	498	18	:	:	PUNCT
ihlr-16470	498	19	1	1	X
ihlr-16470	498	20	)	)	PUNCT
ihlr-16470	498	21	who	who	PRON
ihlr-16470	498	22	must	must	AUX
ihlr-16470	498	23	rely	rely	VERB
ihlr-16470	498	24	on	on	ADP
ihlr-16470	498	25	the	the	DET
ihlr-16470	498	26	warning	warning	NOUN
ihlr-16470	498	27	(	(	PUNCT
ihlr-16470	498	28	the	the	DET
ihlr-16470	498	29	choice	choice	NOUN
ihlr-16470	498	30	of	of	ADP
ihlr-16470	498	31	the	the	DET
ihlr-16470	498	32	word	word	NOUN
ihlr-16470	498	33	prescribe	prescribe	NOUN
ihlr-16470	498	34	in	in	ADP
ihlr-16470	498	35	the	the	DET
ihlr-16470	498	36	element	element	NOUN
ihlr-16470	498	37	suggests	suggest	VERB
ihlr-16470	498	38	that	that	SCONJ
ihlr-16470	498	39	it	it	PRON
ihlr-16470	498	40	is	be	AUX
ihlr-16470	498	41	the	the	DET
ihlr-16470	498	42	doctor	doctor	NOUN
ihlr-16470	498	43	who	who	PRON
ihlr-16470	498	44	must	must	AUX
ihlr-16470	498	45	be	be	AUX
ihlr-16470	498	46	warned	warn	VERB
ihlr-16470	498	47	,	,	PUNCT
ihlr-16470	498	48	which	which	PRON
ihlr-16470	498	49	is	be	AUX
ihlr-16470	498	50	discussed	discuss	VERB
ihlr-16470	498	51	below	below	ADV
ihlr-16470	498	52	)	)	PUNCT
ihlr-16470	498	53	;	;	PUNCT
ihlr-16470	498	54	and2)proofofreliance	and2)proofofreliance	NUM
ihlr-16470	498	55	.	.	PUNCT
ihlr-16470	499	1	for	for	ADP
ihlr-16470	499	2	example	example	NOUN
ihlr-16470	499	3	,	,	PUNCT
ihlr-16470	499	4	a	a	DET
ihlr-16470	499	5	plaintiff	plaintiff	NOUN
ihlr-16470	499	6	may	may	AUX
ihlr-16470	499	7	not	not	PART
ihlr-16470	499	8	recover	recover	VERB
ihlr-16470	499	9	if	if	SCONJ
ihlr-16470	499	10	he	he	PRON
ihlr-16470	499	11	or	or	CCONJ
ihlr-16470	499	12	she	she	PRON
ihlr-16470	499	13	did	do	AUX
ihlr-16470	499	14	not	not	PART
ihlr-16470	499	15	read	read	VERB
ihlr-16470	499	16	the	the	DET
ihlr-16470	499	17	included	include	VERB
ihlr-16470	499	18	warning	warning	NOUN
ihlr-16470	499	19	,	,	PUNCT
ihlr-16470	499	20	even	even	ADV
ihlr-16470	499	21	if	if	SCONJ
ihlr-16470	499	22	that	that	DET
ihlr-16470	499	23	warning	warning	NOUN
ihlr-16470	499	24	would	would	AUX
ihlr-16470	499	25	have	have	AUX
ihlr-16470	499	26	been	be	AUX
ihlr-16470	499	27	inadequate	inadequate	ADJ
ihlr-16470	499	28	if	if	SCONJ
ihlr-16470	499	29	relied	rely	VERB
ihlr-16470	499	30	upon.145	upon.145	PROPN
ihlr-16470	499	31	3	3	NUM
ihlr-16470	499	32	.	.	PUNCT
ihlr-16470	499	33	learned	learn	VERB
ihlr-16470	499	34	intermediary	intermediary	ADJ
ihlr-16470	499	35	doctrine	doctrine	NOUN
ihlr-16470	499	36	the	the	DET
ihlr-16470	499	37	learned	learn	VERB
ihlr-16470	499	38	intermediary	intermediary	ADJ
ihlr-16470	499	39	doctrine	doctrine	NOUN
ihlr-16470	499	40	is	be	AUX
ihlr-16470	499	41	very	very	ADV
ihlr-16470	499	42	important	important	ADJ
ihlr-16470	499	43	in	in	ADP
ihlr-16470	499	44	drug	drug	NOUN
ihlr-16470	499	45	liability	liability	NOUN
ihlr-16470	499	46	cases	case	NOUN
ihlr-16470	499	47	because	because	SCONJ
ihlr-16470	499	48	it	it	PRON
ihlr-16470	499	49	resolves	resolve	VERB
ihlr-16470	499	50	the	the	DET
ihlr-16470	499	51	questions	question	NOUN
ihlr-16470	499	52	of	of	ADP
ihlr-16470	499	53	who	who	PRON
ihlr-16470	499	54	the	the	DET
ihlr-16470	499	55	drug	drug	NOUN
ihlr-16470	499	56	company	company	NOUN
ihlr-16470	499	57	must	must	AUX
ihlr-16470	499	58	warn	warn	VERB
ihlr-16470	499	59	and	and	CCONJ
ihlr-16470	499	60	who	who	PRON
ihlr-16470	499	61	must	must	AUX
ihlr-16470	499	62	rely	rely	VERB
ihlr-16470	499	63	on	on	ADP
ihlr-16470	499	64	that	that	DET
ihlr-16470	499	65	warning	warning	NOUN
ihlr-16470	499	66	and	and	CCONJ
ihlr-16470	499	67	it	it	PRON
ihlr-16470	499	68	insulates	insulate	VERB
ihlr-16470	499	69	the	the	DET
ihlr-16470	499	70	drug	drug	NOUN
ihlr-16470	499	71	companies	company	NOUN
ihlr-16470	499	72	from	from	ADP
ihlr-16470	499	73	liability	liability	NOUN
ihlr-16470	499	74	for	for	ADP
ihlr-16470	499	75	off	off	ADP
ihlr-16470	499	76	-	-	PUNCT
ihlr-16470	499	77	label	label	NOUN
ihlr-16470	499	78	prescriptions	prescription	NOUN
ihlr-16470	499	79	.	.	PUNCT
ihlr-16470	500	1	under	under	ADP
ihlr-16470	500	2	this	this	DET
ihlr-16470	500	3	doctrine	doctrine	NOUN
ihlr-16470	500	4	,	,	PUNCT
ihlr-16470	500	5	the	the	DET
ihlr-16470	500	6	drug	drug	NOUN
ihlr-16470	500	7	company	company	NOUN
ihlr-16470	500	8	fulfills	fulfill	VERB
ihlr-16470	500	9	its	its	PRON
ihlr-16470	500	10	obligations	obligation	NOUN
ihlr-16470	500	11	by	by	ADP
ihlr-16470	500	12	informing	inform	VERB
ihlr-16470	500	13	the	the	DET
ihlr-16470	500	14	prescribing	prescribe	VERB
ihlr-16470	500	15	doctor	doctor	NOUN
ihlr-16470	500	16	of	of	ADP
ihlr-16470	500	17	a	a	DET
ihlr-16470	500	18	drug	drug	NOUN
ihlr-16470	500	19	's	's	PART
ihlr-16470	500	20	inherent	inherent	ADJ
ihlr-16470	500	21	risks.146	risks.146	NOUN
ihlr-16470	500	22	courts	court	NOUN
ihlr-16470	500	23	apply	apply	VERB
ihlr-16470	500	24	the	the	DET
ihlr-16470	500	25	learned	learn	VERB
ihlr-16470	500	26	intermediary	intermediary	ADJ
ihlr-16470	500	27	doctrine	doctrine	NOUN
ihlr-16470	500	28	on	on	ADP
ihlr-16470	500	29	a	a	DET
ihlr-16470	500	30	case	case	NOUN
ihlr-16470	500	31	-	-	PUNCT
ihlr-16470	500	32	by	by	ADP
ihlr-16470	500	33	-	-	PUNCT
ihlr-16470	500	34	case	case	NOUN
ihlr-16470	500	35	basis	basis	NOUN
ihlr-16470	500	36	.	.	PUNCT
ihlr-16470	501	1	however	however	ADV
ihlr-16470	501	2	,	,	PUNCT
ihlr-16470	501	3	it	it	PRON
ihlr-16470	501	4	is	be	AUX
ihlr-16470	501	5	applied	apply	VERB
ihlr-16470	501	6	almost	almost	ADV
ihlr-16470	501	7	universally	universally	ADV
ihlr-16470	501	8	in	in	ADP
ihlr-16470	501	9	cases	case	NOUN
ihlr-16470	501	10	involving	involve	VERB
ihlr-16470	501	11	prescription	prescription	NOUN
ihlr-16470	501	12	drugs	drug	NOUN
ihlr-16470	501	13	and	and	CCONJ
ihlr-16470	501	14	medical	medical	ADJ
ihlr-16470	501	15	devices	device	NOUN
ihlr-16470	501	16	because	because	SCONJ
ihlr-16470	501	17	the	the	DET
ihlr-16470	501	18	doctrine	doctrine	NOUN
ihlr-16470	501	19	takes	take	VERB
ihlr-16470	501	20	into	into	ADP
ihlr-16470	501	21	account	account	NOUN
ihlr-16470	501	22	enough	enough	ADV
ihlr-16470	501	23	to	to	PART
ihlr-16470	501	24	ensure	ensure	VERB
ihlr-16470	501	25	that	that	SCONJ
ihlr-16470	501	26	consumer	consumer	NOUN
ihlr-16470	501	27	products	product	NOUN
ihlr-16470	501	28	are	be	AUX
ihlr-16470	501	29	safe	safe	ADJ
ihlr-16470	501	30	?	?	PUNCT
ihlr-16470	502	1	two	two	NUM
ihlr-16470	502	2	anorneys	anorney	NOUN
ihlr-16470	502	3	from	from	ADP
ihlr-16470	502	4	consumers	consumer	NOUN
ihlr-16470	502	5	union	union	PROPN
ihlr-16470	502	6	discuss	discuss	VERB
ihlr-16470	502	7	the	the	DET
ihlr-16470	502	8	system	system	NOUN
ihlr-16470	502	9	's	's	PART
ihlr-16470	502	10	weaknesses	weakness	NOUN
ihlr-16470	502	11	and	and	CCONJ
ihlr-16470	502	12	needed	need	VERB
ihlr-16470	502	13	improvements	improvement	NOUN
ihlr-16470	502	14	,	,	PUNCT
ihlr-16470	502	15	40	40	NUM
ihlr-16470	502	16	trial	trial	NOUN
ihlr-16470	502	17	26	26	NUM
ihlr-16470	502	18	,	,	PUNCT
ihlr-16470	502	19	28	28	NUM
ihlr-16470	502	20	(	(	PUNCT
ihlr-16470	502	21	nov	nov	PROPN
ihlr-16470	502	22	.	.	PROPN
ihlr-16470	502	23	2004	2004	NUM
ihlr-16470	502	24	)	)	PUNCT
ihlr-16470	502	25	(	(	PUNCT
ihlr-16470	502	26	"	"	PUNCT
ihlr-16470	502	27	fda	fda	PROPN
ihlr-16470	502	28	regulations	regulation	NOUN
ihlr-16470	502	29	are	be	AUX
ihlr-16470	502	30	the	the	DET
ihlr-16470	502	31	•ceiling	•ceiling	NOUN
ihlr-16470	502	32	'	'	PUNCT
ihlr-16470	502	33	as	as	ADP
ihlr-16470	502	34	wen	wen	PROPN
ihlr-16470	502	35	as	as	ADP
ihlr-16470	502	36	the	the	DET
ihlr-16470	502	37	•floor	•floor	NOUN
ihlr-16470	502	38	'	'	PUNCT
ihlr-16470	502	39	of	of	ADP
ihlr-16470	502	40	requirements	requirement	NOUN
ihlr-16470	502	41	for	for	ADP
ihlr-16470	502	42	drug	drug	NOUN
ihlr-16470	502	43	makers	maker	NOUN
ihlr-16470	502	44	.	.	PUNCT
ihlr-16470	503	1	"	"	PUNCT
ihlr-16470	503	2	)	)	PUNCT
ihlr-16470	503	3	.	.	PUNCT
ihlr-16470	504	1	143	143	X
ihlr-16470	504	2	.	.	PUNCT
ihlr-16470	505	1	see	see	VERB
ihlr-16470	505	2	miller	miller	PROPN
ihlr-16470	505	3	,	,	PUNCT
ihlr-16470	505	4	196	196	NUM
ihlr-16470	505	5	f.	f.	PROPN
ihlr-16470	505	6	supp	supp	PROPN
ihlr-16470	505	7	.	.	PUNCT
ihlr-16470	506	1	at	at	ADP
ihlr-16470	506	2	1124	1124	NUM
ihlr-16470	506	3	(	(	PUNCT
ihlr-16470	506	4	2002	2002	NUM
ihlr-16470	506	5	)	)	PUNCT
ihlr-16470	506	6	.	.	PUNCT
ihlr-16470	507	1	144	144	NUM
ihlr-16470	507	2	.	.	PUNCT
ihlr-16470	507	3	seeid	seeid	NOUN
ihlr-16470	507	4	.	.	PUNCT
ihlr-16470	508	1	145	145	NUM
ihlr-16470	508	2	.	.	PUNCT
ihlr-16470	509	1	heafey	heafey	PROPN
ihlr-16470	509	2	&	&	CCONJ
ihlr-16470	509	3	kennedy	kennedy	PROPN
ihlr-16470	509	4	supra	supra	PROPN
ihlr-16470	509	5	note	note	VERB
ihlr-16470	509	6	120	120	NUM
ihlr-16470	509	7	at§	at§	NOUN
ihlr-16470	509	8	10.03	10.03	NUM
ihlr-16470	509	9	;	;	PUNCT
ihlr-16470	509	10	see	see	VERB
ihlr-16470	509	11	also	also	ADV
ihlr-16470	509	12	,	,	PUNCT
ihlr-16470	509	13	motus	motus	PROPN
ihlr-16470	509	14	v.	v.	ADP
ihlr-16470	509	15	pfizer	pfizer	PROPN
ihlr-16470	509	16	,	,	PUNCT
ihlr-16470	509	17	inc	inc	PROPN
ihlr-16470	509	18	.	.	PROPN
ihlr-16470	509	19	,	,	PUNCT
ihlr-16470	509	20	358	358	NUM
ihlr-16470	509	21	f.3d	f.3d	NUM
ihlr-16470	509	22	659	659	NUM
ihlr-16470	509	23	,	,	PUNCT
ihlr-16470	509	24	661	661	NUM
ihlr-16470	509	25	(	(	PUNCT
ihlr-16470	509	26	9th	9th	ADJ
ihlr-16470	509	27	cir	cir	NOUN
ihlr-16470	509	28	.	.	PUNCT
ihlr-16470	509	29	2004	2004	NUM
ihlr-16470	509	30	)	)	PUNCT
ihlr-16470	510	1	(	(	PUNCT
ihlr-16470	510	2	"	"	PUNCT
ihlr-16470	510	3	because	because	SCONJ
ihlr-16470	510	4	the	the	DET
ihlr-16470	510	5	doctor	doctor	NOUN
ihlr-16470	510	6	testified	testify	VERB
ihlr-16470	510	7	that	that	SCONJ
ihlr-16470	510	8	he	he	PRON
ihlr-16470	510	9	did	do	AUX
ihlr-16470	510	10	not	not	PART
ihlr-16470	510	11	read	read	VERB
ihlr-16470	510	12	the	the	DET
ihlr-16470	510	13	warning	warning	NOUN
ihlr-16470	510	14	label	label	NOUN
ihlr-16470	510	15	that	that	PRON
ihlr-16470	510	16	accompanied	accompany	VERB
ihlr-16470	510	17	zoloft	zoloft	PROPN
ihlr-16470	510	18	or	or	CCONJ
ihlr-16470	510	19	rely	rely	VERB
ihlr-16470	510	20	on	on	ADP
ihlr-16470	510	21	information	information	NOUN
ihlr-16470	510	22	provided	provide	VERB
ihlr-16470	510	23	by	by	ADP
ihlr-16470	510	24	[	[	X
ihlr-16470	510	25	pfizer	pfizer	X
ihlr-16470	510	26	]	]	PUNCT
ihlr-16470	510	27	...	...	PUNCT
ihlr-16470	510	28	the	the	DET
ihlr-16470	510	29	adequacy	adequacy	NOUN
ihlr-16470	510	30	of	of	ADP
ihlr-16470	510	31	pfizer	pfizer	NOUN
ihlr-16470	510	32	's	's	PART
ihlr-16470	510	33	warnings	warning	NOUN
ihlr-16470	510	34	is	be	AUX
ihlr-16470	510	35	irrelevant	irrelevant	ADJ
ihlr-16470	510	36	....	....	PUNCT
ihlr-16470	511	1	[	[	X
ihlr-16470	511	2	therefore	therefore	X
ihlr-16470	511	3	]	]	X
ihlr-16470	511	4	a	a	DET
ihlr-16470	511	5	product	product	NOUN
ihlr-16470	511	6	defect	defect	NOUN
ihlr-16470	511	7	claim	claim	NOUN
ihlr-16470	511	8	based	base	VERB
ihlr-16470	511	9	on	on	ADP
ihlr-16470	511	10	insufficient	insufficient	ADJ
ihlr-16470	511	11	warnings	warning	NOUN
ihlr-16470	511	12	can	can	AUX
ihlr-16470	511	13	not	not	PART
ihlr-16470	511	14	survive	survive	VERB
ihlr-16470	511	15	summary	summary	NOUN
ihlr-16470	511	16	judgment	judgment	NOUN
ihlr-16470	511	17	if	if	SCONJ
ihlr-16470	511	18	stronger	strong	ADJ
ihlr-16470	511	19	warnings	warning	NOUN
ihlr-16470	511	20	would	would	AUX
ihlr-16470	511	21	not	not	PART
ihlr-16470	511	22	have	have	AUX
ihlr-16470	511	23	altered	alter	VERB
ihlr-16470	511	24	the	the	DET
ihlr-16470	511	25	conduct	conduct	NOUN
ihlr-16470	511	26	of	of	ADP
ihlr-16470	511	27	the	the	DET
ihlr-16470	511	28	prescribing	prescribing	NOUN
ihlr-16470	511	29	physician	physician	NOUN
ihlr-16470	511	30	.	.	PUNCT
ihlr-16470	511	31	"	"	PUNCT
ihlr-16470	511	32	)	)	PUNCT
ihlr-16470	511	33	.	.	PUNCT
ihlr-16470	512	1	146	146	NUM
ihlr-16470	512	2	.	.	PUNCT
ihlr-16470	512	3	miller	miller	PROPN
ihlr-16470	512	4	,	,	PUNCT
ihlr-16470	512	5	196	196	NUM
ihlr-16470	512	6	f.	f.	PROPN
ihlr-16470	512	7	supp	supp	PROPN
ihlr-16470	512	8	.	.	PUNCT
ihlr-16470	513	1	2d	2d	PROPN
ihlr-16470	513	2	at	at	ADP
ihlr-16470	513	3	1121	1121	NUM
ihlr-16470	513	4	(	(	PUNCT
ihlr-16470	513	5	2002	2002	NUM
ihlr-16470	513	6	)	)	PUNCT
ihlr-16470	513	7	(	(	PUNCT
ihlr-16470	513	8	citing	cite	VERB
ihlr-16470	513	9	nichols	nichols	PROPN
ihlr-16470	513	10	v.	v.	ADP
ihlr-16470	513	11	cent	cent	NOUN
ihlr-16470	513	12	.	.	PUNCT
ihlr-16470	514	1	merch	merch	PROPN
ihlr-16470	514	2	.	.	PUNCT
ihlr-16470	514	3	,	,	PUNCT
ihlr-16470	514	4	inc	inc	PROPN
ihlr-16470	514	5	.	.	PROPN
ihlr-16470	514	6	,	,	PUNCT
ihlr-16470	514	7	16	16	NUM
ihlr-16470	514	8	kan.app.2d	kan.app.2d	NOUN
ihlr-16470	514	9	65	65	NUM
ihlr-16470	514	10	,	,	PUNCT
ihlr-16470	514	11	67	67	NUM
ihlr-16470	514	12	,	,	PUNCT
ihlr-16470	514	13	817	817	NUM
ihlr-16470	514	14	p.2d	p.2d	SYM
ihlr-16470	514	15	1131	1131	NUM
ihlr-16470	514	16	,	,	PUNCT
ihlr-16470	514	17	1133	1133	NUM
ihlr-16470	514	18	(	(	PUNCT
ihlr-16470	514	19	kan	kan	PROPN
ihlr-16470	514	20	.	.	PUNCT
ihlr-16470	515	1	ct	ct	PROPN
ihlr-16470	515	2	.	.	PUNCT
ihlr-16470	516	1	app	app	PROPN
ihlr-16470	516	2	.	.	PROPN
ihlr-16470	516	3	1991	1991	NUM
ihlr-16470	516	4	)	)	PUNCT
ihlr-16470	516	5	)	)	PUNCT
ihlr-16470	516	6	.	.	PUNCT
ihlr-16470	517	1	2006	2006	NUM
ihlr-16470	517	2	]	]	PUNCT
ihlr-16470	517	3	anti	anti	NOUN
ihlr-16470	517	4	-	-	NOUN
ihlr-16470	517	5	depressants	depressant	NOUN
ihlr-16470	517	6	and	and	CCONJ
ihlr-16470	517	7	children	child	NOUN
ihlr-16470	517	8	221	221	NUM
ihlr-16470	517	9	the	the	DET
ihlr-16470	517	10	complex	complex	ADJ
ihlr-16470	517	11	role	role	NOUN
ihlr-16470	517	12	physicians	physician	NOUN
ihlr-16470	517	13	play	play	VERB
ihlr-16470	517	14	in	in	ADP
ihlr-16470	517	15	the	the	DET
ihlr-16470	517	16	treatment	treatment	NOUN
ihlr-16470	517	17	of	of	ADP
ihlr-16470	517	18	patients.147	patients.147	PROPN
ihlr-16470	517	19	as	as	ADP
ihlr-16470	517	20	a	a	DET
ihlr-16470	517	21	result	result	NOUN
ihlr-16470	517	22	,	,	PUNCT
ihlr-16470	517	23	this	this	DET
ihlr-16470	517	24	doctrine	doctrine	NOUN
ihlr-16470	517	25	effectively	effectively	ADV
ihlr-16470	517	26	relieves	relieve	VERB
ihlr-16470	517	27	a	a	DET
ihlr-16470	517	28	manufacturer	manufacturer	NOUN
ihlr-16470	517	29	of	of	ADP
ihlr-16470	517	30	liability	liability	NOUN
ihlr-16470	517	31	.	.	PUNCT
ihlr-16470	518	1	in	in	ADP
ihlr-16470	518	2	the	the	DET
ihlr-16470	518	3	case	case	NOUN
ihlr-16470	518	4	of	of	ADP
ihlr-16470	518	5	ssris	ssris	NOUN
ihlr-16470	518	6	,	,	PUNCT
ihlr-16470	518	7	manufacturers	manufacturer	NOUN
ihlr-16470	518	8	may	may	AUX
ihlr-16470	518	9	be	be	AUX
ihlr-16470	518	10	relieved	relieve	VERB
ihlr-16470	518	11	of	of	ADP
ihlr-16470	518	12	liability	liability	NOUN
ihlr-16470	518	13	even	even	ADV
ihlr-16470	518	14	if	if	SCONJ
ihlr-16470	518	15	they	they	PRON
ihlr-16470	518	16	failed	fail	VERB
ihlr-16470	518	17	to	to	PART
ihlr-16470	518	18	adequately	adequately	ADV
ihlr-16470	518	19	warn	warn	VERB
ihlr-16470	518	20	the	the	DET
ihlr-16470	518	21	medical	medical	ADJ
ihlr-16470	518	22	community	community	NOUN
ihlr-16470	518	23	.	.	PUNCT
ihlr-16470	519	1	148	148	NUM
ihlr-16470	519	2	nevertheless	nevertheless	ADV
ihlr-16470	519	3	,	,	PUNCT
ihlr-16470	519	4	some	some	DET
ihlr-16470	519	5	courts	court	NOUN
ihlr-16470	519	6	have	have	AUX
ihlr-16470	519	7	rejected	reject	VERB
ihlr-16470	519	8	the	the	DET
ihlr-16470	519	9	doctrine	doctrine	NOUN
ihlr-16470	519	10	in	in	ADP
ihlr-16470	519	11	cases	case	NOUN
ihlr-16470	519	12	involving	involve	VERB
ihlr-16470	519	13	drugs	drug	NOUN
ihlr-16470	519	14	and	and	CCONJ
ihlr-16470	519	15	medical	medical	ADJ
ihlr-16470	519	16	devices	device	NOUN
ihlr-16470	519	17	for	for	ADP
ihlr-16470	519	18	contraception	contraception	NOUN
ihlr-16470	519	19	and	and	CCONJ
ihlr-16470	519	20	some	some	PRON
ihlr-16470	519	21	vaccines.149	vaccines.149	VERB
ihlr-16470	519	22	these	these	DET
ihlr-16470	519	23	courts	court	NOUN
ihlr-16470	519	24	have	have	AUX
ihlr-16470	519	25	rejected	reject	VERB
ihlr-16470	519	26	the	the	DET
ihlr-16470	519	27	learned	learn	VERB
ihlr-16470	519	28	intermediary	intermediary	ADJ
ihlr-16470	519	29	doctrine	doctrine	NOUN
ihlr-16470	519	30	in	in	ADP
ihlr-16470	519	31	cases	case	NOUN
ihlr-16470	519	32	involving	involve	VERB
ihlr-16470	519	33	contraception	contraception	NOUN
ihlr-16470	519	34	because	because	SCONJ
ihlr-16470	519	35	the	the	DET
ihlr-16470	519	36	choice	choice	NOUN
ihlr-16470	519	37	of	of	ADP
ihlr-16470	519	38	contraception	contraception	NOUN
ihlr-16470	519	39	is	be	AUX
ihlr-16470	519	40	personal	personal	ADJ
ihlr-16470	519	41	rather	rather	ADV
ihlr-16470	519	42	than	than	ADP
ihlr-16470	519	43	medical	medical	ADJ
ihlr-16470	519	44	,	,	PUNCT
ihlr-16470	519	45	thus	thus	ADV
ihlr-16470	519	46	the	the	DET
ihlr-16470	519	47	consumer	consumer	NOUN
ihlr-16470	519	48	is	be	AUX
ihlr-16470	519	49	entitled	entitle	VERB
ihlr-16470	519	50	to	to	PART
ihlr-16470	519	51	direct	direct	VERB
ihlr-16470	519	52	communication	communication	NOUN
ihlr-16470	519	53	from	from	ADP
ihlr-16470	519	54	the	the	DET
ihlr-16470	519	55	drug	drug	NOUN
ihlr-16470	519	56	manufacturers	manufacturer	NOUN
ihlr-16470	519	57	in	in	ADP
ihlr-16470	519	58	order	order	NOUN
ihlr-16470	519	59	to	to	PART
ihlr-16470	519	60	make	make	VERB
ihlr-16470	519	61	her	she	PRON
ihlr-16470	519	62	decision.150	decision.150	VERB
ihlr-16470	519	63	the	the	DET
ihlr-16470	519	64	doctrine	doctrine	NOUN
ihlr-16470	519	65	has	have	AUX
ihlr-16470	519	66	not	not	PART
ihlr-16470	519	67	applied	apply	VERB
ihlr-16470	519	68	in	in	ADP
ihlr-16470	519	69	cases	case	NOUN
ihlr-16470	519	70	where	where	SCONJ
ihlr-16470	519	71	vaccines	vaccine	NOUN
ihlr-16470	519	72	''	''	PUNCT
ihlr-16470	519	73	were	be	AUX
ihlr-16470	519	74	administered	administer	VERB
ihlr-16470	519	75	to	to	ADP
ihlr-16470	519	76	all	all	DET
ihlr-16470	519	77	comers	comer	NOUN
ihlr-16470	519	78	in	in	ADP
ihlr-16470	519	79	a	a	DET
ihlr-16470	519	80	'	'	PUNCT
ihlr-16470	519	81	clinic	clinic	NOUN
ihlr-16470	519	82	-	-	PUNCT
ihlr-16470	519	83	type	type	NOUN
ihlr-16470	519	84	'	'	PUNCT
ihlr-16470	519	85	setting	setting	NOUN
ihlr-16470	519	86	without	without	SCONJ
ihlr-16470	519	87	a	a	DET
ihlr-16470	519	88	physicians	physician	NOUN
ihlr-16470	519	89	particularized	particularize	VERB
ihlr-16470	519	90	weighing	weighing	NOUN
ihlr-16470	519	91	of	of	ADP
ihlr-16470	519	92	the	the	DET
ihlr-16470	519	93	product	product	NOUN
ihlr-16470	519	94	's	's	PART
ihlr-16470	519	95	risks	risk	NOUN
ihlr-16470	519	96	and	and	CCONJ
ihlr-16470	519	97	benefits	benefit	NOUN
ihlr-16470	519	98	for	for	ADP
ihlr-16470	519	99	each	each	DET
ihlr-16470	519	100	recipient	recipient	NOUN
ihlr-16470	519	101	••••	••••	NOUN
ihlr-16470	519	102	"	"	PUNCT
ihlr-16470	519	103	151	151	NUM
ihlr-16470	519	104	it	it	PRON
ihlr-16470	519	105	is	be	AUX
ihlr-16470	519	106	highly	highly	ADV
ihlr-16470	519	107	unlikely	unlikely	ADJ
ihlr-16470	519	108	that	that	SCONJ
ihlr-16470	519	109	courts	court	NOUN
ihlr-16470	519	110	will	will	AUX
ihlr-16470	519	111	reject	reject	VERB
ihlr-16470	519	112	the	the	DET
ihlr-16470	519	113	learned	learn	VERB
ihlr-16470	519	114	intermediary	intermediary	ADJ
ihlr-16470	519	115	doctrine	doctrine	NOUN
ihlr-16470	519	116	for	for	ADP
ihlr-16470	519	117	cases	case	NOUN
ihlr-16470	519	118	involving	involve	VERB
ihlr-16470	519	119	ssris	ssris	NOUN
ihlr-16470	519	120	because	because	SCONJ
ihlr-16470	519	121	the	the	DET
ihlr-16470	519	122	typical	typical	ADJ
ihlr-16470	519	123	ssri	ssri	PROPN
ihlr-16470	519	124	patient	patient	NOUN
ihlr-16470	519	125	requires	require	VERB
ihlr-16470	519	126	a	a	DET
ihlr-16470	519	127	physician	physician	NOUN
ihlr-16470	519	128	's	's	PART
ihlr-16470	519	129	attention	attention	NOUN
ihlr-16470	519	130	.	.	PUNCT
ihlr-16470	520	1	·	·	PUNCT
ihlr-16470	520	2	unlike	unlike	ADP
ihlr-16470	520	3	the	the	DET
ihlr-16470	520	4	decision	decision	NOUN
ihlr-16470	520	5	to	to	PART
ihlr-16470	520	6	use	use	VERB
ihlr-16470	520	7	contraceptives	contraceptive	NOUN
ihlr-16470	520	8	,	,	PUNCT
ihlr-16470	520	9	the	the	DET
ihlr-16470	520	10	decision	decision	NOUN
ihlr-16470	520	11	to	to	PART
ihlr-16470	520	12	use	use	VERB
ihlr-16470	520	13	an	an	DET
ihlr-16470	520	14	ssri	ssri	NOUN
ihlr-16470	520	15	is	be	AUX
ihlr-16470	520	16	not	not	PART
ihlr-16470	520	17	primarily	primarily	ADV
ihlr-16470	520	18	a	a	DET
ihlr-16470	520	19	personal	personal	ADJ
ihlr-16470	520	20	choice	choice	NOUN
ihlr-16470	520	21	.	.	PUNCT
ihlr-16470	521	1	instead	instead	ADV
ihlr-16470	521	2	,	,	PUNCT
ihlr-16470	521	3	ssris	ssris	PROPN
ihlr-16470	521	4	are	be	AUX
ihlr-16470	521	5	used	use	VERB
ihlr-16470	521	6	to	to	PART
ihlr-16470	521	7	treat	treat	VERB
ihlr-16470	521	8	serious	serious	ADJ
ihlr-16470	521	9	medical	medical	ADJ
ihlr-16470	521	10	conditions	condition	NOUN
ihlr-16470	521	11	and	and	CCONJ
ihlr-16470	521	12	diseases	disease	NOUN
ihlr-16470	521	13	diagnosed	diagnose	VERB
ihlr-16470	521	14	by	by	ADP
ihlr-16470	521	15	a	a	DET
ihlr-16470	521	16	physician	physician	NOUN
ihlr-16470	521	17	,	,	PUNCT
ihlr-16470	521	18	rather	rather	ADV
ihlr-16470	521	19	than	than	ADP
ihlr-16470	521	20	as	as	ADP
ihlr-16470	521	21	ways	way	NOUN
ihlr-16470	521	22	to	to	PART
ihlr-16470	521	23	avoid	avoid	VERB
ihlr-16470	521	24	undesired	undesired	ADJ
ihlr-16470	521	25	circumstances	circumstance	NOUN
ihlr-16470	521	26	.	.	PUNCT
ihlr-16470	522	1	the	the	DET
ihlr-16470	522	2	treatment	treatment	NOUN
ihlr-16470	522	3	of	of	ADP
ihlr-16470	522	4	depression	depression	NOUN
ihlr-16470	522	5	is	be	AUX
ihlr-16470	522	6	not	not	PART
ihlr-16470	522	7	simply	simply	ADV
ihlr-16470	522	8	a	a	DET
ihlr-16470	522	9	matter	matter	NOUN
ihlr-16470	522	10	of	of	ADP
ihlr-16470	522	11	the	the	DET
ihlr-16470	522	12	patient	patient	NOUN
ihlr-16470	522	13	's	's	PART
ihlr-16470	522	14	will	will	NOUN
ihlr-16470	522	15	,	,	PUNCT
ihlr-16470	522	16	but	but	CCONJ
ihlr-16470	522	17	requires	require	VERB
ihlr-16470	522	18	the	the	DET
ihlr-16470	522	19	consultation	consultation	NOUN
ihlr-16470	522	20	,	,	PUNCT
ihlr-16470	522	21	consideration	consideration	NOUN
ihlr-16470	522	22	,	,	PUNCT
ihlr-16470	522	23	and	and	CCONJ
ihlr-16470	522	24	diagnosis	diagnosis	NOUN
ihlr-16470	522	25	of	of	ADP
ihlr-16470	522	26	a	a	DET
ihlr-16470	522	27	medical	medical	ADJ
ihlr-16470	522	28	professional	professional	NOUN
ihlr-16470	522	29	.	.	PUNCT
ihlr-16470	523	1	additionally	additionally	ADV
ihlr-16470	523	2	,	,	PUNCT
ihlr-16470	523	3	the	the	DET
ihlr-16470	523	4	need	need	NOUN
ihlr-16470	523	5	for	for	ADP
ihlr-16470	523	6	diagnosis	diagnosis	NOUN
ihlr-16470	523	7	and	and	CCONJ
ihlr-16470	523	8	physician	physician	NOUN
ihlr-16470	523	9	directed	direct	VERB
ihlr-16470	523	10	treatment	treatment	NOUN
ihlr-16470	523	11	for	for	ADP
ihlr-16470	523	12	depression	depression	NOUN
ihlr-16470	523	13	and	and	CCONJ
ihlr-16470	523	14	other	other	ADJ
ihlr-16470	523	15	ssri	ssri	PROPN
ihlr-16470	523	16	indications	indication	NOUN
ihlr-16470	523	17	distinguishes	distinguish	VERB
ihlr-16470	523	18	the	the	DET
ihlr-16470	523	19	use	use	NOUN
ihlr-16470	523	20	of	of	ADP
ihlr-16470	523	21	ssris	ssris	NOUN
ihlr-16470	523	22	from	from	ADP
ihlr-16470	523	23	clinic	clinic	NOUN
ihlr-16470	523	24	-	-	PUNCT
ihlr-16470	523	25	administered	administer	VERB
ihlr-16470	523	26	vaccines	vaccine	NOUN
ihlr-16470	523	27	.	.	PUNCT
ihlr-16470	524	1	for	for	ADP
ihlr-16470	524	2	example	example	NOUN
ihlr-16470	524	3	,	,	PUNCT
ihlr-16470	524	4	ssris	ssris	PROPN
ihlr-16470	524	5	are	be	AUX
ihlr-16470	524	6	not	not	PART
ihlr-16470	524	7	administered	administer	VERB
ihlr-16470	524	8	en	en	NOUN
ihlr-16470	524	9	masse	masse	NOUN
ihlr-16470	524	10	to	to	ADP
ihlr-16470	524	11	the	the	DET
ihlr-16470	524	12	public	public	NOUN
ihlr-16470	524	13	like	like	ADP
ihlr-16470	524	14	vaccinations	vaccination	NOUN
ihlr-16470	524	15	during	during	ADP
ihlr-16470	524	16	the	the	DET
ihlr-16470	524	17	flu	flu	NOUN
ihlr-16470	524	18	season	season	NOUN
ihlr-16470	524	19	.	.	PUNCT
ihlr-16470	525	1	unlike	unlike	ADP
ihlr-16470	525	2	clinical	clinical	ADJ
ihlr-16470	525	3	vaccinations	vaccination	NOUN
ihlr-16470	525	4	,	,	PUNCT
ihlr-16470	525	5	ssris	ssris	PROPN
ihlr-16470	525	6	are	be	AUX
ihlr-16470	525	7	prescribed	prescribe	VERB
ihlr-16470	525	8	only	only	ADV
ihlr-16470	525	9	after	after	ADP
ihlr-16470	525	10	proper	proper	ADJ
ihlr-16470	525	11	diagnoses	diagnosis	NOUN
ihlr-16470	525	12	thereby	thereby	ADV
ihlr-16470	525	13	providing	provide	VERB
ihlr-16470	525	14	the	the	DET
ihlr-16470	525	15	patient	patient	NOUN
ihlr-16470	525	16	the	the	DET
ihlr-16470	525	17	benefit	benefit	NOUN
ihlr-16470	525	18	of	of	ADP
ihlr-16470	525	19	the	the	DET
ihlr-16470	525	20	''	''	PUNCT
ihlr-16470	525	21	physician	physician	NOUN
ihlr-16470	525	22	's	's	PART
ihlr-16470	525	23	particularized	particularize	VERB
ihlr-16470	525	24	weighing	weighing	NOUN
ihlr-16470	525	25	of	of	ADP
ihlr-16470	525	26	the	the	DET
ihlr-16470	525	27	product	product	NOUN
ihlr-16470	525	28	's	's	PART
ihlr-16470	525	29	risks	risk	NOUN
ihlr-16470	525	30	and	and	CCONJ
ihlr-16470	525	31	benefits	benefit	NOUN
ihlr-16470	525	32	for	for	ADP
ihlr-16470	525	33	[	[	PUNCT
ihlr-16470	525	34	that	that	PRON
ihlr-16470	525	35	]	]	X
ihlr-16470	525	36	recipient	recipient	NOUN
ihlr-16470	525	37	.	.	PUNCT
ihlr-16470	526	1	"152	"152	NOUN
ihlr-16470	526	2	147	147	NUM
ihlr-16470	526	3	.	.	PUNCT
ihlr-16470	527	1	with	with	ADP
ihlr-16470	527	2	respect	respect	NOUN
ihlr-16470	527	3	to	to	ADP
ihlr-16470	527	4	drugs	drug	NOUN
ihlr-16470	527	5	and	and	CCONJ
ihlr-16470	527	6	medical	medical	ADJ
ihlr-16470	527	7	devices	device	NOUN
ihlr-16470	527	8	,	,	PUNCT
ihlr-16470	527	9	the	the	DET
ihlr-16470	527	10	prescribing	prescribing	NOUN
ihlr-16470	527	11	physician	physician	NOUN
ihlr-16470	527	12	is	be	AUX
ihlr-16470	527	13	viewed	view	VERB
ihlr-16470	527	14	as	as	ADP
ihlr-16470	527	15	a	a	DET
ihlr-16470	527	16	"	"	PUNCT
ihlr-16470	527	17	learned	learn	VERB
ihlr-16470	527	18	intermediary	intermediary	NOUN
ihlr-16470	527	19	"	"	PUNCT
ihlr-16470	527	20	whose	whose	DET
ihlr-16470	527	21	specialized	specialized	ADJ
ihlr-16470	527	22	knowledge	knowledge	NOUN
ihlr-16470	527	23	and	and	CCONJ
ihlr-16470	527	24	experience	experience	NOUN
ihlr-16470	527	25	enable	enable	VERB
ihlr-16470	527	26	him	he	PRON
ihlr-16470	527	27	or	or	CCONJ
ihlr-16470	527	28	her	she	PRON
ihlr-16470	527	29	to	to	PART
ihlr-16470	527	30	evaluate	evaluate	VERB
ihlr-16470	527	31	the	the	DET
ihlr-16470	527	32	complex	complex	ADJ
ihlr-16470	527	33	and	and	CCONJ
ihlr-16470	527	34	technical	technical	ADJ
ihlr-16470	527	35	information	information	NOUN
ihlr-16470	527	36	in	in	ADP
ihlr-16470	527	37	the	the	DET
ihlr-16470	527	38	warning	warning	NOUN
ihlr-16470	527	39	and	and	CCONJ
ihlr-16470	527	40	assess	assess	VERB
ihlr-16470	527	41	the	the	DET
ihlr-16470	527	42	product	product	NOUN
ihlr-16470	527	43	's	's	PART
ihlr-16470	527	44	risks	risk	NOUN
ihlr-16470	527	45	and	and	CCONJ
ihlr-16470	527	46	benefits	benefit	NOUN
ihlr-16470	527	47	in	in	ADP
ihlr-16470	527	48	treating	treat	VERB
ihlr-16470	527	49	a	a	DET
ihlr-16470	527	50	particular	particular	ADJ
ihlr-16470	527	51	patient	patient	NOUN
ihlr-16470	527	52	.	.	PUNCT
ihlr-16470	528	1	application	application	NOUN
ihlr-16470	528	2	of	of	ADP
ihlr-16470	528	3	the	the	DET
ihlr-16470	528	4	learned	learn	VERB
ihlr-16470	528	5	intermediary	intermediary	ADJ
ihlr-16470	528	6	doctrine	doctrine	NOUN
ihlr-16470	528	7	in	in	ADP
ihlr-16470	528	8	the	the	DET
ihlr-16470	528	9	context	context	NOUN
ihlr-16470	528	10	of	of	ADP
ihlr-16470	528	11	prescription	prescription	NOUN
ihlr-16470	528	12	products	product	NOUN
ihlr-16470	528	13	also	also	ADV
ihlr-16470	528	14	reflects	reflect	VERB
ihlr-16470	528	15	concern	concern	NOUN
ihlr-16470	528	16	that	that	SCONJ
ihlr-16470	528	17	direct	direct	ADJ
ihlr-16470	528	18	patient	patient	ADJ
ihlr-16470	528	19	warnings	warning	NOUN
ihlr-16470	528	20	on	on	ADP
ihlr-16470	528	21	prescription	prescription	NOUN
ihlr-16470	528	22	products	product	NOUN
ihlr-16470	528	23	would	would	AUX
ihlr-16470	528	24	interfere	interfere	VERB
ihlr-16470	528	25	with	with	ADP
ihlr-16470	528	26	the	the	DET
ihlr-16470	528	27	doctor­	doctor­	NOUN
ihlr-16470	528	28	patient	patient	NOUN
ihlr-16470	528	29	relationship	relationship	NOUN
ihlr-16470	528	30	.	.	PUNCT
ihlr-16470	529	1	heafey	heafey	PROPN
ihlr-16470	529	2	&	&	CCONJ
ihlr-16470	529	3	kennedy	kennedy	PROPN
ihlr-16470	529	4	,	,	PUNCT
ihlr-16470	529	5	supra	supra	PROPN
ihlr-16470	529	6	note	note	PROPN
ihlr-16470	529	7	120	120	NUM
ihlr-16470	529	8	,	,	PUNCT
ihlr-16470	529	9	§	§	PROPN
ihlr-16470	529	10	10.03	10.03	NUM
ihlr-16470	529	11	.	.	PUNCT
ihlr-16470	529	12	148	148	NUM
ihlr-16470	529	13	.	.	PUNCT
ihlr-16470	530	1	/d	/d	INTJ
ihlr-16470	530	2	.	.	PUNCT
ihlr-16470	531	1	(	(	PUNCT
ihlr-16470	531	2	noting	note	VERB
ihlr-16470	531	3	that	that	SCONJ
ihlr-16470	531	4	if	if	SCONJ
ihlr-16470	531	5	the	the	DET
ihlr-16470	531	6	prescribing	prescribing	NOUN
ihlr-16470	531	7	physician	physician	NOUN
ihlr-16470	531	8	did	do	AUX
ihlr-16470	531	9	not	not	PART
ihlr-16470	531	10	rely	rely	VERB
ihlr-16470	531	11	on	on	ADP
ihlr-16470	531	12	the	the	DET
ihlr-16470	531	13	warning	warning	NOUN
ihlr-16470	531	14	,	,	PUNCT
ihlr-16470	531	15	or	or	CCONJ
ihlr-16470	531	16	was	be	AUX
ihlr-16470	531	17	aware	aware	ADJ
ihlr-16470	531	18	of	of	ADP
ihlr-16470	531	19	the	the	DET
ihlr-16470	531	20	risk	risk	NOUN
ihlr-16470	531	21	from	from	ADP
ihlr-16470	531	22	other	other	ADJ
ihlr-16470	531	23	sources	source	NOUN
ihlr-16470	531	24	,	,	PUNCT
ihlr-16470	531	25	the	the	DET
ihlr-16470	531	26	physician	physician	NOUN
ihlr-16470	531	27	's	's	PART
ihlr-16470	531	28	conduct	conduct	NOUN
ihlr-16470	531	29	is	be	AUX
ihlr-16470	531	30	considered	consider	VERB
ihlr-16470	531	31	the	the	DET
ihlr-16470	531	32	superseding	superseding	NOUN
ihlr-16470	531	33	cause	cause	NOUN
ihlr-16470	531	34	that	that	PRON
ihlr-16470	531	35	breaks	break	VERB
ihlr-16470	531	36	the	the	DET
ihlr-16470	531	37	chain	chain	NOUN
ihlr-16470	531	38	ofliability	ofliability	NOUN
ihlr-16470	531	39	)	)	PUNCT
ihlr-16470	531	40	.	.	PUNCT
ihlr-16470	532	1	149	149	NUM
ihlr-16470	532	2	,	,	PUNCT
ihlr-16470	532	3	/d	/d	PUNCT
ihlr-16470	532	4	.	.	PROPN
ihlr-16470	533	1	150	150	NUM
ihlr-16470	533	2	.	.	PUNCT
ihlr-16470	534	1	/d	/d	INTJ
ihlr-16470	534	2	.	.	PUNCT
ihlr-16470	535	1	151	151	NUM
ihlr-16470	535	2	.	.	PUNCT
ihlr-16470	536	1	/d	/d	INTJ
ihlr-16470	536	2	.	.	PUNCT
ihlr-16470	537	1	152	152	NUM
ihlr-16470	537	2	.	.	PUNCT
ihlr-16470	538	1	heafey&kennedy	heafey&kennedy	NOUN
ihlr-16470	538	2	,	,	PUNCT
ihlr-16470	538	3	supranote	supranote	VERB
ihlr-16470	538	4	120	120	NUM
ihlr-16470	538	5	,	,	PUNCT
ihlr-16470	538	6	§	§	PROPN
ihlr-16470	538	7	10.03	10.03	NUM
ihlr-16470	538	8	.	.	PUNCT
ihlr-16470	539	1	222	222	NUM
ihlr-16470	539	2	indiana	indiana	PROPN
ihlr-16470	539	3	hbalmlaw	hbalmlaw	PROPN
ihlr-16470	539	4	review	review	PROPN
ihlr-16470	540	1	[	[	X
ihlr-16470	540	2	vol	vol	NOUN
ihlr-16470	540	3	.	.	PUNCT
ihlr-16470	541	1	3:201	3:201	NUM
ihlr-16470	541	2	the	the	DET
ihlr-16470	541	3	learned	learn	VERB
ihlr-16470	541	4	intermediary	intermediary	ADJ
ihlr-16470	541	5	doctrine	doctrine	NOUN
ihlr-16470	541	6	places	place	VERB
ihlr-16470	541	7	liability	liability	NOUN
ihlr-16470	541	8	upon	upon	SCONJ
ihlr-16470	541	9	the	the	DET
ihlr-16470	541	10	prescribing	prescribing	NOUN
ihlr-16470	541	11	physician	physician	NOUN
ihlr-16470	541	12	.	.	PUNCT
ihlr-16470	542	1	it	it	PRON
ihlr-16470	542	2	is	be	AUX
ihlr-16470	542	3	the	the	DET
ihlr-16470	542	4	physician	physician	NOUN
ihlr-16470	542	5	's	's	PART
ihlr-16470	542	6	duty	duty	NOUN
ihlr-16470	542	7	to	to	PART
ihlr-16470	542	8	adequately	adequately	ADV
ihlr-16470	542	9	weigh	weigh	VERB
ihlr-16470	542	10	the	the	DET
ihlr-16470	542	11	risks	risk	NOUN
ihlr-16470	542	12	and	and	CCONJ
ihlr-16470	542	13	rewards	reward	NOUN
ihlr-16470	542	14	of	of	ADP
ihlr-16470	542	15	a	a	DET
ihlr-16470	542	16	particular	particular	ADJ
ihlr-16470	542	17	course	course	NOUN
ihlr-16470	542	18	of	of	ADP
ihlr-16470	542	19	treatment	treatment	NOUN
ihlr-16470	542	20	when	when	SCONJ
ihlr-16470	542	21	prescribing	prescribing	NOUN
ihlr-16470	542	22	medication	medication	NOUN
ihlr-16470	542	23	.	.	PUNCT
ihlr-16470	543	1	whether	whether	SCONJ
ihlr-16470	543	2	the	the	DET
ihlr-16470	543	3	physician	physician	NOUN
ihlr-16470	543	4	has	have	AUX
ihlr-16470	543	5	met	meet	VERB
ihlr-16470	543	6	this	this	DET
ihlr-16470	543	7	duty	duty	NOUN
ihlr-16470	543	8	depends	depend	VERB
ihlr-16470	543	9	not	not	PART
ihlr-16470	543	10	only	only	ADV
ihlr-16470	543	11	oil	oil	NOUN
ihlr-16470	543	12	the	the	DET
ihlr-16470	543	13	warnings	warning	NOUN
ihlr-16470	543	14	provided	provide	VERB
ihlr-16470	543	15	by	by	ADP
ihlr-16470	543	16	the	the	DET
ihlr-16470	543	17	manufacturer	manufacturer	NOUN
ihlr-16470	543	18	,	,	PUNCT
ihlr-16470	543	19	but	but	CCONJ
ihlr-16470	543	20	also	also	ADV
ihlr-16470	543	21	the	the	DET
ihlr-16470	543	22	prevailing	prevail	VERB
ihlr-16470	543	23	knowledge	knowledge	NOUN
ihlr-16470	543	24	in	in	ADP
ihlr-16470	543	25	the	the	DET
ihlr-16470	543	26	field	field	NOUN
ihlr-16470	543	27	.	.	PUNCT
ihlr-16470	544	1	153	153	NUM
ihlr-16470	544	2	for	for	ADP
ihlr-16470	544	3	ssris	ssris	NOUN
ihlr-16470	544	4	,	,	PUNCT
ihlr-16470	544	5	the	the	DET
ihlr-16470	544	6	prevalent	prevalent	ADJ
ihlr-16470	544	7	knowledge	knowledge	NOUN
ihlr-16470	544	8	in	in	ADP
ihlr-16470	544	9	the	the	DET
ihlr-16470	544	10	field	field	NOUN
ihlr-16470	544	11	can	can	AUX
ihlr-16470	544	12	play	play	VERB
ihlr-16470	544	13	an	an	DET
ihlr-16470	544	14	important	important	ADJ
ihlr-16470	544	15	role	role	NOUN
ihlr-16470	544	16	because	because	SCONJ
ihlr-16470	544	17	of	of	ADP
ihlr-16470	544	18	the	the	DET
ihlr-16470	544	19	ongoing	ongoing	ADJ
ihlr-16470	544	20	debate	debate	NOUN
ihlr-16470	544	21	about	about	ADP
ihlr-16470	544	22	ssris	ssris	NOUN
ihlr-16470	544	23	and	and	CCONJ
ihlr-16470	544	24	suicidality	suicidality	NOUN
ihlr-16470	544	25	.	.	PUNCT
ihlr-16470	545	1	although	although	SCONJ
ihlr-16470	545	2	much	much	ADJ
ihlr-16470	545	3	of	of	ADP
ihlr-16470	545	4	the	the	DET
ihlr-16470	545	5	literature	literature	NOUN
ihlr-16470	545	6	indicates	indicate	VERB
ihlr-16470	545	7	that	that	SCONJ
ihlr-16470	545	8	ssris	ssris	NOUN
ihlr-16470	545	9	do	do	AUX
ihlr-16470	545	10	not	not	PART
ihlr-16470	545	11	cause	cause	VERB
ihlr-16470	545	12	suicidality	suicidality	NOUN
ihlr-16470	545	13	,	,	PUNCT
ihlr-16470	545	14	the	the	DET
ihlr-16470	545	15	vigorous	vigorous	ADJ
ihlr-16470	545	16	and	and	CCONJ
ihlr-16470	545	17	public	public	ADJ
ihlr-16470	545	18	nature	nature	NOUN
ihlr-16470	545	19	of	of	ADP
ihlr-16470	545	20	claims	claim	NOUN
ihlr-16470	545	21	of	of	ADP
ihlr-16470	545	22	a	a	DET
ihlr-16470	545	23	relationship	relationship	NOUN
ihlr-16470	545	24	between	between	ADP
ihlr-16470	545	25	ssris	ssris	NOUN
ihlr-16470	545	26	and	and	CCONJ
ihlr-16470	545	27	suicidality	suicidality	NOUN
ihlr-16470	545	28	could	could	AUX
ihlr-16470	545	29	serve	serve	VERB
ihlr-16470	545	30	to	to	PART
ihlr-16470	545	31	put	put	VERB
ihlr-16470	545	32	a	a	DET
ihlr-16470	545	33	physician	physician	NOUN
ihlr-16470	545	34	on	on	ADP
ihlr-16470	545	35	notice	notice	NOUN
ihlr-16470	545	36	beyond	beyond	ADP
ihlr-16470	545	37	the	the	DET
ihlr-16470	545	38	warnings	warning	NOUN
ihlr-16470	545	39	included	include	VERB
ihlr-16470	545	40	on	on	ADP
ihlr-16470	545	41	the	the	DET
ihlr-16470	545	42	drug	drug	NOUN
ihlr-16470	545	43	label.154	label.154	NOUN
ihlr-16470	545	44	although	although	SCONJ
ihlr-16470	545	45	drug	drug	NOUN
ihlr-16470	545	46	manufacturers	manufacturer	NOUN
ihlr-16470	545	47	may	may	AUX
ihlr-16470	545	48	avoid	avoid	VERB
ihlr-16470	545	49	liability	liability	NOUN
ihlr-16470	545	50	through	through	ADP
ihlr-16470	545	51	the	the	DET
ihlr-16470	545	52	learned	learn	VERB
ihlr-16470	545	53	intermediary	intermediary	ADJ
ihlr-16470	545	54	doctrine	doctrine	NOUN
ihlr-16470	545	55	,	,	PUNCT
ihlr-16470	545	56	there	there	PRON
ihlr-16470	545	57	are	be	VERB
ihlr-16470	545	58	still	still	ADV
ihlr-16470	545	59	complaints	complaint	NOUN
ihlr-16470	545	60	.	.	PUNCT
ihlr-16470	546	1	surrounding	surround	VERB
ihlr-16470	546	2	manufacturers	manufacturer	NOUN
ihlr-16470	546	3	'	'	PART
ihlr-16470	546	4	decisions	decision	NOUN
ihlr-16470	546	5	regarding	regard	VERB
ihlr-16470	546	6	clinical	clinical	ADJ
ihlr-16470	546	7	trials.155	trials.155	PROPN
ihlr-16470	546	8	the	the	DET
ihlr-16470	546	9	questions	question	NOUN
ihlr-16470	546	10	raised	raise	VERB
ihlr-16470	546	11	cast	cast	VERB
ihlr-16470	546	12	doubt	doubt	NOUN
ihlr-16470	546	13	on	on	ADP
ihlr-16470	546	14	whether	whether	SCONJ
ihlr-16470	546	15	doctors	doctor	NOUN
ihlr-16470	546	16	and	and	CCONJ
ihlr-16470	546	17	the	the	DET
ihlr-16470	546	18	fda	fda	PROPN
ihlr-16470	546	19	are	be	AUX
ihlr-16470	546	20	able	able	ADJ
ihlr-16470	546	21	to	to	PART
ihlr-16470	546	22	rely	rely	VERB
ihlr-16470	546	23	on	on	ADP
ihlr-16470	546	24	clinical	clinical	ADJ
ihlr-16470	546	25	data	datum	NOUN
ihlr-16470	546	26	as	as	ADP
ihlr-16470	546	27	accurate	accurate	ADJ
ihlr-16470	546	28	representations	representation	NOUN
ihlr-16470	546	29	·	·	PUNCT
ihlr-16470	546	30	of	of	ADP
ihlr-16470	546	31	the	the	DET
ihlr-16470	546	32	drug	drug	NOUN
ihlr-16470	546	33	when	when	SCONJ
ihlr-16470	546	34	choosing	choose	VERB
ihlr-16470	546	35	to	to	PART
ihlr-16470	546	36	prescribe	prescribe	VERB
ihlr-16470	546	37	.	.	PUNCT
ihlr-16470	547	1	the	the	DET
ihlr-16470	547	2	drug	drug	NOUN
ihlr-16470	547	3	or	or	CCONJ
ihlr-16470	547	4	grant	grant	VERB
ihlr-16470	547	5	approval	approval	NOUN
ihlr-16470	547	6	for	for	ADP
ihlr-16470	547	7	marketing	marketing	NOUN
ihlr-16470	547	8	.	.	PUNCT
ihlr-16470	548	1	controversy	controversy	NOUN
ihlr-16470	548	2	surrounding	surround	VERB
ihlr-16470	548	3	the	the	DET
ihlr-16470	548	4	publication	publication	NOUN
ihlr-16470	548	5	of	of	ADP
ihlr-16470	548	6	trial	trial	NOUN
ihlr-16470	548	7	results	result	NOUN
ihlr-16470	548	8	bas	bas	AUX
ihlr-16470	548	9	been	be	AUX
ihlr-16470	548	10	highlighted	highlight	VERB
ihlr-16470	548	11	by	by	ADP
ihlr-16470	548	12	ssri	ssri	PROPN
ihlr-16470	548	13	manufacturers	manufacturer	NOUN
ihlr-16470	548	14	who	who	PRON
ihlr-16470	548	15	have	have	AUX
ihlr-16470	548	16	chosen	choose	VERB
ihlr-16470	548	17	not	not	PART
ihlr-16470	548	18	to	to	PART
ihlr-16470	548	19	publish	publish	VERB
ihlr-16470	548	20	unfavorable	unfavorable	ADJ
ihlr-16470	548	21	clinical	clinical	ADJ
ihlr-16470	548	22	results	result	NOUN
ihlr-16470	548	23	.	.	PUNCT
ihlr-16470	549	1	.,6	.,6	PROPN
ihlr-16470	550	1	ill	ill	ADJ
ihlr-16470	550	2	.	.	PUNCT
ihlr-16470	551	1	clinical	clinical	ADJ
ihlr-16470	551	2	trials	trial	NOUN
ihlr-16470	551	3	clinical	clinical	ADJ
ihlr-16470	551	4	trials	trial	NOUN
ihlr-16470	551	5	are	be	AUX
ihlr-16470	551	6	vital	vital	ADJ
ihlr-16470	551	7	to	to	ADP
ihlr-16470	551	8	the	the	DET
ihlr-16470	551	9	bealthcare	bealthcare	NOUN
ihlr-16470	551	10	industry	industry	NOUN
ihlr-16470	551	11	for	for	ADP
ihlr-16470	551	12	several	several	ADJ
ihlr-16470	551	13	reasons	reason	NOUN
ihlr-16470	551	14	.	.	PUNCT
ihlr-16470	552	1	these	these	DET
ihlr-16470	552	2	trials	trial	NOUN
ihlr-16470	552	3	are	be	AUX
ihlr-16470	552	4	the	the	DET
ihlr-16470	552	5	basis	basis	NOUN
ihlr-16470	552	6	for	for	ADP
ihlr-16470	552	7	fda	fda	PROPN
ihlr-16470	552	8	approval	approval	NOUN
ihlr-16470	552	9	,	,	PUNCT
ihlr-16470	552	10	and	and	CCONJ
ihlr-16470	552	11	they	they	PRON
ihlr-16470	552	12	influence	influence	VERB
ihlr-16470	552	13	the	the	DET
ihlr-16470	552	14	physician	physician	NOUN
ihlr-16470	552	15	's	's	PART
ihlr-16470	552	16	decision	decision	NOUN
ihlr-16470	552	17	to	to	PART
ihlr-16470	552	18	administer	administer	VERB
ihlr-16470	552	19	a	a	DET
ihlr-16470	552	20	drug	drug	NOUN
ihlr-16470	552	21	for	for	ADP
ihlr-16470	552	22	certain	certain	ADJ
ihlr-16470	552	23	indications	indication	NOUN
ihlr-16470	552	24	..	..	PUNCT
ihlr-16470	553	1	companies	company	NOUN
ihlr-16470	553	2	are	be	AUX
ihlr-16470	553	3	required	require	VERB
ihlr-16470	553	4	by	by	ADP
ihlr-16470	553	5	the	the	DET
ihlr-16470	553	6	fda	fda	PROPN
ihlr-16470	553	7	to	to	PART
ihlr-16470	553	8	rigorously	rigorously	ADV
ihlr-16470	553	9	test	test	VERB
ihlr-16470	553	10	new	new	ADJ
ihlr-16470	553	11	drugs	drug	NOUN
ihlr-16470	553	12	to	to	PART
ihlr-16470	553	13	show	show	VERB
ihlr-16470	553	14	that	that	SCONJ
ihlr-16470	553	15	they	they	PRON
ihlr-16470	553	16	are	be	AUX
ihlr-16470	553	17	.safe	.safe	ADJ
ihlr-16470	553	18	,	,	PUNCT
ihlr-16470	553	19	effective	effective	ADJ
ihlr-16470	553	20	,	,	PUNCT
ihlr-16470	553	21	and	and	CCONJ
ihlr-16470	553	22	ready	ready	ADJ
ihlr-16470	553	23	for	for	ADP
ihlr-16470	553	24	marlcetiilg	marlcetiilg	NOUN
ihlr-16470	553	25	.	.	PUNCT
ihlr-16470	554	1	therefore	therefore	ADV
ihlr-16470	554	2	,	,	PUNCT
ihlr-16470	554	3	a	a	DET
ihlr-16470	554	4	company	company	NOUN
ihlr-16470	554	5	's	's	PART
ihlr-16470	554	6	failure	failure	NOUN
ihlr-16470	554	7	to	to	PART
ihlr-16470	554	8	disclose	disclose	VERB
ihlr-16470	554	9	all	all	DET
ihlr-16470	554	10	information	information	NOUN
ihlr-16470	554	11	found	find	VERB
ihlr-16470	554	12	in	in	ADP
ihlr-16470	554	13	clinical	clinical	ADJ
ihlr-16470	554	14	trials	trial	NOUN
ihlr-16470	554	15	can	can	AUX
ihlr-16470	554	16	have	have	VERB
ihlr-16470	554	17	·	·	PUNCT
ihlr-16470	554	18	a	a	DET
ihlr-16470	554	19	serious	serious	ADJ
ihlr-16470	554	20	impact	impact	NOUN
ihlr-16470	554	21	on	on	ADP
ihlr-16470	554	22	the	the	DET
ihlr-16470	554	23	consuming	consume	VERB
ihlr-16470	554	24	public	public	NOUN
ihlr-16470	554	25	.	.	PUNCT
ihlr-16470	555	1	this	this	DET
ihlr-16470	555	2	impact	impact	NOUN
ihlr-16470	555	3	is	be	AUX
ihlr-16470	555	4	especially	especially	ADV
ihlr-16470	555	5	true	true	ADJ
ihlr-16470	555	6	with	with	ADP
ihlr-16470	555	7	the	the	DET
ihlr-16470	555	8	prevalence	prevalence	NOUN
ihlr-16470	555	9	of	of	ADP
ihlr-16470	555	10	off­	off­	NOUN
ihlr-16470	555	11	label	label	NOUN
ihlr-16470	555	12	uses	use	VERB
ihlr-16470	555	13	since	since	SCONJ
ihlr-16470	555	14	doctors	doctor	NOUN
ihlr-16470	555	15	rely	rely	VERB
ihlr-16470	555	16	on	on	ADP
ihlr-16470	555	17	data	datum	NOUN
ihlr-16470	555	18	from	from	ADP
ihlr-16470	555	19	clinical	clinical	ADJ
ihlr-16470	555	20	studies	study	NOUN
ihlr-16470	555	21	in	in	ADP
ihlr-16470	555	22	determining	determine	VERB
ihlr-16470	555	23	if	if	SCONJ
ihlr-16470	555	24	an	an	DET
ihlr-16470	555	25	off	off	ADP
ihlr-16470	555	26	-	-	PUNCT
ihlr-16470	555	27	label	label	NOUN
ihlr-16470	555	28	use	use	NOUN
ihlr-16470	555	29	may	may	AUX
ihlr-16470	555	30	be	be	AUX
ihlr-16470	555	31	appropriate	appropriate	ADJ
ihlr-16470	555	32	for	for	ADP
ihlr-16470	555	33	a	a	DET
ihlr-16470	555	34	particular	particular	ADJ
ihlr-16470	555	35	patient	patient	NOUN
ihlr-16470	555	36	.	.	PUNCT
ihlr-16470	556	1	with	with	ADP
ihlr-16470	556	2	the	the	DET
ihlr-16470	556	3	debate	debate	NOUN
ihlr-16470	556	4	surrounding	surround	VERB
ihlr-16470	556	5	ssris	ssris	NOUN
ihlr-16470	556	6	,	,	PUNCT
ihlr-16470	556	7	it	it	PRON
ihlr-16470	556	8	w8	w8	VERB
ihlr-16470	556	9	$	$	SYM
ihlr-16470	556	10	particularly	particularly	ADV
ihlr-16470	556	11	disconcerting	disconcerting	ADJ
ihlr-16470	556	12	when	when	SCONJ
ihlr-16470	556	13	glaxosmithk.line	glaxosmithk.line	PROPN
ihlr-16470	556	14	admitted	admit	VERB
ihlr-16470	556	15	in·2004	in·2004	NOUN
ihlr-16470	556	16	that.it.bad	that.it.bad	PUNCT
ihlr-16470	556	17	not	not	PART
ihlr-16470	556	18	revealed.clinical	revealed.clinical	ADJ
ihlr-16470	556	19	data	datum	NOUN
ihlr-16470	556	20	suggesting	suggest	VERB
ihlr-16470	556	21	their	their	PRON
ihlr-16470	556	22	ssri	ssri	NOUN
ihlr-16470	556	23	,	,	PUNCT
ihlr-16470	556	24	paxil	paxil	NOUN
ihlr-16470	556	25	,	,	PUNCT
ihlr-16470	556	26	may	may	AUX
ihlr-16470	556	27	increase	increase	VERB
ihlr-16470	556	28	the	the	DET
ihlr-16470	556	29	risk	risk	NOUN
ihlr-16470	556	30	of	of	ADP
ihlr-16470	556	31	suicidality	suicidality	NOUN
ihlr-16470	556	32	in	in	ADP
ihlr-16470	556	33	cbildren.157	cbildren.157	PROPN
ihlr-16470	556	34	to	to	PART
ihlr-16470	556	35	truly	truly	ADV
ihlr-16470	556	36	understand	understand	VERB
ihlr-16470	556	37	the	the	DET
ihlr-16470	556	38	impact	impact	NOUN
ihlr-16470	556	39	of	of	ADP
ihlr-16470	556	40	the	the	DET
ihlr-16470	556	41	decision	decision	NOUN
ihlr-16470	556	42	of	of	ADP
ihlr-16470	556	43	what	what	PRON
ihlr-16470	556	44	a	a	DET
ihlr-16470	556	45	drug	drug	NOUN
ihlr-16470	556	46	manufacturer	manufacturer	NOUN
ihlr-16470	556	47	does	do	AUX
ihlr-16470	556	48	and	and	CCONJ
ihlr-16470	556	49	does	do	VERB
ihlr-16470	556	50	not	not	PART
ihlr-16470	556	51	153	153	NUM
ihlr-16470	556	52	.	.	PUNCT
ihlr-16470	557	1	heafey	heafey	PROPN
ihlr-16470	557	2	&	&	CCONJ
ihlr-16470	557	3	kennedy	kennedy	PROPN
ihlr-16470	557	4	,	,	PUNCT
ihlr-16470	557	5	supra	supra	PROPN
ihlr-16470	557	6	note	note	PROPN
ihlr-16470	557	7	120	120	NUM
ihlr-16470	557	8	,	,	PUNCT
ihlr-16470	557	9	§	§	PROPN
ihlr-16470	557	10	10.03	10.03	NUM
ihlr-16470	557	11	(	(	PUNCT
ihlr-16470	557	12	stating	state	VERB
ihlr-16470	557	13	that	that	SCONJ
ihlr-16470	557	14	drug	drug	NOUN
ihlr-16470	557	15	manufacturers	manufacturer	NOUN
ihlr-16470	557	16	may	may	AUX
ihlr-16470	557	17	not	not	PART
ihlr-16470	557	18	be	be	AUX
ihlr-16470	557	19	hable	hable	ADJ
ihlr-16470	557	20	ifthe	ifthe	NOUN
ihlr-16470	557	21	physician	physician	NOUN
ihlr-16470	557	22	is	be	AUX
ihlr-16470	557	23	aware	aware	ADJ
ihlr-16470	557	24	of	of	ADP
ihlr-16470	557	25	the	the	DET
ihlr-16470	557	26	danger	danger	NOUN
ihlr-16470	557	27	fiom	fiom	VERB
ihlr-16470	557	28	another	another	DET
ihlr-16470	557	29	source	source	NOUN
ihlr-16470	557	30	)	)	PUNCT
ihlr-16470	557	31	.	.	PUNCT
ihlr-16470	558	1	154	154	NUM
ihlr-16470	558	2	.	.	PUNCT
ihlr-16470	558	3	stoffelmayr	stoffelmayr	PROPN
ihlr-16470	558	4	,	,	PUNCT
ihlr-16470	558	5	supra	supra	PROPN
ihlr-16470	558	6	note	note	NOUN
ihlr-16470	558	7	101	101	NUM
ihlr-16470	558	8	,	,	PUNCT
ihlr-16470	558	9	at283	at283	PROPN
ihlr-16470	558	10	(	(	PUNCT
ihlr-16470	558	11	arguing	argue	VERB
ihlr-16470	558	12	that	that	SCONJ
ihlr-16470	558	13	manufiieturers	manufiieturer	NOUN
ihlr-16470	558	14	have	have	AUX
ihlr-16470	558	15	constructive	constructive	ADJ
ihlr-16470	558	16	,	,	PUNCT
ihlr-16470	558	17	if	if	SCONJ
ihlr-16470	558	18	not	not	PART
ihlr-16470	558	19	actual	actual	ADJ
ihlr-16470	558	20	.	.	PUNCT
ihlr-16470	559	1	knowledge	knowledge	NOUN
ihlr-16470	559	2	ofadveme	ofadveme	PROPN
ihlr-16470	559	3	effeets	effeet	NOUN
ihlr-16470	559	4	clocumcnted	clocumcnte	VERB
ihlr-16470	559	5	in	in	ADP
ihlr-16470	559	6	the	the	DET
ihlr-16470	559	7	field	field	NOUN
ihlr-16470	559	8	,	,	PUNCT
ihlr-16470	559	9	perhaps	perhaps	ADV
ihlr-16470	559	10	this	this	PRON
ihlr-16470	559	11	can	can	AUX
ihlr-16470	559	12	also	also	ADV
ihlr-16470	559	13	be	be	AUX
ihlr-16470	559	14	applied	apply	VERB
ihlr-16470	559	15	to	to	ADP
ihlr-16470	559	16	physicians	physician	NOUN
ihlr-16470	559	17	who	who	PRON
ihlr-16470	559	18	presaibe	presaibe	VERB
ihlr-16470	559	19	drugs	drug	NOUN
ihlr-16470	559	20	that	that	PRON
ihlr-16470	559	21	are	be	AUX
ihlr-16470	559	22	widely	widely	ADV
ihlr-16470	559	23	speculated	speculate	VERB
ihlr-16470	559	24	to	to	PART
ihlr-16470	559	25	pose	pose	VERB
ihlr-16470	559	26	a	a	DET
ihlr-16470	559	27	risk	risk	NOUN
ihlr-16470	559	28	to	to	ADP
ihlr-16470	559	29	a	a	DET
ihlr-16470	559	30	certain	certain	ADJ
ihlr-16470	559	31	patient	patient	ADJ
ihlr-16470	559	32	category	category	NOUN
ihlr-16470	559	33	)	)	PUNCT
ihlr-16470	559	34	.	.	PUNCT
ihlr-16470	560	1	155	155	NUM
ihlr-16470	560	2	.	.	PUNCT
ihlr-16470	561	1	see	see	VERB
ihlr-16470	561	2	david	david	PROPN
ihlr-16470	561	3	bjerldie	bjerldie	PROPN
ihlr-16470	561	4	,	,	PUNCT
ihlr-16470	561	5	putting	put	VERB
ihlr-16470	561	6	trials	trial	NOUN
ihlr-16470	561	7	on	on	ADP
ihlr-16470	561	8	the	the	DET
ihlr-16470	561	9	record	record	NOUN
ihlr-16470	561	10	,	,	PUNCT
ihlr-16470	561	11	time	time	NOUN
ihlr-16470	561	12	mao	mao	PROPN
ihlr-16470	561	13	.	.	PROPN
ihlr-16470	562	1	,	,	PUNCT
ihlr-16470	562	2	july	july	PROPN
ihlr-16470	562	3	5	5	NUM
ihlr-16470	562	4	,	,	PUNCT
ihlr-16470	562	5	2004	2004	NUM
ihlr-16470	562	6	at	at	ADP
ihlr-16470	562	7	42	42	NUM
ihlr-16470	562	8	(	(	PUNCT
ihlr-16470	562	9	stating	state	VERB
ihlr-16470	562	10	drug	drug	NOUN
ihlr-16470	562	11	trial$	trial$	NUM
ihlr-16470	562	12	are	be	AUX
ihlr-16470	562	13	misleading	mislead	VERB
ihlr-16470	562	14	due	due	ADP
ihlr-16470	562	15	to	to	ADP
ihlr-16470	562	16	data	datum	NOUN
ihlr-16470	562	17	that	that	PRON
ihlr-16470	562	18	is	be	AUX
ihlr-16470	562	19	left	leave	VERB
ihlr-16470	562	20	out	out	ADP
ihlr-16470	562	21	)	)	PUNCT
ihlr-16470	562	22	.	.	PUNCT
ihlr-16470	563	1	156	156	NUM
ihlr-16470	563	2	.	.	PUNCT
ihlr-16470	563	3	liebert	liebert	PROPN
ihlr-16470	563	4	.	.	PUNCT
ihlr-16470	564	1	supra	supra	PROPN
ihlr-16470	564	2	note	note	PROPN
ihlr-16470	564	3	9	9	NUM
ihlr-16470	564	4	,	,	PUNCT
ihlr-16470	564	5	at	at	ADP
ihlr-16470	564	6	567	567	NUM
ihlr-16470	564	7	.	.	NOUN
ihlr-16470	564	8	157	157	NUM
ihlr-16470	564	9	.	.	PUNCT
ihlr-16470	565	1	i	i	PRON
ihlr-16470	565	2	d.	d.	PROPN
ihlr-16470	565	3	2006	2006	NUM
ihlr-16470	565	4	]	]	PUNCT
ihlr-16470	566	1	anti	anti	X
ihlr-16470	566	2	~	~	NOUN
ihlr-16470	566	3	depressants	depressant	NOUN
ihlr-16470	566	4	and	and	CCONJ
ihlr-16470	566	5	children	child	NOUN
ihlr-16470	566	6	223	223	NUM
ihlr-16470	566	7	publish	publish	NOUN
ihlr-16470	566	8	,	,	PUNCT
ihlr-16470	566	9	one	one	PRON
ihlr-16470	566	10	must	must	AUX
ihlr-16470	566	11	understand	understand	VERB
ihlr-16470	566	12	the	the	DET
ihlr-16470	566	13	approval	approval	NOUN
ihlr-16470	566	14	process	process	NOUN
ihlr-16470	566	15	and	and	CCONJ
ihlr-16470	566	16	the	the	DET
ihlr-16470	566	17	duties	duty	NOUN
ihlr-16470	566	18	of	of	ADP
ihlr-16470	566	19	the	the	DET
ihlr-16470	566	20	manufacturer	manufacturer	NOUN
ihlr-16470	566	21	.	.	PUNCT
ihlr-16470	567	1	a.	a.	NOUN
ihlr-16470	567	2	new	new	ADJ
ihlr-16470	567	3	drug	drug	NOUN
ihlr-16470	567	4	approval	approval	NOUN
ihlr-16470	567	5	before	before	SCONJ
ihlr-16470	567	6	a	a	DET
ihlr-16470	567	7	manufacturer	manufacturer	NOUN
ihlr-16470	567	8	can	can	AUX
ihlr-16470	567	9	introduce	introduce	VERB
ihlr-16470	567	10	a	a	DET
ihlr-16470	567	11	drug	drug	NOUN
ihlr-16470	567	12	into	into	ADP
ihlr-16470	567	13	commerce	commerce	NOUN
ihlr-16470	567	14	it	it	PRON
ihlr-16470	567	15	must	must	AUX
ihlr-16470	567	16	gain	gain	VERB
ihlr-16470	567	17	fda	fda	PROPN
ihlr-16470	567	18	approval	approval	NOUN
ihlr-16470	567	19	for	for	ADP
ihlr-16470	567	20	the	the	DET
ihlr-16470	567	21	intended	intend	VERB
ihlr-16470	567	22	use	use	NOUN
ihlr-16470	567	23	by	by	ADP
ihlr-16470	567	24	showing	show	VERB
ihlr-16470	567	25	the	the	DET
ihlr-16470	567	26	drug	drug	NOUN
ihlr-16470	567	27	is	be	AUX
ihlr-16470	567	28	safe	safe	ADJ
ihlr-16470	567	29	and	and	CCONJ
ihlr-16470	567	30	effective	effective	ADJ
ihlr-16470	567	31	for	for	ADP
ihlr-16470	567	32	its	its	PRON
ihlr-16470	567	33	intended	intended	ADJ
ihlr-16470	567	34	use.158	use.158	NOUN
ihlr-16470	567	35	in	in	ADP
ihlr-16470	567	36	order	order	NOUN
ihlr-16470	567	37	to	to	PART
ihlr-16470	567	38	show	show	VERB
ihlr-16470	567	39	that	that	SCONJ
ihlr-16470	567	40	the	the	DET
ihlr-16470	567	41	drug	drug	NOUN
ihlr-16470	567	42	is	be	AUX
ihlr-16470	567	43	safe	safe	ADJ
ihlr-16470	567	44	and	and	CCONJ
ihlr-16470	567	45	effective	effective	ADJ
ihlr-16470	567	46	,	,	PUNCT
ihlr-16470	567	47	the	the	DET
ihlr-16470	567	48	manufacturers	manufacturer	NOUN
ihlr-16470	567	49	must	must	AUX
ihlr-16470	567	50	conduct	conduct	VERB
ihlr-16470	567	51	clinical	clinical	ADJ
ihlr-16470	567	52	trials	trial	NOUN
ihlr-16470	567	53	in	in	ADP
ihlr-16470	567	54	controlled	control	VERB
ihlr-16470	567	55	studies	study	NOUN
ihlr-16470	567	56	for	for	ADP
ihlr-16470	567	57	the	the	DET
ihlr-16470	567	58	intended	intend	VERB
ihlr-16470	567	59	patient	patient	NOUN
ihlr-16470	567	60	group	group	NOUN
ihlr-16470	567	61	.	.	PUNCT
ihlr-16470	568	1	additionally	additionally	ADV
ihlr-16470	568	2	,	,	PUNCT
ihlr-16470	568	3	manufacturers	manufacturer	NOUN
ihlr-16470	568	4	must	must	AUX
ihlr-16470	568	5	provide	provide	VERB
ihlr-16470	568	6	the	the	DET
ihlr-16470	568	7	fda	fda	PROPN
ihlr-16470	568	8	with	with	ADP
ihlr-16470	568	9	information	information	NOUN
ihlr-16470	568	10	regarding	regard	VERB
ihlr-16470	568	11	the	the	DET
ihlr-16470	568	12	method	method	NOUN
ihlr-16470	568	13	,	,	PUNCT
ihlr-16470	568	14	population	population	NOUN
ihlr-16470	568	15	,	,	PUNCT
ihlr-16470	568	16	and	and	CCONJ
ihlr-16470	568	17	dosages	dosage	NOUN
ihlr-16470	568	18	of	of	ADP
ihlr-16470	568	19	the	the	DET
ihlr-16470	568	20	clinical	clinical	ADJ
ihlr-16470	568	21	trial	trial	NOUN
ihlr-16470	568	22	.	.	PUNCT
ihlr-16470	569	1	at	at	ADP
ihlr-16470	569	2	this	this	DET
ihlr-16470	569	3	stage	stage	NOUN
ihlr-16470	569	4	of	of	ADP
ihlr-16470	569	5	the	the	DET
ihlr-16470	569	6	testing	testing	NOUN
ihlr-16470	569	7	,	,	PUNCT
ihlr-16470	569	8	companies	company	NOUN
ihlr-16470	569	9	are	be	AUX
ihlr-16470	569	10	required	require	VERB
ihlr-16470	569	11	to	to	PART
ihlr-16470	569	12	provide	provide	VERB
ihlr-16470	569	13	the	the	DET
ihlr-16470	569	14	fda	fda	PROPN
ihlr-16470	569	15	with	with	ADP
ihlr-16470	569	16	data	datum	NOUN
ihlr-16470	569	17	from	from	ADP
ihlr-16470	569	18	all	all	DET
ihlr-16470	569	19	trials	trial	NOUN
ihlr-16470	569	20	.	.	PUNCT
ihlr-16470	570	1	still	still	ADV
ihlr-16470	570	2	,	,	PUNCT
ihlr-16470	570	3	the	the	DET
ihlr-16470	570	4	approval	approval	NOUN
ihlr-16470	570	5	process	process	NOUN
ihlr-16470	570	6	remains	remain	VERB
ihlr-16470	570	7	flawed	flawed	ADJ
ihlr-16470	570	8	because	because	SCONJ
ihlr-16470	570	9	until	until	SCONJ
ihlr-16470	570	10	very	very	ADV
ihlr-16470	570	11	recently	recently	ADV
ihlr-16470	570	12	,	,	PUNCT
ihlr-16470	570	13	the	the	DET
ihlr-16470	570	14	fda	fda	PROPN
ihlr-16470	570	15	did	do	AUX
ihlr-16470	570	16	not	not	PART
ihlr-16470	570	17	require	require	VERB
ihlr-16470	570	18	drug	drug	NOUN
ihlr-16470	570	19	companies	company	NOUN
ihlr-16470	570	20	to	to	PART
ihlr-16470	570	21	test	test	VERB
ihlr-16470	570	22	new	new	ADJ
ihlr-16470	570	23	drugs	drug	NOUN
ihlr-16470	570	24	in	in	ADP
ihlr-16470	570	25	pediatric	pediatric	ADJ
ihlr-16470	570	26	populations.159	populations.159	NOUN
ihlr-16470	570	27	thus	thus	ADV
ihlr-16470	570	28	,	,	PUNCT
ihlr-16470	570	29	the	the	DET
ihlr-16470	570	30	approval	approval	NOUN
ihlr-16470	570	31	process	process	NOUN
ihlr-16470	570	32	left	leave	VERB
ihlr-16470	570	33	a	a	DET
ihlr-16470	570	34	void	void	NOUN
ihlr-16470	570	35	in	in	ADP
ihlr-16470	570	36	an	an	DET
ihlr-16470	570	37	important	important	ADJ
ihlr-16470	570	38	area	area	NOUN
ihlr-16470	570	39	of	of	ADP
ihlr-16470	570	40	fda	fda	PROPN
ihlr-16470	570	41	concern	concern	NOUN
ihlr-16470	570	42	.	.	PUNCT
ihlr-16470	571	1	158	158	X
ihlr-16470	571	2	.	.	PUNCT
ihlr-16470	572	1	(	(	PUNCT
ihlr-16470	572	2	a	a	X
ihlr-16470	572	3	)	)	PUNCT
ihlr-16470	572	4	necessity	necessity	NOUN
ihlr-16470	572	5	of	of	ADP
ihlr-16470	572	6	effective	effective	ADJ
ihlr-16470	572	7	approval	approval	NOUN
ihlr-16470	572	8	of	of	ADP
ihlr-16470	572	9	application	application	NOUN
ihlr-16470	572	10	no	no	DET
ihlr-16470	572	11	person	person	NOUN
ihlr-16470	572	12	shall	shall	AUX
ihlr-16470	572	13	introduce	introduce	VERB
ihlr-16470	572	14	or	or	CCONJ
ihlr-16470	572	15	deliver	deliver	VERB
ihlr-16470	572	16	for	for	ADP
ihlr-16470	572	17	introduction	introduction	NOUN
ihlr-16470	572	18	into	into	ADP
ihlr-16470	572	19	interstate	interstate	ADJ
ihlr-16470	572	20	commerce	commerce	NOUN
ihlr-16470	572	21	any	any	DET
ihlr-16470	572	22	new	new	ADJ
ihlr-16470	572	23	drug	drug	NOUN
ihlr-16470	572	24	,	,	PUNCT
ihlr-16470	572	25	unless	unless	SCONJ
ihlr-16470	572	26	an	an	DET
ihlr-16470	572	27	approval	approval	NOUN
ihlr-16470	572	28	of	of	ADP
ihlr-16470	572	29	an	an	DET
ihlr-16470	572	30	.application	.application	NOUN
ihlr-16470	572	31	filed	file	VERB
ihlr-16470	572	32	pursuant	pursuant	ADV
ihlr-16470	572	33	to	to	ADP
ihlr-16470	572	34	subsection	subsection	NOUN
ihlr-16470	572	35	(	(	PUNCT
ihlr-16470	572	36	b	b	NOUN
ihlr-16470	572	37	)	)	PUNCT
ihlr-16470	572	38	or	or	CCONJ
ihlr-16470	572	39	{	{	PUNCT
ihlr-16470	572	40	j	j	NOUN
ihlr-16470	572	41	)	)	PUNCT
ihlr-16470	572	42	of	of	ADP
ihlr-16470	572	43	this	this	DET
ihlr-16470	572	44	section	section	NOUN
ihlr-16470	572	45	is	be	AUX
ihlr-16470	572	46	effective	effective	ADJ
ihlr-16470	572	47	with	with	ADP
ihlr-16470	572	48	respect	respect	NOUN
ihlr-16470	572	49	to	to	ADP
ihlr-16470	572	50	such	such	ADJ
ihlr-16470	572	51	drug	drug	NOUN
ihlr-16470	572	52	.	.	PUNCT
ihlr-16470	573	1	(	(	PUNCT
ihlr-16470	573	2	b	b	X
ihlr-16470	573	3	)	)	PUNCT
ihlr-16470	573	4	filing	filing	NOUN
ihlr-16470	573	5	application	application	NOUN
ihlr-16470	573	6	;	;	PUNCT
ihlr-16470	573	7	contents	content	NOUN
ihlr-16470	573	8	(	(	PUNCT
ihlr-16470	573	9	l	l	NOUN
ihlr-16470	573	10	)	)	PUNCT
ihlr-16470	573	11	any	any	DET
ihlr-16470	573	12	person	person	NOUN
ihlr-16470	573	13	may	may	AUX
ihlr-16470	573	14	file	file	VERB
ihlr-16470	573	15	with	with	ADP
ihlr-16470	573	16	the	the	DET
ihlr-16470	573	17	secretary	secretary	NOUN
ihlr-16470	573	18	an	an	DET
ihlr-16470	573	19	application	application	NOUN
ihlr-16470	573	20	with	with	ADP
ihlr-16470	573	21	respect	respect	NOUN
ihlr-16470	573	22	to	to	ADP
ihlr-16470	573	23	any	any	DET
ihlr-16470	573	24	drug	drug	NOUN
ihlr-16470	573	25	subject	subject	NOUN
ihlr-16470	573	26	to	to	ADP
ihlr-16470	573	27	the	the	DET
ihlr-16470	573	28	provisions	provision	NOUN
ihlr-16470	573	29	of	of	ADP
ihlr-16470	573	30	subsection	subsection	NOUN
ihlr-16470	573	31	(	(	PUNCT
ihlr-16470	573	32	a	a	NOUN
ihlr-16470	573	33	)	)	PUNCT
ihlr-16470	573	34	of	of	ADP
ihlr-16470	573	35	this	this	DET
ihlr-16470	573	36	section	section	NOUN
ihlr-16470	573	37	.	.	PUNCT
ihlr-16470	574	1	such	such	ADJ
ihlr-16470	574	2	person	person	NOUN
ihlr-16470	574	3	shall	shall	AUX
ihlr-16470	574	4	submit	submit	VERB
ihlr-16470	574	5	to	to	ADP
ihlr-16470	574	6	the	the	DET
ihlr-16470	574	7	secretary	secretary	NOUN
ihlr-16470	574	8	as	as	ADP
ihlr-16470	574	9	a	a	DET
ihlr-16470	574	10	part	part	NOUN
ihlr-16470	574	11	of	of	ADP
ihlr-16470	574	12	the	the	DET
ihlr-16470	574	13	application	application	NOUN
ihlr-16470	574	14	..	..	PUNCT
ihlr-16470	575	1	(	(	PUNCT
ihlr-16470	575	2	a	a	X
ihlr-16470	575	3	)	)	PUNCT
ihlr-16470	575	4	full	full	ADJ
ihlr-16470	575	5	reports	report	NOUN
ihlr-16470	575	6	of	of	ADP
ihlr-16470	575	7	investigations	investigation	NOUN
ihlr-16470	575	8	which	which	PRON
ihlr-16470	575	9	have	have	AUX
ihlr-16470	575	10	been	be	AUX
ihlr-16470	575	11	made	make	VERB
ihlr-16470	575	12	to	to	PART
ihlr-16470	575	13	show	show	VERB
ihlr-16470	575	14	whether	whether	SCONJ
ihlr-16470	575	15	or	or	CCONJ
ihlr-16470	575	16	not	not	PART
ihlr-16470	575	17	such	such	ADJ
ihlr-16470	575	18	drug	drug	NOUN
ihlr-16470	575	19	is	be	AUX
ihlr-16470	575	20	safe	safe	ADJ
ihlr-16470	575	21	for	for	ADP
ihlr-16470	575	22	use	use	NOUN
ihlr-16470	575	23	and	and	CCONJ
ihlr-16470	575	24	whether	whether	SCONJ
ihlr-16470	575	25	such	such	ADJ
ihlr-16470	575	26	drug	drug	NOUN
ihlr-16470	575	27	is	be	AUX
ihlr-16470	575	28	effective	effective	ADJ
ihlr-16470	575	29	in	in	ADP
ihlr-16470	575	30	use	use	NOUN
ihlr-16470	575	31	;	;	PUNCT
ihlr-16470	575	32	(	(	PUNCT
ihlr-16470	575	33	b	b	X
ihlr-16470	575	34	)	)	PUNCT
ihlr-16470	575	35	a	a	DET
ihlr-16470	575	36	full	full	ADJ
ihlr-16470	575	37	list	list	NOUN
ihlr-16470	575	38	of	of	ADP
ihlr-16470	575	39	the	the	DET
ihlr-16470	575	40	articles	article	NOUN
ihlr-16470	575	41	used	use	VERB
ihlr-16470	575	42	as	as	ADP
ihlr-16470	575	43	components	component	NOUN
ihlr-16470	575	44	of	of	ADP
ihlr-16470	575	45	such	such	ADJ
ihlr-16470	575	46	drug	drug	NOUN
ihlr-16470	575	47	;	;	PUNCT
ihlr-16470	575	48	(	(	PUNCT
ihlr-16470	575	49	c	c	X
ihlr-16470	575	50	)	)	PUNCT
ihlr-16470	575	51	a	a	DET
ihlr-16470	575	52	full	full	ADJ
ihlr-16470	575	53	statement	statement	NOUN
ihlr-16470	575	54	of	of	ADP
ihlr-16470	575	55	the	the	DET
ihlr-16470	575	56	composition	composition	NOUN
ihlr-16470	575	57	of	of	ADP
ihlr-16470	575	58	such	such	ADJ
ihlr-16470	575	59	drug	drug	NOUN
ihlr-16470	575	60	;	;	PUNCT
ihlr-16470	575	61	(	(	PUNCT
ihlr-16470	575	62	d	d	X
ihlr-16470	575	63	)	)	PUNCT
ihlr-16470	575	64	a	a	DET
ihlr-16470	575	65	full	full	ADJ
ihlr-16470	575	66	description	description	NOUN
ihlr-16470	575	67	of	of	ADP
ihlr-16470	575	68	the	the	DET
ihlr-16470	575	69	methods	method	NOUN
ihlr-16470	575	70	used	use	VERB
ihlr-16470	575	71	in	in	ADP
ihlr-16470	575	72	,	,	PUNCT
ihlr-16470	575	73	and	and	CCONJ
ihlr-16470	575	74	the	the	DET
ihlr-16470	575	75	facilities	facility	NOUN
ihlr-16470	575	76	and	and	CCONJ
ihlr-16470	575	77	controls	control	NOUN
ihlr-16470	575	78	used	use	VERB
ihlr-16470	575	79	for	for	ADP
ihlr-16470	575	80	,	,	PUNCT
ihlr-16470	575	81	the	the	DET
ihlr-16470	575	82	manufacture	manufacture	NOUN
ihlr-16470	575	83	,	,	PUNCT
ihlr-16470	575	84	processing	processing	NOUN
ihlr-16470	575	85	,	,	PUNCT
ihlr-16470	575	86	and	and	CCONJ
ihlr-16470	575	87	packing	packing	NOUN
ihlr-16470	575	88	of	of	ADP
ihlr-16470	575	89	such	such	ADJ
ihlr-16470	575	90	drug	drug	NOUN
ihlr-16470	575	91	;	;	PUNCT
ihlr-16470	575	92	(	(	PUNCT
ihlr-16470	575	93	e	e	X
ihlr-16470	575	94	)	)	PUNCT
ihlr-16470	575	95	such	such	ADJ
ihlr-16470	575	96	samples	sample	NOUN
ihlr-16470	575	97	of	of	ADP
ihlr-16470	575	98	such	such	ADJ
ihlr-16470	575	99	drug	drug	NOUN
ihlr-16470	575	100	and	and	CCONJ
ihlr-16470	575	101	of	of	ADP
ihlr-16470	575	102	the	the	DET
ihlr-16470	575	103	articles	article	NOUN
ihlr-16470	575	104	used	use	VERB
ihlr-16470	575	105	as	as	ADP
ihlr-16470	575	106	components	component	NOUN
ihlr-16470	575	107	thereof	thereof	ADV
ihlr-16470	575	108	as	as	SCONJ
ihlr-16470	575	109	the	the	DET
ihlr-16470	575	110	secretary	secretary	NOUN
ihlr-16470	575	111	may	may	AUX
ihlr-16470	575	112	require	require	VERB
ihlr-16470	575	113	;	;	PUNCT
ihlr-16470	575	114	(	(	PUNCT
ihlr-16470	575	115	f	f	X
ihlr-16470	575	116	)	)	PUNCT
ihlr-16470	575	117	specimens	specimen	NOUN
ihlr-16470	575	118	of	of	ADP
ihlr-16470	575	119	the	the	DET
ihlr-16470	575	120	labeling	labeling	NOUN
ihlr-16470	575	121	proposed	propose	VERB
ihlr-16470	575	122	to	to	PART
ihlr-16470	575	123	be	be	AUX
ihlr-16470	575	124	used	use	VERB
ihlr-16470	575	125	for	for	ADP
ihlr-16470	575	126	such	such	ADJ
ihlr-16470	575	127	drug	drug	NOUN
ihlr-16470	575	128	.	.	PUNCT
ihlr-16470	576	1	the	the	DET
ihlr-16470	576	2	applicant	applicant	NOUN
ihlr-16470	576	3	shall	shall	AUX
ihlr-16470	576	4	file	file	VERB
ihlr-16470	576	5	with	with	ADP
ihlr-16470	576	6	the	the	DET
ihlr-16470	576	7	application	application	NOUN
ihlr-16470	576	8	the	the	DET
ihlr-16470	576	9	patent	patent	NOUN
ihlr-16470	576	10	number	number	NOUN
ihlr-16470	576	11	and	and	CCONJ
ihlr-16470	576	12	the	the	DET
ihlr-16470	576	13	expiration	expiration	NOUN
ihlr-16470	576	14	date	date	NOUN
ihlr-16470	576	15	of	of	ADP
ihlr-16470	576	16	any	any	DET
ihlr-16470	576	17	patent	patent	NOUN
ihlr-16470	576	18	which	which	PRON
ihlr-16470	576	19	claims	claim	VERB
ihlr-16470	576	20	the	the	DET
ihlr-16470	576	21	drug	drug	NOUN
ihlr-16470	576	22	for	for	ADP
ihlr-16470	576	23	which	which	PRON
ihlr-16470	576	24	the	the	DET
ihlr-16470	576	25	applicant	applicant	NOUN
ihlr-16470	576	26	submitted	submit	VERB
ihlr-16470	576	27	the	the	DET
ihlr-16470	576	28	application	application	NOUN
ihlr-16470	576	29	or	or	CCONJ
ihlr-16470	576	30	which	which	PRON
ihlr-16470	576	31	claims	claim	VERB
ihlr-16470	576	32	a	a	DET
ihlr-16470	576	33	method	method	NOUN
ihlr-16470	576	34	of	of	ADP
ihlr-16470	576	35	using	use	VERB
ihlr-16470	576	36	such	such	ADJ
ihlr-16470	576	37	drug	drug	NOUN
ihlr-16470	576	38	and	and	CCONJ
ihlr-16470	576	39	with	with	ADP
ihlr-16470	576	40	respect	respect	NOUN
ihlr-16470	576	41	to	to	ADP
ihlr-16470	576	42	which	which	PRON
ihlr-16470	576	43	a	a	DET
ihlr-16470	576	44	claim	claim	NOUN
ihlr-16470	576	45	of	of	ADP
ihlr-16470	576	46	patent	patent	NOUN
ihlr-16470	576	47	infringement	infringement	NOUN
ihlr-16470	576	48	could	could	AUX
ihlr-16470	576	49	reasonably	reasonably	ADV
ihlr-16470	576	50	be	be	AUX
ihlr-16470	576	51	asserted	assert	VERB
ihlr-16470	576	52	if	if	SCONJ
ihlr-16470	576	53	a	a	DET
ihlr-16470	576	54	person	person	NOUN
ihlr-16470	576	55	not	not	PART
ihlr-16470	576	56	licensed	license	VERB
ihlr-16470	576	57	by	by	ADP
ihlr-16470	576	58	the	the	DET
ihlr-16470	576	59	owner	owner	NOUN
ihlr-16470	576	60	engaged	engage	VERB
ihlr-16470	576	61	in	in	ADP
ihlr-16470	576	62	the	the	DET
ihlr-16470	576	63	manufacture	manufacture	NOUN
ihlr-16470	576	64	,	,	PUNCT
ihlr-16470	576	65	use	use	NOUN
ihlr-16470	576	66	,	,	PUNCT
ihlr-16470	576	67	or	or	CCONJ
ihlr-16470	576	68	sale	sale	NOUN
ihlr-16470	576	69	of	of	ADP
ihlr-16470	576	70	the	the	DET
ihlr-16470	576	71	drug	drug	NOUN
ihlr-16470	576	72	.	.	PUNCT
ihlr-16470	577	1	if	if	SCONJ
ihlr-16470	577	2	an	an	DET
ihlr-16470	577	3	application	application	NOUN
ihlr-16470	577	4	is	be	AUX
ihlr-16470	577	5	filed	file	VERB
ihlr-16470	577	6	under	under	ADP
ihlr-16470	577	7	this	this	DET
ihlr-16470	577	8	subsection	subsection	NOUN
ihlr-16470	577	9	for	for	ADP
ihlr-16470	577	10	a	a	DET
ihlr-16470	577	11	drug	drug	NOUN
ihlr-16470	577	12	and	and	CCONJ
ihlr-16470	577	13	a	a	DET
ihlr-16470	577	14	patent	patent	NOUN
ihlr-16470	577	15	which	which	PRON
ihlr-16470	577	16	claims	claim	VERB
ihlr-16470	577	17	such	such	ADJ
ihlr-16470	577	18	drug	drug	NOUN
ihlr-16470	577	19	or	or	CCONJ
ihlr-16470	577	20	a	a	DET
ihlr-16470	577	21	method	method	NOUN
ihlr-16470	577	22	of	of	ADP
ihlr-16470	577	23	using	use	VERB
ihlr-16470	577	24	such	such	ADJ
ihlr-16470	577	25	drug	drug	NOUN
ihlr-16470	577	26	is	be	AUX
ihlr-16470	577	27	issued	issue	VERB
ihlr-16470	577	28	after	after	ADP
ihlr-16470	577	29	the	the	DET
ihlr-16470	577	30	filing	filing	NOUN
ihlr-16470	577	31	date	date	NOUN
ihlr-16470	577	32	but	but	CCONJ
ihlr-16470	577	33	before	before	ADP
ihlr-16470	577	34	approval	approval	NOUN
ihlr-16470	577	35	of	of	ADP
ihlr-16470	577	36	the	the	DET
ihlr-16470	577	37	application	application	NOUN
ihlr-16470	577	38	,	,	PUNCT
ihlr-16470	577	39	the	the	DET
ihlr-16470	577	40	applicant	applicant	NOUN
ihlr-16470	577	41	shall	shall	AUX
ihlr-16470	577	42	amend	amend	VERB
ihlr-16470	577	43	the	the	DET
ihlr-16470	577	44	application	application	NOUN
ihlr-16470	577	45	to	to	PART
ihlr-16470	577	46	include	include	VERB
ihlr-16470	577	47	the	the	DET
ihlr-16470	577	48	information	information	NOUN
ihlr-16470	577	49	required	require	VERB
ihlr-16470	577	50	by	by	ADP
ihlr-16470	577	51	the	the	DET
ihlr-16470	577	52	preceding	precede	VERB
ihlr-16470	577	53	sentence	sentence	NOUN
ihlr-16470	577	54	.	.	PUNCT
ihlr-16470	578	1	upon	upon	SCONJ
ihlr-16470	578	2	approval	approval	NOUN
ihlr-16470	578	3	of	of	ADP
ihlr-16470	578	4	the	the	DET
ihlr-16470	578	5	application	application	NOUN
ihlr-16470	578	6	,	,	PUNCT
ihlr-16470	578	7	the	the	DET
ihlr-16470	578	8	secretary	secretary	NOUN
ihlr-16470	578	9	shall	shall	AUX
ihlr-16470	578	10	publish	publish	VERB
ihlr-16470	578	11	information	information	NOUN
ihlr-16470	578	12	submitted	submit	VERB
ihlr-16470	578	13	under	under	ADP
ihlr-16470	578	14	the	the	DET
ihlr-16470	578	15	two	two	NUM
ihlr-16470	578	16	preceding	precede	VERB
ihlr-16470	578	17	sentences	sentence	NOUN
ihlr-16470	578	18	.	.	PUNCT
ihlr-16470	579	1	the	the	DET
ihlr-16470	579	2	secretary	secretary	NOUN
ihlr-16470	579	3	shall	shall	AUX
ihlr-16470	579	4	,	,	PUNCT
ihlr-16470	579	5	in	in	ADP
ihlr-16470	579	6	consultation	consultation	NOUN
ihlr-16470	579	7	with	with	ADP
ihlr-16470	579	8	the	the	DET
ihlr-16470	579	9	director	director	NOUN
ihlr-16470	579	10	of	of	ADP
ihlr-16470	579	11	the	the	DET
ihlr-16470	579	12	national	national	PROPN
ihlr-16470	579	13	institutes	institutes	PROPN
ihlr-16470	579	14	of	of	ADP
ihlr-16470	579	15	health	health	PROPN
ihlr-16470	579	16	and	and	CCONJ
ihlr-16470	579	17	with	with	ADP
ihlr-16470	579	18	representatives	representative	NOUN
ihlr-16470	579	19	of	of	ADP
ihlr-16470	579	20	the	the	DET
ihlr-16470	579	21	drug	drug	NOUN
ihlr-16470	579	22	manufacturing	manufacturing	NOUN
ihlr-16470	579	23	industry	industry	NOUN
ihlr-16470	579	24	,	,	PUNCT
ihlr-16470	579	25	review	review	NOUN
ihlr-16470	579	26	and	and	CCONJ
ihlr-16470	579	27	develop	develop	VERB
ihlr-16470	579	28	guidance	guidance	NOUN
ihlr-16470	579	29	,	,	PUNCT
ihlr-16470	579	30	as	as	ADP
ihlr-16470	579	31	appropriate	appropriate	ADJ
ihlr-16470	579	32	,	,	PUNCT
ihlr-16470	579	33	on	on	ADP
ihlr-16470	579	34	the	the	DET
ihlr-16470	579	35	inclusion	inclusion	NOUN
ihlr-16470	579	36	of	of	ADP
ihlr-16470	579	37	women	woman	NOUN
ihlr-16470	579	38	and	and	CCONJ
ihlr-16470	579	39	minorities	minority	NOUN
ihlr-16470	579	40	in	in	ADP
ihlr-16470	579	41	clinical	clinical	ADJ
ihlr-16470	579	42	trials	trial	NOUN
ihlr-16470	579	43	required	require	VERB
ihlr-16470	579	44	by	by	ADP
ihlr-16470	579	45	clause	clause	NOUN
ihlr-16470	579	46	(	(	PUNCT
ihlr-16470	579	47	a	a	NOUN
ihlr-16470	579	48	)	)	PUNCT
ihlr-16470	579	49	,	,	PUNCT
ihlr-16470	579	50	and	and	CCONJ
ihlr-16470	579	51	(	(	PUNCT
ihlr-16470	579	52	g	g	NOUN
ihlr-16470	579	53	)	)	PUNCT
ihlr-16470	579	54	any	any	DET
ihlr-16470	579	55	assessments	assessment	NOUN
ihlr-16470	579	56	required	require	VERB
ihlr-16470	579	57	under	under	ADP
ihlr-16470	579	58	section	section	NOUN
ihlr-16470	579	59	355c	355c	PROPN
ihlr-16470	579	60	of	of	ADP
ihlr-16470	579	61	this	this	DET
ihlr-16470	579	62	title	title	NOUN
ihlr-16470	579	63	.	.	PUNCT
ihlr-16470	580	1	21	21	NUM
ihlr-16470	580	2	u.s.c.a	u.s.c.a	PROPN
ihlr-16470	580	3	.	.	PUNCT
ihlr-16470	580	4	§	§	PROPN
ihlr-16470	580	5	355	355	NUM
ihlr-16470	580	6	(	(	PUNCT
ihlr-16470	580	7	west	west	NOUN
ihlr-16470	580	8	2004	2004	NUM
ihlr-16470	580	9	)	)	PUNCT
ihlr-16470	580	10	.	.	PUNCT
ihlr-16470	581	1	159	159	NUM
ihlr-16470	581	2	.	.	PUNCT
ihlr-16470	582	1	hazard	hazard	NOUN
ihlr-16470	582	2	,	,	PUNCT
ihlr-16470	582	3	supra	supra	PROPN
ihlr-16470	582	4	note	note	PROPN
ihlr-16470	582	5	8,at478~79	8,at478~79	NUM
ihlr-16470	582	6	.	.	PUNCT
ihlr-16470	583	1	224	224	NUM
ihlr-16470	583	2	indiana	indiana	PROPN
ihlr-16470	583	3	health	health	PROPN
ihlr-16470	583	4	law	law	PROPN
ihlr-16470	583	5	review	review	NOUN
ihlr-16470	583	6	[	[	X
ihlr-16470	583	7	vol	vol	NOUN
ihlr-16470	583	8	.	.	PUNCT
ihlr-16470	584	1	3:201	3:201	NUM
ihlr-16470	584	2	b.	b.	PROPN
ihlr-16470	584	3	pediatric	pediatric	ADJ
ihlr-16470	584	4	research	research	PROPN
ihlr-16470	584	5	the	the	DET
ihlr-16470	584	6	fda	fda	PROPN
ihlr-16470	584	7	did	do	AUX
ihlr-16470	584	8	not	not	PART
ihlr-16470	584	9	require	require	VERB
ihlr-16470	584	10	pediatric	pediatric	ADJ
ihlr-16470	584	11	testing	testing	NOUN
ihlr-16470	584	12	of	of	ADP
ihlr-16470	584	13	new	new	ADJ
ihlr-16470	584	14	drugs	drug	NOUN
ihlr-16470	584	15	until	until	ADP
ihlr-16470	584	16	1997.160	1997.160	NUM
ihlr-16470	584	17	instead	instead	ADV
ihlr-16470	584	18	,	,	PUNCT
ihlr-16470	584	19	the	the	DET
ihlr-16470	584	20	fda	fda	PROPN
ihlr-16470	584	21	attempted	attempt	VERB
ihlr-16470	584	22	to	to	PART
ihlr-16470	584	23	ensure	ensure	VERB
ihlr-16470	584	24	that	that	SCONJ
ihlr-16470	584	25	the	the	DET
ihlr-16470	584	26	companies	company	NOUN
ihlr-16470	584	27	did	do	AUX
ihlr-16470	584	28	not	not	PART
ihlr-16470	584	29	market	market	VERB
ihlr-16470	584	30	drugs	drug	NOUN
ihlr-16470	584	31	for	for	ADP
ihlr-16470	584	32	pediatric	pediatric	ADJ
ihlr-16470	584	33	use	use	NOUN
ihlr-16470	584	34	unless	unless	SCONJ
ihlr-16470	584	35	pediatric	pediatric	ADJ
ihlr-16470	584	36	testing	testing	NOUN
ihlr-16470	584	37	had	have	AUX
ihlr-16470	584	38	been	be	AUX
ihlr-16470	584	39	conducted	conduct	VERB
ihlr-16470	584	40	.	.	PUNCT
ihlr-16470	585	1	161	161	NUM
ihlr-16470	585	2	unfortunately	unfortunately	ADV
ihlr-16470	585	3	,	,	PUNCT
ihlr-16470	585	4	this	this	DET
ihlr-16470	585	5	method	method	NOUN
ihlr-16470	585	6	did	do	AUX
ihlr-16470	585	7	not	not	PART
ihlr-16470	585	8	adequately	adequately	ADV
ihlr-16470	585	9	protect	protect	VERB
ihlr-16470	585	10	children	child	NOUN
ihlr-16470	585	11	because	because	SCONJ
ihlr-16470	585	12	it	it	PRON
ihlr-16470	585	13	deterred	deter	VERB
ihlr-16470	585	14	pediatric	pediatric	ADJ
ihlr-16470	585	15	research	research	NOUN
ihlr-16470	585	16	rather	rather	ADV
ihlr-16470	585	17	than	than	ADP
ihlr-16470	585	18	encourage	encourage	VERB
ihlr-16470	585	19	it	it	PRON
ihlr-16470	585	20	,	,	PUNCT
ihlr-16470	585	21	even	even	ADV
ihlr-16470	585	22	when	when	SCONJ
ihlr-16470	585	23	the	the	DET
ihlr-16470	585	24	drug	drug	NOUN
ihlr-16470	585	25	was	be	AUX
ihlr-16470	585	26	widely	widely	ADV
ihlr-16470	585	27	used	use	VERB
ihlr-16470	585	28	in	in	ADP
ihlr-16470	585	29	pediatric	pediatric	ADJ
ihlr-16470	585	30	populations	population	NOUN
ihlr-16470	585	31	through	through	ADP
ihlr-16470	585	32	off	off	ADP
ihlr-16470	585	33	-	-	PUNCT
ihlr-16470	585	34	label	label	NOUN
ihlr-16470	585	35	use	use	NOUN
ihlr-16470	585	36	.	.	PUNCT
ihlr-16470	586	1	162	162	NUM
ihlr-16470	586	2	nothing	nothing	PRON
ihlr-16470	586	3	was	be	AUX
ihlr-16470	586	4	being	be	AUX
ihlr-16470	586	5	done	do	VERB
ihlr-16470	586	6	to	to	PART
ihlr-16470	586	7	ensure	ensure	VERB
ihlr-16470	586	8	that	that	SCONJ
ihlr-16470	586	9	off-:label	off-:label	PROPN
ihlr-16470	586	10	uses	use	VERB
ihlr-16470	586	11	were	be	AUX
ihlr-16470	586	12	safe	safe	ADJ
ihlr-16470	586	13	for	for	ADP
ihlr-16470	586	14	children	child	NOUN
ihlr-16470	586	15	and	and	CCONJ
ihlr-16470	586	16	very	very	ADV
ihlr-16470	586	17	little	little	ADJ
ihlr-16470	586	18	research	research	NOUN
ihlr-16470	586	19	was	be	AUX
ihlr-16470	586	20	done	do	VERB
ihlr-16470	586	21	concerning	concern	VERB
ihlr-16470	586	22	the	the	DET
ihlr-16470	586	23	possible	possible	ADJ
ihlr-16470	586	24	effects	effect	NOUN
ihlr-16470	586	25	these	these	DET
ihlr-16470	586	26	drugs	drug	NOUN
ihlr-16470	586	27	may	may	AUX
ihlr-16470	586	28	have	have	VERB
ihlr-16470	586	29	on	on	ADP
ihlr-16470	586	30	a	a	DET
ihlr-16470	586	31	highly	highly	ADV
ihlr-16470	586	32	sensitive	sensitive	ADJ
ihlr-16470	586	33	population	population	NOUN
ihlr-16470	586	34	.	.	PUNCT
ihlr-16470	587	1	163	163	NUM
ihlr-16470	587	2	under	under	ADP
ihlr-16470	587	3	the	the	DET
ihlr-16470	587	4	earlier	early	ADJ
ihlr-16470	587	5	regulation	regulation	NOUN
ihlr-16470	587	6	scheme	scheme	NOUN
ihlr-16470	587	7	the	the	DET
ihlr-16470	587	8	fda	fda	PROPN
ihlr-16470	587	9	's	's	PART
ihlr-16470	587	10	attempts	attempt	NOUN
ihlr-16470	587	11	to	to	PART
ihlr-16470	587	12	protect	protect	VERB
ihlr-16470	587	13	children	child	NOUN
ihlr-16470	587	14	were	be	AUX
ihlr-16470	587	15	almost	almost	ADV
ihlr-16470	587	16	completely	completely	ADV
ihlr-16470	587	17	without	without	ADP
ihlr-16470	587	18	effect	effect	NOUN
ihlr-16470	587	19	.	.	PUNCT
ihlr-16470	588	1	these	these	DET
ihlr-16470	588	2	early	early	ADJ
ihlr-16470	588	3	schemes	scheme	NOUN
ihlr-16470	588	4	included	include	VERB
ihlr-16470	588	5	incentives	incentive	NOUN
ihlr-16470	588	6	for	for	ADP
ihlr-16470	588	7	voluntary	voluntary	ADJ
ihlr-16470	588	8	testing	testing	NOUN
ihlr-16470	588	9	,	,	PUNCT
ihlr-16470	588	10	and	and	CCONJ
ihlr-16470	588	11	later	later	ADV
ihlr-16470	588	12	,	,	PUNCT
ihlr-16470	588	13	drug	drug	NOUN
ihlr-16470	588	14	companies	company	NOUN
ihlr-16470	588	15	were	be	AUX
ihlr-16470	588	16	only	only	ADV
ihlr-16470	588	17	required	require	VERB
ihlr-16470	588	18	to	to	PART
ihlr-16470	588	19	test	test	VERB
ihlr-16470	588	20	a	a	DET
ihlr-16470	588	21	product	product	NOUN
ihlr-16470	588	22	in	in	ADP
ihlr-16470	588	23	pediatric	pediatric	ADJ
ihlr-16470	588	24	studies	study	NOUN
ihlr-16470	588	25	if	if	SCONJ
ihlr-16470	588	26	they	they	PRON
ihlr-16470	588	27	articulated	articulate	VERB
ihlr-16470	588	28	a	a	DET
ihlr-16470	588	29	reason	reason	NOUN
ihlr-16470	588	30	it	it	PRON
ihlr-16470	588	31	would	would	AUX
ihlr-16470	588	32	be	be	AUX
ihlr-16470	588	33	used	use	VERB
ihlr-16470	588	34	in	in	ADP
ihlr-16470	588	35	children	child	NOUN
ihlr-16470	588	36	.	.	PUNCT
ihlr-16470	589	1	therefore	therefore	ADV
ihlr-16470	589	2	,	,	PUNCT
ihlr-16470	589	3	virtually	virtually	ADV
ihlr-16470	589	4	no	no	DET
ihlr-16470	589	5	burden	burden	NOUN
ihlr-16470	589	6	was	be	AUX
ihlr-16470	589	7	placed	place	VERB
ihlr-16470	589	8	upon	upon	SCONJ
ihlr-16470	589	9	the	the	DET
ihlr-16470	589	10	companies	company	NOUN
ihlr-16470	589	11	to	to	PART
ihlr-16470	589	12	ensure	ensure	VERB
ihlr-16470	589	13	pediatric	pediatric	ADJ
ihlr-16470	589	14	safety	safety	NOUN
ihlr-16470	589	15	,	,	PUNCT
ihlr-16470	589	16	placing	place	VERB
ihlr-16470	589	17	children	child	NOUN
ihlr-16470	589	18	in	in	ADP
ihlr-16470	589	19	a	a	DET
ihlr-16470	589	20	figurative	figurative	ADJ
ihlr-16470	589	21	"	"	PUNCT
ihlr-16470	589	22	black	black	ADJ
ihlr-16470	589	23	hole	hole	NOUN
ihlr-16470	589	24	"	"	PUNCT
ihlr-16470	589	25	in	in	ADP
ihlr-16470	589	26	terms	term	NOUN
ihlr-16470	589	27	of	of	ADP
ihlr-16470	589	28	clinical	clinical	ADJ
ihlr-16470	589	29	knowledge	knowledge	NOUN
ihlr-16470	589	30	and	and	CCONJ
ihlr-16470	589	31	regulatory	regulatory	ADJ
ihlr-16470	589	32	protection	protection	NOUN
ihlr-16470	589	33	.	.	PUNCT
ihlr-16470	590	1	164	164	NUM
ihlr-16470	590	2	manufacturers	manufacturer	NOUN
ihlr-16470	590	3	merely	merely	ADV
ihlr-16470	590	4	avoided	avoid	VERB
ihlr-16470	590	5	marketing	marketing	NOUN
ihlr-16470	590	6	drugs	drug	NOUN
ihlr-16470	590	7	to	to	ADP
ihlr-16470	590	8	children	child	NOUN
ihlr-16470	590	9	and	and	CCONJ
ihlr-16470	590	10	left	leave	VERB
ihlr-16470	590	11	room	room	NOUN
ihlr-16470	590	12	for	for	ADP
ihlr-16470	590	13	off	off	ADP
ihlr-16470	590	14	-	-	PUNCT
ihlr-16470	590	15	label	label	NOUN
ihlr-16470	590	16	uses	use	NOUN
ihlr-16470	590	17	to	to	PART
ihlr-16470	590	18	fill	fill	VERB
ihlr-16470	590	19	the	the	DET
ihlr-16470	590	20	need	need	NOUN
ihlr-16470	590	21	for	for	ADP
ihlr-16470	590	22	pediatric	pediatric	ADJ
ihlr-16470	590	23	care	care	NOUN
ihlr-16470	590	24	,	,	PUNCT
ihlr-16470	590	25	which	which	PRON
ihlr-16470	590	26	resulted	result	VERB
ihlr-16470	590	27	in	in	ADP
ihlr-16470	590	28	children	child	NOUN
ihlr-16470	590	29	becoming	become	VERB
ihlr-16470	590	30	"	"	PUNCT
ihlr-16470	590	31	de	de	X
ihlr-16470	590	32	facto	facto	X
ihlr-16470	590	33	research	research	NOUN
ihlr-16470	590	34	subjects	subject	NOUN
ihlr-16470	590	35	...	...	PUNCT
ihlr-16470	590	36	deprived	deprive	VERB
ihlr-16470	590	37	of	of	ADP
ihlr-16470	590	38	the	the	DET
ihlr-16470	590	39	[	[	X
ihlr-16470	590	40	protection	protection	NOUN
ihlr-16470	590	41	]	]	PUNCT
ihlr-16470	590	42	of	of	ADP
ihlr-16470	590	43	the	the	DET
ihlr-16470	590	44	controlled	control	VERB
ihlr-16470	590	45	supervision	supervision	NOUN
ihlr-16470	590	46	of	of	ADP
ihlr-16470	590	47	a	a	DET
ihlr-16470	590	48	clinical	clinical	ADJ
ihlr-16470	590	49	trial	trial	NOUN
ihlr-16470	590	50	.	.	PUNCT
ihlr-16470	591	1	"165	"165	PUNCT
ihlr-16470	591	2	to	to	PART
ihlr-16470	591	3	address	address	VERB
ihlr-16470	591	4	the	the	DET
ihlr-16470	591	5	problems	problem	NOUN
ihlr-16470	591	6	presented	present	VERB
ihlr-16470	591	7	by	by	ADP
ihlr-16470	591	8	the	the	DET
ihlr-16470	591	9	regulatory	regulatory	ADJ
ihlr-16470	591	10	scheme	scheme	NOUN
ihlr-16470	591	11	,	,	PUNCT
ihlr-16470	591	12	the	the	DET
ihlr-16470	591	13	fda	fda	PROPN
ihlr-16470	591	14	promulgated	promulgate	VERB
ihlr-16470	591	15	the	the	DET
ihlr-16470	591	16	"	"	PUNCT
ihlr-16470	591	17	final	final	ADJ
ihlr-16470	591	18	rule	rule	NOUN
ihlr-16470	591	19	"	"	PUNCT
ihlr-16470	591	20	in	in	ADP
ihlr-16470	591	21	j	j	PROPN
ihlr-16470	591	22	997.166	997.166	NUM
ihlr-16470	591	23	this	this	DET
ihlr-16470	591	24	rule	rule	NOUN
ihlr-16470	591	25	was	be	AUX
ihlr-16470	591	26	composed	compose	VERB
ihlr-16470	591	27	of	of	ADP
ihlr-16470	591	28	three	three	NUM
ihlr-16470	591	29	parts	part	NOUN
ihlr-16470	591	30	(	(	PUNCT
ihlr-16470	591	31	1	1	NUM
ihlr-16470	591	32	)	)	PUNCT
ihlr-16470	591	33	the	the	DET
ihlr-16470	591	34	rule	rule	NOUN
ihlr-16470	591	35	applied	apply	VERB
ihlr-16470	591	36	to	to	ADP
ihlr-16470	591	37	both	both	CCONJ
ihlr-16470	591	38	new	new	ADJ
ihlr-16470	591	39	and	and	CCONJ
ihlr-16470	591	40	marketed	market	VERB
ihlr-16470	591	41	drugs	drug	NOUN
ihlr-16470	591	42	widely	widely	ADV
ihlr-16470	591	43	used	use	VERB
ihlr-16470	591	44	in	in	ADP
ihlr-16470	591	45	children	child	NOUN
ihlr-16470	591	46	;	;	PUNCT
ihlr-16470	591	47	(	(	PUNCT
ihlr-16470	591	48	2	2	X
ihlr-16470	591	49	)	)	PUNCT
ihlr-16470	591	50	the	the	DET
ihlr-16470	591	51	fda	fda	PROPN
ihlr-16470	591	52	"	"	PUNCT
ihlr-16470	591	53	could	could	AUX
ihlr-16470	591	54	require	require	VERB
ihlr-16470	591	55	clinical	clinical	ADJ
ihlr-16470	591	56	data	datum	NOUN
ihlr-16470	591	57	for	for	ADP
ihlr-16470	591	58	all	all	DET
ihlr-16470	591	59	pediatric	pediatric	ADJ
ihlr-16470	591	60	subpopulations	subpopulation	NOUN
ihlr-16470	591	61	;	;	PUNCT
ihlr-16470	591	62	"	"	PUNCT
ihlr-16470	591	63	and	and	CCONJ
ihlr-16470	591	64	(	(	PUNCT
ihlr-16470	591	65	3	3	X
ihlr-16470	591	66	)	)	PUNCT
ihlr-16470	591	67	if	if	SCONJ
ihlr-16470	591	68	a	a	DET
ihlr-16470	591	69	manufacture	manufacture	NOUN
ihlr-16470	591	70	met	meet	VERB
ihlr-16470	591	71	certain	certain	ADJ
ihlr-16470	591	72	criteria	criterion	NOUN
ihlr-16470	591	73	,	,	PUNCT
ihlr-16470	591	74	it	it	PRON
ihlr-16470	591	75	could	could	AUX
ihlr-16470	591	76	obtain	obtain	VERB
ihlr-16470	591	77	a	a	DET
ihlr-16470	591	78	full	full	ADJ
ihlr-16470	591	79	or	or	CCONJ
ihlr-16470	591	80	partial	partial	ADJ
ihlr-16470	591	81	waiver	waiver	NOUN
ihlr-16470	591	82	for	for	ADP
ihlr-16470	591	83	its	its	PRON
ihlr-16470	591	84	product.167	product.167	NOUN
ihlr-16470	591	85	under	under	ADP
ihlr-16470	591	86	the	the	DET
ihlr-16470	591	87	final	final	ADJ
ihlr-16470	591	88	rule	rule	NOUN
ihlr-16470	591	89	,	,	PUNCT
ihlr-16470	591	90	if	if	SCONJ
ihlr-16470	591	91	a	a	DET
ihlr-16470	591	92	manufacturer	manufacturer	NOUN
ihlr-16470	591	93	failed	fail	VERB
ihlr-16470	591	94	to	to	PART
ihlr-16470	591	95	conduct	conduct	VERB
ihlr-16470	591	96	pediatric	pediatric	ADJ
ihlr-16470	591	97	trials	trial	NOUN
ihlr-16470	591	98	,	,	PUNCT
ihlr-16470	591	99	the	the	DET
ihlr-16470	591	100	fda	fda	PROPN
ihlr-16470	591	101	could	could	AUX
ihlr-16470	591	102	deem	deem	VERB
ihlr-16470	591	103	the	the	DET
ihlr-16470	591	104	drug	drug	NOUN
ihlr-16470	591	105	misbranded	misbrande	VERB
ihlr-16470	591	106	.	.	PUNCT
ihlr-16470	592	1	168	168	NUM
ihlr-16470	592	2	however	however	ADV
ihlr-16470	592	3	,	,	PUNCT
ihlr-16470	592	4	just	just	ADV
ihlr-16470	592	5	prior	prior	ADV
ihlr-16470	592	6	to	to	ADP
ihlr-16470	592	7	the	the	DET
ihlr-16470	592	8	promulgation	promulgation	NOUN
ihlr-16470	592	9	of	of	ADP
ihlr-16470	592	10	the	the	DET
ihlr-16470	592	11	final	final	ADJ
ihlr-16470	592	12	rule	rule	NOUN
ihlr-16470	592	13	,	,	PUNCT
ihlr-16470	592	14	i	i	PRON
ihlr-16470	592	15	d.	d.	PROPN
ihlr-16470	592	16	160	160	NUM
ihlr-16470	592	17	.	.	PUNCT
ihlr-16470	593	1	ld	ld	PROPN
ihlr-16470	593	2	.	.	PUNCT
ihlr-16470	594	1	at	at	ADP
ihlr-16470	594	2	478	478	NUM
ihlr-16470	594	3	.	.	NOUN
ihlr-16470	594	4	161	161	NUM
ihlr-16470	594	5	.	.	PUNCT
ihlr-16470	595	1	i	i	PRON
ihlr-16470	595	2	d.	d.	PROPN
ihlr-16470	595	3	162	162	NUM
ihlr-16470	595	4	.	.	PUNCT
ihlr-16470	596	1	this	this	DET
ihlr-16470	596	2	regulatory	regulatory	ADJ
ihlr-16470	596	3	approach	approach	NOUN
ihlr-16470	596	4	evinced	evince	VERB
ihlr-16470	596	5	a	a	DET
ihlr-16470	596	6	shield	shield	NOUN
ihlr-16470	596	7	and	and	CCONJ
ihlr-16470	596	8	a	a	DET
ihlr-16470	596	9	sword	sword	NOUN
ihlr-16470	596	10	on	on	ADP
ihlr-16470	596	11	the	the	DET
ihlr-16470	596	12	marketplace	marketplace	NOUN
ihlr-16470	596	13	.	.	PUNCT
ihlr-16470	597	1	while	while	SCONJ
ihlr-16470	597	2	protecting	protect	VERB
ihlr-16470	597	3	children	child	NOUN
ihlr-16470	597	4	from	from	ADP
ihlr-16470	597	5	false	false	ADJ
ihlr-16470	597	6	or	or	CCONJ
ihlr-16470	597	7	misleading	misleading	ADJ
ihlr-16470	597	8	claims	claim	NOUN
ihlr-16470	597	9	on	on	ADP
ihlr-16470	597	10	drug	drug	NOUN
ihlr-16470	597	11	labels	label	NOUN
ihlr-16470	597	12	,	,	PUNCT
ihlr-16470	597	13	it	it	PRON
ihlr-16470	597	14	also	also	ADV
ihlr-16470	597	15	deterred	deter	VERB
ihlr-16470	597	16	pharmaceutical	pharmaceutical	ADJ
ihlr-16470	597	17	companies	company	NOUN
ihlr-16470	597	18	from	from	ADP
ihlr-16470	597	19	testing	test	VERB
ihlr-16470	597	20	drugs	drug	NOUN
ihlr-16470	597	21	on	on	ADP
ihlr-16470	597	22	children	child	NOUN
ihlr-16470	597	23	.	.	PUNCT
ihlr-16470	598	1	thus	thus	ADV
ihlr-16470	598	2	,	,	PUNCT
ihlr-16470	598	3	pediatricians	pediatrician	NOUN
ihlr-16470	598	4	were	be	AUX
ihlr-16470	598	5	left	leave	VERB
ihlr-16470	598	6	to	to	PART
ihlr-16470	598	7	speculate	speculate	VERB
ihlr-16470	598	8	appropriate	appropriate	ADJ
ihlr-16470	598	9	dosages	dosage	NOUN
ihlr-16470	598	10	to	to	PART
ihlr-16470	598	11	treat	treat	VERB
ihlr-16470	598	12	their	their	PRON
ihlr-16470	598	13	young	young	ADJ
ihlr-16470	598	14	patients	patient	NOUN
ihlr-16470	598	15	or	or	CCONJ
ihlr-16470	598	16	otherwise	otherwise	ADV
ihlr-16470	598	17	avoid	avoid	VERB
ihlr-16470	598	18	prescribing	prescribe	VERB
ihlr-16470	598	19	drugs	drug	NOUN
ihlr-16470	598	20	altogether	altogether	ADV
ihlr-16470	598	21	....	....	PUNCT
ihlr-16470	599	1	163	163	X
ihlr-16470	599	2	.	.	PUNCT
ihlr-16470	599	3	/d	/d	INTJ
ihlr-16470	599	4	.	.	PUNCT
ihlr-16470	600	1	at	at	ADP
ihlr-16470	600	2	479	479	NUM
ihlr-16470	600	3	.	.	PUNCT
ihlr-16470	600	4	164	164	NUM
ihlr-16470	600	5	.	.	PUNCT
ihlr-16470	601	1	see	see	VERB
ihlr-16470	601	2	randall	randall	PROPN
ihlr-16470	601	3	baldwin	baldwin	PROPN
ihlr-16470	601	4	clark	clark	PROPN
ihlr-16470	601	5	,	,	PUNCT
ihlr-16470	601	6	9	9	NUM
ihlr-16470	601	7	u.	u.	NOUN
ihlr-16470	601	8	chi	chi	PROPN
ihlr-16470	601	9	.	.	PUNCT
ihlr-16470	602	1	l.	l.	PROPN
ihlr-16470	602	2	sch	sch	PROPN
ihlr-16470	602	3	.	.	PUNCT
ihlr-16470	603	1	roundtable	roundtable	ADJ
ihlr-16470	603	2	1	1	NUM
ihlr-16470	603	3	,	,	PUNCT
ihlr-16470	603	4	speed	speed	NOUN
ihlr-16470	603	5	,	,	PUNCT
ihlr-16470	603	6	safety	safety	NOUN
ihlr-16470	603	7	and	and	CCONJ
ihlr-16470	603	8	dignity	dignity	NOUN
ihlr-16470	603	9	:	:	PUNCT
ihlr-16470	603	10	pediatric	pediatric	ADJ
ihlr-16470	603	11	pharmaceutical	pharmaceutical	NOUN
ihlr-16470	603	12	development	development	NOUN
ihlr-16470	603	13	in	in	ADP
ihlr-16470	603	14	an	an	DET
ihlr-16470	603	15	age	age	NOUN
ihlr-16470	603	16	of	of	ADP
ihlr-16470	603	17	optimism	optimism	NOUN
ihlr-16470	603	18	,	,	PUNCT
ihlr-16470	603	19	10	10	NUM
ihlr-16470	603	20	-	-	SYM
ihlr-16470	603	21	13	13	NUM
ihlr-16470	603	22	(	(	PUNCT
ihlr-16470	603	23	2002	2002	NUM
ihlr-16470	603	24	)	)	PUNCT
ihlr-16470	603	25	.	.	PUNCT
ihlr-16470	604	1	165	165	NUM
ihlr-16470	604	2	.	.	PUNCT
ihlr-16470	604	3	hazard	hazard	NOUN
ihlr-16470	604	4	,	,	PUNCT
ihlr-16470	604	5	supra	supra	PROPN
ihlr-16470	604	6	note	note	NOUN
ihlr-16470	604	7	8	8	NUM
ihlr-16470	604	8	,	,	PUNCT
ihlr-16470	604	9	at	at	ADP
ihlr-16470	604	10	478	478	NUM
ihlr-16470	604	11	-	-	SYM
ihlr-16470	604	12	79	79	NUM
ihlr-16470	604	13	.	.	PUNCT
ihlr-16470	604	14	166	166	NUM
ihlr-16470	604	15	.	.	PUNCT
ihlr-16470	605	1	i	i	PRON
ihlr-16470	605	2	d	d	PROPN
ihlr-16470	605	3	at484	at484	PROPN
ihlr-16470	605	4	.	.	PUNCT
ihlr-16470	606	1	167	167	NUM
ihlr-16470	606	2	.	.	PUNCT
ihlr-16470	607	1	/d	/d	INTJ
ihlr-16470	607	2	.	.	PUNCT
ihlr-16470	608	1	168	168	NUM
ihlr-16470	608	2	.	.	PUNCT
ihlr-16470	609	1	/d	/d	INTJ
ihlr-16470	609	2	.	.	PUNCT
ihlr-16470	610	1	at489	at489	PROPN
ihlr-16470	610	2	.	.	PUNCT
ihlr-16470	611	1	2006	2006	NUM
ihlr-16470	611	2	]	]	X
ihlr-16470	611	3	ann	ann	PROPN
ihlr-16470	611	4	-	-	PUNCT
ihlr-16470	611	5	depressants	depressant	NOUN
ihlr-16470	611	6	and	and	CCONJ
ihlr-16470	611	7	children	child	NOUN
ihlr-16470	611	8	225	225	NUM
ihlr-16470	611	9	congress	congress	PROPN
ihlr-16470	611	10	passed	pass	VERB
ihlr-16470	611	11	the	the	DET
ihlr-16470	611	12	food	food	NOUN
ihlr-16470	611	13	and	and	CCONJ
ihlr-16470	611	14	drug	drug	PROPN
ihlr-16470	611	15	administration	administration	PROPN
ihlr-16470	611	16	modernization	modernization	PROPN
ihlr-16470	611	17	act	act	NOUN
ihlr-16470	611	18	of	of	ADP
ihlr-16470	611	19	1997	1997	NUM
ihlr-16470	611	20	(	(	PUNCT
ihlr-16470	611	21	fdama	fdama	PROPN
ihlr-16470	611	22	)	)	PUNCT
ihlr-16470	611	23	,	,	PUNCT
ihlr-16470	611	24	which	which	PRON
ihlr-16470	611	25	called	call	VERB
ihlr-16470	611	26	for	for	ADP
ihlr-16470	611	27	voluntary	voluntary	ADJ
ihlr-16470	611	28	pediatric	pediatric	NOUN
ihlr-16470	611	29	testing.169	testing.169	ADP
ihlr-16470	611	30	the	the	DET
ihlr-16470	611	31	fdama	fdama	NOUN
ihlr-16470	611	32	sought	seek	VERB
ihlr-16470	611	33	to	to	PART
ihlr-16470	611	34	encourage	encourage	VERB
ihlr-16470	611	35	pediatric	pediatric	ADJ
ihlr-16470	611	36	testing	testing	NOUN
ihlr-16470	611	37	by	by	ADP
ihlr-16470	611	38	providing	provide	VERB
ihlr-16470	611	39	incentives	incentive	NOUN
ihlr-16470	611	40	to	to	ADP
ihlr-16470	611	41	the	the	DET
ihlr-16470	611	42	manufacturer	manufacturer	NOUN
ihlr-16470	611	43	rather	rather	ADV
ihlr-16470	611	44	than	than	ADP
ihlr-16470	611	45	threatening	threaten	VERB
ihlr-16470	611	46	sanctions	sanction	NOUN
ihlr-16470	611	47	.	.	PUNCT
ihlr-16470	612	1	170	170	NUM
ihlr-16470	612	2	with	with	ADP
ihlr-16470	612	3	the	the	DET
ihlr-16470	612	4	passage	passage	NOUN
ihlr-16470	612	5	of	of	ADP
ihlr-16470	612	6	the	the	DET
ihlr-16470	612	7	fdama	fdama	NOUN
ihlr-16470	612	8	,	,	PUNCT
ihlr-16470	612	9	the	the	DET
ihlr-16470	612	10	fda	fda	PROPN
ihlr-16470	612	11	's	's	PART
ihlr-16470	612	12	authority	authority	NOUN
ihlr-16470	612	13	to	to	PART
ihlr-16470	612	14	promulgate	promulgate	VERB
ihlr-16470	612	15	the	the	DET
ihlr-16470	612	16	final	final	ADJ
ihlr-16470	612	17	rule	rule	NOUN
ihlr-16470	612	18	was	be	AUX
ihlr-16470	612	19	immediately	immediately	ADV
ihlr-16470	612	20	called	call	VERB
ihlr-16470	612	21	into	into	ADP
ihlr-16470	612	22	question	question	NOUN
ihlr-16470	612	23	and	and	CCONJ
ihlr-16470	612	24	fell	fall	VERB
ihlr-16470	612	25	into	into	ADP
ihlr-16470	612	26	general	general	ADJ
ihlr-16470	612	27	non	non	NOUN
ihlr-16470	612	28	-	-	NOUN
ihlr-16470	612	29	enforcement	enforcement	NOUN
ihlr-16470	612	30	until	until	SCONJ
ihlr-16470	612	31	the	the	DET
ihlr-16470	612	32	court	court	NOUN
ihlr-16470	612	33	officially	officially	ADV
ihlr-16470	612	34	determined	determine	VERB
ihlr-16470	612	35	that	that	SCONJ
ihlr-16470	612	36	the	the	DET
ihlr-16470	612	37	final	final	ADJ
ihlr-16470	612	38	rule	rule	NOUN
ihlr-16470	612	39	was	be	AUX
ihlr-16470	612	40	outside	outside	ADP
ihlr-16470	612	41	the	the	DET
ihlr-16470	612	42	bounds	bound	NOUN
ihlr-16470	612	43	of	of	ADP
ihlr-16470	612	44	fda	fda	PROPN
ihlr-16470	612	45	authority	authority	PROPN
ihlr-16470	612	46	.	.	PUNCT
ihlr-16470	613	1	171	171	NUM
ihlr-16470	613	2	unfortunately	unfortunately	ADV
ihlr-16470	613	3	,	,	PUNCT
ihlr-16470	613	4	the	the	DET
ihlr-16470	613	5	fdama	fdama	NOUN
ihlr-16470	613	6	did	do	AUX
ihlr-16470	613	7	not	not	PART
ihlr-16470	613	8	adequately	adequately	ADV
ihlr-16470	613	9	meet	meet	VERB
ihlr-16470	613	10	the	the	DET
ihlr-16470	613	11	needs	need	NOUN
ihlr-16470	613	12	that	that	PRON
ihlr-16470	613	13	the	the	DET
ihlr-16470	613	14	final	final	ADJ
ihlr-16470	613	15	rule	rule	NOUN
ihlr-16470	613	16	was	be	AUX
ihlr-16470	613	17	promulgated	promulgate	VERB
ihlr-16470	613	18	to	to	PART
ihlr-16470	613	19	address	address	VERB
ihlr-16470	613	20	.	.	PUNCT
ihlr-16470	614	1	172	172	NUM
ihlr-16470	614	2	as	as	SCONJ
ihlr-16470	614	3	the	the	DET
ihlr-16470	614	4	fdama	fdama	NOUN
ihlr-16470	614	5	approached	approach	VERB
ihlr-16470	614	6	sunset	sunset	PROPN
ihlr-16470	614	7	,	,	PUNCT
ihlr-16470	614	8	congress	congress	PROPN
ihlr-16470	614	9	pushed	push	VERB
ihlr-16470	614	10	for	for	SCONJ
ihlr-16470	614	11	a	a	DET
ihlr-16470	614	12	new	new	ADJ
ihlr-16470	614	13	statute	statute	NOUN
ihlr-16470	614	14	to	to	PART
ihlr-16470	614	15	take	take	VERB
ihlr-16470	614	16	its	its	PRON
ihlr-16470	614	17	place	place	NOUN
ihlr-16470	614	18	.	.	PUNCT
ihlr-16470	615	1	in	in	ADP
ihlr-16470	615	2	2001	2001	NUM
ihlr-16470	615	3	,	,	PUNCT
ihlr-16470	615	4	president	president	PROPN
ihlr-16470	615	5	bush	bush	PROPN
ihlr-16470	615	6	signed	sign	VERB
ihlr-16470	615	7	the	the	DET
ihlr-16470	615	8	best	good	ADJ
ihlr-16470	615	9	pharmaceuticals	pharmaceutical	NOUN
ihlr-16470	615	10	for	for	ADP
ihlr-16470	615	11	children	child	NOUN
ihlr-16470	615	12	act	act	NOUN
ihlr-16470	615	13	(	(	PUNCT
ihlr-16470	615	14	bpca	bpca	PROPN
ihlr-16470	615	15	)	)	PUNCT
ihlr-16470	615	16	,	,	PUNCT
ihlr-16470	615	17	the	the	DET
ihlr-16470	615	18	successor	successor	NOUN
ihlr-16470	615	19	of	of	ADP
ihlr-16470	615	20	fdama	fdama	NOUN
ihlr-16470	615	21	,	,	PUNCT
ihlr-16470	615	22	into	into	ADP
ihlr-16470	615	23	law.173	law.173	NOUN
ihlr-16470	615	24	the	the	DET
ihlr-16470	615	25	bpca	bpca	PROPN
ihlr-16470	615	26	contains	contain	VERB
ihlr-16470	615	27	essentially	essentially	ADV
ihlr-16470	615	28	the	the	DET
ihlr-16470	615	29	same	same	ADJ
ihlr-16470	615	30	requirements	requirement	NOUN
ihlr-16470	615	31	as	as	ADP
ihlr-16470	615	32	the	the	DET
ihlr-16470	615	33	fdama	fdama	NOUN
ihlr-16470	615	34	and	and	CCONJ
ihlr-16470	615	35	likewise	likewise	ADV
ihlr-16470	615	36	did	do	AUX
ihlr-16470	615	37	not	not	PART
ihlr-16470	615	38	provide	provide	VERB
ihlr-16470	615	39	the	the	DET
ihlr-16470	615	40	fda	fda	PROPN
ihlr-16470	615	41	with	with	ADP
ihlr-16470	615	42	the	the	DET
ihlr-16470	615	43	power	power	NOUN
ihlr-16470	615	44	necessary	necessary	ADJ
ihlr-16470	615	45	to	to	PART
ihlr-16470	615	46	protect	protect	VERB
ihlr-16470	615	47	pediatric	pediatric	ADJ
ihlr-16470	615	48	patients	patient	NOUN
ihlr-16470	615	49	.	.	PUNCT
ihlr-16470	616	1	174	174	NUM
ihlr-16470	616	2	therefore	therefore	ADV
ihlr-16470	616	3	,	,	PUNCT
ihlr-16470	616	4	congress	congress	PROPN
ihlr-16470	616	5	sought	seek	VERB
ihlr-16470	616	6	to	to	PART
ihlr-16470	616	7	augment	augment	VERB
ihlr-16470	616	8	the	the	DET
ihlr-16470	616	9	bpca	bpca	NOUN
ihlr-16470	616	10	and	and	CCONJ
ihlr-16470	616	11	in	in	ADP
ihlr-16470	616	12	2003	2003	NUM
ihlr-16470	616	13	,	,	PUNCT
ihlr-16470	616	14	congress	congress	PROPN
ihlr-16470	616	15	enacted	enact	VERB
ihlr-16470	616	16	the	the	DET
ihlr-16470	616	17	pediatric	pediatric	ADJ
ihlr-16470	616	18	research	research	NOUN
ihlr-16470	616	19	equity	equity	NOUN
ihlr-16470	616	20	act	act	NOUN
ihlr-16470	616	21	of	of	ADP
ihlr-16470	616	22	2003	2003	NUM
ihlr-16470	616	23	(	(	PUNCT
ihlr-16470	616	24	prea	prea	PROPN
ihlr-16470	616	25	)	)	PUNCT
ihlr-16470	616	26	.	.	PUNCT
ihlr-16470	617	1	175	175	NUM
ihlr-16470	617	2	the	the	DET
ihlr-16470	617	3	prea	prea	PROPN
ihlr-16470	617	4	codifies	codify	VERB
ihlr-16470	617	5	many	many	ADJ
ihlr-16470	617	6	of	of	ADP
ihlr-16470	617	7	the	the	DET
ihlr-16470	617	8	provisions	provision	NOUN
ihlr-16470	617	9	of	of	ADP
ihlr-16470	617	10	the	the	DET
ihlr-16470	617	11	final	final	ADJ
ihlr-16470	617	12	rule	rule	NOUN
ihlr-16470	617	13	and	and	CCONJ
ihlr-16470	617	14	requires	require	VERB
ihlr-16470	617	15	drug	drug	NOUN
ihlr-16470	617	16	manufac­	manufac­	PROPN
ihlr-16470	617	17	turers	turer	NOUN
ihlr-16470	617	18	to	to	PART
ihlr-16470	617	19	conduct	conduct	VERB
ihlr-16470	617	20	pediatric	pediatric	ADJ
ihlr-16470	617	21	testing	testing	NOUN
ihlr-16470	617	22	for	for	ADP
ihlr-16470	617	23	new	new	ADJ
ihlr-16470	617	24	drugs	drug	NOUN
ihlr-16470	617	25	,	,	PUNCT
ihlr-16470	617	26	unless	unless	SCONJ
ihlr-16470	617	27	the	the	DET
ihlr-16470	617	28	manufacturer	manufacturer	NOUN
ihlr-16470	617	29	can	can	AUX
ihlr-16470	617	30	show	show	VERB
ihlr-16470	617	31	that	that	SCONJ
ihlr-16470	617	32	pediatric	pediatric	ADJ
ihlr-16470	617	33	testing	testing	NOUN
ihlr-16470	617	34	would	would	AUX
ihlr-16470	617	35	be	be	AUX
ihlr-16470	617	36	"	"	PUNCT
ihlr-16470	617	37	impossible	impossible	ADJ
ihlr-16470	617	38	or	or	CCONJ
ihlr-16470	617	39	highly	highly	ADV
ihlr-16470	617	40	impracticable	impracticable	ADJ
ihlr-16470	617	41	,	,	PUNCT
ihlr-16470	617	42	"	"	PUNCT
ihlr-16470	617	43	thus	thus	ADV
ihlr-16470	617	44	placing	place	VERB
ihlr-16470	617	45	the	the	DET
ihlr-16470	617	46	burden	burden	NOUN
ihlr-16470	617	47	on	on	ADP
ihlr-16470	617	48	the	the	DET
ihlr-16470	617	49	manufacturer	manufacturer	NOUN
ihlr-16470	617	50	.	.	PUNCT
ihlr-16470	618	1	176	176	NUM
ihlr-16470	618	2	the	the	DET
ihlr-16470	618	3	implementation	implementation	NOUN
ihlr-16470	618	4	provides	provide	VERB
ihlr-16470	618	5	an	an	DET
ihlr-16470	618	6	interesting	interesting	ADJ
ihlr-16470	618	7	dichotomy	dichotomy	NOUN
ihlr-16470	618	8	in	in	ADP
ihlr-16470	618	9	pediatric	pediatric	ADJ
ihlr-16470	618	10	testing	testing	NOUN
ihlr-16470	618	11	requirements	requirement	NOUN
ihlr-16470	618	12	;	;	PUNCT
ihlr-16470	618	13	pediatric	pediatric	ADJ
ihlr-16470	618	14	testing	testing	NOUN
ihlr-16470	618	15	is	be	AUX
ihlr-16470	618	16	not	not	PART
ihlr-16470	618	17	mandatory	mandatory	ADJ
ihlr-16470	618	18	,	,	PUNCT
ihlr-16470	618	19	but	but	CCONJ
ihlr-16470	618	20	drug	drug	NOUN
ihlr-16470	618	21	companies	company	NOUN
ihlr-16470	618	22	receive	receive	VERB
ihlr-16470	618	23	lucrative	lucrative	ADJ
ihlr-16470	618	24	incentives	incentive	NOUN
ihlr-16470	618	25	for	for	ADP
ihlr-16470	618	26	carrying	carry	VERB
ihlr-16470	618	27	out	out	ADP
ihlr-16470	618	28	pediatric	pediatric	ADJ
ihlr-16470	618	29	clinical	clinical	ADJ
ihlr-16470	618	30	trials	trial	NOUN
ihlr-16470	618	31	.	.	PUNCT
ihlr-16470	619	1	177	177	NUM
ihlr-16470	619	2	still	still	ADV
ihlr-16470	619	3	,	,	PUNCT
ihlr-16470	619	4	the	the	DET
ihlr-16470	619	5	prea	prea	PROPN
ihlr-16470	619	6	fails	fail	VERB
ihlr-16470	619	7	to	to	PART
ihlr-16470	619	8	address	address	VERB
ihlr-16470	619	9	the	the	DET
ihlr-16470	619	10	serious	serious	ADJ
ihlr-16470	619	11	risks	risk	NOUN
ihlr-16470	619	12	posed	pose	VERB
ihlr-16470	619	13	by	by	ADP
ihlr-16470	619	14	a	a	DET
ihlr-16470	619	15	lack	lack	NOUN
ihlr-16470	619	16	of	of	ADP
ihlr-16470	619	17	clinical	clinical	ADJ
ihlr-16470	619	18	data	datum	NOUN
ihlr-16470	619	19	for	for	ADP
ihlr-16470	619	20	off	off	ADP
ihlr-16470	619	21	-	-	PUNCT
ihlr-16470	619	22	label	label	NOUN
ihlr-16470	619	23	uses	use	NOUN
ihlr-16470	619	24	and	and	CCONJ
ihlr-16470	619	25	does	do	AUX
ihlr-16470	619	26	not	not	PART
ihlr-16470	619	27	present	present	VERB
ihlr-16470	619	28	a	a	DET
ihlr-16470	619	29	final	final	ADJ
ihlr-16470	619	30	solution.178	solution.178	ADJ
ihlr-16470	619	31	169	169	NUM
ihlr-16470	619	32	.	.	PUNCT
ihlr-16470	620	1	see	see	VERB
ihlr-16470	620	2	i	i	PRON
ihlr-16470	620	3	d.	d.	PROPN
ihlr-16470	620	4	at485	at485	PROPN
ihlr-16470	620	5	170	170	NUM
ihlr-16470	620	6	.	.	PUNCT
ihlr-16470	621	1	hazard	hazard	NOUN
ihlr-16470	621	2	,	,	PUNCT
ihlr-16470	621	3	supra	supra	PROPN
ihlr-16470	621	4	note	note	NOUN
ihlr-16470	621	5	8	8	NUM
ihlr-16470	621	6	,	,	PUNCT
ihlr-16470	621	7	at	at	ADP
ihlr-16470	621	8	484	484	NUM
ihlr-16470	621	9	-	-	SYM
ihlr-16470	621	10	86	86	NUM
ihlr-16470	621	11	(	(	PUNCT
ihlr-16470	621	12	stating	state	VERB
ihlr-16470	621	13	that	that	SCONJ
ihlr-16470	621	14	fdama	fdama	NOUN
ihlr-16470	621	15	provides	provide	VERB
ihlr-16470	621	16	six	six	NUM
ihlr-16470	621	17	month	month	NOUN
ihlr-16470	621	18	patent	patent	NOUN
ihlr-16470	621	19	extension	extension	NOUN
ihlr-16470	621	20	for	for	ADP
ihlr-16470	621	21	manufacturers	manufacturer	NOUN
ihlr-16470	621	22	who	who	PRON
ihlr-16470	621	23	conducted	conduct	VERB
ihlr-16470	621	24	pediatric	pediatric	ADJ
ihlr-16470	621	25	tests	test	NOUN
ihlr-16470	621	26	)	)	PUNCT
ihlr-16470	621	27	.	.	PUNCT
ihlr-16470	622	1	171	171	NUM
ihlr-16470	622	2	.	.	PUNCT
ihlr-16470	622	3	!	!	PUNCT
ihlr-16470	623	1	d.	d.	PROPN
ihlr-16470	623	2	at	at	ADP
ihlr-16470	623	3	489	489	NUM
ihlr-16470	623	4	.	.	PUNCT
ihlr-16470	624	1	172	172	NUM
ihlr-16470	624	2	.	.	PUNCT
ihlr-16470	624	3	trial	trial	NOUN
ihlr-16470	624	4	lawyers	lawyer	NOUN
ihlr-16470	624	5	of	of	ADP
ihlr-16470	624	6	america	america	PROPN
ihlr-16470	624	7	,	,	PUNCT
ihlr-16470	624	8	supra	supra	PROPN
ihlr-16470	624	9	note	note	PROPN
ihlr-16470	624	10	142	142	NUM
ihlr-16470	624	11	,	,	PUNCT
ihlr-16470	624	12	at	at	ADP
ihlr-16470	624	13	28	28	NUM
ihlr-16470	624	14	{	{	PUNCT
ihlr-16470	624	15	''	''	PUNCT
ihlr-16470	624	16	pharmaceutical	pharmaceutical	ADJ
ihlr-16470	624	17	companies	company	NOUN
ihlr-16470	624	18	regularly	regularly	ADV
ihlr-16470	624	19	violate	violate	VERB
ihlr-16470	624	20	[	[	PUNCT
ihlr-16470	624	21	d	d	X
ihlr-16470	624	22	]	]	X
ihlr-16470	625	1	[	[	X
ihlr-16470	625	2	fdama	fdama	NOUN
ihlr-16470	625	3	which	which	PRON
ihlr-16470	625	4	]	]	PUNCT
ihlr-16470	625	5	requir	requir	VERB
ihlr-16470	625	6	{	{	PUNCT
ihlr-16470	625	7	ed	ed	NOUN
ihlr-16470	625	8	]	]	X
ihlr-16470	625	9	them	they	PRON
ihlr-16470	625	10	to	to	PART
ihlr-16470	625	11	disclose	disclose	VERB
ihlr-16470	625	12	clinical	clinical	ADJ
ihlr-16470	625	13	trials	trial	NOUN
ihlr-16470	625	14	....	....	PUNCT
ihlr-16470	626	1	[	[	X
ihlr-16470	626	2	i)n	i)n	ADJ
ihlr-16470	626	3	fact	fact	NOUN
ihlr-16470	626	4	.	.	PUNCT
ihlr-16470	627	1	the	the	DET
ihlr-16470	627	2	law	law	NOUN
ihlr-16470	627	3	has	have	VERB
ihlr-16470	627	4	no	no	DET
ihlr-16470	627	5	enforcement	enforcement	NOUN
ihlr-16470	627	6	mechanism	mechanism	NOUN
ihlr-16470	627	7	and	and	CCONJ
ihlr-16470	627	8	provides	provide	VERB
ihlr-16470	627	9	no	no	DET
ihlr-16470	627	10	penalties	penalty	NOUN
ihlr-16470	627	11	.	.	PUNCT
ihlr-16470	627	12	''	''	PUNCT
ihlr-16470	627	13	)	)	PUNCT
ihlr-16470	627	14	.	.	PUNCT
ihlr-16470	628	1	source	source	NOUN
ihlr-16470	628	2	is	be	AUX
ihlr-16470	628	3	not	not	PART
ihlr-16470	628	4	very	very	ADV
ihlr-16470	628	5	neutral	neutral	ADJ
ihlr-16470	628	6	.	.	PUNCT
ihlr-16470	629	1	173	173	NUM
ihlr-16470	629	2	.	.	X
ihlr-16470	629	3	21	21	NUM
ihlr-16470	630	1	u.s.c.a	u.s.c.a	PROPN
ihlr-16470	630	2	.	.	PUNCT
ihlr-16470	631	1	§	§	PROPN
ihlr-16470	631	2	355a	355a	PROPN
ihlr-16470	631	3	(	(	PUNCT
ihlr-16470	631	4	west	west	PROPN
ihlr-16470	631	5	2004	2004	NUM
ihlr-16470	631	6	)	)	PUNCT
ihlr-16470	631	7	;	;	PUNCT
ihlr-16470	631	8	hazard	hazard	NOUN
ihlr-16470	631	9	,	,	PUNCT
ihlr-16470	631	10	supra	supra	PROPN
ihlr-16470	631	11	note	note	NOUN
ihlr-16470	631	12	8	8	NUM
ihlr-16470	631	13	,	,	PUNCT
ihlr-16470	631	14	at	at	ADP
ihlr-16470	631	15	493	493	NUM
ihlr-16470	631	16	.	.	PUNCT
ihlr-16470	631	17	174	174	NUM
ihlr-16470	631	18	.	.	PUNCT
ihlr-16470	632	1	like	like	ADP
ihlr-16470	632	2	the	the	DET
ihlr-16470	632	3	fdama	fdama	NOUN
ihlr-16470	632	4	,	,	PUNCT
ihlr-16470	632	5	the	the	DET
ihlr-16470	632	6	bpca	bpca	PROPN
ihlr-16470	632	7	provides	provide	VERB
ihlr-16470	632	8	a	a	DET
ihlr-16470	632	9	six	six	NUM
ihlr-16470	632	10	month	month	NOUN
ihlr-16470	632	11	patent	patent	NOUN
ihlr-16470	632	12	extension	extension	NOUN
ihlr-16470	632	13	in	in	ADP
ihlr-16470	632	14	return	return	NOUN
ihlr-16470	632	15	for	for	ADP
ihlr-16470	632	16	voluntary	voluntary	ADJ
ihlr-16470	632	17	pediatric	pediatric	ADJ
ihlr-16470	632	18	clinical	clinical	ADJ
ihlr-16470	632	19	testing	testing	NOUN
ihlr-16470	632	20	.	.	PUNCT
ihlr-16470	633	1	also	also	ADV
ihlr-16470	633	2	,	,	PUNCT
ihlr-16470	633	3	like	like	ADP
ihlr-16470	633	4	the	the	DET
ihlr-16470	633	5	fdama	fdama	NOUN
ihlr-16470	633	6	,	,	PUNCT
ihlr-16470	633	7	bpca	bpca	PROPN
ihlr-16470	633	8	provides	provide	VERB
ihlr-16470	633	9	a	a	DET
ihlr-16470	633	10	six	six	NUM
ihlr-16470	633	11	month	month	NOUN
ihlr-16470	633	12	patent	patent	NOUN
ihlr-16470	633	13	extension	extension	NOUN
ihlr-16470	633	14	in	in	ADP
ihlr-16470	633	15	return	return	NOUN
ihlr-16470	633	16	for	for	ADP
ihlr-16470	633	17	voluntary	voluntary	ADJ
ihlr-16470	633	18	pediatric	pediatric	ADJ
ihlr-16470	633	19	clinical	clinical	ADJ
ihlr-16470	633	20	testing	testing	NOUN
ihlr-16470	633	21	.	.	PUNCT
ihlr-16470	634	1	also	also	ADV
ihlr-16470	634	2	,	,	PUNCT
ihlr-16470	634	3	like	like	ADP
ihlr-16470	634	4	the	the	DET
ihlr-16470	634	5	fdama	fdama	NOUN
ihlr-16470	634	6	,	,	PUNCT
ihlr-16470	634	7	''	''	PUNCT
ihlr-16470	634	8	the	the	DET
ihlr-16470	634	9	bpca	bpca	PROPN
ihlr-16470	634	10	...	...	PUNCT
ihlr-16470	634	11	maintain	maintain	VERB
ihlr-16470	634	12	[	[	PUNCT
ihlr-16470	634	13	e	e	X
ihlr-16470	634	14	]	]	X
ihlr-16470	634	15	the	the	DET
ihlr-16470	634	16	voluntary	voluntary	ADJ
ihlr-16470	634	17	incentive	incentive	NOUN
ihlr-16470	634	18	scheme	scheme	NOUN
ihlr-16470	634	19	"	"	PUNCT
ihlr-16470	634	20	to	to	PART
ihlr-16470	634	21	encourage	encourage	VERB
ihlr-16470	634	22	pharmaceutical	pharmaceutical	ADJ
ihlr-16470	634	23	companies	company	NOUN
ihlr-16470	634	24	to	to	PART
ihlr-16470	634	25	test	test	VERB
ihlr-16470	634	26	more	more	ADJ
ihlr-16470	634	27	of	of	ADP
ihlr-16470	634	28	their	their	PRON
ihlr-16470	634	29	drugs	drug	NOUN
ihlr-16470	634	30	on	on	ADP
ihlr-16470	634	31	children	child	NOUN
ihlr-16470	634	32	,	,	PUNCT
ihlr-16470	634	33	with	with	ADP
ihlr-16470	634	34	the	the	DET
ihlr-16470	634	35	result	result	NOUN
ihlr-16470	634	36	of	of	ADP
ihlr-16470	634	37	better	well	ADJ
ihlr-16470	634	38	labeling	labeling	NOUN
ihlr-16470	634	39	and	and	CCONJ
ihlr-16470	634	40	greater	great	ADJ
ihlr-16470	634	41	therapeutic	therapeutic	ADJ
ihlr-16470	634	42	indications	indication	NOUN
ihlr-16470	634	43	for	for	ADP
ihlr-16470	634	44	pediatric	pediatric	ADJ
ihlr-16470	634	45	populations	population	NOUN
ihlr-16470	634	46	.	.	PUNCT
ihlr-16470	635	1	see	see	VERB
ihlr-16470	635	2	hazard	hazard	NOUN
ihlr-16470	635	3	,	,	PUNCT
ihlr-16470	635	4	supra	supra	PROPN
ihlr-16470	635	5	note	note	NOUN
ihlr-16470	635	6	8	8	NUM
ihlr-16470	635	7	,	,	PUNCT
ihlr-16470	635	8	at	at	ADP
ihlr-16470	635	9	491·2	491·2	NUM
ihlr-16470	635	10	,	,	PUNCT
ihlr-16470	635	11	495	495	NUM
ihlr-16470	635	12	.	.	PUNCT
ihlr-16470	636	1	175	175	NUM
ihlr-16470	636	2	.	.	NUM
ihlr-16470	636	3	21	21	NUM
ihlr-16470	637	1	u.s.c.a	u.s.c.a	PROPN
ihlr-16470	637	2	.	.	PUNCT
ihlr-16470	638	1	§	§	PROPN
ihlr-16470	638	2	355c	355c	PROPN
ihlr-16470	638	3	(	(	PUNCT
ihlr-16470	638	4	west	west	NOUN
ihlr-16470	638	5	2004	2004	NUM
ihlr-16470	638	6	)	)	PUNCT
ihlr-16470	638	7	;	;	PUNCT
ihlr-16470	638	8	ld	ld	PROPN
ihlr-16470	638	9	.	.	PUNCT
ihlr-16470	639	1	at	at	ADP
ihlr-16470	639	2	500	500	NUM
ihlr-16470	639	3	.	.	PUNCT
ihlr-16470	640	1	176	176	NUM
ihlr-16470	640	2	.	.	PUNCT
ihlr-16470	641	1	hazard	hazard	NOUN
ihlr-16470	641	2	,	,	PUNCT
ihlr-16470	641	3	supra	supra	PROPN
ihlr-16470	641	4	note	note	NOUN
ihlr-16470	641	5	8	8	NUM
ihlr-16470	641	6	,	,	PUNCT
ihlr-16470	641	7	at	at	ADP
ihlr-16470	641	8	500	500	NUM
ihlr-16470	641	9	.	.	PUNCT
ihlr-16470	641	10	177	177	NUM
ihlr-16470	641	11	.	.	PUNCT
ihlr-16470	641	12	!	!	PUNCT
ihlr-16470	642	1	d.	d.	PROPN
ihlr-16470	642	2	at	at	ADP
ihlr-16470	642	3	502	502	NUM
ihlr-16470	642	4	-03	-03	NUM
ihlr-16470	642	5	.	.	PUNCT
ihlr-16470	642	6	178	178	NUM
ihlr-16470	642	7	.	.	PUNCT
ihlr-16470	643	1	promulgation	promulgation	NOUN
ihlr-16470	643	2	of	of	ADP
ihlr-16470	643	3	the	the	DET
ihlr-16470	643	4	prea	prea	PROPN
ihlr-16470	643	5	does	do	AUX
ihlr-16470	643	6	not	not	PART
ihlr-16470	643	7	sufficiently	sufficiently	ADV
ihlr-16470	643	8	remedy	remedy	VERB
ihlr-16470	643	9	the	the	DET
ihlr-16470	643	10	shortcomings	shortcoming	NOUN
ihlr-16470	643	11	of	of	ADP
ihlr-16470	643	12	the	the	DET
ihlr-16470	643	13	bpca	bpca	PROPN
ihlr-16470	643	14	.	.	PUNCT
ihlr-16470	644	1	although	although	SCONJ
ihlr-16470	644	2	pediatric	pediatric	ADJ
ihlr-16470	644	3	clinical	clinical	ADJ
ihlr-16470	644	4	testing	testing	NOUN
ihlr-16470	644	5	is	be	AUX
ihlr-16470	644	6	now	now	ADV
ihlr-16470	644	7	mandatory	mandatory	ADJ
ihlr-16470	644	8	in	in	ADP
ihlr-16470	644	9	new	new	ADJ
ihlr-16470	644	10	drugs	drug	NOUN
ihlr-16470	644	11	,	,	PUNCT
ihlr-16470	644	12	already	already	ADV
ihlr-16470	644	13	marketed	market	VERB
ihlr-16470	644	14	drugs	drug	NOUN
ihlr-16470	644	15	may	may	AUX
ihlr-16470	644	16	escape	escape	VERB
ihlr-16470	644	17	the	the	DET
ihlr-16470	644	18	burden	burden	NOUN
ihlr-16470	644	19	of	of	ADP
ihlr-16470	644	20	conducting	conduct	VERB
ihlr-16470	644	21	research	research	NOUN
ihlr-16470	644	22	on	on	ADP
ihlr-16470	644	23	children	child	NOUN
ihlr-16470	644	24	.	.	PUNCT
ihlr-16470	644	25	.	.	PUNCT
ihlr-16470	644	26	.	.	PUNCT
ihlr-16470	645	1	while	while	SCONJ
ihlr-16470	645	2	the	the	DET
ihlr-16470	645	3	prea	prea	PROPN
ihlr-16470	645	4	ensures	ensure	VERB
ihlr-16470	645	5	that	that	SCONJ
ihlr-16470	645	6	the	the	DET
ihlr-16470	645	7	newest	new	ADJ
ihlr-16470	645	8	drugs	drug	NOUN
ihlr-16470	645	9	will	will	AUX
ihlr-16470	645	10	be	be	AUX
ihlr-16470	645	11	tested	test	VERB
ihlr-16470	645	12	on	on	ADP
ihlr-16470	645	13	children	child	NOUN
ihlr-16470	645	14	,	,	PUNCT
ihlr-16470	646	1	226	226	NUM
ihlr-16470	646	2	indiana	indiana	PROPN
ihlr-16470	646	3	health	health	PROPN
ihlr-16470	646	4	law	law	PROPN
ihlr-16470	646	5	review	review	NOUN
ihlr-16470	646	6	[	[	X
ihlr-16470	646	7	vol	vol	NOUN
ihlr-16470	646	8	.	.	PUNCT
ihlr-16470	647	1	3:201	3:201	NUM
ihlr-16470	647	2	c.	c.	PROPN
ihlr-16470	647	3	recent	recent	ADJ
ihlr-16470	647	4	developments	development	NOUN
ihlr-16470	647	5	/	/	SYM
ihlr-16470	647	6	required	require	VERB
ihlr-16470	647	7	publication	publication	NOUN
ihlr-16470	647	8	doctors	doctor	NOUN
ihlr-16470	647	9	and	and	CCONJ
ihlr-16470	647	10	pharmacists	pharmacist	NOUN
ihlr-16470	647	11	rely	rely	VERB
ihlr-16470	647	12	on	on	ADP
ihlr-16470	647	13	data	datum	NOUN
ihlr-16470	647	14	from	from	ADP
ihlr-16470	647	15	clinical	clinical	ADJ
ihlr-16470	647	16	trials	trial	NOUN
ihlr-16470	647	17	when	when	SCONJ
ihlr-16470	647	18	determining	determine	VERB
ihlr-16470	647	19	a	a	DET
ihlr-16470	647	20	course	course	NOUN
ihlr-16470	647	21	of	of	ADP
ihlr-16470	647	22	treatment	treatment	NOUN
ihlr-16470	647	23	.	.	PUNCT
ihlr-16470	648	1	data	datum	NOUN
ihlr-16470	648	2	required	require	VERB
ihlr-16470	648	3	for	for	ADP
ihlr-16470	648	4	premarket	premarket	NOUN
ihlr-16470	648	5	approval	approval	NOUN
ihlr-16470	648	6	is	be	AUX
ihlr-16470	648	7	very	very	ADV
ihlr-16470	648	8	reliable	reliable	ADJ
ihlr-16470	648	9	and	and	CCONJ
ihlr-16470	648	10	widely	widely	ADV
ihlr-16470	648	11	available	available	ADJ
ihlr-16470	648	12	.	.	PUNCT
ihlr-16470	649	1	however	however	ADV
ihlr-16470	649	2	,	,	PUNCT
ihlr-16470	649	3	when	when	SCONJ
ihlr-16470	649	4	a	a	DET
ihlr-16470	649	5	manufacturer	manufacturer	NOUN
ihlr-16470	649	6	performs	perform	VERB
ihlr-16470	649	7	testing	testing	NOUN
ihlr-16470	649	8	after	after	SCONJ
ihlr-16470	649	9	the	the	DET
ihlr-16470	649	10	drug	drug	NOUN
ihlr-16470	649	11	is	be	AUX
ihlr-16470	649	12	approved	approve	VERB
ihlr-16470	649	13	,	,	PUNCT
ihlr-16470	649	14	generally	generally	ADV
ihlr-16470	649	15	to	to	PART
ihlr-16470	649	16	determine	determine	VERB
ihlr-16470	649	17	secondary	secondary	ADJ
ihlr-16470	649	18	uses	use	NOUN
ihlr-16470	649	19	,	,	PUNCT
ihlr-16470	649	20	a	a	DET
ihlr-16470	649	21	manufacturer	manufacturer	NOUN
ihlr-16470	649	22	may	may	AUX
ihlr-16470	649	23	choose	choose	VERB
ihlr-16470	649	24	not	not	PART
ihlr-16470	649	25	to	to	PART
ihlr-16470	649	26	publish	publish	VERB
ihlr-16470	649	27	negative	negative	ADJ
ihlr-16470	649	28	trials	trial	NOUN
ihlr-16470	649	29	and	and	CCONJ
ihlr-16470	649	30	provide	provide	VERB
ihlr-16470	649	31	the	the	DET
ihlr-16470	649	32	medical	medical	ADJ
ihlr-16470	649	33	journals	journal	NOUN
ihlr-16470	649	34	only	only	ADV
ihlr-16470	649	35	with	with	ADP
ihlr-16470	649	36	the	the	DET
ihlr-16470	649	37	data	datum	NOUN
ihlr-16470	649	38	from	from	ADP
ihlr-16470	649	39	the	the	DET
ihlr-16470	649	40	most	most	ADV
ihlr-16470	649	41	attractive	attractive	ADJ
ihlr-16470	649	42	trials.179	trials.179	PROPN
ihlr-16470	649	43	thus	thus	ADV
ihlr-16470	649	44	,	,	PUNCT
ihlr-16470	649	45	a	a	DET
ihlr-16470	649	46	large	large	ADJ
ihlr-16470	649	47	amount	amount	NOUN
ihlr-16470	649	48	of	of	ADP
ihlr-16470	649	49	clinical	clinical	ADJ
ihlr-16470	649	50	data	datum	NOUN
ihlr-16470	649	51	is	be	AUX
ihlr-16470	649	52	suspect	suspect	ADJ
ihlr-16470	649	53	,	,	PUNCT
ihlr-16470	649	54	and	and	CCONJ
ihlr-16470	649	55	may	may	AUX
ihlr-16470	649	56	not	not	PART
ihlr-16470	649	57	provide	provide	VERB
ihlr-16470	649	58	physicians	physician	NOUN
ihlr-16470	649	59	with	with	ADP
ihlr-16470	649	60	a	a	DET
ihlr-16470	649	61	clear	clear	ADJ
ihlr-16470	649	62	picture	picture	NOUN
ihlr-16470	649	63	of	of	ADP
ihlr-16470	649	64	the	the	DET
ihlr-16470	649	65	risks	risk	NOUN
ihlr-16470	649	66	surrounding	surround	VERB
ihlr-16470	649	67	a	a	DET
ihlr-16470	649	68	medication	medication	NOUN
ihlr-16470	649	69	.	.	PUNCT
ihlr-16470	650	1	·	·	PUNCT
ihlr-16470	650	2	indeed	indeed	ADV
ihlr-16470	650	3	,	,	PUNCT
ihlr-16470	650	4	it	it	PRON
ihlr-16470	650	5	has	have	AUX
ihlr-16470	650	6	been	be	AUX
ihlr-16470	650	7	noted	note	VERB
ihlr-16470	650	8	that	that	SCONJ
ihlr-16470	650	9	"	"	PUNCT
ihlr-16470	650	10	one	one	NUM
ihlr-16470	650	11	of	of	ADP
ihlr-16470	650	12	the	the	DET
ihlr-16470	650	13	greatest	great	ADJ
ihlr-16470	650	14	roadblocks	roadblock	NOUN
ihlr-16470	650	15	to	to	ADP
ihlr-16470	650	16	understanding	understand	VERB
ihlr-16470	650	17	the	the	DET
ihlr-16470	650	18	safety	safety	NOUN
ihlr-16470	650	19	and	and	CCONJ
ihlr-16470	650	20	efficacy	efficacy	NOUN
ihlr-16470	650	21	of	of	ADP
ihlr-16470	650	22	trials	trial	NOUN
ihlr-16470	650	23	is	be	AUX
ihlr-16470	650	24	the	the	DET
ihlr-16470	650	25	lack	lack	NOUN
ihlr-16470	650	26	of	of	ADP
ihlr-16470	650	27	public	public	ADJ
ihlr-16470	650	28	access	access	NOUN
ihlr-16470	650	29	and	and	CCONJ
ihlr-16470	650	30	.	.	PUNCT
ihlr-16470	650	31	.	.	PUNCT
ihlr-16470	650	32	.	.	PUNCT
ihlr-16470	651	1	disclosure	disclosure	NOUN
ihlr-16470	651	2	of	of	ADP
ihlr-16470	651	3	these	these	DET
ihlr-16470	651	4	data	data	NOUN
ihlr-16470	651	5	sets	set	NOUN
ihlr-16470	651	6	....	....	PUNCT
ihlr-16470	652	1	"	"	PUNCT
ihlr-16470	652	2	180	180	NUM
ihlr-16470	652	3	concerns	concern	NOUN
ihlr-16470	652	4	over	over	ADP
ihlr-16470	652	5	trial	trial	NOUN
ihlr-16470	652	6	publication	publication	NOUN
ihlr-16470	652	7	recently	recently	ADV
ihlr-16470	652	8	garnered	garner	VERB
ihlr-16470	652	9	more	more	ADJ
ihlr-16470	652	10	attention	attention	NOUN
ihlr-16470	652	11	due	due	ADP
ihlr-16470	652	12	to	to	ADP
ihlr-16470	652	13	reports	report	NOUN
ihlr-16470	652	14	showing	show	VERB
ihlr-16470	652	15	thatglaxosmithkline	thatglaxosmithkline	NOUN
ihlr-16470	652	16	published	publish	VERB
ihlr-16470	652	17	reports	report	NOUN
ihlr-16470	652	18	on	on	ADP
ihlr-16470	652	19	the	the	DET
ihlr-16470	652	20	success	success	NOUN
ihlr-16470	652	21	of	of	ADP
ihlr-16470	652	22	its	its	PRON
ihlr-16470	652	23	ssri	ssri	NOUN
ihlr-16470	652	24	(	(	PUNCT
ihlr-16470	652	25	paxil	paxil	NOUN
ihlr-16470	652	26	)	)	PUNCT
ihlr-16470	652	27	,	,	PUNCT
ihlr-16470	652	28	but	but	CCONJ
ihlr-16470	652	29	withheld	withhold	VERB
ihlr-16470	652	30	findings	finding	NOUN
ihlr-16470	652	31	that	that	SCONJ
ihlr-16470	652	32	the	the	DET
ihlr-16470	652	33	drug	drug	NOUN
ihlr-16470	652	34	was	be	AUX
ihlr-16470	652	35	no	no	PRON
ihlr-16470	652	36	more	more	ADV
ihlr-16470	652	37	effective	effective	ADJ
ihlr-16470	652	38	than	than	ADP
ihlr-16470	652	39	the	the	DET
ihlr-16470	652	40	placebo	placebo	NOUN
ihlr-16470	652	41	in	in	ADP
ihlr-16470	652	42	pediatric	pediatric	ADJ
ihlr-16470	652	43	populations	population	NOUN
ihlr-16470	652	44	and	and	CCONJ
ihlr-16470	652	45	may	may	AUX
ihlr-16470	652	46	increase	increase	VERB
ihlr-16470	652	47	the	the	DET
ihlr-16470	652	48	risk	risk	NOUN
ihlr-16470	652	49	of	of	ADP
ihlr-16470	652	50	suicide	suicide	NOUN
ihlr-16470	652	51	.	.	PUNCT
ihlr-16470	653	1	181	181	NUM
ihlr-16470	654	1	the	the	DET
ihlr-16470	654	2	fda	fda	PROPN
ihlr-16470	654	3	did	do	AUX
ihlr-16470	654	4	not	not	PART
ihlr-16470	654	5	recognize	recognize	VERB
ihlr-16470	654	6	that	that	SCONJ
ihlr-16470	654	7	ssris	ssris	PROPN
ihlr-16470	654	8	may	may	AUX
ihlr-16470	654	9	cause	cause	VERB
ihlr-16470	654	10	suicidality	suicidality	NOUN
ihlr-16470	654	11	in	in	ADP
ihlr-16470	654	12	children	child	NOUN
ihlr-16470	654	13	and	and	CCONJ
ihlr-16470	654	14	teenagers	teenager	NOUN
ihlr-16470	654	15	because	because	SCONJ
ihlr-16470	654	16	drug	drug	NOUN
ihlr-16470	654	17	makers	maker	NOUN
ihlr-16470	654	18	were	be	AUX
ihlr-16470	654	19	permitted	permit	VERB
ihlr-16470	654	20	to	to	PART
ihlr-16470	654	21	bury	bury	VERB
ihlr-16470	654	22	clinical	clinical	ADJ
ihlr-16470	654	23	trial	trial	NOUN
ihlr-16470	654	24	results	result	NOUN
ihlr-16470	654	25	when	when	SCONJ
ihlr-16470	654	26	outcomes	outcome	NOUN
ihlr-16470	654	27	were	be	AUX
ihlr-16470	654	28	bad	bad	ADJ
ihlr-16470	654	29	or	or	CCONJ
ihlr-16470	654	30	inconclusive	inconclusive	ADJ
ihlr-16470	654	31	.	.	PUNCT
ihlr-16470	655	1	this	this	PRON
ihlr-16470	655	2	is	be	AUX
ihlr-16470	655	3	exactly	exactly	ADV
ihlr-16470	655	4	what	what	PRON
ihlr-16470	655	5	happened	happen	VERB
ihlr-16470	655	6	when	when	SCONJ
ihlr-16470	655	7	trials	trial	NOUN
ihlr-16470	655	8	suggested	suggest	VERB
ihlr-16470	655	9	a	a	DET
ihlr-16470	655	10	link	link	NOUN
ihlr-16470	655	11	between	between	ADP
ihlr-16470	655	12	ssris	ssris	NOUN
ihlr-16470	655	13	and	and	CCONJ
ihlr-16470	655	14	suicide.182	suicide.182	PROPN
ihlr-16470	655	15	currently	currently	ADV
ihlr-16470	655	16	,	,	PUNCT
ihlr-16470	655	17	there	there	PRON
ihlr-16470	655	18	is	be	VERB
ihlr-16470	655	19	a	a	DET
ihlr-16470	655	20	push	push	NOUN
ihlr-16470	655	21	from	from	ADP
ihlr-16470	655	22	both	both	CCONJ
ihlr-16470	655	23	congress	congress	PROPN
ihlr-16470	655	24	and	and	CCONJ
ihlr-16470	655	25	the	the	DET
ihlr-16470	655	26	nation	nation	NOUN
ihlr-16470	655	27	's	's	PART
ihlr-16470	655	28	medicaljournals	medicaljournal	NOUN
ihlr-16470	655	29	to	to	PART
ihlr-16470	655	30	require	require	VERB
ihlr-16470	655	31	that	that	SCONJ
ihlr-16470	655	32	drug	drug	NOUN
ihlr-16470	655	33	companies	company	NOUN
ihlr-16470	655	34	publish	publish	VERB
ihlr-16470	655	35	all	all	DET
ihlr-16470	655	36	clinical	clinical	ADJ
ihlr-16470	655	37	trials	trial	NOUN
ihlr-16470	655	38	.	.	PUNCT
ihlr-16470	656	1	183	183	NUM
ihlr-16470	656	2	in	in	ADP
ihlr-16470	656	3	the	the	DET
ihlr-16470	656	4	wake	wake	NOUN
ihlr-16470	656	5	of	of	ADP
ihlr-16470	656	6	glaxosmithkline	glaxosmithkline	PROPN
ihlr-16470	656	7	's	's	PART
ihlr-16470	656	8	admission	admission	NOUN
ihlr-16470	656	9	and	and	CCONJ
ihlr-16470	656	10	the	the	DET
ihlr-16470	656	11	fda	fda	PROPN
ihlr-16470	656	12	's	's	PART
ihlr-16470	656	13	implementation	implementation	NOUN
ihlr-16470	656	14	of	of	ADP
ihlr-16470	656	15	the	the	DET
ihlr-16470	656	16	black	black	PROPN
ihlr-16470	656	17	box	box	PROPN
ihlr-16470	656	18	label	label	NOUN
ihlr-16470	656	19	on	on	ADP
ihlr-16470	656	20	ssris	ssris	NOUN
ihlr-16470	656	21	,	,	PUNCT
ihlr-16470	656	22	several	several	ADJ
ihlr-16470	656	23	prestigious	prestigious	ADJ
ihlr-16470	656	24	medical	medical	NOUN
ihlr-16470	656	25	/d	/d	PUNCT
ihlr-16470	656	26	.	.	PUNCT
ihlr-16470	657	1	at	at	ADP
ihlr-16470	657	2	503	503	NUM
ihlr-16470	657	3	-	-	PUNCT
ihlr-16470	657	4	04	04	NUM
ihlr-16470	657	5	.	.	PUNCT
ihlr-16470	658	1	pediatricians	pediatrician	NOUN
ihlr-16470	658	2	may	may	AUX
ihlr-16470	658	3	still	still	ADV
ihlr-16470	658	4	find	find	VERB
ihlr-16470	658	5	a	a	DET
ihlr-16470	658	6	dearth	dearth	NOUN
ihlr-16470	658	7	of	of	ADP
ihlr-16470	658	8	information	information	NOUN
ihlr-16470	658	9	on	on	ADP
ihlr-16470	658	10	drugs	drug	NOUN
ihlr-16470	658	11	the	the	DET
ihlr-16470	658	12	commonly	commonly	ADJ
ihlr-16470	658	13	prescribe	prescribe	NOUN
ihlr-16470	658	14	...	...	PUNCT
ihlr-16470	658	15	moreover	moreover	ADV
ihlr-16470	658	16	,	,	PUNCT
ihlr-16470	658	17	combining	combine	VERB
ihlr-16470	658	18	the	the	DET
ihlr-16470	658	19	incentive	incentive	NOUN
ihlr-16470	658	20	structure	structure	NOUN
ihlr-16470	658	21	of	of	ADP
ihlr-16470	658	22	the	the	DET
ihlr-16470	658	23	bpca	bpca	NOUN
ihlr-16470	658	24	with	with	ADP
ihlr-16470	658	25	the	the	DET
ihlr-16470	658	26	mandatory	mandatory	PROPN
ihlr-16470	658	27	prea	prea	PROPN
ihlr-16470	658	28	is	be	AUX
ihlr-16470	658	29	contradictory	contradictory	ADJ
ihlr-16470	658	30	...	...	PUNCT
ihlr-16470	659	1	congress	congress	PROPN
ihlr-16470	659	2	has	have	AUX
ihlr-16470	659	3	codified	codify	VERB
ihlr-16470	659	4	both	both	CCONJ
ihlr-16470	659	5	mandatory	mandatory	ADJ
ihlr-16470	659	6	and	and	CCONJ
ihlr-16470	659	7	incentive	incentive	NOUN
ihlr-16470	659	8	-	-	PUNCT
ihlr-16470	659	9	based	base	VERB
ihlr-16470	659	10	initiatives	initiative	NOUN
ihlr-16470	659	11	...	...	PUNCT
ihlr-16470	659	12	in	in	ADP
ihlr-16470	659	13	attempting	attempt	VERB
ihlr-16470	659	14	to	to	PART
ihlr-16470	659	15	placate	placate	VERB
ihlr-16470	659	16	the	the	DET
ihlr-16470	659	17	pharmaceutical	pharmaceutical	NOUN
ihlr-16470	659	18	industry	industry	NOUN
ihlr-16470	659	19	while	while	SCONJ
ihlr-16470	659	20	addressing	address	VERB
ihlr-16470	659	21	the	the	DET
ihlr-16470	659	22	problems	problem	NOUN
ihlr-16470	659	23	of	of	ADP
ihlr-16470	659	24	off	off	ADP
ihlr-16470	659	25	-	-	PUNCT
ihlr-16470	659	26	label	label	NOUN
ihlr-16470	659	27	prescribing	prescribing	NOUN
ihlr-16470	659	28	for	for	ADP
ihlr-16470	659	29	children	child	NOUN
ihlr-16470	659	30	,	,	PUNCT
ihlr-16470	659	31	congress	congress	PROPN
ihlr-16470	659	32	has	have	AUX
ihlr-16470	659	33	created	create	VERB
ihlr-16470	659	34	a	a	DET
ihlr-16470	659	35	legislative	legislative	ADJ
ihlr-16470	659	36	paradox	paradox	NOUN
ihlr-16470	659	37	:	:	PUNCT
ihlr-16470	659	38	the	the	DET
ihlr-16470	659	39	law	law	NOUN
ihlr-16470	659	40	requires	require	VERB
ihlr-16470	659	41	drug	drug	NOUN
ihlr-16470	659	42	companies	company	NOUN
ihlr-16470	659	43	to	to	PART
ihlr-16470	659	44	test	test	VERB
ihlr-16470	659	45	their	their	PRON
ihlr-16470	659	46	products	product	NOUN
ihlr-16470	659	47	on	on	ADP
ihlr-16470	659	48	children	child	NOUN
ihlr-16470	659	49	,	,	PUNCT
ihlr-16470	659	50	and	and	CCONJ
ihlr-16470	659	51	when	when	SCONJ
ihlr-16470	659	52	they	they	PRON
ihlr-16470	659	53	comply	comply	VERB
ihlr-16470	659	54	with	with	ADP
ihlr-16470	659	55	the	the	DET
ihlr-16470	659	56	law	law	NOUN
ihlr-16470	659	57	,	,	PUNCT
ihlr-16470	659	58	they	they	PRON
ihlr-16470	659	59	receive	receive	VERB
ihlr-16470	659	60	a	a	DET
ihlr-16470	659	61	lucrative	lucrative	ADJ
ihlr-16470	659	62	reward	reward	NOUN
ihlr-16470	659	63	.	.	PUNCT
ihlr-16470	660	1	it	it	PRON
ihlr-16470	660	2	is	be	AUX
ihlr-16470	660	3	the	the	DET
ihlr-16470	660	4	same	same	ADJ
ihlr-16470	660	5	perplexing	perplexing	ADJ
ihlr-16470	660	6	logic	logic	NOUN
ihlr-16470	660	7	that	that	PRON
ihlr-16470	660	8	led	lead	VERB
ihlr-16470	660	9	the	the	DET
ihlr-16470	660	10	united	united	PROPN
ihlr-16470	660	11	states	states	PROPN
ihlr-16470	660	12	district	district	PROPN
ihlr-16470	660	13	court	court	NOUN
ihlr-16470	660	14	for	for	ADP
ihlr-16470	660	15	the	the	DET
ihlr-16470	660	16	district	district	PROPN
ihlr-16470	660	17	of	of	ADP
ihlr-16470	660	18	columbia	columbia	PROPN
ihlr-16470	660	19	to	to	PART
ihlr-16470	660	20	conclude	conclude	VERB
ihlr-16470	660	21	that	that	SCONJ
ihlr-16470	660	22	an	an	DET
ihlr-16470	660	23	incentive	incentive	NOUN
ihlr-16470	660	24	scheme	scheme	NOUN
ihlr-16470	660	25	and	and	CCONJ
ihlr-16470	660	26	a	a	DET
ihlr-16470	660	27	"	"	PUNCT
ihlr-16470	660	28	command	command	NOUN
ihlr-16470	660	29	and	and	CCONJ
ihlr-16470	660	30	control	control	NOUN
ihlr-16470	660	31	approach	approach	NOUN
ihlr-16470	660	32	"	"	PUNCT
ihlr-16470	660	33	were	be	AUX
ihlr-16470	660	34	incompatible	incompatible	ADJ
ihlr-16470	660	35	,	,	PUNCT
ihlr-16470	660	36	in	in	ADP
ihlr-16470	660	37	striking	strike	VERB
ihlr-16470	660	38	down	down	ADP
ihlr-16470	660	39	the	the	DET
ihlr-16470	660	40	fda	fda	PROPN
ihlr-16470	660	41	final	final	ADJ
ihlr-16470	660	42	rule	rule	NOUN
ihlr-16470	660	43	.	.	PUNCT
ihlr-16470	661	1	179	179	NUM
ihlr-16470	661	2	.	.	PUNCT
ihlr-16470	661	3	liebert	liebert	PROPN
ihlr-16470	661	4	,	,	PUNCT
ihlr-16470	661	5	supra	supra	PROPN
ihlr-16470	661	6	note	note	NOUN
ihlr-16470	661	7	9	9	NUM
ihlr-16470	661	8	.	.	NOUN
ihlr-16470	661	9	180	180	NUM
ihlr-16470	661	10	.	.	PUNCT
ihlr-16470	661	11	symposium	symposium	NOUN
ihlr-16470	661	12	,	,	PUNCT
ihlr-16470	661	13	supra	supra	PROPN
ihlr-16470	661	14	note	note	NOUN
ihlr-16470	661	15	3	3	NUM
ihlr-16470	661	16	,	,	PUNCT
ihlr-16470	661	17	at	at	ADP
ihlr-16470	661	18	338	338	NUM
ihlr-16470	661	19	.	.	PUNCT
ihlr-16470	662	1	181	181	NUM
ihlr-16470	662	2	.	.	PUNCT
ihlr-16470	663	1	liebert	liebert	PROPN
ihlr-16470	663	2	,	,	PUNCT
ihlr-16470	663	3	supra	supra	PROPN
ihlr-16470	663	4	note	note	NOUN
ihlr-16470	663	5	9	9	NUM
ihlr-16470	663	6	.	.	NOUN
ihlr-16470	663	7	182	182	NUM
ihlr-16470	663	8	.	.	PUNCT
ihlr-16470	664	1	tell	tell	VERB
ihlr-16470	664	2	the	the	DET
ihlr-16470	664	3	truth	truth	NOUN
ihlr-16470	664	4	about	about	ADP
ihlr-16470	664	5	antidepressants	antidepressant	NOUN
ihlr-16470	664	6	on	on	ADP
ihlr-16470	664	7	drug	drug	NOUN
ihlr-16470	664	8	labels	label	NOUN
ihlr-16470	664	9	and	and	CCONJ
ihlr-16470	664	10	in	in	ADP
ihlr-16470	664	11	medical	medical	ADJ
ihlr-16470	664	12	journals	journal	NOUN
ihlr-16470	664	13	,	,	PUNCT
ihlr-16470	664	14	newsday	newsday	PROPN
ihlr-16470	664	15	,	,	PUNCT
ihlr-16470	664	16	sept	sept	PROPN
ihlr-16470	664	17	.	.	PROPN
ihlr-16470	664	18	15	15	NUM
ihlr-16470	664	19	,	,	PUNCT
ihlr-16470	664	20	2004	2004	NUM
ihlr-16470	664	21	,	,	PUNCT
ihlr-16470	664	22	at	at	ADP
ihlr-16470	664	23	a42	a42	NOUN
ihlr-16470	664	24	.	.	PUNCT
ihlr-16470	664	25	183	183	NUM
ihlr-16470	664	26	.	.	PUNCT
ihlr-16470	665	1	missing	miss	VERB
ihlr-16470	665	2	drug	drug	NOUN
ihlr-16470	665	3	data	datum	NOUN
ihlr-16470	665	4	,	,	PUNCT
ihlr-16470	665	5	wash	wash	NOUN
ihlr-16470	665	6	.	.	PUNCT
ihlr-16470	666	1	post	post	NOUN
ihlr-16470	666	2	,	,	PUNCT
ihlr-16470	666	3	june	june	PROPN
ihlr-16470	666	4	30	30	NUM
ihlr-16470	666	5	,	,	PUNCT
ihlr-16470	666	6	2004	2004	NUM
ihlr-16470	666	7	,	,	PUNCT
ihlr-16470	666	8	at	at	ADP
ihlr-16470	666	9	a20	a20	NOUN
ihlr-16470	666	10	.	.	PUNCT
ihlr-16470	667	1	2006	2006	NUM
ihlr-16470	667	2	]	]	PUNCT
ihlr-16470	667	3	anti	anti	NOUN
ihlr-16470	667	4	-	-	NOUN
ihlr-16470	667	5	depressants	depressant	NOUN
ihlr-16470	667	6	and	and	CCONJ
ihlr-16470	667	7	children	child	NOUN
ihlr-16470	667	8	227	227	NUM
ihlr-16470	667	9	journals184	journals184	PROPN
ihlr-16470	667	10	began	begin	VERB
ihlr-16470	667	11	requiring	require	VERB
ihlr-16470	667	12	drug	drug	NOUN
ihlr-16470	667	13	companies	company	NOUN
ihlr-16470	667	14	to	to	PART
ihlr-16470	667	15	publicly	publicly	ADV
ihlr-16470	667	16	register	register	VERB
ihlr-16470	667	17	a	a	DET
ihlr-16470	667	18	trial	trial	NOUN
ihlr-16470	667	19	before	before	ADP
ihlr-16470	667	20	enrolling	enrol	VERB
ihlr-16470	667	21	patients	patient	NOUN
ihlr-16470	667	22	as	as	ADP
ihlr-16470	667	23	a	a	DET
ihlr-16470	667	24	prerequisite	prerequisite	NOUN
ihlr-16470	667	25	for	for	ADP
ihlr-16470	667	26	publication	publication	NOUN
ihlr-16470	667	27	.	.	PUNCT
ihlr-16470	668	1	185	185	NUM
ihlr-16470	668	2	such	such	DET
ihlr-16470	668	3	a	a	DET
ihlr-16470	668	4	registration	registration	NOUN
ihlr-16470	668	5	plan	plan	NOUN
ihlr-16470	668	6	would	would	AUX
ihlr-16470	668	7	fall	fall	VERB
ihlr-16470	668	8	short	short	ADV
ihlr-16470	668	9	of	of	ADP
ihlr-16470	668	10	requiring	require	VERB
ihlr-16470	668	11	publication	publication	NOUN
ihlr-16470	668	12	of	of	ADP
ihlr-16470	668	13	all	all	DET
ihlr-16470	668	14	trial	trial	NOUN
ihlr-16470	668	15	data	datum	NOUN
ihlr-16470	668	16	,	,	PUNCT
ihlr-16470	668	17	but	but	CCONJ
ihlr-16470	668	18	could	could	AUX
ihlr-16470	668	19	provide	provide	VERB
ihlr-16470	668	20	greater	great	ADJ
ihlr-16470	668	21	public	public	ADJ
ihlr-16470	668	22	awareness	awareness	NOUN
ihlr-16470	668	23	of	of	ADP
ihlr-16470	668	24	trials	trial	NOUN
ihlr-16470	668	25	and	and	CCONJ
ihlr-16470	668	26	generate	generate	VERB
ihlr-16470	668	27	public	public	ADJ
ihlr-16470	668	28	concern	concern	NOUN
ihlr-16470	668	29	if	if	SCONJ
ihlr-16470	668	30	a	a	DET
ihlr-16470	668	31	large	large	ADJ
ihlr-16470	668	32	number	number	NOUN
ihlr-16470	668	33	of	of	ADP
ihlr-16470	668	34	registered	register	VERB
ihlr-16470	668	35	trials	trial	NOUN
ihlr-16470	668	36	are	be	AUX
ihlr-16470	668	37	not	not	PART
ihlr-16470	668	38	later	later	ADV
ihlr-16470	668	39	published	publish	VERB
ihlr-16470	668	40	.	.	PUNCT
ihlr-16470	669	1	186	186	NUM
ihlr-16470	669	2	still	still	ADV
ihlr-16470	669	3	,	,	PUNCT
ihlr-16470	669	4	the	the	DET
ihlr-16470	669	5	efficacy	efficacy	NOUN
ihlr-16470	669	6	of	of	ADP
ihlr-16470	669	7	such	such	DET
ihlr-16470	669	8	an	an	DET
ihlr-16470	669	9	approach	approach	NOUN
ihlr-16470	669	10	is	be	AUX
ihlr-16470	669	11	questionable	questionable	ADJ
ihlr-16470	669	12	.	.	PUNCT
ihlr-16470	670	1	registry	registry	NOUN
ihlr-16470	670	2	systems	system	NOUN
ihlr-16470	670	3	are	be	AUX
ihlr-16470	670	4	likely	likely	ADJ
ihlr-16470	670	5	to	to	PART
ihlr-16470	670	6	inundate	inundate	VERB
ihlr-16470	670	7	the	the	DET
ihlr-16470	670	8	public	public	NOUN
ihlr-16470	670	9	with	with	ADP
ihlr-16470	670	10	more	more	ADJ
ihlr-16470	670	11	registered	register	VERB
ihlr-16470	670	12	trials	trial	NOUN
ihlr-16470	670	13	than	than	SCONJ
ihlr-16470	670	14	can	can	AUX
ihlr-16470	670	15	easily	easily	ADV
ihlr-16470	670	16	be	be	AUX
ihlr-16470	670	17	sorted	sort	VERB
ihlr-16470	670	18	and	and	CCONJ
ihlr-16470	670	19	identified	identify	VERB
ihlr-16470	670	20	.	.	PUNCT
ihlr-16470	671	1	furthermore	furthermore	ADV
ihlr-16470	671	2	,	,	PUNCT
ihlr-16470	671	3	the	the	DET
ihlr-16470	671	4	public	public	NOUN
ihlr-16470	671	5	may	may	AUX
ihlr-16470	671	6	not	not	PART
ihlr-16470	671	7	know	know	VERB
ihlr-16470	671	8	how	how	SCONJ
ihlr-16470	671	9	to	to	PART
ihlr-16470	671	10	utilize	utilize	VERB
ihlr-16470	671	11	the	the	DET
ihlr-16470	671	12	information	information	NOUN
ihlr-16470	671	13	for	for	ADP
ihlr-16470	671	14	their	their	PRON
ihlr-16470	671	15	safety	safety	NOUN
ihlr-16470	671	16	,	,	PUNCT
ihlr-16470	671	17	or	or	CCONJ
ihlr-16470	671	18	worse	bad	ADJ
ihlr-16470	671	19	,	,	PUNCT
ihlr-16470	671	20	those	those	PRON
ihlr-16470	671	21	who	who	PRON
ihlr-16470	671	22	may	may	AUX
ihlr-16470	671	23	effectively	effectively	ADV
ihlr-16470	671	24	use	use	VERB
ihlr-16470	671	25	the	the	DET
ihlr-16470	671	26	information	information	NOUN
ihlr-16470	671	27	may	may	AUX
ihlr-16470	671	28	not	not	PART
ihlr-16470	671	29	even	even	ADV
ihlr-16470	671	30	be	be	AUX
ihlr-16470	671	31	aware	aware	ADJ
ihlr-16470	671	32	of	of	ADP
ihlr-16470	671	33	the	the	DET
ihlr-16470	671	34	system	system	NOUN
ihlr-16470	671	35	's	's	PART
ihlr-16470	671	36	existence	existence	NOUN
ihlr-16470	671	37	.	.	PUNCT
ihlr-16470	672	1	because	because	SCONJ
ihlr-16470	672	2	they	they	PRON
ihlr-16470	672	3	are	be	AUX
ihlr-16470	672	4	implemented	implement	VERB
ihlr-16470	672	5	at	at	ADP
ihlr-16470	672	6	the	the	DET
ihlr-16470	672	7	journal	journal	ADJ
ihlr-16470	672	8	level	level	NOUN
ihlr-16470	672	9	,	,	PUNCT
ihlr-16470	672	10	these	these	DET
ihlr-16470	672	11	registry	registry	NOUN
ihlr-16470	672	12	systems	system	NOUN
ihlr-16470	672	13	are	be	AUX
ihlr-16470	672	14	an	an	DET
ihlr-16470	672	15	excellent	excellent	ADJ
ihlr-16470	672	16	first	first	ADJ
ihlr-16470	672	17	step	step	NOUN
ihlr-16470	672	18	in	in	ADP
ihlr-16470	672	19	fighting	fight	VERB
ihlr-16470	672	20	data	data	NOUN
ihlr-16470	672	21	suppression	suppression	NOUN
ihlr-16470	672	22	for	for	ADP
ihlr-16470	672	23	several	several	ADJ
ihlr-16470	672	24	reasons	reason	NOUN
ihlr-16470	672	25	.	.	PUNCT
ihlr-16470	673	1	since	since	SCONJ
ihlr-16470	673	2	they	they	PRON
ihlr-16470	673	3	are	be	AUX
ihlr-16470	673	4	implemented	implement	VERB
ihlr-16470	673	5	at	at	ADP
ihlr-16470	673	6	the	the	DET
ihlr-16470	673	7	journal	journal	ADJ
ihlr-16470	673	8	level	level	NOUN
ihlr-16470	673	9	,	,	PUNCT
ihlr-16470	673	10	they	they	PRON
ihlr-16470	673	11	are	be	AUX
ihlr-16470	673	12	implemented	implement	VERB
ihlr-16470	673	13	quickly	quickly	ADV
ihlr-16470	673	14	and	and	CCONJ
ihlr-16470	673	15	efficiently	efficiently	ADV
ihlr-16470	673	16	,	,	PUNCT
ihlr-16470	673	17	provide	provide	VERB
ihlr-16470	673	18	effective	effective	ADJ
ihlr-16470	673	19	economic	economic	ADJ
ihlr-16470	673	20	incentive	incentive	NOUN
ihlr-16470	673	21	to	to	ADP
ihlr-16470	673	22	the	the	DET
ihlr-16470	673	23	manufacturers187	manufacturers187	PROPN
ihlr-16470	673	24	,	,	PUNCT
ihlr-16470	673	25	and	and	CCONJ
ihlr-16470	673	26	can	can	AUX
ihlr-16470	673	27	be	be	AUX
ihlr-16470	673	28	done	do	VERB
ihlr-16470	673	29	with	with	ADP
ihlr-16470	673	30	relatively	relatively	ADV
ihlr-16470	673	31	little	little	ADJ
ihlr-16470	673	32	cost	cost	NOUN
ihlr-16470	673	33	.	.	PUNCT
ihlr-16470	674	1	yet	yet	ADV
ihlr-16470	674	2	,	,	PUNCT
ihlr-16470	674	3	due	due	ADP
ihlr-16470	674	4	to	to	ADP
ihlr-16470	674	5	the	the	DET
ihlr-16470	674	6	systems	system	NOUN
ihlr-16470	674	7	shortcomings	shortcoming	NOUN
ihlr-16470	674	8	it	it	PRON
ihlr-16470	674	9	remains	remain	VERB
ihlr-16470	674	10	merely	merely	ADV
ihlr-16470	674	11	a	a	DET
ihlr-16470	674	12	first	first	ADJ
ihlr-16470	674	13	step	step	NOUN
ihlr-16470	674	14	.	.	PUNCT
ihlr-16470	675	1	one	one	NUM
ihlr-16470	675	2	possible	possible	ADJ
ihlr-16470	675	3	way	way	NOUN
ihlr-16470	675	4	to	to	PART
ihlr-16470	675	5	augment	augment	VERB
ihlr-16470	675	6	the	the	DET
ihlr-16470	675	7	changes	change	NOUN
ihlr-16470	675	8	initiated	initiate	VERB
ihlr-16470	675	9	at	at	ADP
ihlr-16470	675	10	the	the	DET
ihlr-16470	675	11	journal	journal	ADJ
ihlr-16470	675	12	level	level	NOUN
ihlr-16470	675	13	is	be	AUX
ihlr-16470	675	14	with	with	ADP
ihlr-16470	675	15	legislative	legislative	ADJ
ihlr-16470	675	16	action	action	NOUN
ihlr-16470	675	17	requiring	require	VERB
ihlr-16470	675	18	drug	drug	NOUN
ihlr-16470	675	19	companies	company	NOUN
ihlr-16470	675	20	to	to	PART
ihlr-16470	675	21	publish	publish	VERB
ihlr-16470	675	22	trial	trial	NOUN
ihlr-16470	675	23	results	result	NOUN
ihlr-16470	675	24	.	.	PUNCT
ihlr-16470	676	1	two	two	NUM
ihlr-16470	676	2	bills	bill	NOUN
ihlr-16470	676	3	have	have	AUX
ihlr-16470	676	4	been	be	AUX
ihlr-16470	676	5	introduced	introduce	VERB
ihlr-16470	676	6	,	,	PUNCT
ihlr-16470	676	7	one	one	NUM
ihlr-16470	676	8	in	in	ADP
ihlr-16470	676	9	the	the	DET
ihlr-16470	676	10	house	house	NOUN
ihlr-16470	676	11	and	and	CCONJ
ihlr-16470	676	12	one	one	NUM
ihlr-16470	676	13	in	in	ADP
ihlr-16470	676	14	the	the	DET
ihlr-16470	676	15	senate	senate	PROPN
ihlr-16470	676	16	,	,	PUNCT
ihlr-16470	676	17	and	and	CCONJ
ihlr-16470	676	18	each	each	PRON
ihlr-16470	676	19	proposes	propose	VERB
ihlr-16470	676	20	a	a	DET
ihlr-16470	676	21	combined	combined	ADJ
ihlr-16470	676	22	registry	registry	NOUN
ihlr-16470	676	23	~	~	SYM
ihlr-16470	676	24	publication	publication	NOUN
ihlr-16470	676	25	system	system	NOUN
ihlr-16470	676	26	.	.	PUNCT
ihlr-16470	677	1	188	188	NUM
ihlr-16470	677	2	the	the	DET
ihlr-16470	677	3	purpose	purpose	NOUN
ihlr-16470	677	4	of	of	ADP
ihlr-16470	677	5	these	these	DET
ihlr-16470	677	6	proposals	proposal	NOUN
ihlr-16470	677	7	has	have	VERB
ihlr-16470	677	8	two	two	NUM
ihlr-16470	677	9	elements	element	NOUN
ihlr-16470	677	10	,	,	PUNCT
ihlr-16470	677	11	(	(	PUNCT
ihlr-16470	677	12	1	1	NUM
ihlr-16470	677	13	)	)	PUNCT
ihlr-16470	677	14	''	''	PUNCT
ihlr-16470	677	15	to	to	PART
ihlr-16470	677	16	create	create	VERB
ihlr-16470	677	17	a	a	DET
ihlr-16470	677	18	centralized	centralized	ADJ
ihlr-16470	677	19	and	and	CCONJ
ihlr-16470	677	20	comprehensive	comprehensive	ADJ
ihlr-16470	677	21	"	"	PUNCT
ihlr-16470	677	22	registry	registry	NOUN
ihlr-16470	677	23	of	of	ADP
ihlr-16470	677	24	clinical	clinical	ADJ
ihlr-16470	677	25	trials	trial	NOUN
ihlr-16470	677	26	,	,	PUNCT
ihlr-16470	677	27	and	and	CCONJ
ihlr-16470	677	28	(	(	PUNCT
ihlr-16470	677	29	2	2	NUM
ihlr-16470	677	30	)	)	PUNCT
ihlr-16470	677	31	"	"	PUNCT
ihlr-16470	677	32	to	to	PART
ihlr-16470	677	33	make	make	VERB
ihlr-16470	677	34	the	the	DET
ihlr-16470	677	35	information	information	NOUN
ihlr-16470	677	36	contained	contain	VERB
ihlr-16470	677	37	in	in	ADP
ihlr-16470	677	38	the	the	DET
ihlr-16470	677	39	registry	registry	NOUN
ihlr-16470	677	40	available	available	ADJ
ihlr-16470	677	41	to	to	ADP
ihlr-16470	677	42	researchers	researcher	NOUN
ihlr-16470	677	43	,	,	PUNCT
ihlr-16470	677	44	health	health	NOUN
ihlr-16470	677	45	care	care	NOUN
ihlr-16470	677	46	providers	provider	NOUN
ihlr-16470	677	47	,	,	PUNCT
ihlr-16470	677	48	patients	patient	NOUN
ihlr-16470	677	49	seeking	seek	VERB
ihlr-16470	677	50	to	to	PART
ihlr-16470	677	51	enroll	enroll	VERB
ihlr-16470	677	52	"	"	PUNCT
ihlr-16470	677	53	in	in	ADP
ihlr-16470	677	54	clinical	clinical	ADJ
ihlr-16470	677	55	trials	trial	NOUN
ihlr-16470	677	56	,	,	PUNCT
ihlr-16470	677	57	and	and	CCONJ
ihlr-16470	677	58	the	the	DET
ihlr-16470	677	59	general	general	ADJ
ihlr-16470	677	60	public	public	NOUN
ihlr-16470	677	61	.	.	PUNCT
ihlr-16470	678	1	189	189	NUM
ihlr-16470	678	2	while	while	SCONJ
ihlr-16470	678	3	the	the	DET
ihlr-16470	678	4	bills	bill	NOUN
ihlr-16470	678	5	are	be	AUX
ihlr-16470	678	6	slightly	slightly	ADV
ihlr-16470	678	7	different	different	ADJ
ihlr-16470	678	8	,	,	PUNCT
ihlr-16470	678	9	each	each	PRON
ihlr-16470	678	10	seeks	seek	VERB
ihlr-16470	678	11	to	to	PART
ihlr-16470	678	12	meet	meet	VERB
ihlr-16470	678	13	these	these	DET
ihlr-16470	678	14	goals	goal	NOUN
ihlr-16470	678	15	in	in	ADP
ihlr-16470	678	16	essentially	essentially	ADV
ihlr-16470	678	17	the	the	DET
ihlr-16470	678	18	same	same	ADJ
ihlr-16470	678	19	fashion	fashion	NOUN
ihlr-16470	678	20	.	.	PUNCT
ihlr-16470	679	1	companies	company	NOUN
ihlr-16470	679	2	would	would	AUX
ihlr-16470	679	3	be	be	AUX
ihlr-16470	679	4	required	require	VERB
ihlr-16470	679	5	to	to	PART
ihlr-16470	679	6	register	register	VERB
ihlr-16470	679	7	their	their	PRON
ihlr-16470	679	8	anticipated	anticipate	VERB
ihlr-16470	679	9	trials	trial	NOUN
ihlr-16470	679	10	prior	prior	ADV
ihlr-16470	679	11	to	to	ADP
ihlr-16470	679	12	commencement	commencement	NOUN
ihlr-16470	679	13	,	,	PUNCT
ihlr-16470	679	14	provide	provide	VERB
ihlr-16470	679	15	an	an	DET
ihlr-16470	679	16	anticipated	anticipate	VERB
ihlr-16470	679	17	conclusion	conclusion	NOUN
ihlr-16470	679	18	date	date	NOUN
ihlr-16470	679	19	,	,	PUNCT
ihlr-16470	679	20	and	and	CCONJ
ihlr-16470	679	21	update	update	VERB
ihlr-16470	679	22	the	the	DET
ihlr-16470	679	23	registry	registry	NOUN
ihlr-16470	679	24	with	with	ADP
ihlr-16470	679	25	the	the	DET
ihlr-16470	679	26	results	result	NOUN
ihlr-16470	679	27	of	of	ADP
ihlr-16470	679	28	the	the	DET
ihlr-16470	679	29	trial	trial	NOUN
ihlr-16470	679	30	.	.	PUNCT
ihlr-16470	680	1	190	190	NUM
ihlr-16470	680	2	similarly	similarly	ADV
ihlr-16470	680	3	,	,	PUNCT
ihlr-16470	680	4	each	each	DET
ihlr-16470	680	5	bill	bill	NOUN
ihlr-16470	680	6	seeks	seek	VERB
ihlr-16470	680	7	to	to	PART
ihlr-16470	680	8	enforce	enforce	VERB
ihlr-16470	680	9	184	184	NUM
ihlr-16470	680	10	.	.	PUNCT
ihlr-16470	681	1	see	see	VERB
ihlr-16470	681	2	liebert	liebert	PROPN
ihlr-16470	681	3	,	,	PUNCT
ihlr-16470	681	4	supra	supra	PROPN
ihlr-16470	681	5	note	note	NOUN
ihlr-16470	681	6	9	9	NUM
ihlr-16470	681	7	(	(	PUNCT
ihlr-16470	681	8	mentioning	mention	VERB
ihlr-16470	681	9	the	the	DET
ihlr-16470	681	10	new	new	PROPN
ihlr-16470	681	11	england	england	PROPN
ihlr-16470	681	12	journal	journal	PROPN
ihlr-16470	681	13	ofmedicine	ofmedicine	PROPN
ihlr-16470	681	14	,	,	PUNCT
ihlr-16470	681	15	annals	annal	VERB
ihlr-16470	681	16	oflnternal	oflnternal	ADJ
ihlr-16470	681	17	medicine	medicine	NOUN
ihlr-16470	681	18	,	,	PUNCT
ihlr-16470	681	19	and	and	CCONJ
ihlr-16470	681	20	lancet	lancet	VERB
ihlr-16470	681	21	as	as	ADP
ihlr-16470	681	22	being	be	AUX
ihlr-16470	681	23	part	part	NOUN
ihlr-16470	681	24	of	of	ADP
ihlr-16470	681	25	the	the	DET
ihlr-16470	681	26	group	group	NOUN
ihlr-16470	681	27	.	.	PUNCT
ihlr-16470	681	28	)	)	PUNCT
ihlr-16470	682	1	185	185	NUM
ihlr-16470	682	2	.	.	PUNCT
ihlr-16470	683	1	newsday	newsday	NOUN
ihlr-16470	683	2	,	,	PUNCT
ihlr-16470	683	3	supra	supra	PROPN
ihlr-16470	683	4	note	note	PROPN
ihlr-16470	683	5	179	179	NUM
ihlr-16470	683	6	(	(	PUNCT
ihlr-16470	683	7	"	"	PUNCT
ihlr-16470	683	8	companies	company	NOUN
ihlr-16470	683	9	can	can	AUX
ihlr-16470	683	10	choose	choose	VERB
ihlr-16470	683	11	not	not	PART
ihlr-16470	683	12	to	to	PART
ihlr-16470	683	13	register	register	VERB
ihlr-16470	683	14	trials	trial	NOUN
ihlr-16470	683	15	,	,	PUNCT
ihlr-16470	683	16	but	but	CCONJ
ihlr-16470	683	17	that	that	PRON
ihlr-16470	683	18	would	would	AUX
ihlr-16470	683	19	mean	mean	VERB
ihlr-16470	683	20	forgoing	forgo	VERB
ihlr-16470	683	21	the	the	DET
ihlr-16470	683	22	marketing	marketing	NOUN
ihlr-16470	683	23	boost	boost	NOUN
ihlr-16470	683	24	of	of	ADP
ihlr-16470	683	25	journal	journal	ADJ
ihlr-16470	683	26	publicity	publicity	NOUN
ihlr-16470	683	27	.	.	PUNCT
ihlr-16470	683	28	"	"	PUNCT
ihlr-16470	683	29	)	)	PUNCT
ihlr-16470	683	30	.	.	PUNCT
ihlr-16470	684	1	186	186	NUM
ihlr-16470	684	2	.	.	PUNCT
ihlr-16470	685	1	see	see	VERB
ihlr-16470	685	2	bjerldie	bjerldie	PROPN
ihlr-16470	685	3	,	,	PUNCT
ihlr-16470	685	4	supra	supra	PROPN
ihlr-16470	685	5	note	note	VERB
ihlr-16470	685	6	1	1	NUM
ihlr-16470	685	7	55	55	NUM
ihlr-16470	685	8	(	(	PUNCT
ihlr-16470	685	9	"	"	PUNCT
ihlr-16470	685	10	a	a	DET
ihlr-16470	685	11	registry	registry	NOUN
ihlr-16470	685	12	wo	will	AUX
ihlr-16470	685	13	n't	not	PART
ihlr-16470	685	14	mean	mean	VERB
ihlr-16470	685	15	that	that	SCONJ
ihlr-16470	685	16	every	every	DET
ihlr-16470	685	17	failed	fail	VERB
ihlr-16470	685	18	trial	trial	NOUN
ihlr-16470	685	19	will	will	AUX
ihlr-16470	685	20	be	be	AUX
ihlr-16470	685	21	published	publish	VERB
ihlr-16470	685	22	,	,	PUNCT
ihlr-16470	685	23	but	but	CCONJ
ihlr-16470	685	24	it	it	PRON
ihlr-16470	685	25	will	will	AUX
ihlr-16470	685	26	make	make	VERB
ihlr-16470	685	27	it	it	PRON
ihlr-16470	685	28	clear	clear	ADJ
ihlr-16470	685	29	that	that	SCONJ
ihlr-16470	685	30	those	those	PRON
ihlr-16470	685	31	trials.took	trials.took	ADP
ihlr-16470	685	32	place	place	NOUN
ihlr-16470	685	33	.	.	PUNCT
ihlr-16470	685	34	"	"	PUNCT
ihlr-16470	685	35	)	)	PUNCT
ihlr-16470	685	36	.	.	PUNCT
ihlr-16470	686	1	187	187	NUM
ihlr-16470	686	2	.	.	PUNCT
ihlr-16470	687	1	inside	inside	ADP
ihlr-16470	687	2	the	the	DET
ihlr-16470	687	3	industry	industry	NOUN
ihlr-16470	687	4	medical	medical	ADJ
ihlr-16470	687	5	journals	journal	NOUN
ihlr-16470	687	6	:	:	PUNCT
ihlr-16470	687	7	editors	editor	NOUN
ihlr-16470	687	8	to	to	PART
ihlr-16470	687	9	publish	publish	VERB
ihlr-16470	687	10	only	only	ADV
ihlr-16470	687	11	registered	register	VERB
ihlr-16470	687	12	trials	trial	NOUN
ihlr-16470	687	13	,	,	PUNCT
ihlr-16470	687	14	am	be	AUX
ihlr-16470	687	15	.	.	PUNCT
ihlr-16470	688	1	pol	pol	PROPN
ihlr-16470	688	2	.	.	PUNCT
ihlr-16470	689	1	network	network	NOUN
ihlr-16470	689	2	-	-	PUNCT
ihlr-16470	689	3	am	am	NOUN
ihlr-16470	689	4	.	.	PUNCT
ihlr-16470	690	1	heallll	heallll	ADJ
ihlr-16470	690	2	line	line	NOUN
ihlr-16470	690	3	,	,	PUNCT
ihlr-16470	690	4	vol	vol	NOUN
ihlr-16470	690	5	.	.	PROPN
ihlr-16470	691	1	10	10	NUM
ihlr-16470	691	2	no	no	NOUN
ihlr-16470	691	3	.	.	NOUN
ihlr-16470	691	4	9	9	NUM
ihlr-16470	691	5	,	,	PUNCT
ihlr-16470	691	6	sept	sept	PROPN
ihlr-16470	691	7	.	.	PROPN
ihlr-16470	691	8	9	9	NUM
ihlr-16470	691	9	,	,	PUNCT
ihlr-16470	691	10	2004	2004	NUM
ihlr-16470	691	11	.	.	PUNCT
ihlr-16470	692	1	188	188	NUM
ihlr-16470	692	2	.	.	PUNCT
ihlr-16470	692	3	christopher	christopher	PROPN
ihlr-16470	692	4	rowland	rowland	PROPN
ihlr-16470	692	5	,	,	PUNCT
ihlr-16470	692	6	bill	bill	NOUN
ihlr-16470	692	7	to	to	PART
ihlr-16470	692	8	seek	seek	VERB
ihlr-16470	692	9	posting	post	VERB
ihlr-16470	692	10	results	result	NOUN
ihlr-16470	692	11	of	of	ADP
ihlr-16470	692	12	drug	drug	NOUN
ihlr-16470	692	13	trials	trial	NOUN
ihlr-16470	692	14	,	,	PUNCT
ihlr-16470	692	15	under	under	ADP
ihlr-16470	692	16	plan	plan	NOUN
ihlr-16470	692	17	,	,	PUNCT
ihlr-16470	692	18	fda	fda	PROPN
ihlr-16470	692	19	could	could	AUX
ihlr-16470	692	20	fine	fine	ADJ
ihlr-16470	692	21	firms	firm	NOUN
ihlr-16470	692	22	that	that	PRON
ihlr-16470	692	23	fail	fail	VERB
ihlr-16470	692	24	to	to	PART
ihlr-16470	692	25	comply	comply	VERB
ihlr-16470	692	26	,	,	PUNCT
ihlr-16470	692	27	boston	boston	PROPN
ihlr-16470	692	28	globe	globe	PROPN
ihlr-16470	692	29	,	,	PUNCT
ihlr-16470	692	30	sept	sept	PROPN
ihlr-16470	692	31	.	.	PROPN
ihlr-16470	692	32	9	9	NUM
ihlr-16470	692	33	,	,	PUNCT
ihlr-16470	692	34	2004	2004	NUM
ihlr-16470	692	35	,	,	PUNCT
ihlr-16470	692	36	at	at	ADP
ihlr-16470	692	37	dl	dl	PROPN
ihlr-16470	692	38	;	;	PUNCT
ihlr-16470	692	39	fair	fair	ADJ
ihlr-16470	692	40	access	access	NOUN
ihlr-16470	692	41	to	to	ADP
ihlr-16470	692	42	clinical	clinical	ADJ
ihlr-16470	692	43	trials	trial	NOUN
ihlr-16470	692	44	act	act	NOUN
ihlr-16470	692	45	of2004	of2004	PROPN
ihlr-16470	692	46	,	,	PUNCT
ihlr-16470	692	47	s.	s.	PROPN
ihlr-16470	692	48	2933	2933	NUM
ihlr-16470	692	49	,	,	PUNCT
ihlr-16470	692	50	i08th	i08th	NOUN
ihlr-16470	692	51	cong	cong	NOUN
ihlr-16470	692	52	.	.	PUNCT
ihlr-16470	692	53	(	(	PUNCT
ihlr-16470	692	54	2004	2004	NUM
ihlr-16470	692	55	)	)	PUNCT
ihlr-16470	692	56	;	;	PUNCT
ihlr-16470	692	57	fair	fair	ADJ
ihlr-16470	692	58	access	access	NOUN
ihlr-16470	692	59	to	to	ADP
ihlr-16470	692	60	clinical	clinical	ADJ
ihlr-16470	692	61	trials	trial	NOUN
ihlr-16470	692	62	act	act	PROPN
ihlr-16470	692	63	,	,	PUNCT
ihlr-16470	692	64	h.r	h.r	PROPN
ihlr-16470	692	65	.	.	PROPN
ihlr-16470	692	66	5252	5252	NUM
ihlr-16470	692	67	,	,	PUNCT
ihlr-16470	692	68	i	i	PROPN
ihlr-16470	692	69	08th	08th	NOUN
ihlr-16470	692	70	cong	cong	PROPN
ihlr-16470	692	71	.	.	PUNCT
ihlr-16470	693	1	(	(	PUNCT
ihlr-16470	693	2	2004	2004	NUM
ihlr-16470	693	3	)	)	PUNCT
ihlr-16470	693	4	.	.	PUNCT
ihlr-16470	694	1	189	189	NUM
ihlr-16470	694	2	.	.	PUNCT
ihlr-16470	695	1	s.	s.	PROPN
ihlr-16470	695	2	2933	2933	NUM
ihlr-16470	695	3	.	.	PUNCT
ihlr-16470	695	4	190	190	NUM
ihlr-16470	695	5	.	.	PUNCT
ihlr-16470	696	1	in	in	ADP
ihlr-16470	696	2	general	general	ADJ
ihlr-16470	696	3	(	(	PUNCT
ihlr-16470	696	4	i	i	NOUN
ihlr-16470	696	5	)	)	PUNCT
ihlr-16470	696	6	conditions	condition	NOUN
ihlr-16470	696	7	for	for	ADP
ihlr-16470	696	8	financial	financial	ADJ
ihlr-16470	696	9	awards	award	NOUN
ihlr-16470	696	10	.	.	PUNCT
ihlr-16470	697	1	e	e	X
ihlr-16470	697	2	~	~	NOUN
ihlr-16470	697	3	cept	cept	NOUN
ihlr-16470	697	4	as	as	SCONJ
ihlr-16470	697	5	provided	provide	VERB
ihlr-16470	697	6	in	in	ADP
ihlr-16470	697	7	paragraph	paragraph	NOUN
ihlr-16470	697	8	(	(	PUNCT
ihlr-16470	697	9	2	2	NUM
ihlr-16470	697	10	)	)	PUNCT
ihlr-16470	697	11	,	,	PUNCT
ihlr-16470	697	12	an	an	DET
ihlr-16470	697	13	entity	entity	NOUN
ihlr-16470	697	14	may	may	AUX
ihlr-16470	697	15	not	not	PART
ihlr-16470	697	16	receive	receive	VERB
ihlr-16470	697	17	an	an	DET
ihlr-16470	697	18	award	award	NOUN
ihlr-16470	697	19	of	of	ADP
ihlr-16470	697	20	a	a	DET
ihlr-16470	697	21	grant	grant	NOUN
ihlr-16470	697	22	,	,	PUNCT
ihlr-16470	697	23	contract	contract	NOUN
ihlr-16470	697	24	,	,	PUNCT
ihlr-16470	697	25	or	or	CCONJ
ihlr-16470	697	26	cooperative	cooperative	ADJ
ihlr-16470	697	27	agreement	agreement	NOUN
ihlr-16470	697	28	under	under	ADP
ihlr-16470	697	29	this	this	DET
ihlr-16470	697	30	act	act	NOUN
ihlr-16470	697	31	for	for	ADP
ihlr-16470	697	32	the	the	DET
ihlr-16470	697	33	conduct	conduct	NOUN
ihlr-16470	697	34	of	of	ADP
ihlr-16470	697	35	a	a	DET
ihlr-16470	697	36	clinical	clinical	ADJ
ihlr-16470	697	37	trial	trial	NOUN
ihlr-16470	697	38	to	to	PART
ihlr-16470	697	39	detennine	detennine	VERB
ihlr-16470	697	40	the	the	DET
ihlr-16470	697	41	safety	safety	NOUN
ihlr-16470	697	42	or	or	CCONJ
ihlr-16470	697	43	effectiveness	effectiveness	NOUN
ihlr-16470	697	44	of	of	ADP
ihlr-16470	697	45	a	a	DET
ihlr-16470	697	46	use	use	NOUN
ihlr-16470	697	47	of	of	ADP
ihlr-16470	697	48	a	a	DET
ihlr-16470	697	49	drug	drug	NOUN
ihlr-16470	697	50	or	or	CCONJ
ihlr-16470	697	51	device	device	NOUN
ihlr-16470	697	52	(	(	PUNCT
ihlr-16470	697	53	referred	refer	VERB
ihlr-16470	697	54	to	to	ADP
ihlr-16470	697	55	in	in	ADP
ihlr-16470	697	56	this	this	DET
ihlr-16470	697	57	section	section	NOUN
ihlr-16470	697	58	as	as	ADP
ihlr-16470	697	59	a	a	DET
ihlr-16470	697	60	'	'	PUNCT
ihlr-16470	697	61	product	product	NOUN
ihlr-16470	697	62	'	'	PUNCT
ihlr-16470	697	63	)	)	PUNCT
ihlr-16470	697	64	unless	unless	SCONJ
ihlr-16470	697	65	the	the	DET
ihlr-16470	697	66	responsible	responsible	ADJ
ihlr-16470	697	67	person	person	NOUN
ihlr-16470	697	68	for	for	ADP
ihlr-16470	697	69	the	the	DET
ihlr-16470	697	70	trial228	trial228	PROPN
ihlr-16470	697	71	indiana	indiana	PROPN
ihlr-16470	697	72	heal1h	heal1h	PROPN
ihlr-16470	697	73	law	law	NOUN
ihlr-16470	697	74	review	review	NOUN
ihlr-16470	697	75	[	[	X
ihlr-16470	697	76	vol	vol	NOUN
ihlr-16470	697	77	.	.	PUNCT
ihlr-16470	698	1	3:201	3:201	NUM
ihlr-16470	698	2	the	the	DET
ihlr-16470	698	3	registry	registry	NOUN
ihlr-16470	698	4	provisions	provision	NOUN
ihlr-16470	698	5	through	through	ADP
ihlr-16470	698	6	a	a	DET
ihlr-16470	698	7	combination	combination	NOUN
ihlr-16470	698	8	of	of	ADP
ihlr-16470	698	9	denying	deny	VERB
ihlr-16470	698	10	federal	federal	ADJ
ihlr-16470	698	11	funding	funding	NOUN
ihlr-16470	698	12	and	and	CCONJ
ihlr-16470	698	13	imposing	impose	VERB
ihlr-16470	698	14	heavy	heavy	ADJ
ihlr-16470	698	15	fines	fine	NOUN
ihlr-16470	698	16	.	.	PUNCT
ihlr-16470	699	1	191	191	NUM
ihlr-16470	699	2	each	each	PRON
ihlr-16470	699	3	of	of	ADP
ihlr-16470	699	4	these	these	DET
ihlr-16470	699	5	bills	bill	NOUN
ihlr-16470	699	6	would	would	AUX
ihlr-16470	699	7	be	be	AUX
ihlr-16470	699	8	a	a	DET
ihlr-16470	699	9	terrific	terrific	ADJ
ihlr-16470	699	10	tool	tool	NOUN
ihlr-16470	699	11	in	in	ADP
ihlr-16470	699	12	protecting	protect	VERB
ihlr-16470	699	13	consumers	consumer	NOUN
ihlr-16470	699	14	,	,	PUNCT
ihlr-16470	699	15	but	but	CCONJ
ihlr-16470	699	16	neither	neither	PRON
ihlr-16470	699	17	successfully	successfully	ADV
ihlr-16470	699	18	passed	pass	VERB
ihlr-16470	699	19	through	through	ADP
ihlr-16470	699	20	committee	committee	NOUN
ihlr-16470	699	21	.	.	PUNCT
ihlr-16470	700	1	despite	despite	SCONJ
ihlr-16470	700	2	not	not	PART
ihlr-16470	700	3	overcoming	overcome	VERB
ihlr-16470	700	4	this	this	DET
ihlr-16470	700	5	hurdle	hurdle	NOUN
ihlr-16470	700	6	,	,	PUNCT
ihlr-16470	700	7	these	these	DET
ihlr-16470	700	8	bills	bill	NOUN
ihlr-16470	700	9	still	still	ADV
ihlr-16470	700	10	provide	provide	VERB
ihlr-16470	700	11	a	a	DET
ihlr-16470	700	12	framework	framework	NOUN
ihlr-16470	700	13	for	for	ADP
ihlr-16470	700	14	how	how	SCONJ
ihlr-16470	700	15	congress	congress	PROPN
ihlr-16470	700	16	may	may	AUX
ihlr-16470	700	17	deal	deal	VERB
ihlr-16470	700	18	with	with	ADP
ihlr-16470	700	19	this	this	DET
ihlr-16470	700	20	issue	issue	NOUN
ihlr-16470	700	21	in	in	ADP
ihlr-16470	700	22	the	the	DET
ihlr-16470	700	23	future	future	NOUN
ihlr-16470	700	24	.	.	PUNCT
ihlr-16470	701	1	the	the	DET
ihlr-16470	701	2	current	current	ADJ
ihlr-16470	701	3	legislative	legislative	ADJ
ihlr-16470	701	4	session	session	NOUN
ihlr-16470	701	5	may	may	AUX
ihlr-16470	701	6	see	see	VERB
ihlr-16470	701	7	similar	similar	ADJ
ihlr-16470	701	8	legislation	legislation	NOUN
ihlr-16470	701	9	introduced	introduce	VERB
ihlr-16470	701	10	.	.	PUNCT
ihlr-16470	702	1	(	(	PUNCT
ihlr-16470	702	2	a	a	X
ihlr-16470	702	3	)	)	PUNCT
ihlr-16470	702	4	agrees	agree	VERB
ihlr-16470	702	5	to	to	PART
ihlr-16470	702	6	register	register	VERB
ihlr-16470	702	7	the	the	DET
ihlr-16470	702	8	trial	trial	NOUN
ihlr-16470	702	9	with	with	ADP
ihlr-16470	702	10	the	the	DET
ihlr-16470	702	11	secretary	secretary	NOUN
ihlr-16470	702	12	in	in	ADP
ihlr-16470	702	13	accordance	accordance	NOUN
ihlr-16470	702	14	with	with	ADP
ihlr-16470	702	15	subsection	subsection	NOUN
ihlr-16470	702	16	(	(	PUNCT
ihlr-16470	702	17	dx1	dx1	PROPN
ihlr-16470	702	18	)	)	PUNCT
ihlr-16470	702	19	;	;	PUNCT
ihlr-16470	702	20	(	(	PUNCT
ihlr-16470	702	21	b	b	X
ihlr-16470	702	22	)	)	PUNCT
ihlr-16470	702	23	agrees	agree	VERB
ihlr-16470	702	24	to	to	PART
ihlr-16470	702	25	provide	provide	VERB
ihlr-16470	702	26	to	to	ADP
ihlr-16470	702	27	the	the	DET
ihlr-16470	702	28	secretary	secretary	NOUN
ihlr-16470	702	29	information	information	NOUN
ihlr-16470	702	30	on	on	ADP
ihlr-16470	702	31	the	the	DET
ihlr-16470	702	32	results	result	NOUN
ihlr-16470	702	33	of	of	ADP
ihlr-16470	702	34	the	the	DET
ihlr-16470	702	35	trial	trial	NOUN
ihlr-16470	702	36	in	in	ADP
ihlr-16470	702	37	accordance	accordance	NOUN
ihlr-16470	702	38	with	with	ADP
ihlr-16470	702	39	subsection	subsection	NOUN
ihlr-16470	702	40	(	(	PUNCT
ihlr-16470	702	41	dx2	dx2	PROPN
ihlr-16470	702	42	)	)	PUNCT
ihlr-16470	702	43	;	;	PUNCT
ihlr-16470	702	44	(	(	PUNCT
ihlr-16470	702	45	c	c	X
ihlr-16470	702	46	)	)	PUNCT
ihlr-16470	702	47	agrees	agree	VERB
ihlr-16470	702	48	to	to	ADP
ihlr-16470	702	49	the	the	DET
ihlr-16470	702	50	disclosme	disclosme	NOUN
ihlr-16470	702	51	to	to	ADP
ihlr-16470	702	52	the	the	DET
ihlr-16470	702	53	public	public	NOUN
ihlr-16470	702	54	of	of	ADP
ihlr-16470	702	55	information	information	NOUN
ihlr-16470	702	56	regarding	regard	VERB
ihlr-16470	702	57	the	the	DET
ihlr-16470	702	58	trial	trial	NOUN
ihlr-16470	702	59	...	...	PUNCT
ihlr-16470	703	1	h.r	h.r	PROPN
ihlr-16470	703	2	.	.	PROPN
ihlr-16470	703	3	5252	5252	NUM
ihlr-16470	703	4	.	.	PUNCT
ihlr-16470	704	1	3	3	X
ihlr-16470	704	2	)	)	PUNCT
ihlr-16470	704	3	the	the	DET
ihlr-16470	704	4	data	data	NOUN
ihlr-16470	704	5	bank	bank	PROPN
ihlr-16470	704	6	shall	shall	AUX
ihlr-16470	704	7	include	include	VERB
ihlr-16470	704	8	a	a	DET
ihlr-16470	704	9	registry	registry	NOUN
ihlr-16470	704	10	of	of	ADP
ihlr-16470	704	11	clinical	clinical	ADJ
ihlr-16470	704	12	trials	trial	NOUN
ihlr-16470	704	13	(	(	PUNCT
ihlr-16470	704	14	whether	whether	SCONJ
ihlr-16470	704	15	federally	federally	ADV
ihlr-16470	704	16	or	or	CCONJ
ihlr-16470	704	17	privately	privately	ADV
ihlr-16470	704	18	funded	fund	VERB
ihlr-16470	704	19	)	)	PUNCT
ihlr-16470	704	20	in	in	ADP
ihlr-16470	704	21	accordance	accordance	NOUN
ihlr-16470	704	22	with	with	ADP
ihlr-16470	704	23	the	the	DET
ihlr-16470	704	24	following	following	NOUN
ihlr-16470	704	25	:	:	PUNCT
ihlr-16470	704	26	(	(	PUNCT
ihlr-16470	704	27	a	a	X
ihlr-16470	704	28	)	)	PUNCT
ihlr-16470	704	29	the	the	DET
ihlr-16470	704	30	registry	registry	NOUN
ihlr-16470	704	31	shall	shall	AUX
ihlr-16470	704	32	include	include	VERB
ihlr-16470	704	33	the	the	DET
ihlr-16470	704	34	information	information	NOUN
ihlr-16470	704	35	required	require	VERB
ihlr-16470	704	36	under	under	ADP
ihlr-16470	704	37	subparagraph	subparagraph	NOUN
ihlr-16470	704	38	(	(	PUNCT
ihlr-16470	704	39	b	b	NOUN
ihlr-16470	704	40	)	)	PUNCT
ihlr-16470	704	41	for	for	ADP
ihlr-16470	704	42	all	all	DET
ihlr-16470	704	43	clinical	clinical	ADJ
ihlr-16470	704	44	trials	trial	NOUN
ihlr-16470	704	45	conducted	conduct	VERB
ihlr-16470	704	46	to	to	PART
ihlr-16470	704	47	test	test	VERB
ihlr-16470	704	48	the	the	DET
ihlr-16470	704	49	safety	safety	NOUN
ihlr-16470	704	50	or	or	CCONJ
ihlr-16470	704	51	effectiveness	effectiveness	NOUN
ihlr-16470	704	52	(	(	PUNCT
ihlr-16470	704	53	including	include	VERB
ihlr-16470	704	54	comparative	comparative	ADJ
ihlr-16470	704	55	effectiveness	effectiveness	NOUN
ihlr-16470	704	56	)	)	PUNCT
ihlr-16470	704	57	of	of	ADP
ihlr-16470	704	58	any	any	DET
ihlr-16470	704	59	drug	drug	NOUN
ihlr-16470	704	60	,	,	PUNCT
ihlr-16470	704	61	biological	biological	ADJ
ihlr-16470	704	62	product	product	NOUN
ihlr-16470	704	63	.	.	PUNCT
ihlr-16470	705	1	or	or	CCONJ
ihlr-16470	705	2	device	device	NOUN
ihlr-16470	705	3	(	(	PUNCT
ihlr-16470	705	4	including	include	VERB
ihlr-16470	705	5	those	those	DET
ihlr-16470	705	6	drugs	drug	NOUN
ihlr-16470	705	7	,	,	PUNCT
ihlr-16470	705	8	biological	biological	ADJ
ihlr-16470	705	9	products	product	NOUN
ihlr-16470	705	10	,	,	PUNCT
ihlr-16470	705	11	or	or	CCONJ
ihlr-16470	705	12	devices	device	NOUN
ihlr-16470	705	13	approved	approve	VERB
ihlr-16470	705	14	or	or	CCONJ
ihlr-16470	705	15	cleared	clear	VERB
ihlr-16470	705	16	by	by	ADP
ihlr-16470	705	17	the	the	DET
ihlr-16470	705	18	secretary	secretary	NOUN
ihlr-16470	705	19	)	)	PUNCT
ihlr-16470	705	20	,	,	PUNCT
ihlr-16470	705	21	except	except	SCONJ
ihlr-16470	705	22	those	those	DET
ihlr-16470	705	23	phase	phase	NOUN
ihlr-16470	705	24	i	i	PRON
ihlr-16470	705	25	clinical	clinical	ADJ
ihlr-16470	705	26	trials	trial	NOUN
ihlr-16470	705	27	conducted	conduct	VERB
ihlr-16470	705	28	to	to	PART
ihlr-16470	705	29	test	test	VERB
ihlr-16470	705	30	solely	solely	ADV
ihlr-16470	705	31	the	the	DET
ihlr-16470	705	32	safety	safety	NOUN
ihlr-16470	705	33	of	of	ADP
ihlr-16470	705	34	an	an	DET
ihlr-16470	705	35	unapproved	unapproved	ADJ
ihlr-16470	705	36	drug	drug	NOUN
ihlr-16470	705	37	or	or	CCONJ
ihlr-16470	705	38	unlicensed	unlicensed	ADJ
ihlr-16470	705	39	biological	biological	ADJ
ihlr-16470	705	40	product	product	NOUN
ihlr-16470	705	41	.	.	PUNCT
ihlr-16470	706	1	the	the	DET
ihlr-16470	706	2	registry	registry	NOUN
ihlr-16470	706	3	may	may	AUX
ihlr-16470	706	4	include	include	VERB
ihlr-16470	706	5	phase	phase	NOUN
ihlr-16470	706	6	i	i	PRON
ihlr-16470	706	7	clinical	clinical	ADJ
ihlr-16470	706	8	trials	trial	NOUN
ihlr-16470	706	9	conducted	conduct	VERB
ihlr-16470	706	10	to	to	PART
ihlr-16470	706	11	test	test	VERB
ihlr-16470	706	12	solely	solely	ADV
ihlr-16470	706	13	the	the	DET
ihlr-16470	706	14	safety	safety	NOUN
ihlr-16470	706	15	of	of	ADP
ihlr-16470	706	16	an	an	DET
ihlr-16470	706	17	unapproved	unapproved	ADJ
ihlr-16470	706	18	drug	drug	NOUN
ihlr-16470	706	19	or	or	CCONJ
ihlr-16470	706	20	unlicensed	unlicensed	ADJ
ihlr-16470	706	21	biological	biological	ADJ
ihlr-16470	706	22	product	product	NOUN
ihlr-16470	706	23	with	with	ADP
ihlr-16470	706	24	the	the	DET
ihlr-16470	706	25	consent	consent	NOUN
ihlr-16470	706	26	of	of	ADP
ihlr-16470	706	27	the	the	DET
ihlr-16470	706	28	responsible	responsible	ADJ
ihlr-16470	706	29	~	~	PROPN
ihlr-16470	706	30	·	·	PUNCT
ihlr-16470	706	31	for	for	ADP
ihlr-16470	706	32	pwposes	pwpose	NOUN
ihlr-16470	706	33	of	of	ADP
ihlr-16470	706	34	tbis	tbis	ADJ
ihlr-16470	706	35	subparagraph	subparagraph	NOUN
ihlr-16470	706	36	,	,	PUNCT
ihlr-16470	706	37	phase	phase	NOUN
ihlr-16470	706	38	i	i	PRON
ihlr-16470	706	39	clinical	clinical	ADJ
ihlr-16470	706	40	trials	trial	NOUN
ihlr-16470	706	41	are	be	AUX
ihlr-16470	706	42	trials	trial	NOUN
ihlr-16470	706	43	described	describe	VERB
ihlr-16470	706	44	in	in	ADP
ihlr-16470	706	45	section	section	NOUN
ihlr-16470	706	46	313.12(a	313.12(a	NUM
ihlr-16470	706	47	)	)	PUNCT
ihlr-16470	706	48	of	of	ADP
ihlr-16470	706	49	title	title	NOUN
ihlr-16470	706	50	21	21	NUM
ihlr-16470	706	51	,	,	PUNCT
ihlr-16470	706	52	code	code	NOUN
ihlr-16470	706	53	of	of	ADP
ihlr-16470	706	54	federal	federal	ADJ
ihlr-16470	706	55	regulations	regulation	NOUN
ihlr-16470	706	56	(	(	PUNCT
ihlr-16470	706	57	or	or	CCONJ
ihlr-16470	706	58	any	any	DET
ihlr-16470	706	59	successor	successor	NOUN
ihlr-16470	706	60	regulations	regulation	NOUN
ihlr-16470	706	61	)	)	PUNCT
ihlr-16470	706	62	.	.	PUNCT
ihlr-16470	707	1	(	(	PUNCT
ihlr-16470	707	2	b	b	X
ihlr-16470	707	3	)	)	PUNCT
ihlr-16470	707	4	the	the	DET
ihlr-16470	707	5	information	information	NOUN
ihlr-16470	707	6	required	require	VERB
ihlr-16470	707	7	under	under	ADP
ihlr-16470	707	8	this	this	DET
ihlr-16470	707	9	subparagraph	subparagraph	NOUN
ihlr-16470	707	10	with	with	ADP
ihlr-16470	707	11	respect	respect	NOUN
ihlr-16470	707	12	to	to	ADP
ihlr-16470	707	13	the	the	DET
ihlr-16470	707	14	clinical	clinical	ADJ
ihlr-16470	707	15	trial	trial	NOUN
ihlr-16470	707	16	involved	involve	VERB
ihlr-16470	707	17	includes	include	VERB
ihlr-16470	707	18	the	the	DET
ihlr-16470	707	19	following	following	NOUN
ihlr-16470	707	20	:	:	PUNCT
ihlr-16470	707	21	(	(	PUNCT
ihlr-16470	707	22	i	i	NOUN
ihlr-16470	707	23	)	)	PUNCT
ihlr-16470	707	24	a	a	DET
ihlr-16470	707	25	description	description	NOUN
ihlr-16470	707	26	of	of	ADP
ihlr-16470	707	27	the	the	DET
ihlr-16470	707	28	purpose	purpose	NOUN
ihlr-16470	707	29	of	of	ADP
ihlr-16470	707	30	the	the	DET
ihlr-16470	707	31	clinical	clinical	ADJ
ihlr-16470	707	32	trial	trial	NOUN
ihlr-16470	707	33	,	,	PUNCT
ihlr-16470	707	34	including	include	VERB
ihlr-16470	707	35	the	the	DET
ihlr-16470	707	36	drug	drug	NOUN
ihlr-16470	707	37	,	,	PUNCT
ihlr-16470	707	38	biological	biological	ADJ
ihlr-16470	707	39	product	product	NOUN
ihlr-16470	707	40	.	.	PUNCT
ihlr-16470	708	1	or	or	CCONJ
ihlr-16470	708	2	device	device	NOUN
ihlr-16470	708	3	to	to	PART
ihlr-16470	708	4	be	be	AUX
ihlr-16470	708	5	tested	test	VERB
ihlr-16470	708	6	.	.	PUNCT
ihlr-16470	709	1	(	(	PUNCT
ihlr-16470	709	2	ii	ii	X
ihlr-16470	709	3	)	)	PUNCT
ihlr-16470	709	4	the	the	DET
ihlr-16470	709	5	eligibility	eligibility	NOUN
ihlr-16470	709	6	criteria	criterion	NOUN
ihlr-16470	709	7	for	for	ADP
ihlr-16470	709	8	participation	participation	NOUN
ihlr-16470	709	9	in	in	ADP
ihlr-16470	709	10	the	the	DET
ihlr-16470	709	11	clinical	clinical	ADJ
ihlr-16470	709	12	trial	trial	NOUN
ihlr-16470	709	13	.	.	PUNCT
ihlr-16470	710	1	(	(	PUNCT
ihlr-16470	710	2	iii	iii	X
ihlr-16470	710	3	)	)	PUNCT
ihlr-16470	710	4	a	a	DET
ihlr-16470	710	5	description	description	NOUN
ihlr-16470	710	6	of	of	ADP
ihlr-16470	710	7	the	the	DET
ihlr-16470	710	8	location	location	NOUN
ihlr-16470	710	9	of	of	ADP
ihlr-16470	710	10	trial	trial	NOUN
ihlr-16470	710	11	sites	site	NOUN
ihlr-16470	710	12	and	and	CCONJ
ihlr-16470	710	13	the	the	DET
ihlr-16470	710	14	start	start	NOUN
ihlr-16470	710	15	date	date	NOUN
ihlr-16470	710	16	of	of	ADP
ihlr-16470	710	17	the	the	DET
ihlr-16470	710	18	trial	trial	NOUN
ihlr-16470	710	19	.	.	PUNCT
ihlr-16470	711	1	(	(	PUNCT
ihlr-16470	711	2	iv	iv	X
ihlr-16470	711	3	)	)	PUNCT
ihlr-16470	711	4	a	a	DET
ihlr-16470	711	5	point	point	NOUN
ihlr-16470	711	6	of	of	ADP
ihlr-16470	711	7	contact	contact	NOUN
ihlr-16470	711	8	for	for	ADP
ihlr-16470	711	9	those	those	PRON
ihlr-16470	711	10	wanting	want	VERB
ihlr-16470	711	11	to	to	PART
ihlr-16470	711	12	enroll	enroll	VERB
ihlr-16470	711	13	in	in	ADP
ihlr-16470	711	14	the	the	DET
ihlr-16470	711	15	trial	trial	NOUN
ihlr-16470	711	16	,	,	PUNCT
ihlr-16470	711	17	including	include	VERB
ihlr-16470	711	18	the	the	DET
ihlr-16470	711	19	identity	identity	NOUN
ihlr-16470	711	20	of	of	ADP
ihlr-16470	711	21	the	the	DET
ihlr-16470	711	22	responsible	responsible	ADJ
ihlr-16470	711	23	person	person	NOUN
ihlr-16470	711	24	.	.	PUNCT
ihlr-16470	712	1	(	(	PUNCT
ihlr-16470	712	2	v	v	X
ihlr-16470	712	3	)	)	PUNCT
ihlr-16470	712	4	the	the	DET
ihlr-16470	712	5	funding	funding	NOUN
ihlr-16470	712	6	source	source	NOUN
ihlr-16470	712	7	or	or	CCONJ
ihlr-16470	712	8	sources	source	NOUN
ihlr-16470	712	9	of	of	ADP
ihlr-16470	712	10	the	the	DET
ihlr-16470	712	11	trial	trial	NOUN
ihlr-16470	712	12	.	.	PUNCT
ihlr-16470	713	1	(	(	PUNCT
ihlr-16470	713	2	vi	vi	X
ihlr-16470	713	3	)	)	PUNCT
ihlr-16470	713	4	the	the	DET
ihlr-16470	713	5	estimated	estimate	VERB
ihlr-16470	713	6	completion	completion	NOUN
ihlr-16470	713	7	date	date	NOUN
ihlr-16470	713	8	for	for	ADP
ihlr-16470	713	9	the	the	DET
ihlr-16470	713	10	trial	trial	NOUN
ihlr-16470	713	11	.	.	PUNCT
ihlr-16470	714	1	for	for	ADP
ihlr-16470	714	2	purposes	purpose	NOUN
ihlr-16470	714	3	of	of	ADP
ihlr-16470	714	4	this	this	DET
ihlr-16470	714	5	section	section	NOUN
ihlr-16470	714	6	,	,	PUNCT
ihlr-16470	714	7	the	the	DET
ihlr-16470	714	8	term	term	NOUN
ihlr-16470	714	9	'	'	PUNCT
ihlr-16470	714	10	completion	completion	NOUN
ihlr-16470	714	11	date	date	NOUN
ihlr-16470	714	12	'	'	PUNCT
ihlr-16470	714	13	means	mean	VERB
ihlr-16470	714	14	the	the	DET
ihlr-16470	714	15	date	date	NOUN
ihlr-16470	714	16	of	of	ADP
ihlr-16470	714	17	the	the	DET
ihlr-16470	714	18	final	final	ADJ
ihlr-16470	714	19	collection	collection	NOUN
ihlr-16470	714	20	of	of	ADP
ihlr-16470	714	21	data	datum	NOUN
ihlr-16470	714	22	from	from	ADP
ihlr-16470	714	23	subjects	subject	NOUN
ihlr-16470	714	24	in	in	ADP
ihlr-16470	714	25	the	the	DET
ihlr-16470	714	26	1rial	1rial	NUM
ihlr-16470	714	27	for	for	ADP
ihlr-16470	714	28	the	the	DET
ihlr-16470	714	29	outcomes	outcome	NOUN
ihlr-16470	714	30	described	describe	VERB
ihlr-16470	714	31	in	in	ADP
ihlr-16470	714	32	clause	clause	NOUN
ihlr-16470	714	33	(	(	PUNCT
ihlr-16470	714	34	vii	vii	PROPN
ihlr-16470	714	35	)	)	PUNCT
ihlr-16470	714	36	.	.	PUNCT
ihlr-16470	715	1	(	(	PUNCT
ihlr-16470	715	2	vii	vii	PROPN
ihlr-16470	715	3	)	)	PUNCT
ihlr-16470	715	4	a	a	DET
ihlr-16470	715	5	description	description	NOUN
ihlr-16470	715	6	of	of	ADP
ihlr-16470	715	7	the	the	DET
ihlr-16470	715	8	primary	primary	ADJ
ihlr-16470	715	9	and	and	CCONJ
ihlr-16470	715	10	secondary	secondary	ADJ
ihlr-16470	715	11	clinical	clinical	ADJ
ihlr-16470	715	12	outcomes	outcome	NOUN
ihlr-16470	715	13	to	to	PART
ihlr-16470	715	14	be	be	AUX
ihlr-16470	715	15	examined	examine	VERB
ihlr-16470	715	16	in	in	ADP
ihlr-16470	715	17	the	the	DET
ihlr-16470	715	18	trial	trial	NOUN
ihlr-16470	715	19	,	,	PUNCT
ihlr-16470	715	20	the	the	DET
ihlr-16470	715	21	time	time	NOUN
ihlr-16470	715	22	at	at	ADP
ihlr-16470	715	23	which	which	PRON
ihlr-16470	715	24	the	the	DET
ihlr-16470	715	25	primary	primary	ADJ
ihlr-16470	715	26	and	and	CCONJ
ihlr-16470	715	27	secondary	secondary	ADJ
ihlr-16470	715	28	outcomes	outcome	NOUN
ihlr-16470	715	29	will	will	AUX
ihlr-16470	715	30	be	be	AUX
ihlr-16470	715	31	assessed	assess	VERB
ihlr-16470	715	32	,	,	PUNCT
ihlr-16470	715	33	and	and	CCONJ
ihlr-16470	715	34	the	the	DET
ihlr-16470	715	35	dates	date	NOUN
ihlr-16470	715	36	and	and	CCONJ
ihlr-16470	715	37	details	detail	NOUN
ihlr-16470	715	38	of	of	ADP
ihlr-16470	715	39	any	any	DET
ihlr-16470	715	40	revisions	revision	NOUN
ihlr-16470	715	41	to	to	ADP
ihlr-16470	715	42	such	such	ADJ
ihlr-16470	715	43	outcomes	outcome	NOUN
ihlr-16470	715	44	.	.	PUNCT
ihlr-16470	716	1	(	(	PUNCT
ihlr-16470	716	2	viii	viii	NOUN
ihlr-16470	716	3	)	)	PUNCT
ihlr-16470	716	4	the	the	DET
ihlr-16470	716	5	actual	actual	ADJ
ihlr-16470	716	6	completion	completion	NOUN
ihlr-16470	716	7	date	date	NOUN
ihlr-16470	716	8	of	of	ADP
ihlr-16470	716	9	the	the	DET
ihlr-16470	716	10	trial	trial	NOUN
ihlr-16470	716	11	and	and	CCONJ
ihlr-16470	716	12	the	the	DET
ihlr-16470	716	13	reasons	reason	NOUN
ihlr-16470	716	14	for	for	ADP
ihlr-16470	716	15	any	any	DET
ihlr-16470	716	16	difference	difference	NOUN
ihlr-16470	716	17	from	from	ADP
ihlr-16470	716	18	such	such	ADJ
ihlr-16470	716	19	actual	actual	ADJ
ihlr-16470	716	20	date	date	NOUN
ihlr-16470	716	21	and	and	CCONJ
ihlr-16470	716	22	the	the	DET
ihlr-16470	716	23	estimated	estimate	VERB
ihlr-16470	716	24	completion	completion	NOUN
ihlr-16470	716	25	date	date	NOUN
ihlr-16470	716	26	submitted	submit	VERB
ihlr-16470	716	27	pursuant	pursuant	ADV
ihlr-16470	716	28	to	to	ADP
ihlr-16470	716	29	clause	clause	NOUN
ihlr-16470	716	30	(	(	PUNCT
ihlr-16470	716	31	vi	vi	NOUN
ihlr-16470	716	32	)	)	PUNCT
ihlr-16470	716	33	.	.	PUNCT
ihlr-16470	717	1	if	if	SCONJ
ihlr-16470	717	2	the	the	DET
ihlr-16470	717	3	trial	trial	NOUN
ihlr-16470	717	4	is	be	AUX
ihlr-16470	717	5	not	not	PART
ihlr-16470	717	6	completed	complete	VERB
ihlr-16470	717	7	,	,	PUNCT
ihlr-16470	717	8	the	the	DET
ihlr-16470	717	9	termination	termination	NOUN
ihlr-16470	717	10	date	date	NOUN
ihlr-16470	717	11	and	and	CCONJ
ihlr-16470	717	12	reasons	reason	NOUN
ihlr-16470	717	13	for	for	ADP
ihlr-16470	717	14	such	such	ADJ
ihlr-16470	717	15	termination	termination	NOUN
ihlr-16470	717	16	.	.	PUNCT
ihlr-16470	718	1	(	(	PUNCT
ihlr-16470	718	2	ix	ix	ADP
ihlr-16470	718	3	)	)	PUNCT
ihlr-16470	718	4	a	a	DET
ihlr-16470	718	5	summary	summary	NOUN
ihlr-16470	718	6	of	of	ADP
ihlr-16470	718	7	the	the	DET
ihlr-16470	718	8	results	result	NOUN
ihlr-16470	718	9	of	of	ADP
ihlr-16470	718	10	the	the	DET
ihlr-16470	718	11	trial	trial	NOUN
ihlr-16470	718	12	,	,	PUNCT
ihlr-16470	718	13	including	include	VERB
ihlr-16470	718	14	summary	summary	NOUN
ihlr-16470	718	15	data	datum	NOUN
ihlr-16470	718	16	tables	table	NOUN
ihlr-16470	718	17	,	,	PUNCT
ihlr-16470	718	18	with	with	ADP
ihlr-16470	718	19	respect	respect	NOUN
ihlr-16470	718	20	to	to	ADP
ihlr-16470	718	21	its	its	PRON
ihlr-16470	718	22	primary	primary	ADJ
ihlr-16470	718	23	and	and	CCONJ
ihlr-16470	718	24	secondary	secondary	ADJ
ihlr-16470	718	25	outcomes	outcome	NOUN
ihlr-16470	718	26	as	as	SCONJ
ihlr-16470	718	27	described	describe	VERB
ihlr-16470	718	28	in	in	ADP
ihlr-16470	718	29	clause	clause	NOUN
ihlr-16470	718	30	(	(	PUNCT
ihlr-16470	718	31	vii	vii	PROPN
ihlr-16470	718	32	)	)	PUNCT
ihlr-16470	718	33	,	,	PUNCT
ihlr-16470	718	34	including	include	VERB
ihlr-16470	718	35	information	information	NOUN
ihlr-16470	718	36	on	on	ADP
ihlr-16470	718	37	the	the	DET
ihlr-16470	718	38	statistical	statistical	ADJ
ihlr-16470	718	39	significance	significance	NOUN
ihlr-16470	718	40	or	or	CCONJ
ihlr-16470	718	41	lack	lack	NOUN
ihlr-16470	718	42	thereof	thereof	ADV
ihlr-16470	718	43	of	of	ADP
ihlr-16470	718	44	such	such	ADJ
ihlr-16470	718	45	results	result	NOUN
ihlr-16470	718	46	.	.	PUNCT
ihlr-16470	719	1	(	(	PUNCT
ihlr-16470	719	2	x	x	X
ihlr-16470	719	3	)	)	PUNCT
ihlr-16470	719	4	safety	safety	NOUN
ihlr-16470	719	5	data	datum	NOUN
ihlr-16470	719	6	concerning	concern	VERB
ihlr-16470	719	7	the	the	DET
ihlr-16470	719	8	trial	trial	NOUN
ihlr-16470	719	9	(	(	PUNCT
ihlr-16470	719	10	including	include	VERB
ihlr-16470	719	11	a	a	DET
ihlr-16470	719	12	sutnmary	sutnmary	NOUN
ihlr-16470	719	13	of	of	ADP
ihlr-16470	719	14	adverse	adverse	ADJ
ihlr-16470	719	15	events	event	NOUN
ihlr-16470	719	16	specifying	specify	VERB
ihlr-16470	719	17	the	the	DET
ihlr-16470	719	18	number	number	NOUN
ihlr-16470	719	19	and	and	CCONJ
ihlr-16470	719	20	type	type	NOUN
ihlr-16470	719	21	of	of	ADP
ihlr-16470	719	22	such	such	ADJ
ihlr-16470	719	23	events	event	NOUN
ihlr-16470	719	24	)	)	PUNCT
ihlr-16470	719	25	.	.	PUNCT
ihlr-16470	719	26	.	.	PUNCT
ihlr-16470	720	1	s.	s.	PROPN
ihlr-16470	720	2	2933	2933	NUM
ihlr-16470	720	3	.	.	PUNCT
ihlr-16470	720	4	191	191	NUM
ihlr-16470	720	5	.	.	PUNCT
ihlr-16470	721	1	s.	s.	PROPN
ihlr-16470	721	2	2933	2933	NUM
ihlr-16470	721	3	(	(	PUNCT
ihlr-16470	721	4	imposing	impose	VERB
ihlr-16470	721	5	fines	fine	NOUN
ihlr-16470	721	6	of	of	ADP
ihlr-16470	721	7	up	up	ADP
ihlr-16470	721	8	to	to	PART
ihlr-16470	721	9	$	$	SYM
ihlr-16470	721	10	10,000	10,000	NUM
ihlr-16470	721	11	per	per	ADP
ihlr-16470	721	12	day	day	NOUN
ihlr-16470	721	13	for	for	ADP
ihlr-16470	721	14	every	every	DET
ihlr-16470	721	15	day	day	NOUN
ihlr-16470	721	16	of	of	ADP
ihlr-16470	721	17	non	non	NOUN
ihlr-16470	721	18	-	-	NOUN
ihlr-16470	721	19	compliance	compliance	NOUN
ihlr-16470	721	20	after	after	ADP
ihlr-16470	721	21	a	a	DET
ihlr-16470	721	22	thirty	thirty	NUM
ihlr-16470	721	23	day	day	NOUN
ihlr-16470	721	24	notice	notice	NOUN
ihlr-16470	721	25	period	period	NOUN
ihlr-16470	721	26	)	)	PUNCT
ihlr-16470	721	27	;	;	PUNCT
ihlr-16470	721	28	h.r	h.r	PROPN
ihlr-16470	721	29	.	.	PROPN
ihlr-16470	721	30	5252	5252	NUM
ihlr-16470	721	31	(	(	PUNCT
ihlr-16470	721	32	gxaxiiximposing	gxaxiiximpose	VERB
ihlr-16470	721	33	the	the	DET
ihlr-16470	721	34	same	same	ADJ
ihlr-16470	721	35	$	$	SYM
ihlr-16470	721	36	10,000	10,000	NUM
ihlr-16470	721	37	a	a	DET
ihlr-16470	721	38	day	day	NOUN
ihlr-16470	721	39	fine	fine	ADJ
ihlr-16470	721	40	,	,	PUNCT
ihlr-16470	721	41	but	but	CCONJ
ihlr-16470	721	42	with	with	ADP
ihlr-16470	721	43	$	$	SYM
ihlr-16470	721	44	15,000	15,000	NUM
ihlr-16470	721	45	cap	cap	NOUN
ihlr-16470	721	46	for	for	ADP
ihlr-16470	721	47	non	non	ADJ
ihlr-16470	721	48	-	-	ADJ
ihlr-16470	721	49	profit	profit	ADJ
ihlr-16470	721	50	organizations	organization	NOUN
ihlr-16470	721	51	)	)	PUNCT
ihlr-16470	721	52	.	.	PUNCT
ihlr-16470	722	1	2006	2006	NUM
ihlr-16470	722	2	]	]	PUNCT
ihlr-16470	722	3	anti	anti	NOUN
ihlr-16470	722	4	-	-	NOUN
ihlr-16470	722	5	depressants	depressant	NOUN
ihlr-16470	722	6	and	and	CCONJ
ihlr-16470	722	7	children	child	NOUN
ihlr-16470	722	8	229	229	NUM
ihlr-16470	722	9	conclusion	conclusion	NOUN
ihlr-16470	722	10	the	the	DET
ihlr-16470	722	11	current	current	ADJ
ihlr-16470	722	12	debate	debate	NOUN
ihlr-16470	722	13	surrounding	surround	VERB
ihlr-16470	722	14	ssrl	ssrl	PROPN
ihlr-16470	722	15	use	use	NOUN
ihlr-16470	722	16	in	in	ADP
ihlr-16470	722	17	children	child	NOUN
ihlr-16470	722	18	is	be	AUX
ihlr-16470	722	19	vital	vital	ADJ
ihlr-16470	722	20	in	in	ADP
ihlr-16470	722	21	many	many	ADJ
ihlr-16470	722	22	respects	respect	NOUN
ihlr-16470	722	23	.	.	PUNCT
ihlr-16470	723	1	ssris	ssris	PROPN
ihlr-16470	723	2	play	play	VERB
ihlr-16470	723	3	an	an	DET
ihlr-16470	723	4	important	important	ADJ
ihlr-16470	723	5	role	role	NOUN
ihlr-16470	723	6	in	in	ADP
ihlr-16470	723	7	pediatric	pediatric	ADJ
ihlr-16470	723	8	care	care	NOUN
ihlr-16470	723	9	despite	despite	SCONJ
ihlr-16470	723	10	the	the	DET
ihlr-16470	723	11	fda	fda	PROPN
ihlr-16470	723	12	's	's	PART
ihlr-16470	723	13	determination	determination	NOUN
ihlr-16470	723	14	that	that	SCONJ
ihlr-16470	723	15	ssri	ssri	PROPN
ihlr-16470	723	16	use	use	NOUN
ihlr-16470	723	17	in	in	ADP
ihlr-16470	723	18	children	child	NOUN
ihlr-16470	723	19	may	may	AUX
ihlr-16470	723	20	increase	increase	VERB
ihlr-16470	723	21	the	the	DET
ihlr-16470	723	22	risk	risk	NOUN
ihlr-16470	723	23	of	of	ADP
ihlr-16470	723	24	suicide	suicide	NOUN
ihlr-16470	723	25	.	.	PUNCT
ihlr-16470	724	1	ongoing	ongoing	ADJ
ihlr-16470	724	2	study	study	NOUN
ihlr-16470	724	3	of	of	ADP
ihlr-16470	724	4	ssris	ssris	NOUN
ihlr-16470	724	5	in	in	ADP
ihlr-16470	724	6	pediatric	pediatric	ADJ
ihlr-16470	724	7	subjects	subject	NOUN
ihlr-16470	724	8	will	will	AUX
ihlr-16470	724	9	greatly	greatly	ADV
ihlr-16470	724	10	reduce	reduce	VERB
ihlr-16470	724	11	the	the	DET
ihlr-16470	724	12	risks	risk	NOUN
ihlr-16470	724	13	associated	associate	VERB
ihlr-16470	724	14	with	with	ADP
ihlr-16470	724	15	pediatric	pediatric	ADJ
ihlr-16470	724	16	ssri	ssri	NOUN
ihlr-16470	724	17	use	use	NOUN
ihlr-16470	724	18	and	and	CCONJ
ihlr-16470	724	19	may	may	AUX
ihlr-16470	724	20	lead	lead	VERB
ihlr-16470	724	21	to	to	ADP
ihlr-16470	724	22	the	the	DET
ihlr-16470	724	23	discovery	discovery	NOUN
ihlr-16470	724	24	of	of	ADP
ihlr-16470	724	25	doses	dose	NOUN
ihlr-16470	724	26	that	that	PRON
ihlr-16470	724	27	are	be	AUX
ihlr-16470	724	28	effective	effective	ADJ
ihlr-16470	724	29	and	and	CCONJ
ihlr-16470	724	30	safe	safe	ADJ
ihlr-16470	724	31	for	for	ADP
ihlr-16470	724	32	use	use	NOUN
ihlr-16470	724	33	in	in	ADP
ihlr-16470	724	34	children	child	NOUN
ihlr-16470	724	35	.	.	PUNCT
ihlr-16470	725	1	at	at	ADP
ihlr-16470	725	2	this	this	DET
ihlr-16470	725	3	time	time	NOUN
ihlr-16470	725	4	manufacturers	manufacturer	NOUN
ihlr-16470	725	5	are	be	AUX
ihlr-16470	725	6	not	not	PART
ihlr-16470	725	7	liable	liable	ADJ
ihlr-16470	725	8	for	for	ADP
ihlr-16470	725	9	adverse	adverse	ADJ
ihlr-16470	725	10	reactions	reaction	NOUN
ihlr-16470	725	11	to	to	PART
ihlr-16470	725	12	ssris	ssris	VERB
ihlr-16470	725	13	as	as	ADV
ihlr-16470	725	14	long	long	ADV
ihlr-16470	725	15	as	as	SCONJ
ihlr-16470	725	16	they	they	PRON
ihlr-16470	725	17	do	do	AUX
ihlr-16470	725	18	not	not	PART
ihlr-16470	725	19	promote	promote	VERB
ihlr-16470	725	20	off	off	ADP
ihlr-16470	725	21	-	-	PUNCT
ihlr-16470	725	22	label	label	NOUN
ihlr-16470	725	23	uses	use	NOUN
ihlr-16470	725	24	of	of	ADP
ihlr-16470	725	25	these	these	DET
ihlr-16470	725	26	drugs	drug	NOUN
ihlr-16470	725	27	and	and	CCONJ
ihlr-16470	725	28	provide	provide	VERB
ihlr-16470	725	29	the	the	DET
ihlr-16470	725	30	physician	physician	NOUN
ihlr-16470	725	31	with	with	ADP
ihlr-16470	725	32	adequate	adequate	ADJ
ihlr-16470	725	33	warning	warning	NOUN
ihlr-16470	725	34	.	.	PUNCT
ihlr-16470	726	1	instead	instead	ADV
ihlr-16470	726	2	,	,	PUNCT
ihlr-16470	726	3	the	the	DET
ihlr-16470	726	4	liability	liability	NOUN
ihlr-16470	726	5	is	be	AUX
ihlr-16470	726	6	appropriately	appropriately	ADV
ihlr-16470	726	7	placed	place	VERB
ihlr-16470	726	8	upon	upon	SCONJ
ihlr-16470	726	9	the	the	DET
ihlr-16470	726	10	physician	physician	NOUN
ihlr-16470	726	11	to	to	PART
ihlr-16470	726	12	seriously	seriously	ADV
ihlr-16470	726	13	weigh	weigh	VERB
ihlr-16470	726	14	the	the	DET
ihlr-16470	726	15	risks	risk	NOUN
ihlr-16470	726	16	and	and	CCONJ
ihlr-16470	726	17	benefits	benefit	NOUN
ihlr-16470	726	18	of	of	ADP
ihlr-16470	726	19	the	the	DET
ihlr-16470	726	20	drug	drug	NOUN
ihlr-16470	726	21	and	and	CCONJ
ihlr-16470	726	22	share	share	VERB
ihlr-16470	726	23	those	those	DET
ihlr-16470	726	24	determinations	determination	NOUN
ihlr-16470	726	25	with	with	ADP
ihlr-16470	726	26	the	the	DET
ihlr-16470	726	27	patient	patient	NOUN
ihlr-16470	726	28	's	's	PART
ihlr-16470	726	29	parent	parent	NOUN
ihlr-16470	726	30	(	(	PUNCT
ihlr-16470	726	31	s	s	NOUN
ihlr-16470	726	32	)	)	PUNCT
ihlr-16470	726	33	or	or	CCONJ
ihlr-16470	726	34	guardian	guardian	NOUN
ihlr-16470	726	35	(	(	PUNCT
ihlr-16470	726	36	s	s	NOUN
ihlr-16470	726	37	)	)	PUNCT
ihlr-16470	726	38	.	.	PUNCT
ihlr-16470	727	1	if	if	SCONJ
ihlr-16470	727	2	,	,	PUNCT
ihlr-16470	727	3	however	however	ADV
ihlr-16470	727	4	,	,	PUNCT
ihlr-16470	727	5	a	a	DET
ihlr-16470	727	6	drug	drug	NOUN
ihlr-16470	727	7	company	company	NOUN
ihlr-16470	727	8	purposely	purposely	ADV
ihlr-16470	727	9	prevented	prevent	VERB
ihlr-16470	727	10	the	the	DET
ihlr-16470	727	11	dissemination	dissemination	NOUN
ihlr-16470	727	12	of	of	ADP
ihlr-16470	727	13	data	datum	NOUN
ihlr-16470	727	14	pertinent	pertinent	ADJ
ihlr-16470	727	15	to	to	ADP
ihlr-16470	727	16	a	a	DET
ihlr-16470	727	17	physician	physician	NOUN
ihlr-16470	727	18	's	's	PART
ihlr-16470	727	19	risk	risk	NOUN
ihlr-16470	727	20	-	-	PUNCT
ihlr-16470	727	21	weighing	weigh	VERB
ihlr-16470	727	22	analysis	analysis	NOUN
ihlr-16470	727	23	,	,	PUNCT
ihlr-16470	727	24	then	then	ADV
ihlr-16470	727	25	the	the	DET
ihlr-16470	727	26	insulation	insulation	NOUN
ihlr-16470	727	27	of	of	ADP
ihlr-16470	727	28	the	the	DET
ihlr-16470	727	29	physician	physician	NOUN
ihlr-16470	727	30	should	should	AUX
ihlr-16470	727	31	be	be	AUX
ihlr-16470	727	32	terminated	terminate	VERB
ihlr-16470	727	33	to	to	PART
ihlr-16470	727	34	allow	allow	VERB
ihlr-16470	727	35	recovery	recovery	NOUN
ihlr-16470	727	36	from	from	ADP
ihlr-16470	727	37	the	the	DET
ihlr-16470	727	38	drug	drug	NOUN
ihlr-16470	727	39	company	company	NOUN
ihlr-16470	727	40	itself	itself	PRON
ihlr-16470	727	41	.	.	PUNCT
ihlr-16470	728	1	perhaps	perhaps	ADV
ihlr-16470	728	2	the	the	DET
ihlr-16470	728	3	most	most	ADV
ihlr-16470	728	4	important	important	ADJ
ihlr-16470	728	5	aspect	aspect	NOUN
ihlr-16470	728	6	of	of	ADP
ihlr-16470	728	7	the	the	DET
ihlr-16470	728	8	ssri	ssri	PROPN
ihlr-16470	728	9	controversy	controversy	NOUN
ihlr-16470	728	10	is	be	AUX
ihlr-16470	728	11	how	how	SCONJ
ihlr-16470	728	12	it	it	PRON
ihlr-16470	728	13	illustrates	illustrate	VERB
ihlr-16470	728	14	the	the	DET
ihlr-16470	728	15	strengths	strength	NOUN
ihlr-16470	728	16	and	and	CCONJ
ihlr-16470	728	17	weaknesses	weakness	NOUN
ihlr-16470	728	18	of	of	ADP
ihlr-16470	728	19	the	the	DET
ihlr-16470	728	20	current	current	ADJ
ihlr-16470	728	21	regulatory	regulatory	ADJ
ihlr-16470	728	22	scheme	scheme	NOUN
ihlr-16470	728	23	.	.	PUNCT
ihlr-16470	729	1	the	the	DET
ihlr-16470	729	2	fda	fda	PROPN
ihlr-16470	729	3	's	's	PART
ihlr-16470	729	4	attempts	attempt	NOUN
ihlr-16470	729	5	to	to	PART
ihlr-16470	729	6	protect	protect	VERB
ihlr-16470	729	7	the	the	DET
ihlr-16470	729	8	consumer	consumer	NOUN
ihlr-16470	729	9	are	be	AUX
ihlr-16470	729	10	often	often	ADV
ihlr-16470	729	11	futile	futile	ADJ
ihlr-16470	729	12	due	due	ADP
ihlr-16470	729	13	to	to	ADP
ihlr-16470	729	14	holes	hole	NOUN
ihlr-16470	729	15	in	in	ADP
ihlr-16470	729	16	the	the	DET
ihlr-16470	729	17	system	system	NOUN
ihlr-16470	729	18	;	;	PUNCT
ihlr-16470	729	19	yet	yet	CCONJ
ihlr-16470	729	20	the	the	DET
ihlr-16470	729	21	holes	hole	NOUN
ihlr-16470	729	22	,	,	PUNCT
ihlr-16470	729	23	such	such	ADJ
ihlr-16470	729	24	as	as	ADP
ihlr-16470	729	25	off	off	ADP
ihlr-16470	729	26	-	-	PUNCT
ihlr-16470	729	27	label	label	NOUN
ihlr-16470	729	28	prescribing	prescribing	NOUN
ihlr-16470	729	29	,	,	PUNCT
ihlr-16470	729	30	can	can	AUX
ihlr-16470	729	31	play	play	VERB
ihlr-16470	729	32	a	a	DET
ihlr-16470	729	33	vital	vital	ADJ
ihlr-16470	729	34	role	role	NOUN
ihlr-16470	729	35	in	in	ADP
ihlr-16470	729	36	health	health	NOUN
ihlr-16470	729	37	care	care	NOUN
ihlr-16470	729	38	and	and	CCONJ
ihlr-16470	729	39	the	the	DET
ihlr-16470	729	40	advancement	advancement	NOUN
ihlr-16470	729	41	of	of	ADP
ihlr-16470	729	42	medical	medical	ADJ
ihlr-16470	729	43	treatment	treatment	NOUN
ihlr-16470	729	44	.	.	PUNCT
ihlr-16470	730	1	such	such	DET
ihlr-16470	730	2	a	a	DET
ihlr-16470	730	3	paradox	paradox	NOUN
ihlr-16470	730	4	may	may	AUX
ihlr-16470	730	5	never	never	ADV
ihlr-16470	730	6	achieve	achieve	VERB
ihlr-16470	730	7	a	a	DET
ihlr-16470	730	8	complete	complete	ADJ
ihlr-16470	730	9	resolution	resolution	NOUN
ihlr-16470	730	10	,	,	PUNCT
ihlr-16470	730	11	yet	yet	CCONJ
ihlr-16470	730	12	more	more	ADJ
ihlr-16470	730	13	can	can	AUX
ihlr-16470	730	14	be	be	AUX
ihlr-16470	730	15	done	do	VERB
ihlr-16470	730	16	to	to	PART
ihlr-16470	730	17	fill	fill	VERB
ihlr-16470	730	18	these	these	DET
ihlr-16470	730	19	holes	hole	NOUN
ihlr-16470	730	20	,	,	PUNCT
ihlr-16470	730	21	whether	whether	SCONJ
ihlr-16470	730	22	through	through	ADP
ihlr-16470	730	23	trial	trial	NOUN
ihlr-16470	730	24	registry	registry	NOUN
ihlr-16470	730	25	or	or	CCONJ
ihlr-16470	730	26	some	some	DET
ihlr-16470	730	27	other	other	ADJ
ihlr-16470	730	28	form	form	NOUN
ihlr-16470	730	29	of	of	ADP
ihlr-16470	730	30	regulation	regulation	NOUN
ihlr-16470	730	31	not	not	PART
ihlr-16470	730	32	yet	yet	ADV
ihlr-16470	730	33	contemplated	contemplate	VERB
ihlr-16470	730	34	.	.	PUNCT
ihlr-16470	731	1	children	child	NOUN
ihlr-16470	731	2	deserve	deserve	VERB
ihlr-16470	731	3	the	the	DET
ihlr-16470	731	4	same	same	ADJ
ihlr-16470	731	5	access	access	NOUN
ihlr-16470	731	6	to	to	ADP
ihlr-16470	731	7	essential	essential	ADJ
ihlr-16470	731	8	medications	medication	NOUN
ihlr-16470	731	9	as	as	ADP
ihlr-16470	731	10	adults	adult	NOUN
ihlr-16470	731	11	.	.	PUNCT
ihlr-16470	732	1	it	it	PRON
ihlr-16470	732	2	is	be	AUX
ihlr-16470	732	3	unfortunate	unfortunate	ADJ
ihlr-16470	732	4	that	that	SCONJ
ihlr-16470	732	5	the	the	DET
ihlr-16470	732	6	recent	recent	ADJ
ihlr-16470	732	7	fda	fda	PROPN
ihlr-16470	732	8	recognition	recognition	NOUN
ihlr-16470	732	9	of	of	ADP
ihlr-16470	732	10	a	a	DET
ihlr-16470	732	11	link	link	NOUN
ihlr-16470	732	12	between	between	ADP
ihlr-16470	732	13	ssris	ssris	PROPN
ihlr-16470	732	14	and	and	CCONJ
ihlr-16470	732	15	suicide	suicide	NOUN
ihlr-16470	732	16	may	may	AUX
ihlr-16470	732	17	scare	scare	VERB
ihlr-16470	732	18	away	away	ADV
ihlr-16470	732	19	many	many	ADJ
ihlr-16470	732	20	patients	patient	NOUN
ihlr-16470	732	21	who	who	PRON
ihlr-16470	732	22	could	could	AUX
ihlr-16470	732	23	benefit	benefit	VERB
ihlr-16470	732	24	from	from	ADP
ihlr-16470	732	25	ssri	ssri	PROPN
ihlr-16470	732	26	treatment	treatment	NOUN
ihlr-16470	732	27	.	.	PUNCT
ihlr-16470	733	1	adults	adult	NOUN
ihlr-16470	733	2	have	have	AUX
ihlr-16470	733	3	used	use	VERB
ihlr-16470	733	4	ssris	ssris	NOUN
ihlr-16470	733	5	for	for	ADP
ihlr-16470	733	6	many	many	ADJ
ihlr-16470	733	7	years	year	NOUN
ihlr-16470	733	8	and	and	CCONJ
ihlr-16470	733	9	have	have	AUX
ihlr-16470	733	10	experienced	experience	VERB
ihlr-16470	733	11	great	great	ADJ
ihlr-16470	733	12	improvement	improvement	NOUN
ihlr-16470	733	13	in	in	ADP
ihlr-16470	733	14	their	their	PRON
ihlr-16470	733	15	quality	quality	NOUN
ihlr-16470	733	16	of	of	ADP
ihlr-16470	733	17	life	life	NOUN
ihlr-16470	733	18	.	.	PUNCT
ihlr-16470	734	1	there	there	PRON
ihlr-16470	734	2	has	have	AUX
ihlr-16470	734	3	been	be	AUX
ihlr-16470	734	4	more	more	ADJ
ihlr-16470	734	5	than	than	ADP
ihlr-16470	734	6	a	a	PRON
ihlr-16470	734	7	decade	decade	NOUN
ihlr-16470	734	8	of	of	ADP
ihlr-16470	734	9	studies	study	NOUN
ihlr-16470	734	10	conducted	conduct	VERB
ihlr-16470	734	11	on	on	ADP
ihlr-16470	734	12	ssris	ssris	NOUN
ihlr-16470	734	13	that	that	PRON
ihlr-16470	734	14	show	show	VERB
ihlr-16470	734	15	that	that	SCONJ
ihlr-16470	734	16	these	these	DET
ihlr-16470	734	17	drugs	drug	NOUN
ihlr-16470	734	18	do	do	AUX
ihlr-16470	734	19	not	not	PART
ihlr-16470	734	20	lead	lead	VERB
ihlr-16470	734	21	to	to	PART
ihlr-16470	734	22	suicide	suicide	VERB
ihlr-16470	734	23	in	in	ADP
ihlr-16470	734	24	adults	adult	NOUN
ihlr-16470	734	25	,	,	PUNCT
ihlr-16470	734	26	and	and	CCONJ
ihlr-16470	734	27	only	only	ADV
ihlr-16470	734	28	one	one	NUM
ihlr-16470	734	29	secondary	secondary	ADJ
ihlr-16470	734	30	study	study	NOUN
ihlr-16470	734	31	showing	show	VERB
ihlr-16470	734	32	a	a	DET
ihlr-16470	734	33	link	link	NOUN
ihlr-16470	734	34	between	between	ADP
ihlr-16470	734	35	ssris	ssris	NOUN
ihlr-16470	734	36	and	and	CCONJ
ihlr-16470	734	37	suicide	suicide	NOUN
ihlr-16470	734	38	in	in	ADP
ihlr-16470	734	39	children	child	NOUN
ihlr-16470	734	40	.	.	PUNCT
ihlr-16470	735	1	this	this	DET
ihlr-16470	735	2	difference	difference	NOUN
ihlr-16470	735	3	can	can	AUX
ihlr-16470	735	4	be	be	AUX
ihlr-16470	735	5	attributed	attribute	VERB
ihlr-16470	735	6	to	to	ADP
ihlr-16470	735	7	the	the	DET
ihlr-16470	735	8	unique	unique	ADJ
ihlr-16470	735	9	physiological	physiological	ADJ
ihlr-16470	735	10	and	and	CCONJ
ihlr-16470	735	11	metabolic	metabolic	NOUN
ihlr-16470	735	12	processes	process	NOUN
ihlr-16470	735	13	in	in	ADP
ihlr-16470	735	14	children	child	NOUN
ihlr-16470	735	15	and	and	CCONJ
ihlr-16470	735	16	adolescents	adolescent	NOUN
ihlr-16470	735	17	,	,	PUNCT
ihlr-16470	735	18	and	and	CCONJ
ihlr-16470	735	19	more	more	ADV
ihlr-16470	735	20	rigorous	rigorous	ADJ
ihlr-16470	735	21	pediatric	pediatric	ADJ
ihlr-16470	735	22	testing	testing	NOUN
ihlr-16470	735	23	requirements	requirement	NOUN
ihlr-16470	735	24	may	may	AUX
ihlr-16470	735	25	help	help	VERB
ihlr-16470	735	26	determine	determine	VERB
ihlr-16470	735	27	the	the	DET
ihlr-16470	735	28	difference	difference	NOUN
ihlr-16470	735	29	at	at	ADP
ihlr-16470	735	30	an	an	DET
ihlr-16470	735	31	earlier	early	ADJ
ihlr-16470	735	32	point	point	NOUN
ihlr-16470	735	33	.	.	PUNCT
ihlr-16470	736	1	through	through	ADP
ihlr-16470	736	2	testing	testing	NOUN
ihlr-16470	736	3	,	,	PUNCT
ihlr-16470	736	4	an	an	DET
ihlr-16470	736	5	appropriate	appropriate	ADJ
ihlr-16470	736	6	dosage	dosage	NOUN
ihlr-16470	736	7	level	level	NOUN
ihlr-16470	736	8	and	and	CCONJ
ihlr-16470	736	9	treatment	treatment	NOUN
ihlr-16470	736	10	course	course	NOUN
ihlr-16470	736	11	could	could	AUX
ihlr-16470	736	12	have	have	AUX
ihlr-16470	736	13	been	be	AUX
ihlr-16470	736	14	determined	determine	VERB
ihlr-16470	736	15	,	,	PUNCT
ihlr-16470	736	16	which	which	PRON
ihlr-16470	736	17	may	may	AUX
ihlr-16470	736	18	eliminate	eliminate	VERB
ihlr-16470	736	19	the	the	DET
ihlr-16470	736	20	risk	risk	NOUN
ihlr-16470	736	21	of	of	ADP
ihlr-16470	736	22	suicidality	suicidality	NOUN
ihlr-16470	736	23	.	.	PUNCT
ihlr-16470	737	1	instead	instead	ADV
ihlr-16470	737	2	doctors	doctor	NOUN
ihlr-16470	737	3	were	be	AUX
ihlr-16470	737	4	forced	force	VERB
ihlr-16470	737	5	to	to	PART
ihlr-16470	737	6	"	"	PUNCT
ihlr-16470	737	7	guess	guess	VERB
ihlr-16470	737	8	"	"	PUNCT
ihlr-16470	737	9	in	in	ADP
ihlr-16470	737	10	their	their	PRON
ihlr-16470	737	11	treatment	treatment	NOUN
ihlr-16470	737	12	of	of	ADP
ihlr-16470	737	13	childhood	childhood	NOUN
ihlr-16470	737	14	depression	depression	NOUN
ihlr-16470	737	15	.	.	PUNCT
ihlr-16470	738	1	the	the	DET
ihlr-16470	738	2	majority	majority	NOUN
ihlr-16470	738	3	of	of	ADP
ihlr-16470	738	4	the	the	DET
ihlr-16470	738	5	steps	step	NOUN
ihlr-16470	738	6	taken	take	VERB
ihlr-16470	738	7	by	by	ADP
ihlr-16470	738	8	the	the	DET
ihlr-16470	738	9	fda	fda	PROPN
ihlr-16470	738	10	are	be	AUX
ihlr-16470	738	11	necessary	necessary	ADJ
ihlr-16470	738	12	to	to	PART
ihlr-16470	738	13	ensure	ensure	VERB
ihlr-16470	738	14	that	that	SCONJ
ihlr-16470	738	15	children	child	NOUN
ihlr-16470	738	16	and	and	CCONJ
ihlr-16470	738	17	parents	parent	NOUN
ihlr-16470	738	18	are	be	AUX
ihlr-16470	738	19	aware	aware	ADJ
ihlr-16470	738	20	of	of	ADP
ihlr-16470	738	21	the	the	DET
ihlr-16470	738	22	risks	risk	NOUN
ihlr-16470	738	23	before	before	SCONJ
ihlr-16470	738	24	they	they	PRON
ihlr-16470	738	25	begin	begin	VERB
ihlr-16470	738	26	ssri	ssri	PROPN
ihlr-16470	738	27	treatment	treatment	NOUN
ihlr-16470	738	28	,	,	PUNCT
ihlr-16470	738	29	yet	yet	CCONJ
ihlr-16470	738	30	some	some	PRON
ihlr-16470	738	31	of	of	ADP
ihlr-16470	738	32	the	the	DET
ihlr-16470	738	33	fda	fda	PROPN
ihlr-16470	738	34	's	's	PART
ihlr-16470	738	35	actions	action	NOUN
ihlr-16470	738	36	may	may	AUX
ihlr-16470	738	37	have	have	AUX
ihlr-16470	738	38	been	be	AUX
ihlr-16470	738	39	a	a	DET
ihlr-16470	738	40	little	little	ADJ
ihlr-16470	738	41	overzealous	overzealous	ADJ
ihlr-16470	738	42	.	.	PUNCT
ihlr-16470	739	1	the	the	DET
ihlr-16470	739	2	previous	previous	ADJ
ihlr-16470	739	3	warnings	warning	NOUN
ihlr-16470	739	4	on	on	ADP
ihlr-16470	739	5	ssri	ssri	ADJ
ihlr-16470	739	6	labels	label	NOUN
ihlr-16470	739	7	indicated	indicate	VERB
ihlr-16470	739	8	the	the	DET
ihlr-16470	739	9	inherent	inherent	ADJ
ihlr-16470	739	10	risks	risk	NOUN
ihlr-16470	739	11	of	of	ADP
ihlr-16470	739	12	suicide	suicide	NOUN
ihlr-16470	739	13	as	as	ADP
ihlr-16470	739	14	a	a	DET
ihlr-16470	739	15	part	part	NOUN
ihlr-16470	739	16	of	of	ADP
ihlr-16470	739	17	depression	depression	NOUN
ihlr-16470	739	18	and	and	CCONJ
ihlr-16470	739	19	urged	urge	VERB
ihlr-16470	739	20	close	close	ADJ
ihlr-16470	739	21	monitoring	monitoring	NOUN
ihlr-16470	739	22	ofssri	ofssri	ADJ
ihlr-16470	739	23	patients	patient	NOUN
ihlr-16470	739	24	.	.	PUNCT
ihlr-16470	740	1	by	by	ADP
ihlr-16470	740	2	adding	add	VERB
ihlr-16470	740	3	the	the	DET
ihlr-16470	740	4	230	230	NUM
ihlr-16470	740	5	indiana	indiana	PROPN
ihlr-16470	740	6	health	health	NOUN
ihlr-16470	740	7	law	law	NOUN
ihlr-16470	740	8	review	review	NOUN
ihlr-16470	740	9	[	[	X
ihlr-16470	740	10	vol	vol	NOUN
ihlr-16470	740	11	.	.	PUNCT
ihlr-16470	740	12	3:201	3:201	NUM
ihlr-16470	740	13	black	black	ADJ
ihlr-16470	740	14	box	box	PROPN
ihlr-16470	740	15	warning	warning	NOUN
ihlr-16470	740	16	,	,	PUNCT
ihlr-16470	740	17	patients	patient	NOUN
ihlr-16470	740	18	may	may	AUX
ihlr-16470	740	19	be	be	AUX
ihlr-16470	740	20	scared	scare	VERB
ihlr-16470	740	21	away	away	ADV
ihlr-16470	740	22	from	from	ADP
ihlr-16470	740	23	reaping	reap	VERB
ihlr-16470	740	24	the	the	DET
ihlr-16470	740	25	benefits	benefit	NOUN
ihlr-16470	740	26	of	of	ADP
ihlr-16470	740	27	these	these	DET
ihlr-16470	740	28	drugs	drug	NOUN
ihlr-16470	740	29	.	.	PUNCT
ihlr-16470	741	1	in	in	ADP
ihlr-16470	741	2	mandating	mandate	VERB
ihlr-16470	741	3	the	the	DET
ihlr-16470	741	4	black	black	PROPN
ihlr-16470	741	5	box	box	PROPN
ihlr-16470	741	6	warning	warning	NOUN
ihlr-16470	741	7	,	,	PUNCT
ihlr-16470	741	8	the	the	DET
ihlr-16470	741	9	fda	fda	PROPN
ihlr-16470	741	10	relied	rely	VERB
ihlr-16470	741	11	on	on	ADP
ihlr-16470	741	12	the	the	DET
ihlr-16470	741	13	columbia	columbia	PROPN
ihlr-16470	741	14	study	study	NOUN
ihlr-16470	741	15	which	which	PRON
ihlr-16470	741	16	undertook	undertake	VERB
ihlr-16470	741	17	the	the	DET
ihlr-16470	741	18	daunting	daunting	ADJ
ihlr-16470	741	19	task	task	NOUN
ihlr-16470	741	20	of	of	ADP
ihlr-16470	741	21	reanalyzing	reanalyze	VERB
ihlr-16470	741	22	data	datum	NOUN
ihlr-16470	741	23	from	from	ADP
ihlr-16470	741	24	twenty	twenty	NUM
ihlr-16470	741	25	-	-	PUNCT
ihlr-16470	741	26	five	five	NUM
ihlr-16470	741	27	studies	study	NOUN
ihlr-16470	741	28	on	on	ADP
ihlr-16470	741	29	pediatric	pediatric	ADJ
ihlr-16470	741	30	ssri	ssri	PROPN
ihlr-16470	741	31	use	use	NOUN
ihlr-16470	741	32	,	,	PUNCT
ihlr-16470	741	33	each	each	PRON
ihlr-16470	741	34	of	of	ADP
ihlr-16470	741	35	which	which	PRON
ihlr-16470	741	36	found	find	VERB
ihlr-16470	741	37	no	no	DET
ihlr-16470	741	38	link	link	NOUN
ihlr-16470	741	39	between	between	ADP
ihlr-16470	741	40	ssris	ssris	NOUN
ihlr-16470	741	41	and	and	CCONJ
ihlr-16470	741	42	suicide	suicide	NOUN
ihlr-16470	741	43	in	in	ADP
ihlr-16470	741	44	children	child	NOUN
ihlr-16470	741	45	.	.	PUNCT
ihlr-16470	742	1	the	the	DET
ihlr-16470	742	2	columbia	columbia	PROPN
ihlr-16470	742	3	study	study	NOUN
ihlr-16470	742	4	results	result	NOUN
ihlr-16470	742	5	may	may	AUX
ihlr-16470	742	6	be	be	AUX
ihlr-16470	742	7	due	due	ADJ
ihlr-16470	742	8	to	to	ADP
ihlr-16470	742	9	incomplete	incomplete	ADJ
ihlr-16470	742	10	data	datum	NOUN
ihlr-16470	742	11	and	and	CCONJ
ihlr-16470	742	12	discrepancies	discrepancy	NOUN
ihlr-16470	742	13	between	between	ADP
ihlr-16470	742	14	the	the	DET
ihlr-16470	742	15	methods	method	NOUN
ihlr-16470	742	16	used	use	VERB
ihlr-16470	742	17	in	in	ADP
ihlr-16470	742	18	the	the	DET
ihlr-16470	742	19	original	original	ADJ
ihlr-16470	742	20	studies	study	NOUN
ihlr-16470	742	21	(	(	PUNCT
ihlr-16470	742	22	such	such	ADJ
ihlr-16470	742	23	as	as	ADP
ihlr-16470	742	24	disparities	disparity	NOUN
ihlr-16470	742	25	in	in	ADP
ihlr-16470	742	26	dosage	dosage	NOUN
ihlr-16470	742	27	:	:	PUNCT
ihlr-16470	742	28	a	a	DET
ihlr-16470	742	29	study	study	NOUN
ihlr-16470	742	30	for	for	ADP
ihlr-16470	742	31	sertraline	sertraline	PROPN
ihlr-16470	742	32	used	use	VERB
ihlr-16470	742	33	adult	adult	NOUN
ihlr-16470	742	34	dosages	dosage	NOUN
ihlr-16470	742	35	while	while	SCONJ
ihlr-16470	742	36	other	other	ADJ
ihlr-16470	742	37	studies	study	NOUN
ihlr-16470	742	38	used	use	VERB
ihlr-16470	742	39	significantly	significantly	ADV
ihlr-16470	742	40	decreased	decrease	VERB
ihlr-16470	742	41	dosages	dosage	NOUN
ihlr-16470	742	42	}	}	PUNCT
ihlr-16470	742	43	.	.	PUNCT
ihlr-16470	743	1	in	in	ADP
ihlr-16470	743	2	relying	rely	VERB
ihlr-16470	743	3	on	on	ADP
ihlr-16470	743	4	the	the	DET
ihlr-16470	743	5	columbia	columbia	PROPN
ihlr-16470	743	6	study	study	NOUN
ihlr-16470	743	7	,	,	PUNCT
ihlr-16470	743	8	the	the	DET
ihlr-16470	743	9	fda	fda	PROPN
ihlr-16470	743	10	ignored	ignore	VERB
ihlr-16470	743	11	years	year	NOUN
ihlr-16470	743	12	of	of	ADP
ihlr-16470	743	13	research	research	NOUN
ihlr-16470	743	14	and	and	CCONJ
ihlr-16470	743	15	may	may	AUX
ihlr-16470	743	16	have	have	AUX
ihlr-16470	743	17	acted	act	VERB
ihlr-16470	743	18	too	too	ADV
ihlr-16470	743	19	quickly	quickly	ADV
ihlr-16470	743	20	.	.	PUNCT
ihlr-16470	744	1	several	several	ADJ
ihlr-16470	744	2	ssris	ssris	NOUN
ihlr-16470	744	3	have	have	AUX
ihlr-16470	744	4	already	already	ADV
ihlr-16470	744	5	been	be	AUX
ihlr-16470	744	6	approved	approve	VERB
ihlr-16470	744	7	for	for	ADP
ihlr-16470	744	8	use	use	NOUN
ihlr-16470	744	9	in	in	ADP
ihlr-16470	744	10	children	child	NOUN
ihlr-16470	744	11	with	with	ADP
ihlr-16470	744	12	a	a	DET
ihlr-16470	744	13	variety	variety	NOUN
ihlr-16470	744	14	of	of	ADP
ihlr-16470	744	15	illnesses	illness	NOUN
ihlr-16470	744	16	.	.	PUNCT
ihlr-16470	745	1	while	while	SCONJ
ihlr-16470	745	2	these	these	DET
ihlr-16470	745	3	drugs	drug	NOUN
ihlr-16470	745	4	have	have	AUX
ihlr-16470	745	5	proven	prove	VERB
ihlr-16470	745	6	safe	safe	ADJ
ihlr-16470	745	7	and	and	CCONJ
ihlr-16470	745	8	effective	effective	ADJ
ihlr-16470	745	9	for	for	ADP
ihlr-16470	745	10	their	their	PRON
ihlr-16470	745	11	approved	approve	VERB
ihlr-16470	745	12	uses	use	NOUN
ihlr-16470	745	13	,	,	PUNCT
ihlr-16470	745	14	the	the	DET
ihlr-16470	745	15	fda	fda	PROPN
ihlr-16470	745	16	's	's	PART
ihlr-16470	745	17	decision	decision	NOUN
ihlr-16470	745	18	may	may	AUX
ihlr-16470	745	19	cause	cause	VERB
ihlr-16470	745	20	some	some	DET
ihlr-16470	745	21	children	child	NOUN
ihlr-16470	745	22	to	to	PART
ihlr-16470	745	23	forego	forego	VERB
ihlr-16470	745	24	the	the	DET
ihlr-16470	745	25	beneficial	beneficial	ADJ
ihlr-16470	745	26	ssri	ssri	NOUN
ihlr-16470	745	27	treatment	treatment	NOUN
ihlr-16470	745	28	.	.	PUNCT